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Abstract
To the colonising bacterium, the human body represents a number of ecological niches,
some of which it could be argued are as hostile to the coloniser as even the most extreme
of ex vivo environments; by the activities of the immune system, these living host niches
are actively dedicated to the prevention of their colonisation. Paradoxically, the normal
human microbiota of each human extends in estimated total number to approximately
1014 per human. This thesis is a compilation of published work that focuses on two
anaerobic bacteria of the normal human microbiota: Bacteroides fragilis predominantly
found in the large intestine; and Propionibacterium acnes predominantly found in the
skin microbiota. When given the opportunity these bacteria can cross the divide between
commensal and pathogen and cause infection. The papers included in this thesis address
aspects of the characteristics of these bacteria that may relate to virulence and the
association of these bacteria with clinical infection.
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Overview
To the colonising bacterium, the human body represents a number of ecological niches,
some of which it could be argued are as hostile to the coloniser as even the most extreme
of ex vivo environments; by the activities of the immune system, these living host niches
are actively dedicated to the prevention of their colonisation. Paradoxically, the normal
human microbiota of each human extends in estimated total number to more than the
number of people that currently colonise the earth; approximately 1014 per human. This
thesis is focussed upon two quite different bacteria of the normal human microbiota,
Bacteroides fragilis from the large intestine and Propionibacterium acnes from the skin
that, when given the opportunity, can cross the divide between commensal and pathogen
and cause infection
My interest in this area started in 1981 when as a post-doctoral researcher, I took
up a position with Professor Bob Gillies, Chair of Clinical Bacteriology at Queen's
University Belfast (QUB). Despite the recognition of the importance of obligately
anaerobic bacteria in human infection in the late 1890s, it was not until the 1970s that the
recognition of the need for treatment of obligate anaerobes, and indeed for prophylactic
antibiotic cover to be inclusive of anaerobes for lower abdominal surgery, became
widespread amongst clinicians. Professor Gerry Collee of the University of Edinburgh,
from where Professor Gillies had moved to QUB, was one of the Clinical Bacteriologists
who fully recognised the potential impact of anaerobic bacteria in relation to morbidity
and mortality. Sadly Professor Gillies died suddenly in 1983.
The study of the potential virulence determinants of the obligately anaerobic
bacterium most frequently isolated from clinical infection, B. fragilis, was in its infancy.
As a member of the normal faecal microbiota B. fragilis is in the minority when
compared with other species, such as B. thetaiotaomicron and B. vulgatus. At that time
there were conflicting reports in the literature concerning both the production and
significance of the production of capsules by B. fragilis and other Bacteroides spp. Prior
to my arrival in the Department of Microbiology and Immunobiology at QUB, John Reid,
a PhD student had successfully carried out some electron microscopy (EM) on
Bacteroides spp, including B. fragilis American Type Culture Collection (ATCC) 23745,
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with the help of Dr Evelyn Dermott, a virologist and cell biologist at QUB. This strain
was favoured by many of the workers at that time, particularly in the USA. My
background in general Microbiology from Edinburgh University as an undergraduate and
in microbial ecology as a post-graduate, under the supervision of Professor John Holding,
meant that I had insight into the importance of nutrient availability in relation to bacterial
polysaccharide expression. In particular, as a result of the both being taught by and
having read Professor Ian Sutherland's book 'Surface Carbohydrates of the Prokaryotic
Cell, 1977, London: Academic Press' I searched the literature for a recipe for a defined
medium that would sustain the growth of B. fragilis, with a view to determining the
effects of altered glucose concentration on extracellular polysaccharide production. I also
applied capsule staining techniques used during my PhD studies, initially at the
University of Edinburgh and latterly at QUB when John Holding moved there during the
final year of my PhD studies. I obtained the type strain National Collection of Type
Cultures (NCTC) 9343, which had been isolated from a peritoneal abscess in 1955 at St
Bartholomew's Hospital, considering that it might be better representative of B. fragilis
than ATCC23745 which was originally isolated from pleural fluid. Growth in the defined
medium immediately revealed within strain capsule variation, which I then discovered
had also been reported in the literature for B. thetaiotaomicron. I developed a simple step
density gradient technique using Percoll, which enabled the separation and enrichment of
populations with different sizes of capsules (Patrick and Reid 1983; pi3). The
mechanism generating the phase variation was unknown and the subject of much debate
with a colleague at that time, a newly appointed lecturer in the Department of
Microbiology and Immunobiology, now Professor Michael Larkin, who had an interest in
bacterial recombination. Lysogenic phage had been suggested as the underlying cause in
B. thetaiotaomicron, but Michael Larkin introduced me to the literature relating to HI
and H2 flagellar variation in Salmonella typhimurium. A DNA inversion mechanism
similar to that of Salmonella seemed the neater hypothesis, particularly as the phase
switch was clearly reversible and reached equilibrium on subculture. I included this in a
summary report that I prepared for Professor Gillies in 1981 (Appendix A; p53). The
determination of the genetic basis of the phase variation remained elusive and
experiments were focussed on studies of the enriched populations in relation to the
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potential role of the capsules in virulence. The recognition of the importance of studying
pathogenic bacteria in vivo was beginning to spread, not least as a result of the influence
of Professor Harrry Smith at the University of Birmingham. I therefore compared the
growth of the different populations in vivo, by using my adaptation for anaerobic bacteria
of a model developed by Professor John Arbuthnott and Professor Gordon Dougan that I
had learnt during a visit to Trinity College Dublin. ATCC 23745, grew unpredictably in
vivo, whereas with NCTC 9343 I obtained highly reproducible growth curves in vivo
(Patrick, Reid and Larkin 1984; pi4). Why ATCC 23745 grew erratically has yet to be
resolved. In parallel, I carried out joint in vitro studies of phagocytosis and serum killing
with John Reid (Reid and Patrick 1984; pi5) and subjected the different capsular types to
extensive EM with some technical help from Alan Coffey (Patrick, Reid and Coffey
1986; pi7) The EM revealed that the non-capsulate population had a marginal electron
dense encapsulating layer capsule only visible by EM.
An attempt to detect IS1 from E. coli K12 in B. fragilis in a project jointly
supervised by Michael Larkin and involving an Honours project student, Garry Blakely
and Michael Larkin's PhD student, Ross Williams proved to be fruitless, suggesting a
lack of stable genetic exchange with intestinal E. coli and indicating the likelihood of
quite distant taxonomic phylogeny, although it did tell us that NCTC 9343 contained a
plasmid (Larkin et al. 1986; pi8).
A novel technique that had recently been introduced into the Department by Dr A
Trudgett on his return from a post-doctoral period at the National Institutes for Health in
Washington DC, was monoclonal antibody (MAb) production. Several fusions yielded
antibodies of disappointing usefulness, which was frustrating, as immunofluorescence
microsocopy (IFM) had been developed in the Department by Dr Praful Shirodaria and
immunogold EM by Evelyn Dermott. A serendipitous meeting with Professor S
Tabaqchali in the queue for the ladies toilets at a Royal Society Discussion meeting in
London led to a Wellcome Trust application for funding being obtained for a post¬
doctoral position for John Reid at St Bartholomew's Hospital. Finally we produced one
stable antibody producing hybridoma in Belfast and intriguingly the antibody only
labelled some of the bacteria in the population (Reid et al 1985; pi 6).
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John Reid tried to produce further MAbs and carried out PAGE and
immunoblotting at St Bartholomew's Hospital, while I carried out the IFM and
immunogold EM on in vitro and in vivo grown populations. These experiments yielded a
further antibody, which indicated that one of the capsulate types, the small capsule, was
antigenically distinct (Reid, Patrick and Tabaqchali 1987; pi6).
My continued studies of capsule expression in relation to virulence indicated that
the large capsule was not necessary for the survival of B. fragilis in vivo, even in the
presence of actively phagocytic cells and that the non-capsulate/EDL population
haemagglutinated, but not the large or small capsule. Disappointingly there was no
evidence for the induction of outer membrane proteins (OMP) such as the iron repressible
OMP of E. coli when the bacteria were grown in vivo, although the results of an Honours
Project student suggested that under haem limitation there was induction of an
approximately 40 kDa OMP (Patrick 1988, Larkin, McGuigan and Patrick 1988, Patrick
et al. 1988, Patrick and Lutton 1990; pp 20-22,24). A collaboration with Dr Joop van
Doom of the Free University of Amsterdam, initiated as result of meeting him at the
International Union of Microbiology Societies Congress in Manchester in 1986, indicated
that there was within strain variation in expression of a fimbrial antigen (Lutton et al.
1989; p23). Professor M Emmerson replaced Professor Gillies in the chair of
Bacteriology from 1985-1989. He agreed to be named as Principal Investigator on my
application to the Medical Research Council (MRC) to obtain personal funding to
continue the in vivo studies and for the development of bacterial flow cytometric analyses
of the antibody labelling. I was subsequently able to employ Debbie Lutton on the
remainder of the MRC funding when I was appointed as a Research Officer with Dr Tom
McNeill, Consulant/Senior Lecturer in Immunology.
With a new fusion partner and slightly modified protocol, Debbie Lutton and I
generated 30 stable hybridoma cell lines secreting antibody specific for surface
components of B. fragilis. The labelling patterns observed with these MAbs demonstrated
beyond any doubt that not only was there phase variation with respect to capsule
expression but that there was antigenic variation of surface polysaccharides within
populations enriched for either the EDL or large capsule. Dr Alastair Crockard of the
Regional Immunology Laboratory allowed us to run bacteria through his Flow
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Cytometer, which enabled the analyses of large numbers of bacteria. I first reported these
results as in invited speaker at the International Congress for Infectious Diseases held in
Montreal in 1990 where I was also invited to participate in a Round Table discussion on
the Pathogenesis of Anaerobic Bacterial Infection, held in English, but translated into
French by Y Pean and Y Buisson (Patrick and Lutton 1990, Brook et al. 1990, Lutton et
al. 1991, Patrick 1993, Patrick and Larkin 1993; pp25-29). Further MAbs produced
during Kevin Wilson's project also indicated that there were antigenically variable
surface proteins. The underlying genetic mechanism generating the variation remained
unknown, but it was clear that antigenic variation of surface polysaccharides also
occurred during in vivo growth (Patrick, Lutton and Crockard 1995; p. 30). Data
generated by a post-graduate student, James McKenna and intercalated Medical Student,
Seamus O'Hagan, gave further insights into the haemagglutination of B. fragilis (Patrick
et al. 1996; p33). Over the same period, Linda Stewart, a Medical Laboratory Scientific
Officer at Craigavon Area Hospital where Dr Nizam Damani was the Consultant
Bacteriologist, carried out her PhD under the joint supervision of myself and Michael
Larkin in which she examined pus and blood culture isolates as well as pus samples
directly, by IFM. In addition we prepared polyclonal antisera specific for the common
antigen of B. fragilis, previously identified by Professor Ian Poxton and Mr Bob Brown at
the University of Edinburgh, using some of their original sera. Using this polyclonal
antiserum the study clearly showed an improvement in detection of B. fragilis by use of
IFM when compared with culture (Patrick et al. 1995, Patrick 1997; pp31, 35). Sadly Dr
McNeill suffered from continued poor health and retired early in 1995.
I provided clinical isolates for a survey of the B. fragilis enterotoxin gene carried
out by Professor Meisel-Mikolajczyk and colleagues at the Medical University of
Warsaw, Poland (Luczak et al. 2001; p42). I also explored the possibility for combining
IFM with fluorescent in situ hybridisation (FISH) using 16S rRNA probes with an
Honours project student Simon Houston. This work was completed by a post-graduate
student Gordon Ramage and clearly highlighted the limitations of FISH where capsular
polysaccharides are present (Ramage, Patrick and Houston 1998; p36). IFM based
detection was extended to the bacterium Microthrix parvicella, which is involved in the
bulking of sludge in waste treatment, in collaboration with Michael Larkin, a PhD student
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Nicola Connery and post-doctoral research assistant Dr Andrew Thompson (Connery et
al., 2002; p43).
From 1988 I had been contributing lectures in Honours level courses on Bacterial
Genetics and Immunology in relation to pathogenic bacteria and in 1990 I initiated an
Honours level course on Bacterial Pathogenesis. I became acutely aware that there was
no suitable text that combined molecular aspects of bacterial pathogenesis, immunology
and the relevant aspects of bacterial genetics. J Wiley and sons offered Michael Larkin
and myself a contract to produce such a text and this was published in 1995, Michael
Larkin contributing the majority of Chapter 9 (Patrick and Larkin 1995; p32).
In 1995 Mr James Nixon, Consultant Orthopaedic Surgeon at Musgrave Park
Hospital initiated a meeting with myself and Professor Sean Gorman of the School of
Pharmacy at QUB to discuss possible reasons for the failure of prosthetic hip implants.
He specialised in the revision of failed implants and was concerned that there were
occasions when the routine diagnostic bacteriology laboratory reported 'no significant
growth' when he thought that there might be infection. As a result I was Principal
investigator on two successive Arthritis Research Campaign grants with Sean Gorman
and James Nixon to investigate the potential role of anaerobic bacteria in failed hip
replacements and the application IFM- based detection methods. As a result of hearing of
the work of Dr Martin Curran in the Regional Histocompatability and Immunogenetics
Laboratory at Belfast City Hospital on the detection of 16S ribosomal DNA, I set up a
collaboration to enable a comparison with the IFM detection methods. Dr Michael
Tunney was employed as the post-doctoral researcher on the grants and my post-graduate
students Gordon Ramage, Donna Hanna and Rebecca Perera contributed to the work. I
also initiated a collaboration with Dr Richard Davis and Dr Neil Anderson in the
Pathology Department at the Royal Victoria Hospital in relation to the histopathological
analysis of tissue samples from sites adjacent to the retrieved implants.
The data from these studies confirmed the involvement of Staphylococcus spp of
the normal microbiota, such as S. epidermidis, and also clearly implicated P. acnes as a
major contributor to the failure of prosthetic joints. In addition they indicated that many
of the isolates were resistant to the antibiotics in current use (Tunney et al. 1998a and
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b, 1999 a and b; Ramage et al. 2003; pp37-40,46). Subsequently this work was extended
by a PhD student, Josephine Glenn, and Orthopaedic Surgical Trainees Seamus
O'Hagan, Michael McMullan and Greg McLorinan. As a result of report of a link
between P. acnes and sciatica, determined by culture of clinical samples, Greg
McLorinan applied both culture and non-culture methods to samples taken during spinal
surgery. The link between P. acnes and sciatica was not proven, but his data indicated
that up to 30% of the surgical wound sites in his study were contaminated by bacteria of
the skin microbiota (McLorinan et al. 2005; p47).
The pathogenic potential of P. acnes remains a key question and I obtained
funding from the Research and Development Office of the Health and Personal Social
Services Northern Ireland (HPSSNI) and subsequently from the British Orthopaedic
Wishbone Trust to examine potential virulence determinants. A post-graduate student,
Susanna Valanne, embarked on the study of an abundant surface associated and secreted
protein that was evident in serotype II P. acnes, but not type I. A Material Transfer
Agreement that I negotiated with the former Corixa Corporation in the USA, gave us
access to a complete genome sequence of P. acnes and led to the identification of this
protein as one of a family of five co-haemolysins (Valanne et al. 2005; p48). The
immuno-purification of the protein was carried out in collaboration with Dr Brian
Wisdom of Biology and Biochemistry at QUB, Dr Derek Fairley of the QUESTOR
centre at QUB helped with the initial phylogenetic analyses and Gisli Einnarsson
provided some technical assistance. Dr Andrew McDowell joined my laboratory as a
post-doctoral researcher employed on a 5 year programme grant from the HPSSNI to
develop the non-culture detection methods for hip prosthesis to a level where they could
be readily adopted in the diagnostic laboratory (McDowell and Patrick 2005; p49). His
interest in bacterial phytogeny sparked further investigation of the P. acnes sub-types,
complementing the MAb typing with sequencing of 16S ribosomal RNA and recA genes.
These data explained some of the anomalies in the typing and resulted in the
identification of a sub-group within the type I P. acnes (McDowell et al. 2005; p50).
During the period from 1999-2001 when Professor Mark Pallen held the Chair of
Microbiology at QUB I was appointed Senior Lecturer in Bacteriology. Mark Pallen's
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boundless enthusiasm and interest in complete sequencing of bacterial genomes alerted
me to the Wellcome Trust Beowulf funding initiative. As result of my expression of
interest in relation to sequencing the B. fragilis genome, I was invited onto the strain
selection committee and to nominate other members and therefore suggested Ian Poxton
from Edinburgh University and Professor Brian Duerden from the University of Wales. I
proposed that the type strain NCTC 9343 should be sequenced, as this exhibited the
complete range of capsular variants and within strain antigenic variation. The Wellcome
Trust staff contacted a number of researchers outside the UK, who I had suggested, with
respect to strain selection. My choice of NCTC 9343 proved to be controversial, a
number of workers in the USA favoured the rifampicin resistant mutant strain 638R as it
was more amenable to genetic manipulation by electroporation. When I then wrote the
application to the Wellcome Trust for funding for the project, to be carried out at the
Wellcome Sanger Institute in the Pathogen Sequencing unit, I requested funding for
sequencing of both strains, and this was subsequently forthcoming. I sent the DNA to the
Sanger Institute where the B. fragilis team, lead by Professor Julian Parkhill, embarked
on the process of shot-gun sequencing, assembly of the sequence and finally the
annotation of the putative coding sequences, Dr Anna Cerdeno-Tarraga being mainly
responsible for the initial annotation.
I had isolated the DNA from an early low passage sub-culture of NCTC 9343
obtained from the NCTC which I had enriched for the EDL but which was antigenically
mixed, in the hope that the sequence might provide some clue as to the mechanism
generating the variation. This strategy was successful as in 2001 Julian Parkhill, phoned
me to say that there were an unusually high number of regions of DNA present in two
alternative orientations. This indicated that specific inversions of these sequences had
been occurring at high frequency in the clonal population from which I had isolated the
DNA. Seven of these 'fragilis invertible regions' were upstream of O-antigen capsule¬
like biosynthesis operons and contained the consensus B. fragilis promoter sequence.
When I looked at the sequences of the inverted repeats that flanked these invertible
regions I realised that they were strikingly similar to those flanking the Hin invertible
region of Salmonella that I had speculated might be involved in controlling capsular
variation in 1981 (Appendix A; p53). Lisa Douglas, one of my PhD students at that time
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of who had been trying to develop a gene knock-out system for B. fragilis in
collaboration with Dr Martin Collins in Agriculture and Food Science at QUB,
investigated the orientation of the invertible promoters in B. fragilis populations enriched
for one type of antigenic surface polysaccharide. Dr Garry Blakely was now a lecturer at
Edinburgh University, having completed his PhD with Michael Larkin and spent a
number years as a Post-doctoral researches at Oxford University, he had considerable
expertise in bacterial recombination. I therefore arranged for Lisa Douglas to spend time
in his laboratory in Edinburgh where she confirmed the interaction of a putative invertase
enzyme with similarity to the Salmonella Hin invertase and present in the NCTC9343
genome, with the inverted repeat region along with Garry Blakely's student Matylda
Sczaniecka (Patrick et al. 2003; p45). The complete genome sequence was published in
2005 and, in addition to the Sanger Institute B. fragilis pathogen sequencing team and
members of the strain selection committee, involved Dr Val Abbrat from the University
of Cape Town South Africa, with whom I had also been collaborating, and Garry Blakely
in relation to the interpretation of the sequence data in relation to DNA repair and
recombination (Cerdeno-Tarraga et al. 2005; p51).
I was invited to contribute a chapter on Bacteroides in three volume text
Molecular Medical Microbiology (Patrick 2001; p44) and update Brian Duerden's
Chapter on Gram-negative non-spore forming obligate anaerobes for the second edition
of Principles and Practice of Clinical Bacteriology (Patrick and Duerden 2006; p52).
Complete genome sequence information has brought about a revolution in both
the manner in which we are able to study bacteria and also the speed with which we can
generate data; with respect to both B. fragilis and P. acnes it opens up the possibility of in
depth analyses of the interactions of these bacteria with the human host as both
commensals and pathogens. The challenge for the future will be the application of this
knowledge to novel means for the prevention, detection and treatment of bacterial
infection.
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SEPARATION OF CAPSULATE AND NON-CAPSULATE BACTEROIDES
FRAGILIS ON A DISCONTINUOUS DENSITY GRADIENT
Sheila Patrick and J. H. Reid
Department ofMicrobiology andImmunobiology, The Queen's University ofBelfast,
Grosvenor Road, Belfast BT12 6BN
Summary. A discontinuous density gradient procedure was used successfully to
separate capsulate and non-capsulate cells of strains of Bacteroides fragilis.
Bacteria from the capsulate fraction retained their capsules on subculture, but
non-capsulate cells reverted to the mixed phenotype.
Introduction
Considerable emphasis has been placed on the importance of the polysaccharide capsule of
Bacteroides fragilis as a virulence determinant (Kasper et al., 1977). In studies with rats, the
polysaccharide capsule has been shown to promote the formation of intra-abdominal abscesses
similar to those found in human infection (Onderdonk et al., 1977).
A homogeneous population of bacteria is necessary to investigate the selective advantage of
the capsule in pathogenesis. Variation in the proportion of capsulate and non-capsulate cells
within individual Bacteroides cultures (Babb and Cummins, 1978) and instability of capsule
production by B. thetaiotaomicron (Burt et al., 1978) have been reported. Booth et al. (1979)
reported that capsulate B. fragilis were resistant to bacteriophage infection and suggested that
this might be used to obtain a capsulate population. Percoll density gradients have been used
for the separation of prokaryotic cells, for example, to synchronise cell division (Dwek, Kobrin
and Grossman, 1980) and to separate Escherichia coli possessing colonisation factor antigen 1
(Giesaef al., 1982). In this paper we report the use ofa discontinuous Percoll densitygradient to
separate capsulate and non-capsulate B. fragilis.
Materials and methods
Bacterial strains. B. fragilis NCTC9343 was supplied by the Department of Bacteriology,
University of Edinburgh Medical School and B. fragilis ATCC23745 by the American Type
Culture Collection, Rockville, MD. B. fragilis NCTC10584 was a departmental stock culture.
Culture methods. Bacteria were grown in defined broth (van Tassell and Wilkins, 1978), the
basal medium of Deacon, Duerden and Holbrook (1978) or on plates of lysed human-blood agar
(LHBA). Cultures were incubated at 37°C in an atmosphere of 90% H2 and 10% CO? in
anaerobic jars with two catalyst sachets per jar.
Microscopy. The presence of capsules was determined by light microscopy with Indian ink
and eosin-carbol fuchsin negative staining (Cruickshank, 1965). The proportion of capsulate
cells was determined by random field counts of eosin-carbol fuchsin stained preparations under
a x 100 oil-immersion objective. All determinations were done with late exponential-phase
cultures containing approximately 108 cfu/ml.
Density gradient centrifugation. Percoll (a colloidal sol of polyvinylpyrrolidone-coated
silica particles; Pharmacia Fine Chemicals Inc., London) is supplied sterile. A stock solution,
isosmotic with physiological saline, was prepared by diluting with 1-5 m NaCl in a ratio of 9:1.
The pH of this solution was adjusted to 7 0 with 1 m HC1. Solutions of 20, 40, 60 and 80%
Percoll were prepared by further dilution with 015 m NaCl.
Received 29 Sep. 1982; accepted 26 Oct. 1982.
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A 2-ml volume of each of these solutions was layered into a test tube to produce a step
gradient with 80% Percoll at the bottom and the 20% solution at the top. A broth culture of the
test organism (2-5 ml) was applied to the top of the 20% layer and the gradient centrifuged at
2600 g for 20 min in a bench centrifuge. After centrifugation the bands were removed with
sterile 2-ml syringes fitted with long needles. Bacteria from the gradients were subcultured
without further processing.
Results
Approx. 17% of the cells in the B. fragilis ATCC23745 culture produced capsules greater
than the width of the cell in size when grown in the defined medium of van Tassel and Wilkins
(1978). Capsules of the same dimension were observed in ruthenium red stained preparations
by electron microscopy. Fewer than 1% of the cells of B. fragilis strains NCTC10584 and
NCTC9343 produced capsules ofsimilar size when grown under the same conditions. Capsules
produced in the basal medium or on LHBA plates were smaller and difficult to assess because the
eosin-carbol fuchsin stain tended to shrink from the edge of the cell to produce a bright halo
similar to that of a small capsule.
After centrifugation of cultures in defined medium on a Percoll density gradient, cells with
Moure. Photomicrographs of Bacteroidesfragilis ATCC23745 grown in defined medium: a. culture before
density gradient centrifugation; b, cells harvested from top of Percoll gradient after centrifugation; c,
cells harvested from interface between 60% and 80% Percoll layers after centrifugation; encapsulate
cell; N = non-capsulate cell.
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large capsules remained on top of the 20% layer and non-capsulate cells were concentrated at the
60-80% interface (figure). Most of the cells of B.fragilis strains ATCC23745 and NCTC10584
were found at either the 0-20% or the 60-80% interface. However, B. fragilis NCTC9343
produced additional bands at the 20-40% and 40-60% interfaces. These bands were formed by
bacteria bearing capsules of graded sizes.
In subcultures of bacteria from the top layer of the density gradient, 90% of the cells of B.
fragilis NCTC10584 and 99% of the cells of B.fragilis strains ATCC23745 and NCTC9343 were
capsulate. Further subcultures of B.fragilis ATCC23745 were examined. Capsulate bacteria
represented 95-100% of the total number of cells for the first three subcultures, after which the
proportion of capsulate cells gradually diminished. Subculture of the 'non-capsulate' fractions
resulted in an immediate return to the initial distribution of capsulate and non-capsulate cells.
Discussion
The method described produced homogeneous suspensions of cells with and without
capsules. The capsulate fraction of B.fragilis strains ATCC23745 and NCTC9343 remained
capsulate after subculture into defined broth and could be used in further studies. A proportion
of cells of the non-capsulate fraction produced capsules when subcultured. This instability
restricts the use of the non-capsulate fraction to investigations in aerobic conditions. In these
conditions growth and biosynthesis of the capsule are prevented although viability of the
phenotypically non-capsulate population is maintained. This useful technique has allowed us
to proceed with in-vitro studies on the interaction ofcapsulate and non-capsulate B.fragilis with
granulocytes and serum.
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THE GROWTH AND SURVIVAL OF CAPSULATE AND
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Summary. The growth of capsulate and non-capsulate Bacteroides
fragilis in chambers implanted in the mouse peritoneal cavity was
compared. Capsulate and essentially non-capsulate (<1% capsulate)
populations of B. fragilis strains NCTC9343 and NCTC10584 consis¬
tently grew exponentially to > 109 cfu/ml within 24 h in vivo, and low
numbers of capsulate bacteria were maintained in the essentially
non-capsulate population; however, the degree of capsulation of the
capsulate population decreased by more than 60%. B. fragilis
ATCC23745 differed from strains NCTC9343 and NCTC10584 in that
growth was unpredictable and only occurred in some of the implanted
chambers. Capsule production by cells of strain ATCC23745 varied
from chamber to chamber: sometimes the proportion of capsulate cells
increased after prolonged implantation. This could occur with either
an increase or decrease in viable numbers in vivo and also after in-vitro
incubation of this strain in chambers. The survival of capsulate and
non-capsulate B. fragilis strains NCTC9343 and ATCC23745 was
compared in aerobic and anaerobic conditions in vitro. In anaerobic
conditions, capsulate and non-capsulate strain NCTC9343 survived
equally well, whereas capsulate ATCC23745 survived better than its
non-capsulate variants. Capsulate populations of both strains survived
better than non-capsulate in aerobic conditions.
Introduction
In-vitro studies indicate that the capsule of Bacteroides fragilis impairs phago¬
cytosis; however, its role in resistance to serum killing is less clear (Reid and Patrick,
1984). Smith (1980) stressed the importance of relating in-vitro investigations to
growth in vivo. Animal models of intra-abdominal bacteroides infections have been
reported by several authors. A study with rats indicated that B. fragilis ATCC23745
induced intra-abdominal abscess formation to a greater extent than other Bacteroides
spp. (e.g., B. distasonis). This was attributed to the polysaccharide capsule of B.
fragilis, because extracted polysaccharide alone caused abscesses. However, the
Received 14 Sep. 1983; revised version accepted 7 Nov. 1983.
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inocula included barium sulphate and sterilised rat caecal contents, and the bacteria
were suspended in glucose broth with peptone and yeast extract (PYG) (Onderdonk et
al., 1977). Kasper et al. (1980) used this model to obtain in-vivo passaged B.fragilis
ATCC23745. O'Keefe et al. (1978) implanted punctured table-tennis balls into the
rabbit peritoneal cavity. Three weeks later, a suspension of B.fragilis ATCC23745 in
chopped-meat-glucose broth was inoculated into the table-tennis balls to provide a
model for studies of the penetration and activity of penicillin G. McConville et al.
(1981) challenged mice intraperitoneally with suspensions of sterile mouse faeces and a
clinical isolate of B.fragilis. Sterile mouse faeces alone induced abscess formation, but.
more abscesses were produced when viable or heat-killed bacteria were added. PYG
and sterilised mouse caecal contents are highly chemotactic for neutrophils in the
absence of serum (Joiner et al., 1980).
In this paper we report the growth of capsulate and essentially non-capsulate
populations of B. fragilis in vivo and compare the survival of capsulate and
non-capsulate bacteria in vitro. As it is difficult to determine the importance of the
additives included in some animal models, we used a modification of the method of
Day et al. (1980), in which bacteria are suspended in a salt solution and enclosed in a
membrane-filter bound chamber. This initially allows free passage of diffusible host
and bacterial factors, but excludes phagocytes.
Materials and methods
Bacterial strains. B.fragilis NCTC9343 was supplied by the Department of Bacteriology,
University of Edinburgh Medical School, and B.fragilis ATCC23745 by the American Type
Culture Collection, Rockville, MD. B. fragilis NCTC10584 was a departmental stock culture.
Bacteria grown from these original cultures are referred to as normal (N) populations. N
populations of strains NCTC9343 and NCTC10584 are <1% capsulate, whereas strain
ATCC23745 is c. 17% capsulate (Patrick and Reid, 1983). Bacteria recovered from the 0-20%^
interface of a Percoll gradient are referred to as capsulate (C) and from the 60-80% interface as»)
non-capsulate (NC).
Animals. Female C57 mice aged 8-12 weeks (given free access to food and water) were used
in all experiments.
Bacterial culture methods. Cultures were incubated at 37°C in an atmosphere of90% H2 and
10% CO2 in anaerobic jars. The standard anaerobic procedures ofCollee et al. (1972) were used.
Stock cultures, grown in defined broth (Van Tassell and Wilkins, 1978), were snap-frozen in
liquid N2 and 1-ml portions were stored at — 70"C or in liquid N2. Capsulate bacteria,
recovered from the 0-20% interface of a Percoll discontinuous density gradient (Patrick and
Reid, 1983) and grown to late log-phase in defined broth, provided a C stock. This was stored as
above.
Total viable counts were determined by seeding lysed human blood agar (LHBA) with six
20-pi drops from a standard 20 G 2-in steel cannula (Astell, London).
Preparation of inocula. Bacteria were grown to late log-phase in the defined broth. C
cultures were then layered on to a cushion of 20% Percoll (Pharmacia, Fine Chemicals Inc.,
London), centrifuged at 2600 g for 20 min in a bench centrifuge, and the 100% C (supernatant)
suspension removed. Non-capsulate (NC) suspensions were obtained from the 60-80%
interface of a Percoll discontinuous density gradient.
Standard suspensions containing (2—5) x 107 cfu/ml were prepared in quarter-strength
Ringer solution (Oxoid) with 0 05% free base of cysteine (RS+cys) and checked with a Pye
Unicam SP 800 spectrophotometer.
In-vitro growth. Triplicate tubes of defined broth were inoculated for each sampling time at
a concentration of (2-5) x I07 cfu/ml. Each set of replicate tubes was incubated in a separate
anaerobic jar and only sampled once.
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In-vivo growth. Day et al. (1980) described a model for in-vivo growth of bacteria in
chambers implanted intraperitoneally in mice. We used this method when chambers containing
strain ATCC23745 were prepared in an anaerobic cabinet (Forma Scientific Inc.; gas mixture
85% N2, 10% H2, 5% CO2). Because the method leaves a gas space inside the chamber, the
following modification was used in all other experiments when chambers were prepared in
aerobic conditions.
Chambers were made from 10-mm lengths of 1-ml polypropylene syringe barrels (Becton
and Dickinson, Dublin). Two holes were made in the sides of the chambers, towards each end,
with a red-hot 25 G needle. A membrane filter (0-45-^m pore; Millipore, Harrow, Middlesex)
.was stuck aseptically on to each end of the barrel with UHU glue (Beecham UHU, Brentford,
Middlesex) and the glue allowed to harden. The chambers were filled through the sides with
standard bacterial suspensions. A 2-ml syringe with a 26 G needle was inserted into one of the
holes and the chamber filled until all the air was excluded (final volume c. 0-2 ml). The two holes
were then sealed with UHU glue and the chambers transferred into bijou bottles containing c. 4-5
ml of RS + cys. These were then stored in an anaerobic jar with an activated Gas Generating Kit
(Oxoid) at room temperature until implanted into the peritoneal cavity of mice; (two chambers
were inplanted in each mouse). LHBA plates were spread with 1 ml of the RS+cys from the
bijou bottles to check for leaking chambers.
Duplicate mice were killed after the required incubation period and the chambers removed.
The membrane filters were punctured with a syringe needle and the chambers washed four times
with 0-2 ml RS. The numbers of viable bacteria in each chamber were determined.
The degree of bacterial capsulation was determined directly by examination of the
suspensions obtained from the chambers, and indirectly by examination of the late log-phase
growth after one subculture in defined broth. Standard suspensions of < 1% capsulate (N) B.
fragilis strains NCTC9343 and NCTC10584, non-capsulate B. fragilis ATCC 23745 and
capsulate populations of all three strains were used as inocula.
Bacterial survival in vitro. Five-ml volumes ofstandard suspensions in RS + cys ofC and NC
variants of B. fragilis NCTC9343 and ATCC23745 were incubated in bijou bottles aerobically
and anaerobically at 37 C for 24 h. The initial and final viable counts were then compared.
Survival of strain ATCC23745 in anaerobically-prepared chambers placed in bijou bottles
containing RS + cys was also determined. Degree of capsulation was determined in a late
log-phase subculture in defined broth.
Microscopy. Capsulation was determined by light microscopy with eosin-carbol fuchsin
negative staining (Cruickshank, 1965) and by electronmicroscopy wth ruthenium red staining
(Springer and Roth, 1973).
The presence of phagocytes on the chamber membrane filters was determined by light
microscopy of methanol-fixed filters stained with M.D.Diff-Quick solutions 1 and 2 (Merz and
Dade AG, Switzerland).
Statistical analyses. Growth curves ofcapsulate and normal populations were compared by
a two-way analysis of variance with linear regression. Growth rates were compared by a test of
significance between the regressions and the length of the lag-phase by comparison of the blocks
of data (F tests) with a Texas T1 59 programmable calculator (Parker, 1979). The survival of
capsulate and non-capsulate bacteria in vitro was compared by Student's't' test. The bars
included in the figures represent the standard errors.
Results
Microscopy of bacteria grown in chambers in-vivo
Suspensions of bacteria obtained from the chambers were examined directly with
eosin-carbol fuchsin staining. Bacteria grown in vivo were smaller than those grown in
defined broth: for example, cells of strain NCTC9343 grown in vivo were
c. 0-7 x 1-0-3-6/rm whereas cells grown in defined broth were 0-9 x 1-4-5-l^m. It was,
therefore, difficult to determine the proportion ofcapsulate cells accurately because the
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Fig. 1.—Survival, growth and percentage capsulation of initially c. 17% capsulate B.fragilis ATCC23745 in
vivo and in vitro in chambers constructed in anaerobic conditions: increase or decrease in total viable
count (logio cfu/ml) in vivo ( I ) and in vitro ( • ); percentage capsulation determined directly on in-vivo
grown bacteria (O) and, after one in-vitro subculture of bacteria incubated in vivo (•) and in vitro (■).
Each symbol represents the results from one chamber. I = standard error in all figs.
eosin-carbol fuchsin stain sometimes shrinks to leave a bright halo. Bacteria grown in
vivo were subcultured once in defined broth and the proportions of capsulate cells were
compared with direct determinations on chamber suspensions.
Strains NCTC9343 and NCTC10584 grown in vivo showed an apparent decrease in
the proportion of capsulate cells after only one subculture in vitro; this was quite
reproducible in replicate experiments. However, the percentage capsulation of B.
fragilis ATCC23745 grown in vivo increased to a varying extent on in-vitro subculture
(fig. 1). Some of these bacteria may not produce capsules in vivo, while retaining the
potential for capsule production, or the capsules may be too small to be seen with the
light microscope. Ruthenium red staining and electronmicroscopy showed the
presence of a thick dark-staining layer outside the membrane on some of the cells.
This resembled the ruthenium red-staining capsule desribed by Kasper (1976).
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Because of these anomalies, the proportion of cells grown in vivo capable of
producing capsules after one in-vitro subculture was used as an indicator of
capsulation for all three strains.
Observation of the implanted chambers
Filters from the ends of the chambers were stained by the Diff-Quick method and




Fig. 2.—In-vivo growth curve of initially 100%capsulate (•) and < 1% capsulate (o) B.fragilis NCTC9343
and percentage capsulation of bacteria grown in vivo after one in-vitro subculture, initially 100%
capsulate (a) and < 1% capsulate (a). The results from five separate experiments are combined for
each growth curve and each point represents the mean of four chambers. Specific growth rate of 100%
C = 0-34 + 0 09/h and of < 1% C = 0-35 + 018/h.
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surfaces of the filters on chambers containing C and N populations. Leukocytes were
not observed on the inner surfaces of the filters. After prolonged incubation, the
chambers in which growth occurred became encased in fibrin and granulation tissue, as
described by Day eta/. (1980) in their work with chambers containing Staphylococcus
aureus.
Growth and survival of B. fragilis
During incubation in vivo for 24 h, C and N populations of B. fragilis NCTC9343
grew exponentially to > 109 cfu/m! and maintained high viable numbers for at least 22
days (fig. 2). Throughout this period the proportion of capsulate cells in the N
population remained low. However, the proportion of capsulate cells in the C






Fig. 3.—Comparison of total viable count and percentage capsulation (after one in-vitro subculture) of
initially 100% capsulate (C) and < 1% capsulate (N) B. fragilis strains NCTC9343 and NCTC 10584
and, initially C and non-capsulalc (NC) strain ATCC23745. Each bar represents the mean of four
chambers and the results are representative of more than one experiment.
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C populations subcultured in defined broth maintained a high level of capsulation
(Patrick and Reid, 1983). The C population had a significantly longer lag-phase than
the N population in vivo, although the growth rates did not differ significantly.
Growth in vivo was slower than in defined broth, with generation times for C bacteria
of 2 06 h in vivo and 1 -60 h in defined broth, and for N bacteria of 1 -96 h in vivo and 1 -42
h in defined broth. The difference in the lag-phase and the selection against capsulate
cells in vivo was not attributable to poor survival in RS -I- cys. When incubated in vitro
at 37°C for 24 h, C and N populations of B.fragilis NCTC9343 maintained similar
-viable numbers anaerobically, whereas the capsulate population survived better than
the non-capsulate in aerobic conditions. B.fragilis NCTC10584 behaved similarly,
but strain ATCC23745 did not (fig. 3).
B.fragilis ATCC23745 did not grow exponentially during incubation for 24 h in
vivo (fig. 3), even if the chambers were constructed and filled in an anaerobic cabinet
(fig. 1). Growth did occur in some chambers after prolonged incubation, but it was
erratic. In-vivo incubation tended to increase the proportion of cells capable of
producing capsules, whether growth occurred or not, but again this was inconsistent.




















Fig. 4.—Survival of 100% capsulate (C) and non-capsulate (NC) B. fragilis strains NCTC9343 and
ATCC23745 incubated aerobically (Aero) and anaerobically (Anaero) in Ringer solution + free base of
cysteine (0-05%) at 37CC for 24 h. Each bar represents the combined results from two separate
experiments, jji. = difference between C and NC statistically significant (p = 005).
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in RS + cys at 37°C (fig. 1). The results summarised in fig. 4 show that the capsule of
ATCC23745 enhances survival aerobically and anaerobically; this could be relevant to
the selection of a capsulate population.
Discussion
In this model, B.fragilis grew in chambers implanted intraperitoneal^ in mice in
the absence of phagocytes and without the addition of adjuvants such as barium
sulphate, sterile mouse faeces or growth medium. However, the physical presence of
the chamber may enhance bacterial growth as the presence of a foreign body in the"
form of a subcutaneously implanted polytetrafluoroethylene tube in guinea pigs
enhanced the growth of S. aureus (Zimmerli et al., 1982).
The present study shows that, in the absence of phagocytes, non-capsulate B.
fragilis strains NCTC9343 and NCTC10584 can proliferate in vivo and have a selective
advantage over capsulate organisms. The reasons for this are not known, but do not
relate to survival aerobically or anaerobically in vitro in Ringer solution with cysteine.
Any differences in the growth rate of the capsulate and non-capsulate variants will
influence the proportions of these cell types in the population, as would the frequency
of switching from one state to the other. The relative importance of these two factors
remains to be determined. Rapid phase or form variation in surface structures of
pathogenic bacteria, without loss of the potential for production, could be an
advantage in a changing host environment (Makela et al., 1980). In studies of B.
thetaiotaomicron by Burt et al. (197S), capsulate cells changed to non-capsulate at a
frequency of M x 10~2 and non-capsulate to capsulate at l-4x 10-2 in vitro at 37°C.
Capsulation is related to colony form in B. thetaiotaomicron, but no change in colony
morphology of capsulate and non-capsulate B.fragilis has been observed in the present
study.
B.fragilis ATCC23745 differed from the other two strains in that growth in vivo in
implanted chambers was unpredictable. There was also a trend towards a higher
proportion of capsulate cells with longer incubation, whether in-vivo growth occurred
or not. O'Keefe et al. (1978) also reported a wide variation in viable counts of B.
fragilis ATCC23745 in vivo. Table-tennis balls implanted intraperitoneally (IP) into
rabbits were inoculated with I ml of broth culture containing 109— 1010 cfu/ml. After
incubation for 4 or 5 days the same dose ofpenicillin G was given to all the rabbits, and
viable counts then ranged from 103—1010 cfu/ml. This variation probably occurred
during the 4-5-day incubation period and was not attributable to antibiotic treatment,
because penicillin G was biologically inactive in heavily infected (> 109 cfu/ml) balls.
B. fragilis ATCC23745 isolated from experimental intraperitoneal abscesses in rats
(Kasper et al., 1980) and subcutaneous abscesses in mice (Simon et al., 1982) produced
more capsular material than the same strain serially subcultured only on blood agar.
B. fragilis ATCC23745, isolated from experimental subcutaneous abscesses in mice,
maintained higher viable numbers in the rabbit intraperitoneal table-tennis ball model
of O'Keefe et al. (1978) than B.fragilis ATCC23745 which had been subcultured ten
times on blood agar (Simon et al., 1982). The present study shows that the degree of
capsulation of strain ATCC23745 can also be enhanced without incubation in vivo and
that the capsule enhances in-vitro survival aerobically and anaerobically.
Although the reasons for the different behaviour of strains NCTC9343 and
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NCTC10584, and ATCC23745 are not clear, the following facts should perhaps be
given further consideration. Strain ATCC23745 was isolated from pleural fluid and
was initially named Sphaerophorus intermedius (Bergan and Hovig, 1968), whereas
strain NCTC9343 was isolated from an appendix abscess and NCTC10584 from pus.
The polysaccharide capsules of strains ATCC23745 and NCTC9343 have been shown
to be chemically and immunochemically different, although the lipopolysaccharide is
similar (Kasper et al., 1983). In-vitro cultures of strain ATCC23745 have a higher
proportion of capsulate cells than strains NCTC9343 and NCTC 10584 (Patrick and
Reid, 1983). Spherical bodies with multilayered walls, sometimes associated with
bacteriophage, have been observed in B.fragilis strain ATCC23745 but not in other
strains examined (Silver et al., 1975; Reid, 1981). Booth et al. (1979) reported a
phage-carrier state in strains of B.fragilis that produced thick capsules. When these
cultures were cured of phage the proportion of capsulate cells decreased. The activity
of bacteriophage in strain ATCC23745 could be a factor involved in the differences
observed in the present study, but direct evidence for this has yet to be obtained.
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Summary. The relative susceptibilities of capsulate and non-capsulate
variants of Bacteroides fragilis to serum and phagocytic killing were
investigated. The capsule of B. fragilis did not confer resistance to
serum killing. Phagocytic killing of non-capsulate B. fragilis occurred
at bacterial concentrations of 1 x 106 and 1 x 107 cfu/ml. Capsulate B.
fragilis organisms were also phagocytosed and killed at a concentration
of 1 x 106 cfu/ml, but phagocytosis and killing were impaired at a
concentration of 1 x 107 cfu/ml.
Introduction
The susceptibility of pathogenic bacteria to phagocytosis and killing by polymor¬
phonuclear leukocytes (PMNL) and macrophages is of major importance in
determining the outcome of the host-pathogen interaction. Casciato et al. (1975) and
Bjornson, Altemeier and Bjornson (1976) demonstrated phagocytosis and killing of B.
fragilis by human leukocytes in vitro. Phagocytosis of B. fragilis in the presence of
serum occurred in aerobic and anaerobic conditions. Ingham et al. (1977 and 1981)
investigated the effect of Bacteroides spp. on the phagocytic killing of facultative
species. Killing of B. fragilis and Proteus mirabilis in mixtures in vitro was impaired
when the concentration of B. fragilis was greater than I x 107 cfu/ml in the phagocytic
system. Tofte et al. (1980) and Jones and Gemmel (1982) reported that both
phagocytic uptake and killing of facultative species were impaired at high concentra¬
tions of bacteroides. None of these studies defined the ratio of capsulate to
non-capsulate bacteroides used in the phagocytic system.
Considerable emphasis has been placed on the importance of the polysaccharide
capsule of B. fragilis ATCC23745 as a virulence determinant (Kasper et al., 1977;
Onderdonk et al., 1977). Kasper et al. (1980) reported that in-vivo passage of this
strain enhanced the production of the capsule but serial subculture in vitro reduced the
proportion ofcapsulate bacteria. Simon et al. (1982) compared phagocytosis of these
strains and successfully demonstrated a reduction in uptake of the in-vivo passaged
variant.
Recently, Percoll density gradient centrifugation was successfully used to separate
capsulate and non-capsulate variants of B. fragilis (Patrick and Reid, 1983). In the
Received 14 Sep. 1983; revised version accepted 9 Nov. 1983.
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present study, the susceptibilities of these variants to phagocytosis, intracellular killing
and the bactericidal action of serum were investigated.
Materials and methods
Bacterial strains. B.fragilis NCTC9343 was supplied by the Department of Bacteriology,
University of Edinburgh Medical School; B.fragilis ATCC23745 by the American Type Culture
Collection, Rockville, MD; and B.fragilis NCTC10584 was a departmental stock culture.
Bacterial culture methods. Bacteria grown in defined broth (Van Tassell and Wilkins, 1978)
were used in all experiments except where otherwise stated. Cultures were incubated at 37°C in
an atmosphere of H2 90% and CO2 10% in anaerobic jars. The standard anaerobic procedures
of Collee et al. (1972) were used.
Stock cultures, grown in defined broth, were snap frozen in liquid N2 and 1-ml portions
stored at — 70°C or in liquid N2. Capsulate bacteria, recovered from the 0-20% interface of a
Percoll (Pharmacia, London) discontinuous density gradient (Patrick and Reid, 1983) and
grown to late log-phase in defined broth, provided a capsulate stock which was stored as above.
Bacteria were also cultured in basal broth (Deacon, Duerden and Holbrook, 1978). Total
viable counts were determined by seeding lysed human blood agar with six 20-p\ drops from a
standard 20-gauge steel cannula (Astell, London).
Preparation of bacteria. Bacteria were grown to late log-phase in defined broth medium.
A 3-ml volume of a capsulate culture preparation was layered on to a 20% Percoll cushion.
After centrifugation at 2600 g for 20 min a homogeneous suspension of capsulate bacteria was
recovered from the 0-20% interface, suspended in quarter strength Ringer solution (Oxoid,
Basingstoke, Hampshire) and centrifuged at 10 OOOp for 30 min at 4°C. Non-capsulate bacteria
obtained from the 60-80% interface of a Percoll density gradient were also washed once in
Ringer solution. Standard bacterial suspensions at concentrations of 1 x 107 or 1 x 108 cfu/ml
were prepared in Hanks' balanced salt solution (HBSS) containing gelatin 0-01% w/v
(GEL-HBSS).
Preparation ofphagocytes. Ficoll isopaque gradients were used to separate leukocytes from
25 ml of heparinised human blood. Leukocytes were washed twice in HBSS, and pure PMNL
preparations were obtained by centrifugation of the leukocyte suspension on a preformed
Percoll sucrose density gradient.
A stock solution of Percoll. isosmotic with physiological saline, was prepared by diluting
nine volumes of Percoll in one volume of tenfold concentrated HBSS. The pH of this solution
was adjusted to 7-2 with 1m HC1, and a 65% Percoll solution was then prepared by the addition of
0-25 m sucrose. Suitable volumes were centrifuged at 21 000 g for 20 min to produce gradients.
Leukocytes suspended in 1 ml of HBSS were applied to the top of a gradient which was then
centrifuged at 600 g for 15 min. A sharp band ofPMNL formed in the lower part of the gradient
just above the band of erythrocytes; the cells were removed carefully with a Pasteur pipette,
washed in HBSS and resuspended to a final concentration of 1 x 107 cells/ml.
Serum. Normal human group AB serum was obtained from the Northern Ireland Blood
Transfusion Service; 2-ml volumes of sera were stored at — 20°C. The total haemolytic
complement value (CH50) was checked routinely, and only sera with normal CH50 values were
used.
Phagocytosis. Sterile siliconised screw-capped glass tubes (98x16 mm) containing a
phagocytic system composed of 0-3 ml of PMNL suspension, 0-3 ml of AB serum, 0-3 ml of
appropriate bacterial suspension and 2-1 ml of GEL-HBSS were incubated at 37°C in aerobic
conditions with end-over-end rotation. GEL-HBSS was used to bring the final volume to 3 0
ml. Final PMNL and serum concentrations were 1 x 106 cells/ml and 10% respectively, and
final bacterial concentrations were either 1 x 107 or 1 x 106 cfu/ml. Appropriate control
mixtures were included. All experiments were performed in duplicate and repeated at least
twice. Phagocytic killing at 0 and 120 min was measured by diluting 01 ml of the reaction
mixture into 9-9 ml of distilled water containing bovine serum albumin 0 01%. After 5 min,
further tenfold dilutions were performed in Ringer solution and total viable counts were
determined. Phagocytic uptake after 0, 30, 60 and 120 min was measured by diluting 0-5 ml of
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the reaction mixture in 1 '5 ml ofchilled GEL-HBSS to stop phagocytosis. The suspension was
centrifuged at 110 g for 4 min at 4°C and the viable bacteria in the supernate were counted.
Light microscopy. Capsules were detected by light microscopy with India ink or
eosin-carbol fuchsin negative staining methods (Cruickshank, Duguid and Swain, 1965).
PMNL were recovered from the phagocytic system by centrifugation at 210# for 4 min and
resuspended in HBSS containing 50% heat-inactivated normal human serum. Smears were
prepared and stained by the M & D Diff-Quick® staining set (Merz and Dade AG, Switzerland).
Preparations were examined with a x 100 oil immersion objective and the number ofbacteria/50
PMNL counted.
Electronmicroscopy. PMNL for electronmicroscopy were recovered from the phagocytic
system by centrifugation at 210 g for 4 min, resuspended in 01 m Sorensen's phosphate buffer pH
7-3 (SPB) containing glutaraldehyde 2-5% v/v and left at 4°C for 1 h. Cells were washed twice in
SPB, resuspended in SPB containing osmic acid 1 % v/v, left at 22°C for 1 h and then washed twice
in SPB, dehydrated in graded ethyl alcohols and embedded in Spurr resin. Sections for
electronmicroscopy were stained with uranyl acetate and lead citrate and viewed in a Philips 301
transmission electronmicroscope.
Results
Bactericidal activity of human serum
Capsulate and non-capsulate variants of two of the three test strains (NCTC9343
and NCTC10584) showed no reduction in viable counts after incubation for 2 h in 10%
normal human serum (table I). The non-capsulate variant of B.fragilis ATCC23745
was also resistant to serum killing, but the capsulate variant of this strain was
susceptible to the bactericidal action of 10% normal human serum (table I). Control
experiments indicated that GEL-HBSS was not toxic to capsulate B. fragilis
ATCC23745.
Table I
Susceptibility ofcapsulate and non-capsulate variants ofB.fragilis to serum andphagocytic killing
Ratio of Total viable count* (cfu/ml) after
bacteria „ ~—
Organism to PMNL 0 min 120 min
B.fragilis NCTC9343 (NC) 10:1 1-5 -1- 0-2 x 107 3-5 + 2-8 xlO6
1:1 1-4 + 0-2 x 106 1-0 + 0-1 x 105
Serum control 1-3 + 0-1 x 106 1-5 + 0-2 x 106
B.fragilis NCTC9343 (C) 10:1 1 l+0-2x 107 1-1+0-1 x 107
1:1 1-1+0-1 x 106 5-2 + 0-9 x 104
Serum control 1-2 + 0-1 x 106 1-0 + 0-1 X 106
B.fragilis NCTC 10584 (NC) 10:1 l-7 + 0-2x 107 4-6 + 0-9 x 106
1:1 2-1+0-1 xlO6 0-9 + 0-1 x 10s
Serum control 1-9 + 0-1 x 106 2-1 +0-2 x 106
B.fragilis NCTC 10584(C) 10:1 1-9 + 0-2 x 107 1-8 + 0-3 x 107
1:1 1-9 + 0-1 x 106 5-5 + 0-3 x 105
Serum control 18 + 0-1 x 106 l-9 + 0-2x 106
B.fragilis ATCC23745 (NC) 10:1 2-9 + 0-3 x 107 3-0 + 0-2x 106
1:1 2-2 + 0-4 x 106 3-5+ 1-0 x 104
Serum control 2-3 + 0-2x 106 2-5 + 0-2 x 105
B.fragilis ATCC23745 (C) 10:1 0-7 + 0-1 x 107 1-0 + 0-9 x 10s
1:1 1-2 + 0-1 x IO6 1-5 + 0-4 x 104
Serum control 1-1+0-1 x 106 2-2 + 0-5 x 104
PMNL = polymorphonuclear leukocyte; C = capsulate; NC = non-capsulate.
* = mean + SE.
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Fig. 1.—A comparison of killing ofcapsulate (C) and non-capsulate (NC) variants of B. fragilis NCTC9343
and ATCC23745 by PMNL and serum. A—bacteria to PMNL ratio = 10:1; B—bacteria to PMNL
ratio = 1:1; C—bacteria without PMNL; all mixtures contained serum.
Killing by polymorphonuclear leukocytes
The results in table I and fig. 1 indicate that phagocytic killing of the three
non-capsulate strains of B. fragilis grown in defined broth occurred at bacterial
concentrations of 1 x 106 and 1 x 107 cfu/ml (i.e., bacteria to PMNL ratios of 1:1 and
10:1 respectively). Non-capsulate B. fragilis NCTC9343 grown in basal broth was
also susceptible to phagocytic killing at both bacterial concentrations (table II).
The capsulate variants of B. fragilis NCTC9343 and NCTC10584 were killed by
Table II
Susceptibility of capsulate and non-capsulate variants of B. fragilis NCTC9343 grown in basal
















6-1 +0-4 x 106












8-5 +0-5 x 106
6-7 + 0-2 x 10
7-4 + 0-3 x I06
5-2 + 0-4 x It)5




PMNL = Polymorphonuclear leukocyte.
*
= Mean±SE.
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PMNL at bacterial concentrations of 1 x 106 cfu/ml. However, when the bacterial
concentration was increased to 1 x 107 cfu/ml, phagocytic killing of these strains was
inhibited (table I and fig. 1). A high proportion (>70%) of capsulate B. fragilis
NCTC9343 grown in basal broth was susceptible to phagocytic killing at both bacterial
concentrations (table II). Killing of capsulate B. fragilis ATCC23745 occurred at
both bacterial concentrations; however, this strain was sensitive to the bactericidal
action of normal human serum (table 1 and fig. 1).
Phagocytosis and killing by polymorphonuclear leukocytes
The rates of phagocytosis and killing ofcapsulate and non-capsulate variants of B.
fragilis NCTC9343 were compared. At bacterial concentrations of 1 x 107 cfu/ml,




T ime (min )
Fig. 2.—Phagocytosis and killing ofnon-capsulate 5./ragi/ijNCTC9343 during incubation with 10% serum
and PMNL. Phagocytic uptake (•) and killing (O) at a bacterial concentration of 1 x 107 cfu/ml;
phagocytic uptake (♦) and killing (o) at a bacterial concentration of 1 x 106 cfu/ml. Controls for uptake
(....) and killing ( ) were bacteria incubated in serum without PMNL. Results from experiments
performed on 3 days were combined and expressed as mean ± SE.
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after incubation for 60 min (fig. 2). However, phagocytosis of capsulate B. fragilis
NCTC9343 was impaired after incubation for 60 min and no killing occurred (fig. 3).
At bacterial concentrations of 1 x 106 cfu/ml, phagocytosis and killing were similar
with each variant (figs 2 and 3).
Microscopy
Phagocyte-associated bacteria were difficult to detect at a low bacteria to PMNL
ratio (1:1) by light microscopy with differential staining. Smears prepared from the
phagocytic system containing non-capsulate B. fragilis NCTC9343 at a high bacteria
to PMNL ratio (10:1) showed numerous PMNL-associated bacteria. When B.
fragilis NCTC9343 was grown in defined broth the mean number of non-capsulate
bacteria per PMNL was 11; growth in basal broth increased the number of
Fig. 3.—Phagocytosis and killing ofcapsulate B. fragilis NCTC9343 during incubation with 10% serum and
PMNL. Phagocytic uptake (a) and killing (a) at a bacterial concentration of 1 x 107 cfu/ml;
phagocytic uptake (■) and killing (□) at a bacterial concentration of 1 x 106 cfu/ml. Controls for
uptake (....) and killing ( ) were bacteria incubated in serum without PMNL. Results from
experiments performed on 3 days were combined and expressed as mean +SE.
BACTEROIDES CAPSULES AND HOST DEFENCES 253
25-1
Fig. 4. B.fragttis NCTC9343 associated with PMNL after incubation for 60 min in 10% scrum at 37 C.
DB=defined broth; BB= basal broth: C -capsuhite: NC=non-capsulate.
phagocyte-associated bacteria to 24 (ftg. 4). Electronmicroscopy confirmed the
intracellular location of these organisms and demonstrated that bacteria were
surrounded by phagosome! membranes (fig. 5A).
Few PMNL-associated capsulate B. fragilis NCTC9343 were observed at a
bacteria to PMNL ratio of 10:1 (figs 4 and 5B). Electronmicroscopy revealed that
some capsulate organisms were associated with the outside of the PMNL membrane
(fig. 6). However, high numbers of capsulate B.fragffis NCTC9343 grown in basal
broth were observed within phagocytes at a bacteria to PMNL ratio of 10:1 (fig. 4).
Discussion
These findings indicate that the capsule of B. fragilis is not responsible for
conferring resistance to serum killing.
Non-capsulate B. fragilis ATCC23745 grown in defined broth was resistant to
serum killing, but the capsulate variant of this strain was susceptible to the bactericidal
action of 10% normal human serum. The phagocytic system used in our study
contained 10% normal human serum and viable counting methods were used to detect
phagocytosis and killing. Phagocytosis of serum-sensitive strains could not be
investigated because phagocytic killing could not be distinguished from serum killing.
Optimum phagocytic killing of both capsulate and non-capsulate B. fragilis
occurred at bacterial concentrations of 1 x 10'® cfu/ml, but differences in the
susceptibility to phagocytic killing were observed at bacterial concentrations of I x 1()7
cfu/ml. The results of our uptake and electronmicroscopy experiments suggest that
ingestion of capsulate B. fragilis was impaired at bacterial concentrations of 1 x 10"
cfu/ml. The surface of a particle must be completely coated with opsonin for
successful phagocytosis (Griffin el a!., 1975). I ncomplete opsonisation ofcapsulate B.
fragilis at high bacterial concentrations with limited amounts of an essential opsonin
(e.g., IgM) could result in the impaired phagocytosis observed in our experiments.
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Fig. 5.—Electronmicrographs of PMNL after incubation for 60 rnin with (A) non-capsulate and (B)
capsulate B.fragilis NCTC9343 in the presence of 10% serum. Scale bar= 1 //m.
BACTEROIDES CAPSULES AND HOST DEFENCES 255
Fig. 6.—Electronmicrograph of capsulate B.fragilis NCTC9343 associated with the membrane ofa PMNL
after incubation for 60 min in the presence of 10% serum. Scale bar = 0-5 /im.
The capsulate variant of B. fragilis NCTC9343 grown in basal broth produced
small capsules and was successfully phagocytosed at bacterial concentrations of 1 x 106
and 1 x 107 cfu/ml; this suggests that the quantity of capsular material is important in
impairing phagocytosis. A reduction in the quantity of opsonin required to
completely cover the surface of organisms grown in basal broth could account for this
observation.
Our results suggest that capsulate and non-capsulate B. fragilis have different
opsonic requirements; this might explain the difference between our results and those
obtained by other workers. Bjornson and Bjornson (1978) and Bjornson, Bjornson
and Kitko (1980) demonstrated that the alternative complement pathway and IgM
were essential for phagocytosis; however, Toftec/a/. (1980) detected opsonisation at a
reduced rate in the absence of the classical complement pathway and antibody. The
proportions of capsulate and non-capsulate bacteria used in their studies were not
defined. The inconsistency in these results might be explained if phagocytosis
experiments were repeated with homogeneous suspensions of capsulate and non-cap¬
sulate B.fragilis.
Ingham el at. (1977 and 1981) observed that phagocytic killing was impaired when
P. mirabilis and high concentrations of B. fragilis (1 x 107 cfu/ml) were mixed with
serum and PMNL in vitro. B.fragilis cells with large capsules might be responsible for
the inhibitory effect. Horwitz and Silverstein (1980) reported that anti-capsular
antibody and complement were essential for opsonisation and phagocytosis of
capsulate Escherichia coli. Opsonisation of capsulate B. fragilis might proceed in a
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similar manner. In the phagocytic system of Ingham et al. (1977), the quantity of
specific anti-capsular antibody may be insufficient to completely opsonise capsulate B.
fragilis at a concentration of 1 x 107 cfu/ml because normal human serum contains low
levels of bacteroides-specific antibodies (Hofstad, 1979). If these partially opsonised
capsulate cells induced premature degranulation of PMNL lysosomes as a result of
attachment to the PMNL membrane in the absence of phagocytosis, and if
opsonisation of P. mirabilis by the alternative complement pathway proceeded at a
slower rate (Tofte el al., 1980), the bactericidal mechanisms of the PMNL would be
depleted before phagocytosis of P. mirabilis occurred. This could explain the
protection from phagocytic killing. Further studies are needed to investigate this
hypothesis.
The authors dedicate this paper to the memory of Professor R.R. Gillies who was Professor
of Clinical Bacteriology at the Queen's University of Belfast from 1976 until his sudden death in
1983.
The authors thank Mr Alan Coffey MLSO and Mr Martin Clulow for technical assistance.
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1. SUMMARY
Electron microscopy and immunogold labelling
with monoclonal antibody (McAb) Bfl identified
an antigen expressed on some in vitro and in vivo
grown Bacteroides fragilis NCTC9343 cells.
Immunoprecipitation with this McAb was used
to enrich for B. fragilis NCTC9343 cells ex¬
pressing the Bfl antigen. The McAb Bfl bound to
an epitope close to the surface of the outer mem¬
brane, but the fibrous capsular network radiating
from the bacterial surface was not labelled. Analy¬
sis by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) and immuno¬
blotting identified 3 high-A/r bands which resisted
heating and protease digestion but were partially
sensitive to sodium periodate treatment.
2. INTRODUCTION
Surface antigens play an important role in
bacterial virulence [1], Since variation in antigenic
expression may occur during in vitro subculture [2]
it is essential to define the antigens expressed by
bacteria before using them in pathogenicity stud¬
ies. B. fragilis is the most common anaerobic
organism isolated from clinical specimens [3];
however, little is known about the organisation of
the surface antigens. A number of reports indicate
that changes in bacteroides surface antigens occur
during in vitro subculture. Variation in capsula¬
tion of B. thetaiotaomicron was reported by Burt et
al. [4], Kasper et al. [5] identified a surface poly¬
saccharide which showed variation during in vitro
and in vivo growth. Non-homogeneous expression
of a heat-labile antigen by populations of the same
B. fragilis strain was reported by Schwan et al. [6].
Patrick and Reid [7] observed that capsulate B.
fragilis separated on a Percoll density gradient
gradually reverted to the non-capsulate form dur¬
ing successive in vitro subcultures.
In this study antigenic expression during in vivo
and in vitro growth of B. fragilis was investigated
using a monoclonal antibody McAb Bfl. Light
microscopy observations were made using im¬
munofluorescence, and the antigen was located on
the bacterial surface by electron microscopy and
immunogold labelling. The nature of the antigen
was investigated using SDS-PAGE and im¬
munoblotting.
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3. MATERIALS AND METHODS
3.1. Bacterial growth conditions
B. fragilis strains were grown to late exponen¬
tial phase in defined broth [8] at 37°C in anaerobic
jars using the procedure of Collee et al. [9], or in
an anaerobic chamber (Forma Scientific) with an
atmosphere of 80% N2, 10% H2 and 10% C02.
Identification was confirmed using the API 20A
system.
3.2. Production of monoclonal antibodies
A BALB/c mouse was immunized with B.
fragilis NCTC9343 whole cells. The mouse was
inoculated intraperitoneally (i.p.) each week for 3
weeks with 0.2 ml of bacterial suspension, and an
additional inoculation was given 4 days prior to
the fusion. Spleen cells from the immunized mouse
were fused with NSl-Ag4/l myeloma cells using
the polyethylene glycol fusion technique [10], Hy¬
brid cell lines were selected in RPMI1640 medium
containing hypoxanthine-aminopterin-thymidine
and 15% fetal calf serum (Gibco). Culture super¬
natant was screened for antibody to B. fragilis
NCTC9343 by enzyme-linked immunosorbent as¬
say (ELISA). Hybridoma supernatant was used in
all experiments.
3.3. Enzyme-linked immunosorbent assay (ELISA)
An indirect ELISA was used to screen for McAb
producing hybridoma cell lines. Wells of PVC
microtiter plates (Becton and Dickenson) were each
coated with bacteria (1 X 106 cells-ml"') sus¬
pended in 50 mM carbonate buffer, pH 9.6. The
plates were incubated at 37°C for 2 h and washed
3 times with phosphate-buffered saline, pH 7.4
(PBS) containing 0.05% Tween-20. Plates were
stored at - 20°C.
Hybridoma culture supernatant (100 pi) was
added to each well, the plates were incubated at
37°C for 1 h and washed as before (dilutions if
required were made in 1% BSA-PBS). Goat anti-
mouse IgG-alkaline phosphatase conjugate (Tago)
diluted 1:3000 in 1% BSA-PBS was added to
each well (100 /al) and the plates were incubated at
37°C for 1 h. After washing, 100 /til p-nitrophenyl
phosphate solution (1 mg-ml-1) (Sigma) in 50
mM carbonate buffer, pH 9.8, containing 1 mM
MgCl, was added to each well. The plate was
incubated at 37°C for 1 h; the reaction was stopped
with 100 fi\ 3 M NaOH and absorbance at 405 nm
was read using a Dynatech automatic plate reader.
3.4. Enrichment for bacterial variants
Capsulate and non-capsulate B. fragilis (de¬
fined by light microscopy) were separated by Per-
coll density gradient centrifugation [7].
Bacteria expressing the surface antigen recog¬
nised by McAb Bfl were enriched using im-
munoprecipitation. Organisms harvested by
centrifugation at 2500 X g for 15 min were washed
once in Ringer solution (RS). Cells were resus-
pended in Bfl hybridoma culture supernatant and
mixed for 60 min at room temperature. Bacteria
were washed 3 times and resuspended in 1 ml RS.
Sepharose beads coated with goat anti-mouse IgG
(Sigma) were washed in sterile RS and added to
the bacterial suspension. Beads were recovered by
sedimentation at 1 X g for 10 min and gently
washed 3 times in RS. The beads were resus¬
pended in 20 ml of defined medium and incubated
anaerobically at 37°C. Stock cultures were pre¬
pared by dispersing 1-ml aliquots and freezing at
— 70°C.
3.5. Preparation of antigen
Bacteria were extracted by the aqueous phenol
method of Westphal and Luderitz [11], The aque¬
ous phase was centrifuged at 10000 X g for 30 min
at 4°C to remove insoluble material, and the su¬
pernatant was lyophilised and stored at -20°C.
Bacteria were also extracted with a glycine buffer,
pH 5.0, containing EDTA. Bacteria harvested from
defined broth culture (500 ml) were resuspended
in 10 ml of 3 mM glycine buffer pH 5.0 containing
10 mM EDTA and incubated at 37°C for 30 min.
Whole cells were removed by centrifugation at
10000 X g for 30 min at 4°C and the extract was
stored at — 20°C. Extracts were treated with pro¬
tease or sodium periodate by the method of Cous-
land and Poxton [12],
3.6. Carbohydrate assay
The carbohydrate concentration was de¬
termined by the method of Morris [13] with D-glu-
cose as a standard.
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3.7. SDS-PAGE
This was performed on 10% vertical slab gels
using the Laemmli buffer system [14] at a constant
current of 40 mA per gel. A standard protein
mixture (Sigma) was used, with an Mr range of
116 000-14000.
3.8. Immunoblotling and enzyme immunoassay
The method of Towbin et al. was used, with the
following modifications [15]. Material was trans¬
ferred to nitrocellulose membrane (Transblot TM
Transfer Medium, BioRad) in 25 mM Tris, 192
mM glycine buffer, pH 8.3, containing 20%
methanol at 350 mA for 1.5 h. After washing for
10 min in Tris-buffered saline (20 mM Tris-HCl,
500 mM NaCl, pH 7.5; TBS) the membrane strip
containing the protein A/r standards was fixed
with 1% acetic acid and stained with amido black.
The rest of the membrane was placed in 3% bovine
serum albumin (BSA-TBS) for 16 h at 4°C. It was
then transferred into hybridoma culture super¬
natant, or an appropriately diluted antiserum, and
incubated for 2 h at room temperature. After 3
washes in 0.025% Tween-20/TBS, the membrane
was placed in goat anti-mouse IgG-alkaline phos¬
phatase conjugate (Tago) diluted 1:3000 in 1%
BSA-TBS and incubated for 1 h at room temper¬
ature. The membrane was washed 3 times in
Tween-20/TBS and placed in a solution of Fast
Red (Sigma) containing naphthol-AS-MX-phos-
phate (Sigma). Colour development took place be¬
tween 5 and 15 min, and the reaction was stopped
by washing in distilled water. All the above steps
were performed with gentle agitation throughout.
3.9. Immunogold labelling and electron microscopy
Bacteria were washed twice in 0.1 M sodium
cacodylate/HCl buffer, pH 7.2 (CB) and fixed in
CB containing 2% paraformaldehyde and 0.1%
glutaraldehyde for 1 h at 4°C. The cells were again
washed in CB, dehydrated in graded alcohols and
embedded in LR White resin. For gold labelling,
ultrathin sections on nickel grids were treated with
McAb Bfl followed by goat anti-mouse IgG 20-nm
gold conjugate (Janssen Pharmaceuticals). The
grids were washed in 0.1% BSA-TBS, pH 8.2, and
rinsed in distilled water. They were then stained
with uranyl acetate and lead citrate and examined
with a Philips 301 transmission electron micro¬
scope.
3.10. Immunofluorescence microscopy
Bacteria were suspended in PBS, fixed on multi-
test slides (Flow Laboratories) and treated with
McAb Bfl followed by rabbit anti-mouse IgG fluo¬
rescein isothiocyanate conjugate (Sigma). Slides
were then washed in PBS and examined under a
100 X objective with a Zeiss fluorescence micro¬
scope.
3.1 J. In vivo passage
Chambers were constructed and implanted in
Fig. 1. Electron micrographs of in vitro-grown H. fragilis
NCTC9343: (a) non-capsulate strain; (b) capsulate strain. Sec¬
tions were treated with monoclonal antibody Bfl and labelled
by the immunogold technique. Arrows indicate the capsule as a
fibrous network. Scale bar= 0.5 ;im.
the mouse peritoneal cavity as previously de¬
scribed [16].
4. RESULTS
Capsulate B. fragilis have an extracellular
fibrous network which is absent on non-capsulate
cells [17]. Electron microscopy and immunogold
labelling with McAb Bfl identified an antigen close







Fig. 2. Analysis of antigens extracted from B. fragilis
NCTC9343 by immunobloiting using monoclonal antibody Bfl
and immune mouse antiserum: antigen extracted with EDTA-
glycine buffer pH 5.0 from II. fragilis NCTC9343 (a and c),
and from enriched B. fragilis NCTC9343 (b and d) and aqueous
phase antigen extracted from B. fragilis NCTC9343 by the
phenol-water method (c). The concentrations of carbohydrate
loaded were: 100 pg in lanes (a) and (b), 50 pg in lanes (c) and
(d) and 15 pg in lane (e). Strips (a) and (b) were blotted with
McAb Bfl and strips (c). (d) and (e) were blotted with mouse
antiserum.
populations, but the fibrous network was not
labelled (Fig. 1). The proportion of labelled
organism did not increase when bacteria grown in
vivo were investigated (unpublished result).
Immunofluorescence was used to study reactiv¬
ity with other Bacteroides strains. Of the 10 B.
fragilis strains investigated, only one, a clinical
isolate, had strong cross-reactivity.
Immunoprecipitation with McAb Bfl enriched
populations for cells expressing the Bfl antigen.
Normal and enriched populations tested in the
API 20A system gave the same profiles. The Bfl
antigen was extracted from cells using a glycine
buffer pH 5.0 containing EDTA. Immunoblotting
with McAb Bfl and mouse antiserum detected 3
diffusely stained high-A/r bands (Fig. 2, lanes a
and c). Detection of antigen improved when ex¬
tracts from enriched cultures were used (Fig. 2.
lanes b and d). The antigen from enriched popula¬
tions was resistant to digestion with protease;
however, the intensity of the immunoblot was
reduced when the antigen extract was treated with
sodium periodate. The antigen resisted heating at
100°C for 3 min. No Bfl antigen was detected in
the aqueous phase from a phenol-water extract by
immunoblotting with either McAb Bfl (result not
shown) or mouse antiserum (Fig. 2, lane e).
5. DISCUSSION
Immunogold labelling demonstrated that the
the Bfl epitope was not expressed by all B. fragilis
NCTC9343 cells, although no structure was ob¬
served by electron microscopy which could be
associated with the labelling pattern. With the
fixation and staining methods used in this study,
capsulate cells had an extracellular fibrous net¬
work and non-capsulate cells no outer layers. A
narrow electron-dense layer, adjacent to the outer
membrane, has been observed on B. fragilis
NCTC9343 by electron microscopy after fixation
in osmium tetroxide and glutaraldehyde (unpub¬
lished result). The relationship between this layer
and the Bfl epitope remains to be determined.
Schwan et al. [6] also observed a similar
non-homogeneous staining pattern with 9 different
strains of B. fragilis using immunofluorescence
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and heterologous rabbit antiserum. This was re¬
lated to the expression of an antigen susceptible to
heating at 100°C for 30 min. The high Mr struc¬
ture containing the Bfl epitope could be a polysac¬
charide or a lipopolysaccharide since it is resistant
to protease digestion, boiling at 100°C for 3 min
and partially sensitive to sodium periodate. The
antigen was not detected in the aqueous phase of a
phenol-water extract; however, the insoluble pel¬
let removed from the aqueous phase by centrifuga-
tion at 10000 Xg could contain the Bfl epitope.
Alternatively, the antigen could be sensitive to
phenol treatment or soluble in the phenol phase.
Some types of lipopolysaccharide extracted from
Citrobacter strains were phenol-soluble [18]. Other
techniques for extracting lipopolysaccharide are
being investigated.
Immunoprecipitation with McAb Bfl is a useful
method of enrichment for B. fragilis cells ex¬
pressing the Bfl antigen. Repeated immunoprecipi¬
tation with McAb should produce homogeneous
populations of bacteria expressing the antigen of
interest. Bacteria not expressing the antigen re¬
main in suspension and can also be recovered.
Such homogeneous populations of bacteria could
be used to determine the factors controlling the
expression of surface antigens and to determine
which antigens are involved in the virulence of B.
fragilis.
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Capsulation of in vitro and in vivo Grown Bacteroides Species
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{Received 28 June 1985; revised 21 October 1985)
By centrifugation on a four step Percoll density gradient cells of Bacteroides species could be
separated according to the size of extracellular structure. The difference in size was visible by
both light and electron microscopy. Two structures were observed on Bacteroides fragilis by
electron microscopy, namely a fibrous network and an electron dense layer. An electron dense
layer was visible on Bacteroides ovatus only when stained with ruthenium red. B. fragilis cells
grown in the mouse peritoneal cavity did not produce a large fibrous network. An electron dense
layer was observed on some cells in the presence of ruthenium red stain and cells possessing this
layer were phagocytosed in vivo.
introduction
The obligate anaerobe Bacteroides fragilis is the Gram-negative anaerobic organism most
commonly isolated from clinical infections, e.g. bacteraemia, wound, intra-abdominal and
urogenital infections (Lindberg et al., 1979). Capsules have been associated with the virulence of
a number of bacteria (Robbins et al., 1980) and the extracellular layers observed on B. fragilis
may fulfil a similar function (Hofstad, 1984). Capsulation of B. fragilis and other Bacteroides
species is subject to variation both in capsule size and in the number of cells producing capsules
within a population (Babb & Cummins, 1978; Burt et al., 1978; Lindberg et al., 1979; Brook et
al., 1984). The factors influencing these variations have yet to be determined, although capsule
size can vary with the growth medium (Patrick & Reid, 1983). Two extracellular structures have
been observed by electron microscopy, a narrow electron dense layer close to the outer
membrane (Kaspereta/., 1977; Lindberg etal., 1979;Reid, 1983; Brook et al., 1984) and a more
extensive fibrous network (Patrick & Reid, 1983; Reid, 1983; Lambe et al., 1984). It has been
suggested that the difference in the appearance of these structures is related to the condensation
of hydrated extracellular material which occurs during preparation for the electron microscope
(Lambe et al., 1984). However, these authors did not define the populations examined with
respect to either the proportion of cells with extracellular structures or variation in the size of
extracellular structure examined by wet India ink stain and light microscopy.
We have previously reported the separation of B. fragilis cells with different sizes of
extracellular structures (or capsules) as defined by light microscopy and wet India ink negative
stain (Patrick & Reid, 1983). We now report on the ultrastructure of these separated populations
after electron microscopy and examine cells with initially large and small extracellular structures
after 24 h growth in the mouse peritoneal cavity.
methods
Bacterial culture. B. fragilis (NCTC 9343) was supplied by the Department of Bacteriology, University of
Edinburgh Medical School, B. fragilis (ATCC 23745) by the American Type Culture Collection, Rockville, Md,
USA, and B. ovatus (ATCC 8483) and B. fragilis (NCTC 10584) were departmental stock cultures. Bacteria were
Abbreviations'. EDL, electron dense layer; EM, electron microscopy; LM, light microscopy; OM, outer
membrane; RR, ruthenium red.
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grown in defined broth (van Tassell & Wilkins, 1978) and incubated at 37 °C in an atmosphere of H2 (90%) and
CO, (10%) in anaerobic jars. The standard anaerobic procedures of Collee et al. (1972) were used.
Separation ofbacteria. Bacteria were grown to late exponential phase in defined broth and layered onto a Percoll
(Pharmacia) discontinuous density gradient, centrifuged at 2600£ for 20 min in a bench centrifuge and the cells
from each interface of the gradient were removed as previously described (Patrick & Reid, 1983).
Microscopy. Capsulation was determined by light microscopy with eosin-carbol fuchsin negative staining
(Cruickshank, 1965). Bacteria were fixed for electron microscopy by washing and resuspending in 01 M-
cacodylate buffer (pH 6-8) containing 2-5% (v/v) glutaraldehyde and incubated for 1 h at 4 °C in the dark. The
bacteria were then washed in 01 M-cacodylate buffer containing 1% (w/v) osmium tetroxide and incubated at
room temperature for 3 h in the dark. Where cultures were stained with ruthenium red (Springer & Roth, 1973)
this was included at both fixation stages at a concentration of 1 mgml"1. Bacteria were then washed before
dehydration in a graded series of alcohols as follows: 50 %, 75 %, 95 % ethanol, absolute ethanol, water free absolute
ethanol and finally two washings in propylene oxide. Each step lasted 10-15 min. Preparations were then
embedded in Spurr resin and ultrathin sections were examined with a Philips 301 transmission electron
microscope.
In vivo culture of bacteria. Chambers were constructed and implanted in the mouse peritoneal cavity as
previously described (Patrick et al., 1984). The chambers were constructed with either 0-45 pm pore membrane
filters (Millipore), which excluded phagocytes, or 3 pm pore filters, which allowed their entry.
RESULTS
Light microscopy
Light microscopy (LM) of Bacteroides species stained negatively with wet India ink or eosin-
carbol fuchsin showed a range of capsule size, the largest being equivalent to the diameter of the
cell (Patrick & Reid, 1983). Cells with the largest size of capsule were easily distinguished by LM
and the proportion of cells with this structure apparently varied with the species and strain.
We separated cells with different capsule sizes on a four step Percoll gradient. Cells with large
capsules were found at the 0-20% (top) interface, cells with intermediate sizes of capsules at the
20-40% and 40-60% interfaces and cells with no capsules by LM at the 60-80% (bottom)
interface.
The pattern of bands observed with populations grown from laboratory stock cultures (normal
populations) showed that B.fragilis NCTC 9343 and NCTC 10584 each had less than 1 % of the
bacterial population with large capsules. B.fragilis ATCC 23745 had 17% of cells with large
capsules, whereas B. ovatus ATCC 8483 had 80% of cells with large capsules. Cells with
Fig. 1. Four step (20, 40, 60 and 80%) Percoll density gradients after centrifugation with B.fragilis
NCTC 9343. Tube 1, pattern of bands when laboratory stock culture was centrifuged. Tubes 2-5,
separation, on the same gradients, of cells from first subculture from each interface: 2, 0-20% (top)
interface; 3, 20-40% interface; 4, 40-60% interface; 5, 60-80% (bottom) interface.
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Table 1. Incidence offibrous network and electron dense layer in B. fragilis (NCTC 9343) and
B. ovatus (ATCC8483) after density gradient separation
Results were obtained by electron microscopy after separation on a discontinuous Percoll gradient (see
Methods): ++, extensive fibrous network: + , presence of structure; —, absence of structure.
Gradient position
0-20% Interface 20-40% Interface 40-60% 60% 60-80%
X
t 5 r
X Interface* Layer* Interface*
Structure B. fragilis B. ovatus B. fragilis B. ovatus B. fragilis B. ovatus B. fragilis
Fibrous
network + + + + + + + - -
Electron
dense layer + - + + l~ + - +
Fig. 2 (b, d) 2 (a, c) 4(o) 3(o, b) 4(6) 5 6
* B. ovatus cells remained in the 60% Percoll layer and did not accumulate at either the 40-60% or the 60-80%
interface.
intermediate capsules were present in all cultures except B. fragilis ATCC 23745. If cells from
the different interfaces were each subcultured in defined medium, the populations could be
enriched to some extent for the cells that predominated at that interface. The results for B.
fragilis NCTC 9343 are illustrated in Fig. 1. The identity of bacterial suspensions taken from the
Percoll interfaces of the enriched cultures was confirmed with the API 20A identification
system and suspensions were streaked out for single colonies to confirm the purity of the
cultures. Therefore the distribution of bacterial cells on the gradients could alter depending on
the culture inoculum and there was a degree of stability in capsule size during the first
subculture.
Electron microscopy of cells grown in vitro
The results are summarized in Table 1.
Cells of B. fragilis and B. ovatus with large capsules, as defined by LM (0-20% Percoll
interface), showed an extensive fibrous network which had a coarser appearance when stained
with ruthenium red (RR) (Fig. 2). B. fragilis cells also had an electron dense layer (EDL)
adjacent to the outer membrane (OM) (Fig. 2b, d).
Cells with less capsular material by LM (20-40 and 40-60% Percoll interfaces) had either a
marginal fibrous network or an EDL (Figs 3 and 4). In the case of B. ovatus an EDL was
observed only when stained with RR (Fig. 3).
Cells which lacked capsular material by LM (60-80% Percoll interface) had no extracellular
structures in the case of B. ovatus; however, an EDL was present in B. fragilis (Figs 5 and 6).
Therefore the range of capsule sizes observed by LM was also observed by EM and B. fragilis,
defined as noncapsulate by LM, had an extracellular EDL.
EM of B. fragilis grown in vivo
B. fragilis taken from the 0-20% (Fig. 2) and 60-80% (Fig. 6) Percoll interfaces was grown for
24 h in chambers implanted in the mouse peritoneal cavity (Patrick et al., 1984). The chambers
were constructed either to exclude or to allow the entry of phagocytic cells. EM indicated that
neither bacterial population produced large amounts of the fibrous network in vivo. Cells had
either small amounts of fibrous network or a narrow EDL or no outer layer, both in the presence
(Fig. la, b) and absence (Fig. 8a, b) of phagocytes. Where phagocytes entered the chamber, it
was apparent that cells with and without the EDL were phagocytosed (Fig. la, b).
All the results shown are representative of at least three replicate experiments.
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Fig. 2. Electron micrographs of cells from the 0-20% Percoll interface to illustrate the fibrous network
(arrowed) on B. ovatus ATCC 8483 (a) and B. fragilis ATCC 23745 (i), and the electron dense layer
(EDL) adjacent to the outer membrane (OM)of B. fragilis ATCC 23745, visible without ruthenium red
(RR) stain. Note the coarser appearance of the fibrous network after RR staining on B. ovatus
ATCC 8483 (c) and B. fragilis ATCC 23745 (d). Bar markers, 0-5 pm in micrographs and 100 nm in
insets showing detail of the outer layers. Abbreviations are the same for all figures.
Fig.3.ElectronmicrographsofBvatusATCC8483fromthe20-40%Percollint rfa eillust tthsm llam un soffibrouse w rk(arr d)visibleinth absenceofRRstain( )ndthEDLfibr usnetworkobserveaf rRRst i i g(b).Bm k rs,seF g.2.
o
Fig.4.Electronmicrographso~BfragilisNCTC9343f omtre20- 0%Pe llin rface,n tstainedwi hRR( )ndfroth40-60%Pe c llint fa ,stai ed withRR(6).Notethatcellshaveith rnEDLrsmallfibr unetworkndt th srbovisibitabsencfRRs i .Bma k rs,seF g.2.
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DISCUSSION
Some of the structural differences in capsular material observed in the present study reflect
different degrees of condensation with RR stain (Fig. 2); in the case of B. ovatus (Fig. 3) electron
dense material was observed only with RR stain. Lambe et al. (1984) suggested that the fibrous
network or glycocalyx condensed to form an EDL where it was not connected to more than one
cell. However, an EDL and a marginal fibrous network were observed on adjacent cells of B.
fragilis (Fig. 4), which by LM had similar sizes of capsules. Also, B.fragilis from the 60-80%
Percoll interface lacked any capsule by LM, yet possessed an EDL by EM. Therefore it is
possible that in some cases the EDL and fibrous network are different in nature. The ability of
the cells to produce these different sized capsules is a relatively stable trait because subculture
from the Percoll interfaces enriched populations for a particular size of capsule (Fig. 1).
An EDL of approximately 35 nm has been observed outside the OM in clinical isolates of B.
fragilis and some strains of Bacteroides thetaiotaomicron and Bacteroides vulgatus by EM after RR
staining (Rasper et al., 1977, 1979). Similar structures have been reported by Lindberg et al.
(1979) and Brook et al. (1984), but none of these authors reported the presence of fibrous
material. Babb & Cummins (1977) observed capsules one to four times the diameter of the cell by
negative stain and LM. These authors considered it likely that this structure differed from the
RR stained layer described by Kasper et al. (1977). These anomalies could be due to differences
in the composition of the culture media (Patrick & Reid, 1983). However, some of the pili-like
structures observed by Brook et al. (1984) in thin sections could be coarse fibrous network
similar to that observed after RR staining of cells from the 0-20% interface (Fig. 2c, d).
B. fragilis ATCC 23745, which possessed the RR staining layer, was reported to induce
abscesses in a rat model of intra-abdominal infection, whereas Bacteroides species lacking this
layer (e.g. B. vulgatus) did not. A crude preparation of polysaccharide material from strain
ATCC 23745, which was thought to correspond to the RR staining layer, produced abscesses in
the rat model in the absence of live bacteria (Onderdonk et al., 1977). Subsequent investigations,
however, indicated that this crude extract contained both capsular material and lipopolysac-
charide (Kasper et al., 1983). It was therefore unclear which of the outer layers of B.fragilis were
the important virulence determinants. In the present study, an EDL was observed on some of
the organisms grown in vivo. Large amounts of fibrous material were not produced in the mouse
model of infection, although some of the cells retained the ability to do so. We have previously
shown that after subculture in defined medium the fibrous network reappeared on up to 40% of
the 0-20% interface cells grown in vivo but on less than 1 % of the 60-80% interface cells (Patrick
et al., 1984). The lack of fibrous network in vivo may relate to the nutrients available in the
intraperitoneally implanted chambers. It remains to be seen, however, why a population with
the ability to produce a fibrous network is not selected, as studies in vitro indicate that the fibrous
network confers resistance to phagocytosis and this resistance is related to the total amount of
fibrous network present; preparations from the 60-80% interface were phagocytosed in vitro
(Reid & Patrick, 1984). It is interesting that populations of B.fragilis NCTC 9343 from the 0-
20% and 60-80% interfaces were resistant to killing by 20% normal human serum whereas B.
ovatus ATCC 8483, which lacked an EDL in the absence of RR stain, was susceptible (Reid,
1983). Cells possessing an EDL were phagocytosed in vivo, but these layers (Figs 7 and 8) cannot
be related to those observed on cells grown in vitro (e.g. Fig. 5) as material from the mouse may
adhere to the bacterial surface.
Clearly it is important to determine the role of the 'classical' capsule of Bacteroides species
(defined by wet India ink negative staining) in the pathogenicity of these organisms and also its
relationship to the EDL observed by EM. Immunoelectron and immunofluorescence
microscopy with monoclonal antibodies indicate that B. fragilis populations are antigenically
heterogeneous (Reid et al., 1985) and a monoclonal antibody with an epitope which is enriched
in cells from the 20-40% interface has been characterized (unpublished result). It therefore
seems that structural differences observed by EM are reflected by differences in antigenicity.
The authors thank Dr Evelyn Dermott for advice and encouragement during the preparation of this manuscript.
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1. SUMMARY
A specific DNA probe, containing a conserved
region of the insertion sequence IS1, was hy¬
bridised to dot blots of total genomic DNA from
2 oral and 5 intestinal Bacteroides spp. Using
Escherichia coli K12 as a positive control and
Pseudomonas aeruginosa, as a negative control,
DNA homologous to the probe could not be de¬
tected in Bacteroides corporis, Bacteroides inter¬
medins, Bacteroides ovatus, Bacteroides vulgatus,
Bacteroides thetaiotaomicron or 2 strains of
Bacteroides fragilis. The total DNA included
plasmid DNA of 30.2, 42.7 and 42.7 MDa from B.
fragilis, B. intermedins and B. corporis, respec¬
tively.
IS1 is commonly found in members of the
Enterobacteriaceae, and it was concluded that the
2 groups of bacteria are not closely related.
2. INTRODUCTION
Insertion sequences are a class of short trans-
posable elements which only encode determinants
associated with their own transposition [1], They
promote a number of genetic changes which in¬
clude insertions, deletions, inversions, duplications
and replicon fusions. They are considered to be
normal constituents of bacterial genomes and re¬
sponsible for many spontaneous mutations. They
also provide portable regions of homology for
homology-dependent recombination mechanisms
and may be the foci for major gene rearrange¬
ments during evolution [2]. The insertion sequence
IS1 was originally discovered as the cause of strong
polar mutations in the galactose operon of E. coli
K12 [3]. Determination of its base sequence of 768
bp has shown it to be the shortest functional
insertion sequence [4], and 2 open reading frames
within the element are conserved and required for
transposition [5,6],
A number of studies have shown that IS1 is
commonly present in the genomes of Enterob¬
acteriaceae. For example, there are 6-10 copies of
IS1 in the genome of E. coli K12 [7,8], 4-19 in E.
coli B [9], 3 in E. coli C [8], more than 40 in
Shigella dysenteriae and Shigella flexneri, 2 in
Shigella hoydii, 1 in Klebsiella aerogenes [8], and 1
or 2 in Serratia marcescens [8,10]. Other related
species such as E. coli W, Salmonella typhimurium
and Proteus mirabilis have either none or only one
copy [8,11], and Ohtsubo et al. [12] concluded that
the evolution of IS1 did not take place at the same
0378-1097/86/S03.50 © 1986 Federation of European Microbiological Societies
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time as the divergence of most of the bacterial
DNA. More distantly related species, such as P.
aeruginosa and Bacillus subtilis have no copies of
I SI [10]. Bacteroides spp. have not been screened
for the presence of IS1 before, although they are
closely associated with members of the Enterob-
acteriaceae in the mammalian intestinal tract.
In this study, 2 oral and 5 intestinal Bacteroides
spp. were screened for the presence of plasmid
DNA and DNA homologous to IS1.
3. MATERIALS AND METHODS
3.1. Organisms
The oral Bacteroides spp used were; B. inter¬
medins NCTC9336 and B. corporis ATCC33545.
The intestinal Bacteroides spp were; B. ovatus
ATCC8463, B. vulgatus NCTC10583, B. thetaio-
taomicron NCTC10582, B. fragilis NCTC9343 and
B. fragilis JC19 (a 1984 clinical isolate from the
Royal Victoria Hospital, Belfast). E. coli K12
NCIB10083 and P. aeruginosa 8602 [13] were used
as positive and negative controls, respectively. All
bacteria were maintained at — 70 °C. Identifica¬
tion of the Bacteroides spp. was confirmed using
the API 20A system.
3.2. Media
The Bacteroides spp. were initially grown on
5% human lysed-blood agar and then on basal
broth medium [14] in anaerobic jars at 37°C as
detailed by Patrick and Reid [15]. Cultures were
incubated aerobically to check for aerobic con¬
taminants. The other bacteria were grown aerobi¬
cally at 37 °C on nutrient agar and nutrient broth
(Oxoid).
3.3. Extraction of DNA and dot blotting
Cells from 500 ml of broth culture were
harvested by centrifugation (10000 Xg for 15
min), resuspended in 10 ml 0.1 M Tris-HCl buffer,
pH 8.0, lysed with lysozyme for 90 min at 37 °C as
described by Maniatis et al. [16], and 1.2 ml 20%
(w/v) SDS was added and the mixture was in¬
cubated for a further 20 min. Protein was removed
by repeated extraction with equal volumes of chlo¬
roform until the aqueous phase was almost clear.
An equal volume of cold absolute ethanol was
added, the DNA spooled out, dissolved in 10 ml
of SSC buffer (0.87 g-l_1 sodium chloride and
0.44 g-1"1 sodium citrate, pH 7.0) and treated
with RNase (Sigma) [16]. Further chloroform ex¬
tractions were done, an equal volume of cold
absolute ethanol added, the DNA spooled out,
dissolved in 3 ml SSC buffer and stored at 4°C
over chloroform. The integrity of the high molecu¬
lar weight DNA was checked by electrophoresis of
2.5 jug of each preparation at 2 V • cm 1 for 6 h in
a 0.5% agarose gel containing 0.25 mg • 1_1
ethidium bromide. DNA concentrations were
estimated as described by Maniatis et al. [16], and
2.5 jug of each dot-blotted onto a nitrocellulose
filter as described by Green et al. [17].
3.4. Hybridisation with the IS1 DNA probe
The specific IS1 DNA probe used was a 240-bp
HaeIII fragment from IS1-L (one of the IS1 copies
flanking the chloramphenicol resistance transpo-
son Tn9) in pJL3-1974 [18]. This fragment was
cloned into the Sma I site of pUC8 [19] by blunt-
end ligation with T4 ligase (Fig. 1). After digesting
pUC8 with a combination of EcoRI and Bam\\\.
the fragment was purified by 2 PAGE runs (5%
polyacrylamide and 4 V ■ cm-1 for 6 h). The frag-
Fig. 1. Construction of specific IS1 DNA probe. A Bam HI (v)
fragment of pJL3-1974 containing IS1-L of Tn9 was extracted
and a 240-bp Hae III (O) fragment cloned into the Sma I site
of pUC8. The 240-bp IS1 probe was extracted after digesting
pUC8 with Bam HI and FcoRl (□). Ampicillin resistance gene
(Ampr), chloramphenicol resistance gene (Camr), lactose op-
eron genes (lacOPZ). Plasmid sizes shown in Kb.
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ment was then end-labelled with [32P]GTP
(Amersham) using DNA polymerase I Klenow
fragment [16]. Extraction of DNA fragments from
gels, solutions for electrophoresis, solutions and
conditions for all enzymes (BRL), hybridisation
procedures and autoradiography were as described
by Maniatis et al. [16].
3.5. Detection and sizing of plasmids
Small-scale plasmid preparations of 10-ml broth
cultures were prepared as described by Maniatis et
al. [16] and plasmids were sized using the method
of Rochelle et al. [20].
4. RESULTS AND DISCUSSION
3 of the Bacteroides spp. B. fragilis NCTC9343,
B. intermedins NCTC9336 and B. corporis
ATCC33547, contained plasmid DNA of 30.2,
42.7 and 42.7 MDa, respectively. However, DNA
homologous to the IS1 probe was not detected in
total DNA from any of the Bacteroides spp. tested
(Fig. 2). Although the probe did not include the
whole of IS1, it was specific for IS1 DNA and
covered 13 and 201 bp of the 2 conserved reading
frames, insA and insB, respectively [5,6]. It can
therefore be concluded that IS1 is not present in
either chromosomal or plasmid DNA of the
Bacteroides spp. tested.
Transfer of antibiotic resistance plasmids be¬
tween various Bacteroides spp. [21,22] and be-
abcdefghi
Fig. 2. Dot hybridisations of bacterial DNAs probed with IS1
DNA. E. coli K12 NCIB10083 (a), B. intermedius NCTC9336
(b), B. corporis ATCC33545 (c), B. ovatus ATCC8483 (d), B.
vulgatus NCTC10583 (e), B. thetaiotaomicron NCTC10582 (f),
B. fragilis NCTC9343 (g), B. fragilis JC19 (h) and P. aeru¬
ginosa 8602 (i).
tween Bacteroides spp. and E. coli [23,24] has
been demonstrated. Therefore, the dissemination
of IS1 among intestinal Bacteroides spp. might be
expected because of their close association with
members of the Enterobacteriaceae. There are 2
possible explanations for the results obtained.
Bacteroides spp. may have diverged from the En¬
terobacteriaceae before IS1 evolved and genetic
transfer has not occurred between the two groups
of bacteria. Alternatively, Bacteroides spp. and
Enterobacteriaceae may be very distantly related
and, although there is some genetic interchange
between them, IS1 cannot function or be stably
maintained in Bacteriodes spp. There is some evi¬
dence that the latter may be the case. Although
the chondroitin lyase gene from B. thetaiotao¬
micron cloned into E. coli was expressed, the
protein had a lower molecular weight [25]. This
suggests that E. coli RNA polymerase may recog¬
nise different start and stop signals. Also, the
transposon Tn4400, which codes for clindamycin
resistance in B. fragilis, carries a tetracycline gene
which is not expressed in B. fragilis. However,
when cloned into E. coli, Tn4400 can express
tetracycline resistance [26]. It is therefore possible
that E. coli genes are not readily expressed in
distantly related Bacteroides spp and that IS1
could not function as a transposon.
ACKNOWLEDGEMENTS
MJL & DRW were supported by the Science
and Engineering Research Council (Grant No.
GR/C/37800).
REFERENCES
[1] Kleckner, N. (1981) Annu. Rev. Genet. 15, 341-404.
[2] Iida, S., Meyer, J. and Arber, W. (1983) In Mobile Genetic
Elements (Shapiro, J.A., Ed.), pp. 159-221. Academic
Press, London.
[3] Jordan, E., Saedler, H. and Starlinger, P. (1968) Mol. Gen.
Genet. 102, 253-263.
[4] Ohtsubo, H. andd^htsubo, E. (1978) Proc. Natl. Acad. Sci.
USA 75, 615-619.
[5] Ohtsubo, H., Nyman, K., Doroszkiewicz, W. and Ohtsubo,
E. (1981) Nature 292, 640-643.
334
[6] Machida, Y., Machida, C. and Ohtsubo, E. (1984) J. Mol.
Biol. 177, 229-245.
[7] Saedler, H. and Heiss, B. (1973) Mol. Gen. Genet. 122,
267-277.
[8] Nyman, K., Nakamura, K., Ohtsubo, H. and Ohtsubo, E.
(1981) Nature 289, 609-612.
[9] Hu, M. and Deonier, R.C. (1981) Gene 16, 161-170.
[10] Brahma, N., Schumacher, A., Cullum, J. and Saedler, H.
(1982) J. Gen. Microbiol. 128, 2229-2234.
[11] Nisen, P., Purucher, M. and Shapiro, L. (1979) J. Bacteriol.
140, 588-596.
[12] Ohtsubo, E., Nyman, K., Nakamura, K. and Ohtsubo, H.
(1981) In Genetic Engineering, Vol. 3 (Setlow, J.K. and
Hollaender, A., Eds.), pp. 35-55. Plenum Press, New
York.
[13] Brammer, W.J.. Clarke, P.H. and Skinner, A.J. (1967) J.
Gen. Microbiol. 47, 87-102.
[14] Deacon, A.G., Duerden, B.I. and Holbrook, W.P. (1978)
J. Med. Microbiol. 11, 81-99.
[15] Patrick, S. and Reid, J.H. (1983) J. Med. Microbiol. 16,
239-241.
[16] Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982)
Molecular Cloning: A laboratory Manual, Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY.
[17] Green, L., Miller, R.D., Dykhuizen, D.E. and Hartl, D.L.
(1984) Proc. Natl. Acad. Sci. USA 81, 4500-4504.
[18] Ishizaki, K. and Ohtsubo, E. (1984) Cold Spring Harbor
Symp. Quant. Biol. 49, 207-213.
[19] Vieira, J. and Messing, J. (1982) Gene 19, 259-268.
[20] Rochelle, P.A., Fry, J.C., Day, M.J. and Bale, M.J. (1985)
J. Gen. Microbiol. 132, 53-59.
[21] Butler, E., Joiner, K.A., Malamy, M., Bartlett, J.C. and
Tally, F.P. (1984) J. Infect. Dis. 150, 20-24.
[22] Privitera, G., Dublanchet, A. and Sebald, M. (1979) J.
Infect. Dis. 139, 97-102.
[23] Burt, S.J. and Woods, D.R. (1976) J. Gen. Microbiol. 93,
405-409.
[24] Rotimi, V.O., Duerden, B.I. and Hafiz, S. (1981) J. Med.
Microbiol. 14, 359-370.
[25] Guthrie, E.P., Shoemaker, N.B. and Salyers, A.A. (1985)
J. Bacteriol. 164, 510-515.
[26] Robillard, N.J., Tally, F.P. and Malamy, M.H. (1985) J.
Bacteriol. 164, 1248-1255.
19
Reid JH, Patrick S and Tabaqchali S.
1987.
Immunochemical characterisation of a polysaccharide antigen of Bacteroidesfragilis
with an IgM monoclonal antibody.
Journal of General Microbiology 133, 171-179.
Journal of General Microbiology (1987), 133, 171-179. Printed in Great Britain 171
Immunochemical Characterization of a Polysaccharide Antigen of
Bacteroides fragilis with an IgM Monoclonal Antibody
By JOHN H. REID,'*t SHEILA PATRICK2 and SOAD TABAQCHALI1
1 Department of Medical Microbiology, St Bartholomew's Hospital Medical College,
London EC1A 7 BE, UK
1 Department of Microbiology and Immunobiology, The Queen's University of Belfast,
Grosvenor Road, Belfast BT12 6BN, UK
(Received 4 March 1986; revised 23 July 1986)
An IgM mouse monoclonal antibody (McAb) Bf4 was produced to a surface polysaccharide of
Bacteroides fragilis NCTC 9343. Immunoblotting showed that McAb Bf4 reacted strongly with
a high molecular mass structure which was sensitive to oxidation with periodate but resisted
protease treatment. An inhibition enzyme-linked immunosorbent assay (ELISA) indicated that
McAb Bf4 did not cross react with the sixteen Bacteroides species and strains tested. Cells of B.
fragilis NCTC 9343 recovered from the various interfaces of a Percoll discontinuous density
gradient were tested in the inhibition ELISA. Bacteria from the 0-20%, 20-40% and 40-60%
interfaces inhibited the ELISA; however, cells from the 60-80% interface did not. Electron
microscopy with immunogold labelling showed that McAb Bf4 did not react with the
extracellular fibrous network on bacteria recovered from the 0-20% interface, or the
extracellular electron dense layer on cells from the 60-80% interface; however, it was associated
with a surface structure on cells from the 20-40% interface. Growth in vivo did not enrich for
bacteria with this structure.
introduction
Bacteroides fragilis is the most common Gram-negative anaerobic organism isolated from
clinical specimens (Gorbach & Bartlett, 1974; Duerden, 1980). However, the factors responsible
for the enhanced virulence of this species are unknown despite the development of a number of
models for studying the pathogenic mechanisms of bacteroides (Hofstad, 1984). Previous
reports have suggested that the capsular polysaccharide of B. fragilis may represent a virulence
factor (Onderdonk et al., 1977; Connolly et al., 1984).
A number of B. fragilis surface antigens have been identified (Kasper, 1976; Babb &
Cummins, 1978; Cousland & Poxton, 1983; Lambe et al., 1984; Weintraub el al., 1985), but little
is known about the distribution and expression of these structures. Variation in the degree of
capsulation of B. fragilis occurs during passage in vitro and in vivo (Kasper et al., 1980; Patrick &
Reid, 1983; Patrick et al., 1984). Cells of B. fragilis with different sizes of capsule can be
separated on a Percoll density gradient and appear to differ structurally when examined by
electron microscopy (Patrick et al., 1986). The relationship between the surface structures
observed by us and either the surface polysaccharide described as 'capsule' by Kasper (1976) or
the glycocalyx reported by Lambe et al. (1984) is unknown. Characterization of these antigens
using highly specific monoclonal antibodies (McAbs) and immunochemical techniques, e.g.
immunoblotting and electron microscopy with immunogold labelling, will provide a way of
comparing the surface structures identified by different research groups. McAbs have been
produced to rough LPS molecules of B. fragilis (Linko-Kettunen et al., 1984) and a high
molecular mass surface structure on B. fragilis (Reid et al., 1985).
t Present address: Coralab Research, Huntingdon Road Laboratories, Cambridge CB3 0DJ, UK.
Abbreviations: McAb, monoclonal antibody; TBS, Tris-buffered saline; CB, cacodylate/HCl buffer; PCP,
phenol-chloroform-petroleum.
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In this study immunoblotting was used to define the immunochemical nature of the structure
recognized by McAb Bf4 and an inhibition enzyme-linked immunosorbent assay (ELISA) was
used to determine the specificity for Bacteroides strains and species. The distribution of the
Bf4 epitope on B. fragilis populations grown in vitro and in vivo was investigated using
immunofluorescence and electron microscopy with immunogold labelling.
METHODS
Bacterial growth conditions. The Bacteroides strains used in this study were as follows: B. fragilis NCTC 9343
from the Department of Microbiology and Immunobiology, the Queen's University of Belfast, UK; B. fragilis
GNAB4 from the Department of Bacteriology, Edinburgh University Medical School, UK; B. ovatus
ATCC 8483, B. distasonis ATCC 8503, B. thetaiotaomicron NCTC 10582, B. fragilis ATCC 23745, NCTC 9344,
NCTC 10584, NCTC 8560 and clinical B. fragilis isolates Bfl2, Bfl7, Bfl8, Bfl9, Bf20, Bf21, Bf25 and Bf30 from
the Department of Medical Microbiology, St Bartholomew's Hospital Medical College, London, UK. B. fragilis
strains grown to late exponential phase in defined broth (van Tassell & Wilkins, 1978) or on horse blood agar plates
were incubated at 37 °C in an anaerobic chamber (Forma) with an atmosphere of 80% (v/v) N2, 10%(v/v) H, and
10% (v/v) CO,. Identification was confirmed using the API system.
Production of McAhs. A BALB/c mouse was immunized with whole cells of B. fragilis NCTC 9343. The mouse
was inoculated intraperitoneally each week for 3 weeks with 0-2 ml of a bacterial suspension of 10 x 10s c.f.u. in
one-quarter strength Ringer's solution, and an additional inoculation of 0-2 ml was given 4 d before fusion. Spleen
cells from the immunized mouse were fused with x 63 Ag-8.653 myeloma cells using the polyethylene glycol fusion
technique (Lemke et al., 1978). Hybrid cell lines were selected in RPMI 1640 medium containing hypoxanthine-
aminopterin-thymidine and 15% (v/v) foetal calf serum (Gibco). Hybridoma culture supernate was screened for
antibody to B. fragilis NCTC 9343 by ELISA (see below). Hybridoma culture supernate was used in all
experiments.
The hybridoma cell line Bf4 was cloned using a limiting dilution method and BALB/c macrophages were used to
assist the growth of hybridoma clones. Cells were concentrated by centrifugation and 1 ml samples stored at
— 80 °C in growth medium containing 15 % (v/v) foetal calf serum and 10% (v/v) dimethyl sulphoxide. Hybridoma
cells from this stock were used to produce large quantities of hybridoma Bf4 culture supernate.
ELISA. An indirect ELISA was used to screen for McAb producing hybridoma cell lines. Wells of PVC
microtitre plates (Becton and Dickenson) were each coated with bacteria (1 x 106 cells ml"1) suspended in 50 mM-
sodium carbonate buffer, pH 9-6. The plates were incubated at 37 °C for 2 h and washed three times with 50 mM-
sodium phosphate buffer, pH 7-4, containing 150 mM-NaCl (PBS) and 0-05% (v/v) Tween 20. Plates were stored at
-20 °C.
Hybridoma culture supernate (100 pi) was added to each well, and the plates were incubated at 37 °C for 1 h and
washed as before [dilutions, if required were made in PBS containing 1 % (w/v) bovine serum albumin (BSA-
PBS)]. Goat anti-mouse IgM (Mu chain specific) and IgG-alkaline phosphatase conjugates (Tago) diluted 1 in
3000 in 1 % (w/v) BSA PBS were added to each well (100 pi) and the plates were incubated at 37 °C for 1 h. After
washing, 100 pi of p-nitrophenyl phosphate (Sigma) (1 mgml"1) in 50 mM-sodium carbonate buffer, pH 9-8,
containing 1 mM-MgCl, was added to each well. The plate was incubated at 37 °C for 1 h; the reaction was stopped
with 100 pi 3 M-NaOH and absorbance (at 405 nm) was read using a BioRad automatic plate reader.
An inhibition ELISA was used to test for cross reactivity with other bacteroides. Bacteria suspended in 0-5 ml
2% (w/v) BSA in PBS to a concentration of 5-0 x 10s c.f.u. ml"1 were mixed with 0-5 ml of hybridoma culture
supernate containing McAb Bf4 and incubated at 4 °C for 18 h. After centrifugation at 5000g, triplicate samples
(100 pi) of the supernate were tested on ELISA plates coated with B. fragilis NCTC 9343.
An ELISA was used to determine the immunoglobulin class of McAb Bf4. Sheep anti-mouse IgG2a (Serotec),
goat anti-mouse IgGl (Sigma), IgG2b (Sigma), IgG3 (Sigma) and IgM (Sigma) were diluted in 50 mM-sodium
carbonate buffer, pH 9-6, and coated onto PVC microtitre plates as before. Hybridoma culture supernate (50 pi)
was added to each well; the plates were incubated for 2 h at 37 °C, and then washed as before. Goat anti-mouse
IgG (specific for light and heavy chains) conjugated to horse-radish peroxidase (Sigma) was diluted 1 in 1000 in
1 % (w/v) BSA in PBS and 50 pi was added to each well. The plates were incubated at 37 °C for 1 h and washed as
above. Orthophenylene diamine (Sigma) substrate (40 mg) was dissolved in 100 ml of a solution containing
100 mM-citric acid, 200 mM-Na2HP04 and 0-01 % (w/v) H,02; 50 pi of the solution was added to each well and the
plates were incubated for 30 min; the reaction was stopped with 1 m-H,S04 and the absorbance read at 520 nm.
Enrichment for bacterial variants. Capsulate and non-capsulate B. fragilis (defined by light microscopy) were
separated by Percoll density gradient centrifugation (Patrick & Reid, 1983).
Preparation ofantigens. Antigens were extracted from bacteria by the aqueous phenol method of Westphal &
Luderitz (1954). The aqueous phase was centrifuged at 10000 g for 30 min at 4 °C to remove insoluble material and
the supernate was stored at — 20 °C.
Antigens from bacteria were also extracted with a glycine buffer containing EDTA. Bacteria harvested from
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500 ml broth were resuspended in 10 ml 3 mM-glycine buffer, pH 5 0, containing 10mM-EDTA, and were
incubated at 37 °C for 30 min. Whole cells were removed by centrifugation at 10000 g for 30 min at 4 °C and the
extract was stored at — 20 °C. Extracts were treated with protease or sodium periodate by the method of Cousland
& Poxton (1984).
Carbohydrate assay. The anthrone method of Morris (1948), with D-glucose as a standard, was used.
SDS-PAGE. This was done on 10% vertical slab gels using the Laemmli buffer system (Laemmli, 1970) at a
constant current of 40 mA per gel.
Immunoblotting and enzyme immunoassay. The method of Tdwbin et at. (1979) was used with the following
modifications. Material was transferred to a nitrocellulose membrane (Transblot TM transfer medium; BioRad)
in 25 mM-Tris/192 mM-glycine buffer, pH 8-3, containing 20% (v/v) methanol at 350 mA for 1-5 h. After washing
for 10 min in Tris-buffered saline (TBS; 20 mM-Tris/HCl, 500 mM-NaCl, pH 7-5) the membrane strip containing
the protein molecular mass standards was fixed with 1 % (v/v) acetic acid and stained with amido black. The rest of
the membrane was placed in 3% (w/v) BSA in TBS (BSA-TBS) for 16 h at 4°C. It was then transferred into
hybridoma culture supernate, or an appropriately diluted mouse derived antiserum, and incubated for 2 h at room
temperature. After three washes in 0-025% (v/v) Tween 20 in TBS, the membrane was placed in goat anti-mouse
IgM-alkaline phosphatase conjugate (Tago) specific for the Mu chain, then diluted 1 in 3000 in 1 % (w/v) BSA in
TBS and incubated for 1 h at room temperature. The membrane was washed three times in Tween 20-TBS and
placed in 50 mM-Tris/HCl buffer, pH 8-2, containing Fast Red (3 mg ml"1) and naphthol-AS-MX-phosphate (0-2
mg ml"1). Colour development took place in 5-15 min, and the reaction was then stopped by washing in distilled
water. All the above steps were done with gentle agitation throughout.
lmmunogold labelling and electron microscopy. Bacteria were washed twice in 100 mM-sodium cacodylate/HCl
buffer, pH 7-2 (CB), and fixed in CB containing 2% (v/v) paraformaldehyde and 0-1 % (v/v) glutaraldehyde for 1 h
at 4 °C. The cells were again washed in CB, dehydrated in graded alcohols and embedded in LR white resin. For
gold labelling, ultrathin sections on nickel grids were treated with McAb Bf4 followed by goat anti-mouse IgM-
40 nm gold conjugate (Janssen). The grids were washed in 0-1 % (v/v) BSA-TBS, pH 8-2, and rinsed in distilled
water. They were then stained with uranyl acetate and lead citrate and examined with a Philips 301 transmission
electron microscope. Ruthenium red staining was done as described previously (Patrick et at., 1986) before the
bacteria were embedded in LR white resin.
Immunofluorescence microscopy. The method was described by Reid et al. (1985).
RESULTS
SDS-PAGE and immunoblotting of the phenol-water extract
Reactions with polyclonal mouse antiserum. SDS-PAGE and immunoblotting with homologous
anti-B. fragilis NCTC 9343 antiserum detected multiple bands (Fig. lc). A diffuse staining
pattern and a series of closely spaced discrete bands (arrowed S) were detected at the top of the
blot. A series of regularly spaced discrete bands was observed in the middle of the blot (labelled
R + n). At least two heavily stained bands were seen in the lower region of the blot.
Reaction with McAb Bf4. Staining was observed only in the high molecular mass region when
McAb Bf4 was used for immunoblotting (Fig. 17>). McAb Bf4 reacted strongly with both the
diffuse staining region and the closely spaced discrete bands.
Treatment ofantigen with protease, periodate and heat. The structure recognized by McAb Bf4
resisted protease digestion (result not shown) and the immunoblot was identical to that for the
control antigen (Fig. 1 b). Oxidation of the antigen preparation with sodium periodate destroyed
the Bf4 antigenic determinant (Fig. 1 a). Pleating at 100 °C for 3 min did not destroy the structure
containing the Bf4 epitope.
SDS-PAGE and immunoblotting ofglycine-EDTA extract
Immunoblotting of the glycine-EDTA extract after SDS-PAGE with McAb Bf4 revealed
multiple closely spaced discrete bands and at least four extra bands in the high molecular mass
region of the blot (Fig. 2b, d). Protease treatment did not affect the closely stained bands but the
extra bands in the top region of the blot disappeared (Fig. 2c). Oxidation with sodium periodate
removed the closely spaced bands, but multiple faintly immunoreactive bands were detected in
the lower region of the blot after treatment (Fig. 2a).
ELISA
McAb Bf4 was identified as an IgM antibody using a sandwich ELISA.
Inhibition studies were done to test the reactivity of McAb Bf4 with other Bacteroides species













Fig. 1. SDS-PAGE and immunoblot analysis of
aqueous phase antigens extracted from B. fragilis
NCTC 9343 by the hot phenol-water method. Perio-
date treated antigen (a) and control (b) were blotted
with McAb Bf4; control antigen was also blotted
with immune mouse antiserum (c). Carbohydrate
loaded was 15 gg per lane.
and strains. Also, cells of B. fragilis NCTC 9343 recovered from the various interfaces of a
Percoll discontinuous density gradient were tested for expression of the Bf4 antigen.
B. ovatus ATCC 8483, B. distasonis ATCC 8503 and B. thetaiotaomicron NCTC 10582 did not
inhibit the ELISA. Four reference strains and nine clinical isolates of B. fragilis were also tested.
Inhibition was detected only with the homologous strain of NCTC 9343.
Bacteria recovered from the 0-20%, 20-40% and 40-60% interfaces of a Percoll
discontinuous density gradient inhibited the ELISA, but cells from the 60-80% interface did
not. No attempt was made to measure the minimum number of cells required to inhibit the
assay.
Immunofluorescence and immunoelectron microscopy
Immunofluorescence and immunoelectron microscopy of cells taken from the four interfaces
of the Percoll gradient gave the same pattern of labelling. The absence of the Bf4 epitope from
the 60-80% interface was confirmed. Cells from this interface are apparently non-capsulate by
light microscopy, but have an extracellular electron dense layer by electron microscopy (Patrick
Fig. 2. SDS-PAGE and immunoblot analysis of antigens extracted from B. fragilis NCTC 9343 with
mild heat and EDTA-glycine buffer, pH 5-0. Antigen treatments were periodate (a) with control (b),
and protease (c) with control (d). Carbohydrate loaded was 50 pg per lane.
et al., 1986). A low proportion of cells from the 0-20% (Fig. 3a) and 40-60% (not illustrated)
interfaces were labelled, but cells from the 20-40% interface were enriched for the Bf4 epitope
(Fig. 36). The surface structures of B. fragilis are not easily resolved with the fixation procedures
required to preserve the reactivity of the antigens for immunoelectron microscopy: therefore
duplicate samples were stained with ruthenium red. The results indicate that the Bf4 epitope is
associated with the marginal fibrous network present on cells from the 20-40% interface (Fig.
3 d), but not with the extensive fibrous network which is present on cells from the 0-20%
interface (Fig. 3c). Two other monoclonal antibodies (Bfl; Reid et al., 1985 and Bf2; not
illustrated) give a similar labelling pattern for each of the interfaces and could not be related to a
specific surface structure.
Cells from the 0-20% interface were grown for 24 h in chambers implanted in the mouse
peritoneal cavity (Patrick et al., 1984). These populations were not enriched for the Bf4 epitope
(Fig. 4). Similar labelling patterns were seen with these populations before and after in vivo
passage (Figs 3 a and 4).
DISCUSSION
Immunoblotting and immunoelectron microscopy showed that McAb Bf4 reacted with an
epitope on a high molecular mass surface polysaccharide. This structure was distinct from the
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Fig. 3. Electron micrographs of cells of B.fragilis NCTC 9343 recovered from the interfaces of a Percoll
discontinuous density gradient, (a) Cells from the 0-20% interface labelled with McAb Bf4 and anti-
mouse IgM immunogold conjugate, note the low proportion of gold labelled cells, (b) Cells from the 20
40% interface labelled as in (a); note that most of the cells are labelled, (c) Cells from the 0-20%
interface stained with ruthenium red; note the extensive fibrous network (*). (J) Cells from the 20 40%
interface stained with ruthenium red; note the marginal fibrous network (F) adjacent to the outer
membrane (OM); CM, cytoplasmic membrane. Bar = 0-5 pm in main micrographs and 100 nm in
Fig. 3(d) insert.
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Fig. 4. Electron micrograph of cells of B. fragilis NCTC 9343 taken from the 0-20% interface of a
Percoll gradient and passaged for 24 h in the mouse peritoneal cavity. Cells were labelled with
McAb Bf4 and anti-mouse IgM immunogold conjugate. Note the low proportion of cells labelled.
Bar = 0-5 pm.
extensive fibrous network, present on cells recovered from the 0-20% interface of a Percoll
density gradient, and the electron dense layer, present on cells from the 60-80% interface. It
was, however, associated with the marginal fibrous network observed on cells from the 20-40%
interface. These results indicate that structures which look different by electron microscopy may
also be antigenically different. Immunogold labelling of cells grown in the mouse peritoneal
cavity gave a heterogeneous labelling pattern which indicates that this epitope was not selected
in vivo.
ELISA inhibition studies showed that McAb Bf4 recognized a type-specific surface antigen.
Kasper et al. (1983) showed that extracted capsular polysaccharide from B. fragilis NCTC 9343
was chemically and antigenically different from that of B. fragilis ATCC 23745, and type-
specific epitopes were identified in the capsular material. This capsular material was detected in
the high molecular mass region of a 20% (w/v) acrylamide gel by silver staining (Weintraub et al.,
1985). Weintraub etal. (1985) also extracted LPS from B. fragilis NCTC 9343 by the hot phenol-
water method and subsequently extracted the aqueous phase with a phenol-chloroform-
petroleum (PCP) mixture: rough LPS only was detected with SDS-PAGE and silver staining.
However, B. fragilis NCTC 9343 could also contain smooth LPS with lor. * polysaccharide side
chains since the PCP extraction procedure preferentially extracts lipophilic rough LPS while
smooth LPS is excluded (Galanos et al., 1969). Cousland & Poxton (1983) have observed
heterogeneity in LPS extracted from a variety of B. fragilis strains by the hot phenol-water
method. They separated LPS extracted from B. fragilis GNAB 92 by electrophoresis on a 10%
(w/v) acrylamide gel and detected possible smooth LPS (labelled S) in the top of the blot.
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McAb Bf4 reacted with B. fragilis NCTC 9343 antigens in this region of the blot. McAb Bf4 did
not react with the typical LPS 'ladder' (Fig. lb, labelled R + n) in the middle of the blot,
suggesting that either the Bf4 epitope was not part of a repeating O-side-chain or the
concentration of the LPS containing short O-side-chains was below a detectable level when
using McAb Bf4. The epitope could be associated with a repeating capsular polysaccharide unit
but the polymer would need to be covalently linked to a lipid to bind SDS, or have a negative
charge for electrophoresis to occur.
E. coli LPS formed non-covalently linked multimers during SDS-PAGE when OT % (w/v) SDS
was used in 15 % (w/v) acrylamide separating gels (Peterson & McGroarty, 1985). The multimers
dissociated when 0-5% (w/v) SDS was used or when separating gels were overlayed with butanol
and left overnight. McAb Bf4 could also be reacting with multimers of B. fragilis NCTC 9343
LPS. The SDS-PAGE conditions were not altered in this study but the hypothesis could be
tested by increasing the SDS concentrations in both the sample buffer and the separating gel, or
by electro-eluting the high molecular mass material from the top section of the gel, and re-
analysing the material by SDS-PAGE and immunoblotting with McAb Bf4.
Poxton et al. (1985) detected protein-LPS complexes when outer membrane extracts of
Pseudomonas aeruginosa were immunoblotted with McAbs specific for the LPS O-antigen. This
report describes a similar observation using a glycine-EDTA extract of B. fragilis NCTC 9343
and immunoblotting with McAb Bf4. There are a number of possible explanations for this
phenomenon. First, protein-LPS complexes released by the glycine-EDTA treatment could
resist solubilization with SDS. Second, antigens could be completely solubilized by detergent but
co-migrate to the same position in the gel. Third, solubilized high molecular mass peptides could
become entangled with long polysaccharide chains containing the Bf4 epitope during
electrophoresis. The stability of antigen complexes could be investigated by affinity
chromatography. We now hope to purify the polysaccharide containing the Bf4 epitope using
affinity chromatography. The structure could then be chemically analysed to determine whether
it is a polysaccharide or a lipopolysaccharide.
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1. Abstract
Although Bacteroides fragilis is the Gram-negative anaerobic bacterium
most commonly isolated from clinical infections the nature of the surface
antigens involved in its virulence remains unclear. The homogeneity of surface
antigens within populations of B. fragilis has been assumed in much of
the published literature; however, electron microscopy and labelling with
monoclonal antibodies have revealed the heterogeneity of surface structures
and antigens within populations of individual strains of B. fragilis. Three
distinct extracellular structures of different size can be observed with the
electron microscope; namely a large capsule, a small capsule and an electron
dense layer. Bacteria with these structures can be separated by Percoll
density gradient centrifugation. Subsequent culture enriches for populations
carrying these structures. In-vitro studies of phagocytosis of B. fragilis
indicate that the large capsule impedes phagocytic uptake where it is present
in sufficient quantity; however, populations of B. fragilis NCTC 9343 growing
in the mouse peritoneal cavity rapidly lose the ability to produce this structure.
This occurs both in the presence and in the absence of phagocytes. Labelling
with a monoclonal antibody specific for the small capsule has shown that
(a) the population does not switch from production of the large capsule
to production of the small capsule and (b) that cells with the small capsule
are phagocytosed in vivo. Labelling with a number of different monoclonal





Bacteroides fragilis is a frequent isolate from such infections as bacteraemia,
wound, intra-abdominal and urogenital infection (1). As yet, the factors that
enable it to be a successful pathogen are not clearly understood. Extracellular
encapsulating structures have long been associated with the virulence of bacteria
(2) where they may act as a barrier to phagocytosis. Many investigations of B.
fragilis pathogenesis have centred on the possible role of similar structures in
its virulence (3).
A crude extract of extracellular polysaccharides from B. fragilis strain ATCC
23745 produced abscesses in a rat model of infection (4). Immunization of both
rats (5) and mice (6) with the crude extract protected against abscess formation
by this strain. The immunity was apparently T-cell mediated.
Pathogenic synergy between bacteroides and enterobacteria occurs in natural
infections. This may be related to the inhibitory effect of bacteroides on the
phagocytosis of other genera of bacteria. A number of researchers, e.g. Jones
and Gemmel (7) and Wei et al. (8), have examined the interaction of Bacteroides
spp. with other bacteria in in-vitro studies of phagocytic uptake and killing.
Undoubtedly the presence of Bacteroides spp. can diminish the phagocytic
uptake and killing of other bacterial species, probably because of the depletion
of opsonins they cause. This may be associated with some factor present in crude
extracts of the surface polysaccharides (9). The precise mechanism of the
protection afforded by Bacteroides spp. remains unknown.
A more detailed analysis of the surface carbohydrates of B. fragilis has shown
that aqueous phenol extractions of polysaccharide contain a complex mixture
of antigens. Most strains of B. fragilis have four different antigens, namely a
rough lipopolysaccharide (LPS), smooth LPS, a common carbohydrate antigen
and a high molecular weight polysaccharide (10).
The presence of fimbriae on some stains of B. fragilis has been associated
with susceptibility to phagocytosis and the ability to agglutinate erythrocytes
(11). It has also been suggested that capsules (12) and surface polysaccharides
(13) may be involved in haemagglutination.
Unfortunately in all the above studies qualitative and quantitative differences
in the surface structures and antigens within the populations examined were
largely unknown.
3. Definition of Surface Structures
A range of extracellular capsule sizes has been observed in wet India ink-stained
preparations of B. fragilis isolates examined by light microscopy (14). Size
differences occurred both within and between strains. Cells from B. fragilis
cultures can be separated according to the size of these surface structures by
Percoll step density gradient centrifugation (15). Bacteria with large capsules
Figure1.ElectronmicrographsofB.fragilisNCTC9343r wnind fin dD t .(a)tethcapsule(st r),bNt smallcapsu e(str ightarrow)ndheelectrondislay r(curvedow).Scbai lfigur s=0.5/mi.
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remain on top of the gradient and those with smaller capsules are found further
down the gradient. If bacteria are taken from the Percoll gradient interface layers
and subcultured there is some enrichment for the different sizes of capsules.
Therefore production of different sizes of capsules is a relatively stable trait
in in-vitro subculture.
Cells with the following extracellular structures can be seen within one strain
by electron microscopy (16):
1 . bacteria with a large fibrous network, corresponding to a large capsule
visible by light microscopy;
2. bacteria with a smaller fibrous network, corresponding to a small capsule
visible by light microscopy; and
3. bacteria with a marginal electron dense layer which appear to be non-
capsulate by light microscopy.
These three structures are illustrated in Figure 1 and will be referred to as the
large capsule, small capsule and electron dense layer (EDL) respectively. A
monoclonal antibody (McAb) has been produced which reacts specifically with
an epitope associated with the small capsule (17). This indicates that the small
capsule is antigenically different from the EDL. The proportion of cells with
these different structures can vary with the strain, nutrient availability and the
composition of the culture inoculum.
4. Surface Structures as Virulence Determinants: In-vitro Studies
Studies with populations homogeneous for the large capsule indicate that when
bacteria with this structure are present in sufficient quantity, in relation to
the numbers of human polymorphonuclear leukocytes (PMNL) present,
phagocytosis is impeded. It is probable that the large capsule mops up opsonin
present in normal human serum (18). Bacteria with the large capsule survive
better under aerobic conditions than cells with just the EDL (19). This has
implications in the initial stages of infections that result from faecal contamination.
In such cases enhanced tolerance of oxygen would be of advantage to B. fragilis.
Cells with either a large or a small capsule do not haemagglutinate erythrocytes,
whereas cells with the EDL haemagglutinate erythrocytes from a variety of
mammalian species (20). The EDL may also be associated with resistance to
killing by normal human serum (18).
5. Phagocytosis in vivo
5.1. Selection of populations
Intra-abdominal abscesses are commonly caused by B. fragilis (1) and the growth
and survival of B. fragilis in chambers implanted in the mouse peritoneal
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cavity has been studied (19). The growth of B. fragilis NCTC 9343, initially
homogeneous for either the large capsule or the EDL, was examined in
either the presence or the absence of leukocytes. The commonest phagocytes
found inside the chambers were PMNL at a concentration of approximately
106_7/ml.
Examination of populations initially homogeneous for the large capsule
indicated that the large capsule was not produced in vivo in either the presence
or absence of phagocytes (Figure 2). Neither was there any selection of bacteria
producing the large discrete capsule from populations initially homogeneous
for the EDL. There are a number of possible explanations for this phenomenon.
Firstly, the nutritional conditions in vivo may be such that the bacteria cannot
produce the large capsule. Secondly, the bacteria may no longer be producing
a discrete capsule, but releasing free slime. Finally there may be some selective
disadvantage in production of a large capsule.
To determine if the in-vivo grown cells were still capable of producing the
large capsule they were subcultured once in vitro and the proportion of cells
Figure 2. Electron micrographs of B. fragilis NCTC 9343, initially bearing the large
capsule, after 24 h growth in chambers implanted in the mouse peritoneal cavity (in vivo).
Note that the large capsule is now absent.
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Time (days)
Figure 3. Total viable count and the proportion of B. fragilis NCTC 9343 that produces
the large capsule (percentage capsulation) on subculture in defined broth: (®) after growth
in vivo in the presence of leukocytes; (o) after growth in vivo in the absence of leukocytes;
( a ) without growth in vivo. Note that the percentage capsulation after only in-vitro
subculture remains high.
with the large capsule recorded by examination with the light microscope
(Figure 3). Bacteria grown overnight in a broth culture of defined medium
continue to produce the large capsule; whereas, after 24 h growth in vivo, there
is a large decrease in the proportion of bacteria capable of producing the large
capsule. There was little difference in this result whether phagocytes were present
or absent. The total viable bacterial count (Figure 3) remained high during a
20-day period. This indicates that the phagocytes are having little impact on
the viable numbers of bacteria, although phagocytosis was observed by electron
microscopy (Figure 4).
5.2. Surface antigens
Structures similar in appearance to the EDL and the small capsule have been
observed on bacteria grown in vivo; however, the normal staining procedures
for electron microscopy do not distinguish between material of bacterial origin
and that of mouse origin. Mouse material could coat the bacterial cell surface.
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Figure 4. Electron micrographs of B. fragilis NCTC 9343, initially bearing the large
capsule, after 24 h growth in vivo. Note the phagocytosed bacteria.
Monoclonal antibodies provide specific probes which, coupled with immunogold
labelling, can identify known antigens. Unfortunately the fixation procedures
required to maintain the reactivity of the surface antigens result in the loss of
detail of the structures under the electron microscope. Therefore, in order to
characterize McAb, parallel samples must be fixed in the normal manner.
Bacteria that all expressed the large capsule before growth in vivo were labelled
with McAb Bf4 which is specific for an epitope associated with the small capsule
of B. fragilis NCTC 9343 (for details of characterization see Chapter 17). A
proportion of the population will bind the McAb (Figure 5a), but there is no
obvious enrichment for bacteria expressing this epitope, even after a 20-day
period in the mouse peritoneal cavity. The heterogeneous labelling pattern was
not caused by the washing procedures required for labelling as all the bacteria
in populations homogeneous for the small capsule were labelled, as were
in-vivo grown bacteria labelled with polyclonal antiserum (Figure 5b). Bacteria
carrying this epitope have also been observed inside phagocytic cells (Figure 5c).
This indicates that the samll capsule does not impede phagocytosis. When in-vivo
grown B. fragilis NCTC 9343 populations were labelled with McAb Bfl
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(Figure 5d), Bf2 and Bf5 (not illustrated) antigenically heterogeneous populations
were again observed. The epitopes labelled by these McAb do not appear to be
associated with structures identifiable by ordinary staining techniques. Bacteria
expressing these epitopes have also been observed inside phagocytic cells.
6. Conclusions
Although the large capsule can impede phagocytosis in in-vitro experiments,
it does not seem to play a role in a mouse model of peritoneal infection. This
highlights the importance of examining the growth of these bacteria in vivo.
It also raises the question of whether the mouse or human immune system could
already be primed to certain B. fragilis surface antigens as a result of its presence
in the gut, thus putting bacteria carrying these antigens at an immediate
disadvantage in an infection.
B. fragilis populations can vary considerably in the surface structures and
antigens produced within one strain. This has important implications in, firstly,
studies of phagocytosis, or indeed any aspect of the pathogenesis of this
bacterium, in which the possible role of surface structures is being investigated
and, secondly, the production of reliable diagnostic tests based on immunological
methods. Finally, it is possible that antigenic heterogeneity and the ability to
switch from the production of one surface structure to another may be one of
the most important virulence determinants of B. fragilis.
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Figure 1. B. intermedius: (a) fibrils on strain 18/23 (x 129000), (b) branched fibrous
processes ( x 95 000).
narrow layer, but in addition produced branched fibrous processes which extended far
from the cell wall (Figure lb).
All strains were hydrophobic: the %HP ranged from 23.8% (±2.7) for strain OMZ227,
to 72.6% (±4.2) for strain OMZ327. There was no relationship between %HP and the
appearance of the RR staining layer or fibrils. No strain caused significant agglutination
of sheep erythrocytes under the conditions described.
Thus, the cell surface of B. intermedius is fibrillar, capsulate, hydrophobic and carries
a layer of polyanionic surface material. It is not known if the three structures described,
which were detected by three different techniques, represent the same surface component.
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Iron Limitation and Induction of Congo Red
Binding in Bacteroides fragilis NCTC 9343
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The ability to chelate iron is an important virulence determinant of pathogenic bacteria
because iron is not readily available in body fluids. A number of successful pathogens
ABSTRACTS 217
produce membrane-bound and excreted chelators in order to trap iron for growth (1).
The ability of Gram-negative bacteria to bind congo red dye to their cell surface has
been linked to their ability to chelate iron (2,3). Many avirulent strains do not bind congo
red; however, their virulence is enhanced by iron supplementation. The possibility of
a similar mechanism(s) in Bacteroidesfragilis has not been investigated although it causes
a wide range of infections (4). B. fragilis shows an absolute requirement for haem (supplied
as haemin) in the medium, with or without iron supplementation (supplied as Fe3+).
When grown in defined medium with excess free iron and excess haem, congo red was
readily bound. This binding was strongly inhibited by haemin in the assay solution. When
grown in haem-limited defined medium, there was an increase in the capacity to bind
congo red as the concentration of free iron was lowered. This increase in congo red binding
under low-iron conditions was accompanied by the appearance of a 40 000 molecular
weight protein in an SDS-PAGE gel of an outer membrane protein preparation. Although
iron use by B. fragilis appears to be complex, it is postulated that there is an inducible
iron uptake mechanism activated under low-iron conditions.
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Fusobacteria and Tropical Ulcers
B. Adriaans and B. S. Drasar
London School of Hygiene and Tropical Medicine, London, UK
Tropical ulcer is an acute localized necrosis of the skin and subcutaneous tissues endemic
in, but not confined to, the tropics. The initial lesion is a small papule overlying an area
of necrotic dermis. The epidermis breaks down to reveal a circumscribed ulcer with regular
indurated margins (1). The aetiology of tropical ulcers is obscure. Some authors regard
the disease as a non-specific response to skin injury, although there is evidence that the
disease is transmissible (2). Reports on the bacteriology of these ulcers have concentrated
on aerobic culture in contrast to the plethora of reports mentioning the presence of fusiform
bacteria and spirochaetes seen in smears. These are fastidious organisms and thus unlikely
to have been detected in culture using the techniques described previously. We attempted
to study the role of these anaerobic bacteria in the pathogenesis of tropical ulcers.
We studied 120 patients with tropical ulcer in five locations in the tropics where the
condition is prevalent. We isolated several anaerobic organisms from the patients with
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The relationship between cell surface structure expression and haemagglutination
Bacteroidesfragilis.
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1. SUMMARY
Bacteroides fragilis populations were separated
according to the size of surface structure. Subcul¬
ture of the separated populations produced cul¬
tures enriched for 3 different structures; a large
capsule, a small capsule and an electron-dense
layer (EDL). The ability of these subpopulations
to haemagglutinate (HA) erythrocytes from a
number of species was examined. Populations
which produced either a large or a small capsule
did not have HA activity, whereas those with an
extracellular EDL did. By mixing populations with
EDL and those with either the large or small
capsule, the degree of HA could be altered. HA
was dependent on the proportion of EDL-bearing
bacteria present. Fimbriae were not observed on
electron microscopy.
2. INTRODUCTION
B. fragilis is the Gram-negative anaerobic
Correspondence to: S. Patrick, Dept. of Microbiology and Im¬
munology, The Queen's University of Belfast, Grosvenor Road,
Belfast BT12 6BN, U.K.
bacterium most commonly isolated from clinical
infection [1]. The precise virulence determinants
of this bacterium have yet to be determined, al¬
though surface structures may be involved [2],
Attachment to eukaryotic cells is an important
virulence determinant in a number of bacteria [3],
and the ability of bacteria to agglutinate erythro¬
cytes has been used as an indication of attachment
[4]. Apparently conflicting reports of haemag¬
glutination in B. fragilis have suggested that
fimbriae [5] and capsule [6,7] are involved. In
these studies the bacterial populations were almost
certainly heterogeneous with respect to surface
structure, as variation in both the size and nature
of surface structure occurs within individual popu¬
lations of B. fragilis [8]. 3 apparently different
surface structures have been observed by electron
microscopy. These are a large capsule, a small
capsule and an EDL. Populations enriched for one
or other of these structures can be obtained by
separation on a Percoll step density gradient and
subculture from the gradient interface layers. In
the present study the relationship between these
different surface structures and agglutination of
erythrocytes from a number of species was studied.
0378-1097/88/S03.50 © 1988 Federation of European Microbiological Societies
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3. MATERIALS AND METHODS
3.1. Bacterial growth conditions
B. fragilis strains were grown to late exponen¬
tial phase in either defined broth [9] or basal broth
[10] at 37°C in an anaerobic cabinet (Don Whit¬
ley) with an atmosphere of 80% N2, 10% H2 and
10% C02. Identification was confirmed with the
API 20A system. Escherichia coli was grown to
late exponential phase in nutrient broth, aerobi-
cally.
3.2. Separation of bacterial subpopulations
Bacterial populations with different sizes of
extracellular structures, as determined by light and
electron microscopy, were separated on a four-step
Percoll density gradient (20%, 40%, 60% and 80%
Percoll) as previously described [11]. Cells from
each interface layer (IL) were subcultured into a
defined broth. The subcultures from the gradient
IL were enriched for cells with the following struc¬
tures: 0-20% IL, large capsule; 20-40% IL, small
capsule; 40-60% IL, small capsule and EDL;
60-80% IL, EDL [8]. The Percoll separation was
repeated and the enriched populations then sub-
cultured into either defined broth or basal broth.
3.3. Haemagglutination tests
Washed suspensions of the enriched bacterial
populations in phosphate buffered saline were ex¬
amined for their ability to cause erythrocyte ag¬
glutination. Both the rocked tile test and the static
settling test as detailed by Old [12] were used with
a variety of different erythrocyte species. Bacterial
cell numbers were estimated with a Corning col¬
orimeter 252 at A600.
In the rocked tile test 0.04 ml of bacterial
suspension (concentration at least 1010 cells/ml)
was mixed with 0.04 ml of 2% (v/v) erythrocyte
suspension on a chilled ceramic tile and agitated
by hand. A positive result was recorded if HA
occurred within 5 min. In the static settling test,
0.1 ml of bacterial suspension (concentration as
specified in the results) was mixed with 0.1 ml of
erythrocyte suspension (2% v/v) in the cavities of
disposable WHO trays (L.I.P. Equipment and
Services Ltd). HA was normally recorded after lh
incubation at 4°C, the time taken for non-ag-
Table 1
Comparison of haemagglutination of a number of erythrocyte species by B. fragilis populations subcultured from the 0-20% a and
60-80% b interface layers of a step density gradient
Strain Interface Erythrocyte species




















a Enriched for large capsule
b Enriched for electron dense layer
c + Haemagglutination within 5 min; —, no haemagglutination.
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glutinated cells to sediment to the centre of the
cavity. Sugar inhibition of the haemagglutination
was investigated by the addition of an equal
volume of 2% (w/v) sugar solution. E. coli strain
G14 was used as a positive control in the haemag¬
glutination test.
3.4. Electron microscopy
Bacteria were negatively stained with 1% am¬
monium molybdate and viewed with a Philips 301
transmission microscope. A fimbriate strain of E.
coli, G14, was used as a positive control.
4. RESULTS
4.1. Rocked tile test for haemagglutination
Of the 6 B. fragilis strains tested, none of the
subpopulations with the large capsule haemag-
glutinated, whereas with the exception of strain
JC10, subpopulations with the EDL agglutinated
all the species of erythrocytes examined (Table 1).
None of the following sugar solutions inhibited
the haemagglutination of strains NCTC9343 and
JC19: D-arabinose, fucose, fructose, galactose, glu¬
cosamine, glucose, mannose, ribose or xylose. The
addition of Percoll to the erythrocytes did not
affect the haemagglutination reaction.
4.2. Static settling test for haemagglutination
The reaction of strains NCTC9343 and
ATCC23745 with human A, B and O blood groups
was also examined in the static settling test. At
bacterial concentrations of 1 X 1010 and 5 X 109,
only the EDL-enriched subpopulation haemag-
glutinated (Fig. 1). At cell concentrations of 2 X
1010, however, subpopulations with the large cap¬
sule were apparently positive. This may be due to
Fig. 1. Static settling test (SST) of HA with human group O
erythrocytes and defined broth (DB) grown B. fragilis
NCTC9343 (bacterial concentration 5xl09/ml). Populations
were enriched for (a) large capsule; (b) small capsule; (c) small
capsule and EDL; (d) EDL. Note strong positive HA only in
(d).
Fig. 2. SST as in Fig. 1 at bacterial concentrations/ml of: row
1, 2X1010; row 2, lXlO10; row 3, 5X109; row 4, 2.5 X109.
Populations were enriched for (a) large capsule; (b) small
capsule; (c) small capsule and EDL; (d) EDL. Photographed
after positive HA in EDL-enriched population had collapsed
inwards (e.g.. Id). Note apparent positive reaction in cavity la
(large capsule enriched)
the physical size of the large capsule preventing
the erythrocytes from settling into the centre of
the well. Even after a 2-h incubation period, by
which time the layer of erythrocytes agglutinated
by the EDL subpopulation had collapsed, the
large capsule subpopulation was still apparently
positive (Fig. 2). Suspensions of cells with the
large capsule, allowed to stand at room tempera¬
ture for a number of days, did not sediment to the
bottom of the container whereas populations
without did (not illustrated). Agitation of the sedi-
mented population returned the suspension to its
original turbidity. Therefore at bacterial con¬
centrations of 2 X 1010, and greater, false positive
results of haemagglutination may occur.
The four subpopulations were grown in a com¬
plex basal medium in which the 0-20% IL (large
capsule) enriched bacteria produced smaller cap¬
sules [13], The 0-20% IL enriched population did
not haemagglutinate (Fig. 3). There was, however,
a gradation in the degree of haemagglutination in
the other subpopulations. The EDL population
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a bed
Fig. 3. SST as in Fig. 1 with basal broth grown bacteria at
concentrations/ml of: row 1, lXlO10; row 2, 5xl09; row 3,
2.5 XlO9; row 4, 1.25 X109. Populations were enriched for (a)
large capsule; (b) small capsule; (c) small capsule and EDL;
(d) EDL. Note the gradation in HA with both the type of
enriched population (columns) and doubling dilution of cell
concentration (rows)
gave the strongest reaction. This is probably due







Fig. 4. SST as in Fig. 1 with B. fragilis ATCC23745 at bacterial
concentrations/ml of: row 1, 1X1010; row 2, 5X109; row 3,
2.5 XlO9; row 4, 1.25XlO9. The bacterial populations were
mixtures of EDL and large capsule enriched bacteria in a series
of proportions from 9 parts EDL: 1 part large capsule (line 1)
to 1 part EDL: 9 parts large capsule (line 9). Note increased
HA (from right to left) with greater proportion of EDL bearing
cells.
Subpopulations with the EDL and the large
capsule (grown in DM) were mixed in a series of
ratios from 1:9 to 9:1 and the ability of the
mixtures to haemagglutinate was examined. The
degree of haemagglutination correlated with the
proportion of bacteria with the EDL (Eigs. 4 and
5a). A similar gradation was obtained when the
EDL subpopulation was mixed with the small
capsule enriched populations (Fig. 5b).
5. DISCUSSION
The results clearly indicate that neither the
large capsule or the small capsule are involved in
HA, whereas, populations enriched for the EDL
do HA. HA tests with populations of B. fragilis
which are not homogeneous with regard to surface
structure may be difficult to interpret as the de¬
gree of HA observed in the static settling test
correlated with the proportion of EDL-carrying B.
fragilis.
No fimbriae were observed on electron mi¬
croscopy, which suggests that the adhesin is closely
associated with the cell surface. Possible adhesive
factors could include the EDL and outer mem¬
brane proteins. An adhesin which can either be
carried on fimbriae or associated with the cell
surface has been described in E. coli [14], In this
instance, the expression of fimbriae and the ad¬
hesin was shown to be under separate genetic
control. B. fragilis fimbriae with no apparent HA
activity have been well characterised [15], If the




Fig. 5. SST of HA with human group B erythrocytes and DB
grown B. fragilis NCTC9343 (bacterial concentration 5 X
109/ml). The bacterial populations were mixtures of EDL
enriched bacteria with (a) large capsule enriched; and (b) small
capsule enriched bacteria in a series of proportions from 9
parts EDL (column 1) to 1 part EDL (column 9). Control,
column 10 with no bacteria.
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and antigenic variation, as in for example Neis¬
seria gonorrhoea [16], adhesins of different speci¬
ficity may be expressed by different strains de¬
pending on which selective pressure are acting on
the bacterial population present.
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Expression of Bacteroidesfragilis fimbria! antigen in vitro and in vivo
DEBORAH LUTTON,* SHEILA PATRICK.*
JOOP van DOORN.t MICHAEL EMMERSON* and
GERRY CLARKE*
*Department ofMicrobiology and Immunobiology, Queen's
University ofBelfast, Grosvenor Road, Belfast BTI2 6BN,
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der Biologic, Vrije Universiteit van Amsterdam, Postbus 7161,
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Bacteroides fragilis is the Gram-negative anaerobic bac¬
terium most frequently isolated from clinical infections.
These include bacteraemia, wound, intra-abdominal and
urogenital infections. Populations within individual strains of
B. fragilis have been shown by transmission electron
microscopy (TEM) to be heterogeneous with respect to
surface structure. Subpopulations with the following surface
structures can be separated by Percoll density gradient
centrifugation: (a) large capsule; (b) small capsule; (c)
electron-dense layer (EDL); and (d) bald cells, i.e. no struc¬
ture visible outside the outer membrane. Subculture from
gradient interfaces results in enrichment of these subpopula-
tions [Ij. Fimbriae have been observed on a number of
B. fragilis strains and are composed of subunits with an
apparent molecular mass of 40 000-42 000 Da [2]. In the
present study, the relationship between encapsulating surface
structures and the presence of fimbrial antigen has been
studied both in vitro and in vivo.
Methods
Microscopy
Light microscopy and thin-section TEM were performed
as previously described [1], Platinum-gold shadowing was
carried out in a Balzer BAE 120 high-vacuum coating unit at
an angle of 20°.
Immunoblotting
Outer membranes were extracted in 3% (v/v) Sarkosyl,
subjected to polyacrylamide-gel electrophoresis (11%, w/v,
gel) and blotted on to nitrocellulose. For dot immunoblotting




Light microscopy and thin-section TEM of strain BE3
showed the presence of encapsulating surface structures
Abbreviations used: TEM, transmission electron microscopy;
EDL, electron-dense layer.
Fig. 1. TEM ofplatinum-gold-shadowed BacteroidesJ
strain BE3
J
(a) Population enriched for large capsules; (b) popj
enriched for small capsules; (c) population enriched f
EDL and non-capsulate by light microscopy. Scale bj
//m.
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similar do those already observed on other strains of
H frogilis [1], Platinum-gold-shadowed preparations, when
ticwcd by TEM, showed clumped fibrillar structures (Fig.
which corresponded to cells bearing a large capsule by
light microscopy and an extensive fibrous network in thin-
><Ction TEM. Subpopulations with the small capsule showed
shorter clumped fibrillar structures and extended individual
strands (Fig. lb).
These structures were not observed on cells which were
non-capsulate by light microscopy and have a narrow EDL
adjacent to the outer membrane by thin-section TEM (Fig.
if). These structures were not observed in preparations
Itcgatively stained with 1% (w/v) ammonium molybdate and
observed by TEM.
Inututnoblotting
(fl) B.fragilis grown in vitro: outer membranes. Popula¬
tions of B. fragilis strain BE3, enriched for different sizes of
encapsulating surface structure as defined by thin-section
TliM, were immunoblotted with antiserum to purified
fimbriae [2], Fimbria! antigen was detected predominantly in
populations with the small capsule and was either absent or
prcsdnt in reduced amounts in populations enriched for the
liirgc capsule, EDL, or bald cells. Immunoblotting of strain
NCTC9343, however, showed fimbrial antigen to be present
In populations enriched for the large capsule, small capsule
«nd EDL, but absent in populations enriched with bald cells.
(b) B. fragilis grown in vitro: whole-cell suspensions.
Immunoblotting of whole-cell suspensions of enriched
populations showed that the fimbrial antigen was associated
with the small capsule and the large capsule population of
ktrpln BE3 and present in all of the populations, with the
exception of bald cells, in strain NCTC9343. Fimbrial
antigen was also detected in all the following strains of
B.fragilis: NCTC9344, 10584; JC6, 10, 11, 14, 15, 17 and
19 (isolated from clinical specimens, Royal Victoria
Hospital, Belfast); GNAB92, 93 and 94 (supplied by Dr I.
Poxton, Department of Bacteriology, University of
Edinburgh); however, no consistent relationship beween the
expression of fimbrial antigen and the presence of the small
capsule has been found. This may be due to fimbriae of
different size altering the mobility of the bacteria during
Percoll density gradient separation or contamination by free
fimbrial antigen. At present the association of fimbrial
antigen with encapsulating surface structure is being pursued
using immunogold labelling and TEM.
(c) B. fragilis grown in vivo: outer membranes. B. fragilis
strains NCTC9343, BE3, GNAB92 and JC17 were grown
for 3 days in chambers implanted in the mouse peritoneal
cavity [3]. Fimbrial antigen was detected in all four strains by
immunoblotting. This indicates that it may be involved in the
virulence of this bacterium; however, the relative importance
of the different surface structures observed to the pathogenic
process remains to be determined.
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1. SUMMARY
The outer membrane protein (OMP) profiles of
four different strains of Bacteroides fragilis, as
determined by Coomassie blue stained poly-
acrylamide gels,. were compared after growth in
broth culture and in the mouse peritoneal cavity.
There was no induction of the expression of large
quantities of novel OMP after growth in vivo.
Mouse immunoglobulin G and albumin were asso¬
ciated with the bacterial OMP, but could be re¬
moved by washing.
2. INTRODUCTION
Bacteroides fragilis is an obligately anaerobic
bacterium which is frequently isolated from clini¬
cal infection resulting from faecal contamination
such as intra-peritoneal infections [1]. Although it
is a relatively minor component of the faecal flora
it accounts for approximately 40% of the bacterial
flora in the irrigation fluid from colonic lavage
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and colonic tissue specimens. This association with
the gut mucosa may contribute to its frequent
isolation from gut associated infection [2], It is
likely that the virulence of this bacterium is de¬
pendent upon a number of factors including the
expression of encapsulating polysaccharides, ex¬
pression of fimbriae, the ability to adhere to
eukaryotic cells, release of extracellular degrada-
tive enzymes and the production of enterotoxin
[3]. The ability to grow and express virulence
determinants in the nutritional conditions present
in the host is of prime importance to the success¬
ful pathogen. Iron is limiting to bacterial growth
in vivo as it is chelated to compounds such as
transferrin in body fluids. As a result of this, novel
OMP involved in iron uptake mechanisms are
induced during growth in vivo and under iron
limitation in in vitro laboratory culture in many
pathogens [4], Haem compounds and transferrin
can both be used by Bacteroides spp. as iron
sources in vitro [5].
Therefore to determine if B. fragilis produces
novel OMP in response to the nutritional condi¬
tions in vivo,., the expression of OMP was com¬
pared after growth in broth culture and in cham¬
bers implanted in the peritoneal cavities of mice.
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3. MATERIALS AND METHODS
3.1. Bacterial strains and growth conditions
The following Bacteroides fragilis strains were
used: strain NCTC9343, the type culture from the
National Collection of Type Cultures, U.K.; strain
GNAB92, a clinical isolate supplied by Dr I.
Poxton, University of Edinburgh, U.K.; strain
BE3, a clinical isolate supplied by Dr J. van Doom,
Free University of Amsterdam, NL; and strain
JC17, a clinical isolate obtained from the Royal
Victoria Hospital, Belfast. Cultures were grown in
defined medium broth [6] at 37 ° C in an anaerobic
cabinet (Don Whitley) with an atmosphere of 80%
N2, 10% H2 and 10% C02. Identification was
confirmed with the API20A system. Bacteria were
also grown in chambers sealed with 0.45 jam mem¬
brane filters (Millipore) and implanted into the
peritoneal cavity of mice as previously described
[7], Populations enriched for expression of an ex¬
tracellular electron dense layer visible by electron
microscopy, but non-capsulate by light mi¬
croscopy [8], were used as inocula.
3.2. SDS-PAGE and immunoblotting
Outer membrane protein preparations were ob¬
tained by placing bacterial suspensions of ap¬
proximately 2-4 X 109 cfu, either unwashed or
washed three times by centrifugation and resus-
pension in 1/4 strength Ringer's solution, in 1 ml
of 3% (w/v) V-lauroyl sarcosinate (Sarkosyl). The
samples were then rotated, end-over-end, for 30
min and centrifuged for 1 h in an Eppendorf
centrifuge 5414 at 9980 X g (P.A. Lambert, per¬
sonal communication, modified from Filip et al.
[9]). The supernatant was discarded and the pellets
stored at — 20 ° C until used. Samples were diluted
1:1 in SDS-reducing buffer (0.0625 M Tris-HCl,
pH 6.8) containing 10% (v/v) glycerol, 2% (w/v)
SDS, 5% (v/v) 2-mercaptoethanol and 0.001%
(w/v) bromophenol blue. Samples were heated at
95 ° C for 5 min before being applied to the gel.
SDS-PAGE was performed on 9% vertical slab
gels using the Laemlli [10] buffer system at a
constant current of 50 mA per gel. The gels were
then stained for protein with Coomassie blue [11].
For immunoblotting material was transferred onto
nitrocellulose membrane after the method of
Towbin et al. [12] as detailed in the Bio-Rad
Transblot Electrophoretic Transfer Cell instruc¬
tion manual (Bio-Rad Laboratories, U.S.A.). Gels
were equilibrated for 30 min in transfer buffer
prior to transfer overnight (18 h) at a constant
voltage of 30 V. The membrane was blocked by
incubation for 1 h at room temperature in 50:50
(v/v) horse serum: phosphate buffered saline
(PBS; pH 7.4). The membrane was then washed
five times in 0.05% (v/v) Tween-20/PBS and in¬
cubated with appropriately diluted rabbit anti-
mouse albumin conjugated to horseradish per¬
oxidase (Nordic) or goat anti-mouse immuno¬
globulin G (H + L) conjugated to horseradish per¬
oxidase (Bio-Rad) in PBS. The membrane was
then given five quick washes, followed by 5 X five-
min washes in Tween/PBS. Finally, the mem¬
brane was placed in freshly prepared diamino-
benzidine substrate (0.5 mg/ml in 0.05 M Tris-HCl
buffer, pH 7.6) with 3 ju.1 of 30% H202/ml of
buffer added immediately prior to use. The reac¬
tion was stopped by washing with distilled water.
All the above steps were performed with gentle
rocking.
4. RESULTS AND DISCUSSION
The outer membrane protein (OMP) profiles of
Bacteroides fragilis strains NCTC9343, GNAB92,
JC17 and BE3 were examined after three days
culture in chambers implanted in the peritoneal
cavities of mice and compared with those obtained
after growth in defined medium broth. Growth in
vivo did not result in the expression of large
amounts of novel outer membrane proteins as
detected by Coomassie blue staining of poly-
acrylamide gels (Fig. 1), as bands which appeared
only in the in vivo cultured bacteria could be
attributed to mouse albumin and mouse im¬
munoglobulin G by immunoblotting (Figs. 2 and
3). Therefbre there was no expression of large
amounts of high molecular mass proteins in re¬
sponse to the nutritional conditions in vivo. The
induction of OMP with a high Mr has been re¬
ported to occur with other pathogenic bacteria
such as Escherichia coli grown in the peritoneal
cavity of guinea pigs [13] and Pseudomonas aeru-
3
ginosa taken directly from the lungs of patients
with cystic fibrosis [14]. One major 33 kDa band
was absent from the in vivo cultured bacteria in
Coomassie blue stained gels (Fig. 1). The signifi¬
cance of the loss of the 33 kDa protein is not
known. There may, however, be other more subtle
differences in OMP expression not detected by
this method. A fimbrial subunit of 40-42 kDa, not
readily visible on Coomassie blue stained gels, was
shown to be produced in reduced amounts under
conditions of iron limitation by immunoblotting
[15].








Fig. 1. Coomassie blue stained polyacrylamide gel (PAG) of
Sarkosyl extracted outer membranes of Bacteroides fragilis
(OMP extracts) strain JC17. Lane 1, after growth in defined
medium broth; lane 2, after growth in vivo and washed 3 X in
1/4 strength Ringer's solution prior to Sarkosyl extraction
(washed); lane 3, after growth in vivo and not washed prior to
Sarkosyl extraction (unwashed); lane 4, molecular weight
standards. Similar results were obtained for strains NCTC9343,
BE3 and GNAB92. Note band of Mr 66 kDa is only present in
unwashed in vivo grown sample and band of 33 kDa is only
present in in vitro grown sample (see arrows). Extract from
2-4 X109 bacteria per lane.
Fig. 2. Immunoblotted PAG of outer membrane extracts re¬
acted with rabbit anti-mouse albumin horseradish peroxidase
conjugate. Lane 1, molecular mass standards as in Fig. 1; lanes
3 and 5, bacteria washed; lanes 2 and 4, bacteria unwashed.
Strain BE3, lanes 2 and 3; strain NCTC9343, lanes 4 and 5.
Note the absence of detectable mouse albumin in the washed
samples (see arrows). Similar results were obtained for strains
JC17 and GNAB92.
It is interesting that a simple wash by centrifu-
gation and resuspension three times in 1 /4
strength Ringer's solution was sufficient to remove
the mouse albumin and IgG from the OMP pre¬
paration, whereas they were not dissociated from
the outer membrane preparation when bacteria
were placed directly from the intraperitoneally
implanted chamber into 3% Sarkosyl. This indi¬
cates that although associated with the outer
membrane the albumin and IgG were not specifi¬
cally bound. This may have implications if im¬
munological methods, such as immunofluores¬
cence or enzyme linked immunosorbent assays,
are used to detect bacteria directly in clinical
4









Fig. 3. Immunoblotted and Coomassie blue-stained PAG of
OMP extracts. Immunoblots were reacted with goat anti-mouse
immunoglobulin G (IgG) heavy and light chain horseradish
peroxidase conjugate. Lanes 1-4 and 10, bacteria washed;
Lanes 5-8 and 9, bacteria unwashed. Strain BE3, lanes 1, 5, 9
and 10; strain NCTC 9343, lanes 2 and 6; strain JC17, lanes 3
and 7; and strain GNAB92, lanes 4 and 8. Note the absence of
detectable heavy and light chain IgG in the washed samples
(see arrows).
specimens [16], as host proteins could mask the
bacterial antigens.
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IN RELATION TO VIRULENCE
S. PATRICK* and D. LUTTON*
The possible virulence determinants of Bac-teroides fragilis include expression of sur¬face structures, release of extracellular en¬zymes and enterotoxin production (1). Of
these, the precise nature of the surface
structures expressed has given rise to much confu¬
sion. Extracted polysaccharides, generally considered
to equate to encapsulating structures, have long been
associated with B. fragilis virulence as these extracts
are known to induce peritoneal abscess formation in
animal models (e.g. 2). More recently fimbriae of two
different sizes have been described which may be in¬
volved in attachment to host cells and surfaces. It is
now becoming clear that B. fragilis can express a
number of different surface structures, identifiable by
electron microscopy (EM), which carry antigenically
different epitopes.
Structures which encapsulate the bacterium can vary
in width from 40 nm to 500 nm as shown by EM of
ultra-thin sections. The 40 to 50 nm structures are
not seen as classical "capsules" by light microscopy
with wet India Ink negative stain (3). Long straight
fimbriae of approximately 30 nm (4) and 4-5 nm in
diameter (5) have also been observed on some
strains by EM negative stain. The 4-5 nm diameter
fimbriae have a polypeptide subunit of Mr 40-42
kDa as shown by immunoblotting. There are other
reports or fibrillar and fimbrial structures visible by
EM (e.g. 6 and 7) which have not yet been fully cha¬
racterised. There is evidence that the expression of
at least some surface structures alter with the growth
conditions. It is likely that each individual strain may
have the potential to express all or some of these
structures in varying proportions.
of capsules can be
separated by Per-
coll density gra¬
dient centrifugation (9). Subculture from the interface
layers of the gradient, in uitro, will enrich for popu¬
lations with the different sized capsules (figures la, b
and c). Bacteria with large capsules remain on top of
the Percoll gradient and those with smaller capsules
are found lower down. By electron microscopy of ul-
trathin sections, the large capsule (LC) appears as a
large fibrous network of up to 500 nm in width (fi¬
gures 2a and 2c). The small capsule (SC) appears as
a marginal fibrous network of up to 50 nm in width
by thin section EM (figures 2a and 2d). Populations
which seem to be non-capsulate by light microscopy
have a marginal electron dense layer (EDL) of up to
40 nm by thin section EM (figures 2a and 2d). The
appearance of the LC and SC is greatly enhanced by
ruthenium red stain ; however, the EDL is clearly vi¬
sible without ruthenium red (9). After platinum/gold
shadowing of whole bacteria the LC and SC have a
fibrillar appearance by EM (figures 3a and b), whe¬
reas the EDL has no associated fibrillar structures (fi¬
gure 3c). Populations enriched for the LC, SC and
EDL will gradually revert to mixed populations with
successive daily subculture.
It is therefore possible to define three apparently dis¬
tinct capsules within individual strains of B. fragilis :
a large capsule, a small capsule and an electron
dense layer. These may have a very different appea¬
rance depending on which microscopical techniques
are used to observe them and, in the case of the
EDL, may be only visible by electron microscopy.
DEFINITION OF CAPSULES
The size of capsules expressed by individual cells va¬
ries within strains of B. fragilis, as determined by
light microscopy (8). Populations with different sizes




We have prepared a number of different monoclonal
antibodies (MAbs) specific for B. fragilis surface po¬
lysaccharides. These have shown antigenic diffe¬




a) Light micrograph of Bacteroides fragilis laboratory stock
culture, stained with eosin-carbol fuchsin. Note the presence of
bacteria with large capsules, small capsules and apparently
non-capsulate bacteria.
b) Four step (20, 40, 60 and 80%) Percoll density gradients af¬
ter centrifugation in a bench centrifuge. Tube 1, pattern of
bands when laboratory stock culture was centrifuged. Tubes 2-
5, separation, on the same gradient, from first subculture into
broth from each interface : 2, 0-20% (top) interface; 3, 20-
40% interface; 4, 40-60% interface; 5, 60-80% interface. Note
enrichment for populations which band at the different inter¬
faces after one overnight subculture. (Reproduced from Patrick
S., Reid J.H. and Coffey A.; J. Gen. Microbiol. 1986, 132,
1099-1109, by permission of the Society for General
Microbiology).
c) Light micrographs of enriched populations stained with eo¬
sin-carbol fuchsin taken from: 1, 0-20% interface; 2, 20-40%
interface; 3, 40-60% interface; 4, 60-80% interface. Note the
enrichment for large capsule, small capsule and apparently
non-capsulate bacteria. Figure lc
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Figure 2 :
a) Electron micrographs (ultra-thin section) of enriched B. fragilis populations taken from: 1, 0-20% interface,
note the large fibrous network or capsule; 2, 20-40% interface, note the marginal fibrous network or small
capsule; 3, 40-60% interface, note some cells with marginal fibrous network (*) and some with a marginal
electron dense layer (arrow); 4, 60-80% interface, note bacteria which appeared to be non-capsulate by light
microscopy have a marginal electron dense layer. (Reproduced from Reid J.H., Patrick S. and Tabaqchali S.;
J. Gen. Microbiol. 1987, 133, 171-179, by permission of the Society for General Microbiology).
b) Equivalent populations to those illustrated in Figure 2a prepared for electron microscopy and immunogold
labelling which, although retaining the antigenicity, does not allow visualisation of the fibrous network or elec¬
tron dense layer. All populations labelled with murine monoclonal antibody BF4. Note association of labelling
with the small capsule population (2) and lack of labelling in the electron dense layer population (4).
(Reproduced from Reid J.H., Patrick S. and Tabaqchali S.; J. Gen. Microbiol. 1987. 133, 171-179, by per¬
mission of the Society for General Microbiology).
c) Electron micrograph of populations enriched from the 0-20% interface layer at higher magnification. Note
the large fibrous network or capsule.
d) Electron micrograph of populations enriched from the 40-60% interface layer. Note the distinct appearance
of the marginal fibrous network or small capsule (*) and the marginal electron dense layer (arrow).
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Figure 3 : Electron micrographs of platinum-gold sha¬
dowed preparations of whole B. fragilis cells:
a) 0-20% interface layer enriched population. Note fi¬
brillar appearance of the large capsule.
b) 20-40% interface layer enriched population. Note
short and extended fibrills associated with the small
capsule.
c) 60-80% interface layer enriched population. Note
the absence of fibrillar structures. (Reproduced from
Lutton et al, Biochem. Soc. Trans. 1989, 17, 758-
759, by permission of the Biochemical Society).
ferent capsular types. The different capsules obser¬
ved by EM are therefore not simply the result of dif¬
ferences in the quantity of capsular material present.
One of these MAbs specifically labels the small cap¬
sule (10). This indicates that the small capsule is anti-
genicaliy different from the EDL, although similar in
size (figure 2b). The same result by can be illustrated
by dual colour fluorescent labelling and examination
with a fluorescence microscope. Populations labelled
with both murine MAb BF4 and a rabbit polyclonal
antiserum show quite clearly that BF4 does not label
the EDL population (figure 4a). Anti-polysaccharide
MAbs, for example BF5, which do not label the
small capsule population, but do label a proportion
of cells within the EDL (figures 4b and 4c) and LC
populations (not illustrated) have provided further evi¬
dence for the antigenic heterogeneity of B. fragilis.
It is possible to quantify the proportion of bacteria la¬
belled within the populations by counting fluores-
cently labelled bacteria by flow cytometry in a
Coulter electronically programmable individual cell
sorter (EPICS V) as illustrated in figure 5. This
confirms the microscopical observations, again sho¬
wing that the SC and EDL are antigenically different.
How the polysaccharides, recognised by these
MAbs, relate to the rough lipopolysaccharide (LPS),
smooth LPS, common polysaccharide antigen and
high molecular weight polysaccharide which can be
detected immunochemically in purified polysaccha¬
ride preparations (11) is yet to be determined. These
labelling results, however, do provide strong evidence
for structural heterogeneity within individual strains
of B. fragilis to the extent that the SC and the EDL
are distinct. The results also illustrate a degree of an¬




The expression of the 40-42 kDa polypeptide subu-
nit of the 5nm diameter fimbriae (figure 6) was exa¬
mined in populations enriched for the various encap¬






antigen is not expressed in B. fragilis strain BE3
when the LC is expressed, although in other strains
the relationship between expression of encapsulating
structures and the fimbriae was not as distinct (12).
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Recent data indicate that a population of strain BE3,
initially enriched for expression of the LC, gradually
begins to express fimbrial antigen as the population
reverts to a culture with mixed encapsulating struc-
Figure 4 : Dual colour fluorescence labelling of small
capsule enriched (SC) and electron dense layer enri¬
ched (EDL) populations.
a) 1. - Murine monoclonal antibody BF4 (M AB BF4)
and fluorescein conjugated secondary antibody;
2. - Rabbit anti-B. fragilis polyclonal antiserum
(PC) and a rhodamine conjugated secondary anti¬
body. Note green fluorescence of monoclonal anti¬
body labelling only the small capsule enriched popu¬
lation.
b) 1. - Monoclonal antibody BF5 (M AB BF5) and
rhodamine conjugated secondary antibody;
2. - Rabbit anti-B. fragilis polyclonal antiserum
and fluorescein conjugated secondary antibody. Note
lack of labelling of the small capsule population and
red fluorescence of monoclonal antibody which labels
only a proportion of the electron dense layer enri¬
ched population.
c) Electron dense layer enriched population labelled
with monoclonal antibody and polyclonal antiserum.
Photographic double exposure of the same feild of
view to show both red and green fluorescence toge¬
ther. Note that only a proportion of the total popula¬
tion are labelled with the monoclonal antibody (red).
tures (unpublished result). Therefore in this strain, ex¬
pression of the large capsule was not associated with
the detection of fimbrial antigen by immunoblotting.
This is further evidence for the heterogeneous nature
of surface structure expression in B. fragilis.
RELATIONSHIP WITH VIRULENCE
It is not yet known in what precise way these diffe¬
rent surface structures relate to the virulence and pa¬
thogenesis of B. fragilis. Expression of the 30 nm
fimbriae (4) is associated with haemagglutination and
may play a role in the specific attachment of B. fra¬
gilis to host cells. The narrower fimbriae of approxi¬
mately 4-5 nm are not associated with haemaggluti¬
nation (5), although the fimbrial polypeptide subunit
of 40-42 kDa has been detected by immunoblotting
in bacteria which were grown intra-peritoneally in
mice (12). Although the LC impedes phagocytosis in
vitro (13), paradoxically it is selected against during
growth in the mouse peritoneal cavity in the pre¬
sence of phagocytes (3). B. fragilis with the LC sur¬
vive better under aerobic conditions and are not in¬
volved in haemagglutination reactions (14, 15).
The possible relationship of the SC to virulence has
not yet been fully investigated. Immunogold labelling
with the MAb specific for the SC has shown that al¬
though a proportion of bacteria growing in vivo ex¬
press the small capsule, there is no strong selection
in favour of this population.
The EDL population is associated with the ability to
agglutinate erythrocytes from a number of species
(15) and is more hydrophobic than the LC popula¬
tion (unpuplished result) which suggests that it may
be involved in attachment mechanisms. The EDL po¬
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Figure 5 : Flow cytometric analyses of small capsule (SC) and electron dense layer (EDL) enriched populations
labelled with monoclonal antibodies BF4 and BF5. Control: populations labelled with only the fluorescein
conjugated secondary antibody. Note that graphs are only significantly higher than control for BF4 with the
SC population and BF5 with the EDL population. Total number of bacterial cells fluorescing within the popula¬
tion is expressed as a percentage. .
Figure 6 : Electron micrograph of negatively stained whole cell of B. fragilis to illustrate the 4-5 nm diameter
fimbriae.
mal human serum, as determined in an in vitro as¬
say (13), although it does not confer resistance to
phagocytosis.
CONCLUSION
It therefore seems that B. fragilis surface structures
and antigens are extremely varied. Expression of dif¬
ferent structures may depend on the selective pres¬
sures acting on a given population at a given time
during an infection. This makes it difficult to inter¬
pret results of studies of the relationship between
surface structures and virulence mechanisms where
the structures present within the population have not
been clearly defined. Not only are there antigenic dif¬
ferences between strains but a high degree of hetero¬
geneity of surface antigen expression occurs within
individual strains. It is likely that much of the appa¬
rent confusion as to the nature of the surface struc¬
tures expressed by B. fragilis and their possible rela¬
tionship with virulence stems from their inherent
heterogeneity.
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EXPRESSION DES STRUCTURES DE SURFACE
EN RELATION AVEC LA VIRULENCE
Les determinants possibles de la virulence de B. fragilis incluent l'expression des struc¬
tures de surface, la liberation d'enzymes extracellulaires et la production d'enterotoxine. A
partir de ceci, la nature precise des structures de surface a conduit h beaucoup de confu¬
sion. 11 devient maintenant evident que B. fragilis peut exprimer un certain nombre de
structures de surface, identifiables en microscopie electronique, qui portent des epitopes
antig6niquement differents. Les structures encapsulant la bacterie peuvent avoir une gros-
seur variant de 40 & 500 nm, comme le montre la section ultra-mince en microscopie
electronique. En microscopie optique par coloration & l'encre de Chine les structures de
40 ci 50 nm ne sont pas vues comme des capsules classiques. De longs fimbriae recti-
lignes d'approximativement 30 nm et 5 nm de diametre ont aussi 6t6 observes chez cer-
taines souches par coloration negative en microscopie electronique. Les fimbriae de 5
nm de diametre ont une sous-unite polypeptidique de Mr 40-42 Kd, comme on peut le
voir en immunoblotting. D'autres structures fibrillaires ou fimbriales ont ete rapportees.
Cela prouve que l'expression d'au moins certaines de ces structures se modifie en fonc-
tion des conditions de croissance. Chaque souche individuelle peut avoir le potentiel pour
exprimer toutes ou certaines de ces structures dans des proportions varies.
Mots cles : B. fragilis - Facteurs de virulence - Capsule.
SUMMARY Bacteroides fragilis can express a number of different surface structures
identifiable by electron microscopy. These include (a) two different types
of fimbriae, 4-5 nm and 30 nm in diameter respectively, and (b) three apparently diffe¬
rent encapsulating structures, a large capsule, small capsule and electron dense layer.
Populations expressing different types of capsule can be enriched for by Percoll den¬
sity gradient centrifugation. A monoclonal antibody, BF4, labels an epitope on the
surface of the small capsule population, but not either the large capsule or electron
dense layer populations. A number of monoclonal antibodies have been characterised
which label a proportion of bacteria within the large capsule and electron dense layer
populations but not the small capsule population. It therefore seems that the small
capsule and electron dense layer are distinct. Monoclonal antibody BF5 only labelled
a proportion of the bacteria within populations enriched for either the large capsule or
electron dense layer. This was quantified by counting the fluorescently labelled bacte¬
ria by flow cytometry in an electronically programmable individual cell sorter (Coulter
EPICS VJ. In B. fragilis strain BE3, expression of the large capsule was not associated
with detection of fimbria! antigen by immunoblotting. Therefore there is evidence for
a high degree of structural and antigenic variability within individual strains of B. fragi¬
lis. This may be relevant to the virulence of this bacterium.
Keys-words : B. fragilis - Virulence factors - Capsule.
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• LES INFECTIONS A GERMES ANAEROBIES SONT RAREMENT MONOMICROBIENNES.
UNE BACTERIE PEUT-ELLE, SEULE, DETERMINER UNE INFECTION ?
♦ Les bacteries ana6robies sont reconnues comme
frequemment responsables d'infections. Elles sont le
plus souvent isolves en association avec des bacteries
aferobles : ces Infections sont consid6r6es comme
mixtes. Elles se d6veloppent au sein de diff6rents tis-
sus : tete et cou, tractus respiratoire, tractus gastroin¬
testinal, tractus genital f6minin, peau et tissus mous.
D y a quelques annees on consid6rait que les infec¬
tions dans lesquelles 6taient impliqu6es des bacteries
ana6robies 6taient obligatoirement mixtes. Actuelle-
ment la preuve est faite qu'une bactbrie ana6robie
est capable de dedencher a elle seule une infection.
11 peut s'agir d'une infection mixte au depart, qu'une
antibloth6rapie selective anti-a6roble a transformfee
en une infection n'impliquant que des bacteries ana6-
robies. L'etude des Peptostreptococcus montre qu'ils
peuvent, seuls, determiner des infections allant de la
surinfectlon d'ulcSres de jambe jusqu'e la septic6mie.
Bacteroides fragilis, et trbs exceptionnellement B.
melaninogenicus, sont capables aussi de dbclencher
seuls des infections septic6miques. Pour traiter les in¬
fections mixtes, une antibiothSrapie qui 6pargne les
bacteries ana6robies conduit h un 6chec souvent de-
sastreux. On peut citer de nombreux exemples :
ost6omy61ites k Staphylococcus epidermidis et B.
fragilis, infections abdominales avec abc6dation se-
condaires, etc... Des infections expbrimentales peu¬
vent etre d6clench6es chez l'animal par l'injection de
bacteries anabrobies seules, provenant de cultures.
En utilisant B. fragilis, on constate que les souches
encapsulbes n'ont pas besoin de 1'aide des germes
aferobies pour exprimer leur pathogbnicite. II est 6ta-
bli que les bacteries anabrobles peuvent etre seules
responsables d'infections. Leur role est trbs sous-es-
timb mals les consequences cliniques d'une antibio-
thbrapie inadaptbe sont toujours graves.
• LES ESPECES BACTERIENNES ANAEROBIES SONT LARGEMENT MAJORITAIRES AU SEIN
DE LA FLORE DIGESTIVE. COMMENT EXPLIQUER L'ABSENCE DE CORRELATION ENTRE
L'IMPORTANCE QUANTITATIVE DE CES ESPECES ET LA PREPONDERANCE QUALITATIVE
DE CERTAINES ESPECES EN PATHOLOGIE INFECTIEUSE ?
♦ Effectivement, les bacteries anabrobles majoritai-
res dans les cavitbs naturelles ne sont pas les plus
frbquemment rencontrbes en pathologie infectieuse.
Certaines propribtbs sont nbcessaires & l'expression
de la virulence :
Propriete d'adhesion
Les capacitbs de fixation de B. fragilis h la mu-
queuse intestinale lui confbrent un avantage majeur
et permettent la premiere btape de l'infection, 1'inva-
sion. Chez 10 patients ayant subi des lavages intesti-
naux pr6-op6ratoires, l'btude du liquide de lavage ne
met en evidence que de rares Bacteroides alors que
50% des bact6ries restant fixbes sur la muqueuse in¬
testinale sont des B. fragilis. Cette fixation rend
compte d'une des difficultes techniques rencontrbes
lors de l'analyse quantitative des flores intestinales :
les bacteries pr6dominantes ne repr6sentent en rba-
lit6 que les bacteries les plus facilement isol6es ! Les
propri6t6s d'adhesion d'une espbce conduisent b un
biais dans son estimation quantitative.
La capsule
La presence d'une capsule polysaccharidique, cons-
tante chez B. fragilis, est un facteur de virulence es-
sentlel. La structure de cette capsule fait l'objet de
nombreux travaux, notamment en microscopie 6lec-
tronique. La meilleure technique d'examen demeure
45
la microscopie ci contraste d'interf6rence differentiel
permettant d'observer B. fragilis en milieu liquide.
C'est une structure variable. Certaines formes seule-
ment conferant la virulence : c'est aux capsules de
grandes tallies que sont attaches les caractfires de pa-
thogenlcite. La capsule inhlbe la migration des ma¬
crophages et supprime la phagocytose : la survie des
Bacteroides est alors prolong6e. Certains tests effec-
tu6s pour 6tudier le rdle de la capsule donnent des
r6sultats contradictoires. Si des Bacteroides sont mis
en culture 18 heures en presence de clindamycine, le
pourcentage de bacteries phagocytees passe de 30%
h 100%. En utilisant la ciprofloxacine, d6nu6e de
toute activity vis-^-vis des Bacteroides, on constate
une diminution de la phagocytose de 50%. Ceci
pourrait expliquer des divergences entre les tesultats
des tests in vitro et l'efficacite th6rapeutique in vivo.
L'effet d'un antibiotique sur la phagocytose doit etre
considers avec autant d 'attention que son effet bac¬
tericide.
Adaptabilite
Les constituants de 1'enveloppe et de la surface bac-
terienne se modifient & l'origine d'un processus
d'adaptation, aux irtecanismes de defenses immuni-
taires entre autres. Le chimiotactisme et la phagocy¬
tose peuvent etre lnhib6s par d'autres facteurs que la
capsule (acide succlnique).
Les toxines
La production d'exotoxine est reconnue depuls long-
temps parmi les bacteries anaSrobies (C. botulinum,
C. tetani, C. difficile). Les endotoxines liposacchari-
diques existent chez les bacteries ana6robies comme
chez les a6robies mais elles apparalssent moins ac¬
tives (les chocs septiques sont moins frequents).
Certaines especes produisent egalement d'autres en¬
zymes : collagSnase de B. melaninogenicus, entero-
toxine de B. fragilis qui serait responsable de diar-
rttee chez l'homme, superoxyde dismutase qui lui
confere une certaine resistance & l'oxygene.
• EST-CE QUE LE ROLE DES BACTERIES ANAEROBIES DANS LES INFECTIONS EST SOUS-
ESTIME ? QUELLES EN SONT LES RAISONS ?
♦ Les difficultes techniques que rencontre le labora-
toire pour isoler les bacteries sont nombreuses. La
toxicite de 1'oxygene pour certaines especes est telle
que leur isolement est Impossible si certaines condi¬
tions de pr6ievement (la fixation des bacteries sur le
site infectieux peut etre 6troite) et d'acheminement
ne sont pas remplies. Leur croissance sur les milieux
de culture est tres lente compar6e ci celle des bacte¬
ries a6ro-ana6robies facultatives qui peuvent inhiber
la croissance des bacteries ana6robies stricts en acidi-
fiant les milieux. Les techniques de culture doivent
etre parfaitement adaptees e leur m6tabolisme (cham-
bre ana6robie). Toute h6moculture doit comporter un
flacon en ana6robiose; il est 6galement souhaitable
d'utiliser un flacon d'hemoculture contenant un
agent hypertonique, ce qui permet d'isoler les bacte¬
ries & parol deficiente. On estime & 10% la frequence
des hemocultures positives £ bacteries ana6robies.
Dans les flores polymicrobiennes, il y a des ph6no-
menes d'antagonisme qui restent encore mal connus.
• EN PRATIQUE, NE FAUDRAIT-IL PAS PRESCRIRE UNE ANTIBIOTHERAPIE ACTIVE SUR
LES GERMES ANAEROBIES CHAQUE FOIS QU'ON SUSPECTE LEUR RESPONSABILITE
DANS UNE INFECTION, SANS ATTENDRE UNE REPONSE HYPOTHETIQUE, ET OBLIGA-
TOIREMENT TARDIVE, DU LABORATOIRE ?
♦ Malgre toutes ces difficultes, le maximum doit etre
fait dans les laboratoires de microbiologic clinique
pour isoler les bacteries ana6robies. Mais il est vrai
que ne pas prescrire un anti-ana6robie parce que le
laboratoire n'a pas isole la bacterie, peut avoir des
consequences graves. Pour y voir plus clair, envisa-
geons certaines situations cliniques :
Infections du pied chez ie diabetique
La presence des bacteries ana6robies dans ces infec¬
tions est extremement fr6quente : 90% des cas (le re¬
servoir de ces germes est cutan6; l'hygtene des pieds
du diabetique doit etre rigoureuse). Devolution dra-
matique vers l'amputation pourrait souvent etre 6vi-
tee. L'antibloth6rapie ne vise que l'eradication des
bacteries aerobies, les ana6robies provoquant une
lente mais inexorable destruction de l'os. Les bacte¬
ries responsables peuvent etre mises en evidence si
le pretevement est soigneux mais il est difficile : l'in-
fection se d6veloppe sous la forme d'une multitude
de micro-abces qui peuvent chacun contenir des
flores diff6rentes. 11 faut gratter longuement l'os












Au total, 45 espdces differentes ont 6t6 isofees : les
cocci anadrobies sont les plus fr6quents, niais 8 h 10
jours sont n^cessaires h leur isolement, on trouve
aussi B. fragilis et d'autres Bacteroides. Dans ce
contexte il apparait legitime de prescrire une antibio-
th6rapie dont le spectre couvre h la fols les bacferies
a£robies et anaerobies.
Infections genitales feminines
Les infections pelvlennes sont mixtes le plus souvent.
Differentes espfeces de Bacteroides sont impliqu£es
(B. fragilis, B. biuius, B. disiens). Les capacities
d'adffesion des bacteries anaerobies £ la muqueuse
jouent un role tfes important.
Infections sur prothese
De nombreuses infections sur prothbse de hanche
pnt provoqu6es par des Peptostreptococcus, dont'a croissance, aussi bien sur les milieux de cultures
que dans les tissus infectes, est tr6s lente. Les pa¬
tients restent asymptomatiques pendant longtemps,
l'infection s'installant a bas bruit. L'origine cutanee
de ces germes est probable. Meme extremement mi-
nutieuse, la disinfection de la peau ne peut Slimmer
100% de la flore cutanSe.
Pathogenic indirecte
La sScrStion de betalactamases par les Bacteroides
peut profeger les germes sensibles, de Paction des
pSnicillines. Ce phSnomSne est observS au cours de
nombreuses infections : amygdalites, pharyngites, in¬
fections respiratoires (otites chroniques, sinusites
chroniques, pneumopathies d'inhalation, abcbs pul-
monaires), infections pelviennes, infections abdomi-
nales, infections cutanSes ou des tissus mous. On
peut ciler de nombreux examples tels que la protec¬
tion du streptocoque A de la penicilline par les beta¬
lactamases de Staphylococcus aureus, Haemophi¬
lus influenzae, Branhamella catharralis, Bacte¬
roides melaninogenicus, B. fragilis. De mSme, les
Bacteroides profegent Escherichia coli dans les in¬
fections abdominales et Neisseria gonorrhoeae dans
les infections pelviennes.
Y. PEAN et Y. BUISSON
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Flow cytometric analysis of within-strain variation in
polysaccharide expression by Bacteroides fragilis by use of
murine monoclonal antibodies
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M. J. LARKIN,t EVELYN DERMOTT and T. A. McNEILL
Department of Microbiology and Immunobiology, Queen's University of Belfast, Grosvenor Road, Belfast BT12 6BN
and tDivision of Genetic Engineering, School of Biology and Biochemistry, Queen's University of Belfast, Northern
Ireland
Summary. The reactivity of four different monoclonal antibodies (MAbs) with populations
of Bacteroides fragilis NCTC 9343, enriched by density gradient centrifugation for a large
capsule, small capsule and electron-dense layer (EDL) only visible by electronmicroscopy,
was examined. The MAbs reacted strongly with polysaccharides present in both the large
capsule- and EDL-enriched populations but not in the small capsule-enriched populations.
The pattern of labelling was determined by immunoblotting, immunofluorescence and
immuno-electronmicroscopy, and flow cytometry. The MAbs labelled cell membrane-
associated epitopes in the large capsule- and EDL-enriched populations and cell-free material
in the EDL population. By immunoblotting, ladders of repeating polysaccharide subunits
were evident in the EDL population but not in the large capsule population. The proportion
of cells labelled within each population was determined by flow cytometry. The reactivity of
another MAb with the small capsule population was confirmed by flow cytometry. A
qualitative indication of epitope expression was obtained by examination of the flow
cytometric profiles. Differential expression of the same saccharide epitope was observed
both between and within structurally distinct B. fragilis populations. The MAbs were species-
specific and cross-reacted with several recent clinical isolates. These polysaccharides may be
relevant to the virulence of B. fragilis.
Introduction
Bacteroides fragilis is a gram-negative anaerobic
species that is an important pathogen, commonly
encountered in clinical infections.1 One of the many
factors that undoubtedly contribute to its virulence is
the expression of particular surface antigens.2 Several
authors have described the encapsulating surface
structures of B. fragilis3~J but, as yet, their relationship
to virulence remains unclear. Individual strains of B.
fragilis have been shown by electronmicroscopy to be
heterogeneous with respect to expression of encapsu¬
lating surface structures; cells with a large capsule, a
small capsule and a marginal electron-dense layer
(EDL) may be separated by Percoll density gradient
centrifugation.7 Within-strain antigenic heterogeneity
has been shown immunologically with anti-polysac-
charide monoclonal antibodies (MAbs).8'9 One MAb
reacts with the small capsule but not with the large
capsule or EDL.9 The surface carbohydrates of B.
Received 4 Dec. 1990; accepted 22 Jan. 1991.
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fragilis have been shown by immunochemical analysis
to be antigenically complex. Most strains possess four
distinct structural elements that can be detected by
immunoblotting—a rough type LPS, a common
antigen, a smooth LPS which runs as a series of closely
spaced bands, and a high Mr antigen which may be
capsular polysaccharide.10 How these components
relate to the different capsules is not known. The aim
of the present study was to obtain MAbs that reacted
with the large capsule or EDL populations and to
confirm that these structures are antigenically different
from the small capsule. Flow cytometry was used to
obtain fast and accurate quantitation of bacterial
labelling. The reactivity of the MAbs with recent
clinical isolates was also determined.
Materials and methods
Bacterial strains
The strains used in this study were B. fragilis NCTC
9343 (National Collection of Type Cultures, Colindale
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Avenue, London) and BE3 (Department of Medical
Microbiology, Vrije Universiteit, Amsterdam), B.
vulgatus NCTC 10583, B. thetaiotaomicron NCTC
10582, B. ovatus ATCC 8483 (American Type Culture
Collection), B. distasonis ATCC 8503, and B. gingivalis
W83 (Laval University, Quebec, Canada); B.fragilis
strains LS1-11, Escherichia coli and Staphylococcus
aureus were recent clinical isolates from the Depart¬
ment of Bacteriology, Craigavon Area Hospital, N.
Ireland.
Culture methods
Bacteria were grown in minimal medium defined
broth.11 Cultures were incubated at 37°C in an
atmosphere of H2 10%, N2 80%, C02 10% in an
anaerobic cabinet MK III (Don Whitley Scientific
Ltd, Shipley, W. Yorks). Identification was confirmed
with the API20A system.
Separation and enrichment ofbacterial populations
Bacterial populations were enriched for different
sizes of encapsulating surface structures by Percoll
(Pharmacia, Uppsala, Sweden) discontinuous density
gradient centrifugation as previously described.7
Preparation ofbacterial outer membranes
Outer membranes were prepared as previously
described.12
Preparation ofpolysaccharide
Polysaccharide was extracted by the Proteinase K
method.13
Production ofMAbs
A BALB/c mouse was immunised with whole cells
of a B. fragilis NCTC 9343 population enriched for
expression of the EDL. The mouse was inoculated
intraperitoneally with 0-5 ml of a bacterial suspension
of 1 x 108 cfu/ml in 0 01 M phosphate-buffered saline,
pH 7-4 (PBS). A further inoculation of 0-2 ml was
given 4 days before the mouse was killed. The spleen
cells from the mouse were fused with P3X 63 Ag8-653
(NS-0/1) mouse myeloma cells by treatment with
polyethylene glycol 16000 (Sigma) 50% in RPMI1640
(Flow Laboratories, Paisley, Scotland) following a
modification of the method of Galfre and Milstein.14
Hybrid cell lines were selected with hypoxanthine-
aminopterin-thymidine in RPMI 1640 medium con¬
taining myoclone fetal calfserum (Gibco) 20%. Culture
supernates were removed and screened by ELISA and
immunofluorescence microscopy for IgG to the EDL
population of B.fragilis NCTC 9343.
Isotyping
The isotype of the MAbs was determined with a
mouse MAb isotyping kit (Amersham International
pic).
Sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting
SDS-PAGE was performed on vertical slab 8% gels
with the Laemmli buffer system.15 For outer mem¬
brane proteins, samples were mixed with 50 p\ of
PAGE sample buffer (0-0625 M Tris-HCl, pH 6-8,
containing SDS 2% w/v, glycerol 10% v/v, 2-mercap-
toethanol 5% v/v and bromophenol blue 0-001% w/v)
and heated in a boiling water bath for 10 min. After
cooling, samples were loaded on to gels. For polysac¬
charide, proteinase K extracts (50 p\) were loaded
on to gels. Gels were run at a constant current of
50 mA/gel. Immunoblotting was performed as previ¬
ously described.12
Culture ofbacteria in vivo
Chambers were constructed, filled with B. fragilis
NCTC 9343 and implanted in the peritoneal cavity of
a mouse as previously described.16 The chambers were
constructed with 3-/rm pore membrane filters (Milli-
pore) which allowed the entry of leucocytes.
Electronmicroscopy
Bacteria were embedded for ultra-thin sectioning as
previously described.9 For negative staining, one drop
of bacterial suspension in distilled water was dried on
to a formavar carbon-coated 400-mesh copper grid
(Agar Aids) which had been glow-discharged. The
grids were labelled with immunogold as previously
described.8 The thin sections were stained with uranyl
acetate for 10 min. The whole bacteria were negatively
stained with a drop of methylamine tungstate (Agar
Aids) 2% w/v in distilled water. The bacteria were
examined with a Phillips CM 10 transmission electron-
microscope.
Dual colour immunofluorescence microscopy
A modification of the staining procedure described
by Johnson et al,17 was used. Separated bacterial
populations were suspended in PBS, fixed on multi-
test slides (Flow Laboratories) and incubated with
MAb supernates. The slides were washed in PBS then
incubated with rabbit anti-R. fragilis polyclonal anti¬
body. The slides were again washed and then
incubated simulataneously with goat anti-mouse fluo¬
rescein conjugate (Sigma) and goat anti-rabbit rhoda-
mine conjugate (Sigma). After a final wash, the slides
were examined with a Leitz fluorescence microscope.
Random fields of view were selected and the number
of bacteria labelled with MAb and polyclonal anti-
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serum were counted. The percentage of each popula¬
tion labelled by MAb was calculated relative to the
total number of cells labelled with polyclonal anti¬
serum.
Flow cytometric analyses
Cells were prepared by a modification of the method
of Nelson et al.18 PBS that had been filtered three
times through 0-22-pm membrane filters was used
throughout. Washed, late exponential phase cultures
of B. fragilis were resuspended to approximately 2 x
108 cfu/ml in PBS. Each sample of 1 ml of bacterial
suspension was centrifuged at 12 000 g in an Eppen-
dorf 5414 centrifuge for 2 min. The pellets were
resuspended in 1 ml of MAb supernate or 1 ml of PBS
(control) and incubated at 37°C for 1 h. Samples were
washed twice in PBS and mixed with 1 ml of
appropriately diluted goat anti-mouse IgG fluorescein
conjugate (Sigma) or goat anti-mouse IgM fluorescein
conjugate (Serotec). The samples were incubated at
37°C for 1 h, washed twice in PBS and resuspended in
1 ml of paraformaldehyde 1% v/v in PBS.
Cells stained with FITC conjugate but without
primary antibody were negative controls. An IgM
MAb, Bf4, previously shown to react with the small-
capsule population9 was used as a positive control for
the fluorescent signal. All samples were sonicated for
20 s at an amplitude of 5 (MSE Soniprep 150) to
break bacterial aggregates. The sonication time was
determined empirically to obtain maximum disruption
of bacterial aggregates without cell membrane break¬
age.
The bacteria were analysed on an EPICS 5 flow
cytometer (Coulter Electronics Ltd) equipped with a
5 W argon laser tuned to 488 nm and operating at a
power output of 100 mW. Before each analysis, the
instrument was calibrated with 1-5-^m fluorescent
microspheres (Polysciences). Monodisperse bacterial
populations were identified on the basis of size by
forward and 90° light scatter signals and gated
appropriately. Single parameter log integral green
fluorescence (LIGFL) signals were obtained from the
gated population. In each sample, 50 000 bacteria
were counted and the percentage ofpositively staining
cells was obtained by subtraction of negative control
histograms from test histograms with the Immuno-
programme of the instrument.
Results
Characterisation ofMAbs and distribution of
epitopes in B. fragilis populations enrichedfor
different encapsulating structures
MAb QUBf5. Immunoblotting of proteinase K
extracts with MAb QUBf5, of isotype IgG2b, showed
a diffuse staining pattern at the top of the blot,
corresponding to a high Mr polysaccharide (fig. la, b
d e f J k
Fig. 1. Immunoblots from SDS-PAGE gels of proteinase K extracts
of B. fragilis NCTC 9343. Lanes a, d, g and j: large capsule
population; lanes b, e, h and k: small capsule population; lanes c, f,
i and 1: EDL population. The blots were probed with MAbs QUBf5
(lanes a-c), QUBf6 (lanes d-f), QUBf7 (lanes g-i) andQUBf8 (lanes
j-b
and c). This polymer was present in smaller amounts
in the small capsule population (fig. lb). A series of
discrete bands of repeating polysaccharide subunits
was found to extend from the high Mr polysaccharide
to the gel front in the EDL population (fig. lc).
Electronmicroscopy and immunogold labelling with
MAb QUBf5 identified a surface-associated antigen
located on the membranes of whole bacteria and on
membrane vesicles or blebs. Only a proportion of the
bacteria within the large capsule and the EDL
populations was labelled (not illustrated). Cells from
the small capsule population did not react with MAb
QUBf5 but labelled blebs appeared to be secreted
from unlabelled cells (fig. 2A). The QUBf5 epitope
was readily released from the large capsule population
in association with membrane blebs (fig. 2B) and from
the EDL population as both membrane blebs and cell-
free material (not illustrated).
The budding of vesicles from the outer membrane
of B. fragilis has been observed (fig. 3A). These vesicles
may carry encapsulating material (fig. 3B).
MAbs QUBf6 and QUBJ7. Two IgG! MAbs, QUBf6
and QUBf7, each reacted with high Mr polysacchar¬
ides to give diffuse staining bands at the top of the
immunoblots (fig. ld-i). The quantity of labelled
polysaccharide was less in the small capsule population
(fig. le and h). Associated fine ladders of repeating
polysaccharide subunits were detected in the EDL
population (fig. If and i). Heterogeneous labelling of
the large capsule (fig. 4A) and the EDL (not illustrated)
populations was detected by electronmicroscopy and
immunogold labelling with each MAb. Labelled cells
were not seen in the small capsule population with
either MAb, although some cell-free material was
detected by MAb QUBf7 (fig. 4B). Cell-associated
polysaccharides were recognised by each MAb in the
large capsule (fig. 4C) and the EDL (fig. 4D)
populations as illustrated with MAb QUBf7. These
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Fig. 2. Negative stained electronmicrographs of (A) the small capsule and (B) the large capsule populations of B.fragilis immunogold labelled
with MAb QUBf5. Note the labelling of excreted vesicles. Bar, 0-5 /rm.
antigens were released from the large capsule popula¬
tion in association with membrane vesicles (fig. 4C)
and from the EDL population as membrane vesicles
and cell-free material (fig. 4D).
MAb QUBfS. An IgG, MAb, QUBf8, was shown
by immunoblotting to recognise a high-Mr polysac¬
charide which produced a diffuse staining band on the
top half of the blot (fig. lj, k and 1). Faint labelling was
detected just behind the gel front in the region of the
rough LPS. The QUBf8 epitope was most readily
detected in the EDL populations where a fine ladder
was seen in the middle region of the blot (fig. 11), As
with the other MAbs, the antigen recognised was
present in smaller quantities in the small capsule
population (fig. Ik). The QUBf8 epitope was shown
by thin-section immuno-electronmicroscopy to be
expressed on a high proportion of cells from the large
capsule and the EDL populations (not illustrated).
Negative staining revealed that the polysaccharide
was cell associated but could be released from the
large capsule population in association with membrane
vesicles and from the EDL population as cell-free
material (not illustrated).
Immunoblotting ofouter membrane extracts
The immunoblotting patterns of Sarkosyl-extracted
outer membranes were similar to those obtained by
proteinase K extraction (fig. 1). No additional bands
were identified in the outer-membrane preparations,
indicating that protein antigens were not detected by
any of the MAbs.
Confirmation ofMAb specificity by
immunofluorescence microscopy andflow
cytometry
The pattern of labelling of the large capsule, small
capsule and EDL populations with the MAbs was
confirmed by immunofluorescence microscopy and
flow cytometry. Strong labelling was associated with
the small capsule populations in the case of MAb Bf4
and with the large capsule and the EDL populations
in the case of the other MAbs (table I and fig. 5). The
proportion of bacteria labelled within the populations
was also measured (table I). For microscopy, popula¬
tions were labelled at the same time with a rabbit
Fig. 3. Thin section electronmicrographs of B. fragilis grown in vivo. Note the release of vesicles from the outer membrane (A) and the
association of encapsulating material with released vesicles (B).
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Fig. 4. Electronmicrographs of B.fragilis immunogold labelled with MAb QUBf7. (A) Ultra-thin section of the large capsule population; note
heterogeneous labelling of bacteria. (B-D) Negatively stained bacteria: (B) small capsule; (C) large capsule and (D) EDL populations; note
cell and vesicle association of labelling with large capsule population and cell free material with EDL population.
polyclonal anti-5. fragilis anti-serum (which labelled
all the bacteria) and with each of the MAbs. Secondary
antibodies of anti-mouse antibody conjugated to
fluorescein and anti-rabbit antibody to rhodamine
were used to assess the labelling. For flow cytometry,
bacteria were identified on the basis of size by forward
and 90° light-scatter signals. Bacterial populations
labelled with the nucleic acid-specific fluorochrome
propidium iodide and identified in the flow cytometer
by a red fluorescent signal were identical to those
identified by size (unpublished result). Bacteria la¬
belled with the MAbs were identified by the fluorescent




Mean (SEM) percentage of population labelled*
Large capsule Small capsule EDL
Bf4 IFM 3 (1)* 96 (5) 0
FC 9 (5)t 94 (3) 4 (4)
QUBf5 IFM 16 (5) 0 28 (5)
FC 23 (8) 1 (1) 25 (9)
QUBf6 IFM 14 (5) 0 42 (12)
FC 37 (5) 7 (7) 47 (14)
QUBf7 IFM 47 (12) 1 (1) 41 (6)
FC 73 (9) 6 (6) 57 (3)
QUBf8 IFM 19 (14) 0 26 (2)
FC 77 (11) 5 (4) 67 (11)
IFM, immunofluorescence microscopy; FC, flow cytometry.
* Each IFM value represents the mean of percentages from three experiments,
t Each FC value represents the mean of percentages from three experiments for MAbs QUBf7
and 8 and four experiments for the other MAbs.












10 Fluorescence intensity channel number (x10)
Fig. S. Flow cytometric profiles. Large capsule (LC), small capsule (SC) and HDL populations of B.fragilis were treated with MAbs QUBf5-
8 or Bf4 or PBS (control) and the appropriate IgG or IgM fluorescein-conjugated secondary antibodies. Number of events: scale 0-1024 (*),
0-512 for other profiles.
signal from an anti-mouse fluorescein-conjugated
secondary antibody. Flow cytometry consistently gave
higher percentage labelling than fluorescence micros¬
copy for most of the MAbs.
Flow cytometric profiles, which relate to the
intensity of fluorescent signal, were obtained consist¬
ently in consecutive experiments. Representative
profiles are illustrated in fig. 5. MAb QUBf8, labelling
the large capsule population, was an exception;
although a biphasic profile was consistently obtained,
the relative sizes of the two peaks varied. MAbs
QUBf5, 6 and 8 all had a biphasic profile when
labelling the large capsule population and a much
broader profile with the EDL population. A single
peak was obtained with MAb QUBf7 for both the LC
and EDL populations, and with MAb Bf4 for the
small capsule population. A small peak at high
fluorescent intensity was also apparent in the large
capsule population with MAb Bf4. A low level of
fluorescent signal was obtained with MAbs 5-8 and
the small capsule population.
Cross-reaction ofthe MAbs with other isolates
The reactivity of MAbs QUBf5, 6, 7 and 8 with
other Bacteroides spp. and with E. coli was tested by
immunofluorescence microscopy. None of the MAbs
cross-reacted with B. vulgatus, B. thetaiotaomicron, B.
ovatus, B. distasonis, B. gingivalis, E. coli or S. aureus.
All reacted with B.fragilis strain BE3. The specificity
of MAb Bf4 was described previously.9 Several recent
clinical isolates, LS1-11, were screened for reactivity
with each of the MAbs. The results are presented in
table II.
Populations of B.fragilis NCTC 9343 grown in vivo
in the mouse for 7 days showed heterogeneous
immunogold labelling with MAbs QUBf7 and 8 (not
illustrated).
Discussion
The exact nature of the polysaccharides produced
by B. fragilis is not yet clear. LPS of B. fragilis was
characterised chemically and immunochemically by
Kasper et al.19 and Weintraub et al.20 The extraction
Table II. Reactivity of B.fragilis MAbs with
a range of recent clinical isolates ofB.fragilis
MAb
Number of isolates* which showed






* A total of 11 isolates (LSI—11) was screened with
each MAb.
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and separation procedures used in both studies resulted
in the selection of only the rough form of B. fragilis
LPS. Further assays by gel electrophoresis of the crude
aqueous phase obtained by phenol-water extraction or
the PCP-insoluble fraction repeatedly failed to detect
the ladder-like pattern characteristic of O-antigen.22
However, Poxton and Brown10 extracted LPS from B.
fragilis by the classical aqueous phenol technique and
demonstrated that, in most strains, LPS was present
as predominantly smooth type. SDS-PAGE analysis
revealed regularly spaced ladder patterns of smooth
LPS molecules possessing increasing numbers of O-
antigen repeating units. Linko-Kettunun et al. pro¬
duced MAbs to the LPS of B. fragilis.22 Each MAb
recognised a common galactose-containing determi¬
nant present in the outer core of the rough LPS.23 The
absence of the long chains of repeating polysaccharide
units led the authors to conclude that B. fragilis LPS
resembled the rough type LPS of gram-negative
bacteria.24
The MAbs described in the present study all reacted
with saccharide epitopes. By immunoblotting, MAb
QUBf5 reacted with B. fragilis antigens to produce a
ladder in the middle of the blot similar to the ladder
which Poxton and Brown suggested was the O-
antigen.10 MAbs QUBf6 and QUBf7 were specific for
different high-Mr polysaccharides. MAb QUBf8 la¬
belled high Mr polysaccharide and also some low Mr
material which stained in a similar position to the core
region of the rough LPS from other bacteria. This
indicates that the Bf8 epitope may be present on a
core or anchoring region of the polysaccharide.
Therefore, by using whole bacteria as antigens for
both immunisation and MAb screening, we obtained
a broader range of MAbs, including one which may
be to the O-antigen.
Immuno-electronmicroscopy showed that these
MAbs labelled epitopes primarily associated with the
large capsule and EDL, but not the small capsule. In
the case of the large capsule population, MAbs
QUBf5-8 recognised epitopes present on both the
bacterial surface and extracellular vesicles. The mem¬
brane vesicles either remained within the fibrous
network of the large capsule or were sloughed off.
Since extracellular vesicles may have associated
capsular or EDL material, it remains unclear whether
the saccharide epitopes are associated with the
membrane bilayer or the encapsulating structures.
Deslauriers et al. observed the release of similar
extracellular vesicles from intact Porphyromonas (Bac-
teroides) gingivalis cells.25 The extracellular vesicles
described consisted of a membrane bilayer and were
thought to contain some periplasmic material. The
release of extracellular OM vesicles has previously
been described in E. coli growing under lysine
limitation26 and also under normal growth condi¬
tions.27 Such a release of membrane vesicles or slime
may be important in virulence. The antigenic sites
located on extracellular structures could result in the
deposition of opsonin, either C3 or specific antibody,
at a distance from the bacterial cell, thus reducing the
effectiveness of the host immune response.
The reaction of each of the anti-polysaccharide
MAbs with a proportion of recent clinical isolates and
bacteria grown in vivo suggests that these polysacchar¬
ides may be relevant to the virulence of B. fragilis.
In contrast with the large capsule population, in the
EDL population the saccharide epitopes were not
firmly surface-associated. Polysaccharides are abun¬
dantly released from these cells as free material,
probably in the form of slime (fig. 4d) similar to that
observed in other bacteria and described as excreted
viscous substances that are not anchored in the
bacterial outer membrane.28
Interestingly, the ladder pattern observed by im¬
munoblotting was associated only with the EDL
population. These ladders are considered to represent
polysaccharide molecules of varying chain lengths,
each step up the ladder corresponding to the addition
of one repeating subunit. Perhaps the polysaccharides
from cells in the EDL population are of varying chain
lengths, or they are more susceptible to breakage of
the chain. Where the polysaccharides remain solely
cell- or vesicle-associated, in the case of the large
capsule population, the chains may remain large and
intact.
There was a low level of labelling of the small
capsule population detectable by flow cytometry,
immunoblotting and immunogold electronmicroscopy
with negative stain. There are a number of possible
explanations of this. Firstly, as the MAb only labelled
extracted and secreted material and not whole cells, it
is possible that the antigenic sites are masked by other
structures. However, electronmicroscopy and
immunogold labelling of thin sections gave a negative
result and, therefore?, did not support this hypothesis.
Secondly, a low proportion of cells from the large
capsule or EDL population may have been present in
the sample. Thirdly, the polysaccharides may be
expressed at a low level because of incomplete
repression of the genes involved in controlling polysac¬
charide synthesis. A few labelled outer membrane
vesicles were observed in the small capsule population
(fig. 2a).
Flow cytometry provided further confirmation of
the labelling pattern of the four MAbs QUBf5-8 and
of MAb Bf4 which reacted with the small capsule. It
also allowed a more rapid and accurate measurement
of the proportion of bacteria labelled within a given
population.
The generally higher percentage labelling obtained
by flow cytometry, when compared with fluorescence
microscopy, may be due to the greater sensitivity of
the flow cytometer which detects fluorescence signals
not readily visible by eye. Alternatively, it may be due
to the harsher fixation procedure used for microscopy.
This may cause the loss of some antigenic sites.
The significance of the fluorescent intensity profiles
obtained by flow cytometry is at yet unclear, although
they were consistently reproducible. The twin peaks
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obtained with MAbs 5, 6 and 8 and the large capsule
population may represent different populations within
the large capsule population. Whether this occurs as a
natural pheonomenon or as a result of the treatment
of bacteria during the labelling procedure is under
investigation. These MAbs gave a broad profile when
labelling the EDL population. The electronmicroscopy
results show that polysaccharides labelled by these
MAbs are released as cell-free material from the EDL
population. Therefore, the broad profile may represent
a continuum from cells from which most of the
polysaccharide has been released as free material, to
those in which most of it remains associated with the
bacterial cell. 0rskov and 0rskov30 noted that even
the mildest extraction procedures, such as cautious
suspension of E. coli in saline, gives a suspension
containing capsular material and LPS. More discrete
peaks (e.g., small capsule population with MAb Bf4)
may relate to the closer association of the polysacchar¬
ide with the cell surface.
We have shown previously that the EDL population
agglutinates erythrocytes from a number of different
animal species.29 The present study shows that a
proportion of the bacteria within these populations
share common epitopes. The polysaccharides recog¬
nised by the MAbs may not be involved in haemagglu-
tination. Alternatively, the polysaccharides may have
different properties in the large capsule and EDL
populations. This might relate in some way to the
variation in polysaccharide chain length detected by
immunoblotting only in the EDL population.
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The assessment of faecal flora in patients with
inflammatory bowel disease by a simplified bacteriological
technique
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Summary. A semi-quantitative bacteriological method was used to study faecal flora in 42
patients with Crohn's disease, 37 with ulcerative colitis and 21 healthy controls. Faecal
homogenates were plated on primary isolation plates by a technique that allowed the growth
of various microbial isolates to be assessed on a visual 1-1—5 + score. This method was first
calibrated against a standard quantitative bacteriological technique, which confirmed the
reliability and reproducibility of the results obtained by the simpler method. Patients with
clinically active Crohn's disease (22) had significantly higher total aerobe scores than patients
with quiescent disease (20) (p< 0-006) or ulcerative colitis (p<004) or normal controls (p<
0 02). The scores of Escherichia coli were parallel to those of total aerobes. Lactobacillus and
bifidobacteria scores were significantly reduced in patients with Crohn's disease compared
to those with ulcerative colitis and controls. The anaerobic flora in both Crohn's disease and
ulcerative colitis was indistinguishable from that of controls. Bacteroides vulgatus and B.
fragilis were the predominant bacteroides in all groups. Patients with ulcerative colitis,
regardless of disease activity, harboured faecal flora that did not differ from that of normal
controls. The abnormal faecal flora in Crohn's disease did not correlate with established
clinical and laboratory indicators of disease activity.
Introduction
The quantitative surface viable count technique
described by Miles et al.1 is the only common
bacteriological method applied for the enumeration of
the various components of the faecal microbial flora.
It has the disadvantage of being laborious and time-
consuming and may influence the number of faecal
samples that can be analysed in a busy laboratory.
Direct microscopic counting of the faecal microbes by
microscopy has also been used to evaluate the
composition of faecal flora but this does not differen¬
tiate between dead and viable bacteria and studies
comparing the two bacteriological methods have
frequently given conflicting results.2 Neither method
can be reproduced with accuracy; direct microscopic
counting is the least reliable. For the analysis of a large
number of faecal samples, the availability of a simple,
reliable and reasonably accurate bacteriological
method is desirable.
A semi-quantitative microbiological method is
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described that can be used for the assessment of faecal
microbial flora in health and disease. This gives results
comparable to those obtained by the standard surface
viable count, a technique which has been widely used
to enumerate bacteria in faecal specimens.3-6 The
results of the application of this method to determine
the composition of the faecal flora in patients with
inflammatory bowel disease are also presented.
Materials and methods
Patients
Twenty-nine patients with inflammatory bowel
disease and 21 healthy individuals were studied. In all
patients the disease was diagnosed by standard
clinical, radiological and histological criteria.7
Forty-two patients had Crohn's disease. In 22 of
these (16 females and 6 males; mean age 38 years), the
disease was considered to be active. Disease activity
was assessed by the presence of significant symptoms,
(e.g., diarrhoea, abdominal pain, weight loss), abnor¬
mal laboratory tests generally accepted as reflecting
active gut inflammation8 and a Crohn's Disease
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Addendum
Cases with unexplained severe immunosuppression
but without evidence of HIV infection have been
described. A recent expert meeting of the World
Health Organization concluded, however, that they
are not epidemic in nature, they may represent
different entities with various causes and that at
present there is no evidence that such a condition
would be transmitted by blood.48
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Summary. The obligately anaerobic Gram-negative intestinal bacterium Bacteroides fragilis is a
frequent cause of sepsis arising from faecal contamination. The precise nature of the virulence
determinants of this bacterium remain to be elucidated: polysaccharides, fimbriae, extracellular
enzymes and enterotoxin may all play a role. It is likely that surface structure variation is also of
prime importance to virulence.
Introduction
The Gram-negative bacterium Bacteroides fragilis is
the obligate anaerobe most frequently isolated from
clinical infection. Sources include intra-abdominal,
vaginal, pilonidal, perianal, brain and lung abscesses.
Recently B. fragilis was reported to be present in
80-90% of cases of peritonitis and Escherichia coli in
approximately 60% of cases.1
Such infections generally arise from faecal con¬
tamination. In the case of intra-abdominal infection
this may be the result of, for example, a ruptured
appendix. Faeces normally contain between 10" and
1012 bacteria per g, which in terms of volume of the
bacteria, leaves little room for anything else. The
anaerobic bacteria within faeces outnumber the
facultative bacteria, such as E. coli by about 1000 to 1.
Thus, anaerobic bacteria constitute approximately
99% of the faecal bacterial mass. Of this, Bacteroides
spp account for 20-30% of the species isolated.2 The
Bacteroides spp fragilis, distasonis, vulgatus, ovatus,
thetaiotaomicron, caccae, eggerthii, merdae, stercoris
and uniformis constitute the 'fragilis group' of bacter¬
oides with B. fragilis as the type species. Prior to
1976,3 B. fragilis, distasonis, ovatus, thetaiotaomicron
and vulgatus were designated subspecies of B. fragi¬
lis, e.g. B. fragilis subsp vulgatus. It is therefore
important to ascertain, when reading the literature,
whether the authors are referring to B. fragilis, the
species, or B. fragilis as a group including the former
subspecies.
As anaerobic bacteria predominate in faeces, the
association of these bacteria with infections resulting
from faecal contamination of body sites is, perhaps,
not surprising. If, however, the composition of the
anaerobes in faeces is examined, the most abundant
species is B. vulgatus, with B. fragilis, the most
common clinical isolate, only a relatively minor
component.4 More recent studies indicate that the
occurrence of B. fragilis in the intestinal flora has
been underestimated. Namavar and colleagues5
investigated the colonic, rather than the faecal flora,
by faecal lavage and biopsy of colonic mucosa. They
estimated the proportion of B. fragilis in the colonic
flora was 44%, in comparison with approximately 4%
in the faecal flora. B. vulgatus accounted for 45% of
the faecal flora and about 30% of the colonic flora.
Possible virulence determinants of B. fragilis
include encapsulating surface structures outside the
outer membrane, filamentous fimbriae, the release of
factor(s) which inhibit phagocytic function, the
release of extracellular degradative enzymes and
enterotoxin.6 There are varying degrees of evidence
for the role these determinants play in virulence, but
it is likely that they all play some part, maybe at
different stages in the pathogenic process. This
review is intended to be a personal view of the current
state of understanding (or lack of) of some of the
virulence determinants of B. fragilis. A discussion of
enterotoxin production by B. fragilis and its role in
diarrhoea is beyond the scope of this review. The
reader is referred to the publications of Myers and
colleagues.7
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Virulence: structures
A confusion ofpolysaccharides
Studies of the virulence determinants of B. fragilis
have been retarded by a general acceptance that,
firstly, any population grown under constant con¬
ditions is homogeneous with respect to surface struc¬
ture expression and that, secondly, the presence of a
polysaccharide capsule is a unique feature of B.
fragilis which is lacking in other Bacteroides spp and
therefore the major virulence determinant. A crude
polysaccharide extract from strain ATCC 23745,
which contains a mixture of polysaccharides,8 will
cause sterile abscess formation in animal models of
infection.9 Immunization with this polysaccharide
mixture protected against abscess formation;10
however, this is far from the complete story of B.
fragilis virulence, or indeed B. fragilis surface poly¬
saccharides.
Evidence for within-strain variation in B. fragilis
capsule expression and for expression of capsules in
other species of the fragilis group was published by
Babb & Cummins in 1978." These authors observed
capsules of different sizes within individual strains of
B. fragilis by light microscopy of wet India ink
preparations. Evidence of possible within-strain anti¬
genic variation was obtained indirectly by Schwann &
Danielsson12 who observed non-homogeneous
staining of B. fragilis by immunofluorescence micro¬
scopy using polyclonal antisera. In 1981 we attempted
to repeat the observations of Babb & Cummins. We
changed the growth medium to determine if this
would alter capsule size, as nutrient availability had
been reported to alter capsule expression in other
bacteria.13 A change from the peptone yeast extract
medium of Duerden and colleagues14 to the minimal
medium of van Tassel & Wilkins15 resulted in greatly
enlarged capsules as observed by light microscopy.
This allowed both the accurate quantification of the
percentage of bacteria within a population bearing
large capsules and the separation of these cells.16 Late
exponential phase culture was layered onto a step
density Percoll gradient with steps of 80, 60, 40 and
20% Percoll (Fig. 1: method detailed in 17). After
centrifugation, material from the gradient interfaces
was sub-cultured into fresh broth, grown and applied
to a gradient a second time (Fig. ICi-iii). It was now
apparent that the gradient centrifugation had en¬
riched for different sub-populations from within one
strain of B. fragilis. Light microscopy revealed that
the 0-20% interface enriched for large capsule (LC)
bacteria (Fig. IDi), the 20-40% interface for small
capsule (SC) bacteria (Fig. IDii), the 40-60% for a
mixture of SC and non-capsulate (NC) bacteria and
the 60-80% interface for only NC bacteria (Fig.
IDiii). A number of strains were examined using this
technique. Not all strains had the small capsule
sub-population (notably strain ATCC 23745) and in
some strains a few bacteria passed through the 80%
Percoll to the bottom of the centrifuge tube.
Ultrathin section and electron microscopy revealed
a large fibrous network in the LC population (Fig.
lEi) and a smaller fibrous network in the SC popula¬
tion (Fig. lEii). Ruthenium red enhanced the elec¬
tron density of both of these structures when
observed by electron microscopy. This suggests that
the major components of the LC and the SC are
negatively charged polysaccharides.
The population which was NC by light microscopy
had a narrow electron dense layer outwith the outer
membrane (Fig. lEiii). This was termed the electron
dense layer (EDL) as it was electron dense (i.e. dark)
by electron microscopy without ruthenium red stain.
This strongly suggests that it has components other
than polysaccharides. A few bacteria within the
60-80% enriched population lacked any visible struc¬
ture outwith the outer membrane. Interestingly NC
B. ovatus lacked an electron dense layer.
Subsequent studies with monoclonal antibodies
(MAbs) using immunofluorescence microscopy,
immunoelectron microscopy, immunoblotting and
flow cyometry revealed, surprisingly, that the SC was
not simply a smaller amount of the LC, but carried
antigenically distinct epitopes18 (Fig. 2). These
studies also revealed that the EDL was antigenically
distinct from the SC and not simply condensed fibrous
material. Immunoblotting after polyacrylamide gel
electrophoresis (PAGE) confirmed that the epitope
associated with the small capsule was present on a
high molecular weight polysaccharide. This, along
with the reactivity of another MAb,19 implied that
there were at least two antigenically distinct polysac¬
charides produced by individual strains of B. fragilis.
Subsequently we produced other MAbs which
unexpectedly reacted with epitopes in both the EDL
and LC population20-21 (Fig. 2). In the LC population
the polysaccharide epitopes remained either asso¬
ciated with the cell surface or excreted vesicles of
outer membrane (extracellular vesicles; ECV),
whereas in the EDL-enriched population the epi¬
topes were associated with copious quantities of
excreted extracellular polysaccharide as well as ECV.
Immuno-labelling for fluorescence and electron
microscopy and flow cytometric analyses revealed a
heterogeneous labelling pattern with the MAbs, i.e.
only a proportion of the bacteria within the LC or
EDL population were labelled with a given MAb22-23
(Fig. 3). It is likely that this reflects antigenic
variation of individual structures. In E. coli, within-
strain variation in epitope expression has been
reported for E. coli K18 and Kl. E. coli K18 and K22
produce capsules which are both composed of polyri-
bosyl-ribitol phosphate. In E. coli K18, however, the
ribose is O-acetylated and this is sufficient to alter the
antigenicity of the molecule. Using antisera specific
for these two serotypes and immuno-electron micro¬
scopy, it was clear that E. coli K18 is in fact a mixture
of bacteria, 40% of which express the acetylated form
of the capsule, the remainder expressing the non-ace-
tyiated form. In E. coli Kl, the polysialic acid capsule
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Fig. 2 Flow cytometric profiles of large capsule (LC), small capsule (SC) and EDL populations of B. fragilis treated with MAbs
QUBf5-8, BF4 or PBS (control) followed by the appropriate IgG or IgM fluorescein-conjugated secondary antibodies. Number
of events: scale 0-124 (*), 0-512 for other profiles. Note that Bf4 is specific for the SC population and that the other MAbs label
the LC and EDL populations. Reproduced, with permission, from Lutton DA, Patrick S, Crockard AD et al, J Med Microbiol
1991; 35: 229-237.
also exhibits within-strain variation, the Kl+ antigen
is O-acetylated and slightly immunogenic, whereas
the Kl~, non-acetylated form is non-immunogenic. It
is thought that the variation is mediated by a genetic
switch which controls the activity of a specific trans-
acetylase enzyme.24 Whether similar mechanisms are
responsible for the within-strain antigenic variation
observed in B. fragilis is a matter for future investi¬
gation.
In a recent publication,25 the authors expressed
surprise at detecting two different polysaccharides in
B. fragilis strain NCTC9343. They suggest that one of
the two polysaccharides may be the same as the
polysaccharide detected by us in the SC population.
Unfortunately they did not define the types of capsule
expressed within their populations by microscopy,
therefore it is difficult to draw any firm conclusions.
This tremendous capacity for within-strain structu¬
ral and antigenic variation of polysaccharide expres¬
sion by B. fragilis must be taken into account when
reading any published literature where the surface
structures of the populations under investigation
have not been defined by both light and electron
microscopy.
Chemical and immunochemical analyses of the
surface polysaccharides have yielded apparently con¬
tradictory results. B. fragilis has been reported to
have a 'strain specific' high molecular weight polysac¬
charide and a largely 'species specific' rough-type
lipopolysaccharide (LPS).8 The LPS was reported to
have a core sugar region and short O-antigen, but no
repeating long chains of polysaccharide linked to the
lipid A. Other authors report a more complex
mixture of surface carbohydrates.26 27 By PAGE and
immunoblotting, Poxton & Brown28 investigated
further the purified rough-LPS and capsular polysac¬
charide fractions obtained after Sephacryl S-300
separation of aqueous phenol extracts by the method
of Kasper and colleagues.8 The fraction containing
the high molecular mass polysaccharide also con¬
tained smooth LPS, which formed a characteristic
ladder pattern on PAGE; the rough-LPS fraction also
contained a low molecular weight common polysac¬
charide antigen which migrates behind the rough
LPS. The low molecular weight polysaccharide was
common to all the B. fragilis strains examined. (Note:
This work is misquoted by Lindberg and colleagues,29
the 'common' polysaccharide antigen does not form a
ladder pattern.) The inability by some workers
(e.g.30) to detect the repeating polysaccharide chains
of smooth-type LPS is undoubtedly due, in part, to
the use of a phenol-chloroform-petroleum ether
(PCP) extraction procedure which will selectively
isolate rough-type LPS. The material remaining
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Fig. 3 Ultra-thin section of B. fragilis treated with MAb followed by the appropriate gold-conjugated secondary antibody. Note
that only a proportion of the bacteria are labelled.
insoluble after the PCP extraction, and normally
discarded, contains the B. fragilis smooth LPS,
common polysaccharide antigen and higher molec¬
ular weight polysaccharide.28
Different proportions of LC, SC and EDL within
the populations used for the extractions will also have
a major influence on the polysaccharides detected.
We have produced a MAb which detects a ladder
pattern, characteristics of smooth-LPS, in immuno-
blots. The ladder pattern was only detectable on
extracts taken from the EDL-enriched population,
and not the LC population. This was also the case for
the more closely spaced ladder patterns associated
with the high molecular weight polysaccharides20
(Fig. 4).
Interestingly, the EDL population releases the
polysaccharide as cell-free slime. Whether the cell-
free polysaccharide is present in chains of different
lengths, while the cell-associated capsular polysac¬
charide is of more uniform chain-length, remains to
be seen. Alternatively, the cell-free polysaccharide
may be more susceptible to chain-breakage.
These results highlight the complexity of B. fragilis
polysaccharides and underline the need to take into
account within-strain variations.
Reports of sugar analysis of the LPS of B. fragilis
include the following sugars: glucose, galactose,
fucose, rhamnose, xylose, glucosamine, galactosa-
mine, ribose, arabinose, mannose (reviewed in29).
Studies of the rough-type LPS detected the rham¬
nose, galactose, glucose, galactosamine and glucos¬
amine. On the basis of the distribution of these
sugars, 17 strains of B. fragilis could be placed into 5
different groups. This core region of LPS could be
detected with a MAb specific for the epitope (3-1-6
linked galactose disaccharide.31"32 The authors
termed this a common antigenic determinant because
the MAb reacted with 96% of strains examined;
however, only an estimated 10% of bacteria within a
population were labelled after itnmunogold labelling
of ultra-thin sections. It was suggested that the low
level of labelling might be related to the growth
phase31 or the harshness of the washing procedures
used during the labelling procedure.32 It is more
abc def ghi
Fig. 4 Immunoblots from SDS PAGE gels of proteinase K
extracts of B. fragilis NCTC 9343. Lanes a, d, g and j: large
capsule population; lanes b, e, h, and k: small capsule
population; lanes c, f, i, and I: EDL population. The blots
were probed with MAbs QUBf5 (lanes a-c), QUBf6 (lanes
D-f), QUBf7 (lane g—i) and QUBf8 (lanes j-l). Reproduced,
with permission, from Lutton DA, Patrick S, Crockard AD et
al, J Med Microbiol 1991; 35: 229-237.
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Fig. 5 Electron micrograph of platinum-gold coated whole
cells of B. fragilis. Note the long strands of material
extending from the bacteria.
likely that the low percentage labelling reflects anti¬
genic heterogeneity within the population22 and this
determinant cannot, therefore, be considered to be a
'common' antigenic determinant.
There have been conflicting reports of the pres¬
ence/absence of L-glycero-D-manno-heptose and
keto-deoxyoctonate(KDO), both of which are
present in enterobacterial LPS. KDO is almost
certainly present, but in a phosphorylated form,
rendering it undetectable in the standard assay.33
The relationship of polysaccharides to virulence is
considered below.
Lipid A
Inter-strain variation in the fatty acid content of the
lipid A of B. fragilis has been reported (reviewed
in29). In the lipids examined, only trace amounts of
the predominant fatty acids associated with entero¬
bacterial LPS (e.g. 3-hydroxytetradecanoic acid)
were detected. The other major differences between
B. fragilis and enterobacterial LPS were (a) in the
number of fatty acids per lipid A (5 for B. fragilis, 6-7
for enterobacteria), (b) fatty acid chain length
(C15-17 for B. fragilis, C12-16 for enterobacteria),
(c) branching hydroxylated and non-hydroxylated
fatty acids in B. fragilis and (d) a lack of 4' phosphoryl
group on the non-reducing glucosamine residue in B.
fragilis. The biological activities of B. fragilis LPS are
discussed below.
It remains to be seen if there are within-strain
differences in the lipid A content of B. fragilis and if
the LC, SC and EDL subpopulations are different in
this respect.
Fimbriae
Studies of the fimbriae of B. fragilis are still in their
infancy. This may be due to technical difficulties in
observing fimbriae by electron microscopy (EM) or a
lack of understanding of the precise growth con¬
ditions required to favour assembly of fimbriae. The
slow progress in characterization of the fimbriae
expressed by B. fragilis may be a clue to the possi¬
bility that structural variation of fimbriae also occurs.
The first report of fimbriae in the published litera¬
ture was as recent as 1984 when Pruzzo and col¬
leagues described filamentous appendages of
approximately 30nm in diameter.34 Subsequently,
van Doom and colleagues described fimbriae of
4-5 nm in diameter.35 These authors raised polyclonal
antiserum to the fimbriae with which they succeeded
in immuno-gold labelling the fimbriae. Immunoblot-
ting revealed a fimbrial subunit of 40-42 kDa,
depending on the strain. They showed that fimbrial
expression was reduced at low iron concentrations
and low temperature.
We have been able to detect the fimbrial subunit by
immunoblotting of bacteria grown in vivo and in the
LC, SC and EDL populations in various strains;36
however, we have only observed intact fimbriae by
EM and negative stain after the bacteria have been
cultured on agar plates, and not after broth culture. It
seems likely that other workers have experienced
difficulty in observing fimbriae on B. fragilis. Possible
explanations for the problems in studying fimbrial
expression include the interference of polysaccharide
in detection of the fimbriae. Long strands of material
are observed when B. fragilis is platinum-gold
shadowed36 or coated (Fig. 5) after broth culture. The
question remains as to whether these are strands of
polysaccharide or polysaccharide covering underly¬
ing protein structures. Polysaccharide could also
mask the epitopes on the fimbriae, making immuno-
gold labelling erratic and difficult. It may be that
fimbrial subunits are expressed, but not always ass¬
embled into intact fimbriae. This underlines the need
for extensive genetic studies of the expression and
control of expression of fimbriae in B. fragilis. Van
Doom and colleagues have started on this road by
determining the N-terminal sequence of their 40-42
kDa fimbrial subunit. Interestingly it does not belong
to the N-methyl phenylalanine family of fimbriae
characteristic of bacteria such as B. nodosus, Pseudo-
monas aeruginosa and Neisseria gonorrhoeae (van
Doom et al, personal communication).
Virulence: mechanisms
Immunomodulation by lipopolysaccharide
The lipopolysaccharide of B. fragilis characteristic¬
ally responds poorly in the tests usually performed to
examine the activity of LPS from enteric bacteria
such as Salmonella spp and E. coli. It is about 10- to
10000-fold less active in limulus lysate gelation,
pyrogenicity, lethality to mice, toxicity to chicken
embryo and the dermal Shwartzman reaction.37 In
spite of this, aqueous phenol extracts of B. fragilis
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polysaccharides are not totally without immunomo¬
dulatory activity. Extracted polysaccharides were
mitogenic for spleen cells derived from mice strains
which respond to enterobacterial endotoxin.
Whether strains of LPS-hyporesponsive mice,
which carry a mutation on the 4th chromosome in the
Lps gene and do not respond to lipid A from
enterobacteria, respond to B. fragilis LPS, remains
an open question. Extracted B. fragilis polysaccha¬
ride is mitogenic for spleen cells from these mice at
high spleen cell density;37-38 however, other immune
reactions of these hyporesponsive mice remain low.38
Unfortunately the extraction procedures used in
these studies would have produced a mixture of
polysaccharides, rather than purified LPS.
For many years B. fragilis LPS was thought to lack
the sugar keto-deoxyoctonate (KDO) in the core
sugar region, as were the oral bacteroides such as
Porphyromonas (Bacteroides) gingivalis. This ass¬
umption was due to a lack of reactivity of the LPS in
the thiobarbituric acid (TBA) method used to detect
KDO. This lack of reactivity stems from phosphory¬
lation of the KDO.33'39 Dephosphorylation of the
LPS results in reactivity in the TBA assay. This
unusual KDO, the lack of phosphorylation of the
glucosamine disaccharide backbone of the lipid A
and differences in the fatty acid composition may all
contribute to the lower toxicity of bacteroides LPS.
The role of components of Bacteroides spp in
endotoxic shock, however, remains to be defined.
Although the LPS has a lower activity than entero¬
bacterial endotoxin, Bacteroides spp are numerically
predominant in faeces and may therefore be as
important in endotoxic shock as are the enterobac¬
teria. Perhaps the role played by Bacteroides spp may
become more evident as treatments based on MAbs
to E. coli LPS come into more general clinical use.
Attachment to host cells
Numerous studies of the attachment of B. fragilis to
host cells, such as tissue culture cell lines and
erythrocytes, have yielded apparently conflicting
results. Both polysaccharides and fimbriae have been
reported to be involved and not involved in attach¬
ment to host cells (see 35-40"42). The results become
less confusing if it is accepted that B. fragilis can
produce more than one type of ligand to mediate host
cell attachment and that expression of these ligands is
subject to within-strain variation. In our studies, we
have shown that by mixing together different propor¬
tions of bacteria with either the LC or EDL it is
possible to correlate the degree of haemagglutination
with the proportion of EDL bacteria within a given
population.43 We have also shown that released
extracellular vesicles (ECV) will cause haemaggluti¬
nation (unpublished result). It is therefore essential
to be aware of, not only the surface structures
expressed by the populations being examined, but
also the amounts of ECV and extracellular polysac¬
charide (EPS) present. If quantities of ECV or EPS
are present they may block attachment sites on tissue
culture cell lines and therefore exclude the bacteria.
In assays which rely on quantifying the attached
bacteria, erroneous negative results may be obtained.
Despite the confusion in identifying which particular
structures are involved in attachment to host cells, it
can be concluded that B. fragilis can successfully
attach to host cells. This ability would be clearly
advantageous in situations where the host's
secretions will wash the bacteria away.
Recent studies have shown that under certain
conditions B. fragilis may penetrate host cells.44 This
may be particularly important in bacteraemia, where
the route of travel of the B. fragilis from an initial
focus of infection in, for example the peritoneal
cavity, to the bloodstream is unclear.
Nutrition in vivo: release of extracellular degradative
enzymes
B. fragilis have been reported to release extracellular
enzymes capable of degrading the components of the
host's extracellular matrix (e.g. hyaluronidase, chon-
droitin sulphatase), host cells and tissues (e.g.
DNAase, lipase, protease and neuraminidase).45
Constitutive expression of a range of periplasm or
outer membrane associated proteases with arylami-
dase activity towards the amino acids leucine, valyl
and glycyl-proline has also been reported.46
In spite of this, B. fragilis is not a progressive,
fast-spreading destructor of the host as is, for
example, Clostridium perfringens. It seems likely that
the enzymes released by B. fragilis act in a localized
area, although some enzymic activity has been
observed in association with released ECV (unpub¬
lished result).
Neuraminidases, which cleave sialic acid from
oligosaccharides on host cell glycoproteins and glyco-
lipids, may have a more subtle effect on the host.
There are more than 20 known naturally occurring
sialic acids formed by various substitutions and
additions to neuraminic acid.47 There is growing
evidence that these sugar residues are involved in the
biological activities of the host cells and molecules.48
A prime example is the movement of lymphocytes
within the host.49 Therefore the released neuramini¬
dase enzymes may subvert the normal function of the
immune system or other systems of the host. The
nanH which encodes for neuraminidase in B. fragilis
has been successfully cloned in E. coli.50 Perhaps
studies of the virulence of B. fragilis lacking this gene
will shed more light on the role of neuraminidase in
pathogenesis.
Nutrition: iron uptake mechanisms
For B. fragilis to grow in vivo, it must be assumed that
it is able to scavenge iron successfully from the
proteins and glycoproteins to which iron is normally
VIRULENCE OF BACTEROIDES FRAGILIS 47
complexed in the host. The growth of B. fragilis in
complex tryptone yeast extract medium in the pres¬
ence and absence of the iron chelating agent 2,2'
dipyridil was compared by Otto and colleagues.
Novel outer membrane proteins (OMP) of Mr 89, 49,
44 and 23.5 kDa were detected only under the
iron-limited conditions.51 Studies with a defined
medium, which was depleted of iron by precipitation
with CaCl2, showed that B. fragilis grown in this
medium had a requirement for protoporphyrin. This
was related to the presence of the 44 kDa OMP.
Further experiments indicated that haemoglobin was
the best utilised source of iron when apotransferrin
was present in the iron-depleted medium. It therefore
appears that in vivo B. fragilis may use haem from
haemoglobin as an iron and protoporphyrin source.52
Interestingly, in the defined medium used, the maxi¬
mum optical density in late exponential phase cul¬
tures, even under iron and protoporphyrin replete
conditions, was approximately 1.5 at OD65o. This
strongly suggests that something else within the
growth medium is also limiting growth.
Studies of both normal human sera, and sera from
rats which had been experimentally infected with B.
fragilis indicated that there was a specific antibody
response to a 44 kDa OMP. This implies that this
protein is indeed expressed in vivo.53 At present there
is no evidence that B. fragilis produces its own
chelating agents. The possibility of having uptake
mechanisms for the chelating agents of, for example,
E. coli has not been ruled out. A comparison of B.
fragilis growing in vivo and in vitro, however, did not
reveal the induction of copious quantities of high Mr
OMP receptors for chelating agents which are charac¬
teristically produced by E. coli under iron limita¬
tion.54
These studies highlight a greater need for attention
to the basic physiology of B. fragilis when grown
under different nutritional conditions and a need to
compare in vivo and in vitro grown cultures.
Evasion ofphagocytosis and complement activity
The large capsule of B. fragilis impairs phagocytic
uptake and killing by human polymorphonuclear
leukocytes in vitro, probably by mopping up host
opsonins. Although the EDL population is readily
phagocytosed in vitro, this population is resistant to
killing by normal human serum.54 Unexpectedly, the
large capsule is selected against in a mouse model of
infection, in the presence of phagocytic cells;22
however, the population which is selected excretes
copious amounts of extracellular polysaccharide,
which shares epitopes with the LC.20 It seems likely
that if sufficient EPS is excreted in vivo it may also
mop up opsonin, thereby reducing phagocytic
activity. The release of ECV may have a similar
function, causing the deposition of opsonins and
perhaps activation of complement at a distance from
the bacterial cell surface. ECV are produced in a
natural infection as they can be detected after
immuno-labelling by both fluorescence and electron
microscopy directly in pus samples (unpublished
result). Pathogenic synergy, whereby B. fragilis pro¬
tects and enhances the survival of other facultatively
anaerobic bacteria in an infection, is known to occur.
The depletion of opsonin56 and release of factor(s)
which inhibit the chemotaxis of polymorphonuclear
leukocytes, such succinic acid,57 are implicated. The
EPS may also coat other facultative bacteria within a
polymicrobial infection and contribute to the
synergy. Interestingly, abscess-derived neutrophils
are reported to harbour viable bacteria and be less
efficient at killing bacteria than neutrophils derived
from either peritoneal aspirates or peripheral blood,
CO
in in vitro experiments.
In a comprehensive study of the opsonization of B.
fragilis, using isolated components of the alternative
complement pathway (ACP), Bjornson et al59
demonstrated that C3 deposition occurred with C3,
properdin, factors H, I, B and D alone. Attachment
to polymorphononuclear leukocytes, uptake and kill¬
ing, however, required other as yet unidentified
'auxilliary' factors present in serum. These results
indicate that resistance of B. fragilis to either comple¬
ment-mediated lysis or phagocytic uptake and killing
is not mediated by a lack of activation of the ACP or
C3 deposition. Unfortunately the surface structures
of the bacterial populations used in this study were
not defined.
Antigenic variation of surface carbohydrates could
play a significant role in the evasion of the specific
immune response. Bacteria taken directly from pus
samples6" and from an animal model of infection21'22
are antigenically heterogeneous when labelled with
carbohydrate specific antibodies.
Conclusion
Despite strenuous effort by many workers, the pre¬
cise virulence determinants of B. fragilis remain
elusive. Part of the reason for this is that within-strain
variation of both surface structures and antigenicity
has been overlooked. Thus, the use of heterogeneous
populations has led to apparently conflicting results.
Surface variation may well turn out to be as
important in the virulence of B. fragilis as it is in other
well-studied pathogenic bacteria.
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REVIEWS IN MEDICAL MICROBIOLOGY
Haemophilus species and clones
T.H. Pennington
Department of Medical Microbiology, University of Aberdeen, Medical School,
Aberdeen AB9 2ZD, UK
Summary. The current taxonomic position of Haemophilus species that infect man is reviewed,
with particular reference to H. influenzae and H. parainfluenzae. Recent studies on the population
genetics of H. influenzae are reviewed. Evidence that the population structure of this species is
clonal is appraised in detail, and a general account is given showing how the techniques of
population genetics and molecular systematics are used for the clonal analysis of bacterial
populations.
Introduction
Most medical microbiologists consider that they have
a clear understanding of attributes, boundaries,
members and biology of the genus Haemophilus.
According to Bergey's Manual1, it is defined as
comprising Gram-negative rods or coccobacilli,
which require preformed growth factors present in
blood, namely X factor (protoporphyrin IX or proto-
heme) and/or V factor (nicotinamide adenine dinu-
cleotide (NAD) or NAD phosphate). Bergey lists 10
species from man, two from pigs, two from poultry
and one from the dog, all of which are obligate
parasites. Of the species that colonize man, H.
influenzae is by far the most important clinically, in
that it causes a number of severe and quantitatively
important infections. H. influenzae is also distinctive
in that it can undergo genetic transformation with
high efficiency.2
The purpose of this review is to consider these
statements in the light of recent work on the popula¬
tion genetics of Haemophilus species and the clonal
concept of bacterial population structure.
A number of reasons make Haemophilus a particu¬
larly appropriate and interesting subject for discuss¬
ion under these headings. Noteworthy, for example,
is the extreme importance played by the requirement
for X and V factors in the definition and subdivisions
of the genus which in taxonomic terms makes it
virtually monothetic, a characteristic considered
undesirable by systematists3. In addition, recent
work has shown that natural populations of H.
influenzae are probably more variable genetically
than those of any other prokaryote or eukaryote
species, thus making the organism as distinctive as the
cheetah, which shows no genetic variability at all.4
Their positions at the extremes of variation make
both species particularly interesting to anyone who
wishes to investigate their evolution, speculate about
their natural history, and make predictions about
how their populations will change in the future. The
work on the population genetics of H. influenzae has
also revealed that its populations, like those of many
other important bacterial pathogens, have a structure
which is basically clonal.
Haemophilus species
The genera Haemophilus, Pasteurella and Actinoba-
cillus together form the family Pasteurellaceae5.
Identification of the genus Haemophilus by determin¬
ing a requirement for X factor or V factor or both,
whilst very useful as an operational characteristic in
the diagnostic laboratory, is unreliable for all strains.
It is therefore unacceptable as an exclusive definitive
feature. Consideration of the porcine organism Hae¬
mophilus pleuropneumoniae provides an illustrative
example of the taxonomic difficulties that have arisen
in this area. This organism generally has a growth
requirement for V factor. However, phenotypically it
has been shown to resemble a Pasteurella haemoly-
tica-like organism which causes porcine necrotizing
pleuropneumonia, and DNA hybridization of the
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The attachment of pathogenic bacteria to mammalian cells is a pivotal step in
the colonization of the host. Attachment is mediated by the interaction of
ligands on the bacterial surface and receptor molecules on the mammalian
cell. Bacteria have evolved with a range of attachment mechanisms, from the
non-specific in terms of cell type and cell surface receptor, to the highly
specific. Virtually all of the known structures on the surface of bacteria are
involved in some way in attachment to target cells, either by promoting or
interfering with attachment. For example, bacterial surface structures may
impede attachment and uptake by phagocytic cells. On the odter hand, attach¬
ment may be a prelude to the phagocytosis of the bacterium by a normally
non-phagocytic host cell.
The structures involved are fimbriae (sometimes referred to as pili), tlagella,
lipopolysaccharide (LPS), extracellular polysaccharides in the form of cap¬
sules or glycocalyx, lipoteichoic acids and outer membrane proteins (OMP).
Fimbriae, first named by Duguid el al. (1955) after die Latin for 'thread' or
'fibre', are generally accepted as very important in bacterial attachment to host
cells. Brinton (1959) named similar structures pili after the Latin for 'hair¬
like' and both names are still in use. Expression of such adhesive structures,
or adhesins, by the bacteria may be regulated by environmental changes
associated with the host cells or the host cells themselves. In the case of
Salmonella spp., an initial attachment event triggers the biosynthesis of further
adhesin molecules (Finlay et al., 1989).
The interaction of the bacterial adhesin with the host cell can also alter
the functions of the host cell. These may include the induction of plasmin
formation, rearrangement of the cytoskeleton to induce phagocytosis of the
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bacterium and, possibly, cytokine release (Hoepelman & Tuomanen, 1992).
Studies of attachment in disease must consider the characterization of the
relevant surface structures on the bacteria, the interaction between the bacterium
and the target cell surface and the characteristics of the target cell surface.
Such studies necessarily involve a wide range ofbiochemical and microbiological
techniques too numerous to detail here, and the reader is directed to Hancock
& Poxton (1988) for a full account. This chapter will deal with techniques and
approaches adopted in our work on the virulence of the obligate anaerobe
Bacteroides fragilis, in relation to the identification of surface structures by
microscopy and their antigenicity. This will provide an insight into the likely
problems and factors to be considered when approaching the study of a
pathogen for the first time.
Characterization of Surface Structures
by Microscopy
Before embarking on any study of bacterial attachment it is essential to define
the surface structures expressed on the surface of the organism, and to ensure
that the population to be studied is homogeneous with respect to expression of
the surface structure of interest. The antigenic heterogeneity of the structures
should also be examined because the parts of the bacterial molecule involved
in attachment may not be expressed by all of the bacteria within a population.
For example, Type 1 fimbriae, involved in attachment by Escherichia coli, may
be subject to both antigenic and phase variation. In the latter there is a switch
from expression to non-expression of the fimbriae at a rate of 10~2—10~3/
cell/generation as the result of inversion of a 314 base-pair segment of DNA
(Tennent et al., 1990). Considerable heterogeneity has been shown with
respect to surface structure/antigen expression in B. fragilis (Patrick & Lutton,
1990). Subpopulations of bacteria, separated by density gradient centrifugation
from a single strain, have different haemagglutinating properties, which
suggests that attachment studies should be approached with caution (Patrick
et al., 1988). A number of simple precautions should, therefore, be taken.
First, the bacteria should be grown in a defined medium to facilitate the
control of available nutrients. For example, nutritional conditions can alter the
size of capsules expressed by E. coli (Sutherland, 1977). Secondly, the phase
of growth of the culture should be known. Stationary-phase cultures should
be avoided because such populations are not homogeneous for any metabolic
parameter, and some of the population will be either dead, dying or utilizing
nutrients released from dead cells. Ideally, bacteria in continuous culture
should be used to ensure their metabolic uniformity. Alternatively, cultures
should be inoculated from a standard inoculum, stored in batches at — 70°C
or in liquid nitrogen, and always harvested at a particular phase of growth,
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such as the late exponential phase. Thirdly, variation in the expression of
surface structures with growth phase should also be determined. Finally,
bacteria grown in vivo, either in an experimental model (e.g. Day et al., 1980;
Patrick et al., 1984), or taken direcdy from clinical specimens, must be
examined for the expression of surface structures implicated in attachment by
the in vitro studies.
The following methods and techniques are regarded as generally appropriate
for any bacterial population to be studied.
Light microscopy
Negative staining with India ink in a wet mount and observation by light
microscopy should be undertaken to determine whether capsules are present
on the bacterium of interest. This is an essential first step which lacks the
drawback of dry preparations, where shrinkage of both the negative stain and
the bacterial cell may give false-positive results. Once the presence of capsules
has been established, dry staining methods can then be compared. If the
latter give the same results, they can be used in further studies. Dry staining
methods are more useful if time is limited and a number of samples are to
be examined, because prepared slides can be stored in the dark at room
temperature and examined later.
Wet India ink method (Cruickshank, 1965)
A large loopful of India ink is mixed on a clean glass slide with a small quantity of
broth culture -or bacteria taken from a colony. A coverslip is then placed on
the suspension and pressed down hard between sheets of blotting paper. The
preparation is viewed by phase-contrast microscopy at xlOOO magnification.
Encapsulated bacterial cells should be seen surrounded by clear areas corre¬
sponding to the capsule, with a background of India ink particles.
Dry eosin/carbol fuchsin method (Cruickshank, 1965)
Carbol fuchsin staining solution (Ziehl—Nielsen's carbol fuchsin diluted 1:5)
has the following composition: basic fuchsin (5 g), absolute ethanol (40 ml),
phenol (5% w/v in distilled water; 500ml). The fuchsin is dissolved in the
alcohol and is added to the phenol solution. For capsule staining this solution
is further diluted 1:5 in distilled water and can be stored in the dark at room
temperature. Eosin staining solution consists of four parts eosin solution
(10% w/v water-soluble yellowish or bluish erythrosin in distilled water) and
one part serum (human, rabbit, sheep or calf) heated at 56°C for 30min. A
crystal of thymol may be added as a preservative. After standing at room
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temperature for a few days, the mixture is centrifuged and the supernatant is
retained. It is stable at room temperature for at least a year.
Staining method. To stain the bacterial cells mix one drop of broth culture
or bacterial suspension in one drop of carbol fuchsin on a clean glass slide and
allow to stand for 30 s. Then add one drop of eosin solution and leave for
1 min. Spread a him of the suspension along the slide with a second clean
slide, as in preparing a blood smear, allow to dry at room temperature, and
examine by light microscopy at x 1000 magnification. The bacteria, particularly
those without capsules, will be much clearer if bright-held phase-contrast
microscopy is used. This gives the bacteria a greenish tinge against the pink
background of the eosin. The matt background of die eosin stain can be
enhanced by adding a loopful of Percoll (20% in saline; Pharmacia Biosystems
(UK) Ltd, Milton Keynes, UK) to the bacterial suspension on the slide.
Figures 6.1 (a, b and c) illustrate bacteria stained using the eosin carbol
fuchsin technique.
Loops should be carefully flamed and allowed to cool before dipping into
the staining solution. For both staining techniques control slides should be
periodically prepared without bacterial culture, to ensure that the stains have
not become contaminated.
Electron microscopy
Electron microscopy is an essential tool which will reveal capsules not visible
by light microscopy, and also whether fimbriae are present on the bacterial
surface.
Ultrathin sectioning of embedded bacteria
This method can be used for determining die presence of capsular material,
and a variety of different methods for embedding, fixation and staining is
available. The method chosen is usually determined by trial and error, because
different types ofbacterial polysaccharide capsule may have different properdes.
Ruthenium red staining after osmium tetroxide and glutaraldehyde fixation is
useful because ruthenium red stains negatively charged polysaccharides. For
successful staining, commercial ruthenium red should first be purified to
remove contaminating ruthenium purple. The use of specific antibody to
stabilize capsules has the disadvantages that structural detail of the capsular
material is lost, and it precludes subsequent immunolabelling to identify
particular structures. If immunolabelling of ultrathin sections is to be carried
out, osmium tetroxide fixation and ruthenium red stain may destroy the
antigenicity of the polysaccharide epitopes. For this reason glutaraldehyde/
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Fig. 6.1. Appearance of Bacteroides fragilis enriched by Percoll density gradient centrifugation.
(i) Unenriched broth; after overnight subculture (ii) from 0-20% interface layer (large capsule
population); (iii) 20—40% interface layer (small capsule population); (iv) 60-80% interface layer
(electron-dense population). Micrographs of large capsule population cells (a, d, g); small capsule
population cells (b, e, h); non-capsulate (electron-dense layer) population cells (c, f, i). Eosirt/
carbol fuchsin-negative stain (a, b, c); ultrathin section electron microscopy (d, e, f); platinum-
gold shadowing electron microscopy (g, h, i).
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paraformaldehyde fixation is used, but this has the disadvantage that capsules
are no longer visible. If facilities are available for crvofixation and freeze
substitution embedding, the appearance of capsular material may be retained
and immunogold labelling may still be successful. The use of Lowicryl K4M
resin and dimethyl formamide as a dehydrating agent may also allow visualization
of capsular material with concomitant immunogold labelling (Bayer, 1990).
Purification of ruthenium red (after Luft, 1971)
1 Place 0.25 g of commercially available ruthenium red in a mortar with a
few drops of 0.5 mol/1 ammonia solution and grind with a pestle. Transfer the
suspension to a V-shaped quick-fit test tube. Adjust the final volume to 10 ml.
2 Incubate the solution at 60°C for 30min in a water bath, with frequent
vigorous stirring with a glass Pasteur pipette.
3 Cool the test tube under tapwater and centrifuge in a bench centrifuge at
1500g for 5 min.
4 Carefully withdraw the supernatant fluid and place in a clean 50-ml
beaker.
5 Allow the supernatant to evaporate in a desiccator containing lOOg each
of anhydrous CaS04, NH4CO3 and NaOH.
6 Store in the desiccator in the dark until ready to use.
Fixation and staining procedure
1 Wash bacteria in cacodylate buffer (0.1 mol/1, pH 6.8) or add a small
quantity of bacteria directly to a large volume of fixative/stain.
2 Incubate in fixative/stain of glutaraldehyde (2.5% v/v), ruthenium red
(1 mg/ml) in cacodylate buffer (0.1 mol/1) for 1 h at 4°C in the dark.
3 Wash three times in buffer. The bacterial suspension will form a granular
pellet. Do not break this up but try to keep it as granular lumps throughout
the further procedures by stirring gently with the end of a Pasteur pipette,
rather than by sucking up and down. This greatly reduces the loss of material
during the procedure.
4 Resuspend in osmium tetroxide (1% w/v), ruthenium red (1 mg/ml)
in cacodylate buffer, as before. Incubate for 3 h at room temperature in the
dark. Wash twice in buffer.
5 Dehydrate in graded ethanol by centrifuging and suspending sequentially
in 30, 50, 75, 95 and 100% ethanol. Repeat the 100% ethanol treatment.
Filter the 100% ethanol through sodium sulphate on Whatman No. 1 filter
paper immediately before use to ensure that it is completely dry. Ensure that
the samples are not in any alcohol solution for longer than 15 min, including
the centrifugation period, though this limits the number of samples that can
be processed at any time.
6 Infiltrate and embed in the resin of choice — LR White is one of the
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simplest to use and is compatible with immunogold labelling of ultrathin
sections. After the final dehydration step, the pelleted bacteria are suspended
in resin—dried 100% ethanol (1:1) for lh and then left overnight in 100%
resin. The resin should be changed two or three times during the next day.
The samples should always be in containers left open to the air as the resin, if
enclosed, may begin to polymerize prematurely. Finally, place the sample, in
resin, into a gelatine or Beem capsule (Agar Scientific Ltd, Cambridge, UK)
and gendy centrifuge to pellet the sample. A paper label can be inserted into
the resin before polymerization by incubadon at 60°C overnight.
7 Ultrathin sections can then be cut, stained — for example with uranyl
acetate — and viewed by electron microscopy.
Negative staining of whole cells for electron microscopy
This is useful to determine the presence of fimbrial structures and llagella.
Glow-discharging of formavar/carbon-coated grids, widrin about 30min of
use, will improve the retendon of material on the grid. Grids are dipped into
the bacterial suspension in distilled water, allowed to drain on filter paper and
then dipped into a drop of stain, such as methylamine tungstate 2% (w/v) in
distilled water, and again allowed to drain. Immunogold labelling may be
carried out before negative staining. Negative stain may also reveal condensed
capsular material as a result of the dehydration of the polysaccharides, which
generally contain 99% water. The interpretation of the appearance of this
condensed material is frequently difficult. The drying that occurs as a result
of placing the bacterium on the grid and into the microscope vacuum, as
opposed to the controlled dehydration after fixation and staining for thin
section, may not always give this material a consistent appearance.
Platinum—gold shadowing of whole cells
This is similar to negative staining in that whole cells are placed on an electron
microscopy grid and shadowed at an angle (e.g. 20°) with platinum and gold
in a high-vacuum coating unit such as a Balzer BAE 120 (Lutton et al., 1989).
Again, interpretation of the structures observed may be difficult because dried
capsular material may have a fibrillar appearance (see Figs. 6.1(g) and (h)).
Definition of the structures associated with the surface of the bacterium
should ideally involve an electron microscopic comparison of whole cells and
thin sections, as well as light microscopy. Figure 6.1 compares three populations
as seen by light microscopy ((a), (b) and (c)), electron microscopy of ultrathin
sections ((d), (e) and (f)) and platinum—gold shadowed whole bacteria ((g), (h)
and (i)). The main points to note are that (i) the large and small capsules after
platinum—gold shadowing are fibrillar in appearance; (ii) the bacteria, which
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are apparently non-capsulate by light microscopy, have a marginal electron-
dense layer in ultrathin sections; this layer is termed electron-dense because it
is visible by electron microscopy in both the presence and absence of ruthenium
red, and suggests that it may have non-polysaccharide components (Patrick
et al., 1986); and (iii) the small round objects visible after platinum—gold
shadowing in both the electron-dense layer population and within the 'fibrils'
of the large capsule are extracellular vesicles that bud from the outer membrane
(Lutton et al., 1991). If these are present in a bacterial population, their
possible involvement in or interference with attachment of the bacteria to host
cells should be taken into account.
Immunological Characterization
of the Surface Structures
Definition of the antigenicity of the observed surface structures facilitates the
study of the antigenic variation that may be evident within strains. Ideally,
monoclonal antibodies (MAbs) specific for particular surface structures should
be prepared. An excellent account of the production of MAbs is given by
Goding (1986). Immunofluorescence microscopy and flow cytometry can then
be used to monitor antigenic variation. Immunogold electron microscopy will
assist in locating the epitope within the bacterium. Methods for immunogold
labelling are provided by Palak & Varndell (1984) and Beesley (1989).
Immunofluorescence microscopy
Preparation and coating of slides
Multiwell slides (Flow Laboratories Ltd, Rickmansworth, UK) are soaked
overnight in a weak solution of Decon (approx. 0.1% v/v), thoroughly rinsed
in tapwater and then in distilled water, and dried. A slightly turbid suspension
(30 pi) of bacteria diluted in phosphate-buffered saline (PBS; (g/1) NaCl,
8.00; K2HPO4, 1.21; KH2PO4, 0.34; pll 7.3) is placed in each well. Optimum
concentrations of bacteria should be determined empirically, so diat an even
distribution of a single layer of bacteria is seen on microscopy. Slides are
dried at 37°C in a fan incubator and fixed by placing them in 100% methanol
at —20°C for lOmin. The slides are then dried at room temperature and
wrapped with a sachet of silica gel. They may be stored at — 70°C for many
months, depending on die stability of the antigens.
Two-step immunolabelling procedure
This is based on Johnson et al. (1978). On removal from storage at —70°C,
the slide is allowed to come to room temperature. Primary antibody (30 pi),
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diluted in PBS or neat hybridoma supernatant, is applied to the well. The
slide is then incubated at 37°C in a humidified plastic box. From this stage
onwards the wells must not be allowed to dry out.
The primary antibody is then washed off wkh PBS with a wash bottle.
Care must be taken to ensure that antibody from one well does not run over
into another. The PBS is therefore directed to the centre of the slide, so that
antibody is washed over the outer edge of the slide.
The slide is then placed in a bath (e.g. a glass staining jar) of PBS and
mixed with a magnetic stirrer for at least 30 min. The back of die slide should
face the magnetic 'flea', in case it damages the bacterial film. The back of die
slide is then dried. The spaces between the wells are also gently dried with a
strip of filter paper; the wells themselves must not be dried.
The appropriate dilution of secondary antibody (e.g. antimouse IgG fluor¬
escein isothiocyanate (FITC) conjugate; 30 pi) is then applied to die well and
the incubation and washing steps are repeated. Finally, the slide is covered
with a mounting fluid, such as 10% (w/v) glycerol in PBS, containing an
antibleaching agent (e.g. photobleaching retardant; Syva Corporation, USA)
and covered with a large coverslip. If this is sealed widt nailvarnish, the slides
can be stored for a few weeks at 4°C in the dark.
Dual labelling can be carried out by adding an extra step. After applying
the primary antibody, such as a murine MAb, and washing, a rabbit polyclonal
antiserum, known to label all the bacteria within a population, may be added.
After washing, the bacteria are incubated with two conjugates together, such
as FITC-conjugated antirabbit immunoglobulin and tetramethylrhodamine
(3-isothiocyanate (TRITC)-conjugated antimouse immunoglobulin. The slide
is then mounted as above. The bacteria can be examined by fluorescence
microscopy with the appropriate filters. The double label allows the detection
of non-homogeneous labelling of a bacterial population by a MAb. Double
exposure of colour film with the same field of view and with filters suitable for
FITC and TRITC will give pictures of a single double-labelled field. A
simpler method is to observe the same field by phase-contrast microscopy
and fluorescence microscopy.
Preparation of Homogeneous Populations
Once structural or antigenic heterogeneity has been established for a bacterial
species, consideration must be given to methods for producing homogeneous
populations, before attachment is studied. Two methods are outlined
below.
Physical size and density gradient centrifugation
Density gradient centrifugation can be used to separate bacteria that express
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different surface structures. Discontinuous density gradients, also referred to
as step gradients, can be prepared with sucrose or other materials, such as
Percoll (Pharmacia Biosystems (UK) Ltd, Milton Keynes, UK). The latter
has the advantage that it is supplied sterile and, when diluted, can be made
isotonic with physiological saline at a physiological pH. The bacterial populations
can be separated on a bench centrifuge, rather than by ultracentrifugation.
In this way, bacteria suspended in Percoll retain their viability. Bacteria
harvested from the gradients can be used either directly or, if expression
of the surface structures is relatively stable, they can be subcultured before
assays of attachment.
Isopycnic density centrifugation has been used to separate E. coli possessing
colonization factor I (Giesa et ai, 1982). Continuous gradients were prepared
in an ultracentrifuge, and the bacterial populations were then applied to the
gradients and centrifuged on a bench centrifuge. Discontinuous gradients may
be prepared as detailed below, and have been used to separate B. fragilis with
different sizes of capsules (Patrick & Reid, 1983; it should be noted that
photomicrographs b and c in this publication arc transposed). Since each
bacterium may vary, empirical studies should be carried out with different
percentage dilutions of Percoll and different centrifugation times. A list of
publications in which Pcrcoll has been used may be obtained from Pharmacia
at the above address.
Preparation of Percoll
If bacteria are to be cultured after separation, the following manipulations
must be conducted under aseptic conditions. Percoll is supplied sterile and
should be dispensed aseptically in 90-ml volumes and stored at 4°C in sterile
bottles sealed with tape.
Percoll is made up in 0.15mol/l sodium chloride and this will be called
'100% Percoll'. A small volume is removed and the amount of 1 mol/1 HC1
required to bring the pi I to approximately 7, based on the number of drops
from a standard 20 pi dropper, is noted. The Percoll should be well mixed as
each drop of HC1 is added, and will become more cloudy in appearance. The
required volume of HC1 per millilitre of the 100% Percoll is calculated,
sterile HC1 is added aseptically, a small volume is removed and the pH
determined. The required volume of IIC1 per 100 ml Percoll should remain
constant within a single batch of Percoll, but this may vary between batches
and should always be rechecked.
Preparation ofgradients
The 100% Percoll (pH 7) can be further diluted with 0.15 mol/1 NaCl to give
80%, 60%, 40% and 20% (v/v) suspensions. These are then placed into
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11 ml/16 mm diameter sterile plastic screw-capped tubes, starting with 80%
at the bottom. The other layers, in decreasing concentration, are then added,
2 ml per layer. If only a few tubes are required the gradient steps can be
layered carefully by hand with a Pasteur pipette. The initial contact of one
layer with another is critical for the integrity of the interface. If the Percoll is
added too quickly the layers will mix. The Percoll should be allowed to run
gently down the side of the tube on to the surface of the layer below. If large
numbers of gradients are required, a peristaltic pump can be used to prepare
them. Stiff narrow-gauge tubing should be inserted into the soft tubing
passing through the pump. To ensure asepsis, 70% (v/v) industrial methylated
spirits in water should be passed through the tubing, followed by sterile saline.
After preparation the interfaces should be clearly visible. Less mixing between
layers occurs if the Percoll suspensions are used straight from the 4°C
refrigerator. If the refrigerator is vibration-free, gradients can be stored
overnight at 4°C. The interfaces will be less obvious on the second day, but
the system will work adequately.
Separation of bacteria
With a Pasteur pipette ca. 2 —2.5 ml of a broth culture is carefully layered on
to the gradient, which is centrifuged in a bench centrifuge with a swing-out
head. The relative centrifugal force and the time of centrifugation for a
particular bacterium will vary, and can only be determined empirically: between
2000 and 3000 g for 20—40min is a good starting point. First, after cen¬
trifugation, the culture medium on top of the 20% layer is removed with a
clean pipette and bacteria are then removed from each of the interfaces with a
Pasteur pipette. Percoll in the 20% layer is then carefully removed, without
disturbing the 20—40% interface, and discarded. Bacteria at the 20—40%
layer are removed next with a clean pipette, the 40% Percoll is discarded, and
so on down the gradient. The use of a clean pipette and discarding of the
Percoll between the interfaces minimizes the contamination of one layer
with another. Even if a distinct band of bacterial culture is not visible at an
interface, it should still be removed, examined by microscopy and subcultured. In
the case of B. fragilis there may be too few cells with a large capsule to be
visible as a band on top of the 20% Percoll. They can, however, be enriched
by subculture from the interface (Fig. 6.1 (i) to (iv)). Since tire enrichment may
not be absolute, it is wise to repeat the density gradient centrifugation after
culture from the interface layers.
Immunological separation
The use of immunomagnetic beads is a simple method for enriching bacteria
that express particular surface epitopes. Immunomagnetic beads can be bought
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already conjugated to either antimouse or antirabbit immunoglobulin. If
MAbs are available for particular epitopes, these can be attached to the
immunomagnetic beads and then used to remove bacteria carrying that epitope
from a mixed population (Fig. 6.2). Since it is difficult to remove the bacteria
from the beads, this technique relies on the subculture of the bacteria and
enrichment of bacteria expressing the epitope.
Coating of antimouse IgG-magnetic beads with murine monoclonal antibody
The precise volumes of antibody to be used will depend on its titre. We have
used the following procedure whh neat supernatant from a hybridoma cell
line. Immunomagnetic beads (50 pi; Dynabead M-450, coated with antimouse
IgG; Dynal Ltd, New Ferry, Wirral, UK) are pipetted into a 1-ml glass test
tube. The tube is clipped to a plastic-coated magnet called a magnetic particle
concentrator (MPC; Dynal Ltd) for at least 1 min. While the test tube is still
clipped to the MPC, the fluid is removed with a pipette and 5 ml sterile PBS
Fig. 6.2. Bacleroides fragilis attached to antimouse IgG-coated immunomagnetic beads via an
anti-S. fragilis polysaccharide mouse monoclonal antibody.
ATTACHMENT IN DISEASE 121
is added. The test tube is removed from the influence of the magnet and the
contents are vortexed. The tube is then replaced in the MPC and the PBS
removed and replaced. This process is repeated twice. These washing steps
remove the sodium azide in which the beads are supplied. The beads are
finally made up to 50 pi in PBS and again vortexed. Monoclonal antibody
supernatant (1 ml) is added and the beads are incubated at room temperature
for 2 — 24 h with very gentle rocking. The beads are then washed again four
times in PBS as above, with gentle rocking for 30min each time. They are
finally suspended in 1 ml PBS, and can be stored at 4°C for up to 2 weeks.
Selective enrichment of bacteria
Bacteria are suspended at a concentration of 107—10s/ml in a defined minimal
medium, suitable for die culture of the bacteria, containing 0.02% (w/v)
Tween 20. The optimal concentration of bacteria should be determined for
different bacteria and antibodies. Beads (0.5 ml), precoated with specific
MAb, are added to 10 ml of bacterial suspension and the mixture is gently
shaken by hand for up to 2 min, placed in tire MPC and washed three times
with broth. The 2-min incubation time is critical and it should not be exceeded.
The beads are then added to fresh broth and a non-relevant MAb, such as
one specific for a viral protein, should be used as a control to monitor non¬
specific binding. The enriched cultures can then be monitored by fluorescence
microscopy or flow cytometry (Lutton et al., 1991) to determine whether there
has been enrichment for a particular epitope.
Study of Attachment
Populations with clearly defined surface structures/antigens can be used in
studies of attachment. The most commonly used methods involve adherence
of bacteria to erythrocytes (haemagglutination), epithelial cells or cells in
tissue culture. These methods are often preliminary to determination of the
specific attachment mechanism involved. Other, more non-specific, methods
of assessing the ability to attach involve determination of the hydrophobicity of
the bacterial surface (see Chapter 2).
Surface hydrophobicity
Hydrophobic interactions are considered to play a major role in the association of
bacteria with phagocytes and epithelial cells. In our studies (unpublished data)
we have used two of the most common methods for determining the surface
hydrophobicity of homogeneous populations of B. fragilis separated by Percoll
density gradient centrifugation.
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Adherence to hydrocarbons
This method is based on the principle that, after brief mixing, hydrophobic
bacteria will bind to hydrophobic solvents such as xylene or cyclohexane
(Rosenberg et al., 1980). Bacteria are centrifuged and washed twice in PUM
buffer (g/1, K2HP04.3H20, 22.2; KH2PO+, 7.26; MgS0+.7H20, 0.2; urea,
1.8; pH 7.1). The bacteria are then resuspended in PUM buffer and the
OD550 nm is determined. The bacterial suspension (1 ml) is then added to a
series of 10 mm diameter glass test tubes. Volumes of the hydrocarbon, in a
range from 50 to 500 pi, are added to each tube. The tubes are incubated at
30°C for lOmin and are then uniformly shaken for 2min. The hydrocarbon
phase is allowed to separate completely before the lower aqueous phase is
carefully removed with a Pasteur pipette. A PUM buffer blank is included as a
control. The change in OD5sonm is then determined for each volume of
added hydrocarbon, and attachment is expressed as the percentage decrease,
which represents the proportion of bacteria excluded from the aqueous phase.
Hydrophobic interaction chromatography
This determines the proportion of a population of bacteria retained on a
hydrophobic gel column, and we have modified the methods of Ismaeel et al.
(1987) and Mozes & Rouxhet (1987). Columns are constructed from Pasteur
pipettes plugged with glass wool, loaded with octyl sepharose CL-4B (Pharmacia
Biosystems (UK) Ltd, Milton Keynes, UK) to a bed height of 30 mm and
equilibrated with an equilibrating solution (ES) of 4mol/l NaCl in 0.05 mol/1
citrate buffer (pll 4.7). Bacteria are washed and resuspended in ES, 100 pi of
the bacterial suspension is diluted in 3 ml of ES and the OD555 nm determined
(OD0, which may be adjusted to 1). The original bacterial suspension (100 pi)
is also applied to the column, followed by 3 ml of ES, which is collected and
the OD55onm determined (OD]). Distilled water (3 ml), adjusted to the same
pll, is then applied to the column, collected and the ODssonm also deter¬
mined (OD2). The proportion of bacteria retained by the column at high
ionic strength RF is given by 100 (ODf) — ODi)/OD0. The proportion
of bacteria retained on the column at low ionic strength RL is given by
100(OD0-OD2)/OD0.
A simpler alternative method is to add 5 ml bacterial suspension in distilled
water or quarter-strength Ringer's solution to a column and determine the
decrease in ODssonm-
Haemagglutination
Haemagglutination is one of the simplest methods for the determination
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of the adherence of bacteria to animal cells. An excellent reference for
haemagglutination methods is Old (1985). Two methods can be used, either
die static settling or the rocked-tile method. Both techniques are very simple
but each has its advantages and disadvantages. It is recommended that both
are used to determine haemagglutination, and that a known positive strain is
included in each test as a control.
Preparation of erythrocytes and bacterial suspension
Whole blood, treated with either heparin or citrate to prevent coagulation,
should be centrifuged at 200# for lOmin and the cells washed gently three
times in PBS. The cells are then made up in PBS to 2 or 3% packed-cell
volume. The erythrocytes can be stored at 4°C for up to 7 days. Blood from as
wide a range of species as possible should be used.
Bacteria are centrifuged, washed and resuspended in PBS. A range of
different concentrations of bacteria should be used to determine their optimal
concentration. It is useful to start at about 1 X Iff' bacteria/ml and proceed
with doubling dilutions.
Rocked-tile method
Equal volumes of the erythrocyte and bacterial suspension in PBS are mixed
on a chilled tile by rocking. Haemagglutination is judged 'by eye' as the
formation of granular clumps of erythrocytes within 5 min (Fig. 6.3). We
have found that this test can easily be carried out on a microscope slide and
haemagglutination viewed as clumping under a low-power objective. To
determine whether sugars inhibit haemagglutination, an equal volume of a
2% (w/v) solution of the sugar of interest is added to the erythrocytes before
the bacteria.
Static settling method
Equal volumes of erythrocyte and bacterial suspension in PBS are added to
round-bottomed wells. The large-size WHO plates are useful because they
are large enough for the haemagglutination to be obvious, but microtitre
plates can also be used. The stationary plates are incubated for a standard
time, either at 4°C or at room temperature. In the absence of haemagglutinating
bacteria, the erythrocytes sediment to the bottom of the well under gravity,
and tumble into the centre of the well to form a discrete button. In the
presence of haemagglutinating bacteria this process is retarded, and the
erythrocytes remain in suspension for longer and settle to form a lawn over
the bottom of the well. This will also eventually collapse into a button in the
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A
Fig. 6.3. 1 Iaemagglutination (IIA) of Bacleroides fragilis determined by the rocked-tile method:
A, capsulate population, FIA-negative; B, mixture of eapsulate and non-capsulate population,
I IA-positive; C, non-capsulate (electron-dense layer) population, IlA-positive.
centre of the well if the well is left stationary for sufficient time. The extent to
which the sedimentation of the erythrocytes is retarded will vary according to
the concentration of bacteria and how well they agglutinate the erythrocytes.
The incubation time is therefore critical: if the plates are left for too long,
positive haemagglutination may be missed. False-positive reactions may occur
at very high bacterial concentrations if the bacteria have large capsules that
retard the bacterial sedimentation under gravity. The physical size of the
bacterium in suspension may prevent the erythrocytes from settling to the
centre of the well even after a long incubation period (Patrick et al., 1988).
This highlights the need to confirm haemagglutination by both the rocked-tile
and the static settling methods.
Where unreproducible haemagglutination results are obtained for a
particular bacterial type, this may be due to variation in the proportion of
haemagglutinating cells within a single population. Separation of a strain into
subpopulations may help to determine whether this is the case. By artificially
mixing the subpopulations, the proportion of haemagglutinating bacteria
required for a positive result can be determined.
Haemagglutination of bacterial populations grown under different environ-
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mental conditions can be compared with the artificially mixed populations.
This can be used to determine the selective pressures that favour a higher
proportion of haemagglutinating bacteria. To test the artificial mixtures, the
haemagglutinating subpopulation (A) is mixed with the non-haemagglutinating
subpopulation (B) in the following amounts: (pi) 20A:180B; 40A:160B and so
on in 20 pi steps, finishing with 180A:20B. This can conveniently be done
directly into the incubation wells with a standard 20 pi dropper pipette. This
results in different ratios of the two bacterial types, but the same final bacterial
concentration. Erythrocyte suspension (0.2 ml) is then added and the degree
ofhaemagglutination monitored. A gradation in the degree ofhaemagglutination
should be observed (Fig. 6.4).
Adherence to epithelial cells
There is a wide variety of methods for studying the degree to which bacteria
adhere to the surface of epithelial cells. The intention here is to illustrate the
methods generally adopted in such studies (see Chapter 8), some of which we
have used in our studies on B. fragilis (unpublished results).
Collection of epithelial cells
Epithelial cells are usually collected from the buccal mucosa of a number of
human volunteers by gentle scraping with a blunt and sterile instrument such
as a wooden spatula or tongue depresser. They may also be collected from
sources such as the urine of healthy females by centrifugation of freshly
voided urine. The cells are suspended in PBS. We have also obtained cells
from bovine and ovine peritoneal mesothclium by gende scraping and sus¬
pending in PBS.
The cells are usually washed two or three times by centrifugation at 200 g
for lOmin and resuspended in PBS. The percentage viability of the cells can
be determined by dye-exclusion, for example, with trypan blue (Gorman
et al., 1986). The concentration of cells in the suspension is adjusted to 105
cells/ml after direct counting with a haemocytometer.
The adherence assay
Bacterial cells are washed twice by centrifugation and are resuspended in PBS
to a concentration of 108 bacteria/ml. This is usually done by adjusting the
OD550 Ilm, based on a previous viable count calibration. The bacterial suspension
(250 pi) is then mixed with an equal volume of epithelial cells in an Eppendorf
centrifuge tube and incubated at 37°C for 1 or 2 h, which is usually sufficient
for the bacteria to attach to the cells. For initial tests it is prudent to determine the
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Fig. 6.4. I hemagglutination (IIA) of Baclcroida J'ragilis capsulate and non-capsulate populations
mixed in a series of proportions: A, nine parts non-capsulate (electron-dense layer): one part
capsulate, strongly I IA-positive to B, one part non-capsulate : nine parts capsulate, I IA-negative;
C, control without bacteria.
optimum incubation time for attachment. The cells are then washed by
centrifugation at 200£ for lOmin to remove any bacteria not firmly attached.
If an Eppendorf centrifuge with a low speed facility is not available, the
Eppendorf tubes can be lowered into the tube holder of a bench centrifuge
swing-out head with a length of cotton thread. A PBS control without added
bacteria should always be included to assess the background level of commensal
bacteria adherent to the epithelial cells.
The cells are finally resuspended in 500 pi PBS, smeared onto a microscope
slide and fixed with methanol. A variety of stains, from fluorescent acridine
orange to Giemsa stain (Sigma Chemical Co (UK) Ltd, Poole, UK), can be
used to detect the adherent bacteria. We have used negative phase-contrast
with a xlOO oil-immersion objective to observe bacteria without staining.
Giemsa stain, which rapidly stains nuclear material in about 45 s, is also
satisfactory and can be washed off with methanol. The bacteria stain blue, as
does the nucleus of the epithelial cells. Other methods that can be used to
determine the attachment of bacterial cells include the use of radioisotope-
labelled bacteria (Calderone et al., 1984; Gorman et al., 1987). The adherence
assay is carried out essentially as above, except that the bacterial cells are
labelled with Tl-leucine. After incubation with the epithelial cells, the mixture
is filtered through a membrane filter (8 pm pore size, Millipore (UK) Ltd,
Watford, UK), washed several times with PBS, transferred to a tissue solubilizer
(e.g. NCS, Amersham International Pic, Amersham, UK) before the addition
of scintillant and scintillation counting. The percentage of bacteria attached to
the cells is given by:




Bacteria attached to at least 50 cells and 50 control cells should be counted.
The distribution of bacterial attachment to cells may be important in analysing
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the data, for example when comparing two sets of data. Most published work
assumes that the distribution is normal and hence uses a /-test, which is
parametric and assumes a normal distribution, to compare the mean and
standard deviation from two sets of data. In our experiments with B. fragilis
(unpublished data), however, and in other published work, it is clear that
adherent bacteria are not normally distributed. It would therefore be more
appropriate to use a non-parametric and distribution-free statistical analysis,
such as die Mann—Whitney U-test. However, there can also be problems
widi this test because it ranks the data and does not work well if cells have
the same number of attached bacteria. The suitability of both these tests is
reviewed by Rosenstein et al. (1985) and Woolfson et al. (1987). In the latter
the conclusion was that, despite the non-normal distributions, the Student's
/-test was probably the more useful method (see Chapter 19).
Adherence to other cells
Experiments similar to those with epithelial cells have been carried out with
cultured cells. Another approach is to assess the adherence of bacteria to a
monolayer of cells cultured on glass cover-slips (Hartley et al., 1978). Here,
the cover-slips (6 x 22 mm) are treated with EDTA (elthylenediamine tetra-
acetic acid) and placed into individual glass tubes. They are then seeded with
about 105 cells (e.g. HeLa cells) and incubated at 37°C for 2 days to produce
a confluent monolayer. The coverslips are then washed with two changes in
PBS, and the bacterial suspension is added. After further incubation for
30min, the cells are washed five times in PBS, fixed with methanol, stained
with Giemsa and mounted on a microscope slide.
Inhibition of adherence
In order further to characterize the nature of the interaction between the
bacteria and the cell surface, substances likely to inhibit attachment specifically
can be added to the adherence assay. Such studies often involve the purification
of bacterial surface structures involved in adhesion, such as the fimbriae, and
modification of the adherence assay. The details of these techniques are
beyond the scope of this chapter. A general review of the approaches adopted
can be found in Arp (1988).
Addition of sugars
Sugars, such as mannose which inhibits haemagglutination by E. coli Type 1
fimbriae (Duguid et al., 1966), may be added to the assay. Ilaemagglutination
that is inhibited by mannose is termed mannose-sensitive, and it is accepted
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that the receptor on the erythrocytes contains mannose. Mannose-resistant
adhesion may involve other sugar receptors on the cells: for example, K99
fimbriae of enterotoxigenic E. coli bind to Neu5Gc(a2-3)Gal(pi-4)Glc-(|fl-l)
ccramide (Smit et a I., 1984) and the P fimbriae of E. coli, involved in pyelo¬
nephritis, bind to Gal(al-4)Gal-disaccharide moieties associated with the P
blood group antigens. The possibilities are extensive. Generally, sugars of
interest are added at about 2% (w/v) to the prepared erythrocytes or epithelial
cells before adding the bacteria. If it is desired to determine the host cell
receptor for a particular bacterial ligand, reference should be made to Karlson
& Stromberg (1986). A general discussion of the importance and diversity of
oligosaccharide moieties in mammalian systems is provided by Rademacher
et al. (1988).
Addition of monoclonal antibodies
Since MAbs bind specifically to target epitopes on bacterial surface structures,
they can be a powerful tool for the determination and characterization of
surface structures associated widi adhesion and their interaction with target cells.
It is assumed that binding of the MAb to an epitope on the surface structure
of interest will interfere with adherence. This approach has been successfully
used for Porphyromonas (Bacteroides) gingivalis fimbriae (Isogai et ai., 1988).
Before adding a MAb in a haemagglutination or adherence assay, it is necessary
further to purify the MAb. This precaution should also be adopted when
using monospecific polyclonal antibodies. We have found that serum, including
fetal calf serum, added to cell culture media, can cause bacterial clumping
and this interferes with the adherence assay. Ascites fluid or cell culture
supernatant is ccntrifuged at 20 000 y for 20min and the resulting supernatant
chromatographed on Sephadex G200 (Pharmacia Biosystems (UK) Ltd)
with PBS as the elution buffer, and the immunoglobulin — usually IgG — is
collected. The MAb is then added to the erythrocyte or cell suspension,
before adding bacteria to the adherence assay. This should be done as twofold
serial dilutions of the MAb in PBS, usually starting at about 1 mg/ml.
Conclusions
The interaction between the bacterial surface and the surfaces of mammalian
cells remains one of the most important steps in the process of pathogenesis.
The interactions are often complex and depend on the species of bacterium
and type of target cell. It is clear diat an approach adopted for one pathogen
may be unsuitable for others. Moreover, bacterial surface structures may be
subject to environmentally induced variation: surface structures or antigens
expressed during an infection may be different from those in laboratory
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culture. The definition of bacterial growth conditions is therefore important.
In addition, genetically controlled phase variation mechanisms may operate
within a population of bacteria in culture. This may result in the heterogeneous
expression of adhesion factors within a single population grown under the
same environmental conditions. Therefore, the use of a defined homogeneous
population of bacteria is also essential. A wide variety of microbiological,
immunological, chemical and biochemical techniques has been used to dissect
the processes involved in attachment. A concerted attempt to understand
these interactions necessarily involves the use of all of these techniques
in combination.
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The survival and growth of populations of the obligately anaerobic pathogenic
bacterium Bacteroides fragilis enriched for large capsules (LCs), small capsules
(SCs) or an electron-dense layer (EDL; non-capsulate by light microscopy) were
examined in a mouse model of infection over a minimum period of 20 d.
Chambers which allowed the influx of leukocytes, but not the efflux of
bacteria, were implanted in the mouse peritoneal cavity. The LC and EDL
populations consistently attained viable cell densities of the order of 108-109
c.f.u. ml 1 within 24 h, whereas the SC population did not. However, after 3 d,
all three bacterial populations maintained total viable numbers of 10s-109
c.f.u. ml 1 within the chambers. LC expression was selected against within 24 h
in the model, the populations becoming non-capsulate by light microscopy,
whereas in the SC population expression of the SC was retained by
approximately 90% of the population. The EDL population remained non-
capsulate by light microscopy throughout. Lymphocytes infiltrated the
chambers to an equal extent for all three B. fragilis populations and at
approximately 1000 times higher concentration than chambers which
contained only quarter-strength Ringer's solution. The presence of neutrophils
within the chambers did not cause a decrease in the total viable bacterial
count. Each population elicited antibodies specific for outer-membrane
proteins and polysaccharide, as detected by immunoblotting, which cross-
reacted with the other populations. Differences were observed in the
immunogenicity of the outer-membrane proteins within the three populations.
Neutrophils were initially the predominant cell type in the chambers, but as
the total leukocyte count increased with incubation time, neutrophils were
outnumbered by other leukocytes. Flow cytometric investigations indicated
that by day 7 the majority of these leukocytes were B-cells. Bearing in mind
the constraints of this model system, it appears that all three populations of B.
fragilis have the potential for in vivo growth and that each elicits an immune
reaction.
Keywords: Bacteroides fragilis, polysaccharide capsules, immune response
INTRODUCTION
The obligately anaerobic bacteria of the genus Bacteroides
are numerically the predominant component of the
normal commensal faecal flora of the colon in all adult
humans, where obligate anaerobes outnumber facul¬
tatively anaerobic bacteria by about 1000 to 1 (Willis,
Abbreviations: EDL, electron-dense layer; LC, large capsule; RS, Ringer's
solution; SC, small capsule.
1991). Of the Bacteroides species in the faecal flora,
Bacteroides vulgatus predominates and is estimated to
account for up to 45 % of the total bacteria present.
Bacteroides fragilis is less prevalent and estimates of its
contribution to the total bacterial faecal flora include 4 %
(Namavar et al., 1989) and up to 13% (Willis, 1991).
However, B. fragilis is estimated to account for 42 % of the
adherent colonic mucosal flora (Namavar et al., 1989). B.
fragilis is the most commonly encountered species in
infection resulting from faecal contamination, whereas B.
vulgatus and other related Bacteroides spp. in the ' B. fragilis'
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group are infrequently isolated. Infections from which B.
fragilis has been isolated include abdominal, pelvic,
perianal and vaginal abscesses (Tally & Ho, 1987).
Peritonitis, resulting from the leakage of the bowel
contents into the peritoneal cavity as a result of, for
example, appendicitis or bowel surgery, is a classical
example of a B. fragilis infection. Although B. fragilis and
related species within the '13. fragilis'' group are not
members of the normal commensal vaginal flora, they are
also responsible for up to half of the upper genital tract,
pelvic and uterine infections in women (Duerden, 1991).
The majority of B. fragilis infections are polymicrobial;
for example, Escherichia coli and Streptococcus milleri are
frequently isolated in association with B. fragilis (Willis,
1991; Patrick et al., 1995). Although the relationship
between these bacterial species may be synergistic, it is
generally considered that antibiotic therapy against the
anaerobic component of the polymicrobial infection is
essential for successful resolution (Rotstein & Meakins,
1990).
The precise virulence determinants of B. fragilis remain to
be defined; however, surface structures (such as capsular
polysaccharides and fimbriae), the release of extracellular
enzymes which degrade components of the host tissue
(e.g. neuraminidase) and the release of factors which
inhibit phagocytic function may all be involved (Patrick,
1993). B. fragilis expresses at least three different types of
encapsulating surface structure which can be characterized
by electron microscopy of ultrathin sections; namely, a
large capsule (LC), a small capsule (SC) and an electron-
dense layer (EDL). The EDL is visible by electron
microscopy but not by light microscopy. Each of these
structures may be produced within a single strain.
Populations bearing these can be enriched by subculture
after Percoll density-gradient centrifugation separation
(Patrick & Larkin, 1993). Labelling with monoclonal
antibodies specific for surface polysaccharides reveals
antigenic variation within these enriched populations
(Patrick & Lutton, 1990a).
The relationship of these encapsulating structures to
virulence is not clear, but it is possible that the EDL plays
a role in attachment to host cells (Patrick, 1988, 1993).
The presence of the LC in B. fragilis impedes phagocytic
uptake and killing in studies of phagocytosis in vitro (Reid
& Patrick, 1984); however, populations enriched for the
LC are rapidly selected against during growth in a mouse
model of infection. Within 24 h, LC-expressing cells
decrease from 99% of the population to less than 30%,
despite the presence of neutrophils (Patrick et al., 1984;
Patrick, 1988). In contrast, after 24 h growth in defined
medium broth culture, LC-expressing cells constitute
more than 90 % of the total population. During con¬
tinuous subculture in vitro the population gradually reverts
to a mixed capsulate and non-capsulate population over a
period of days (S. Patrick, unpublished data). It may be
that in vivo the bacteria switch from the production of a
discrete capsule structure to release of free slime. Surface-
associated polysaccharide in the LC population and
excreted polysaccharide in the EDL population have
common epitopes (Lutton et al., 1991).
In the present study we determine the immune reaction to
the LC, SC and EDL populations in an infection localized
within chambers implanted in the mouse peritoneal cavity
over a minimum period of 20 d. The generation of
immunoglobulin specific for both outer-membrane pro¬
teins and polysaccharides was demonstrated for each
population. The influx of neutrophils and B-lymphocytes
into the chambers was observed and not found to affect
the total viable bacterial numbers.
METHODS
Bacterial strains. The strain used in this study was Bacteroides
fragilis NCTC 9343 (National Collection of Type Cultures,
Colindale Avenue, London).
In vitro culture methods. Bacteria were incubated in minimal
defined medium (MDM) broth (van Tassell & Wilkins, 1978).
Cultures were incubated at 37 °C in an atmosphere of
H2/N2/C02 (10:80:10, by vol.) in an anaerobic cabinet (MK
III Don Whitley Scientific). Identification was confirmed with
the API20A system.
Separation and enrichment of bacterial populations. Bacterial
populations were enriched for different sizes of encapsulating
surface structures by Percoll (Pharmacia) discontinuous density-
gradient centrifugation as previously described (Patrick &
Larkin, 1993). Populations enriched for the SC by Percoll
gradient centrifugation were further enriched, in an anaerobic
atmosphere, using immunomagnetic beads (Dynabead M-450
Dynal) coated with anti-mouse immunoglobulin and mouse
monoclonal antibody Bf4 (Reid eta/., 1987), which is specific for
the SC population; this was followed by one subculture in
MDM broth. The efficiency of the immunomagnetic bead
enrichment method was tested by mixing LC and SC bacteria
obtained from Percoll gradient separation in a ratio of 1 :1 and
enriching from this population with the coated immuno¬
magnetic beads. Following overnight culture in broth it was
estimated by light microscopy and negative staining that less
than 1 % of the population had LCs. The enrichment of the SC
population was confirmed by flow cytometric analysis as
previously described (Lutton et al., 1991).
Preparation of bacterial outer membranes and poly¬
saccharide. Outer-membrane proteins were prepared as pre¬
viously described (Patrick & Lutton, 1990b). In brief, bacterial
suspensions were rotated ' end-over-end' for 30 min in 3 %
(w/v) IV-lauroylsarcosinate (Sarkosyl). After centrifugation in
an Eppendorf centrifuge 5414 at 9980 g the supernatant fraction
was discarded and the pellet containing the outer membrane was
retained. Polysaccharide was extracted by the proteinase K
method (Brown et ai, 1989).
SDS-PAGE and immunoblotting. SDS-PAGE was performed
on vertical slab gels (8%, w/v) and immunoblotted as
previously described (Lutton et al., 1991). The human serum
sample was obtained from a patient who was blood-culture
positive for B. fragilis. The sera and chamber fluids were used at
a dilution of 1 in 100.
In vivo culture of bacteria. Chambers were constructed and
implanted (two per mouse) in the mouse peritoneal cavity as
previously described (Patrick et al., 1984; Lutton, 1991). The
chambers were sealed with 3 (im pore membrane filters (Type
SSWP, Millipore) which allowed entry of leukocytes but not
leakage of bacteria. If filled and sealed chambers were in¬
cubated in MDM broth there was no growth in the broth. The
bacterial inoculum consisted of a suspension (0-2 ml) of
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approximately 5 x 107 c.f.u. ml-1 in quarter-strength Ringer's
solution (RS) containing 0'5 g L-cysteine L1 (the L-cysteine
helps to maintain the viability of B. fragilis in RS). The bacterial
cultures were not exposed to air at any stage in the preparation
of the chambers. All manipulations, from the standardization of
the bacterial suspensions by optical density reading to filling and
sealing the chambers, were carried out inside an anaerobic
cabinet. Chambers were transported to the operating theatre in
bottles containing RS inside a sealed anaerobic jar and only
removed immediately prior to implantation in the mouse. After
implantation of the chambers in the mouse for 1, 3, 7, 14, 20 or
44 d the mice were killed, bled from the heart and the chambers
removed. After clotting, the serum was separated and stored at
— 20 °C. The chamber contents (0-2 ml) were removed and the
inside of the chamber washed out vigorously with a further
1-8 ml sterile 0-01 M PBS (0-15 M NaCl, 0-0075 M Na2HP04,
0-0025 M NaH2P04. 2HaO), pH 7-4, in 0-2 ml amounts. The
data were obtained from four to eight mice, for each sampling
day, and a minimum of two independently set-up experiments,
with the exception of the initially SC population on days 7, 14
and 44 where two mice were examined. Each of the chambers
was examined individually, except where the total leukocyte
count was low when the contents of two chambers from the
same mouse were pooled for examination of the leukocyte
populations. Control chambers containing only RS and RS with
Percoll were also examined.
Examination of chamber contents. The total viable bacterial
numbers within the chambers were determined by carrying out
serial dilutions in RS and plating onto lysed blood agar as
previously described (Patrick et al., 1984). All manipulations
were carried out inside an anaerobic cabinet. An aliquot (0-2 ml)
of the diluted chamber contents was subcultured overnight in
MDM broth. Eosin/carbol fuchsin capsule smears of bacteria,
taken directly from the chambers and after overnight subculture,
were examined by light microscopy (Patrick & Larkin, 1993).
The SC expression was also examined by flow cytometric
analysis (Lutton et al., 1991).
Heparin (50 pi) was added to 1-5 ml of the diluted chamber
contents in PBS which were incubated at 37 °C for 30 min to
remove non-specific surface immunoglobulin from the leuko¬
cytes. The chamber contents were then centrifuged at 330 £ for
5 min in an MSE Mistral 3000i and the supernatant fraction (i.e.
chamber fluid) removed and stored at —20 °C. The cell pellet
was washed twice by centrifugation and resuspension in PBS
containing foetal calf serum (0-1 %, v/v; FCS). The total viable
leukocyte count was determined by microscopy using a
haemocytometer counting chamber with the cells suspended in
trypan blue (0-08%, w/v). For differential staining the cells
were resuspended at a concentration of 1 X 106 cells mL1 in
RPMI1640 medium (Gibco) containing FCS (5%, v/v) and
centrifuged in a cytospin (Shandon Elliot) at 400 r.p.m. for
10 min. The slides were air-dried and either stored at room
temperature prior to esterase staining or at —20 °C.
Identification of leukocyte populations. Identification of
chamber-infiltrating leukocytes was carried out by morpho¬
logical, cytochemical and flow cytometric techniques. Prepara¬
tions from normal mouse peripheral blood and peritoneal
washes were used as positive controls for the staining pro¬
cedures. Morphological analyses were performed on Diff-Quik
(Merz-Dade) or haematoxylin-stained preparations. Mono¬
cytes/macrophages were identified following a-naphthol stain¬
ing of leukocyte preparations (Li et al., 1973).
B-lymphocytes were identified by flow cytometric analyses of
cell suspensions which had been labelled with the mouse B-
lymphocyte marker anti-mouse Ly-5 (B220)-fluorescein-con-
jugated antibody (Coulter Immunology) as follows. Hepar-
inized chamber contents were incubated at 37 °C for 30 min to
remove non-specific surface immunoglobulin, then washed
twice by centrifugation in PBS containing bovine serum
albumin (2%, w/v) and incubated with the B-cell marker for
30 min at 4 °C in the dark. The samples were then washed twice
as before and finally suspended in PBS containing para¬
formaldehyde (1 %, v/v) prior to flow cytometric analysis.
Heparinized mouse peripheral blood was labelled as above,
except that the red blood cells were lysed with Immuno-lyse
reagent (Coulter Immunology). Lysis was stopped by the
addition of Immuno-lyse fixative (Coulter Immunology). The
leukocytes were then washed twice as above and resuspended in
PBS/paraformaldehyde. An irrelevant fluorescein-conjugated
antibody, anti-human CD4 (Becton Dickinson), was used as a
negative control.
Analyses were carried out with an EPICS 5 flow cytometer
(Coulter Electronics) equipped with a 5 W argon laser and
tuned to 488 nm and operating at a power output of 300 mW at
the following setting: forward angle light scatter (FALS) gain,
10; 90° light scatter (LS) detector, 420 V; green fluorescence
detector, 1300 V. The lymphocyte population was identified on
the basis of size by FALS and 90° LS signals and gated
appropriately. Single parameter log integral green fluorescence
signals were obtained from the gated population. Five thousand
cells were counted in each sample and the percentage of
positively staining cells was obtained by subtraction of negative
control histograms from test histograms using the instrument's
Immuno-programme.
Statistics. The error bars on the graphs represent the confidence
limits at 5% probability (sigman.t) where n is a minimum of
four.
RESULTS
Bacterial viability and leukocyte analyses
Populations of B. fragilis initially enriched for the LC, SC
and EDL grew in the chambers and attained viable cell
densities of over 109 c.f.u. ml-1 (Fig. 1); however, growth









Fig. 1. Total viable bacterial counts (TVC) of B. fragilis
populations enriched for the LC (--O--), SC (• • • A' • ) and EDL
(—□—) during incubation in implanted chambers. Error bars
represent confidence limits at 5% probability.
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Fig. 2. Total viable leukocyte counts (TIC) in chambers
containing only quarter-strength RS with 0-5 g L-cysteine I"1
or B. fragilis enriched for the LC (--O--), SC (• • • A'' )
and EDL (—□—) during incubation in vivo. Data are not
available for the SC population on days 1 and 3. Error bars
represent confidence limits at 5% probability.
Fig. 3. Numbers of neutrophils in chambers containing B. fragilis
populations enriched for the LC (O) and EDL (□). Data were
obtained from differential microscopical counts and calculated
from the total leukocyte count. Data are not available for the
SC population. Error bars represent confidence limits at 5%
probability.
first day of incubation. Out of a total of 10 mice examined
24 h after chamber implantation, no viable bacteria were
detected in both chambers from three of the mice and the
total viable bacterial count was less than or equivalent to
the starting inoculum in both chambers removed from
three other mice. The remainder attained total viable
bacterial numbers of greater than 109 c.f.u. ml-1. After 3 d
incubation, the numbers of viable SC population bacteria
in all the mice examined were similar to those of the LC-
and EDL-enriched populations. In chambers containing
either the LC or EDL populations total viable bacterial
counts of between 108 and 109 c.f.u. ml-1 were obtained
consistently (Fig. 1). Host material, probably fibrin,
gradually built up on the external surface of the chamber
membrane filters and by day 7 the chambers were fully
encased. The chamber contents also became progressively
more viscous during the incubation period. Whether this
was due to host- or bacteria-derived material is not
known. Observation of the filters revealed that the
membrane filters of control chambers without bacteria
did not have the same level of deposition of host material,
although they did become encased in a thin film, and their
contents were less viscous.
The LC-enriched population changed from 99 % LC to
97-98 % non-capsulate by light microscopy within 24 h
and remained at this level for the 20 d period. This
decrease in LC-expressing bacteria was evident on direct
examination of the chamber contents as well as after one
overnight subculture of the chamber contents in MDM
broth. The change was therefore not due to environmental
modulation. This decrease in the number of LC-ex¬
pressing bacteria does not occur on subculture directly
from the Percoll gradient into MDM broth where
95-100% of the bacteria continue to express the LC. In
populations enriched for the SC, an average of 91 %
(range 80—96 %) of bacteria were estimated to express the
SC by light microscopy and an average of 96 % (range
90-99 %) by flow cytometric analysis using monoclonal
antibody Bf4, throughout the 44 d incubation period. The
rest of the population was non-capsulate by light mi¬
croscopy, with the exception of day 7, where L5 % of the
population expressed the LC. The EDL population
remained non-capsulate by light microscopy when exam¬
ined directly upon removal from the chamber and also
after one subculture of the chamber contents into MDM
broth.
The total leukocyte count in the chambers increased
progressively with the duration of implantation in the
mouse after an initial decrease between day 1 and day 3,
and was in excess of that observed in control chambers
containing only diluent (quarter-strength RS with 0'5 g l-
cysteine 1 ) (Fig. 2). To determine if any residual Percoll
in the bacterial inocula had an effect, an 80 % suspension
of Percoll, diluted 1 in 500 in RS, was incubated in the
chamber model for 3 and 21 d. This resulted in similar
leukocyte infiltration to that observed with chambers
containing only RS.
Differential counts performed on Diff-Quik-stained cyto-
spin preparations indicated that neutrophils were the
predominant infiltrating cell at day 1 (97 % and 94 % for
chambers containing the EDL and LC populations,
respectively). However, by day 14, against a background
of increasing total leukocyte count (Fig. 2), neutrophils
comprised only 9% (EDL chambers) and 12% (LC
chambers) of the total leukocyte count. The numbers of
neutrophils in the chambers are illustrated in Fig. 3.
Neutrophils containing phagocytosed bacteria were ob¬
served by electron microscopy (not illustrated). Classi¬
fication of the other leukocytes by microscopy proved
difficult due to the distorted morphology of the cells. It is
1972
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Fig. 4. Representative flow cytometric profiles of Ly-5 (B220) expression by lymphocytes from mice with implanted
chambers containing B. fragilis enriched for the EDL population after 7 d (a, b) and 21 d (c, d) incubation, (a, c) Peripheral
blood; (b, d) chamber contents; dotted line, Ly-5 (B220) positive; solid line, control anti-human T-lymphocyte CD4; X-axis,
fluorescence intensity channel number 0-255; Y-axis, number of events scale 0-50. The means of the percentages of Ly-5
(B220)-positive leukocytes are indicated on each graph.
possible that the altered shape of the cells present in the
chambers occurred as a result of cellular activation.
Cytochemical staining for oc-naphthol acetate esterase
activity was observed with circulating monocytes and
peritoneal macrophages, but not with mononuclear cells
in the chambers containing B. fragilis or diluent.
Experiments with the EDL population indicated that
leukocytes which entered the chamber after the initial
influx of neutrophils were B-lymphocytes. Flow cyto¬
metric profiles (Fig. 4) of Ly-5 (B220)-labelled cells
indicated that on day 7 approximately 75 % of the
mononuclear cells were positive. Analysis of leukocytes
from day 21 samples, however, revealed a high level of
labelling ofchamber leukocytes with the control antibody.
As the proportion of the cells positive for Ly-5 (B220) is
calculated relative to labelling with the control antibody,
this resulted in an apparent decrease in the numbers of
Ly-5 (B220)-positive cells.
Immunoblotting
Sera taken from the mice in which chambers had been
implanted were reacted with electroblots of proteinase K
(polysaccharide) and Sarkosyl (outer membrane) extracts
of each of the LC, SC and EDL populations and detected
with alkaline-phosphatase-conjugated anti-mouse IgG
(heavy and light chains). Immunoblotting showed a
progressive increase in labelling during the time of
incubation in the mice. Each of the three populations
elicited antibodies reactive with the other populations.
Protein and polysaccharide antigens each elicited specific
antibody. Selected immunoblots illustrating the reactivity
with Sarkosyl extracts are illustrated in Fig. 5. A number
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Fig. 6. Immunoblot from poiyacrylamide gels of Sarkosyl (a)
and proteinase K (b) extracts from in-vitro-grown B. fragilis
enriched for the LC (lane 1), SC (lane 2) and EDL (lane 3)
populations probed with a human serum sample from a patient
whose blood was culture positive for B. fragilis and anti-human
IgG alkaline phosphatase conjugate. Molecular mass markers
are indicated on the left.
of antigens present in the LC, EDL (Fig. 5) and SC (not
illustrated) Sarkosyl extracts in the 31-40 kDa region did
not react with the sera from mice implanted with the LC
population. In the proteinase K extracts a broad diffuse
band in the high molecular mass region of the blot, with
an associated fine ladder pattern was observed. This is
characteristic of high molecular mass polysaccharide and
similar to the pattern previously observed with mono¬
clonal antibody labelling (Reid et al., 1987; Lutton et al.,
1991). There was no labelling of the polysaccharide
recognized by QUBf5 (Lutton et al., 1991), which has a
ladder band-pattern similar to that of the O-antigen of
other bacteria. The reactivity of antibodies in chamber
fluids, obtained after removal of the bacteria and leuko¬
Fig. 5. Representative immunoblots from
polyacrylamide gels of Sarkosyl extracts of
/n-Wtro-grown B. fragilis enriched for the LC
(a), SC (b) and EDL (c) populations probed
with sera from mice in which chambers
containing either the LC- or EDL-enriched
populations had been implanted. The
numbers represent the duration in days of
implantation of chambers in the mouse.
Note broad band antigens (brackets) which
are not reactive with the LC sera. The
' reaction of sera from mice with SC-
containing chambers is not illustrated.
Reaction with sera from mice with chambers
containing only quarter-strength RS with
0-5 g cysteine I"1 did not produce a pattern
of bands. Molecular mass markers are
indicated on the left.
cytes by centrifugation, with Sarkosyl-extracted outer-
membrane proteins was also examined. Specific antibody
was detected later than in the mouse sera and was of a
lower titre. The reactivity of one human serum sample
from a patient from whose blood B. fragilis had been
isolated (Fig. 6) was also compared. The human serum
reacted with outer-membrane proteins and poly¬
saccharides from the LC, SC and EDL populations.
DISCUSSION
The growth of the LC- and EDL-enriched populations
within the chambers was consistent and reproducible.
The exception was the SC population, which on occasion
failed to grow or did not reach high viable numbers
within the first 24 h of implantation. However, where the
SC population did survive, by 3 d the viable numbers
were equivalent to those of the other populations and
were maintained at that level for up to 44 d. It is possible
that the SC population has to adapt in some way for
growth in the peritoneal environment, or that some
selection is taking place within the population which is
not necessary for the initial survival of the LC and EDL
populations. The chamber model did not require the
addition of, for example, E. coli or adjuvant for bacterial
growth. B. fragilis cells for implantation were suspended
in quarter-strength RS with L-cysteine (0-5 g l"1) and not
exposed to oxidizing conditions, which reduce total viable
numbers. It may be that the dependence of B. fragilis on E.
coli for survival within the peritoneal cavity in a fibrin clot
model of infection (Verweij et al., 1991) relates to the
metabolic activity of the E. coli which keeps the sur¬
rounding environment suitably reduced, thus enabling B.
fragilis to maintain viability. This eventually results in an
environment which is sufficiently reduced to allow
multiplication of the B. fragilis. Synergy between B. fragilis
and E. coli, in the initial stages of infection, may be related
to redox potential.
Monitoring of the cellular response to chambers con¬
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the chambers in quantity and that there was no apparent
difference between the LC, SC and EDL populations in
terms of the numbers of leukocytes which entered the
chambers. In concordance with the findings of Verweij et
al. (1991), neutrophils were readily identified within the
chambers as the initially predominant cell type. In their
studies of mixed infections of E. coli and B. fragilis strain
BE1, neutrophils were the predominant cell type 2 h after
implantation of a fibrin clot in the rat peritoneal cavity. In
the present study, labelling with the Ly-5 (B220) mouse B-
lymphocyte marker suggests that B-lymphocytes become
the predominant cell type within the chamber by day 7,
although after 21 d incubation, non-specific labelling with
the control antibody made B-lymphocyte quantification
difficult. The total viable leukocyte count, however,
remained high. The non-specific labelling may be due to
immunoglobulin associated with the leukocyte surface
membrane or be a consequence of alteration of the surface
membrane receptors resulting from cellular activation.
Interestingly, the leukocytes apparently remain viable at a
redox potential sufficiently low to support the survival
and multiplication of B. fragilis.
Immunoglobulins specific for protein and polysaccharide
antigens were detectable in blood sera, which indicated
that each of the LC, EDL and SC populations elicited
immunoglobulin which cross-reacted with the other
populations. It therefore appears that sufficient bacterial
antigens leak from the chambers to elicit antibody
production in secondary lymphoid organs and tissues.
Immunoglobulin, of a lower titre, was also detectable in
the chamber fluids. This may reflect either diffusion of
antibody molecules back into the chambers or generation
of antibody by the infiltrating B-lymphocytes. The
immunoblots showed differences between the immuno¬
globulin elicited by the LC population when compared
with the SC and EDL populations. Certain epitopes in the
31- -40 kDa region, although present in the LC population,
did not elicit specific immunoglobulin (Fig. 5), whereas
the same epitopes in the SC and EDL populations did. It
would be of interest to examine the reactivity of these sera
against bacterial populations grown under iron-restricted
conditions to determine if there was immunoglobulin
specific for the 44 kDa iron-repressible outer-membrane
protein (Otto et al., 1991). Examination of the single
human serum sample indicated that there were immuno¬
globulins specific for proteins and high molecular mass
polysaccharide epitopes in LC, SC and EDL populations.
Examination of polysaccharide expression in bacteria
present in pus samples from a variety of different body
sites by use of monoclonal antibodies indicates that
epitopes associated with the LC, SC and EDL may each be
present (Patrick et al., 1995).
In spite of the immune reaction, in terms of immuno¬
globulin production, the influx of leukocytes into the
chambers and the presence of quantities of phagocytosed
bacteria inside neutrophils, the number of viable bacteria
remains high. How this relates to the virulence deter¬
minants of the bacteria and how much the activities of the
leukocytes are impaired are as yet unresolved questions.
Studies on neutrophils removed from B. fragilis-induced
abscesses indicate that, although the B. fragilis cells inside
the neutrophils are not killed, the neutrophils are still
functional (Finlay-Jones et al., 1991).
This model of infection allows both the growth of bacteria
and the immune response to be monitored over a period
of weeks. As the bacteria cannot escape from the chamber,
but host cells and fluids can enter, this model is a
compromise between the open-ended chamber models,
from which bacteria may translocate, and the enclosed
chambers, which do not allow interaction of the bacteria
with host cells (Genco & Arko, 1994). The model is
useful, not only because it yields data about fundamental
aspects of the immune response to bacterial infection, but
it also provides a model for prolonged infection. Whether
or not an infection is established in the initial instance may
be dependent on bacteria—immune-system interactions in
the first few hours after contamination by the bacteria.
This has obvious implications for the prevention of post¬
operative infections (Verweij et al., 1991). However, an
abscess, once established, may persist for long periods and
infections may recur at the same site. For example, B.
fragilis has been isolated from persistent pilonidal and
perineal abscesses and persistent and recurrent sepsis in
the peritoneal cavity (Rotstein & Meakins, 1990). As the
bacterial population is limited to the confines of the
chamber, any changes in the bacterial population can be
related directly to the growth and survival of the bacterial
inoculum and not to leakage of the bacteria.
The relationship between this chamber model and biofilm
formation on prosthetic devices and implants is also
worth consideration, particularly with a view to using the
model for the determination of antibiotic activity in vivo.
The chamber contents are highly viscous and packed with
bacteria and leukocytes. The viscosity of the chamber
contents may be due to fibrin matrix, as occurs in abscesses
(Rotstein, 1992), other host components, bacterial poly¬
saccharide or a mixture of components.
In conclusion, the results of this study indicate that,
within the confines of this model, the LC, SC and EDL
populations each have the potential for growth in vivo, and
each elicits an immune reaction. This model therefore
allows the detailed study of the interactions of B. fragilis
with the immune system.
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Immunological detection of Bacteroides fragilis in clinical
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Summary. A monospecific polyclonal antiserum, prepared against Bacteroides fragilis
common polysaccharide antigen purified by polyacrylamide gel immunoblot detected B.
fragilis, B. thetaiotaomicron, B. ovatus and Prevotella melaninogenica in pus samples from
various anatomical sites by immunofluorescence microscopy of the pus. With standard
clinical laboratory culture methods, 36 % of 147 samples were positive for one or more of the
above bacteria. Of these, B. fragilis accounted for 33%. By immunofluorescent labelling of
pus with the common antigen antiserum the detection of these bacteria in the samples
increased to 50%. All nine of the blood cultures in which B. fragilis was detected by culture
contained bacteria positive for the common antigen. Immunofluorescent labelling of pus
samples with a selection of monoclonal antibodies specific for surface polysaccharides which
are known to be antigenically variable in culture in vitro and in an animal model of infection
showed that these polysaccharides are also variable in natural infection. The results indicate
that the common polysaccharide antigen, in contrast to the variable surface polysaccharides,
is a suitable target for the immunodetection of B. fragilis in clinical samples from a range of
anatomical sites.
Introduction
Bacteroides fragilis is the gram-negative obligately
anaerobic bacterium most commonly isolated from
clinical specimens. It has been isolated, either alone or
as a component of mixed infection, from a range of
sites in the body, including the peritoneal cavity,
genito-urinary tract, blood, lungs and perianal area.1
The pathogenic contribution of B. fragilis in these
mixed infections is apparent when the anaerobes are
not taken into account in the treatment of the infection
and this fails to resolve.2 B. fragilis is a commensal of
the gut and can account for up to 13% of the faecal
flora whereas other members of the "fragilis group " of
Bacteroides spp. (Bacteroides sensu s trie to), such as B.
vulgatus, predominate. However, in the adherent
colonic mucosal flora, B. fragilis is the predominant
Bacteroides spp. with an estimated incidence of
c. 42%.3
As a result of difficulties in maintaining the viability
of B. fragilis during the transportation of clinical
Received 22 Nov. 1994; accepted 29 Jan. 1995.
specimens and the time taken to culture the bacteria,
direct immunological detection of B. fragilis in clinical
material by immunofluorescence microscopy has been
studied by several workers. These studies have in¬
volved the use of a commercially available kit
(Fluoretec, Pfizer Diagnostics) based on pooled rabbit
polyclonal antisera specific for type strains of
Bacteroides spp. (B. fragilis, B. vulgatus, B. distasonis,
B. ovatus and B. thetaiotaomicron). The detection of
Bacteroides spp. by immunofluorescence when com¬
pared with culture were reported as 81 %,4 87 %5 and
97 %.6 The usefulness of this kit as a monitor of faecal
contamination of water has also been examined;7
however, it was not considered to be sufficiently
sensitive for the routine monitoring of faecal con¬
tamination of disinfected drinking water. The po¬
tential diagnostic use of a mouse monoclonal antibody
(MAb) specific for the core region of the lipopoly-
saccharide (LPS) has also been investigated.8
Although this MAb gave good specific labelling of B.
fragilis and reacted with 96 % of the clinical isolates
examined, it labelled only c. 10% of the bacteria
within a given strain. We have shown previously that
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labelling with MAbs specific for polysaccharide epi¬
topes demonstrates within-strain antigenic variation
in B.fragilis9 and it appears that these variable epitopes
are immunodominant. Polyclonal antisera raised to
whole bacterial cells are also strain specific. This could
explain the lack of agreement between the detection of
B. fragilis by culture and immunofluorescence micro¬
scopy in these earlier studies. Therefore, there is a
need to identify a non-variable antigen common to B.
fragilis that could form the basis of an immuno-
diagnostic test.
In the present study, the suitability of the common
polysaccharide antigen described by Poxton and
Brown10 was investigated. This polysaccharide antigen
migrates behind the rough form of the LPS and before
the smooth form of the LPS on polyacrylamide gel
electrophoresis and was reported to be common to
seven strains of B. fragilis examined by immuno-
blotting with mono-specific polyclonal antiserum.
This study examined, by immunofluorescence
microscopy, the reactivity ofa monospecific polyclonal
antiserum raised against this polysaccharide antigen
with pus samples (and the corresponding pure culture
isolates) from a range of different body sites and blood
culture samples. The corresponding reactivity of a
number of MAbs specific for variable polysaccharide
antigens of B. fragilis was also examined.
Materials and methods
Bacterial strains
The strains used in this study were B. fragilis NCTC
9343 (National Collection of Type Cultures, Colindale
Avenue, London), NCTC 10584, ATCC 23745
(American Type Culture Collection, Rockville, MD,
USA); B. vulgatus NCTC 10583; B. thetaiotaomicron
NCTC 10582; B. ovatus ATCC 8483; B. distasonis
ATCC 8503; and clinical isolates of B. fragilis and
other Bacteroides spp. obtained from Craigavon Area
Hospital, Belfast City Hospital and Royal Victoria
Hospital NI (designated LS, JC and including one
metronidazole resistant strain, BCHlMzr), the Free
University, Amsterdam, NL (designated BE) and
University of Edinburgh, Scotland (designated
GNAB). The Escherichia coli and Staphylococcus
aureus strains used were recent clinical isolates from
the bacteriology laboratory at Craigavon Area Hos¬
pital, Northern Ireland.
Specimens
The clinical samples were all obtained in Northern
Ireland. The majority came from Craigavon Area
Hospital, Craigavon; however, a few were also
obtained from South Tyrone Hospital, Tyrone, Daisy
Hill Hospital, Newry and the Royal Victoria Hospital,
Belfast.
Ninety-eight pus samples (Study 1) which had been
sent to the laboratories for routine diagnostic testing
were examined in detail and information concerning
treatment was recorded from the patient's case history
where available. These samples were subject to routine
laboratory culture techniques (as detailed below) and
examined by immunofluorescence microscopy for
their reactivity with rabbit polyclonal antiserum to B.
fragilis common polysaccharide antigen (CAg anti¬
serum) and seven mouse MAbs specific for B.fragilis
as detailed below. The pure culture isolates ofB.fragilis,
other Bacteroides spp. and Prevotella melaninogenica
obtained from these samples were also examined by
immunofluorescence microscopy for their reactivity
with the CAg antiserum and the seven MAbs. A
further 49 pus samples (Study 2) were examined for the
presence or absence of B.fragilis by routine diagnostic
methods and their reactivity with the CAg antiserum
by immunofluorescence microscopy.
Ten blood culture bottles of which nine were
culture-positive for Bacteroides spp. were examined
for their reactivity with the CAg antiserum and three
of these were also examined with the MAbs.
The pus samples were obtained by surgical drainage
or aspiration and were placed in sterile bottles in
volumes of 1-20 ml. The pus samples were either
plated out directly (as detailed below) or inoculated
into Brain Heart Infusion Broth (Unipath) for 24 h.
Blood culture bottles (Roche Diagnostic System) were
inoculated with 10 ml of the patient's blood and
incubated at 37°C aerobically and anaerobically for a
total of 7 days. The cultures were examined by eye for
bacterial growth three times a day for the first 48 h and
once a day for the next 5 days. If growth was apparent
in the anaerobic blood culture bottle, a sample was
seeded to anaerobic blood agar and the identification
procedures performed as detailed below.
Identification by culture
Samples were routinely plated on the following agar
media: horse blood agar (BA; Unipath); anaerobic
horse blood agar (ABA; Gibco); colistin-nalidixic
acid agar (CNA; Unipath); anaerobic blood agar plus
gentamicin 50 pg/m\ (ABA + GM). After inoculation,
antibiotic disks containing penicillin (1 unit) and
gentamicin (10 pg) were applied to the BA and CNA
plates and the plates were incubated at 37°C in an
aerobic atmosphere with CO., 10%. Disks containing
penicillin (1 unit) and metronidazole (5 ^g) were
applied to the ABA + GM plate and gentamicin
(10 pg), penicillin (1 unit) and metronidazole (5 pg) to
the ABA plate. Cultures were incubated at 37°C in an
atmosphere of H2 10%, N2 80% and C02 10% in an
anaerobic cabinet (Forma Scientific).
The aerobic plates were examined for colonies after
24 and 48 h and the isolates were gram-stained.
Coliform isolates were identified with the API20E
system (bioMerieux), S. aureus with Staphaurex
(Murex Diagnostic), and Streptococcus spp. and
Enterococcus spp. with the Lancefield serotyping kit
Streptex (Murex Diagnostic). Streptococci which
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could not be classified with the Streptex kit were
identified with the API20 STREP (bioMerieux). Small
pin head colonies with a characteristic sweet smell that
were identified as Group A, C or F, or were otherwise
unidentifiable, were classified as Str. milleri.
The anaerobic plates were examined after at least
48 h and metronidazole-sensitive organisms were
gram-stained. Single colonies were re-streaked on
ABA and after 24 h the following tests were performed
with the pure cultures: API20A (bioMerieux), ATB
32A (bioMerieux) and the Mastring ID 8 (Mast
Laboratories).
Pure culture in brain heart infusion broth with
glycerol 10%, pus samples and blood cultures were
stored in liquid nitrogen for future examination.
Preparation of antiserum
Monospecific polyclonal antiserum was raised to B.
fragilis NCTC 9343 as described previously. Briefly,
the monospecific polyclonal antiserum described by
Poxton and Brown10 was used to identify the common
polysaccharide antigen on guide strips of nitrocellulose
after SDS-PAGE and immunoblotting. Small pieces
of nitrocellulose containing the common antigen were
cut from the unlabelled part of the nitrocellulose and
dissolved in dimethylsulphoxide. This was mixed with
an equal volume of Freund's complete adjuvant
(Difco) and OT-ml amounts were inoculated subcu-
taneously at four sites on the back of a New Zealand
White rabbit. Subsequently, the antigen in Freund's
incomplete adjuvant was inoculated four times at c. 2-
week intervals. A further two inoculations of antigen
in PBS were made at approximately monthly intervals
and the rabbit was bled after each booster dose.
Antisera were tested by both immunofluorescence
microscopy and immunoblotting.
Immunofluorescence microscopy
Samples (10 p\) from blood culture bottles or pus
were applied to one well of a multi-well slide (Flow
Laboratories). Four doubling dilutions in phosphate-
buffered saline (PBS) were made along the length of
the slide. For pure bacterial cultures, a suspension of
c. 107 bacteria/ml in PBS (30 p\) was applied to the
slide. A duplicate series of dilutions ofeach sample was
made on the same slide. The slides were air-dried and
then fixed in methanol 100% for lOmin at — 20°C.
Slides with pus or blood culture samples were blocked
with undiluted human serum for lOmin. For single
labelling, the slides were incubated with either un¬
diluted murine MAb supernates or polyclonal rabbit
antiserum diluted 1 in 100 in PBS for 45 min, washed
in PBS and then incubated for 45 min with sheep anti-
rabbit fluorescein conjugate (Sigma) diluted 1 in 100 in
PBS. After a final wash, the slides were examined with
a Leitz fluorescence microscope. For dual labelling,
the slides were incubated with MAb supernates,
washed, incubated with polyclonal rabbit antiserum,
washed and incubated with sheep anti-rabbit
fluorescein and goat anti-mouse rhodamine diluted 1
in 100 before a final wash." To estimate the sensitivity
of the labelling, Evan's Blue (Gurr; 0-05% w/v) was
included during incubation with the conjugate. The
slides were mounted with glycerol PBS containing an
anti-photobleaching agent (Citifluor; Agar Scientific
Ltd, Essex). The proportion of bacteria labelled with
the antisera was determined by eye and confirmed by
photographing the same field of view with filters
suitable for viewing the green fluorescence of the
fluorescein followed by filters suitable for viewing the
red fluorescence of the Evan's blue staining with a
fluorescence microscope. The percentage of bacteria
labelled with the antisera was estimated by counting
the total number of bacteria in each of the photo¬
graphs. A minimum of 200 bacteria were counted for
each estimation. Similarly, where samples were doubly
labelled with a MAb and polyclonal antiserum, fields
of view were photographed with filters suitable for
viewing either the fluorescein (green) or rhodamine
(red) dyes. Double-colour photographic exposure of
the same field with the two different filter types
sequentially were also examined.
Clinical samples were scored positive by immuno¬
fluorescence if at least three positive bacterial cells
were observed in a sample after extensive examination
of the micro-well slide. Each slide was examined for
c. 10 min. The intensity of fluorescence was also noted.
Results
Sensitivity of labelling with the polyclonal antiserum
to CAg
A number of different strains of B. fragilis and
related bacteria were examined for their reactivity with
rabbit polyclonal anti-serum specific for CAg by
immunofluorescence microscopy. The total number of
bacteria was estimated microscopically after being
stained with Evan's blue. All the strains of B. fragilis
examined were positive for CAg and between 80 and
100 % of the bacteria were labelled with the polyclonal
antiserum (table I). B. ovatus and B. thetaiotaomicron
Table 1. Sensitivity of labelling of B. fragilis strains with the





positive (%) positive (%)
NCTC 9343 LS54* 99
EDL population 103 LS66* 98
SC population 95 LS67* 97
LC population 92 BE1 80
NCTC 10584 99 BE3 89
ATCC 23745 96 JC6 98
GNAB 4 86 JC15 100
GNAB 82 96 JC17 98
GNAB 92 98 JC19 100
BCH1 Mzr 100
EDL, electron dense layer; SC, small capsule; LC, large capsule.
""Clinical isolates from the current study.
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Table II. Detection of Bacteroides spp. and related genera in pus samples by culture
and immunolabelling with antiserum to CAg (Study 1)
Number of
Source of specimen samples
received
Number culture-positive for CAg positive,
Bacteroides
Other and Prevotella
B. fragilis* Bacteroides and culture-
PrevoteUa spp. negative
Perianal abscess 15 11 0 2
Abdominal abscess 10 4 1 2
Pilonidal abscess 9 2 5 1
Bartholin's abscess 6 1 0 0
Ischiorectal abscess 4 2 1 1
Vaginal abscess 1 1 0 0
Diverticular abscess 1 1 0 0
Groin abscess 3 1 0 2
Groin neoplasm abscess 1 1 0 0
Colostomy 1 1 0 0
Abscess at pacemaker 1 0 0 0
Haematoma 1 0 0 0
Skin wounds 31 0 0 2
Pleural fluid 2 0 0 1
Gall bladder abscess 2 0 0 1
Liver abscess 3 0 0 0
Brain abscess 2 0 0 0
Pancreatic abscess 1 0 0 0
Peritoneal fluid 1 0 0 0
Parotid abscess 1 0 0 0
Subphrenic abscess 2 0 0 0
Total 98 25 7 12
*All these samples were positive when directly labelled with the CAg antiserum.
Table IIIA. Bacteria isolated from B. fragilis culture-positive
pus samples
Organisms isolated Abscess site
B. fragilis Perianal (2), colostomy (1)
B. fragilis, E. coli Perianal (2), ischiorectal (1)
B. fragilis, Str. milleri Abdominal (1), perianal (2),
groin (1), pilonidal (1)
B. fragilis, Str. milleri, E. coli Perianal (3), abdominal (1),
vaginal (1), ischiorectal (1)
B. fragilis, Str. agalactiae Perianal (1), pilonidal (1)
B. fragilis, Str. viridans Abdominal (1)
B. fragilis, E. coli, Str. milleri, Bartholin's (1)
Str. agalactiae
B. fragilis, E. coli, Str. agalactiae Diverticular (1), groin
neoplasm (1)
B. fragilis, Group C streptococci Perianal (1)
B. fragilis, P. melaninogenica Abdominal (1)
Table IIIB. Bacteria isolated from Bacteroides spp. and
Prevotella spp. culture-positive pus samples
Organisms isolated Abscess site
P. melaninogenica Abdominal wound (1)
P. melaninogenica, Pilonidal (1)
Peptostreptococcus sp.
P. melaninogenica, E. coli, Str. milleri Pilonidal (2)
B. thetaiolaomicron, E. coli, Str. milleri, Ischiorectal (1)
Proteus mirabilis
Bacteroides sp., Str. milleri Pilonidal (1)
Bacteroides sp., Str. milleri, Pilonidal (1)
Peptostreptococcus sp.
Table IV. Bacteria isolated on repeat culture from CAg-
positive but Bacteroides and Prevotella culture-negative pus
samples
were labelled with lower intensity but similar sen¬
sitivity to B. fragilis, and B. distasonis gave negative
results.
Detection of Bacteroides spp. in pus samples
The source of the 98 pus samples examined in Study
1, the culture results for Bacteroides spp. and related
genera and the reactivity with the CAg antiserum by
immunofluorescence microscopy are shown in table II.
The bacteria isolated from samples positive for B.
fragilis, Bacteroides spp. and the related genus
Prevotella by initial culture are shown in tables IIIA
and IIIB respectively. Pus samples that were culture-
negative for Bacteroides and Prevotella spp., but
Organisms initially . ,
• ? . . Abscess site
None Buttock (skin wound)*t, labial (skin
wound), abdominal!
E. coli Gall bladder, pilonidal!, groin,
perianal, abdominal*!
Str. milleri Pleural fluid, ischiorectal*!
E. coli, Str. milleri Perianal*
S. aureus, Str. pyogenes Groin!
*B. fragilis isolated after re-culture of the sample.
!Positive with one or more B. fragilis-specific MAb (see table IX).
positive by immunofluorescence with the CAg anti¬
serum are detailed in table IV. These 12 specimens
which were negative for Bacteroides and Prevotella
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Table V. Detection of B. fragilis in pus samples by both














Perianal abscess 9 9 0
Pilonidal abscess 8 4 2
Unspecified pus 7 3 1
Abdominal abscess 4 2 1
Scrotum abscess 4 1 2
Pelvic abscess 2 0 2
Mastoid maxillary sinus 3 0 2
Suprapubic abscess 1 1 0
Pleural cavity 1 1 0
Hernia wound abscess 1 0 1
Pouch of Douglas 1 0 0
Neck abscess 1 0 0
Quinsy 1 0 0
Wound abscess 1 0 0
Abdominal drain fluid 1 0 0
Tibial abscess 1 0 0
Breast abscess 1 0 0
Back abscess 1 0 0
Gall bladder abscess 1 0 0
Total 49 21 11
*All except one of these samples were also positive when labelled
with the CAg antiserum.
spp. on initial routine testing in the laboratory, but
immunofluorescence-positive with the CAg anti¬
serum, were retrieved from storage in liquid nitrogen
and re-cultured. Of these, B. fragilis was isolated from
four (table IV).
Of a further 49 pus samples examined in Study 2, 21
were positive by culture for B. fragilis. Eleven of the
culture-negative samples were positive by immuno¬
fluorescence with CAg antiserum (table V). Immuno¬
fluorescence labelling of a typical pus sample is
illustrated in fig. 1. With the exception of one sample in
Study 2, if a sample was positive for B. fragilis on
culture it was also positive by immunofluorescence
with the CAg antiserum. Of the samples positive for
Bacteroides spp. or P. melaninogenica, or both, only
one (no. 3), which was positive for an unidentified
Bacteroides sp., was negative by immunofluorescence.
In total, 36 % of the pus samples were positive for B.
fragilis and related bacteria by culture and 50 % were
positive by immunofluorescence microscopy with the
CAg antiserum.
Investigation of the patients'' case histories
The antibiotic treatment recorded in the case his¬
tories of patients whose specimens were either CAg
antiserum- or culture-positive for B. fragilis is given in
table VI. Although metronidazole was prescribed
before drainage of the abscesses, samples nos. 11 and
15 were still positive for B. fragilis on culture. One
sample (no. 68) was culture-negative and the antibiotic
treatment was changed to co-fluampicil; however, the
current study indicated that this sample was CAg-
positive. Examination of the case histories also
revealed that four patients had recurrent infections at
the same anatomical site (table VII).
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Table VI. Antibiotics* administered to patients with either B. fragilis and related




before drainage after drainage
A
4 Co-fluampicil NI
11 Cefuroxime and metronidazole Cefuroxime and metronidazole
14 Co-fluampicil NI
15 Gentamicin and metronidazole Gentamicin and metronidazole
18 NI Ampicillin and metronidazole
23 Co-fluampicil NI
56 Flucloxacillin NI











information obtained from patients' case histories, where available.
Table VII. Bacteria isolated from successive samples obtained from the same
patient* based on information in patients' case histories
Sample no. Abscess site Date Culture result
23 Ischiorectal 14.02.89
12.08.90
* B. fragilis, Sir. milleri











Str. milleri, B. fragilis,
P. melaninogenica
*Str. milleri, B. fragilis
No growth




*Str. milleri, B. fragilis, E. coli
Str. milleri, B. fragilis, E. coli
♦Denotes pus sample examined in Study 1.
Detection of B. fragilis from blood culture bottles
Nine blood culture bottles from which B. fragilis
was isolated, and one from which B. distasonis was
isolated, were examined for their reactivity with the
CAg antiserum. All nine cultures positive for B.
fragilis were also positive by immunofluorescence with
the CAg antiserum; however, the B. distasonis-positive
blood culture bottle was CAg-negative. Fig. 2
illustrates typical labelling of a blood culture sample.
Reactivity of B. fragilis clinical samples and pure
cultures with murine MAbs
Twenty-five pus samples (from Study 1) and three
blood culture bottles, which were all CAg positive,
were examined by immunofluorescence microscopy
for their reactivity with six murine MAbs specific for
the surface polysaccharides of B. fragilis associated
with the large capsule and electron-dense layer popu¬
lations. The corresponding pure culture isolated was
also examined in each case. MAb QUBf5 is specific
for the polysaccharide which forms on PAGE and
immunoblotting a pattern similar to that of the
O-antigen of other bacterial species. The other MAbs
are specific for higher molecular mass polysaccharide
associated with the large capsule and electron-dense
layer populations of B. fragilis.9
Four of the pus samples did not react with any of the
MAbs when examined directly and the rest reacted
with a variable selection of the MAbs. All of the pure
culture isolates of B. fragilis obtained from these
samples were positive for at least one of the MAbs
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Fig. 2. Micrograph of blood culture labelled with rabbit antiserum to CAg and anti-rabbit immunoglobulin fluorescein conjugate ( x 100).
(table VIII). There was no apparent relationship
between the site of origin of the sample and the MAb
labelling. Double labelling with both the CAg anti¬
serum and the MAbs confirmed that the MAbs label a
varying proportion of the B. fragilis cells present
within a pure culture isolate. This was also the case
when pus and blood culture samples were examined
directly, without prior culture. Fig. 3 illustrates double
labelling of a blood culture. MAb QUBfll, which
reacted with all of the pure cultures and 24 of the 28
samples, labelled only 7-15% of the bacterial popu¬
lation. Labelling also indicated that outer membrane
vesicles were present in the pus samples.
Examination of the samples that were culture
negative for B. fragilis and related bacteria, but were
positive with the CAg antiserum, indicated that seven
of 12 of these samples also reacted with at least one of
the MAbs (table IX). Samples from which Bacteroides
spp. (other than B. fragilis) or P. melaninogenica, or
both, were cultured and which were positive with the
CAg antiserum (table IIIB), were negative with all the
MAbs. This suggests that the polysaccharides recog¬
nised by these MAbs are specific to B. fragilis.
Sixteen of the pure culture isolates from Study 1
were examined for their reactivity with a MAb (Bf4)
specific for a high molecular mass polysaccharide
associated with the small capsule population of B.
fragilis.12 An estimated 1 %, or less, of the bacteria
within these populations were labelled with the MAb.
Similarly, the proportion of the bacteria positive with
the CAg antiserum, which were also positive with
MAb Bf4 when pus samples were examined directly,
was C 1 %.
Discussion
The results confirm that the heterogeneous labelling
pattern of MAbs specific for high molecular mass
polysaccharides of B. fragilis, previously observed in
culture collection strains and in bacteria grown in a
mouse model of peritoneal infection,13 also occurred in
the recent clinical isolates of B. fragilis obtained in the
study. Variable labelling was also apparent when pus
samples were examined directly, without prior culture.
Polysaccharides associated with the large capsule,
small capsule and electron-dense layer populations912
were all detected in the pus samples with the MAbs.
This indicates that antigenic variation in the poly¬
saccharides of B. fragilis is apparent during the course
of natural infection and raises the possibility that
antigenic variation of surface polysaccharides is re¬
lated to the virulence of B. fragilis. Interestingly, there
was no obvious relationship between the labelling
pattern of the MAbs and a particular site of infection.
It is possible that variable antigens are the immuno¬
dominant antigens in B. fragilis as inoculation with
whole cells produces antisera that do not label all the
bacterial cells in other strains1415 and are thus too
insensitive for use as a diagnostic test for the presence
of B. fragilis. Furthermore, all the polysaccharide-
specific MAbs that were raised with whole bacteria as
an inoculum were specific for the antigenically variable
polysaccharides which are not expressed by all the
bacteria within a given population of B. fragilis}6 18 It
is possible that these immunodominant variable poly¬
saccharides mask the common polysaccharide. The
unsuitability of the variable polysaccharides as targets
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Table VIII. Reactivity of clinical samples (S) and the corresponding pure culture




Reaction with MAb QUBf
'8 9 10
Perianal/ischiorectal abscess
14 + + + + — - + - + + + +
16 — — — — — — + — + — + —
23 L +
26 + - + -
52 - — — — + + — — — - + +
54 + + + + + + - — + - + +
61 — — — + + — — + + + +
67 + t + + + + - - — - + +
75 — - + + + + - — — — + +
80 + + + + + + + + + + + +
87 — — — — + + — — + + + +
92 + + - — + + - — + + + +
95 + + — — + + — — + + + +
Abdominal abscess
11 - - - -
13 - - - -
66 + + + -





18 + + + +

























































C, pure culture; S, pus sample.
for the immunological detection of B. fragilis in clinical
samples is emphasised. The sensitivity of labelling is
not sufficient to allow detection of B. fragilis in all
instances. It is unlikely that even a mixture of these
MAbs could be used effectively as some samples and
isolates reacted with only one MAb.
In contrast, a monospecific polyclonal antiserum
specific for the CAg of B. fragilis10 labelled between 80
and 100% of the bacteria within 16 strains of B.
fragilis obtained from culture collections and isolates
from Northern Ireland, Edinburgh and Amsterdam,
and also populations of strain NCTC 9343 enriched
for the large capsule, small capsule or electron-dense
layer. The antiserum recognised B. fragilis, B.
thetaiotaomicron, B. ovatus and P. melaninogenica but
not B. vulgatus or B. distasonis. Why this poly¬
saccharide is common to some species of Bacteroides
and Prevotella but not other species of Bacteroides
is unclear. Interestingly, there is evidence for the
horizontal transfer of genes between Bacteroides and
Prevotella spp.19 By labelling bacteria directly in pus
samples, the detection of these species was increased
above that obtained by culture only. The culture-
negative immunofluorescence microscopy-positive
samples are unlikely to represent false positives, as (i)
four of these yielded viable B. fragilis when the
isolation procedures were performed a second time
from the stored pus samples, with particular care to
minimise the exposure of the material to air and not as
part of the normal day-to-day activity of the diagnostic
laboratory, and (ii) a number of culture-negative
samples were also positive by immunofluorescence
microscopy with MAbs specific for B. fragilis poly¬
saccharides (table IX) which, because of the specificity
of the MAbs, indicates that B.fragilis cells were present
in these specimens but were non-viable. Therefore, this
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Fig. 3. Micrographs of blood culture labelled with (i) rabbit antiserum to CAg and anti-rabbit immunoglobulin fluorescein conjugate and (ii)
mouse MAb QUBfl 1 and anti-mouse immunoglobulin rhodamine conjugate. The same field of view was photographed with filters to show:







study highlights the problems of detecting obligate
anaerobes in clinical specimens by culture alone in a
routine diagnostic laboratory and indicates that the
CAg is a suitable target for immuno-detection. If the
CAg antiserum alone had been used for the detection
of B. fragilis and related bacteria, two samples that
were positive by culture would have been mis-reported
as negative. This represents an underestimate of 1-2 %
of the total of 147 samples examined in the study. In
contrast with the current diagnostic laboratory culture
methods, the incidence of B. fragilis and related
bacteria was underestimated by c. 14%. Although
relatively few blood culture bottles were examined, in
all nine instances where B. fragilis was isolated, the
blood culture was positive with the CAg antiserum.
Thus, there is the potential for immediate confirmation
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Table IX. Reactivity of pus samples negative for B. fragilis
and related bacteria, but CAg-positive with MAbs specific
for B. fragilis NCTC 9343 surface polysaccharides
Reaction with MAb QUBf
Sample no.
5 7 8 9 10 11
28 - + - + - +
34* - + + -- +
35 - + --- +
57* -- + + + +
68 -- + - + +
70* -- + - + +
94 +- + - + +
—, negative; +, positive. *B. fragilis culture positive after re-
culture. Four samples were negative with all the MAbs.
of B. fragilis in blood culture bottles at the point
when growth in the bottle is first observed. The current
study examined pus samples and blood culture bottles
exclusively. The usefulness of such a test with swab
samples remains to be elucidated.
This study also exemplifies the classical poly¬
microbial infections in which B. fragilis are involved
and which have been much studied, in particular in
relation to E. coli.20 E. coli was isolated in association
with B. fragilis in c. 46% of instances; however, Sir.
milleri was present along with B. fragilis in 68 % of
cases in this study. Str. milleri is a facultative pathogen
that has been isolated from a similar range of body
sites to that of B. fragilis.21 The possible synergic
interaction between Str. milleri and B. fragilis warrants
further investigation.
Of a total of 45 pus samples from perianal, pilonidal
or ischiorectal sites, 39 were positive for B. fragilis and
related bacteria in this study. The high incidence of B.
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MOLECULAR DIAGNOSTICS
Evaluation of the polymerase chain reaction for early
diagnosis of leptospirosis
P. D. BROWN, C. GRAVEKAMP+ D. G. CARRINGTONt H. VAN DE KEMP+, R. A. HARTSKEERLJ,
C. N. EDWARDS*, C. 0. R. EVERARD+, W. J. TERPSTRAJ and P. N. LEVETT§
University of the West indies. Faculty of Medical Sciences and * Department of Medicine, Queen Elizabeth Hospital,
Bridgetown, Barbados, f Leptospira Laboratory, St Michael, Barbados, West Indies and % Department of Biomedical
Research, Royal Tropical Institute, Meibergdreef 39, 1105 AZ, Amsterdam, The Netherlands
Summary. Early diagnosis of leptospirosis is important because severe leptospiral infection
can run a fulminant course. The polymerase chain reaction (PCR) was evaluated for the
detection of leptospires in clinical samples from patients with acute leptospiral infection.
Blood and urine samples from 71 patients with leptospirosis were examined by PCR, culture
or serology. Samples from 44 (62 %) patients with the diagnosis of leptospirosis were positive
by PCR as compared to 34 (48 %) by culture. The presence of leptospires was demonstrated
by PCR in 13 patients before the development of antibodies, as well as in two patients who
were seronegative during their illness and at autopsy. Samples from 16 patients without
leptospirosis were seronegative and culture negative, and also negative by PCR. We conclude
that PCR is a rapid, sensitive and specific means of diagnosing leptospiral infection, especially
during the first few days of the disease.
Introduction
Leptospirosis is considered to be one of the most
widespread zoonoses worldwide.1 Barbados, the most
easterly of all the Caribbean islands, has a population
of c. 260000 inhabitants and a land mass of 430 km2.
The tropical climate, combined with the pre¬
dominantly black soils which are slightly alkaline, and
the dense population of rodents and dogs distributed
throughout the country, make it an ideal environment
for the maintenance and spread of leptospirosis.
In Barbados, leptospirosis has been recognised as an
important disease affecting man since it was first
described in 1939.2 Since then, the disease has been
investigated in hospital patients, dogs, livestock and
wild-life, and leptospiral isolates have been identified.3
Until the end of 1989 only three serovars (him,
copenhageni and arborea), of the 20 or so detected in
the Caribbean, were identified among over 100 Lepto¬
spira isolates from hospital patients in Barbados over
the preceding 10-year period. A fourth serovar (bajan)
has since been identified.3 Presently, the ratio of
presumptive infecting serogroups in hospital patients
is Autumnalis 60%, Icterohaemorrhagiae 23%,
Ballum 14% and others 3 %. On average, 33 cases of
Received 7 Nov. 1994; accepted 1 Feb. 1995.
{^Correspondence should be sent to Dr P. N. Levett.
severe human leptospirosis are recorded in Barbados
each year with an associated case fatality rate of
14-2%.3
Accurate diagnosis is important as it gives insight
into the extent of the public health problem. Moreover,
early diagnosis is particularly important for the clinical
management of patients because treatment of lepto¬
spirosis can be effective if initiated early. Serology
usually does not contribute to early diagnosis of
leptospirosis, because antibodies become detectable
around the seventh day of the disease. Conventional
methods such as dark-field microscopy or culture to
detect leptospires in clinical samples are either un¬
reliable or too slow to contribute to a rapid di¬
agnosis.1-4 Leptospires circulate in the blood of the
patient until about the 10th day after the onset of
symptoms.
With the introduction of PCR, rapid detection of
small numbers of leptospires in clinical samples has
become practical due to specific amplification of
leptospiral DNA.5"7 This is important as leptospirosis
can run a fulminant course and patients may die before
the development of the characteristic clinical mani¬
festations of leptospirosis or the appearance of lepto¬
spiral antibodies or both, and, therefore, the disease
may go unrecognised. Post-mortem diagnosis may fail
because leptospires may die before inoculation of
culture medium and specific antibodies may not yet be
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Preface
This book has evolved from lectures given in Bacterial Pathogenesis, Bac¬
terial Genetics and Immunology courses to Honours year General Micro¬
biology, Medical Microbiology, Genetics and Molecular Biology Students
at the Queen's University of Belfast. Our intention is to provide material
for the stronger student and hopefully to stretch, rather than confuse, other
students. The book should also be of use to students in specialist post¬
graduate courses as well as post-graduates embarking on research into bac¬
terial virulence. We hope that this text will fill the gap between excellent
general texts such as Mechanisms of Microbial Disease (Eds Schaechter M.,
Medoff G., Eisenstein B. I., 2nd Edn, Williams and Wilkins) and more
specialist texts such as Molecular Basis of Bacterial Pathogenesis (Eds Iglewski
B. H., Clark V. L., Academic Press) and Molecular Biology ofBacterial Infection
(Eds Hormaeche C. E., Penn C. W., Smyth C. J., Cambridge University
Press). Our intention is to bring virulence into the context of both the host's
immune response and the genetic systems which have evolved in bacteria,
by considering molecular interactions. To this end the book covers the
host's response to bacterial infection first, before the virulence determinants
of bacteria, and ends with the genetic mechanisms which control the
expression of bacterial virulence determinants. It is assumed that the under¬
lying infections and pathogenesis of disease caused by individual bacteria
are already familiar to the reader, as are fundamental aspects of micro¬
biology, immunology, genetics, biochemistry and cell biology. Although
biased towards human pathogens many of the general principles are equ¬
ally applicable to veterinary pathogens.
1 Pathogenic Bacteria in Context:
An Overview
Bacteria are major recyclers on this planet; they degrade organic matter,
solubilise inorganic compounds such as clay, contribute to the weathering
of rock and degrade toxic pollutants generated by the industrial world. In
short, bacteria as a group are capable of a wider range of chemical and
metabolic activity than any other group of living organisms. The diversity
of bacteria is exemplified by the range of environments that they can
inhabit. They can inhabit environments with extremes of temperature, sal¬
inity and pressure as well as habitats devoid of oxygen. They have been
isolated from environments with temperatures near to freezing and from
lakes with both high salinity and temperatures of 44 °C. Thermophilic bac¬
teria grow optimally between 55 and 75 °C; their habitats include naturally
occurring hot muds and compost heaps. Some groups of bacteria utilise
inorganic compounds as an energy source, some also photosynthesise in
the absence of oxygen, while others conduct anaerobic respiration. It could
be argued that this is due to the genetic diversity and plasticity of bacteria.
Only mankind has matched their ability to survive in such extreme environ¬
ments, in this case largely due to the evolution of the human brain rather
than to the metabolic diversity that is exhibited by bacteria. In all these
diverse environments, the resistance of the ecological niche to colonisation
(which relates to the degree of adaptation required by the organism) is
passive. The environment may be subject to rapid physical and chemical
change, but the changes are not brought about by active participation of
the environment. The only 'active' competition is from other species com¬
peting for the same niche. Bacterial colonisation of an ecological niche
inside other living organisms is, however, another matter. Most multicellu¬
lar organisms have evolved mechanisms to resist colonisation by microbes
and this has culminated in the evolutionary splendour of the mammalian
immune system; thus in colonising the living host the bacterium is faced
with an environment which is actively dedicated to the prevention of its
colonisation. Bacteria that can survive within this specialist niche are said
to have 'determinants of virulence'; these are the attributes which allow
them to survive. Those bacteria which cause abnormalities in the host as a
result of colonisation are 'pathology generators' or pathogenic.
A large number of bacteria, the commensal flora, inhabit animals without
being pathogenic. All animals have a commensal flora, which in the case of
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humans is estimated at 10'4 microbial cells per person. In fact each human is
inhabited by more bacteria than there are humans on the planet. In man,
bacteria inhabit the skin, intestine, upper respiratory tract and genito¬
urinary tract and can be considered technically to be outside the host. The
commensal bacteria do not multiply to the detriment of the host, provided
they remain in the appropriate ecological niche. Indeed the commensal flora
is considered to be largely beneficial to the host and may even be essential
for its normal function. Where the commensal bacteria cross the boundaries
of these habitats and enter into the host, under what could be considered
abnormal conditions (for example as a result of mechanical injury to the
host), they may have the potential to become pathogens.
The commensal bacteria and the truly pathogenic bacteria are part of the
group of bacteria involved largely in the recycling of organic material and
can be nutritionally classified as chemo-organotrophs: organic compounds
are their major carbon source and energy is obtained from degradation of
organic compounds rather than inorganic compounds or from light. Of this
large group of bacteria only a minority are pathogenic and can multiply at
the expense of a living host and cause disease. Therefore in the context of
the general ecology of the planet and the bacteria which populate it, the
pathogenic bacteria could be considered a curiosity; however, in the context
of their potential to inflict damage on the human population, they represent
a major threat to mankind. It is therefore not surprising that much time
and effort has been invested in trying to understand the nature of virulent
bacteria, thus enabling the development of means to prevent them from
inhabiting this particular ecological niche. With the advent of clean water
supplies, safe sewage disposal, successful antimicrobial therapy in the form
of antibiotic treatment and vaccination programmes there was a brief per¬
iod of complacency in the western world when it seemed that bacterial
infections were no longer a large threat to the human population. In the
context of the whole world, however, the bacterium Mycobacterium tubercu¬
losis still kills approximately 3 million people each year, more than any
other single infectious disease. Even in the western world bacterial diseases
remain a problem. For example in the United States of America sexually
transmitted disease caused by Chlamydia trachomatis is thought to affect 3
million people annually and gonorrhoea is still the most frequently
reported of the officially notifiable diseases, even though AIDS is also
officially notifiable.
The study of pathogenic bacteria and an understanding of how they
evolve and adapt should lead to better management of disease and more
successful targeting of therapy. To do this requires knowledge of a number
of areas which relate to both the bacterium and host. The biochemical con¬
stituents of the bacterium and the host are the starting point. An under¬
standing of bacterial genetics and the regulation of bacterial gene
expression within the host is also essential, as is an understanding of the
PATHOGENIC BACTERIA IN CONTEXT 3
interaction of the bacterial constituents with the host cells and systems.
The bacteriologist studying virulence has therefore to be an amalgam of
biochemist, geneticist, cell biologist and immunologist. With the recent
advances in understanding in all these areas, and of the molecules involved
in the workings of biological systems in general, bacterial pathogenesis has
become an exciting and fast-moving area of study. To date the molecular
basis of bacterial virulence is known in part for only a few bacteria and
these are by and large the simpler systems where one key characteristic of
the bacterium, for example production of a toxin, can be clearly correlated
with virulence. For most pathogenic bacteria many different characteristics
or factors contribute to virulence and these may vary depending on the
stage of infection; virulence is said to be 'multifactorial'. As the pathogenic
process cannot be removed from the bacterial interactions with the host, it
is very difficult to relate characteristics of the bacterium growing in culture
media to virulence in the natural infection. Therefore studies of virulence
have two essential requirements: firstly a suitable model system which
mimics as closely as possible the natural infection so that putative virulence
determinants can be identified; and secondly it is necessary to confirm that
putative virulence determinants are expressed by the bacterium during the
course of a natural infection. Thus clinical material must also be investi¬
gated. One of the most exciting models now being used to identify bacterial
genes necessary for virulence which may be expressed only in response to
host stimuli is in vivo expression technology (IVET). Regions of the bac¬
terial chromosome are isolated, enzymically cut, modified and are inserted
back into the genome in such a way that genes which are switched on in
vivo can be identified.
As we more clearly understand molecular biology, both in the broad
sense of all biological molecules and in the sense of manipulation of deoxy¬
ribonucleic acid (DNA), so our understanding of the fascinating co-evol¬
ution of pathogenic bacteria and the mammalian immune system will
increase. In the long term this should lead to a further reduction of the
large impact this minor group of bacteria has on human history.
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The haemagglutinating and enzymic activities of the obligately anaerobic pathogenic
bacterium Bacteroides fragilis were examined. Outer membrane vesicles are released from
the surface of B. fragilis. They can be detected by electron microscopy in ultrathin sections
and bacterial suspensions after negative staining. Electron microscopy and immunogold
labelling with a MAb specific for surface polysaccharide of B. fragilis confirmed that the
vesicles carried outer membrane associated epitopes. The haemagglutinating activity of
whole cells from populations of B. fragilis strains NCTC9343, BE3 and LS66 enriched by
Percoll density gradient centrifugation for a large capsule (LC), electron dense layer (EDL;
non-capsulate by light microscopy) and outer membrane vesicles (OMV) which had been
purified by centrifugation from EDL-enriched populations were compared using human
and horse erythrocytes. The enzymic activity of OMV, LC- and EDL-enriched populations,
as detected by the API ZYM kit, was compared for strains NCTC 9343 and BE3. Purified
OMV from the strains examined exhibited both haemagglutinating and enzymatic activity.
HaemaggIutination by the EDL-enriched population was sensitive to treatment with sodium
periodate. The LC-enriched population haemagglutinated only after ultrasonic removal of
the capsule. This indicates that the LC masks a haemagglutinin. The results suggest a
potential role for OMV in the virulence of B. fragilis. © 1996 Academic Press Limited
Key words: Bacteroides fragilis; outer membrane vesicles; haemagglutination; extracellular
enzymes.
Introduction
The obligately anaerobic bacteria of the genus Bacteroides are numerically the
predominant component of the normal commensal faecal flora of the colon in
all adult humans, where obligate anaerobes outnumber facultatively anaerobic
bacteria by about 1000 to 1.1 Bacteroides fragilis is the species most commonly
isolated from infections resulting from faecal contamination, despite being
outnumbered by other Bacteroides species within the faecal flora. It is, however,
the predominant Bacteroides sp. in the adherent colonic mucosal flora.2 Although
* Author to whom correspondence should be addressed.
0882-4010/96/040191 + 12 $18.00/0 © 1996 Academic Press Limited
192 S. Patrick et at.
B. fragilis and related species within the 'fragilis group' of Bacteroides spp.
(Bacteroides sensu stricto) are not members of the normal commensal vaginal
flora, they are also responsible for up to half of the upper genital tract, pelvic and
uterine infections in women.3 Infections from which B. fragilis has been isolated
include abdominal, pelvic, perianal and vaginal abscesses.4 The majority of
B. fragilis infections are polymicrobial; for example, Escherichia coli and
Streptococcus milleri are frequently isolated in association with B. fragilis,1,5 The
precise virulence determinants of B. fragilis remain to be defined; however, surface
structures (such as capsular polysaccharides and fimbriae), extracellular enzymes
which degrade components of the host tissue and the release of factors which
inhibit phagocytic function may all be involved.6
Both fimbriae7,8 and encapsulating structures9 are implicated in the ability of
B. fragilis to attach to host cells. Vel et at. reported periodate sensitive
haemagglutination which did not correlate with the presence or absence of
capsules. All of the strains they examined were capsulate by light microscopy
but not all haemagglutinated.10 Pruzzo and colleagues later reported encapsulated
haemagglutinating strains in which haemagglutination (HA) was lost after
treatment with alpha-glucosidase. It is possible that in these studies the bacterial
populations examined contained a mixture of bacteria with different encapsulating
surface structures.7,8
A major problem in studies of B. fragilis is the heterogeneous nature of
encapsulating surface structure expression within individual strains.6 This
heterogeneity is obvious when the bacteria are grown in a glucose-rich defined
minimal medium such as that of van Tassell and Wilkins.11 B. fragilis may express
at least three different types of capsule which can be characterized by electron
microscopy of ultrathin sections; namely, a large capsule (LC), a small capsule
(SC) and an electron dense layer (EDL). The EDL is not visible by light microscopy.
Each of these structures may be produced by different cells within a single
strain. Thus to relate a particular surface structure to attachment requires careful
definition of the bacterial populations used in the experiment.
LC, SC or EDL populations can be enriched by subculture after Percoll density
gradient centrifugation separation.12 In studies of enriched populations, the EDL
population was shown to haemagglutinate human (A, B and 0 blood groups),
horse, guinea pig, rabbit, sheep, mouse and chicken erythrocytes, whereas the
LC-enriched population did not.13 The EDL-enriched population are non-capsulate
by light microscopy and fimbriae are not observed by electron microscopy in the
strains when they are grown in defined medium broth.13 It therefore seems that
B. fragilis is not only capable of producing more than one type of ligand which
mediates host cell attachment, but that the expression of these ligands may be
subject to within-strain variation.
The release of extracellular enzymes by B. fragilis such as hyaluronidase,
chondroitin sulphatase, DNAase, protease and lipase, with the potential to degrade
components of the host tissues, has long been recognized.16 Other workers have
presented evidence for a link between neuraminidase activity of B. fragilis and
the ability to agglutinate erythrocytes and attach to tissue culture cells.16
Macfarlane and colleagues have documented a range of proteolytic and
glycosidase activity,17,18 in studies relating to protease activity of B. fragilis as part
of the normal intestinal microflora. They reported some protease activity in
particulate matter released from B. fragilis cells, although 90% of extracellular
protease activity was in a soluble form.17 They suggested that the particulate
matter corresponds to vesicles released from the outer membrane. The release




Fig. 1. Micrographs of ultrathin sections of B. fragilis strain BE3 enriched for (a) the LC and (b) the
EDL by Percoll density gradient centrifugation (bar: 0.5 /jm). Note EDL adjacent to the outer membrane
(arrow).
(a) (b) (c)
Fig. 2. Slide haemagglutination of human erythrocytes by LC-enriched B. fragilis NCTC 9343 after
ultrasonication for (a) 30 s, (b) 50 s and (c) 60 s examined by light microscopy. Note that the LC-enriched
population only agglutinates erythrocytes after ultrasonication (arrow) and that ultrasonication for
60s destroys haemagglutinating activity ( x 10 objective).
of outer membrane vesicles (OMV) from a range of Gram-negative bacteria,
including Poryphoromonas (Bactericides) gingivalis, has been reported. It has
been postulated that these vesicles are involved in virulence as the reported
biological activities of OMV include enzymatic activity, toxicity to host cells and
attachment to surfaces, other bacteria and erythrocytes.19 We have previously
reported the observation of OMV in B. fragilis.u
In the present study we compare haemagglutination and enzymic activity of
the EDL-enriched population and preparations of OMV. Enzymic activity was
monitored with the API ZYM system which is a rapid and simple method for
determining a range of enzymic activities. The sensitivity of the haemagglutinin
in the EDL population to sodium periodate treatment was also examined. The
194 S. Patrick et al.
(a) (b)
Fig. 3. Eosin/carbol fuchsin stained capsule smear of a B. fragilis population enriched for the large
capsule (a) before and (b) after ultrasonication for 50 s at an amplitude of 5/im ( x 100 objective).
(a) (b)
Fig. 4. Slide haemagglutination of human erythrocytes with EDL-enriched B. fragilis after incubation
of the bacteria for (a) 30min in PBS and (b) 30 min in 0.01 m sodium periodate. Note erythrocyte
agglutination in (a) and reduction in erythrocyte agglutination after treatment of the bacteria with
sodium periodate for 30 min in (b). ( x 10 objective).
reactivity of the sodium periodate treated EDL-enriched populations with a number
of monoclonal antibodies (MAbs) specific for B. fragilis was determined by
fluorescence microscopy. The non-haemagglutinating LC-enriched population was
tested for HA after ultrasonic destruction of the LC.
Results
Haemagglutinating activity of LC- and EDL-enriched populations after ultrasonic
treatment
Populations of strains NCTC 9343, LS66 and BE3, enriched for either the LC,
illustrated in Fig. 1(a), or the EDL, illustrated in Fig. 1(b), were ultrasonicated to
determine the effect on haemagglutination. Ultrasonic treatment of the EDL-
enriched population for longer than 60s destroyed haemagglutinating activity.
The LC-enriched population became haemagglutinating after 30 s ultrasonication,
but treatment for more than 50 s destroyed this activity (Fig. 2). Examination
of the LC-population by light microscopy after negative staining showed that
ultrasonication had destroyed the majority of the large capsules (Fig. 3).
Activities of EDL-enriched populations after sodium periodate treatment
Treatment of the EDL-population with 0.01 m sodium periodate for 30 min reduced
haemagglutinating activity (Fig. 4). After 40 min of treatment with 0.01 m sodium
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(a) (b)
Fig. 5. Micrograph of EDL-enriched population of B. fragilis immunolabelled with monoclonal
antibody QUBf7 and anti-mouse fluorescein conjugated antibody after incubation in (a) phosphate
buffered saline or (b) 0.01 m sodium periodate for 1 h (x100 objective; micrographs exposed and
printed under identical conditions). Note absence of labelled OMV and reduced labelling resulting in
clearly defined bacterial shapes after sodium periodate treatment (arrow, labelled OMV).
Fig. 6. Examples of OMV release from the surface of B. fragilis observed by electron microscopy
of ultrathin section (bar: 0.1 /im). Note that the vesicles appear to bud from the outer membrane
(arrows) and are bound by a single membrane.
periodate or 30 min with 0.1 m sodium periodate haemagglutinating activity was
completely destroyed. The reactivity of the EDL population with MAbs QUBf 5, 6,
7, 9 and 11, specific for high molecular mass surface polysaccharides of B. fragilis
outer membranes, was reduced but not totally destroyed after treatment for one
hour with 0.01 m sodium periodate, although there was a marked reduction in
the labelling of bacterial cells and destruction of the OMV labelling (Fig. 5).
Haemagglutinating and enzymatic activity of outer membrane vesicles
The release of single membrane bound vesicles from the surface of B. fragilis
can be observed by electron microscopy of ultrathin sections (Fig. 6). These are
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Fig. 7. Electron micrograph of supernatant fraction of EDL-enriched population of B. fragilis after
centrifugation to pellet bacterial cells and negative staining with methylamine tungstate (bar: 0.5 ;im).
Note the quantity of outer membrane vesicles.
Fig. 8. Electron micrograph of ultrathin section of LC-enriched population of B fragilis (bar. 0.5 /im).
Note vesicles within the LC (arrows).
released in quantity in broth cultures of the EDL-enriched population and can be
observed by electron microscopy after negative staining (Fig. 7). The LC-enriched
population also produces OMV, but to a lesser extent, as determined by electron
microscopy of negatively stained preparations. Examination of ultrathin sections
indicates that some vesicles are apparently trapped within the LC (Fig. 8).
Suspensions of OMV were obtained from EDL-enriched populations of B. fragilis
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Fig. 9. Electron micrographs of OMV from B. fragilis strains (a) NCTC 9343, (b) BE3, (c) LS 66 and
(d) single vesicle from NCTC 9343, immunolabelled with monoclonal antibody QUBf5 and anti-mouse
gold conjugated antibody (bar: 0.5/(m).
strains NCTC 9343, LS 66 and BE3. Immunogold labelling with MAb QUBf5,
specific for a polysaccharide found in outer membrane extracts of B. fragilis, was
used to verify the presence of bacterial outer membrane associated epitopes (Fig.
9). After polyacrylamide gel electrophoresis and immunoblotting, the antigen
labelled by MAb QUBf5 has a ladder-pattern similar to that of the O-antigen of
enteric bacteria.14 All three strains labelled with this MAb, which confirms that
the vesicles carry outer membrane associated epitopes and indicates that they
originate from the outer membrane by budding as illustrated in Fig. 6. OMV from
each of the three strains of B. fragilis agglutinated horse and human erythrocytes.
Enzymatic activity of OMV isolated from NCTC 9343 and BE3 EDL-populations
(but not strain LS66) was compared with that of whole cells with the API ZYM
system. There was no difference in the range of enzymes produced by whole
bacteria with either the LC or EDL. The enzymic activities of strains NCTC 9343
and BE3 whole cells and OMV are indicated in Table 1.
Discussion and conclusions
The electron microscopy of ultrathin sections indicates that the vesicles are bound
by a single membrane and the MAb labelling results clearly illustrate that OMV
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Table 1 A comparison of the enzymic activity of outer membrane vesicles, large
capsule- and electron dense layer-enriched whole cells of B. fragilis strains NCTC
9343 and BE3
Enzyme Strain NCTC 9343 Strain BE3
Bacterial cells' OMV Bacterial cells' OMV
Alkaline phosphatase + + + +
Esterase + — + —
Esterase lipase + + — +
Leucine arylamidase + — + —
Acid phosphatase + + + +
Phosphohydrolase + + — +
a-Galactosidase + + + —
/i-Galactosidase + + + +
^-Glucuronidase + — — +
a-Glucosidase + + + +
Glucosaminidase + + + +
a-Fucosidase + — + —
Activity of the following enzymes was not detectable with the API ZYM system; lipase, valine
arylamidase, cystine arylamidase, trypsin, chymotrypsin, /f-glucosidase, a-mannosidase.
'Large capsule and electron dense layer cells had the same enzyme profile.
carry epitopes associated with the outer membrane of B. fragilis. Whether or not
there is peptidoglycan present is unknown, although previous reports of similar
structures observed in other bacteria indicated that they are lacking in
peptidoglycan.19 The results also indicate a potential role for OMV in the
pathogenesis and virulence of B. fragilis. The HA and enzymic activity of the OMV
suggests that they may be able to attach to host cells and subsequently attack
the host cell enzymatically. Enzymic activity associated with OMV is well
documented in Porphyromonas {Bacteroides) gingivaIis which is associated with
perdiodontal disease.2123 Previous work has documented a range of enzymic
activity for B. fragilis in relation to the activity of B. fragilis in the normal intestinal
flora,17,18 a potential means for the rapid identification of B. fragilis20 and a possible
role in virulence.15 A precise relationship between the production of these enzymes
and virulence, however, remains to be determined. There are reports that
neuraminidase activity may have a role in attachment to mammalian cheek
epithelial cells, the human cell line Intestine 407 and agglutination of erythrocytes
of unspecified origin, whereby the neuraminidase exposes a receptor for a B.
fragilis ligand.16 In contrast, Namavar et at. did not find a correlation between
neuraminidase activity and attachment to the colon derived tissue culture cell
line WiDr or agglutination of chicken erythrocytes.24 As the glycosylation of
peptides and lipids will vary between different species and different tissue-types
within one species, resulting in different glycotypes of the same peptide or lipid,25
it may be that the B. fragilis ligand receptors of the cell-types used in these two
studies differ in the degree of sialylation of the oligosaccharides. As the role of
oligosaccharide moieties in the regulation of the activities of host cells and
molecules becomes more apparent, the role of B. fragilis extracellular enzymes
in virulence may become clearer. In a study of B. fragilis which had been
mutagenized in the nanH neuraminidase gene, deletion mutants did not grow as
well as the wild-type in a rat pouch model of infection. NanH insertion mutants,
capable of reversion to NanHh, did so after 48 h infection.26 It will be of interest
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to obtain a more detailed picture of the complete enzymic activity associated with
OMV and their potential role in virulence.
The ability of OMV to agglutinate erythrocytes may be important, not only in
terms of the putative role of OMV in virulence, but also in relation to experimental
studies of attachment. In studies of the attachment of B. fragilis to host cells,
where attachment is monitored by counting of attached bacteria, it is imperative
that the quantities of OMV present in suspensions of bacteria are closely
monitored. OMV attaching to host cells could block attachment sites and therefore
may give false negative results for the potential adhesion of B. fragilis to host
cells and surfaces.
The results indicate that haemagglutination by the EDL population is mediated by
carbohydrate moieties as haemagglutinating activity was destroyed by periodate
treatment for 30min. The epitopes recognized by the high molecular mass
polysaccharide specific MAbs were also periodate sensitive; however, although
OMV labelling was destroyed, labelling of bacterial cells was of reduced intensity,
but not completely destroyed after periodate treatment for 60min. The effect of
sodium periodate treatment on HA by OMV remains to be determined. HA
inhibition experiments with hybridoma culture medium containing these MAbs
were inconclusive as foetal bovine serum, present in the hybridoma growth
medium, inhibited HA by B. fragilis EDL-population.27 Therefore the role of the
epitopes recognized by these MAbs in HA remains to be resolved. The LC
apparently masks a haemagglutinin as this population haemagglutinated after
removal of the LC by ultrasonication. ittherefore appears that there is the potential
for variation within B. fragilis strains from bacteria with a large capsule in which
the haemagglutinin is masked to bacteria with the electron dense layer in which
the haemagglutinin is exposed.
In conclusion, these results highlight the importance of using bacterial
populations which are well defined in terms of not only the types of encapsulating
surface structure but also in terms of the presence of OMV in studies of attachment
to host cells. Possible roles of OMV in virulence include their ability to disseminate,
not only enzymic activity but also possibly toxic activity in the host, both in terms
of enterotoxins and endotoxin, whereby the vesicle may penetrate epithelial
barriers impermeable to bacterial cells. The association of endotoxic activity with
OMV is reported in other species such as Actinobacillus actinomycetemcomitans,28
OMV associated LT-toxin of Escherichia coli has also been reported.29 The release
of OMV may prove to have important implications for the pathogenesis of B.
fragilis as the biological activities of B. fragilislPS appear to be more extensive than
early reports in the literature indicate,30-31 and also in relation to enterotoxigenic B.
fragilis strains.32
The present study raises the possibility that OMV could act as packets of
enzymes with the ability to attach to host cells. Whether in so doing they have
an impact on the activities of the host cell and/or the nutrition of B. fragilis in
vivo, and contribute to the pathogenesis of B. fragilis, remains to be determined.
Materials and methods
Bacterial strains and culture methods. The strains used were B. fragilis NCTC9343
(National Collection of Type Cultures, Colindale Avenue, London, U.K.), LS66 (clinical isolate
from an abdominal abscess, Craigavon Area Hospital, Northern Ireland, U.K.)5 and BE3
(kindly supplied by DM MacLaren, Free University of Amsterdam, NL). Bacteria were grown
200 S. Patrick et al.
in minimal defined medium (MDM) broth which contained, per litre, (NH4)2S04, 2 g; sodium
citrate, 0.5 g; vitamin B12, 5 mg; KH2P04, 7 g; K2HP04, 8 g; MnCI2.4H20, 10 mg; MgCI2.2H20,
20 mg; FeCI3.6H20, 0.3 mg; CaCI2.2H20, 30 mg; NaHC03, 4g; cysteine HCI, 0.5 g; glucose,
10 g; haemin, 5 mg; and resazurin, 1 mg.11 Cultures were incubated in an atmosphere of
H2 (10%), N2 (80%), C02 (10%) in an anaerobic cabinet (MK III Don Whitley Scientific).
Identification was confirmed with the API20A system. Bacterial populations, enriched for
eitherthe large capsule (LC) or electron dense layer (EDL; non-capsulate by light microscopy)
by Percoll (Pharmacia) discontinuous density-gradient centrifugation12 were prepared for
all three strains.
Electron microscopy of ultrathin sections. Bacterial fixation and staining were carried
out as previously described.33 Briefly, preparations were fixed in glutaraldehyde (2.5% v/
v) in cacodylate buffer (0.1 m; pH 6.8) for 1 h at 4°C in the dark, followed by osmium
tetroxide (1% w/v) in cacodylate buffer for 3 h at room temperature in the dark. Ruthenium
red stain (1 mg/ml) was included at both fixation stages. After dehydration in a graded
series of alcohols the preparations were embedded in Spurr or LR white resin.
Preparation of outer membrane vesicles. Late exponential-phase EDL-enriched B. fragiiis
strains NCTC 9343, BE3 and LS66 cultures in MDM broth (20 ml) was centrifuged at 7245 x g
in an MSE High Speed 18 Centrifuge to pellet the bacterial cells. The supernatant fraction
was drawn off and washed twice by centrifugation at 30790 x g in a Beckman L5-50B
ultracentrifuge. The supernatant fraction was removed and the pellet was resuspended in
1 ml of either phosphate buffered saline (0.01 m), pH 7.4 (PBS) or 0.15 m NaCI (saline). The
presence of OMV and the absence of bacteria was confirmed by light microscopy and
electron microscopy. Preparations for electron microscopy were either negative-stained
directly using methylamine tungstate 2% w/v in distilled water or after immunogold
labelling. Suspensions in distilled water were applied to Formvar/carbon coated nickel
grids. For immunolabelling, the grids were then placed sequentially in (i) bovine serum
albumin (BSA; 1% w/v) in PBS, for 15min, (ii) hybridoma culture supernatant for 2 h, (iii)
BSA (0.1% w/v) in 20 mm Tris-HCI saline, pH 8.2, (TBS) prior to washing in a stream of
drops of TBS (total volume approximately 8 ml), (iv) BSA-TBS (1% w/v) for 15 min, (v) anti-
mouse gold conjugated antibody (Janssen) for 2 h, (vi) washed as in (iii) in BSA-TBS
(0.1% w/v) followed by distilled water. The grids were observed with a Phillips CM10
electron microscope. All incubations were carried out at room temperature.12'14-34
Ultrasonic treatment. Bacterial suspension (1 ml) of approximately 3 x 109cfu/ml in PBS
was sonicated in an MSE 150 soniprep for various time periods at an amplitude of 5 /im
in an Eppendorf 1.5 ml plastic centrifuge tube. After ultrasonic treatment the sample was
centrifuged at 7245 x g, the supernatant fraction removed and the pellet resuspended in
PBS. The bacteria were negatively stained with eosin/carbol fuchsin. A loopfull of bacterial
culture was applied to a clean dry slide and mixed with a loopfull of carbol fuchsin (Ziel-
Nielsen's carbol fuchsin diluted 1:5) and allowed to stand for 30 s. This was then mixed
with a drop of eosin staining solution (four parts water-soluble yellowish or bluish erythrosin
10% w/v in distilled water to one part rabbit serum which has been heated at 56°C for
30 min) and allowed to stand for 1 min. The suspension was then spread along the slide
with a second clean slide, allowed to dry and examined by light microscopy for the
presence or absence of capsules and whole bacterial cells.12
Sodium periodate treatment. Sodium periodate (0.1 and 0.01 m in PBS) was prepared
immediately prior to use. Bacterial suspensions (approximately 2 x 109 cfu/ml) were washed
twice by centrifugation, resuspended in sodium periodate and incubated in the dark at
37°C for different time periods. Suspensions were then washed twice by centrifugation to
remove any residual sodium periodate. The absence of sodium periodate activity was
monitored by wetting starch/potassium iodide impregnated paper (Johnsons of Hendon
Ltd) with the supernatant fraction. The starch paper turns blue with sodium periodate
activity. Bacterial suspensions which were incubated in PBS without sodium periodate
were processed in parallel as a control.
Haemagglutination. Heparinized whole human blood group 0 and horse blood
erythrocytes were washed three times by centrifugation at 200 x g and resuspended to 2%
packed cell volume. Bacterial (approximately 2 x109 cfu/ml) or OMV (prepared as above)
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suspensions (20/d) in PBS were mixed with the erythrocyte suspension (20 /d) on a chilled
ceramic tile and agitated by hand. A positive result was recorded if haemagglutination
occurred within 5min. Suspensions were also examined for haemagglutination with an
inverted light microscope.
Use ofAPI ZYM kits to assess enzymatic activity. Bacterial suspensions of approximately
1 x 109cfu/ml or OMV, prepared as above, in saline (40/d) were dispensed in the cupules
of the API ZYM kit. The kits were incubated for 4 h at 37°C and reagents added according
to the manufacturer's instructions. Enzymic activity was recorded as positive if a score of
1 or greater was obtained after assessment of the colour intensity using the manufacturer's
colour chart as a guide.
Immunofluorescence microscopy. Bacterial suspensions in PBS were applied to multiweil
microscope slides, dried at 37°C and fixed in methanol at —20°C for lOmin. The bacteria
were then reacted with mouse monoclonal antibodies followed by anti-mouse
immunoglobulin G (heavy and light chain) conjugated to fluorescein isothiocyanate (FITC)
as previously described.12 Slides were examined with a Leitz fluorescence microscope.
J. McK was in receipt of a European Social Fund studentship.
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The use of temporary or permanent implants fabricated from polymeric biomaterials
within the body has increased dramatically in recent years. Unfortunately, bacteria adhere
to the surface of these medical devices, producing biofilms. Device-related infection may
result in tissue destruction, systemic dissemination of the pathogen and dysfunction of the
device, causing increased morbidity and mortality. These infections are resistant to
immune defence mechanisms and are difficult to treat with antimicrobial agents. Removal
of the device may be necessary with attendant distress to the patient and cost. Considerable
research effort is currently directed towards reducing, if not eliminating, infection of
medical devices. Strategies under investigation include the use of electric fields to improve
antibiotic therapy, physiochemical modification of the biomaterial surface to create anti-
adhesive surfaces to prevent bacterial adhesion and incorporation of antimicrobial agents
into medical device polymers.
Keywords: Medical devices; prostheses; infection; biofilm; adhesion; antibiotic resistance.
INTRODUCTION
The development of synthetic biomaterials for
temporary or permanent implantation consti¬
tutes a significant advance in modern medicine.
The increased use of medical devices such as
intravenous catheters, endotracheal tubes, uret¬
eral stents, prosthetic heart valves and ortho¬
paedic devices led Gristina to predict that
'Ultimately, almost every human in technologi¬
cally advanced societies will host a biomaterial'
[1]. Unfortunately, infection which can result in
considerable morbidity and mortality in patients
is a frequent complication associated with the
use of these devices (Table 1). Infections
associated with medical devices are typically
caused by bacteria of the normal microbiota,
such as those of the skin, and are characterized
by a low inoculum and poor response to
antibiotic therapy. We now review the factors
which affect bacterial adhesion to medical
devices and the strategies currently being
employed in an attempt to improve treatment
of such infections.
MICROBIAL ADHESION
Microorganisms have a natural tendency to
adhere to surfaces as a survival mechanism.
This can occur in any environment, not just the
living host but also, for example, in natural
aquatic environments and industrial systems.
The general outcome of bacterial colonization
of surfaces is the formation of an adherent layer,
or biofilm, composed of bacteria embedded in an
organic matrix. The organic matrix is usually
generated by the bacteria, although within the
environment of the living host it is possible that
material derived from the host will also be
present.
It has been suggested that bacterial adhesion to a
surface occurs in a sequential manner, being
Address for correspondence: Michael Tunney, Department of Microbiology and Immunobiology, School of Clinical Medicine,
Royal Victoria Hospital Site, The Queen's University of Belfast, Grosvenor Road, Belfast BT12 6BN, UK.
0954-139X © 1996 Rapid Science Publishers
196 TUNNEYet at.
Table 1. Infection rates associated with implanted medical devices
Medical device Incidence of infection
(%)
Orthopaedic prostheses 1-2






S. aureus, S. epidermidis, E. coli, Propionibacterium acnes,
Bacteroides fragilis
S. aureus, S. epidermidis
Ps. aeruginosa, S. aureus, £. faecaiis, Candida spp
S. epidermidis, Ps. aeruginosa
Enterococcus spp. S. aureus, E. co/i
S. epidermidis, S. aureus
influenced by both physical and chemical factors
[2], These may include the properties of the
material surface as well as the nature of the
molecules adsorbed onto the surface from the
surrounding fluids to form a layer termed the
conditioning film. Although no irrefutable
theory has been developed to explain the
fundamental mechanisms of bacterial adhesion,
most hypotheses recognize four phases in the
process (Fig. 1).
Microorganisms may arrive at the surface of a
medical device via a number of different routes:
introduction during the insertion of a medical
device, transient bacteraemia, or through the site
of exit of the medical device from the body.
Attachment phase 1 involves movement of the
bacteria to the device surface by either Brownian
motion or bacterial chemotaxis and motility.
This is followed by phase 2, requiring initial
adhesion according to the DLVO (Derjaguin and
Landau, Verwey and Overbeek) theory. At a
distance of approximately 50 nm the bacterium
will be attracted to the surface by van der Waals'
forces. Frequently, both the bacterium and
device polymer possess the same charge and,
therefore, the electrostatic repulsive force
becomes higher the closer the bacterium moves
to the surface. These forces, acting in concert,
govern the long-range interactions between the
bacterium and the device surface. Closer to the
surface are two regions where the attractive
forces are greater than the repulsive forces. These
are called the secondary minimum, which occurs
at approximately 10 nm from the surface, and the
primary minimum, at approximately 1 nm from
the surface. These are separated by a maximum
energy barrier where repulsive forces predomi¬
nate. Bacterial adhesion at the secondary mini¬
mum is reversible, and bacteria may become
detached as a result of fluid shear forces.
Bacterial surface structures, such as fimbriae,
flagella or surface polysaccharides, are thought
to play a key role in the ability of some bacteria
to overcome this maximum energy barrier and
thus allow the bacteria to reach the primary
minimum [2], These bacterial structures are
sometimes termed 'bridging polymers'. When
the bacterium reaches the primary minimum,
adhesion becomes irreversible.
At phase 3, specific interactions, involving
bonding (covalent, ionic and hydrogen), occur
between the surface and the bacterium.
In phase 4, colonization occurs, with the attached
bacteria synthesizing and secreting a variety of
exopolymeric substances of which extracellular
polysaccharides (EPS) account for approximately
90% of the mass. The bacteria become encased in
this material, which is sometimes referred to as
the glycocalyx. Further bacterial cell division
produces microcolonies within the matrix. Under
suitable conditions, a continuous biofilm rapidly
becomes established (Fig. 2). Extensive biofilm
has been identified on endotracheal tubes
retrieved from patients in intensive care after
only 24 hours intubation [3]. The biofilm may
subsequently be enlarged by the attachment of
more free-living bacteria from the surrounding
fluid medium along with bacterial replication
and exopolysaccharide production.
The clinical impact of microbial adhesion to
biomaterials is that a formed biofilm may result
in tissue destruction, dysfunction of the pros¬
thetic device and systemic dissemination of the
pathogen. Within the biofilm, the bacteria may
be protected from the host defences and the
action of antimicrobial agents. These infections
are therefore difficult to treat and this may
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PHASE 1 PHASE 2 PHASE 3 PHASE 4
BIOMATERIAL
Fig.l. Schematic diagram of bacterial adhesion to a biomaterial surface. Phase 1: transport of bacteria to the biomaterial
surface. Phase 2 (boxed inset): A, attractive van der Waals forces overcome repulsive electrostatic forces and the bacteria
move closer to the surface; B, bacteria at secondary minimum (dotted line) adhere reversibly to biomaterial surface; C,
bacteria use fimbriae (or bridging polymers) to overcome the energy barrier and reach the primary minimum (dashed line)
where adhesion is irreversible. Phase 3: bonding of bacteria to surface. Phase 4: colonization of surface and formation of a
bacterial biofilm.
Fig. 2. Scanning electron micrograph of a bacterial biofilm on a retrieved ureteral stent.
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necessitate removal of the device. Gristina and
Costerton [4] described that, in 19 of 25 patients
with medical device-related infection, the causa¬
tive bacteria grew in glycocalyx-enclosed bio-
films adherent to the surface of the biomaterial.
The most common pathogens isolated in the
study were Staphylococcus aureus, Pseudomonas
aeruginosa and Escherichia coli. They concluded
that microbial adherence and biofilm growth
were fundamental to infection involving bio-
materials, and that it may be a factor in the
susceptibility to infection of patients with
implanted devices.
Bacteria have been isolated from within biofilms
on the surfaces of a wide variety of medical
devices, including urinary catheters/stents, con¬
tinuous ambulatory peritoneal dialysis (CAPD)
catheters, endotracheal tubes and orthopaedic
prostheses [5]. The bacteria most commonly
isolated from within these biofilms are S.
aureus, S. epidermidis, E. coli and Ps. aeruginosa
(Table 1).
Several studies have recently examined biofilm
formation on ureteral stents. Reid et al [6] found
that of 30 retrieved ureteral stents, 90% had
adherent pathogens on the surface, of which 45%
were present in low numbers (101-102 adherent
organisms cm-3 of suspending buffer), and 55%
were present in small and large microcolony
biofilms (>2xl02-107 adherent organisms
cm-3). The organisms isolated were mainly
Gram-positive cocci with a smaller number of
Gram-negative rods. While no association was
found between the presence of bacterial biofilm
and the development of symptomatic infection,
the adherent organisms were isolated despite
prophylactic antimicrobial therapy being given
to all the patients. In another study of 40
retrieved ureteral stents, a profuse biofilm
(>104 cfu cm-2 of stent surface) was present
on 28% of stents [7]. Gram-positive cocci
accounted for seven of the 13 organisms isolated;
Enterococcus spp for five of the isolates and S.
aureus for two. Gram-negative rods isolated
included E. coli (two isolates) and Ps. aeruginosa
(one isolate). The ureteral stents in this study
were also colonized by bacteria despite the use of
a peroperative antibiotic in every patient at stent
insertion. Gorman et al [8] reported that a viable
microbial biofilm was present on 25 of 32
Tenchkoff catheters retrieved from CAPD
patients. The most commonly isolated bacteria
in this study were coagulase-negative staphylo¬
cocci (in particular, S. epidermidis), S. aureus and
Ps. aeruginosa. Fitzgerald [9] reported that 1-5%
of indwelling hip prostheses became infected,
whereas Nasser et al [10] reported that the
incidence of infection is approximately 1% over
the lifetime of the hip prosthesis. The most
commonly isolated bacteria in these studies
were S. aureus, S. epidermidis and Ps. aeruginosa.
It is likely, however, that the incidence of
obligately anaerobic bacteria, particularly in
prosthetic-joint infection is underestimated [11].
Factors which influence adhesion
It is generally accepted that three important
components are involved in the initial adhesion
process to biomaterials: bacteria, suspending
fluids and substrata.
Bacteria
Bacterial cell-surface components, such as fim¬
briae and polysaccharides, are considered to
promote adhesion to surfaces. Filamentous
structures extending from the bacterial cell
surface, for example fimbriae or polysaccharides,
may help to initiate attachment by bridging the
electrostatic repulsive forces at the surface of the
device [2], as discussed above. Exopolysacchar-
ide production may therefore be critical to
biofilm formation during both the period of
initial interaction of the bacterium with the
surface to be colonized and during the later
stages of biofilm formation. Clearly, an under¬
standing of the nature and control of expression
of these molecules is central to our under¬
standing of the factors which influence biofilm
formation. In particular, it is clear that not only
are bacterial polysaccharides complex in terms of
their structure and components, their production
is variable both between and within strains [12,
13] and may be subject to both phenotypic and
genotypic variation. It is likely that different
polysaccharides produced by an individual
strain of bacteria may be involved at different
stages of the attachment process. This topic is
reviewed in depth by Allison [14],
Specific interactions between bacterial surface
molecules and host cell surfaces are well
documented [15] and it is likely that similar
interactions occur between bacteria and host
components which may coat the surface of an
implanted device (see below).
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Suspending fluids
On implantation in the body, medical devices are
usually surrounded by suspending fluids such as
urine, blood, saliva and synovial fluid. These
body fluids contain various proteins such as
fibronectin, laminin, fibrin, collagen and
immunoglobulins which are almost immediately
coated onto the biomaterial surface to form the
conditioning film [16]. Bacteria may possess
binding sites for glycoproteins and proteoglycan
within the conditioning film, thereby promoting
their adhesion (see above). Whether or not the
biomaterial is colonized by bacteria or host cells
may depend on which first contacts the
biomaterial, or which one is a better competitor
for the surface. Cheung and Fischetti [17]
showed that fibrinogen or fibrin is the dominant
plasma mediator of staphylococcal adherence to
intravascular catheters. Gorman et al [18]
showed that the formation of a conditioning
film on polyurethane and silicone peritoneal
catheters by pre-treatment with artificial spent
dialysate significantly reduced bacterial adher¬
ence to their surfaces.
The conditioning films formed on ureteral stents
have been recently described [19]. An examina¬
tion of the surface of retrieved stents by X-ray
photoelectron spectroscopy revealed the pres¬
ence of adsorbed nitrogen, and in some cases
calcium and phosphate. Energy dispersive X-ray
analysis confirmed the presence of calcium,
magnesium, phosphorus and carbonate apatite
crystals. The changes in surface composition
were not thought to be due to leaching or
degradation as scanning electron microscopy
(SEM) showed deposits on the surface of the
material. The authors also described an in-vitro
study in which a stent incubated in urine for 24
hours had an adsorbed conditioning film,
making its surface quite different from a control
stent which had not been incubated in urine.
The variable composition of the suspending fluid
is also thought to have an impact on bacterial
adhesion. For example, within the urinary tract,
electrolytes, pH, urea and creatinine concentra¬
tions have all been shown to affect the adhesion
process. Reid et al [20] showed that an
environmental pH in the range 5-8 and a low
urea concentration increased adherence. In a
similar study [21], it was shown that adhesion
of S. epidermidis was significantly increased in the
presence of magnesium and calcium, but sig¬
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nificantly decreased in the presence of the
chelating agent ethylenediaminetetraacetic acid.
Altered in-vitro adherence of coagulase-negative
staphylococci to surfaces has been demonstrated
if the organisms are grown in an environment
equilibrated with 5% CO2 [22], Similarly, Bonner
et al [23] described a significant increase in the
adherence of a ureteral stent biofilm isolate,
Enterococcus faecalis, to polyurethane when it was
grown in an atmosphere equilibrated with 5%
co2.
Substrata
As with the bacterial and fluid components,
there are certain properties of a biomaterial that
can influence adhesion and biofilm formation
[24],
Although a biomaterial surface may appear
smooth to the naked eye, SEM invariably
shows it to be uneven and possessing irregula¬
rities. These defects have often been thought to
provide niches for bacterial adhesion. Reid et al
[25] showed by SEM that the surface of urinary
catheters was uneven. Similarly, Gorman et al
[26] showed by confocal laser scanning micro¬
scopy that the surface roughness or microrugos-
ity of peritoneal catheters increased during
implantation, and that adherence of S. epider¬
midis to these rough catheters was significantly
greater than to unused (control) catheters.
Factors which may be involved in the production
of increased roughness during medical device
implantation may include shear forces arising
from fluid dynamics and host or bacterial
degradation of the device biomaterial. In both
studies, the authors suggested that surface
irregularities could offer attachment points for
infecting bacteria. Bacterial adherence to mater¬
ials of different surface microrugosity has been
investigated. An experimental polymer
(Vivathane) which had an extremely smooth
surface, was shown to prevent bacterial adher¬
ence and biofilm formation when used as a
biliary stent [27], In contrast, C-Flex and
polyethylene stents which were shown to have
surface irregularities were colonized easily by
bacteria, and the lumen became blocked after 6
and 10 days, respectively.
The influence of bacterial and biomaterial surface
hydrophobicity on microbial attachment remains
unclear. Illustrating this problem, a hydrophilic
E. coli isolate and a hydrophobic S. aureus isolate
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showed no difference in adherence capability to
either hydrophobic latex or hydrophilic polymer-
coated urinary catheters [28]. In contrast to the
results of this study, Roberts et al [29] showed
that hydrophobic bacteria did not adhere to a
hydrophilic catheter surface, however, Reid et al
[30] reported that adherence of Lactobacillus
acidophilus to polymer surfaces increased with
increasing hydrophobicity of the surface, but in
further work, Reid et al [31] reported that a
conditioning film is rapidly deposited on a
biomaterial on insertion in the body, altering its
surface properties. They therefore suggested that
it was misguided to assume that surface hydro¬
phobicity measurement prior to device insertion
was relevant to bacterial adhesion in vivo.
ROLE OF THE BACTERIAL
GLYCOCALYX
Apart from its adherent properties, which have
been described previously, a number of roles
have been suggested for the bacterial glycocalyx.
These include resistance to antibiotic therapy,
attenuation of the host response and retention of
host nutrients.
Treatment of biomaterial-associated infection is
extremely difficult because, although the infec¬
tion may be temporarily controlled with large
doses of antibiotics, it quickly recurs on with¬
drawal of therapy. This problem was demon¬
strated in early work by Nickel et al [32] who
reported tobramycin resistance of Ps. aeruginosa
grown on Silkolatex catheter material. Free-
living cells of Ps. aeruginosa were shown to be
completely killed by 50 pg ml-1 of tobramycin.
Discs of catheter material were then exposed to
the flow of artificial urine containing cells of Ps.
aeruginosa. A thick adherent biofilm formed on
the surface of the discs after 8 hours, and a
significant number of cells within the biofilm
were found to be still viable after 12 hours of
exposure to 1000 pg ml-1 of tobramycin. After
dispersal of the biofilm into a culture medium,
the cells were again killed by 50 pg ml-1 of
tobramycin. The results of this study suggested
that the organism did not develop resistance to
tobramycin as a results of genotypic changes but
rather that growth within the biofilm conferred a
level of resistance to antibiotics. The exact
mechanism for this antimicrobial resistance
remains controversial. Initially, it was thought
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that the glycocalyx could act as a simple
diffusion barrier to inhibit the access of antibiotic
molecules to the bacterial cell [33]. Alternatively,
it was suggested that the negatively charged
glycocalyx could bind positively charged anti¬
biotic molecules, such as those of the amino¬
glycoside group [34]. However, this could not
account for the resistance to neutral and
negatively charged antibiotics. More recently,
Nichols [35] suggested that antimicrobial resis¬
tance was not due to low permeability but due to
the production of extracellular enzymes such as
/^-lactamase, which can inactivate antibiotics
diffusing into the biofilm, thereby reducing the
concentrations reaching the bacteria positioned
closer to the material surface. Adding support to
this theory, Giwercman et al [36] demonstrated
that Ps. aeruginosa growing in a biofilm adherent
to catheter material can produce 32 times more
^-lactamase than the same cells in suspension,
and therefore has a greater potential to inactivate
antibiotics than do the suspended microorgan¬
isms. Compounding this problem of biofilm
resistance, Naylor et al [37] and Costerton et al
[38] have both suggested that antibiotic resis¬
tance is fundamentally a feature of phenotypic
alterations of bacterial metabolism which occurs
as a result of bacterial growth within a biofilm.
Production of a bacterial glycocalyx may also act
to impede the host immune system. Peters et al
[39] showed that the production of glycocalyx by
S. epidermidis interfered with the normal phago¬
cytic function of polymorphonuclear leukocytes,
decreased production of T and B cells and
inhibited immunoglobulin production.
Other work has shown that the glycocalyx can
optimize growth conditions by retention of
nutrients such as iron close to cell surfaces and
it may also act as a barrier against iron
sequestering proteins of the host such as
lactoferrin and transferrin [40],
PREVENTION AND TREATMENT OF
BIOMATERIAL-RELATED INFECTION
Given the persistent nature of biomaterial-
centred infections and the possible severe
consequences for the individual patient, mea¬
sures to prevent such infections are urgently
needed [41]. Long-term oral antibiotic therapy
has not been shown to be effective in preventing
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such infections, and, indeed, has been shown to
have a detrimental effect on the normal flora
with development of resistant organisms. Strat¬
egies which have evolved for the treatment of
biomaterial-related infections include improved
antibiotic therapy, physicochemical modification
of the biomaterial surface to create anti-adhesive
and hence anti-infective surfaces, and coupling
or incorporation of antimicrobial agents to or
into polymers to prevent bacterial colonization.
Improved antibiotic therapy
Growth of bacteria within a biofilm on the
surface of a medical device confers a level of
resistance to antibiotics, which may render
conventional antibiotic therapy ineffective [32],
Several studies have described recent develop¬
ments which have attempted to overcome this
problem and improve antibiotic efficacy.
The inherent resistance of biofilm bacteria to
antibiotic therapy can be overcome when the
antibiotic is used in the presence of a relatively
weak electrical field. Recent work in this novel
area has described how the presence of an
electrical field lowered the concentrations of [I-
lactams, amines and macrolide antibiotics
required to kill biofilm bacteria [42], The authors
suggested that the weak electrical field may
drive the antibiotic through the biofilm matrix.
In a related study, Davis et al [43] reported that
iontophoresis (compound delivery by charge)
with gold, carbon and platinum electrodes
effectively reduced or eliminated both Gram-
positive and Gram-negative inocula in synthetic
urine.
Another strategy which has been employed to
improve antimicrobial activity is the use of a
surface-active agent in association with an
antibiotic. In a recent study, Soboh et al [44]
described the use of a polycationic protein,
protamine sulphate, in combination with the
fluoroquinolone, ciprofloxacin, against a clinical
isolate of Ps. aeruginosa. Protamine sulphate (50
pg ml-1) combined with ciprofloxacin (0.5 pg
ml-1) reduced the number of viable cells by 99%,
whereas protamine sulphate or ciprofloxacin
alone resulted in an 108% increase and 59%
decrease respectively, after 24 hours. The
observed synergistic effect was considered to be
due to protamine sulphate denaturing the
glycocalyx, thereby enhancing ciprofloxacin
penetration through the biofilm or, alternatively,
due to an alteration in membrane permeability
and a dilation of ionic channels by protamine
sulphate which facilitated transport of ciproflox¬
acin to the cytoplasm.
Physicochemical modification of the
biomaterial surface
Surface modification of a biomaterial may lead to
altered surface properties and thus to altered
interactions with proteins and microbial cells.
Surface functional groups may be introduced
that possess inherent antimicrobial activity and
to which antimicrobial substances can be
attached or coupled.
Jansen et al [45] described how the radiation
modification of polyurethane by the hydrophilic
substance, hydroxyethyl methacrylate, rendered
the polyurethane surface hydrophilic and sig¬
nificantly reduced the adhesion of two coagulase-
negative staphylococcal strains. Bridgett et al [46]
also showed that coating a silicone cerebrospinal
shunt catheter with Hydromer, a hydrophilic
material which creates a hydrophilic layer on
the shunt surface, significantly reduced the
adherence of five strains of S. epidermidis and
one strain of S. aureus. The authors suggested that
the reduction in adherence may have been due to
a weakening of hydrophobic interactions
between the polymer surface and the bacterial
cell surface.
Humphries et al [47] described how the modifica¬
tion of a series of surfaces using graft copolymers
prevented bacterial adhesion. The copolymers
had polyethylene glycol (PEG) side-chains and a
backbone that was either uncharged, acidic, basic
or amphoteric. The greatest reduction in adhesion
was achieved with copolymers containing the
most charged groups in the polymer backbone.
The graft copolymers were considered to be
adsorbed onto the surfaces via their backbone in
such a way that the orientation of the PEG side-
chains formed a steric barrier which inhibited
bacterial adhesion. Similarly, Bridgett et al [48]
showed that the adherence of three clinical
isolates of S. epidermidis to polystyrene surfaces
was significantly reduced when the surface was
modified using a series of 16 Pluroriic surfactants.
They suggested that the adsorption of surfactants
on the polystyrene surface created a sterically
stabilized surface which conferred non-specific
anti-adhesive properties. In related work, Desai
and Hubbell [49] modified polyethylene tereph-
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thalate films using poly(ethylene oxide). They
found that adherence of S. epidermidis, S. aureus
and Ps. aeruginosa was significantly less on the
surface-modified films and they believed that this
was due to a reduction in fibrinogen adsorption
to these poly(ethylene oxide)-treated surfaces.
The cationic surfactant tridodecylmethylammo-
nium chloride (TDMAC) has been used to bind
antibiotics to catheter surfaces. For example,
Trooskin et al [50] showed that the binding of
penicillin to peritoneal catheters pre-treated with
TDMAC significantly reduced adherence of S.
aureus. Similarly, Kamal et al [51] described how
the binding of cefazolin to TDMAC pre-treated
intravascular catheters significantly reduced
infection in situ.
Incorporation of antimicrobial agents
Possibly the most effective way of inhibiting
bacterial growth is by incorporating antibacterial
agents either directly into the polymer, or into a
coating which can then be applied to the
polymer. If such polymer/antimicrobial agent-
systems are brought in contact with an aqueous
medium, the drug should be released, providing
a high local concentration surrounding the
polymer. These devices should be able to prevent
bacterial adhesion to the polymer surface and
eradicate any adherent organisms present on it,
thereby preventing further colonization and
infection (Fig. 3).
To date, the incorporation of antimicrobial
agents, in particular antibiotics, into hydrogel-
coated medical devices has been conducted very
much on an ad hoc basis by many clinicians. A
variety of antibiotics and antibacterial agents
have been used in this manner, with mixed
results. The first attempt to incorporate an
antibiotic into a catheter was described by
Lazarus et al [52], wherein cephalothin was
imbibed into Hydron, a hydrophilic polymer,
which was then used to coat the surface of latex
Foley catheters. A significant reduction in
bacteriuria was observed with the cephalothin-
releasing catheters, compared to control cathe¬
ters, in a clinical trial involving 60 patients.
Unfortunately, other clinical studies to determine
the efficacy of the coated catheter concluded that
it did not significantly reduce bacteriuria and
was, therefore, of no potential benefit to the
patient [53, 54]. More recently, Huaijin [55]
described a silicone catheter with kanamycin
incorporated into the tip. A significant reduction
in the associated infection rate resulted with this
tip and it was also reported that therapeutic
levels of kanamycin were maintained in the
urine for a period of 20-24 days post-insertion.
Jansen et al [56] have shown that by coating
polyurethane intravascular catheters with
Hydrocath, a hydrophilic poly-N-vinylpyrroli-
done coating, an antibiotic may also be incorpo¬
rated. Teicoplanin loaded into the catheter was
shown to be released in large amounts for up to 5







Fig. 3. Schematic diagram showing the effect of (A) conventional antibiotic therapy, and (B) an antibiotic-containing
polymer.
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adherent bacteria, thereby preventing catheter
colonization for at least 48 hours.
The amount of antibiotic incorporated into the
polymer and its release rate has recently been
shown to be important. Schierholz et al [57],
investigating rifampicin incorporation into cere¬
brospinal fluid shunts, concluded that foreign
body infection could be prevented only if the
drug were released in the environment of the
implant over a long period of time and at a
concentration exceeding the minimum bacterici¬
dal concentration of the infecting organism.
There are conflicting reports as to the effective¬
ness of ciprofloxacin-loaded catheters in prevent¬
ing bacterial adherence and subsequent
infection. Reid et al [58] showed in vitro that
pre-incubation of silicone catheters with cipro¬
floxacin resulted in a 99% reduction of adherent
Ps. aeruginosa cells in comparison with the
reduction on control catheters. However, in
another study Stickler et al [59] showed that if
Ps. aeruginosa was suspended in urine, equal
colonization of both ciprofloxacin-loaded and
control catheters occurred.
Antibiotics have also been incorporated into
polymethylmethacrylate bone cement to prevent
infection developing after a primary joint
replacement. Buchholz et al [60] reported that
incorporation of antibiotics into the bone cement
significantly reduced the risk of infection after a
total hip replacement.
A variety of antimicrobial agents other than
antibiotics have been examined in an attempt to
prevent microbial adherence to urinary catheters.
An in-vitro study has shown that silver-coated
catheters are effective in preventing Ps. aerugi¬
nosa adherence [61]. The result of this work has
been confirmed by the results of several clinical
trials. Liedberg et al [62] showed that, in a trial
involving 90 patients, bacteriuria after 5 days
catheterization was significantly less in patients
who had silver-coated catheters inserted. In
another clinical trial, a silver oxide-coated
catheter was shown significantly to lower the
incidence of urinary tract infection in women not
receiving antimicrobial therapy [62], The anti¬
microbial activity of silver is thought to be due to
the release of silver ions which have a broad
spectrum of activity, which includes anaerobic
organisms. It has been suggested that the silver
ions act by binding to bacterial DNA or to the
bacterial membrane [61]. Other agents which
have been shown to be effective in preventing
bacterial adherence to biomaterials include non¬
steroidal anti-inflammatory drugs, methyl and
propyl parabens, iodine, tantalum and chlorhex-
idine in conjunction with silver sulphadiazine.
CONCLUSION
Bacteria are highly adaptive organisms, and
implanted devices provide attractive surfaces
for colonization with a subsequent increased
risk of device-associated infection. Therefore, as
Gristina concluded, 'Biomaterial surfaces must
be modified to improve compatibility and tissue
integration and to resist microbial colonization in
the race for the surface' [1].
As described herein, biomaterial surface mod¬
ification can effectively reduce bacterial adhe¬
sion; however, it remains unclear which strategy
is most effective. Several studies have shown
that physicochemical modification of a biomater¬
ial surface can effectively reduce bacterial
adhesion [44-46]. On the other hand, Reid et al
[31] suggested that this approach was inap¬
propriate as the modified biomaterial surface
would be rapidly coated by a conditioning film
on insertion in the body, thus altering the surface
characteristics again. Harkes et al [63] also
concluded that physicochemical modification of
the surface would not prevent bacterial adhesion
and suggested that incorporation of antimicro¬
bial agents directly into the polymer would be
more effective. Further current research involves
the use of techniques such as ion implantation
and chemical vapour deposition to create
surfaces which promote macromolecular and
tissue integration, rather than allowing microbial
colonization. In addition, the coating of bio¬
materials with healthy tissue cells prior to
implantation may promote tissue integration
and prevent bacterial adhesion; however, the
success or otherwise of such a strategy would be
dependent upon the virulence determinants of
the infecting bacteria.
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ABSTRACT
Bacteroides fragilis is a component of the normal commensal colonic flora
of all adult humans and is the most common Gram negative obligately
anaerobic bacterium isolated from clinical specimens. Within an individual
strain three encapsulating surface structures ofdifferent morphologies can be
observed by electron microscopy, namely a large capsule, small capsule and
electron dense layer. Although morphologically distinct, the large capsule
and electron dense layer have shared polysaccharide epitopes, which are
absent in the small capsule. High molecular mass polysaccharide specific
monoclonal antibody-labelling of populations enriched for either the large
capsule or electron dense layer reveals antigenic variation within these
populations. These high molecular mass polysaccharides are therefore not
ideal targets for the immunodiagnosis of B. fragilis in clinical specimens. In
contrast the common antigen may prove to be a suitable target.
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INTRODUCTION
Within-strain variation of bacterial surface structures, in terms of their
presence or absence {phase variation), as well as antigenic variation of
individual structures, are well documented phenomena in a number of
pathogenic bacteria where it appears that this ability is directly linked with
virulence [1,2]. Such variation enables the bacterium to cope successfully
with the unique environment of the living host, which unlike other
environments is not passive, but is actively trying to prevent colonisation
with an array of defensive mechanisms. An understanding of the complexity
of bacterial surface structure variation is important in relation to our
understanding of the virulence of bacteria and therefore our long-term ability
to treat disease. In the short-term, the identification of stable, as opposed to
variable, antigens is necessary if the potential for the immunodiagnosis of
bacteria using antibodies specific for surface structures is to be fully
developed. Equally, where the generation of structural variation involves
genetic rearrangements, the identification of stable DNA sequences is a
necessity if genetic probes for virulence genes are to be used for bacterial
identification.
Variation in the expression of capsules within individual strains of
Bacteroides fragilis has been long recognised [3], although the implications
of this with regard to the virulence of the bacterium and the potential for the
immunodiagnosis of the bacterium have perhaps not been given due
attention.
BACTEROIDES FRAGILIS PRODUCES THREE
MORPHOLOGICALLY DIFFERENT CAPSULES
Bacteroides fragilis is capable of producing three morphologically different
encapsulating surface structures: 1) a large capsule (LC), visible by both light
and electron microscopy, 2) a small capsule (SC) visible by both light and
electron microscopy and 3) an electron dense layer (EDL), only visible by
electron microscopy (Figure 1). All of these structures may be produced by
an individual B. fragilis isolate[4]. Populations can be enriched for these
structures by Percoll step density gradient centrifugation on a gradient
composed of 80%, 60%, 40% and 20% suspensions of Percoll[5]. Bacteria
with large capsules remain on top of the gradient, bacteria with a small
capsule are found at the 20-40% interface, and bacteria with an electron
dense layer at the 60-80% interface. The bacteria at the 40-60% interface are
a mixture of those with small capsules and those with an electron dense layer.
The enriched populations retain their capsular types after sub-culture from
the interface layers into broth culture overnight. Sub-cultures re-applied to
the Percoll gradient band predominantly at the relevant interface and
microscopy reveals the enriched populations.
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Fig. 1 Electron micrographs of ultrathin sections of Bacteroides fragilis
illustrating encapsulating surface structures a) large capsule, b) small capsule
and c) electron dense layer.
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BACTEROIDES FRAGILIS CAPSULES ARE ANTIGENICALLY
VARIABLE
Monoclonal antibodies (MAbs), specific for high molecular mass
polysaccharides, give different labelling patterns after polyacrylamide gel
electrophoresis and immunoblotting of polysaccharide extracts (Figure 2).
MAb QUBf5 labels a ladder which is similar to the O-antigen of other Gram
negative bacteria. Other MAbs give a wide high molecular mass band and
some (e.g. QUBf7) have an associated fine ladder pattern, characteristic of
polysaccharides with varying numbers of repeating units.
Techniques such as immunogold electron microscopy, of both ultrathin
section and negatively stained whole cells, immunofluorescence microscopy
and flow cytometric analyses have shown antigenic differences both between
and within the morphologically different capsule types. The small capsule has
an epitope which is absent from the LC and EDL[6], The LC and EDL,
although morphologically different, have shared epitopes. Labelling of
populations homogeneous for the LC and EDL has also revealed antigenic
variation within these populations [7], The proportion of bacteria labelled
within the population can be quantified either by microscopy or flow
cytometric analyses. Different Mabs label different proportions of
morphologically similar populations (Table).
To determine if antigenic variation is a widespread phenomenom in B.
fragilis, twenty-five pus samples, from a range of anatomical sites, were
examined for their reactivity with 7 MAbs[8], The pus sample was labelled
and examined by fluorescence microscopy, as was the B. fragilis isolate
obtained from the specimen. Epitopes associated with the large capsule,
small capsule and electron dense layer were each detected in the infected pus.
Different pus samples were reactive with different groups of the 7 MAbs and
there was no apparent relationship between labelling with a particular MAb
and a particular anatomical site. If a pus sample was positive for a MAb, the
corresponding isolate was also positive. However, in a few instances, the pus
sample was negative and the pure culture was positive for a particular MAb.
The labelling revealed antigenic heterogeneity both within the pus sample and
the pure culture isolates; only a proportion of the bacteria in an individual
pus sample or pure culture were labelled. Three blood cultures from patients
with B. fragilis bacteraemia also labelled with varied groups of MAbs and
were antigenically variable. B. fragilis grown in vivo in a mouse model of
infection also exhibit antigenic variation of surface antigens[9].
How these antigenic variations are generated within the polysaccharides of
B. fragilis remains to be determined. Interestingly, it is known that very small
changes in the composition of a polysaccharide, for example the presence or
absence of an acetyl group, is sufficient to change the antigenicity of a
polysaccharide. Well-documented examples include K2a/K2ab, K18/K22 and
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Fig, 2 Examples of murine monoclonal antibody labelling of immunoblots of
Bacteroides fragilis polysaccharide extracts after PAGE. The blots were
reacted with MAbs QUBF 7, 18, 19 and 5 followed by anti-mouse alkaline
phosphatase conjugated antiserum. Note reactivity in the high molecular
mass region and the ladder patterns associated with QUBF5 and 7.
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Table 1. Proportion ofBacteroidesfragilis NCTC9343 population
labelled with murine monoclonal antibodies, as determined by flow
cytometric analyses.
Population
Mean percentage of population labelled by
monoclonal antibody:
QUBF4 QUBF5 QUBF6 QUBF7 QUBF8
Large capsule 9±5* 23±8 37±5 12±9 77±11
Small capsule 94±3 1±1 7±7 6±6 5±4
Electron dense layer 4±4 25±9 47±14 57±3 67±11
* standard error ofmean
Table 2. Detection ofBacteroidesfragilis and related species in pus
samples





* 46 B. fragilis; 4 P. melaninogenica; 2 Bacteroides sp.;
1 B. thetaiotaomicron
** all ofthe culture positive samples were also positive for the common
antigen, with the exception ofone B. fragilis and one Bacteroides sp.
culture positive sample
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K1+/K1- capsular polysaccharides of Escherichia coli which only differ in
the presence or absence of an O-acetyl group. These slight differences in the
primary structure are sufficient to generate different epitopes[10].
The relationship between the variable high molecular mass polysaccharides
and the polysaccharides A and B described by Pantosti and colleagues [11]
remains to be determined. Inoculation of these polysaccharides into mice
gives some protection against subsequent intraperitoneal challenge with B.
fragilis (Tzianobos, this book). It would be interesting to investigate the
bacterial populations in abscesses from the small number of mice, which
although inoculated with the purified polysaccharides A and B, still develop
abscesses.
Within and between strain antigenic variation of high molecular mass
polysaccharides of B. fragilis is a phenomenon which seems to be
widespread; it can be observed in culture collection strains and recent clinical
isolates, during the course of natural infection and in a mouse model of
infection. It therefore seem likely that antigenic variation is important in
relation to the virulence of B. fragilis, particularly in relation to long-term
infection.
IMMUNODETECTION IN PUS SAMPLES AND THE
BACTEROIDES FRAGILIS COMMON ANTIGEN
Previous reports of commercially available kits for the immunodetection of
Bacteroides spp, based on pooled polyclonal rabbit serum, indicated that
they were not as successful as detection by culture[12-14]. The use of a
MAb specific for the core region of the lipopolysaccharide was also
investigated and again was less successful than identification by culture; this
Mab only labelled c. 10% of the bacteria within a given strain[15].
As a result of the inherent variation of the high molecular mass
polysaccharides and therefore the potential for low sensitivity of
immunodiagnostic tests based on these antigens, the high molecular mass
polysaccharides may not be ideal targets for the detection of B. fragilis in
clinical samples with immunological probes. This could explain the lack of
agreement between the detection of B. fragilis by culture and by
immunodetection methods in the published literature. Therefore there is a
need to identify a non-variable antigen common to B. fragilis. The common
antigen of B. fragilis, first reported by Poxton and Brown in 1986 in the 7
strains they examined [16], may prove to be a suitable candidate and a better
target for an immunodiagnostic test.
In relation to the high molecular mass variable antigens of B. fragilis, the
common antigen is observed after polyacrylamide gel electrophoresis and
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immunoblotting at a lower molecular mass position(Figure 3). By extraction
of the common antigen and re-inoculation it is possible to obtain
monospecific polyclonal antiserum specific for the common antigen. The
potential use of the common antigen as a target for immunodetection was
investigated using a monospecific polyclonal antiserum and
immunofluorescence microsopy in two separate studies involving a total of
147 pus samples and 10 blood cultures[8].
Immunofluorescence labelling of 16 bacterial strains (including those
enriched for the LC, SC and EDL, culture collection strains and recent
clinical isolates obtained from Edinburgh, Amsterdam and Northern Ireland)
with the anti-common antigen serum and Evan's Blue as a counter-stain,
gave an average of96% sensitivity with a minimum of 80%. B. ovatus and B.
thetaiotaomicron labelled with a similar sensitivity, but lower intensity and B.
distasonis was negative. The polyclonal antiserum also reacted with
Prevotella melaninogenica.
Pus samples arriving in the laboratory were tested with the standard culture
procedure which involved inoculation onto horse blood agar (ABA);
anaerobic horse blood agar (BA); colistin-nalidixic acid agar (CNA);
anaerobic blood agar plus 50pg/ml gentamicin (ABA+GM). Penicillin and
gentamicin discs were applied to BA and CNA. Penicillin and metronidazole
were applied to ABA+GM and gentamicin, penicillin and metronidazole to
ABA. The anaerobes were identified with the API20A, ATB 32A and
Mastring ID 8 systems. The pus samples were also processed for
immunofluorescence microscopy using the polyclonal antiserum specific for
the common antigen as a probe.
The results ofcomparing the standard clinical laboratory isolation procedures
with immuno- labelling of the pus samples and immunofluorescence
microscopy are summarised in Table 2. The specimens which were positive
by culture for B. fragilis, B. thetaiotaomicron, P. melaninogenica or
Bacteroides sp, with two exceptions, were also positive for the common
antigen by immunofluorescence microscopy. A further 14% were positive for
the common antigen and not by initial culture. Investigation of 12 of the
specimens which were positive for the common antigen, but negative on
initial routine testing in the laboratory, indicated that 6 of these labelled with
some of the MAbs specific for the variable high molecular mass
polysaccharides, thus confirming the presence ofB. fragilis in the sample. A
second attempt at culturing B. fragilis from these specimens after storage in
the liquid nitrogen resulted in the isolation of B. fragilis from four samples.
This study indicates that the use of the immunofluorescence technique alone
would have underestimated the incidence ofB. fragilis and related species by
1-2%, whereas with the current diagnostic laboratory culture methods it was
underestimated by c. 14%.
Nine blood culture bottles, from which B. fragilis had been isolated, were








Fig. 3 Immunoblots of Bacteroides fragilis polysaccharide extracts after
PAGE reacted with rabbit polyclonal antiserum followed by anti-rabbit
alkaline phosphatase conjugated antiserum, a) antiserum prepared with whole
cells of strain NCTC 9343, b) antiserum prepared with immunoblot purifed
strain NCTC 9343 common antigen, c) antiserum prepared with immunoblot
purified strain NCTC 9344 common antigen. Note lower molecular mass
common antigen (arrow).
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common antigen and these were all also positive for the common antigen.
One blood culture which was positive for B. distasonis was negative for the
common antigen.
CONCLUSION
It therefore appears that the common antigen, in contrast to the variable high
molecular mass polysaccharides, has the potential to be a suitable target for
the immunodetection ofB. fragilis in clinical samples.
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Abstract
We have demonstrated that pure cultures of Bacteroides fragilis can be riboprobed with the oligoprobes BAC303 and
EUB338, whilst simultaneously immunolabelled with either the mAb QUBF7, or polyclonal antiserum specific for a
common antigen of B. fragilis. We were also able to distinguish between pure cultures of B. fragilis and Escherichia coli,
by means of combined immunolabelling and riboprobing. The success of the combined technique is critically dependent on
the size of the bacterial capsules, bacterial growth phase, antibody diluent and the length of the washing steps. The combined
FISH and immunolabelling of bacteria has potential applications in studies of bacteria of medical and veterinary importance,
as well as bacteria from other environments, as it yields information about both the identity and antigen expression of
individual bacterial cells. © 1998 Elsevier Science B.V. All rights reserved.
Keywords: rRNA; Oligonucleotide probe; Immunolabelling; Bacterial identification
1. Introduction
The potential for replacing or augmenting
culture-dependent methods of bacterial identification
by rapid immunological or molecular diagnostic
methods has been the subject of many studies (e.g.,
Greisen et ah, 1994; Patrick et ah, 1995) as routine
Abbreviations: cAg, common antigen of B. fragilis; DAPI,
4',6'-diamidino-2-phenylindole; EDL, electron dense layer; FISH,
fluorescent in situ hybridisation; FITC. fluorescein isothiocyanate;
HB. hybridisation buffer; LC, large capsule; mAb, monoclonal
antibodies; PBS, phosphate buffered saline; PCR, polymerase
chain reaction; rRNA, ribosomal RNA; SC, small capsule; TRITC,
trimethylrhodamine isothiocyanate
Corresponding author. Tel.: +44-012-322-405-03 ext. 2739;
fax: +44-012-324-391-81; e-mail: s.patrick@qub.ac.uk.
identification by culture is time consuming and
costly. In particular the detection of obligately anaer¬
obic bacteria in clinical samples by culture alone can
considerably underestimate the true incidence of in¬
fection (Patrick et ah, 1995). Such detection methods
are also potentially useful in studies of the virulence
of pathogenic bacteria.
With respect to molecular methods for bacterial
identification, our understanding of bacterial taxon¬
omy and ecology and our ability to identify bacteria
has been considerably enhanced through the applica¬
tion of 16S and 23S rRNA oligonucleotide probes
(Greisen et ah, 1994; Roller et ah, 1994; DeLong
and Shah, 1990; Greisen et ah, 1994; Poulsen et ah,
1994; Amman et ah, 1995). I6S and 23S rRNA
sub-units fold in a precise manner to form ribosomes
0022-1759/98/$ 19.00 © 1998 Elsevier Science B.V. All rights reserved.
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(Relman, 1993). The nucleotide sequences of the
rRNA molecules contain conserved and variable re¬
gions. thus making both the rRNA and correspond¬
ing DNA gene sequences ideal targets for taxonomic
studies (Woese, 1987). The 16S and 23S subunits
contain sequences of ribosomal nucleic acid that are
evolutionarily conserved between taxonomic groups,
whilst concomitantly exhibiting sequence variations
between different organisms. Therefore, when differ¬
ent bacteria are phylogenetically close the rRNA
sequences are less varied (Relman, 1993). This se¬
quence conservation and variation can be used as a
criterion of bacterial taxonomic classification
(Woese, 1987; Amman et al., 1995). The rRNA
sequences are used as templates to design comple¬
mentary oligonucleotide probes, according to the
required specificity, in order to probe and identify
bacteria directly without prior culture (Amman et al.,
1992; Greisen et al., 1994).
The identification of medically important and un-
culturable bacteria using a number of nucleic acid
detection techniques has been described (Greisen et
al., 1994; Amman et al., 1995). A range of comple¬
mentary universal, genus or species-specific oligo¬
nucleotide sequences, which act as either primers for
amplification of the bacterial rRNA genes, or as
direct complementary probes for the rRNA molecule,
have been utilised for PCR, dot-blot hybridisation,
and FISH, in the detection and identification of
bacteria present in clinical samples (Relman, 1993;
Greisen et al., 1994; Poulsen et al., 1994; Raskin et
al., 1995; Licht et al., 1996; Wilson et al., 1997).
FISH not only permits the detection and identifica¬
tion of bacteria, but also allows direct visualisation
of the cellular morphology and provides an indica¬
tion of the physiological state of the bacterium.
Immunological detection of bacteria through the
application of indirect immunofluorescence is well
documented (e.g., Desmonts et al., 1990; Patrick et
al., 1995). Bacteria within a clinical sample, for
example blood, pus, or cerebrospinal fluid, can be
immunolabelled as a means of location and identifi¬
cation of infecting bacteria.
Individually, immunofluorescence microscopy and
FISH, using rRNA specific oligonucleotide probes,
allow the detection of culturable, and also viable but
not culturable bacteria, whilst providing both a rapid
and specific identification.
The aim of this study is to investigate the poten¬
tial for combining FISH and immunofluorescence
microscopy of bacteria. In combination, these tech¬
niques could allow not only the identification of
specific bacteria without prior culture, but also pro¬
vide details of antigen expression, morphology and
the physiological state of bacteria. This could be
particularly useful in studies of bacterial virulence
determinant expression in situ, as the culture of
bacteria in artificial media may radically alter the
expression of virulence determinants (Smith, 1990).
Here we demonstrate that both FISH and immunola-
belling can be performed concomitantly on the same
bacterial cell.
2. Materials and methods
2.1. Bacterial culture and treatment
B. fragilis NCTC9343, electron dense layer (EDL)
population, small capsule (SC) population, and large
capsule (LC) population were grown in defined min¬
imal medium (van Tassell and Wilkins, 1978) as
previously described (Patrick and Larkin, 1993). E.
coli 0128 was grown in nutrient broth. The organ¬
isms were grown under anaerobic (Don Whitley Mk.
Ill anaerobic cabinet, 80% N2. 10% C02 and 10%
02) and aerobic conditions, respectively, at 37°C for
18 h. The cultures were re-inoculated into 10 ml of
defined minimal medium and nutrient broth, respec¬
tively, for 5 h until the bacterial populations had
reached exponential phase growth to yield a bacterial
density of 1 X 108 cfu per ml.
2.2. Removal of the large capsule
Sodium periodate (0.02 M) was prepared in sterile
d^O. The LC population was centrifuged for 2 min
at 14000 g. The bacteria were then washed twice in
1 X PBS (130 mM NaCl, 10 niM Na2HP04, 10 mM
NaH2P04.2H20 [pH 7.2]) and the pellets retained.
These were treated with sodium periodate and incu¬
bated for 1 h at 37°C in the dark. The bacteria were
centrifuged at 14000 g and subsequently washed
twice in PBS. The cells were resuspended in PBS.
The suspension was then adjusted to the same bacte¬
rial density as above. Bacteria, suspended in PBS as
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above, were sonicated in an MSE 150 soniprep for
50 s at an amplitude of 5 microns and washed as
above. Removal of the capsule was monitored by
light microscopy of capsule smears (Patrick et al.,
1996).
2.3. Bacteroides population separation
B. fragilis NCTC9343 was grown to late expo¬
nential phase and the three capsular populations sep¬
arated by density gradient centrifugation using a
Percoll gradient, as described by Patrick and Reid
(1983).
2.4. Fluorescent in situ hybridisation (FISH)
FISH, in relation to time, temperature and buffer,
was empirically optimised to maximise signal inten¬
sity (Stahl and Amman, 1991).
2.4.1. Slide preparation
12-well Teflon coated slides (ICN Biomedicals,
Aurora, OH, USA) were soaked in Decon solution
(1% v/v in dH:0) for 1 h, washed in dH20 and air
dried. The slides were immersed in gelatin (0.1%
w/v in dH^O) and chromium potassium sulphate
(0.01% w/v in d^O [Sigma, St Louis, USA]),
removed and air dried.
2.4.2. Cell fixation and storage
B. fragilis and E. coli cells, at the appropriate
density, were spotted onto each well of a slide in 10
p.\ volumes, under anaerobic and aerobic conditions,
respectively, and air dried. The slides were then
immersed in paraformaldehyde (4% w/v in 3 X PBS:
390 mM NaCl, 30 mM Na,HP04, 30 mM
NaH2P04.2H20 [pH 7.2]), for 30 min at 4°C. The
slides were removed, washed briefly with 1 X PBS
and immersed in ice cold absolute ethanol for 10 min
at — 20°C. The slides were then removed, air dried
and stored at — 20°C for up to several months with¬
out any apparent deterioration of hybridisation sig¬
nal.
2.4.3. Oligonucleotide probes
Three oligonucleotide probes were selected based
on published findings, all numberings list the corre¬
sponding positions in the E. coli 16S rRNA. The
following oligonucleotide probes were selected:
BAC303 (5'-CCAATGGGGGACCTT-3'X a probe
showing 100% similarity to 16S rRNA sequences of
the genera Bacteroides and Prevotella at the posi¬
tions 303-319 of the 16S rRNA (Manz et al„ 1996);
EUB338 (5'-GCTGCCTCCCGTAGGAGT-3'), a eu-
bacterial probe specific for all eubacteria and ranging
from positions 338-355 on the 16S rRNA (Amman
et al., 1995); and a eukaryotic oligonucleotide probe
(5'-ACCAGACTTGCCCTCC-3') ranging from posi¬
tions 502-516 of 16S rRNA (Amman et al., 1995).
The oligonucleotide probes were synthesised by Eu-
rogentec (Abingdon, UK) and covalently linked at
the 5' end with a fluorescein marker, purified by
HPLC and stored at — 20°C in ddH20 at a concen¬
tration of 50 T)g/pA.
2.4.4. Pre-hybridisation
The slides were removed from storage and dried
in a 37°C incubator. They were then washed in a
series of ethanol washes (50%, 80% and 98% v/v in
dH^O) for 3 min each and then allowed to air dry.
2.4.5. Hybridisation
Hybridisation buffer (HB: 0.9 M NaCl, 20 mM
Tris/HCl and 0.01% sodium dodecyl sulphate [pH
7.2]) at volumes of 8/x 1 was spotted onto each slide
well, then 1 /xl aliquots of each of the EUB338 and
BAC303 oligonucleotide probes were applied to the
buffer. The eukaryotic probe was used as a control to
monitor non-specific oligoprobe binding. Filter paper
(3M Whatman, Maidstone, Kent, UK) was placed
inside a polypropylene screw cap tube (Corning, NY,
USA), which acted as the hybridisation chamber, the
paper was soaked with HB. The slide was placed in
the tube and the cells hybridised in an incubator at
44°C for 3 h.
2.4.6. Post-hybridisation (FISH only)
The slides were rinsed with HB and then incu¬
bated for 1 h at 54°C in HB within a water bath. The
slide was then rinsed in ddH?0 to remove salt
precipitant, and dried at 37°C. The cells were
counter-stained with 10 p\ (10 pg/m\) of 4',6'-di-
amidino-2-phenylindole (DAPI) on each well and
incubated at 4°C for 30 min. The DAPI stain was
washed off the slide with 1 X PBS and allowed to air
dry. The slides were then mounted in Citifluor (Agar
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Scientific, Stanstead, Essex, UK), and the coverslip
sealed with nail varnish.
2.4.7. Post-hybridisation (Combined FISH and im-
munolabelling)
The slides were briefly washed with a small
volume of freshly prepared HB at 54°C, rinsed with
ddH20 and then dried at 37°C. Primary monoclonal
antibody (mouse anti-6. fragilis, NCTC9343 EDL
population, IgG2) QUBF7, produced from BALB/c
ascites (Lutton et al., 1991), or polyclonal antisera
(rabbit anti-B. fragilis common antigen (cAg)
(Patrick et al., 1995)) was appropriately diluted in
1 X PBS. The antibody was applied in 10 p\ vol¬
umes to each well and incubated at 37°C for 20 min.
The antibody was rinsed off quickly with HB and
washed for 10 min in HB at 37°C. The slides were
then removed from washing and the secondary anti¬
body applied. The secondary antibodies (goat anti-
mouse or goat anti-rabbit IgG trimethylrhodamine
isothiocyanate (TRITC) conjugated [Sigma]) and
DAPI were appropriately diluted in 1 X PBS. The
antibody/DAPI mixture, after application, was incu¬
bated and washed as above. The slides were then
mounted and viewed as before. To control for non¬
specific antibody binding, wells without previous
primary antibody incubation were incubated with
secondary antibody.
2.4.8. Microscopic and photographic details
Slides were viewed using a Leitz Dialux 20 fluo¬
rescence microscope fitted with a WILD HPS 50
photoautomatic system. The microscope was fitted
with filters for rhodamine or fluorescein and a triple
blue/green/red filter. Photographs were taken on
Fuji colour 400 ASA film.
3. Results
3.1. The effects of growth phase on the riboprobe
signal intensity
Broth grown B. fragilis NCTC9343. EDL popula¬
tion, were sampled at one hourly time intervals
post-inoculation (1-10 hours) and fixed onto the
slides as described above. The bacteria were hy¬
bridised with the probes EUB338 and BAC303. It
was demonstrated that the fluorescent signal inten¬
sity varied when the cells were fixed at different
stages of growth. Bacteria fixed at early exponential
phase (1-2 hours) showed very low levels of fluo¬
rescence intensity, as did bacteria in death phase
(8-9 hours). Those bacteria fixed at late exponential
phase (5 h) showed optimal fluorescence intensity
(results not illustrated).
3.2. The effects of in situ hybridisation on B. fragilis
capsular populations
The three capsular populations were fixed as de¬
scribed above. Late exponential phase B. fragilis
NCTC9343 population expressing a large capsule
(LC), small capsule (SC) or narrow electron dense
surface layer, only visible by electron microscopy
(EDL), were hybridised with the EUB338 and
BAC303 probes. Fig. 1 shows a weaker signal inten¬
sity in the LC (Fig. 1, iii) when compared with both
the SC and the EDL. To investigate whether the
capsular material was responsible for the poor signal
observed, the capsule was removed by either sodium
periodate treatment or mild ultrasonication. Capsule
loss was monitored by negative-staining and mi¬
croscopy. It was shown that signal intensity was
improved after the LC was removed by either method.
This suggests that the capsule may be responsible for
the poor hybridisation signal obtained.
3.3. Combined FISH and immunolabelling on B.
fragilis
When the optimised FISH was combined with the
immunolabelling method described by Patrick and
Larkin (1993) a low riboprobe fluorescent signal
intensity was observed. This suggests that the probe
Fig. 1. Micrographs of B. fragilis NCTC9343, EDL population, SC population and LC population, hybridised with probes EUB338 and
BAC303 and viewed with a fluorescein filter: (i) EDL population; (ii) SC population; and (iii) LC population (X100). Note that the
fluorescent signals of the EDL and SC populations are markedly more intense than the fluorescent signal of the LC population.
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had become dissociated from the rRNA and leached
from the cell during immunolabelling, giving a poor
signal. It was identified that the signal was being lost
during the 30 min washing steps and also when the
primary mAb was undiluted hybridoma culture su¬
pernatant. Therefore, by reducing the washing times
to 10 min and using either mAb produced in ascites
fluid or polyclonal antisera, diluted in PBS the loss
of the riboprobe fluorescent signal was minimised.
B. fragilis NCTC9343, EDL population, first hy¬
bridised with the BAC303 and EUB338 probes, fol¬
lowed by immunolabelling with either mAb QUBF7
or polyclonal antiserum specific for the B. fragilis
cAg is illustrated in Figs. 2 and 3. The combined
labelling permitted simultaneous specific identifica¬
tion of the B. fragilis. In the case of the anti-cAg
serum, all the bacteria within the population were
labelled with both the antiserum and the oligoprobe
(Fig. 2). In contrast, with mAb QUBF7 only a
proportion of the population carried this epitope and
were labelled Fig. 3.
3.4. Identification of B. fragilis in a mixed popula¬
tion of E. coli / B. fragilis using combined FISH and
immunolabelling
An EDL population of B. fragilis NCTC9343 and
a population of E. coli 0128 were prepared as
above, then mixed together at the appropriate cellular
density, spotted onto slides and fixed as described
above. Fig. 4 illustrates the combined labelling of the
mixed bacterial population. The B. fragilis cells
appeared yellow/orange in colour as a result of
labelling with both the oligoprobe and the anti-cAg
serum.
4. Discussion
The combined technique of FISH and immuno¬
fluorescence labelling can potentially improve our
ability to detect and identify bacteria. We have
demonstrated that labelling of a pure culture of B.
fragilis could be performed with the 16S rRNA
probes, EUB338 and BAC303, followed by labelling
with either monoclonal antibodies or polyclonal anti¬
serum. The technique was also applied to a mixed
culture of B. fragilis and E. coli, and we were able
to distinguish the two bacteria from each other by
means of rabbit anti-B. fragilis common antigen
specific polyclonal antiserum.
The success of the combined labelling technique
is dependent on a number of critical factors. Firstly,
as reported by others (e.g., Poulsen et al., 1993), the
intensity of the fluorescent signal from the 16S
rRNA probe was dependent on growth phase, with
optimal fluorescent signal intensity observed in the
exponential phase. This is thought to relate to the
ribosomal content of the bacterial cell. Secondly,
populations of bacteria with LC exhibited a reduced
fluorescent signal with 16S rRNA probe labelling
when compared to a population of the same bacterial
strain which did not express the large capsule (EDL
population). Removal of the LC with either sodium
periodate treatment or mild ultrasonication prior to
FISH resulted in fluorescent intensities similar to
those of the EDL population. This suggests that the
LC provides a barrier to penetration of the oligo¬
nucleotide probe, and that the differences are not due
to different physiological states of the LC and EDL
populations. This is in contrast to the results of
Poulsen et al. (1993) who reported that, with E. coli,
Fig. 2. Micrograph of the same field of B. fragilis NCTC9343, EDL population, hybridised with probes EUB338 and BAC303 and
immunolabelled with polyclonal antiserum specific for the B. fragilis common antigen: (i) viewed with fluorescent filter to show oligoprobe
labelling; (ii) viewed with the rhodamine filter to show antibody labelling; and (iii) viewed with the red/blue/green filter to show
combined labelling (X 100). Note that the combined label permits the visualisation of a pure culture of B. fragilis with the oligoprobe.
whilst simultaneously visualising expression of the B. fragilis common antigen.
Fig. 3. Micrographs of B. fragilis NCTC9343, EDI. population, hybridised with probes EUB338 and BAC303 and immunolabelled with
mAb QUBF7, (i) viewed with fluorescent filter to show oligoprobe labelling; (ii) viewed with the rhodamine filter to show antibody
labelling (x 100). Note that the epitope recognised by mAb QUBF7 is not expressed by all of the bacteria in the population.
Fig. 4. Micrographs of a mixture of B. fragilis NCTC9343 EDL population and E. coli 0128 hybridised with probes EUB338 and
BAC303. immunolabelled with anti-B. fragilis common antigen polyclonal antiserum and viewed with a red/blue/green filter (X100).
Note the yellow/orange colour of the B. fragilis which are labelled by both the oligoprobe and the antiserum (X 100).
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the fluorescent signal intensity was altered only by
the ribosomal content of the cell and not the nature
of the outer layers of the bacterium. Finally, in
relation to fluorescent immunolabelling, post-
oligoprobing, the prolonged washing procedure in
PBS normally adopted for immunolabelling (Patrick
and Larkin, 1993) reduced the fluorescent labelling
of the oligoprobes, as did the use of undiluted hy-
bridoma cell culture supernatant as the primary anti¬
body. Therefore, the length of the washing steps was
reduced, such that they were sufficient to prevent
non-specific immunolabelling while retaining oligo-
probe signal intensity. The washing steps were car¬
ried out in hybridisation buffer rather than PBS. The
reduction in oligoprobe signal resulting from the use
of undiluted hybridoma cell culture supernatant for
the primary antibody may have occurred because the
high pH or the composition of the hybridoma growth
medium promoted dissociation of the probe. Filter
concentrated mAb, ascites fluid or polyclonal antis-
era diluted in PBS appeared to have no detrimental
effect on the oligoprobe labelling.
As a research tool, combined FISH and immuno¬
labelling provides the opportunity to concomitantly
investigate a variety of parameters. For example, the
complexities of bacterial populations in biofilms may
be investigated with respect to the interactions of
bacteria in situ, whilst also exploring whether the
physiological state and morphology vary. Further¬
more, the bacterial population may be monitored for
antigenic variation. The technique may potentially be
applied to studies of clinical material, models of
infection and other environmental samples. In partic¬
ular, the ability to not only specifically identify
bacteria in situ, but monitor virulence determinant
expression without culture is particularly useful in
studies of bacterial pathogenesis as the character¬
istics of bacteria growing in vivo may differ consid¬
erably from those growing in vitro (Smith, 1990).
The application of the combined FISH and im¬
munolabelling technique directly to clinical detection
and diagnosis of bacteria is more problematic, given
the dependence of fluorescent signal on the physio¬
logical state of the bacterium and the potential for
surface structures such as capsules to restrict oligo¬
probe entry. These factors do not present a difficulty
when detecting bacteria by immunolabelling, pro¬
vided the target antigen is known to be stably ex¬
pressed, is common to all strains, and is present on
the bacterial surface (Patrick, 1997).
As flow cytometry has been used to detect fluo-
rescently labelled bacteria after either immunola¬
belling (Lutton et al., 1991) or FISH (Bauman and
Bentvelzen, 1988), there is also the potential for flow
cytometric analysis of bacteria labelled by a combi¬
nation of the techniques.
The amplification of rRNA gene sequences by
PCR as a means of detecting bacteria in clinical
samples has been described (Greisen et al., 1994).
Although PCR amplification of rRNA gene se¬
quences can provide a rapid positive identification of
bacteria, this technique does not, however, provide
information pertaining to the morphology, physio¬
logical activity and antigenic character of the bacte¬
ria. We are currently in the process of assessing and
comparing PCR of the rRNA gene and combined
FISH and immunolabelling for bacterial detection in
clinical samples.
While the ability to rapidly identify bacteria within
clinical samples without prior culture is attractive,
both in terms of the potential speed with which
positive identification can be made and the possibil¬
ity of detecting bacteria which may be non-cultura-
ble, it is likely that in the short term such techniques
will remain as a supplement to culture methods. This
is particularly the case where the antibiotic sensitiv¬
ity profiles of the bacteria are required. In the longer
term, if problems relating to oligoprobe signal inten¬
sity are overcome, then one of the major advantages
of labelling the whole bacterial cell rather than ex¬
tracted DNA is the ability to correlate the results
with bacterial cell morphology and thus reduce the
chance of false-positive results, an attribute not
demonstrated by PCR.
5. Conclusion
The combination of FISH and immunolabelling of
bacteria provides a potentially useful research tool in
the context of both the studies of bacterial pathogen¬
esis and general studies of environmental bacteria, as
it permits concomitant in situ identification of bacte¬
ria and information pertaining to surface antigen
expression.
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Our aim was to determine if the detection rate ofinfection of tal hip replacements could be
improved by examining the removed prostheses.
Immediate transfer of prostheses to an anaerobic
atmosphere, followed by mild ultrasonication to
dislodge adherent bacteria, resulted in the culture of
quantifiable numbers of bacteria, from 26 of the 120
implants examined. The same bacterial species were
cultured by routine microbiological techniques from
only five corresponding tissue samples. Tissue removed
from 18 of the culture-positive implants was suitable
for quantitative tissue pathology and inflammatory
cells were present in all samples. Furthermore,
inflammatory cells were present in 87 % of tissue
samples taken from patients whose implants were
culture-negative. This suggests that these implants
may have been infected by bacteria which were not
isolated by the techniques of culture used.
The increased detection of bacteria from prostheses
by culture has improved postoperative antibiotic
therapy and should reduce the need for further
revision.
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Despite the use of ultra-clean-air operating theatres and
antibiotic-impregnated bone cement,' between 2%2 and
15% of all revision hip operations are because of infection
of the implant. Unfortunately, after revision the rate of
infection is higher than after primary procedures, with as
many as 40% of revised hips becoming reinfected.3 This
has been attributed to the presence of unrecognised infec¬
tion at the time of the first revision,3 possibly because
bacteria colonising the surface of implants grow predom¬
inantly in adherent biofilms and may not be detected by
aspiration or by standard culture techniques.7 In addition,
the well-proven incidence of anaerobic bacteria in joint
infection emphasises the need for special methods of
culture.
We aimed to improve the isolation of bacteria from hip
prostheses removed at revision operations by using mild
ultrasonication to dislodge bacteria adhering to the surface
of the implant, and strict anaerobic techniques.
Patients and Methods
From March 1996 to May 1997 we retrieved 120 hip
prostheses from patients at revision operations. There were
70 women and 50 men with a mean age of 69 years (27 to
92). The mean interval from the previous joint replacement
to the revision operation was 8.8 years (4 months to 24
years). All had standard preoperative care.
The skin was painted with Betadine (Seton Healthcare,
Oldham, UK) and the incision area covered with an adhe¬
sive plastic drape. All operations were carried out with
vertical laminar air flow and the operating team wore
disposable impervious drapes. Routine antibiotic prophy¬
laxis consisted of 2 g of cefamandole (Kefadol; Dista Prod¬
ucts Ltd, Basingstoke, UK) given intravenously at the time
of the induction of anaesthesia. Further doses of 1 g of
cefamandole were given at eight and 16 hours after surgery.
Cefamandole is recommended by the British National For¬
mulary for surgical prophylaxis since it is a broad-spectrum
antibiotic for both Gram-positive and Gram-negative bac¬
teria. The removed femoral and acetabular components
were placed aseptically in separate sterile bags. Tissue in
contact with the implants was also removed and placed in
sterile bottles. All specimens were immediately placed in
an anaerobic jar for transport to an anaerobic cabinet.
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Fig. I
SEM showing the bacterial biofilm on a retrieved orthopaedic implant viewed at a magnification of (a) X700 and (b) X 1500.
high-power field: 0, absent; 1, 1 to 10 cells; 2, 10 to 20
cells; or 3, 20 or more cells.
Results
Quantifiable numbers, from 2 X 10h to >106, of bacteria
were cultured from 26 of the 120 samples examined (22%).
The infection in seven of the samples was caused by a
single Staphylococcus species. Three other samples were
infected by a combination of two Staphylococcus species.
The anaerobic bacterium, Propionibacterium acnes, was
isolated as the single infecting organism in 12 samples and
a further four samples were infected by a combination of P.
acnes and an aerobic Gram-positive coccus (Table I); 16 of
the 26 samples (62%) therefore involved P. acnes. SEM
confirmed that bacteria were able to grow within a con¬
fluent biofilm on the surface of the prosthesis (Fig. 1).
Organisms similar to those isolated from the implants were
cultured from only five of the 26 corresponding tissue
samples. All the other tissue samples were culture-negative.
No bacteria were isolated from the 20 control prostheses.
Tissue samples from 18 of the 26 culture-positive
implants were suitable for histological examination and
inflammatory cells were present in all 18 samples (Table 1).
Lymphocyte and macrophage infiltration was more exten¬
sive than polymorphonuclear leucocyte infiltration with 17
samples having lymphocyte and macrophage scores of 1 to
3 compared with only ten with polymorphonuclear leuco¬
cyte scores of 1 to 3 (Table II).
Tissue samples from 63 of the 94 culture-negative
implants were also suitable for histological examination;
inflammatory cells were present in 55 (87%). Lymphocyte
and macrophage infiltration was again more extensive than
polymorphonuclear leucocyte infiltration. Of the 55 tissue
samples, 52 and 54 had lymphocyte and macrophage scores
of between 1 and 3, respectively, whereas only 31 samples
had a similar level of polymorphonuclear leucocyte infiltra¬
tion (Table II).
We examined the hospital records of 18 of the 26
patients with culture-positive implants and of 52 of the 94
patients with culture-negative implants. Of the 18 culture-
positive patients, 12 had a preoperative diagnosis of either
aseptic loosening or dislocation, and the other six patients
had been suspected of having infection. In four of these six
patients, however, no bacteria had been cultured from
either joint fluid aspirated preoperatively or from tissue
samples removed at the time of surgery. Preoperative
aspiration of joint fluid in the other two patients resulted in
the isolation of Staphylococcus epidermidis (case 4) and S.
aureus (case 7). Similar organisms to those isolated pre¬
operatively were cultured from the implants after sonica-
tion and from the surrounding tissue after homogenisation.
Of the 52 patients with culture-negative implants, 50 had a
preoperative diagnosis of either aseptic loosening or dis-
Table II. The relationship between inflammatory cell presence and bacterial isolation by culture
Inflammatory cell score
PMN* LYMt MAC*
0 I 2 3 0 1 2 3 0 1 2 3
Number of culture-positive implants 8 6 4 0 1 10 7 0 J 4 6 7
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could therefore have resulted from intraoperative seeding
or haematogenous spread.
We found high inflammatory scores in 87% of the tissue
samples from patients whose implants were culture-negative.
Infiltration with lymphocytes and macrophages was pre¬
dominant, which suggests that the implants removed from
these patients may have also been infected by low-virulence
organisms which were not isolated by the techniques used.
Similar results were obtained by Fehring and McAlister in
a smaller study of nine patients in whom the histological
evaluation was positive and the cultures negative; in six
there was a high clinical suspicion of infection.
We believe that infection of retrieved hip prostheses is
currently underestimated. We recommend that the removed
implants are sonicated to dislodge adherent bacteria and
then sampled directly to improve bacterial isolation under
anaerobic conditions. The examination of tissue alone does
not always result in the isolation of the causative organism.
The improved detection and isolation allow the use of
suitable antibiotics for a longer postoperative period, which
should improve the clinical outcome. We are now using
polyclonal antisera and monoclonal antibodies specific for
the infecting bacteria and 16S rRNA oligo¬
nucleotide probes to increase the detection of non-cultur-
able bacteria.
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The susceptibilities of 49 isolates recovered from orthopedic implants to seven antimicrobial agents were
evaluated by the broth microdilution method. Ciprofloxacin and vancomycin were more active than gentamicin,
representing aminoglycosides which are routinely incorporated into bone cement, and also more active than the
peroperative antimicrobial agents cefamandole and erythromycin. The use of ciprofloxacin and vancomycin in
vivo, therefore, warrants further evaluation.
Total hip replacement has become commonplace in recent
years because of the success of this procedure in restoring
function to the affected joint (6). Unfortunately, bacterial in¬
fection has been a significant complication following this pro¬
cedure, with implant infection implicated in 22% of revision
operations in a recent study (12). Removal and replacement of
the prosthesis are usually required to eradicate the infection,
with attendant patient trauma and increased cost (1, 8). Anti¬
biotic treatment to reduce the risk of recurrent infection in¬
cludes the use of antibiotic-impregnated bone cement for pros¬
thesis fixation at revision surgery (3) and the intravenous
administration of antibiotics during revision surgery. In
Musgrave Park Hospital, Belfast, United Kingdom, genta¬
micin is incorporated into bone cement and the cephalosporin
cefamandole (Kefadol) is used for routine antimicrobial pro¬
phylaxis. When patients undergoing revision hip surgery are
allergic to cefamandole, erythromycin is usually employed pro-
phylactically.
Gentamicin resistance among bacteria isolated from in¬
fected hip joints has been reported. In a study of 33 infected
hip joints, Weber and Lautenbach (13) noted that 29% of
bacteria isolated preoperatively were resistant to gentamicin.
Interestingly, following the use of gentamicin-impregnated
bone cement, resistance increased to 41% of bacteria isolated
postoperatively. In another study of cemented total hip arthro¬
plasty infection caused by coagulase-negative staphylococci
(CNS), Hope et al. (5) reported that the use of gentamicin-
impregnatcd cement in the primary arthroplasty was associ¬
ated with the emergence of gcntamicin-resistant CNS in sub¬
sequent infection. Of 34 hip implants at revision surgery in
which gentamicin-impregnated cement had been used at the
previous operation, 30 (88%) later grew at least one strain of
gentamicin-resistant CNS. In contrast, of 57 hip implants at
revision surgery in which gentamicin was not included in the
bone cement, only 9 (16%) later grew gentamicin-resistant
CNS. In addition, an earlier study to determine the efficacy of
antimicrobial agents in eradicating the normal skin microbiota
prior to surgery reported that 18 of 152 patients (12%) had
* Corresponding author. Mailing address: School of Pharmacy, The
Queen's University of Belfast, 97 Lisburn Rd., Belfast BT9 7BL,
United Kingdom. Phone: 01232-272017. Fax: 01232-247794. E-mail: s
.gorman@qub.ac.uk.
cefamandole-resistant Staphylococcus epidermidis, leading the
authors to conclude that preoperative antimicrobial prophy¬
laxis with cefamandole would have failed to protect these pa¬
tients from the S. epidermidis which colonized their skin (11).
The aim of the present study was, therefore, to determine the
susceptibilities of bacteria isolated from revision hip prostheses
to the commonly used antimicrobial agents gentamicin, cefa¬
mandole, and erythromycin and also to a range of alternative
antimicrobial agents.
Twenty-six of 120 implants removed consecutively from pa¬
tients undergoing revision hip surgery at Musgrave Park Hos¬
pital during the 14-month period from March 1996 to May
1997 were diagnosed as infected (12). From these infected
implants, 49 clinical isolates were recovered. Review of the
hospital notes for 18 patients with culture-positive implants
and 52 patients with culture-negative implants revealed that
infection prior to revision was suspected in only 8 cases (11%).
Implants from 6 of these patients (75%) were subsequently
diagnosed as infected in our study. Seven of the implants were
infected by a single Staphylococcus sp„ and a further three
were infected by a combination of two Staphylococcus spp. The
anaerobic bacterium Propionibacterium acnes was isolated as
the single infecting organism from 12 implants, and a further 4
implants were infected by a combination of P. acnes and a
gram-positive coccus. The isolates comprised the following: S.
epidermidis, 17 strains; Staphylococcus aureus, 4 strains; Staph¬
ylococcus hominis, 3 strains; Staphylococcus capitis, 2 strains;
Staphylococcus haemolyticus, 2 strains; Staphylococcus sciuri, 1
strain; Micrococcus sp., 1 strain; and P. acnes, 19 strains.
The following antimicrobial agents were used: gentamicin
sulfate, erythromycin, and fusidic acid (Sigma Chemical Co.,
Poole, Dorset, United Kingdom); cefamandole naftate as Ke¬
fadol (Dista Products Ltd., Basingstoke, United Kingdom);
cefotaxime as Claforan (Roussel Laboratories Ltd., Uxbridge,
United Kingdom); ciprofloxacin as Ciproxin (Bayer pic, New¬
bury, United Kingdom), and vancomycin as Vancocin (Eli Lilly
and Company Ltd., Basingstoke, United Kingdom). MICs
were determined by the broth microdilution method (9, 10).
Serial twofold dilutions of each antimicrobial were prepared in
cation-supplemented Mueller-Hinton broth (MHB with 50 mg
of Ca2+ and 25 mg of Mg2+ per liter; Unipath Ltd., Basing¬
stoke, United Kingdom) within dilution schemes of 0.5 to 1,024
p,g/ml (gentamicin, cefamandole, cefotaxime, and erythromy-
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Range 50% 90% Range 50% 90%
Gentamicin <0.5-512 8 64 l—> 1,024 32 1,024
Cefamandole <0.5-64 1 32 <0.5->1,024 1 64
Cefotaxime <0.5-64 2 16 <0.5-> 1,024 64 512
Erythromycin <0.5->l,024 16 >1,024 <0.5-> 1,024 256 >1,024
Vancomycin 0.25-2 1 2 1-64 32 64
Ciprofloxacin 0.125-2 0.5 1 0.125-64 8 32
Fusidic acid <0.125-32 1 8 1—>256 16 >256
Gentamicin <0.5-512 16 128 26 l-> 1,024 32 1,024
Cefamandole <0.5-64 2 64 63 1-512 16 128
Cefotaxime <0.5-32 4 16 77 4-> 1,024 128 1,024
Erythromycin <0.5->l,024 256 >1,024 6 2-> 1,024 >1,024 >1,024
Vancomycin 0.25-2 1 2 100 1-64 32 64
Ciprofloxacin 0.125-2 0.5 1 100 0.125-64 16 32
Fusidic acid <0.125-16 0.25 16 NA" 1—>256 64 >256
Gentamicin <0.5-16 4 8 NA 2-128 8 64
Cefamandole <0.5 <0.5 <0.5 100 <0.5^4 <0.5 1
Cefotaxime <0.5-1 <0.5 <0.5 100 <0.5-128 <0.5 2
Erythromycin <0.5-> 1,024 <0.5 >1,024 NA <0.5-> 1,024 <0.5 >1,024
Vancomycin <0.125-1 0.5 0.5 NA 4->256 8 32
Ciprofloxacin 0.5-1 1 1 NA 1-128 8 32




" NA, no MIC breakpoint approved by the National Committee for Clinical Laboratory Standards.
cin) and 0.125 to 256 p-g/ml (vancomycin, ciprofloxacin, and
fusidic acid). The microdilution trays were stored in sealed
plastic bags at — 70°C and used within 3 weeks.
The inoculum for facultative isolates to be tested was pre¬
pared by adjusting the turbidity of an actively growing broth
culture in MHB to an optical density at 540 nm equivalent to
1 X 10s CFU/ml. The suspension was further diluted to pro¬
vide a final inoculum density of 5 X 105 CFU/ml. Anaerobic
isolates to be tested were grown on anaerobic horse blood agar
plates at 37°C for 48 h in an anaerobic chamber (Don Whitley
Scientific, Shipley, United Kingdom). The inoculum was pre¬
pared by suspending bacteria from these plates in prereduced
MHB, which provided optimal growth conditions for the P.
acnes isolates. The suspension was then adjusted by spectro¬
photometry measurement to provide a final inoculum density
of 106 CFU/ml.
The microdilution trays were removed from the freezer and
thawed, and trays to be used for anaerobic bacteria were equil¬
ibrated in the anaerobic chamber for 4 h. The final inoculum
(100 |xl) was added to each well of the microdilution trays.
Facultative isolates were incubated in air at 37°C for 24 h, and
the anaerobic P. acnes isolates were incubated in the anaerobic
chamber at 37°C for 48 h. After incubation, the MIC was read
as the lowest concentration of each antimicrobial agent which
inhibited visible growth of the test isolate. Quality assurance
testing was performed with Enterococcus faecalis ATCC 22697
and Bacteroides fragilis ATCC 25285.
In order to determine the minimum bactericidal concentra¬
tion (MBC), 20-p.l aliquots were inoculated onto Mueller-Hin-
ton agar plates which were incubated as described previously.
The MBC was defined as the lowest antibiotic concentration
that produced greater than 99.9% killing of the initial inocu¬
lum.
The results of this study are summarized in Tables 1 and 2.
Control strains gave reproducible results, with MICs within
National Committee for Clinical Laboratory Standards limits
and 1 dilution of the mean. The majority of facultative isolates
were resistant to gentamicin and erythromycin. In contrast,
there was less resistance of facultative isolates to cefamandole,
cefotaxime, and fusidic acid. Vancomycin and ciprofloxacin
were most effective against the facultative isolates. All P. acnes
strains were susceptible to cefamandole, cefotaxime, vancomy¬
cin, ciprofloxacin, and fusidic acid. However, higher concen¬
trations of both gentamicin and erythromycin were required to
inhibit the P. acnes strains. Based on overall MBCs at which
90% of strains tested were killed, ciprofloxacin was the most
active bactericidal agent tested, followed in decreasing order
by cefamandole, vancomycin, cefotaxime, gentamicin, fusidic
acid, and erythromycin.
Although higher antibiotic concentrations are achieved lo¬
cally with antibiotic-impregnated bone cement (4), this in vitro
study has shown by the high numbers of gentamicin-resistant
bacteria which were isolated that the routine use of gentami-
cin-impregnated bone cement may be ineffective. This finding
was not unexpected as virtually all the retrieved implants had
been fixed in place with gentamicin-impregnated bone cement,
and it supports the results previously reported by Weber and
Lautenbach (13). The use of erythromycin peroperatively in
patients who are allergic to cephalosporins may also be inef¬
fective, based on the high proportion of erythromycin-resistant
bacteria isolated. The results described herein suggest that the
use of other agents, for example, vancomycin and ciprofloxa¬
cin, in bone cement and peroperatively, respectively, could be
more effective for the elimination of implant infection at the
time of revision hip surgery and for the prevention of further
implant infection. Previous studies have reported that the sta¬
bility and physicochemical properties of vancomycin are not
adversely affected by its addition to bone cement (7) and have
also shown that the drug is released in sufficient concentrations
to treat and prevent experimentally induced S. aureus osteo¬
myelitis in rats (2). Further work to determine the efficacy of
these antibiotics against bacteria growing within adherent bio-
films on the surface of implant biomaterials is under way.
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MIC (p.g/ml) MBC (p-g/ml)
Range 50% 90% Range 50% 90%
S. epidermidis (17) Gcntamicin <0.5-512 16 256 1—>1,024 128 >1,024
Cefamandole <0.5-64 4 32 1-512 16 64
Cefotaxime <0.5-32 4 16 4-> 1,024 128 512
Erythromycin <0.5->l,024 >1,024 >1,024 2-> 1,024 >1,024 >1,024
Vancomycin 1-2 2 2 8-64 16 64
Ciprofloxacin 0.25-1 0.5 1 0.5-64 16 32
Fusidic acid <0.125-16 0.5 16 l->256 >256 >256
S. aureus (4) Gentamicin 16-32 16-32
Cefamandole 32 64-512
Cefotaxime 2-4 256-> 1,024
Erythromycin 2-16 2-> 1,024
Vancomycin 0.5-1 16-32
Ciprofloxacin 0.5-1 1-32
Fusidic acid <0.125-0.25 16-128
S. hominis (3) Gcntamicin <0.5-32 2-64
Cefamandole 1-64 l-> 1,024
Cefotaxime 2-4 64-> 1,024
Erythromycin 128-> 1,024 l,024-> 1,024
Vancomycin 1 16-32
Ciprofloxacin 0.25-2 0.25-32
Fusidic acid 0.25-32 4->256






Fusidic acid <0.125-0.25 32-64
S. haemolyticus (2) Gentamicin 64 256-512
Cefamandole 32-64 64
Cefotaxime 32-64 64-256
Erythromycin 32-> 1,024 >1,024
Vancomycin 1-2 1-32
Ciprofloxacin 0.25 8-16
Fusidic acid 1-8 4->256






Fusidic acid 0.25 >256






Fusidic acid <0.125 4
The technical assistance of Stcf McGralh, School of Pharmacy, The
Queen's University of Belfast, is gratefully acknowledged.
Michael Tunncy and these investigations were funded by the Arthri¬
tis Research Campaign. UK (project grant number P0522); Gordon
Ramage was funded by a Department of Education for Northern
Ireland research studentship.
REFERENCES
1. Dreghorn, C. R.. and I). L. Hamblen. 1989. Revision arthroplasty: a high
price to pay. Br. Med. J. 298:b48-649.
2. Gerhart, T. N., R. D. Roux, P. A. Hanff, G. L. Horowitz, A. A. Renshaw, and
W. C. Hayes. 1993. Antibiotic-loaded biodegradable bone cement for pro¬
phylaxis and treatment of experimental osteomyelitis in rats. J. Orthop. Res.
11:250-255.
3. Hanssen, A. 1)., and J. A. Rand. 1994. Treatment of the infected total knee
arthroplasty with insertion of another prosthesis. Clin. Orthop. Rclat. Res.
309:44-55.
4. Henry, S. L., and k. P. Galloway. 1995. Local antibacterial therapy for the
management of infections—pharmacokinetic considerations. Clin. Pharma-
cokinet. 29:36-45.
5. Hope. P. G., K. G. Kristinsson, P. Norman, and R. A. Elson. 1989. Deep
Vol. 42, 1998 NOTES 3005
infection of cemented total hip arthroplasties caused by coagulase-negative
staphylococci. J. Bone Joint Surg. 71B:851-855.
6. Law, H. T., R. H. Fleming, M. F. X. Gilmore, I. D. McCarthy, and S. P. F.
Hughes. 1986. In vitro measurement and computer modelling of the diffu¬
sion of antibiotic in bone cement. J. Biomed. Eng. 8:149-155.
7. Lawson, K. J., K. E. Marks, J. Brems, and S. Rehm. 1990. Vancomycin vs
tobramycin elution from polymethylmethacrylate: an in vitro study. Ortho¬
pedics 13:521-524.
8. Learmonth, I. D. 1993. Prevention of infection in the 1990s. Orthop. Clin. N.
Am. 24:735-741.
9. National Committee for Clinical Laboratory Standards. 1993. Methods for
antimicrobial testing of anaerobic bacteria, 3rd ed. Approved standard.
NCCLS document Mil-A3. National Committee for Clinical Laboratory
Standards, Villanova, Pa.
10. National Committee for Clinical Laboratory Standards. 1997. Methods for
dilution antimicrobial susceptibility tests for bacteria that grow aerobically,
4th ed. Approved standard. NCCLS document M7-A4. National Committee
for Clinical Laboratory Standards, Villanova, Pa.
11. Tanzer, M., J. Miller, and G. K. Richards. 1994. Preoperative assessment of
skin colonization and antibiotic effectiveness in total knee arthroplasty. Clin.
Orthop. Relat. Res. 299:163-168.
12. Tunney, M. M., S. Patrick, S. P. Gorman, J. R. Nixon, N. Anderson, R. I.
Davis, D. Hanna, and G. Ramage. 1998. Improved detection of infection in
hip replacements: a currently underestimated problem. J. Bone Joint Surg.
80:568-572.
13. Weber, F. A., and E. E. G. Lautenbach. 1986. Revision of infected total hip
arthroplasty. Clin. Orthop. Relat. Res. 211:108-115.
39
Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon J, Gorman
SP, Davis RI and Anderson N.
1999a.
Detection of prosthetic hip infection at revision arthroplasty by
immunofluorescence microscopy and polymerase chain reaction amplification
of bacterial 16S rRNA gene.
Journal of Clinical Microbiology 37, 3281-3290.
Journal of Clinical Microbiology, Oct. 1999, p. 3281-3290
0095-1137/99/S04.00 + 0
Copyright © 1999, American Society for Microbiology. All Rights Reserved.
Vol. 37, No. 10
Detection of Prosthetic Hip Infection at Revision Arthroplasty
by Immunofluorescence Microscopy and PCR Amplification of
the Bacterial 16S rRNA Gene
MICHAEL M. TUNNEY,1 SHEILA PATRICK,1* MARTIN D. CURRAN,5 GORDON RAMAGE,1
DONNA HANNA,1 JAMES R. NIXON,4 SEAN P. GORMAN,2 RICHARD I. DAVIS,5
and NEIL ANDERSON5
Department of Microbiology and Immunobiology, School of Clinical Medicine, The Queen's University of Belfast,
Belfast BT12 6BNf Regional Histocompatibility and Immunogenetics Laboratory, Belfast City Hospital, Belfast BT9
7TS,3 Withers Orthopaedic Centre, Musgrave Park Hospital, Belfast BT9 7JB,4 School of Pharmacy, The Queen's
University of Belfast, Belfast BT9 7BL,2 and Department of Pathology, The Royal Group of Hospitals
and Dental Hospital Health and Social Services Trust, Belfast BT12 6BA,S United Kingdom
Received 19 January 1999/Returned for modification 2 May 1999/Acceptcd 26 June 1999
In this study the detection rates of bacterial infection of hip prostheses by culture and nonculture methods
were compared for 120 patients with total hip revision surgery. By use of strict anaerobic bacteriological
practice during the processing of samples and without enrichment, the incidence of infection by culture of
material dislodged from retrieved prostheses after ultrasonication (sonicate) was 22%. Bacteria were observed
by immunofluorescence microscopy in 63% of sonicate samples with a monoclonal antibody specific for
Propionibacterium acnes and polyclonal antiserum specific for Staphylococcus spp. The bacteria were present
either as single cells or in aggregates of up to 300 bacterial cells. These aggregates were not observed without
sonication to dislodge the biofilm. Bacteria were observed in all of the culture-positive samples, and in some
cases in which only one type of bacterium was identified by culture, both coccoid and coryneform bacteria were
observed by immunofluorescence microscopy. Bacteria from skin-flake contamination were readily distinguish¬
able from infecting bacteria by immunofluorescence microscopy. Examination of skin scrapings did not reveal
large aggregates of bacteria but did reveal skin cells. These were not observed in the sonicates. Bacterial DNA
was detected in 72% of sonicate samples by PCR amplification of a region of the bacterial 16S rRNA gene with
universal primers. All of the culture-positive samples were also positive for bacterial DNA. Evidence of
high-level infiltration either of neutrophils or of lymphocytes or macrophages into associated tissue was
observed in 73% of patients. Our results indicate that the incidence of prosthetic joint infection is grossly
underestimated by current culture detection methods. It is therefore imperative that current clinical practice
with regard to the detection and subsequent treatment of prosthetic joint infection be reassessed in the light
of these results.
Over 50,000 total hip replacement operations are performed
annually in the United Kingdom and about 200,000 are per¬
formed annually in the United States. The majority of patients
undergoing hip replacement experience dramatic relief of pain
and restoration of satisfactory hip function (15). A proportion
(approximately 20% in Europe [6]) fail, and prosthesis removal
and replacement are usually required, with attendant patient
trauma and increased medical costs (9). Aseptic mechanical
loosening is reported to be the most common cause of pros¬
thetic joint failure (15), after which standard bacteriological
culture of specimens from periprosthetic tissue or aspirates is
used to detect infection. Estimates of the incidence of infection
as a cause of hip failure are usually in the range of 10% (12) to
15% (20), although some studies report an incidence as low as
2% (3) of all revision operations. Failure of the second implant
postrevision, however, may be due to infection in up to 40% of
patients (10). It has been suggested that the higher rate of
infection postrcvision could be due to a longer operating time,
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University of Belfast, Grosvenor Rd„ Belfast BT12 6BN, United King¬
dom. Phone: 01232-263205. Fax: 01232-439181. E-mail: s.patrick@qub
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increased scar tissue formation, or unrecognized infection at
the initial revision operation. Our recent study at The Queen's
University of Belfast (37) implicates unrecognized infection as
a major cause of prosthetic joint failure. In this study, which
was the first to combine sampling by mild ultrasonication to
dislodge the bacteria growing within adherent biofilms on the
surface of the removed prosthesis with the use of strict anaer¬
obic techniques, we cultured bacteria from 22% of retrieved
prostheses (26 of 120 implants). Detection of infections which
arise from opportunistic pathogens of the normal microbiota,
in particular, the skin, is always problematic, as a clear distinc¬
tion must be made between infection and potential contami¬
nation. This is particularly the case when broth enrichments
are used. Our prosthetic joint isolates were obtained by direct
plating of the dislodged material onto agar plates and not as a
result of broth enrichment. Also, ultrasonication to dislodge
the biofilm was required to detect infection by culture. Fur¬
thermore, mock processing of a number of autoclaved implants
failed to detect any bacteria. It is therefore highly unlikely that
the bacteria isolated were present in the sample as a result of
exogenous contamination.
Review of the notes for 18 of the 26 patients with culture-
positive implants revealed that infection was suspected as the
cause of loosening in only 6 patients. Joint fluid, aspirated
prcoperatively and prior to antibiotic administration, and tis-
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sue removed at the time of surgery were processed by the
routine clinical laboratory. In only two patients was infection
confirmed and were bacteria cultured. In our laboratory, viable
bacteria were isolated from only five tissue samples corre¬
sponding to prostheses from which bacteria were isolated. This
lack of bacteria in cultures of the tissue samples may be due to
either the bacteriostatic or the bactericidal effects of cefaman-
dole administered at the time of operation or the host's de¬
fenses. In contrast, bacteria growing within a biofilm on device
surfaces have greater resistance to antibiotics (40). Investiga¬
tion of the antibiotic sensitivity of our isolates indicated that
the majority were more than 1,000 times more resistant (min¬
imum bactericidal concentration, >1,024 |rg/ml) to cefaman-
dole when growing within in vitro model biofilms than when
growing in broth culture (39, 40). These results suggest that the
device materials are the major sites colonized by the bacteria in
this type of infection and highlight the importance of sampling
directly from the prosthesis. In our study the anaerobic bacte¬
rium Propionibacterium acnes was isolated either alone or in
association with Staphylococcus spp. from 62% of patients.
Other published studies report either very low isolation rates
for anaerobic bacteria (2) or failure to isolate any (1, 13). This
indicates that adherence to strict anaerobic bacteriological
practice can increase the detection of prosthetic joint infection
and alter our perception of the major causative organisms.
When pathological examination of associated tissue has
been carried out, a good correlation between detection of
infection by culture and the presence of neutrophilic polymor¬
phonuclear leukocytes in the tissue has been obtained (1, 12,
13, 28). For example, a recent study which involved the detec¬
tion of infection by both culture and histological assessment of
a tissue inflammatory response in five or six tissue specimens
reported that 41 of 297 (14%) patients were infected (2). It has
been suggested that the observation of neutrophilic infiltration
in the associated tissues is a useful means of diagnosing pros¬
thetic joint infection.
Our studies of the inflammatory response in associated tis¬
sues showed that in eight of the culture-positive patients neu¬
trophils were not detected, although lymphocytes or macro¬
phages were present. It may be that the lymphocyte or
macrophage infiltration is in response to the slow release of
bacterial components from a bacterial biofilm growing on the
device surface. Histopathological examination of associated
tissue samples taken from culture-negative patients showed
that 8 had evidence of a high level of neutrophilic infiltration
and that a further 36 with low levels or no evidence of neutro¬
phils had large numbers of lymphocytes or macrophages. In
total, 87% of our culture-negative patients had evidence either
of neutrophilic or of lymphocyte or macrophage infiltration
into tissue and may have been infected. These results suggest
that even with improved sampling procedures the detection of
infection by culture may still be an underestimate of the real
incidence of infection. Our study highlights potential inade¬
quacies in current clinical diagnostic methodology (37).
The detection of bacterial rRNA genes as an indicator of the
presence of bacteria is an established technique that has been
used for the detection of both environmental and medically
important bacteria (17,42). PCR amplification of bacterial 16S
rRNA genes has been used successfully to detect bacteria that
cause a variety of infections including postoperative endoph¬
thalmitis (19, 24), septic arthritis (5), and meningitis (30). In
infections such as those of prosthetic joints, however, in which
the infectious agents are opportunistic pathogens that may be
members of the normal microbiota (e.g., the skin), the poten¬
tial contamination of samples must be addressed. The direct
immunological detection of bacteria in clinical samples can be
achieved by the use of monoclonal antibodies (MAbs) and
polyclonal antiserum prepared against the bacteria implicated
in the clinical infection (32). This technique allows the direct
visualization of the bacterial morphology and visual compari¬
son with potential skin-flake contamination.
The aim of the present study was, first, to determine if
prosthetic hip infection could be detected reliably by noncul-
ture methods with culture-positive samples. Second, in the
light of the inflammatory response in the associated tissues, the
aim of the study was to ascertain if nonculturable bacteria were
present in culture-negative patient samples. We therefore
compared the use of (i) immunolabelling in conjunction with
fluorescence microscopy and (ii) PCR amplification of a region
of the bacterial 16S rRNA gene for the detection of prosthetic
hip infection while taking suitable steps to eliminate and to
control for potential contamination by bacteria of the normal
microbiota.
MATERIALS AND METHODS
Clinical sample collection and processing. One hundred twenty prosthetic hip
implants were retrieved from patients undergoing revision hip surgery at Mus-
grave Park Hospital, Belfast, United Kingdom, during the 14-month period from
March 1996 to April 1997. All patients underwent standardized preoperative
hygiene procedures. Following skin preparation with Betadine (Seton Health¬
care, Oldham, United Kingdom) the incision area was covered with an adhesive
plastic drape. All operations were carried out in operating theaters in which a
vertical laminar air flow provided a clean environment and all members of the
operating team wore disposable impervious drapes. Routine antibiotic prophy¬
laxis consisted of 2 g of cefamandole (Kefadol; Dista Products Ltd., Basingstoke,
United Kingdom) given intravenously at the time of anesthetic induction. Fur¬
ther 1-g doses of cefamandole were given 8 and 16 h after surgery. Cefamandole
is recommended by the British National Formulary for surgical prophylaxis. It is
a broad-spectrum antibiotic active against both gram-positive and gram-negative
bacteria. On removal, the surgeon aseptically placed the femoral and acetabular
components in separate sterile bags. Tissue in contact with the implants was also
removed and placed in sterile bottles. The femoral and acetabular components
and the tissue samples were immediately placed in an anaerobic jar for trans¬
portation to an anaerobic cabinet (37).
Bacterial isolation and identification. Samples were handled within the closed
atmosphere of an anaerobic cabinet (Don Whitley Mk. Ill anaerobic cabinet;
80% N2, 10% C02, and 10% H2; Don Whitley Scientific Ltd., Shipley, United
Kingdom). The gas atmosphere of the cabinet was continuously pumped through
a solution of 2% glutaraldehyde, and operators wore surgical gloves throughout
processing. Bacteria growing within adherent biofilms on the surface of the
prostheses were dislodged by mild ultrasonication (5 min, 50 Hz) into Ringer's
solution (25% [vol/vol]) containing cysteine (0.05% [vol/vol]) as a reducing agent
(37). This procedure has been shown to have no effect on the viability of pure
culture isolates. The use of Ringer's solution rather than broth as a diluent
ensured that the bacteria did not multiply within the sonicate prior to further
processing. Determination of total viable bacterial counts was performed as
follows: Volumes (0.5 ml) of sonicate were plated onto each of five blood agar
(BA) and five anaerobic blood agar (ABA) plates. A known weight of tissue was
homogenized (3 min) in Ringer's solution (25% [vol/vol], 5 ml). Three 0.5-ml
volumes of homogenized tissue were plated onto BA and ABA plates. The
remaining volume of homogenized tissue was added in equal amounts to tryp-
tone soy broth (TSB) and cooked meat broth (CMB) for enrichment. BA and
ABA plates were incubated at 37°C aerobically and anaerobically, respectively,
and were examined after 1, 2, 4, and 7 days. Samples were recorded as positive
if colonies were observed on a minimum of four of the five plates. The TSB and
CMB were incubated at 37°C aerobically and anaerobically, respectively. Both
broths were subcultured on days 7 and 14: on BA for aerobic incubation and on
ABA for anaerobic incubation. All plates were incubated at 37°C for 48 h. To
determine the likelihood that contaminating bacteria were introduced during the
sampling procedure, 20 retrieved orthopedic implants were sterilized in a hot-air
oven and were processed as described above. In addition, three researchers in
our laboratory scraped flakes from the surfaces of their skin into sterile bags
containing Ringer's solution, which were then processed as described above.
Pure bacterial cultures, obtained by picking isolated colonies from the viable
count plates, were identified with commercially available kits. Cultures were
stored both on Protect Bacterial Preservers (Technical Service Consultants Ltd.,
Heywood, United Kingdom) at — 70°C and on Mueller-Hinton agar slopes at
4°C, which were subcultured at 3-month intervals. The remaining sonicate from
each sample was centrifuged (1,000 X g, 20 min), and the concentrated sonicate
was stored in 1-ml aliquots at — 70°C for further analysis.
Bacterial strains. The strains used in this study were Bacteroides fragilis NCTC
9343 (National Collection of Type Cultures, Colindale, United Kingdom); Pep-
tostreptococcus magnus NCTC 11804; Peptostreptococcus micros NCTC 11808;
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Escherichia coli 0128, kindly supplied by C. Smyth, Trinity College Dublin,
Ireland; and Corynebacterium diphtheriae, Corynebacterium hofmanni, and
Corynebacterium xerosis from the culture collection of the Department of Micro¬
biology and Immunobiology, School of Clinical Medicine, The Queen's Univer¬
sity of Belfast. The clinical isolates used in this study (Staphylococcus aureus,
Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus capitis, Pro-
pionibacterium acnes, and Micrococcus sp.) were all isolated at the Department of
Microbiology and Immunobiology, School of Medicine, from retrieved prosthetic
hip implants as described above (37).
Immunological detection of bacteria, (i) Production of polyclonal antisera. A
New Zealand White rabbit was immunized with whole cells of S. epidermidis. The
rabbit was inoculated subcutaneously at four sites on the back with 0.1 ml of a
bacterial suspension of 108 CFU/ml in 0.01 M phosphate-buffered saline (PBS
[pH 7.4]; 0.15 M NaCl, 0.0075 M Na2HP04, 0.0025 M NaH2P04 • 2H20). Two
further inoculations of bacteria in PBS were made at approximately monthly
intervals, and the rabbit was test bled 2 weeks after the final inoculation. The
reactivity of the antiserum was then tested by immunofluorescence microscopy
(IFM) as described previously (23).
(ii) Production of MAbs. Four BALB/c mice were immunized with whole cells
of two P. acnes strains. The mice were inoculated intraperitoneally with 0.2 ml of
a bacterial suspension of 108 CFU/ml in 0.01 M PBS. Further 0.2-ml inoculations
were given after 1 month. Serum was tested by immunofluorescence after 3 days,
and the mice with the highest titer of antiserum were inoculated again 1 week
later. One mouse was killed after 5 days, and the spleen cells from the mouse
were fused with P3X 63 Ag8-653 (NS-0/1) mouse myeloma cells by a modifica¬
tion of the method of Galfre and Milstein (16) as described previously (23).
Hybridoma cell lines, which produced P. acnes-specific antibodies, were then
cloned by limiting dilution (18).
(iii) IFM. A modification of the IFM procedure described by Lutton et al. (23)
was used. Samples of sonicate obtained from prosthetic joints (1 ml) were further
centrifuged (10,000 X g; 20 min), and the resulting pellets were resuspended in
100 (jlI of PBS. Samples (10 pi) were then applied in duplicate to multiwell slides.
The slides were air dried and then fixed in 100% methanol for 10 min at -20°C.
The slides were dually labelled for IFM with a combination of MAb QUBPa3
supernatant, which reacted with all P. acnes strains isolated in our previous study,
and S. epidermidis polyclonal antiserum, which reacted with all Staphylococcus
spp. strains isolated in our previous study (37). The reactivity of MAb QUBPa3
with S. aureus, S. epidermidis, B. fragilis, E. coli, P. magnus, P. micros, C. diph¬
theriae, C. hofmanni, and C. xerosis was also tested. Similarly, the reactivity of the
S. epidermidis polyclonal antiserum with B. fragilis, E. coli, and the gram-positive
anaerobic cocci P. magnus and P. micros was tested. For dual labelling, the slides
were incubated with undiluted MAb QUBPa3 supernatant, washed, and incu¬
bated with rabbit anti-S1. epidermidis polyclonal antiserum diluted 1 in 200 in PBS.
The slides were again washed and then incubated simultaneously with sheep
anti-rabbit fluorescein conjugate (Sigma) and goat anti-mouse rhodamine con¬
jugate (Sigma). After a final wash, all slides were mounted with glycerol-PBS
containing an antiphotobleaching agent (Citifluor; Agar Scientific Ltd, Essex,
United Kingdom) and were examined with a Leitz fluorescent microscope.
For clinical sonicate samples the detection of bacteria on duplicate wells by
immunofluorescence was given a score of between 0 and 3 by using the following
criteria: 0, no bacteria; 1, 1 to 10 bacteria/well; 2, 10 to 50 bacteria/well; 3, 50 or
more bacteria/well.
To determine whether bacteria detected by immunofluorescence in concen¬
trated sonicate samples could have resulted from skin-flake contamination, skin
from researchers working at the Department of Microbiology and Immunobiol¬
ogy, School of Clinical Medicine, was scraped with sterile scalpels into 1-ml
volumes of PBS. These were then processed in the same way as the sonicate
samples and were examined by dual-labelling IFM.
(iv) CSLM. Selected wells were examined by confocal scanning laser micros¬
copy (CSLM) with a Leica NCS-NT confocal scanning laser microscope.
Molecular detection of bacteria, (i) PGR sensitivity. Sensitivity tests were
performed with E. coli, B. fragilis, and all the organisms isolated from retrieved
orthopedic implants and listed above. Facultative isolates were grown on BA at
37°C for 24 h, and anaerobic isolates were grown on ABA in the anaerobic
cabinet for a similar time period. Single colonies of each isolate were inoculated
into TSB (10 ml); B. fragilis, however, was inoculated into defined minimal
medium (41). Isolates were incubated as described above, and the actively grow¬
ing cultures were adjusted to an optical density at 540 nm equivalent to 108
CFU/ml and were diluted in 10-fold serial dilutions with PBS. Viable cells were
counted as the number of CFU by triplicate plating of diluted samples on either
BA or ABA and counting the colonies after incubation at 37°C for 24 h. From
10-fold serial dilutions containing from 108 to 10° CFU/ml, 1-ml volumes were
retained for DNA extraction.
(ii) PCR laboratory conditions and control measures. PCR was carried out
under stringent conditions in a hospital diagnostic laboratory accredited by the
American Society for Histocompatibility and Immunogenetics. All DNA manip¬
ulations pre- and post-PCR were performed in separate designated rooms with
separate pipetting devices to avoid contamination of the samples with foreign
DNA. Furthermore, as in other studies (4, 27), UV light was used to irradiate all
equipment used in the preamplification steps to prevent contaminating DNA
from causing false-positive results. Master-mixture water controls and DNA
extraction controls were used for every batch of samples processed.
TABLE 1. Comparison of the detection rates of prosthetic hip








Culture of tissue only 120 5 4
Culture of tissue and implants" 120 26 22
Immunofluorescence microscopy 113 71 63
16S rRNA gene amplification 118 85 72
Inflammatory cell infiltration 81 59'' 73
a Use of mild ultrasonication to dislodge bacteria growing within adherent
biofilms and strict anaerobic procedures.
b Inflammatory score greater than 1.
(iii) DNA extraction. Aliquots (1 ml) of prosthesis sonicate or bacterial culture
were centrifuged at 10,000 X g for 15 min. The pellets were resuspended by
vortex mixing in 200 pi of cell lysis buffer (10 mM Tris-HCl [pH 8.0], 5 mM
EDTA, 0.5% sodium dodecyl sulfate, proteinase K [100 pg/mlj). This reaction
took place at 55°C for 3 h, after which the temperature was adjusted to 37°C and
the reaction mixture was incubated overnight. The temperature of the samples
was increased to 55°C for 1 h before DNA extraction was performed by the
addition of equal volumes of saturated phenol-chloroform. After vortex mixing
and centrifugation at 10,000 X g for 15 min, the aqueous phase was removed and
the DNA was precipitated by the addition of 100% ethanol (2.5 volumes), 3 M
sodium acetate (pH 5.2) (0.1 volume), and 2 pi of See DNA (Amersham,
Aylesbury, United Kingdom). Following brief vortex mixing and centrifugation at
10,000 X g for 15 min, the supernatant was poured off and the DNA pellet was
washed by the addition of 1 ml of 70% ethanol. Following further brief vortex
mixing and centrifugation at 10,000 X g for 15 min, any residual ethanol traces
were removed by vacuum drying. The extracted DNA was then dissolved in 50 pi
of TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA) and was stored at -20°C.
(iv) Oligonucleotide primers. Oligonucleotide primers were synthesized by
Perkin-Elmer-Applied Biosystems, Warrington, United Kingdom. The target
DNA sequence was the 16S rRNA gene. Sequence alignment by the clustal
method with a weighted residue weight table (34) was carried out with the 16S
rRNA genes of the following bacteria: S. capitis, S. epidermidis, Staphylococcus
haemolyticus, P. acnes, Micrococcus agilis, B. fragilis, E. coli, and a Peptostrepto-
coccus sp. The primer set selected was D1 (5'-GAG GAA GGT RGG GAY
GAC GT) and D2 (5'-AGG CCC GGG AAC GYA TTY ACC G) for amplifi¬
cation of a 216-bp fragment of the 16S rRNA gene. The positions of D1 and D2
are 1199 to 1219 and 1394 to 1415 of the E. coli 16S rRNA positions, respectively
(R = AG, Y = CT).
(v) DNA amplification. The PCR mixture, which was made up to 50 pi in
sterile double-distilled water, contained 5 pi of 10X PCR buffer (Perkin-Elmer-
Applied Biosystems), 5 pi of MgCl2 (25 mM), each deoxynucleotide triphosphate
(Pharmacia Biotech, Milton Keynes, United Kingdom) at a concentration of 200
pM, 20 pM each primer, and 3 U of Ampli7a<y polymerase (Perkin-Elmer-
Applied Biosystems). Two microliters of lysate containing target DNA was added
to the PCR mixture, which was incubated at 96°C for 5 min. PCR was performed
for 30 cycles of 1 min at 96°C, 2 min at 55°C, and 1 min at 72°C using a
Perkin-Elmer Gene-Amp PCR System 9600 (Perkin-Elmer-Applied Biosys¬
tems). The final cycle ended with a 5-min extension at 72°C, and the PCR
products were stored in the thermocycler at 15°C until they were collected.
After amplification, 6 pi of the amplified product was run on a 1.5% agarose
gel in lx Tris-borate-EDTA. DNA bands were detected by ethidium bromide
staining and were visualized by UV light photography.
RESULTS
Incidence of infection. Our results indicate that the use of
nonculture methods as opposed to culture methods signifi¬
cantly (P < 0.05; chi-square test) increases the level of detec¬
tion of infected prostheses (Table 1). By including only sam¬
ples positive by both IFM and 16S rRNA detection and with an
inflammatory cell infiltration score (see Table 3) of greater
than 1, a conservative estimate for the level of infection in
culture-negative samples is 25 of 94 (27%). In contrast, if all
samples that were positive by either IFM or 16S rRNA detec¬
tion are included, the level of infection increases to 69 of 94
(73%) samples.
Immunological detection of bacteria. MAb QUBPa3, which
reacted with all of the P. acnes strains isolated in our previous
study (37), did not cross-react with S. aureus, S. epidermidis, B.
fragilis, E. coli, P. magnus, P. micros, C. diphtheriae, C. hof-
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FIG. 1. Examples of confocal laser scanning micrographs of bacteria in ma¬
terial removed by ultrasonication (sonicate) from culture-negative hip prostheses
to illustrate coccoid cells present singly and in small groups (a) and in a large
aggregate (b). Bacteria were labelled with anti-Staphylococcus spp. polyclonal
antiserum and an anti-P. aoies-specific MAb, followed by labelling with suitable
fluorescently conjugated secondary antibodies.
manni, or C. xerosis by IFM. Similarly, the polyclonal anti-
serum raised to S. epidermidis, which reacted with all Staphy¬
lococcus strains isolated in our previous study (37), did not
cross-react with B. fragilis, E. coli, P. magnus, or P. micros.
Bacteria were observed singly, in small groups, and in large
aggregates by IFM (Fig. la and b). In addition, both P. acnes
and Staphylococcus spp. were found together in large aggre¬
gates in several instances (Fig. 2a and b). The aggregates were
between 3 and 4.5 |xm in depth, as estimated by CSLM, and
consisted of several layers of bacterial cells (Fig. 3). These
aggregates were observed only after ultrasonication of the
prostheses. When a selected number of prostheses were placed
J. Clin. Microbiol.
FIG. 2. Confocal laser scanning micrographs of sonicates obtained from cul¬
ture-negative hip prostheses to illustrate a large number of coccoid cells associ¬
ated with a smaller number of coryneform cells (a) and a large number of
coryneform cells associated with a smaller number of coccoid cells (b) labelled as
described in the legend to Fig. I.
in Ringer's solution and the solution was removed and pro¬
cessed without ultrasonication, the occasional individual bac¬
terial cell was observed in samples in which large aggregates
were observed after ultrasonication. No bacteria were visible
by IFM when three researchers at the Department of Micro¬
biology and Immunobiology, School of Clinical Medicine,
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FIG. 3. Confocal laser scanning micrograph illustrating the depth of the
dislodged biofilm aggregate of coccoid cells shown in Fig. lb. The series of
images were captured at 0.5-pm intervals from the top (image in the box) to the
bottom (images displayed left to right) of the aggregate. The depth of this
aggregate was estimated to be 3.5 fxm.
scraped their skin flakes into the bags containing Ringer's
solution that are normally used for the retrieved prostheses,
and the contents of the bags were then processed in the same
manner as bags containing prostheses. Concentrated skin
scrapings were also applied to microscope slides and were
processed for IFM. No large aggregates of bacteria which
resembled those observed in the sonicates were detected. IFM
revealed sparse small groups of bacteria (up to live or six cells),
some isolated bacterial cells, and skin cells (Fig. 4). Skin cells
were not observed in sonicates.
All 24 clinical sonicate samples which were positive by cul¬
ture were also positive by IFM (Table 2). In 11 of the samples
the same bacteria that had been isolated by culture were de¬
tected by IFM. A further 11 samples that were positive by
culture for either a Staphylococcus sp. or P. acnes were positive
for both organisms by IFM.
Bacteria were also detected by IFM in 47 of the 89 (53%)
culture-negative samples examined. Staphylococcus spp. and P.
acnes were detected alone in 20 and 19 samples, respectively,
and both organisms were detected in a further 8 samples (Ta¬
ble 3). Staphylococcus spp. were found in greater quantity than
P. acnes, with 17 of the 20 Staphylococcus-positive samples
having IFM scores of 2 or 3, which corresponds to between 10
and greater than 50 bacteria per field of view. In comparison,
only 3 of 19 P. acnes-positive samples had a similar score.
Molecular detection of bacteria. The lower limits of detec¬
tion of S. aureus, S. epidermidis, S. hominis, S. capitis, P. acnes,
Micrococcus spp., E. coli, and B. fragilis bacterial cells by PCR
amplification of a region of the bacterial 16S rRNA gene were
examined. Results indicated that, by our protocol, P. acnes and
Micrococcus spp. were detected only at concentrations greater
than or equal to 10s CFU/ml (data not shown). The remaining
six organisms could be detected if they were present in num¬
bers greater than or equal to 104 CFU/ml (data not shown).
FIG. 4. Immunofluorescence micrographs of material scraped from skin il¬
lustrate an isolated bacterial cell and a skin cell (a) and a small group of bacteria
(b). Immunolabelling was carried out as described in the legend to Fig. 1.
Bacterial DNA was amplified from sonicate samples of all 25
implants which were culture positive (Table 2). Bacterial DNA
was also amplified from sonicate samples of 60 of the 93 (65%)
culture-negative implants examined (Table 3).
Comparison of tissue pathology and immunological and
molecular detection. All 25 of the culture-positive samples
were also positive by IFM and 16S rRNA gene amplification.
Tissue pathology results were available for 18 of these patients,
and in 8 of these patients neutrophilic infiltration was not
observed. Lymphocytes or macrophages were, however, ob¬
served in all 18 patients (Table 2). A giant cell-foreign body
reaction was also noted in three of the culture-positive tissue
samples.
Of the 94 culture-negative samples, 38 (40%) were positive
by both IFM and 16S rRNA gene amplification. Tissue pathol¬
ogy was available for 32 of the 38 samples, and there was
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TABLE 2. Bacteria detected from culture-positive retrieved prosthetic hip implants by culture, 1FM, and bacterial 16S rRNA gene detection
and associated tissue inflammatory response
Tissue infiltration by inflammatory IF.. .
c i D t • / \ - i + a cells (score)" resu 16S rRNA geneSample no. Bactermm(a) isolated ' I detection
PMN4, I.YNf MAC' Morphology Score"
1 5. epidermidis 1 1 2 Cocci 3 +
2 S. epidermidis 2 1 3 Cocci 3 +
3 S. aureus 0 1 0 Cocci 2 +
4 S. capitis 0 0 1 Cocci 1 +
5 S. epidermidis 0 1 2 Cocci and P. acnes 2 +
6 S. hominis 0 1 2 Cocci and P. acnes 1 +
7 S. epidermidis 1 1 3 P. acnes 2 +
8 S. epidermidis and S. hominis 0 2 3 Cocci 2 +
9 S. epidermidis and S. hominis 1 2 3 Cocci 2 +
10 S. epidermidis and S. capitis 2 2 2 Cocci and P. acnes 1 +
11 P. acnes 2 2 3 P. acnes 1 +
12 P. acnes 1 1 1 P. acnes 1 +
13 P. acnes NS'' NS NS P. acnes 3 +
14 P. acnes 0 2 3 Cocci and P. acnes 2 +
15 P. acnes 0 1 2 Cocci and P. acnes 2 +
16 P. acnes 2 2 3 Cocci and P. acnes 1 +
17 P. acnes NS NS NS Cocci and P. acnes 3 +
18 P. acnes NS NS NS Cocci and P. acnes 3 +
19 P. acnes NS NS NS Cocci and P. acnes 1 +
20 P. acnes NS NS NS Cocci and P. acnes 1 +
21 P. acnes NS NS NS Cocci and P. acnes 1 +
22 P. acnes 0 1 2 NDl; ND +
23 S. haemolyticus and P. acnes 1 1 1 Cocci and P. acnes 1 +
24 Micrococcus sp. and P. acnes 1 2 3 Cocci and P. acnes 1 +
25 S. epideimidis and P. acnes NS NS NS Cocci 1 +
" Number of inflammatory cells per high-power field: 0, no cells; 1, 1 to 10 cells; 2, 10 to 20 cells; 3, 20 or more cells.
b PMN, polymorphonuclear leukocyte.
c LYM, lymphocyte.
d MAC, tissue macrophage.
' Number of bacteria per well: 0, no bacteria; 1, 1 to 10 bacteria; 2, 10 to 50 bacteria; 3, 50 or more bacteria.
'' NS, not suitable for histological examination.
KND, not done due to insufficient sample volume.
evidence of inflammatory cell infiltration in 29 samples. Two of
the three samples in which tissue infiltration was not observed
had IFM scores of 3, equivalent to 50 or more bacteria per well
(Table 3). Neutrophilic infiltration was not observed in 12 of
the 29 samples, although lymphocytes or macrophages were
evident. A further eight samples were negative by 16S rRNA
gene amplification but positive by immunolabelling, and one of
these eight samples was also negative for inflammatory cell
infiltration.
Seventeen samples were positive by 16S gene amplification
but negative by IFM. Tissue pathology was available for only
seven of these samples, and cell infiltration was observed in
four samples. Tissue pathology results were available for 15
samples which were negative by both IFM and 16S rRNA gene
detection. There was evidence of a giant cell-foreign body
reaction in one of these, and the inflammatory cell score was
zero for only one sample. Tissue pathology was not available
for the remaining 12 culture-, IFM-, and 16S rRNA gene
amplification-negative samples.
DISCUSSION
This study is the first to compare immunological and DNA
detection methods with culture for the detection of bacterial
infection of retrieved prosthetic hip joints. Bacteria were de¬
tected by immunolabelling and fluorescence microscopy with a
P. acnes-specific MAb and polyclonal antiserum specific for
Staphylococcus spp. only after the retrieved prostheses were
subjected to mild ultrasonic treatment to dislodge the bacteria
growing within a biofilm on the prosthetic joint surface. By this
method bacteria were detected in all of the samples which were
positive by culture and in 53% of the culture-negative samples.
Bacteria, either coccoid or coryneform in morphology, were
clearly visible by IFM. These were recorded as containing
either P. acnes or Staphylococcus spp. due to the lack of cross-
reactivity of the antibodies with other coccoid bacteria which
are implicated in prosthetic implant infection, such as P. mag-
nus (14) and other commensal and pathogenic coryneform
bacteria. Therefore, the total number of samples positive by
immunodetection was 71 of 113 (63%).
Previously, we have observed bacterial biofilms on retrieved
prostheses by scanning electron microscopy (37); however,
processing for scanning electron microscopy precludes exami¬
nation of the biofilm by other methods. The use of CSLM in
the present study showed that bacteria dislodged from im¬
plants by ultrasonication could be found in aggregates that
varied in depth from 3 to 4.5 p,m and that consisted of several
layers of bacterial cells. It therefore seems that infecting bac¬
teria growing within adherent biofilms are removed in large
aggregates by the ultrasonication procedure. As the diluent
used throughout was Ringer's salt solution, no enrichment was
involved. Samples were also stored at — 70°C; therefore, these
aggregates could not have arisen as a result of multiplication of
contaminating bacteria. It is worth noting that as these aggre¬
gates may contain over 300 bacteria, our estimates of the num¬
ber of bacteria infecting an implant (37), calculated by total
viable colony count per implant, are likely to be a gross un-
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TABLE 3. Bacteria detected from culture-negative retrieved prosthetic hip implants by IFM and bacterial 16S rRNA




















detectionPMN" LYM" MAC Morphology Score6 PMN LYM" MAC Morphology Score6
1 1 2 3 Cocci 3 + 38 3 1 1 P. acnes 1 _
2 1 2 3 Cocci 3 + 39 NS NS NS P. acnes 1 ND*
3 0 2 0 Cocci 3 + 40 1 3 3 Cocci and P. acnes 3 +
4 0 0 0 Cocci 3 + 41 0 0 0 Cocci and P. acnes 3 +
5 3 3 2 Cocci 2 + 42 2 2 3 Cocci and P. acnes 2 +
6 1 3 3 Cocci 2 + 43 1 2 3 Cocci and P. acnes 2 +
7 0 2 3 Cocci 2 + 44 0 2 2 Cocci and P. acnes 2 +
8 0 1 1 Cocci 2 + 45 1 1 2 Cocci and P. acnes 1 +
9 1 2 3 Cocci 2 + 46 0 2 3 Cocci and P. acnes 1 +
10 0 2 3 Cocci 2 + 47 NS NS NS Cocci and P. acnes 2 -
11 0 2 2 Cocci 1 + 48 1 2 3 0 +
12 0 1 3 Cocci 1 + 49 1 1 3 0 +
13 NS« NS NS Cocci 2 + 50 1 1 2 0 +
14 NS NS NS Cocci 2 + 51 0 1 1 0 +
15 NS NS NS Cocci 1 + 52 0 0 0 0 +
16 1 2 3 Cocci 3 - 53 0 0 0 0 +
17 1 2 3 Cocci 3 - 54 0 0 0 0 +
18 1 2 1 Cocci 2 - 55 0 1 3 ND +
19 NS NS NS Cocci 3 - 56 0 1 2 ND +
20 NS NS NS Cocci 3 - 57 0 1 2 ND +
21 2 2 3 P. acnes 2 + 58 0 0 3 ND +
22 1 2 3 P. acnes 2 + 59 0 0 0 ND +
23 2 2 3 P. acnes 1 + 60 2 3 3 0 -
24 2 2 3 P. acnes 1 + 61 1 3 3 0 -
25 3 2 2 P. acnes 1 + 62 1 2 3 0 -
26 1 2 3 P. acnes 1 + 63 1 2 3 0 -
27 1 2 3 P. acnes 1 + 64 1 2 2 0 -
28 0 1 2 P. acnes 1 + 65 0 2 3 0 -
29 0 1 2 P. acnes 1 + 66 0 2 3 0 -
30 1 1 1 P. acnes 1 + 67 1 1 2 0 -
31 0 1 1 P. acnes 1 + 68 1 1 1 0 -
32 0 0 1 P. acnes 1 + 69 0 1 1 0 -
33 0 0 0 P. acnes 1 + 70 0 1 1 0 -
34 NS NS NS P. acnes 1 + 71 0 0 1 0 -
35 NS NS NS P. acnes 1 + 72 0 0 1 0 -
36 NS NS NS P. acnes 1 + 73 0 0 0 0 -
37 0 0 0 P. acnes 3 —
a A further 21 samples not suitable for histological examination were negative by IFM, of which 10 were positive and 11 were negative by 16S rRNA gene detection.
6 Number of inflammatory cells per high-power field: 0, no cells: 1, 1 to 10 cells; 2, 10 to 20 cells; 3, 20 or more cells.
' PMN, polymorphonuclear leukocyte.
d LYM, lymphocyte.
e MAC, tissue macrophage.
"Number of bacteria per well: 0, no bacteria; 1, 1 to 10 bacteria; 2, 10 to 50 bacteria; 3, 50 or more bacteria.
s NS, not suitable for histological examination.
h ND, not done due to insufficient sample volume.
derestimate. Each bacterial aggregate will give rise to only 1
CFU, and therefore, the total number of bacteria colonizing
the implant will be considerably more than the number of CFU
counted. Examination for potential skin-flake contamination,
generated by scraping and rubbing the skin surfaces of labo¬
ratory personnel, showed that bacteria present as a result of
this type of contamination should have been easily distinguish¬
able by IFM from bacterial aggregates dislodged from the
prosthesis biofilm. Skin cells were not observed in the soni¬
cates. Examination of skin scrapings revealed few bacteria and
no large aggregates. The estimated density of P. acnes ranges
from 102 to 105 per cm2 of skin (26), and propionibacteria
account for approximately half of the total skin microbiota
(35). It would therefore take gross skin contamination for this
to be visible by immunofluorescence microscopy. Contamina¬
tion of the prostheses by the skin of the patient, surgical op¬
erating staff, or laboratory personnel should have easily been
detectable. Furthermore, if prostheses were placed in diluent
which was then aspirated, without sonication, bacterial aggre¬
gates were not detected in the diluent. If prostheses were
placed in fresh diluent and then sonicated, bacteria could be
observed in some samples. Sonication was therefore necessary
to remove the adherent bacteria, which again makes it highly
unlikely that the bacteria detected arose from skin contami¬
nants. The contamination of clinical samples by the normal
skin microbiota is a potential problem in clinical diagnostic
procedures involving an enrichment step in which small num¬
bers of contaminants have the opportunity to multiply along
with infecting microbes. We have clearly shown that when no
enrichment step is used and samples are processed in Ringer's
solution rather than broth diluent, it is possible to distinguish
between infecting and contaminating microbes. This is proba-
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bly largely due to quantitative differences; if there are any
contaminating bacteria they are few in number compared to
the number of infecting microbes.
Bacterial 16S rRNA was detected in all culture-positive sam¬
ples by use of two broad-range oligonucleotide primers that
had been designed in order to amplify by PCR rRNA genes
from a wide spectrum of bacteria implicated in prosthetic hip
infection. Bacterial 16S rRNA genes (termed PCR positive)
were detected in all of the culture-positive samples and in a
further 65% of the culture-negative samples. In total, 85 of 118
(72%) samples were positive by PCR. Culture-negative, PCR-
positive samples are unlikely to represent samples with false-
positive results as suitable stringent control procedures were
carried out to ensure that such samples were not positive due
to the presence of contaminating bacterial DNA (4, 27). The
lower limit of detection was also estimated to be approximately
104 CFU/ml. Samples were therefore unlikely to be positive as
a result of exogenous contamination. Various methods could
have been used to increase the efficiency of the PCR, including
the use of nested PCR; however, as these should also have
increased the chance of detecting contaminants, they were not
used. In a comparison of culture and 16S rRNA gene detection
methods for detection of total knee arthroplasty infection, a
similar level of infection was reported. Evidence of bacterial
infection on the basis of PCR amplification of synovial fluid
aspirates was reported for 32 of 50 specimens (64%) (25).
Although the data for the tissue pathology are incomplete,
both the rRNA gene detection and IFM results related well to
the presence of inflammatory cells in implant-associated tissue;
in only three instances was the inflammatory cell score zero. In
two of these the IFM score was high, which suggests that the
negative tissue pathology result may have been due to inade¬
quate tissue sampling (1).
In some instances, although the tissue pathology score was
high, bacteria were only evident in low numbers by IFM. It may
be that some of the bacteria are strongly adherent to the device
and sonication is insufficient to remove them, an observation
we have made with in vitro models of biofilms (38). Also, in
some cases the bacteria may predominantly colonize bone
rather than the prosthesis. Alternatively, any infecting bacteria
may not have reacted with our sera. We are addressing these
issues. The lack of observation of neutrophilic infiltration in
eight of the culture-positive samples, in which lymphocytes or
macrophages were present, suggests that neutrophil infiltration
should perhaps not be used as the sole indicator of infection.
It is likely that prosthetic joint infection may be quite vari¬
able in nature, depending on the type of infecting bacteria,
whether the infection is polymicrobial, and the length of time
that the implant has been infected. When bacteria are preva¬
lent in the surrounding tissues, the infection may be typified by
high levels of neutrophil infiltration in tissue; however, when
the majority of bacteria are growing on the device surface
within a biofilm, the infection may be typified by lymphocyte
and macrophage infiltration. Within the tissues, cells of the
immune system will come into contact with living whole bac¬
terial cells, whereas it is likely that the major immunostimu-
lants of biofilm bacteria will be secreted or released products.
An immunoglobulin response to polysaccharides, thought to
be mainly teichoic acids, released by S. epidennidis is detect¬
able in the serum of patients with prosthetic joint infection
(21). Teichoic acids are well recognized as belonging to the
group of immunomodulatory molecules which may be present
in or released from the bacterial cell envelope (31). Whether
the bacteria involved in these infections, other than S. aureus,
are able to produce other immunomodulatory molecules, such
as superantigen toxins, is unknown. The immunostimulatory
properties of P. acnes are well documented and comparable to
those of bacteria such as Mycobacterium tuberculosis and Bor-
detella pertussis (11). Therefore, low-grade chronic infection
with P. acnes could be sufficient to stimulate the observed
inflammatory cell infiltration. A lack of a neutrophilic inflam¬
matory response is characteristic of diseases such as typhoid
and tuberculosis, which are caused by bacteria which grow
intracellularly (33). Interestingly, there are reports in the lit¬
erature that P. acnes can also grow intracellularly (11). It
should also be noted that the presence of giant cells without
evidence of neutrophils, although indicative of reaction to the
device materials (28), may not necessarily rule out bacterial
infection of the device.
The detection of bacteria in sonicates from patients with
culture-negative implants indicates that these implants were
colonized by bacteria which were not isolated by the microbi¬
ological techniques used. This may be because the implants
were infected with viable but nonculturable bacteria. Interest¬
ingly, in some instances only one type of bacterium was de¬
tected by culture, but both coccoid and coryneform bacteria
were observed by IFM. The possibility that the bacteria were
nonculturable as a result of the cefamandole administered
intravenously at the time of operation must be addressed,
although it is generally considered that bacteria growing within
an adherent biofilm on the implant surface are protected from
antibiotic therapy (36). We examined the antibiotic sensitivi¬
ties of the bacteria that we isolated from prostheses. The
majority were approximately 1,000 times more resistant (min¬
imum bactericidal concentration, >1,024 p.g/ml) to cefaman¬
dole when they were growing within in vitro model biofilms
than when they were growing in broth culture (39, 40). This
indicates that it is unlikely that the cefamandole rendered the
bacteria unculturable. Naylor et al. (29) and Costerton et al.
(7) have previously proposed that alterations of bacterial me¬
tabolism may be responsible for the enhanced antibiotic resis¬
tance of bacteria growing within a biofilm.
The detection of bacterial DNA in culture-negative clinical
samples by PCR amplification despite prolonged antibiotic
therapy resulted in several researchers concluding that antibi¬
otic administration did not eradicate the infecting bacteria but
rendered them nonculturable. For example, Canvin et al. (5)
described a case of septic arthritis in a patient with rheumatoid
arthritis and prosthetic knee joints. Cultures of synovial fluid
from the patient's knees were initially positive for S. aureus but
rapidly became sterile after 1 week of antibiotic therapy. How¬
ever, synovial fluid samples taken until 10 weeks of therapy
showed the persistence of S. aureus by the presence of specific
staphylococcal DNA by PCR, leading the investigators to con¬
clude that either nonviable debris persisted after infection or
that organisms were still viable but rendered nonculturable by
antibiotic administration. Similarly, Ni et al. (30) used PCR to
detect meningococcal DNA in 54 cerebrospinal fluid samples
for which antibiotic administration had prevented isolation by
conventional culture techniques. In the present study, the ob¬
servation of whole bacterial cells by IFM indicates that our
samples do not only contain bacterial DNA debris. Another
possible explanation for the lack of viability is that the bacteria
from the implants are sensitive to mild ultrasonication. Al¬
though pure cultures of laboratory-grown bacteria are not
killed by this level of ultrasound (37), bacteria which have been
growing in vivo and subsequently stressed by removal from the
patient and transportation to the laboratory for processing may
have greater sensitivity.
It is also possible that viable but nonculturable bacteria are
so highly adapted to the environment of the in vivo biofilm that
the conditions required for their continued growth, and there-
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fore successful isolation, are not met by the growth media and
isolation procedures used. In effect, growth within the in vivo
biofilm renders the bacteria more fastidious with respect to
growth requirements. One possible explanation for the diffi¬
culty in the isolation of these bacteria could be the dilution of
bacterial signaling molecules, of which a critical concentration
may be necessary to trigger growth of the bacteria. Quorum
sensing, involving, for example, 7V-acyl homoserine lactones in
gram-negative bacteria (8) and peptide pheromone in gram-
positive bacteria (22), is well characterized. Whether pro¬
longed growth in this environment also results in irreversible
genotypic changes remains an open question. Bacterial patho¬
gens subjected to the highly variable challenge of the human
immune system are well known for genetically based reversible
variation (31); however, bacteria growing for long periods in
what may be a relatively static environment, largely protected
from the immune system, may, in the long term, become less
adaptable.
Advantages and disadvantages are associated with the use of
both 16S rRNA gene amplification and immunolabelling to
detect infection. Benefits of both methods include rapid detec¬
tion of infection when culture techniques have proved ineffec¬
tive and the ability to detect bacteria in clinical samples in the
presence of antimicrobial drugs. The major advantage of
rRNA gene detection is that the use of universal broad-range
primers allows recognition of any bacteria that may be present
and polymicrobial infections can be detected as it is not nec¬
essary to predict which bacteria maybe present. In contrast, for
immunological detection of infection to be effective, the MAbs
and polyclonal antiserum must be prepared against the bacte¬
ria thought to cause the infection, and other bacteria will
therefore not be detected. This could explain why more cul¬
ture-negative samples were positive for infection by rRNA
gene detection than by immunolabelling in the present study.
As well as being a disadvantage, this requirement can also be
an advantage as the identity of the infecting bacteria can be
ascertained immunologically. Also, direct visualization of the
bacterial morphology makes it very unlikely that a false-posi¬
tive diagnosis will be made or, indeed, that contaminating
bacteria will be mistaken for infecting bacteria. In contrast,
bacterial 16S rRNA gene amplification alone does not identify
the infecting bacteria. For definitive identification of infecting
bacteria, the amplification products could be directly se¬
quenced or, in the case of mixed infections, first cloned into E.
coli plasmid vectors and then sequenced.
In conclusion, this study implicates unrecognized infection
as a potential major cause of prosthetic hip failure. IFM allows
a rapid quantitative and qualitative assessment of infected
prostheses and distinguishes the bacteria from the infected
prostheses from bacteria that may result from skin contamina¬
tion. The IFM results indicate that 63% of retrieved hip pros¬
theses may be colonized with bacteria. 16S rRNA genes were
detected from 72% of retrieved prostheses. We are investigat¬
ing the nature of the bacteria detectable by PCR amplification
but not by IFM. The follow-up of these patients with respect to
the successes of the second prostheses is a critical part of our
study; however, the treatment of patients with primary pros¬
theses must be addressed in the short term, given the long-term
nature of this type of infection. Unfortunately, neither of the
nonculture detection methods allows the determination of an¬
timicrobial susceptibility. This limitation can be partly over¬
come, however, by using current knowledge of prosthetic hip
infection as a guide to the expected pathogens and their anti¬
microbial susceptibilities, in particular when they are growing
within biofilms. The improved detection of infection could
then be coupled with appropriate antibiotic therapy for a
longer postoperative period, and this should improve the clin¬
ical outcomes for patients undergoing revision hip surgery.
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determined by the portion of the urinary tract in which the test biomaterial
is destined to reside. For example, there will be more urine flow in the
ureters than in the more stagnant portions of the bladder. Therefore, a
biomaterial being tested for use as a ureteral stent should be tested in more
dynamic conditions to mimic the flow of urine over the biomaterial surface
in vivo. Models such as those described within, especially where urine flow
is involved, will prove useful for testing novel biodegradable biomaterials
for use as urinary prostheses. In practice, urine flow may encourage surface
layers of the degradable polymer to be shed, thereby assisting the removal
of encrusting deposits and adherent microorganisms. Such biomimetic bio¬
materials may have a role to play in the development of improved urinary
tract devices.
[42] Detection of Prosthetic Joint Biofilm Infection Using
Immunological and Molecular Techniques
By Michael M. Tunney, Sheila Patrick, Martin D. Curran,
Gordon Ramage, Neil Anderson, Richard I. Davis,
Sean P. Gorman, and James R. Nixon
Introduction
Total hip replacement is one of the most successful and cost-effective
surgical operations ever devised, with over 50,000 hip replacements per¬
formed annually in the United Kingdom and 200,000 in the U.S. The
majority of patients who undergo hip replacement experience dramatic
relief of preoperative pain and restoration of satisfactory hip function.1 A
proportion (approximately 20% in Europe)2 fail, and prosthesis removal
and replacement (revision hip arthroplasty) is usually required with further
trauma for the patient and increased cost to the Health Service.3 Studies
have reported that between 24 and 15%5 of all revision operations result
from infection of the implant. Unfortunately, the rate of infection is higher
after revision hip arthroplasty than after primary procedures, with as many
as 40% of revised hip joints failing due to infection.6 It has been suggested
1 R. H. Fitzgerald, Orthop. Clin. N. Am. 23, 259 (1992).
2 P. Christel and P. Djian, Curr. Opp. Rheum. 6, 161 (1994).
3 C. R. Dreghorn and D. L. Hamblen, Br. Med. J. 298, 648 (1989).
4 R. L. Barrack and W. H. Harris, J. Bone Joint Surg. 75, 66 (1993).
5 P. F. Lachiewicz, G. D. Rogers, and H. C. Thomason, J. Bone Joint Surg. 78, 749 (1996),
6 J. A. Dupont, Clin. Orthop. Relar. R 211, 122 (1986).
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Fig. Scanning electron micrograph showing bacterial biofilm on a retrieved orthope¬
dic implant.
that this higher rate of infection postrevision may be due to unrecognized
infection at the initial revision operation.6 This may be because bacteria
colonizing the surface of implanted biomaterials grow predominantly in
adherent biofilms7 (Fig. 1) and may not be detected by aspiration and
routine culture techniques, which fail to examine the retrieved prostheses.8
Additionally, given the well-proven incidence of anerobic bacteria in joint
infection,9 it is likely that this is also due to the fastidious culture require¬
ments of anaerobic bacteria.
This article describes how the detection of bacteria by culture from
revision hip prostheses can be improved by employing strict anaerobic
techniques and by using mild ultrasonication to dislodge bacteria adhering
to the surface of the retrieved implants. Nonculture techniques that can
be used to further improve the detection of infection, including examination
of the inflammatory response in implant-associated tissue and the detection
of bacteria using immunological and polymerase chain reaction (PCR)-
based molecular approaches, are also described.
7 M M. Tunney, S. P. Gorman, and S. Patrick, Rev. Med. Microbiol. 7, 195 (1996).
8 A. G. Gristina and J. W. Costerton, J. Bone Joint Surg. 67, 264 (1985).
91. Brook and E. H. Frazier, Am. J. Med. 94, 21 (1993).
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Improved Culture Technique for Detection of Infection
Current clinical laboratory practice for the detection of prosthetic hip
infection involves the culture of bacteria from joint fluid aspirated peropera-
tively and from tissue samples removed at the time of surgery. A previous
study has shown that mild ultrasonication of retrieved tissue, bone, and
cement can increase the number of bacterial isolates cultured compared
with the numbers cultured from joint fluid or swabs of excised tissue and
prosthetic surfaces.8
Sample Collection
1. When removed from the patient, the femoral and acetabular compo¬
nents of the prosthetic hip are placed aseptically in separate sterile
bags.
2. Tissue in contact with the implants is also removed and placed in
sterile bottles.
3. The femoral and acetabular components of the prostheses and the
tissue samples are placed immediately in an anaerobic jar (e.g.,Oxoid
Anaerobic Jar HP11, Unipath Ltd., Basingstoke, UK) containing a
catalyst (e.g., Oxoid Low Temperature Catalyst BR42, Unipath Ltd.)
and a Gaspak (e.g., Oxoid Gas Generating Kit BR038B, Unipath
Ltd.) is added immediately.
4. The jar is transported to the laboratory and placed in an anaerobic
cabinet (e.g., Don Whitley Mk III, Don Whitley Scientific Ltd.,
Shipley, UK) containing an atmosphere of 80% N2, 10% H2, and
10% COz (v/v/v), where it is opened.
Sample Processing
The two parts of the prostheses are processed independently.
Prostheses
1. Ringer's solution (25%, v/v) is prereduced by the addition of l-
cysteine (1%, v/v) and by the subsequent removal of oxygen by
either boiling at a temperature of 100° for 1 hr in a water bath or
microwaving at full power (650 W) for 5 min. On cooling, the Ringer's
solution is stored in the anaerobic cabinet prior to use.
2. Separate 100-ml volumes of prereduced Ringer's solution are added
to the sterile bags containing the prostheses.
3. The prostheses are removed from the cabinet inside the sealed bags
and any material attached to the prosthesis surface is dislodged into
the Ringer's solution using mild ultrasonication (5 min in a 150-W
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ultrasonic bath operating at a nominal frequency of 50 Hz). Ringer's
solution is removed from the sealed bags and is placed in sterile
bottles that are immediately transferred to the anaerobic cabinet. It
is essential that this part of the procedure be performed quickly and
efficiently to minimize exposure to air of any anaerobic bacteria
present.
4. Total viable bacterial counts are performed by spreading 0.5-ml vol¬
umes of sonicate onto five blood agar [BA; 40 g/liter, Oxoid blood
agar base No. 2, Unipath Ltd.; 5% (w/v) Oxoid horse blood, Unipath
Ltd.] and five anaerobic blood agar (ABA; 47 g/liter, GIBCO anaero¬
bic blood agar base, GIBCO Ltd., Paisley, UK) plates, which are
stored in the anaerobic cabinet prior to use.
5. To enhance detection of bacteria that may be present in low numbers,
two 5-ml volumes of each sonicate are concentrated using separate
Millipore Sterifill units [Millipore (UK) Ltd., Watford, UK] and
separate 0.22-/xm filters (Supor-200 membrane filters, Gelman Sci¬
ences, Ann Arbor, MI), which are then placed on both a BA and
an ABA plate.
6. The remaining 85 ml of each sonicate is centrifuged for 20 min at
10,000g and the pellet produced is resuspended in 3 ml Ringer's
solution, which is then dispensed into 1-ml volumes that are stored
at -70°.
Tissue
1. A known weight of tissue is homogenized for 3 min in 5 ml prereduced
Ringer's solution using a mechanical homogenizer, and total viable
bacterial counts are performed by spreading 0.5-ml volumes of ho¬
mogenized tissue onto three BA and three ABA plates.
2. To detect bacteria present in low numbers, the remaining volume of
homogenized tissue is added in equal amounts to tryptone soya broth
(TSB; 30 g/liter, Oxoid tryptone soya broth, Unipath Ltd.) and
cooked meat broth (CMB; 100 g/liter, Oxoid CM 81, Unipath Ltd.)
for enrichment.
Bacterial Culture and Identification
BA and ABA plates are incubated at 37° aerobically and anaerobically,
respectively, and examined after 1, 2, 4, and 7 days. The TSB and CMB
are incubated at 37° aerobically and anaerobically, respectively, and subcul-
tured onto both BA and ABA after 7 and 14 days. These plates are then
incubated either aerobically or anaerobically at 37° for another 7 days.
All bacteria cultured are counted to allow direct quantitation of the
number of infecting bacteria. Pure cultures of any bacteria isolated are
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gram stained and identified using commercially available biochemical test
galleries (e.g., API20A, APIStaph, Biomerieux, Paris, France).
Nonculture Techniques for Detection of Infection
Histological Examination of Tissue
Assessment ofhistopathological reactions in tissue samples can be quan¬
tified easily and it has been shown that the presence of acute or chronic
inflammation in tissue samples correlates well with culture results and can,
therefore, be used to aid diagnosis of infection.10"12
1. Selected tissue samples are fixed in formal saline histological fixative
(Gurr, BDH, Davidson and Hardy Ltd., Belfast, UK). Representative
samples are then processed and embedded in paraffin wax, and 5-
fxm sections are cut and stained using a hematoxylin and eosin stain.
2. All slides are subsequently assessed microscopically without prior
knowledge of culture results using the following technique. The he¬
matoxylin and eosin stained sections are scanned at low power (X100
objective) and the areas of the slide containing the heaviest inflam¬
matory infiltrate are selected for further examination at a higher
magnification (X400 objective). If the sample is considered satisfac¬
tory, the number of inflammatory cells per high power field is assessed
over five randomly selected fields.
3. The following parameters are assessed in each tissue sample:
a. Acute inflammatory response (infiltration with polymorphonu¬
clear leukocytes).
b. Chronic inflammatory response (infiltration with lymphocytes
and tissue macrophages).
For each type of inflammatory cell, the slide is graded according to the
following scheme:
0 absent
1 1-10 cells/high power field
2 10-20 cells/high power field
3 20 or more cells/high power field
10 T. K. Fehring and J. A. McAlister, Clin. Orthop. Relat. R 304, 229 (1994).
11 J. M. Mirra, H. C. Amstutz, M. Matos, and R. Gold, Clin. Orthop. Re/at. R117, 221 (1976),
12 W. J. Kraemer, R. Saplys, J. P. Waddell, and J. Morton, J. Arthroplasty 8, 611 (1993).
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Molecular Detection of Infection
The detection of bacterial 16S ribosomal RNA (rRNA) genes as an
indicator of the presence of bacteria is a recognized technique that has
been used for the detection of both environmental and medically important
bacteria.1344 Because bacterial rRNA gene sequences contain regions that
are conserved within the prokaryotes and regions that are unique to differ¬
ent bacterial genera and species, they provide an ideal tool for the specific
detection and identification of bacteria. The availability of a growing data¬
base of rRNA sequences and the ability to amplify rRNA-encoding genes
(rDNA) from the limited amount of material that is available for analysis
via PCR further enhance the suitability of rRNA sequences for detection
and subsequent identification of bacteria.15
DNA Extraction
All steps are carried out in 1.5-ml Eppendorf tubes.
1. Centrifuge a 1-ml amount of prosthesis sonicate at 10,000g for 15
min at room temperature. Discard the supernatant.
2. Lysozyme (1-2 mg/ml) in 10 mM Tris (pH 8.0) and 50 mM glucose
can also be used to help in the extraction but attention to contamina¬
tion with exogenous bacterial DNA must be taken into account.
3. Suspend pelleted cells by vortex mixing in 200 /xl cell lysis buffer
[containing 10 mM Tris (pH 8.0), 5 mM EDTA, 0.5% sodium dode-
cyl sulfate (SDS), and proteinase K (100 /xg/ml)] and incubate at
55° for 3 hr.
4. Adjust the temperature to 37° and leave reaction mixture overnight.
5. Increase the temperature of reaction mixture to 55° for 1 hr.
6. Add an equal volume of saturated phenol/chloroform, vortex thor¬
oughly, and centrifuge at 10,000g for 15 min at room temperature.16
Repeat this step if necessary.
7. Remove the aqueous supernatant to a new tube, being careful to
leave the interface behind.
8. Add ethanol (100%, 2.5 volumes), 3 M sodium acetate, pH 5.2 (0.1
volumes), and 2 /xl of See DNA® (Pharmacia Biotech, Piscataway,
NJ). Vortex briefly and centrifuge at 10,000g for 15 min at room
temperature.
13 K. Griesen, M. Loeffelholz, A. Purohit. and D. Lcong, J. Clin. Microbiol. 32, 335 (1994).
14 M. J. Wilson. A. J. Weightman, and W. G. Wade, Rev. Med. Microbiol. 8, 91 (1997).
15 T. M. Schmidt and D. A. Relman, Methods Enzymol. 235, 205 (1994).
16 T. Maniatis, E. F. Frilsch. and J. Sambrook, "Molecular Cloning: A Laboratory Manual."
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982.
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9. Pour off supernatant and wash the pelleted DNA with 1 ml of 70%
(v/v) ethanol. Vortex briefly and centrifuge at 10,000g for 15 min
at room temperature.
10. Remove the supernatant and dry the pel let in a vacuum dryer (DNA
Plus, Heto Laboratory Equipment).
11. Dissolve extracted DNA in 50 pi of TE [10 mM Tris (pH 8.0),
1 mM EDTA] buffer and store at -20°.
Oligonucleotide Primer Design
Using DNAstar computer software (Megalign), alignments of eubacte-
rial 16S rRNA gene sequences can be constructed. From these it is possible
to improve the range of previously published broad-range PCR primer
pairs" by adding in a number of degeneracies in the primers. An example
of primer sequences that can be used are as follows:
Dl: 5'-GAG GAA GGT RGG GAY GAC GT
D2: 5'-AGG CCC GGG AAC GYA TTY ACC G
R = AG, Y = CT.
Both primers flank a hypervariable region that aids in 16S rRNA micro¬
bial identification.
Polymerase Chain Reaction Amplification
The PCR mixture is made up to 50 pi in sterile water and contains 5
pi of 10X PCR buffer (Perkin-Elmer, Norwalk, CT), 5 pi MgCl2 (25 mM),
200 pAf of each deoxynucleotide triphosphate (Pharmacia Biotech, Piscata-
way, NJ), 20 pM of each primer, 3 units of AmpliTaq polymerase (Perkin-
Elmer Corporation, UK), and 2 pi of lysate containing target DNA.
The typical PCR run profile is a 5-min denaturation of 96°, followed
by 30 cycles of 1 min at 96°, 2 min at the annealing temperature of 55°,
and 1 min at 72°. The final cycle is ended with a 5-min extension at 72°,
and the reaction is then held at 15° until the tubes are removed from the
thermocycler (Perkin-Elmer Gene-Amp PCR System 9600; Perkin-Elmer
Corporation, UK). After amplification. 6 pi of the amplified product is run
on a 1.5% (w/v) agarose gel in IX Tris-borate-EDTA (TBE). DNA bands
are detected by ethidium bromide staining and visualized by UV light pho¬
tography.
The sensitivity of the extraction procedures should be investigated by
extracting DNA from 10-fold serial dilutions of pure cultures and subse-
17 M. N. Widjojoatmodjo, A. C. Fluit, and J. Verhoef, /. Clin. Microbiol. 33, 2601 (1995).
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quently determining the limits of detection following PCR amplification
and agarose gel electrophoresis.
Single-Stranded Conformational Polymorphism Electrophoresis
Single-stranded conformational polymorphism (SSCP) is a simple
method that can be used to detect nucleotide sequence changes in PCR
products.18 It is ideally suited for fingerprinting the hypervariable sequences
of the 16S rRNA of eubacteria, providing a rapid preliminary identification
for any PCR-positive samples. It also allows the detection of polymicrobial
infections, as more than one SSCP profile will be apparent. The following
is a brief outline of the procedure.
1. After thermal cycling, 4 pi of the PCR mixture is added to 11 pi
of sequencing sample buffer [5 mM EDTA (pH 8.0), 0.25% (w/v)
bromphenol blue, in deionized formamide] and heated for 5 min
at 96°.
2. The denatured DNA is then placed directly on ice for 10 min before
being applied to the gel in 10-pl volumes. Bacterial standards are
also applied to the gel for direct comparison. The optimal gel compo¬
sition is 0.5X mutation detection enhancement gel (Flowgen,
Shenstone, Staffordshire, UK), 0.6X TBE, 0.04% (w/v) ammonium
persulfate solution, and 0.004% (v/v) /V,/V,/V',./V'-tetramethylethyl-
enediamine.
3. Electrophoresis is performed at 23° on a Sequi-Gen, vertical gel
electrophoresis apparatus (Bio-Rad, Richmond, CA) for 5 hr at 20 W
constant power.
4. After electrophoresis, SSCP patterns are detected by silver staining
according to the method of Bassam et al.19 Briefly, the procedure is
as follows.
a. Gels are fixed in 10% (v/v) glacial acetic acid for 30 min at room
temperature and washed with deionized water four times for 2 min each.
b. Gels are then color impregnated for 30 min at room temperature
with 0.1% (w/v) silver nitrate and 0.056% (v/v) formaldehyde.
c. Gels are then washed for 30 sec with deionized water prior to
color development. Color development is for 2 to 10 min with a mixture
of 30 g/liter sodium carbonate, 0.056% (v/v) formaldehyde, and 4 mg/
liter sodium thiosulfate. The color reaction is stopped by the addition
of 10% (v/v) glacial acetic acid.
18 J. R. Ken and M. D. Curran, Clin. Mol. Pathol. 49, 315 (1996).
19 B. J. Bassam, G. Caetano-Anolles, and P. M. Gresshoff, Anal. Biochem. 196, 80 (1991).
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DNA Sequencing
For definitive identification of bacteria, the PCR amplification products
are sequenced directly by the dideoxynucleotide chain termination proce¬
dure using the PRISM Ready Reaction Terminator Cycle Sequencing Kit
and read using a Model 373A automated sequencer (Applied Biosystems
Inc.).
Immunological Detection of Infection
Direct immunological detection of bacteria in clinical samples can be
achieved by the use of monoclonal antibodies (MAbs) and polyclonal anti¬
serum prepared against the bacteria implicated in the clinical infection.20
Detailed methods describing the production of polyclonal antiserum
and MAbs can be found in the laboratory manual of Harlow and Lane21 and
the textbook of Goding.22 A brief description of both techniques follows.
Production of Polyclonal Antiserum
A New Zealand White rabbit is immunized with whole cells of bacteria.
The rabbit is inoculated subcutaneously at four sites on the back with 0.1
ml of a bacterial suspension of 1 X 108 cfu (colony-forming units)/ml in
0.01 M phosphate-buffered saline (PBS). A further two inoculations of
bacteria in PBS are made at approximately monthly intervals and the rabbit
is test bled 2 weeks after the final booster dose. The blood is allowed to
clot at 37° for 1 hr and contract at 4° overnight after which the serum is
tested by immunofluorescence microscopy.
Production of MAbs
A BALB/c mouse is immunized by whole bacterial cells. The mouse is
inoculated intraperitoneally with 0.2 ml of a bacterial suspension of 1 X
108 cfu/ml in 0.01 M PBS. A further inoculation of 0.2 ml is given 4 days
before the mouse is killed. Spleen cells from the mouse are fused with
P3X 63 Ag8-653 (NS-0/1) mouse myeloma cells by treatment with 50%
polyethylene glycol 16000 (Sigma, Dorset, UK) in RPMI1640 (Flow Labo¬
rs. Patrick, L. D. Stewart, N. Damani, K. G. Wilson, D. A. Lutton, M. J. Larkin, I. Poxton,
and R. Brown, J. Med. Microbiol. 43, 99 (1995).
21 E. Harlow and D. Lane, "Antibodies: A Laboratory Manual." Cold Spring Harbor Labora¬
tory, Cold Spring Harbor, NY, 1988.
22 J. W. Goding, "Monoclonal Antibodies: Principle and Practice." Academic Press, Lon¬
don, 1986.
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ratories, Paisley, UK) using a modification of the method described by
Galfre and Milstein.23 Hybrid cell lines are selected with hypoxanthine-
aminopterin-thymidine in RPMI 1640 medium (G1BCO, Grand Island,
NY) containing 20% myoclone fetal calf serum (GIBCO). Culture superna-
tants are removed and screened by immunoblotting and immunofluores¬
cence for IgG specific for the bacteria used for inoculation.
Immunofluorescence Microscopy
For further information on this technique, readers are directed to the
detailed description of the technique provided by Patrick and Larkin.24
The method in brief is as follows.
1. One-milliliter samples of prosthesis sonicate are centrifuged (10,000g,
15 min, room temperature) and the resulting pellets suspended in
100 PBS.
2. Samples (10 pi) are then applied in duplicate to multiwell slides. The
slides are air-dried and fixed in methanol (100%, 10 min) at -20°,
after which they may be stored for up to 6 months at -20°.
3. Samples are then examined by dual labeling using the following pro¬
cedure:
a. Incubate the slides in a humidified box with undiluted MAb su-
pernate for 45 min.
b. Wash slides briefly with a wash bottle containing PBS and then
wash for 30 min in a bath containing PBS.
c. Incubate slides with polyclonal rabbit antiserum diluted in PBS
for 45 min and repeat washing step.
d. Incubate slides for 45 min simultaneously with goat antimouse
rhodamine conjugate (Sigma, Poole, UK) and sheep antirabbit fluores¬
cein conjugate (Sigma), both diluted in PBS as recommended by the
manufacturer.
e. After a final wash, mount slides with glycerol-PBS containing an
antiphotobleaching agent (e.g., Citifluor, Agar Scientific Ltd., Essex,
UK) and examine using a fluorescence microscope (e.g., Leitz fluores¬
cence microscope) with filters suitable for examining fluorescein and
rhodamine separately and in combination.
23 G. Gatfre and C. Milstein, Methods EnzymoL 73, 1 (1981).
24 S. Patrick and M. J. Larkin, in "Microbial Biofilms: Formation and Control" (S. P. Denver
and S. P. Gorman, eds.), p. 109. Blackwell Scientific Publications, Oxford, 1993.
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4. For detection of bacteria on each well by immunofluorescence mi¬





3 50 or more bacteria/well
Concluding Remarks
The use of strict anaerobic techniques and mild ultrasonication de¬
scribed herein has resulted in bacteria being cultured from 26 of 120 (22%)
retrieved implants examined.25 Review of the notes from 18 of these 26
individuals revealed that infection prior to revision was only suspected in
6 cases and that in only 2 of these cases were bacteria cultured from
preoperative aspirates or tissue removed at the time of surgery using con¬
ventional microbiological techniques.
We have also used the nonculture techniques described in this article
to detect infection of retrieved prosthetic hip joint.26 Results obtained using
these techniques confirmed those obtained using bacterial detection by
culture following mild ultrasonication of the implants, with all culture-
positive samples immunofluorescence microscopy-positive and positive for
the presence of bacterial 16S rRNA genes and associated tissue samples
positive for the presence of inflammatory cells indicative of infection.25
Their use also revealed the presence of bacteria in a large number of
culture-negative samples, with 68% having detectable bacterial rRNA gene
sequences, 53% having a positive immunofluorescence result, and 87% of
associated tissue samples positive for the presence of inflammatory cells
indicative of infection.25 The use of these nonculture techniques to improve
the detection of prosthetic joint biofilm infection coupled with appropriate
postoperative antibiotic therapy should improve the clinical outcome for
patients undergoing revision hip surgery.
25 M. M. Tunney, S. Patrick, S. P. Gorman, J. R. Nixon, N. Anderson, R. I. Davis, D. Hanna,
and G. Ramage, J. Bone Joint Surg. 80, 568 (1998).
26 M. M. Tunney, S. Patrick, M. D. Curran, G. Ramage, D. Hanna, J. R. Nixon, S. P. Gorman,
R. 1. Davis, and N. Anderson, J. Clin. Microbiol. 37, in press (1999).
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Bacteroides fragilis is a constituent of the normal resident microbiota of the human intestine and is the
gram-negative obligately anaerobic bacterium most frequently isolated from clinical infection. Surface poly¬
saccharides are implicated as potential virulence determinants. We present evidence of within strain immu¬
nochemical variation of surface polysaccharides in populations that are noncapsulate by light microscopy as
determined by monoclonal antibody labelling. Expression of individual epitopes can be enriched from a
population of an individual strain by use of immunomagnetic beads. Also, individual colonies in which either
>94% or <7% of the bacteria carry an individual epitope retain this level of expression when subcultured into
broth. In broth cultures where >94% of the bacteria carry a given epitope, there is no enrichment for other
epitopes recognized by different polysaccharide-specific monoclonal antibodies. This intrastrain variation has
important implications for the development of potential vaccines or immunodiagnostic tests.
Bacteroides fragilis is the gram-negative strictly anaerobic
bacterium most frequently isolated from clinical infection. The
major source of these infections is the normal resident colonic
microbiota, where Bacteroides spp. outnumber facultatively an¬
aerobic bacteria such as Escherichia coli by a factor of between
102 and 103 (4). In the fecal microbiota, the predominant
Bacteroides spp. is B. vulgatus, with B. fragilis a relatively minor
component. Namavar and colleagues (6) report a relatively
higher proportion of B. fragilis in the adherent mucosal micro¬
biota; however, this was not confirmed by Poxton and col¬
leagues (19). It therefore appears that the frequency with
which B. fragilis is isolated from infection compared to other
Bacteroides spp. of the resident microbiota cannot be explained
simply by weight of numbers.
The potential virulence determinants of B. fragilis have been
the subject of many investigations (9). It is clear that a number
of factors may contribute to the virulence of B. fragilis, includ¬
ing surface structures, release of extracellular enzymes, iron-
scavenging mechanisms, and enterotoxin production; however,
extracellular polysaccharides have been considered to play a
key role in B. fragilis virulence. Encapsulating structures have
been implicated in resistance to complement-mediated killing,
phagocytic uptake, and killing (21) and abscess formation in an
animal model (27). Many studies have failed to take into ac¬
count not only within-strain variation in capsule production but
also between- and within-strain antigenic variation of different
types of capsules. By electron microscopy, it is possible to
identify within an individual strain of B. fi-agilis bacteria with
either large or small capsules which are fibrous in appearance
but are antigenically different, as well as bacteria with an en¬
capsulating electron-dense layer (EDL) adjacent to the outer
membrane (15, 16). The EDL bacteria are noncapsulate by
light microscopy, whereas the small and large capsules are
clearly visible with negative staining. Expression of the differ¬
ent capsular types is inheritable as populations can be enriched
by subculture from different interfaces of Percoll step density
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gradients. Microscopical observation of the populations en¬
riched for the three capsular types with monoclonal antibodies
(MAbs) specific for surface polysaccharides shows that non¬
capsulate bacteria are antigenically different from bacteria with
the small capsules but have shared epitopes with large-capsule
bacteria. In addition, immunofluorescent and immunogold la¬
belling for fluorescence and electron microscopy, respectively,
reveals antigenic variation in populations which appear to be
structurally homogeneous (5, 13, 22, 23). This phenomenon
has been observed in recent clinical isolates from a variety of
anatomical sites, in isolates from different geographical loca¬
tions, and in culture collection type cultures (17). By polyacryl-
amide gel electrophoresis (PAGE) and immunoblotting with
MAbs specific for surface polysaccharides, distinctive patterns
are observed within the noncapsulate population of an indi¬
vidual strain. These results indicate that an individual B. fragilis
strain may produce a number of antigenically different surface
polysaccharides (5, 9, 10).
The aim of the present study was to investigate intrastrain
variation in B. fragilis populations which were homogeneous
with respect to encapsulation. The stability of expression of
individual polysaccharide epitopes within B. fragilis popula¬
tions which are noncapsulate by light microscopy (EDL en¬
riched) was therefore examined.
We now report that populations already enriched for cap¬
sule type can also be enriched for expression of individual sur¬
face polysaccharide epitopes in both broth and plate cultures.
MATERIALS AND METHODS
Bacterial strains and culture methods. The strains used were B. fragilis NCTC
9343 (National Collection of Type Cultures, London, United Kingdom), LS66
and LS54 (clinical isolates from an abdominal abscess and a perianal abscess
respectively; Craigavon Area Hospital, Northern Ireland, United Kingdom) (17),
and JC17 (clinical isolate from an abscess; Belfast City Hospital, Northern
Ireland, United Kingdom). All strains were enriched on Percoll density gradients
for populations which were noncapsulate by light microscopy. Bacteria were
grown in defined minimal medium (DM) broth or on DM plates (28) in an
anaerobic cabinet (Mk. Ill anaerobic cabinet; 80% N2, 10% C02, and 10% H2;
Don Whitley Scientific, Shipley, United Kingdom). Identification was confirmed
with the API20A (Biomerieux, Marcy L'Etoile, France) system.
Production and characterization of polyclonal antisera and MAbs. Polyclonal
antiserum specific for B. fragilis NCTC 9343 common antigen was produced as
previously described (17). Polyclonal antiserum specific for B. fragilis NCTC 9344
common antigen was the kind gift of I. Poxton, University of Edinburgh. MAb
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production and initial characterization of some of the MAbs are detailed in
reference 5. MAb QUBF 12 does not cross-react with E. coli but does cross-react
with Bacteroides thetaiotaomicron, B. vulgatus, and B. ovatus. The other MAbs do
not cross-react with E. coli, B. vulgatus, B. distasonis, B. ovatus, B. thetaiotaomi¬
cron, or Porphyromonas gingiva lis.
Where necessary, hybridoma culture supernatants were concentrated in
Vivaspin 15 concentrator filter units (Vivascience Ltd., Lincoln, United King¬
dom), and suitable working dilutions in 0.01 M phosphate-buffered saline (PBS;
0.15 M NaCl, 0.0075 M Na2HP04, 0.0025 M NaH2P04 • 2H20 [pH 7.4]) were
determined empirically. Sodium dodecyl sulfate-PAGE was performed on ver¬
tical slab gels (8%), which were immunoblotted as previously described (5), using
a crude aqueous phenol extract prepared as described by Poxton and Brown (18).
Separation and enrichment of bacterial populations. Bacterial populations
which were noncapsulate by light microscopy were enriched by subculture from
the 60 to 80% interface layer of Percoll (Pharmacia, Uppsala, Sweden) discon¬
tinuous density gradients after centrifugation as previously described (11). En¬
capsulation was monitored by eosin-carbol fuchsin negative staining for light
microscopy (1). When required, these populations were further enriched by using
immunomagnetic beads as detailed below. Dynal M-280 magnetic beads pre-
coated with sheep anti-mouse immunoglobulin [Dynal (UK) Ltd., Merseyside,
United Kingdom] were used as described by Patrick and Larkin (11). In brief, the
beads were washed by placing the tube containing the beads in a magnetic
particle concentrator and removing the PBS by pipette. Washed beads were
suspended in hybridoma culture supernatant containing the relevant antibody,
incubated at room temperature with gentle rocking for 24 h, and again washed
in PBS. The following steps were all carried out inside an anaerobic cabinet to
ensure bacterial viability. The beads were incubated with bacterial suspension
(108 CFU/ml) in DM plus 0.02% (vol/vol) Tween 20 (Sigma Chemical Co. Ltd.,
Poole, United Kingdom) with gentle rocking for 2 min and washed three times
in DM. The beads were then inoculated into DM and incubated at 37°C in the
anaerobic cabinet until bacterial growth was visible.
Immunofluorescence microscopy. Bacterial suspensions in PBS were applied
to multiwell microscope slides, dried at 37°C, and fixed either in methanol at
-20°C for 10 min or in paraformaldehyde (4% [wt/vol] in 3X PBS [390 mM
NaCl, 30 mM Na2HP04, 30 mM NaH2P04 • 2H20 {pH 7.2}) at 4°C for 30 min
(20). For single labelling, the bacteria were then reacted with a suitable dilution
of concentrated mouse MAb hybridoma supernatant followed by goat anti-
mouse immunoglobulin G (heavy and light chain) conjugated to fluorescein
isothiocyanate (FITC; Sigma) as previously described (11). For dual labelling,
after incubation of the slides with MAb, they were washed, incubated with anti-
B. fragilis common antigen polyclonal rabbit antiserum (17), washed, and incu¬
bated with sheep anti-rabbit FITC and goat anti-mouse tetramethyl rhodamine
isothiocyanate (TRITC; Sigma) before a final wash (11). Slides were examined
with a Leitz fluorescence microscope. An estimate of the proportion of bacteria
fluorescing was obtained either by comparing FITC-labelled bacteria with bright-
field phase-contrast view or by comparing populations dual labelled with anti-
rabbit polyclonal antiserum and an anti-rabbit FITC conjugate and with mouse
MAb and an anti-mouse TRITC conjugate. All estimations of percentage label¬
ling involved counting a minimum of 100 bacterial cells per well.
Colony lifts and immunoreaction. For colony lifts, total viable counts were
carried out after serial 10-fold dilution in Ringer's solution (25% [wt/vol]) with
cysteine (0.05%) and spread plating onto DM agar. Unless stated otherwise, the
plates were incubated for 48 h. Plates with approximately 150 or fewer colonies
were chosen and processed as follows. Discs of nitrocellulose (Millipore UK Ltd.,
Watford, United Kingdom) were gently applied to the agar plate and lifted once
the whole nitrocellulose disc appeared to be wet. A maximum of three lifts were
carried out on each plate. For sterile lifts, the nitrocellulose discs were auto-
claved prior to use. The nitrocellulose discs were then air dried at room tem¬
perature (approximately 22°C) under aerobic conditions for a minimum of 1 h,
blocked with dried milk (5% [wt/vol]; Marvel, Chivers Ireland Ltd., Dublin,
Ireland) in PBS with Tween 20 (0.05%) for 1 h at 37°C, washed five times rapidly
in PBS-Tween followed by five 5-min washes, and either allowed to dry and
stored at room temperature in sealed polythene bags for later immunoreaction
or used immediately. For immunoreaction, the discs were incubated with the
appropriate mouse MAb diluted in PBS for 1 h at 37°C with gentle rocking and
washed rapidly five times in PBS-Tween followed by 5-min washes with gentle
rocking. The discs were then incubated for 1 h as described above with goat
anti-mouse alkaline phosphatase conjugate (Bio-Rad Laboratories Ltd., Hemel
Hempsted, United Kingdom). The discs were washed as before except that the
final wash was carried out in Tris buffer (50 mM Tris HC1 [pH 9.4]) prior to
incubation in the substrate (Bio-Rad alkaline phosphatase substrate kit; p-ni-
troblue tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate) accord¬
ing to the manufacturer's instructions. Once the substrate color had reached
sufficient intensity, the reaction was stopped by immersion in distilled water and
the nitrocellulose was blotted dry with filter paper. Control reactions in which the
MAb was replaced with PBS were also processed. Colonies from the control
reaction appeared light grey in color, which may have been due to background
bacterial alkaline phosphatase activity; however, positive colonies were obviously
bright purple-blue. Positive colonies were counted and compared with the initial
colony count of the agar plate.
Protocol for determination of antigen expression in broth and plate cultures.
For estimates of the proportion of bacteria expressing an epitope in broth
1 2 3 4 5 6 7
FIG. 1. Immunoblots of hot phenol-water extracts from B. fragilis NCTC
9343 after PAGE reacted with rabbit anti-B. fragilis NCTC 9343 common antigen
antiserum (track 1), rabbit anti-5. fragilis NCTC 9344 common antigen antiserum
(track 2), and MAbs QUBF 12 (track 3), QUBF 5 (track 4), QUBF 6 (track 5),
QUBF 7 (track 6), and QUBF 8 (track 7).
culture, four replicate 100-ml volumes were inoculated and incubated at 37°C in
the anaerobic cabinet until they had reached an optical density at 600 nm of 0.3
(equivalent to approximately 3 X 108 CFU/ml). The proportion of bacteria
within each broth which labelled with a given MAb was estimated by immuno¬
fluorescence microscopic examination of 20 separate-microscope slide wells for
each broth. A minimum of 100 bacteria were counted in each of the 20 wells.
A 10-fold dilution series was carried out for each of the replicate broth cultures
and three replicate spread plates prepared for each dilution. Three colony lifts
were taken from each of two replicate spread plates for antibody reaction.
Twenty colonies were picked from each of the remaining spread plates (80
colonies in total), and the number of bacteria which labelled with a given MAb
was estimated for each colony by immunofluorescence microscopy. Analyses of
variance indicated that there was no significant difference between the replicate
broth cultures (95% probability).
RESULTS
Epitope expression in broth culture. Immunomagnetic bead
separation and broth enrichment with MAbs QUBF 6 and 7,
specific for high-molecular-mass polysaccharide with an asso¬
ciated fine ladder pattern, and MAb QUBF 12, which recog¬
nizes an antigen similar in molecular mass to the B. fragilis
common antigen (Fig. 1), was successful as assessed by immu¬
nofluorescence microscopy. The proportions of bacteria within
a population which expressed the various epitopes could be
increased from 15 to 76% (QUBF 6), from 21 to 74%, (QUBF
7), and from 22 to 56% (QUBF 12) with two subsequent im¬
munomagnetic bead separations and broth enrichments. The
degree of enrichment obtained on different occasions was not,
however, always consistent. On a separate occasion, the QUBF
6 epitope was increased only to 32% after two enrichment steps.
Stability of QUBF 6 and 7 epitope expression in B. fragilis
noncapsulate populations. The reactivity of MAbs QUBF 6
and 7 which are specific for high-molecular-mass polysaccha¬
ride with an associated fine ladder pattern was examined on
pre- and post-immunomagnetic bead-enriched cultures of B.
fragilis NCTC 9343. The proportion of bacteria labelling within
replicate broth cultures was determined by immunofluores¬
cence microscopy, and the proportion of colonies which la¬
belled on spread plates prepared from the broth cultures was
determined by colony blotting. The proportion of colonies
which were positive was similar to that of the proportion of
individual bacterial cells positive by immunofluorescence mi¬
croscopy in the original broth culture (Table 1). Similar results
were obtained for three other strains of B. fragilis (Table 2),
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TABLE 1. Reactivity of broth cultures and colonies of noncapsulate B. fragilis NCTC 9343 with
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although the proportion of bacteria that labelled was not the
same for different strains labelled with the same MAb. The
failure to detect any positive colonies by immunofluorescence
microscopy after random selection of 20 colonies per plate,
where it was estimated by colony lifts that 14% of the colonies
were positive, is probably due to the small sample size.
The proportion of bacteria labelling within the individual
colonies was assessed by immunofluorescence and phase-con¬
trast microscopy. Either 94% or more of the cells in a colony
were positive by immunofluorescence or less than 7% of the
bacteria labelled (Fig. 2 and Table 3). The proportion of col¬
onies showing 94% or greater labelling as estimated by immu¬
nofluorescence microscopy, scored as positive colonies, was
comparable with the proportion of immunoreactive colonies
on the nitrocellulose lifts and in the original broth culture
(Table 1). To determine the relationship between colonies
positive by blotting and the proportion of the population la¬
belled by immunofluorescence microscopy, lifts were carried
out with sterile nitrocellulose and the plates were reincubated
for 24 h to allow the colonies to regrow. Colonies were then
picked off and analyzed by immunofluorescence microscopy.
Colonies with 94% or more bacteria positive by immunofluo¬
rescence were also positive by immunoblotting. Immunoblot-
negative colonies related to those with 7% or less of the pop¬
ulations labelling by immunofluorescence microscopy.
Examination of the proportion of bacteria labelling in im-
munoblot-negative colonies indicated that this was consistent
in the four replicate broth cultures inoculated in parallel. The
proportion of bacteria within these immunoblot-negative col¬
onies was, with the exception of strain LS66, considerably less
than the proportion which labelled in the original broth cul¬
ture. An increase in the length of incubation of the colonies
from 48 to 144 h and concomitant increase in colony size did
not increase the proportion of the bacteria within the colony
which were labelled. With the exception of strain LS66, there
was a clear difference in the degree of labelling in immunoblot-
negative colonies between QUBF 6 and QUBF 7. Continuous
daily subculture of colonies of strain NCTC 9343 in DM broth
for 5 days resulted in a maintenance of the level of expression
of the epitopes at either 94% or greater or 7% or less for both
QUBF 6 and QUBF 7.
Cross-reactivity of epitope-enriched populations with other
B. fragilis-specific MAbs. Populations enriched using immuno-
magnetic beads coated with either QUBF 6 (specific for high-
molecular-mass polysaccharide) or QUBF 12 (specific for a
band similar in molecular mass to the common antigen) and
subcultured in DM broth were examined for reactivity with
other MAbs by immunofluorescence microscopy (Table 4), as
were populations enriched by subculture of colonies immuno-
blot positive for QUBF 6 and 7 (specific for high-molecular-
mass polysaccharide) into DM broth (Table 5). Reactivity of
the enriched populations with MAbs showed that with none of
the MAbs tested was the proportion of bacteria labelled as
great as that labelled with the MAb for which the population
had been enriched.
QUBF 6 and 7 immunoblot-positive colonies were subcul¬
tured into DM broth and examined for reactivity with QUBF
5 and other MAbs specific for high-molecular-mass polysac¬
charides (Table 5). With the exception of the reactivity of MAb
QUBF 7 with QUBF 6-positive cultures, only a very small
proportion of the bacteria reacted.
DISCUSSION
The results clearly illustrate intrastrain antigenic variation of
the surface polysaccharides of B. fragilis. The epitopes recog¬
nized by the MAbs are present on distinct bacterial cells and
are detectable on highly variable proportions of bacterial cells
within individual natural populations as determined by immu¬
nofluorescence and immunoelectron microscopy (9).
The results show conclusively that the proportion of bacte¬
rial cells within a population which express these variable poly¬
saccharides can be enriched by using immunomagnetic beads
coated with the relevant MAb, followed by broth culture. The
lack of reproducibility in the level of enrichment obtained by
using immunomagnetic beads on different occasions was prob¬
ably due to varying numbers of outer membrane vesicles (14)
attaching to the magnetic bead bound antibodies and thus
preventing bacterial attachment.
The proportion of bacteria which were labelled with MAbs
QUBF 6 and 7, which both label polysaccharide in the high-
molecular-mass region and an associated fine ladder pattern,
was different within the same population of a given strain
(Tables 1 and 2). For example, in two strains 50% or more of
the bacteria were labelled with MAb QUBF 7, but very few or
none of the cells labelled with MAb QUBF 6. This finding
TABLE 2. Immunoreactivity of noncapsulate B. fragilis
strains with MAbs QUBF 6 and 7
% of bacterial cells in % of colonies labelled
broth culture labelled by immunoreaction
MAb Strain by immunofluores¬
cence microscopy
(mean ± SE)
after growth of broth
culture on agar plates
(mean ± SE)
QUBF 6 NCTC 9343 15 ± 2 14 ± 1
LS54 6 ± 2 1
LS66 22 ± 3 19
JC17 0 0
QUBF 7 NCTC 9343 21 ± 2 20 ± 3
LS54 50 ± 6 53 ± 5
LS66 <1 0
JC17 50 + 1 60
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FIG. 2. Light micrographs of B. fragilis NCTC 9343, prepared from single colonies, immunolabelled with both mouse MAb plus anti-mouse TRITC conjugate and
rabbit anti-B. fragilis polyclonal antiserum plus anti-rabbit FITC conjugate viewed (100X objective) with fluorescein filters (a) and the same field viewed with rhodamine
filters (b). (i) Colony labelled with MAb QUBF 6 in which 95% or more of the bacteria are labelled; (ii) another colony labelled with MAb QUBF 6 in which only a
small proportion of the total bacterial population is labelled.
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TABLE 3. Proportion of bacteria within colonies, either positive or
negative by colony blotting, which label with MAbs QUBF 6
and 7 by immunofluorescence microscopy
B. fragilis
strain
% of bacteria (:mean ± SE)"
Positive colony Negative colony
QUBF 6 QUBF 7 QUBF 6 QUBF 7
NCTC 9343 97 ± 1 94 ± 2 3 ± 1 7 ± 1
LS54 ND 99 ± 1 <1 5 ± 2
LS66 99 ± 0.5 ND <1 <1
JC17 NR 99 ± 1 <1 4 ± 1
" ND, not done; NR, no reaction.
suggests that although these polysaccharides appear to be im-
munochemically similar after PAGE and immunoblotting, they
are antigenically different and that the number of bacteria
within a population which express these epitopes varies from
strain to strain. The level of expression of MAbs QUBF 6 and
7 within individual colonies was, however, strikingly reproduc¬
ible. Examination of individual colonies, picked from an agar
plate, showed either a high proportion (>94%) or low propor¬
tion (<7%) of bacteria labelled for all the strains examined.
These proportions were maintained on subculture of individual
colonies into broth. This is similar to the phenomenon of
enrichment for expression of different capsule types after Per-
coll density gradient centrifugation (9), which is also main¬
tained on subculture into broth. The relationship between the
number of colonies positive for a given epitope and the pro¬
portion of bacteria that were labelled in the broth culture from
which the colonies were derived was also consistent. It is likely
that colonies with a low proportion of bacteria expressing the
epitope were derived from a cell which did not initially carry
the epitope and that some type of switching mechanism has
generated the variants. The rate of switching appeared to occur
at a constant rate for the epitopes examined, as the estimated
level of expression remained constant for different colonies
and between experiments carried out at different times. The
proportion of bacteria expressing an epitope was maintained
when colonies were subcultured into broth continuously for up
to 5 days. This finding suggests that either the switching mech¬
anism observed within the colonies does not function in the
relatively homogeneous environment of the broth culture or it
occurs at a much slower rate. Given the apparent constant rate
of change in the colonies, it is likely that there is an underlying
genetic basis to the mechanism that generates the variation.
This is a well-documented phenomenon in other pathogenic
bacteria (24). It remains to be determined if there is also an
environmental influence on this type of variation. Possibilities
include external influences such as nutrient availability or
changes in the redox potential in the microenvironment. An¬
other possibility is that bacterial signalling molecules such as
for example the A-acyl homoserine lactones (2) are involved.
TABLE 4. Reactivity of noncapsulate B. fragilis NCTC 9343 broth
cultures with different MAbs after enrichment for epitope
expression by use of immunomagnctic beads
Reactive MAb
% of bacteria labelled by immunofluorescence
microscopy (mean ± SE)
QUBF 6 enriched QUBF 12 enriched
QUBF 6 76 ± 3 42 ± 3
QUBF 12 32 ± 2 56
QUBF 5 7 ± 3 8 ± 2
TABLE 5. Proportion of B. fragilis NCTC 9343 bacteria in broth
culture, derived from colonies positive for either QUBF 6
or 7 by colony blotting, which are MAb reactive
by immunofluorescence microscopy
% of bacteria labelled by immunofluorescence
microscopy (mean ± SE)
Reactive MAb
Enriched from QUBF 6- Enriched from QUBF 7-
positive colony positive colony
QUBF 6 98 1.5
QUBF 7 10 99
QUBF 8 1.5 1
QUBF 12 0 <1
QUBF 5 1 0
These have been well characterized in other gram-negative
bacteria, although to date no evidence has been presented for
the production of these or similar molecules in Bacteroides spp.
An environmental influence could perhaps explain the differ¬
ences observed between the colonies and the broth culture.
The lack of cross-reactivity of populations enriched from
colonies in which 98% or more labelled with a given MAb with
other MAbs (Table 5) suggests that enrichment for one poly¬
saccharide epitope does not result in coenrichment for a sec¬
ond epitope. Whether this represents exclusive production of
one antigenic type or the masking of one by another remains to
be determined. The patterns generated by PAGE and immu¬
noblotting, illustrated in Fig. 1, suggest that B. fragilis may ex¬
press three distinct components extractable by the hot phenol-
water method. It is likely that these three components are the
smooth lipopolysaccharide (QUBF 5), high-molecular-mass
polysaccharide (QUBF 6 to 8), and common antigen (QUBF
12) described by Poxton and Brown (18). Furthermore, the lack
of cross-reactivity of the populations enriched from QUBF 6-
or 7-positive colonies with the other MAbs examined (Table 5)
indicates that there are at least three antigenic types of high-
molecular-mass polysaccharide with an associated ladder pat¬
tern. A further two MAbs, which also did not cross-react with
populations enriched from QUBF 6- or 7-positive colonies,
have a PAGE pattern indicative of high-molecular-mass poly¬
saccharide but lacking the ladder pattern (unpublished data).
The precise nature of the biochemical differences which
generate these different patterns of labelling are unknown. It is
possible for polysaccharides to be biochemically similar in
terms of components (e.g., sugar moieties) but for a wide
variety of antigenic variation to be generated by alteration of
either the linkage of the substituent moieties, their chemical
substitution, or both. Antigenic variation generated by these
means is well documented in the polysaccharides of other
pathogenic bacteria such as Haemophilus influenzae, E. coli,
and Neisseria meningitidis (12). As yet, no chemical analyses
have been carried out on the antigens described in this report.
Their relationship with the chemically characterized polysac¬
charides A and B described by Pantosti and coauthors (7, 8) is
therefore unknown. Polysaccharides A and B were obtained
from the fraction referred to as capsular polysaccharide (CP)
by boiling in 5% acetic acid for 1 h. MAbs specific for either A
or B revealed a broad high molecular mass band after PAGE
and immunoblotting of the CP fraction. After acetic acid hy¬
drolysis, a narrower band in the highest-molecular-mass region
of the broad band was visible for both fractions A and B and
their respective MAbs. It therefore appears that polysaccha¬
rides A and B also give a similar pattern after PAGE and
immunoblotting. A ladder pattern associated with the broad
band was detected in the CP fraction by using polyclonal an-
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tiserum. These authors suggested that this ladder pattern rep¬
resented the ladder pattern described by ourselves in the small
capsule subpopulation enriched from strain NCTC 9343 by
Percoll density gradient centrifugation (23) and also the ladder
pattern interpreted by Poxton and Brown as a possible O
antigen (18). The ladder pattern illustrated by Poxton and
Brown is similar to that detected by our MAb QUBF 5 (Fig. 1)
and has wider-spaced bands than that illustrated by Pantosti
and coauthors (8). Their ladder pattern is, however, similar in
appearance to that observed in the small-capsule population
(5, 23). As strain NCTC 9343 normally contains a mixture of
large-capsule, small-capsule, and noncapsulate bacteria, it is like¬
ly that polysaccharides A and B were extracted from a popula¬
tion with a mixture of types of capsule as well as antigenic types.
The biological activity of our phenol-water extracts was not
investigated. Delahooke and coauthors (3), however, com¬
pared the immunomodulatory activity of polysaccharide mate¬
rial extracted from B. fragilis by different methods and reported
a high level of in vitro biological activity in phenol-water ex¬
tracts. Material extracted from B. fragilis NCTC 9343 grown in
the same defined medium as we used (28) was 10 times more
active in the Limulus amoebocyte lysate assay than material
obtained from E. coli 018:KT. These authors acknowledge
that their B. fragilis extracts were probably heterogeneous both
in Mr and molecular composition. It would be interesting to
relate this biological activity to the potential variety of compo¬
nents identified in the present study.
The capacity for antigenic variation could clearly be advan¬
tageous to the survival of B. fragilis in both its pathogenic mode
of existence and in its role as a member of the normal intestinal
microbiota. These results also have implications for any studies
of the virulence of B. fragilis and the chemical nature of these
polysaccharides. Inter- and intrastain variation can be clearly
observed not only in recent clinical isolates but also directly in
pus samples with MAb labelling and immunofluorescence mi¬
croscopy (17, 25, 26). Studies of the immunological diversity of
B. fragilis which rely only on whole-cell dot immunobinding or
enzyme-linked immunosorbent assay (7) will not detect this
within-strain diversity. The intrastrain variation will result in
titers in such assays which reflect the proportion of the bacteria
within the population which are expressing the epitope. This
intrinsic variability of the surface polysaccharides will also need to
be taken into account in the production of potential vaccines
and immunodiagnostic tests based on polysaccharides.
In conclusion, surface polysaccharides of noncapsulate
B. fragilis are antigenically highly variable within individual
strains. Different antigenic types can be detected on different
bacterial cells within an individual population of a given strain.
The proportion of bacterial cells carrying any given epitope will
be variable depending on the strain and how it has been cul¬
tured in the laboratory. Production of the same polysaccharide
by all the bacteria within a strain of B. fragilis is unlikely and
cannot be assumed.
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SUMMARY
Background: Bacteroides fragilis is a member of normal human flora and welt known pathogenic agent. This
bacterium produces many virulence factors. In 1984 new virulence factor - enterotoxin was described. The aim
of the study was to search for enterotoxin gene in B. fragilis strains isolated from clinical specimens.
Material and Methods: Strains isolated in Poland, Great Britain, France and the Netherlands were cultured on
BBE medium. For DNA isolation Genomic DNA PREP PLUS isolation kit manufactured byA&A Biotechno¬
logy (Poland) was used. In order to detect enterotoxin (fragilysin) gene, polymerase chain reaction (PCR) was
applied utilizing the following primers: 404 (GAG CGG AAG ACG GTG TAT GTG ATT TGT) and 407
(TGC TCA GCG CCC AGT ATA TGA CCT AGT). DNA obtained from bacterial cells was amplified in
thermocycler Techne. The amplification products were detected by the electrophoresis in 1% agarose gel.
Results: Among 65 investigated B. fragilis strains, the enterotoxin gene was detected in DNA isolated from 12
strains.
Conclusion: The enterotoxin producing B. fragilis strains were detected among strains isolated from different cli¬
nical specimens in Poland, Great Britain, the Netherlands and France.
BACKGROUND
Bacteroides fragilis, a member of the B. fragilis gro¬
up, is a Gram-negative asporulating encapsulated
anaerobic rod. This bacterium is bile-stimulated and
extremely saccharolytic. It inhabits the colon of heal¬
thy animals and humans. Bacteroides fragilis is the
most often isolated anaerobe from clinical speci¬
mens as the etiological agent of endogenic suppura¬
tive soft tissue infections, abscess or bacteremia [1].
The most important virulence factors of B. fragilis
are: capsule, lipopolysaccharide (LPS), outer mem¬
brane proteine (OMP), pili, short-chain fatty acids
[2], The role in pathology and mechanisms of action
of those virulence factors were studied in different
laboratories. The structure and biological activity of
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the capsule comprised the impact on the abscess
formation, the antiphagocytic activity and the me¬
chanisms of adhesion [3]. The structure and biologi¬
cal activity of B. fragilis lipopolysaccharide was de¬
scribed by many authors [4-8], In 1984 the acute
form of enteric disease characterized by profuse
diarrhoea, loss of appetite and depression with
a high mortality rate was observed in 24-48 h new¬
born lambs. None of the well established diarrho-
eagenic infectious agents appeared to be the cause.
Because of the acute nature of the clinical picture of
infection, the authors postulated that the cause of
infection is a bacterium with a classic enterotoxin se¬
cretory activity. Myers et al [9] isolated B. fragilis for
the first time and described its enterotoxin activity.
Enterotoxin activity was tested through the observa¬
tion of accumulation of fluid in the lamb intestinal
loop (test LIL) [10]. The association of diarrhoea in
foals and young pigs with enterotoxigenic B. fragilis
(ETBF) was also established (Myers et al 1987)
[11,12]. The acceptance of B. fragilis as a new diarr-
hoeic causative agent in animals led directly to the
questions whether it is possible to isolate the entero¬
toxigenic B. fragilis strains from the human gut flora
and whether these could be the diarrhoeic agent.
The observations by Meyers et al provided a positive
response [13]. The study of Shoop et al [14] has
shown the presence of ETBF in municipal sewage.
The observations of Weikel et al [15] have shown
that the enterotoxin can be tested on human colo¬
nic epithelial cells HT29/C1. Van Tassel et al was the
first to isolate purified enterotoxin and describe its
structure [16]. Very soon in different countries, stra¬
ins of B. fragilis ETBF were detected: USA [17], Fran¬
ce [18], Italy [19], the Netherlands [20], Japan [21],
Poland [22-25], Bangladesh [26], Sweden [27], As
isolation of enterotoxin producing strains was descri¬
bed by different authors, it appeared to be worth¬
while to test the strains isolated in different countries.
The aim of the present study was to test the DNA
from the strains isolated in different countries using




Sixty five Bacteroides fragilis strains isolated from
human extraintestinal sources in different countries
(tab I.) were used in the experiment.
1) Out of 65 strains 18 were isolated in Poland:
1/B, 2/B, 3/B, 5/B, 6/B, 7/B, 8/B, 9/B, 10/B,
11/B, 12/B, 13/B, 14/B, 15/B, 17/B, 18/B, 19/B,
2 2/B.
2) Seventeen were isolated in Belfast UK: JC6,
JC15, JC17, JC19, LS27, LS54, LS66, LS67, BE1,
BE3, CNAB4, CNAB82, GNAB92, DK2, DK5,
DK9, DK10.
3) Ten were isolated in Edinburgh UK: 3367,
3422, 3505, 3718, 3822, 3823, 3837, 3845,
3851, 3871.
4) Ten strains were isolated in Rosendaal NL: 1H,
2H, 3H, 4H, 5H, 6H, 7H, 8H, 9H, 10H.
5) Ten strains were isolated in Lille France: 9755,
9760, 9762, 9771, 9778, 9701, 9810, 9813,
9816, 9817.
Two reference strains: Bacteroides fragilis NCTC
11295 (ETBF) and IPL 323 (NTBF) were also used
as a controls.
Media
Strains were cultured on Columbia agar (Oxoid)
enriched with sheep blood, hemin and vitamin K.
DNA extraction
DNA was isolated using Genomic DNA PREP PLUS
isolation kit manufactured by A&A Biotechnology
(Poland).
PCR reaction
To detect enterotoxin-fragilysine gene polymerase
chain reaction was applied.
Following primers were utilised: 404 (GAG CCG
AAG ACG GTG TAT GTG ATT TGT) and 407 (TGC
TCA GCG CCC ACT ATA TGA CCT AGT). DNA
obtained from bacterial cells was amplified in
a thermocycler (Techne). The temperature profile
was as follows: 1 cycle (4 min. 94°C), 40 cycles
(1 min. 94°C, 1min. 52°C, 1 min. 74°C).
Electrophoresis
Amplification products were detected by electro¬
phoresis in 1% agarose gel with ethidium bromide
added.
RESULTS
Out of 65 strains under investigation 12 appeared
to belong to Bacteroides fragilis possessing an ente¬
rotoxin gene (Table 1, Figure 1).
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Table 1. Results of PCR detected enterotoxin gene in DNA isolated







Great Britain 1 17 3
Great Britain II 10 2
Figure 1. Agarose gel electrophoresis of amplified DNA from selected
B. fragilis strains. Lane 1:123 bp DNA ladder. Lane 2: NCTC
11295 (ETBF) strain. Lane 3: IPL 323 (NTBF) strain.
Lane 4:18/B strain. Lane 5:3505 strain. Lane 6: 22/B strain.
Lane 7: 3823 strain.
DISCUSSION
During the 1990s a relative decrease of anaerobic
infections has been reported. Nevertheless, ana¬
erobic bacteria are still a frequent cause of diseases
associated with severe morbidity and even mortali¬
ty. Among anaerobic bacteria the most commonly
encountered in the clinical practice are gram-nega¬
tive rods of the B. fragilis group. In this group,
which currently contains 10 species, the most im¬
portant are B. fragilis and B. thetaiota-omicron. B.
fragilis rods are recovered from most intraabdomi¬
nal infections and infections of other sites below
the diaphragm [27]. Although anaerobic infections
have been diagnosed in most anatomic sites of the
body, the majority arise from the indigenous flora
of the mucosa membranes. Since all these organi¬
sms are endogenous it is always a predisposing fac¬
tor for anaerobic infection [27], The virulence fac¬
tors and the mechanisms of infections of B. fragilis
species have been analysed in detail [3], Since
1984 [9] a new virulence factor in B. fragilis strains
has been observed. Enterotoxin (fragilysine) produ¬
ced by some of the strains altered the prespective
on the importance of those strains [8,11,14], Very
carefully described the structure of the enterotoxin
and the mechanisms of its action [15,16] lead to
the new trial to answer several questions. The va¬
rious methods of determining the strains able to
produce the enterotoxin: cytotoxicity on HT/29/C1
[22] or PCR [20] helped to establish whether ente¬
rotoxin production comprises a new characteristic
of some B. fragilis strains or whether those strains
were overlooked in earlier studies. In previous stu¬
dies [20,24] it was shown that before 1984 in Po¬
land and in Holland strains possessing the ability to
produce enterotoxin were present. The majority of
strains of enterotoxin producing ETBF were isola¬
ted from fecal samples of diarrheic people. Some
of the publications assure us that the ETBF strains
can be isolated out of the extraintestinal sources
[21,28]. We have shown previously that the ente¬
rotoxin producing ETBF B. fragilis can be isolated
together with the toxin producing Clostridium diffi¬
cile [29]. The interaction of those two infectious
agents appeared to provide a new field for experi¬
mentation. Because of all those reasons we deci¬
ded to collect strains from different countries. From
earlier reports we know that B. fragilis ETBF strains
isolated in Poland were shown to produce highly
variable amounts of cytotoxin, and the lack of ge¬
netic relationship between the strains was demon¬
strated by different PCR-mediated DNA typing
procedures [30]. It was also shown that B. fragilis
enterotoxin gene can appear in different alleles
[31].
CONCLUSIONS
The results of the experiments reported in this stu¬
dy provide the first steps to compare the Bactero-
ides fragilis strains isolated in different countries
and to study the role of ETBF strains in different
kinds of infections.
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Abstract Physiological studies on M. parvicella have been conducted to determine the rate of growth of this
organism in pure culture. The organism displayed a doubling time of 128 days despite its profuse abundance
in a local Wastewater Treatment Plant (WWTW). An extensive survey has been ongoing since February
2000 into the extent of M. parvicella in the WWTW. A suite of monoclonal and polyclonal antibodies has
been developed to detect and quantify M. parvicella.
Keywords Activated sludge; bulking; immunofluorescence; Microthrix parvicella
Introduction
In the last ten years M. parvicella has been recorded as being the most frequently present
filamentous micro-organism in bulking sludge in Europe (Eikelboom etal., 1998; Wanner
et al., 1998). Its presence in biological nutrient removal (bio-NR) plants is seasonal and
appears to be stimulated by temperature and dissolved oxygen (DO) concentration. Despite
its profuse abundance in bulking sludge during winter and spring, it is slow growing in pure
culture and has an optimum growth temperature of 12°C-15°C (Knoop and Kunst, 1998)
making biochemical and physiological studies difficult. In addition, its filamentous nature
means that it is difficult to enumerate by conventional direct means.
Immunological methods have been reported for the detection of specific populations of
filamentous and non-filamentous bacteria in wastewater systems other than M. parvicella
(Howgrave-Graham and Steyn, 1988 and Raskin etal., 1998). M. parvicella has been detect¬
ed in sludge using fluorescent in situ hybridisation (FISH) (Erhart et al., 1997) but with vari¬
able results, and requiring a methodology not suitable for routine analysis within the water
industry. The relative ease with which the signal produced using immuno-technologies
offers the possibility of quantitative immunofluorescence microscopy (IFM) to complement
diagnostic FISH, and provide the basis of quick quantitative and qualitative analyses.
We describe here the results of a long-term survey of municipal WWTWs within
Northern Ireland, a number of physiological growth experiments on pure cultures of M.
parvicella and the production and use of a range of antibodies specific to M. parvicella.
Methods
Microthrix parvicella RN1 (Rossetti et al., 1997) was obtained from Dr. Valter Tandoi
(Water Research Institute, Rome). The growth medium (R2AM) used was a modified form
of R2A (Reasoner and Geldreich, 1985), with the additions of (mg per litre medium);
CaCl2.2H-,0, 50; NaEDTA, 50; Na9Mo04, 20; cycloheximide; 20, NMS Trace Elements
(Atlas, 1995), vitamins (Eikelboom, 1968). Supplements to this medium, where






Figure 1 Volume of Suspended Solids (VSS) vs.
temperature of sludge
Figure 2 Regression of OD (550 nm) of
M. parvicella in microtitre plate wells (R2A, n = 16)
sterilised spent M. parvicella culture supernatant. Cell quantification was by microBCA
Protein Assay Kit (Pierce), spectrophotometric analysis (optical density of cultures @550
nm, in microtitre plates).
Polyclonal antibodies and monoclonal antibodies were produced from whole live cells
according to previously published methods (Lutton et al., 1991). IFM followed the meth¬
ods previously reported (Ramage etal., 1998), using methanol fixed cells.
Results and discussion
Survey of WWTWs
A 12-month survey regarding the extent of M. parvicella in a municipal WWTW, was car¬
ried out from February 2000. This involved the measurement of a number of physical and
chemical parameters on a weekly basis (Figure 1). It was found that as temperature
increased seasonally, the volume of suspended solids (VSS, in mis) did not reduce, as found
elsewhere (Knoop and Kunst (1998), Mamais et al. (1998)) with the exception of several
samples from October 2000 which were investigated (Connery et al., in preparation).
Indeed, this plant has exhibited poor settling continuously during this study, which began in
September 1999. Quantities of M. parvicella filaments in these samples are seen to follow
the trend observed for settling (data not published).
Physiological studies
Despite the abundance ofM. parvicella in the WWTW sludge, RN1 has been found to grow
slowly in pure culture, with a doubling time of 128 days (Figure 2). It has been shown that
the culturability of aged Mycobacterium tuberculosis cultures is greatly improved when
grown in spent culture supernatant (Sun and Zhang, 1999) and the effect of "autoinducing"
compounds on Actinomycetes has now been widely reported (see Horinouchi and Beppu,
1992). Some of the work reported here investigated the existence of such a factor (be it an
autoregulatory compound or one which is indigenous to sludge), to explain the slow growth
observed in pure culture. Typical growth yields can be seen in Table 1 for M. parvicella.
The organism was grown on R2AM medium and in R2AM supplemented with sterilised
sludge supernatant obtained from the WWTW on 8/3/2000. This sludge sample did not
improve the growth yield beyond that of the non-supplemented medium, R2AM. Figure 3
Table 1 Growth yields expressed as total protein of M. parvicella in
sludge-supplemented media. (n = 5, p<0.05)
Medium A Medium B Medium C
Sludge supernatant Sludge supernatant -
Glucose, Pyruvate - Glucose, Pyruvate
R2AM base - R2AM base
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Figure 3 Growth yields for M. parvicella grown on R2AM with spent culture supernatant(2) and sludge
supernatant from 2/2/00. (n = 5, p<0.05)
illustrates a similar experiment using a sludge supplement obtained on 2/2/2000 (bars 3 and
4) which indicates that some of these supplements may actually inhibit growth. Growth of
M. parvicella in R2AM medium supplemented with the supernatant of spent culture was
also examined (Figure 3). When grown in the presence of re-used culture medium, growth
yields were not significantly increased.
Detection of filaments in sludge by IFM
Polyclonal and monoclonal antibodies have been obtained and characterised (Thompson et
al., in preparation). A range of mixed slurries from activated waste treatment systems were
examined forM parvicella using conventional means (Eikelboom, 1968) and IFM. All the
antibodies described detected natural populations ofM. parvicella in samples, though some
showed brighter fluorescence across a range of samples than others. A cocktail of the mon¬
oclonal antibodies was found to be the most reliable method of detecting filaments in situ,
as the intensity of the autofluorescing background material often reduced the clarity of spe-
Figure 4 Immunofluorescence by anti-M parvicella rabbit polyclonal antibody of putative M. parvicella filaments
found in samples taken from Belfast WWTW. Clockwise, starting at top left, fluorescent image of labelled aerat¬
ed foam sample, phase image of same field of view, phase image of labelled anoxic liquor sample, fluorescent
image of same field of view. All views at (approx.) x 800 using a Nikon CP950 digital camera with zoom. Bar
represents 20 pm. All samples were methanol fixed, and secondary antibodies were FITC-conjugated
cific antibody staining when only one monoclonal was used. On the basis of IFM analysis,
M. parvicella was found to be the dominant filament within the WWTW and indeed, it was
the dominant microorganism. We also observed different patterns of fluorescence within
the same works WWTW at different sampling locations (Figure 4).
Samples were drawn from different locations within the same aerated Carrousel-type
system; from a non-aerated ("anoxic") section, mid-aerated and from the final point before
discharge to settling tanks (the point where maximum aeration might be expected). The
polyclonal antibody showed increasing fluorescence with an increase in aeration. It is
possible that this was the result of increased expression of an epitope associated with oxida¬
tive metabolism. It is also notable that it was possible to elucidate a fine structure within
M. parvicella in sludge samples, particularly in brightly fluorescing examples.
Conclusions
M. parvicella has been seen to be present all year round in this WWTW as determined from
February 2000 to February 2001. This plant has observed the phenomenon of bulking since
February 2000. The growth yield of M. parvicella is not improved when grown in the
presence of sludge from this plant obtained on either February 2nd or March 8th, 2000. The
same may be said for the addition of spent M. pan'icella culture supernatant. The organism
is slow growing with a doubling time of 128 days. A range of specific antibodies has been
produced against M. parvicella RN1 which have been shown to show varying reactivity
against putative M. parvicella filaments found in the WWTW.
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Bacteroides are present in: the, faeces and tire the pre¬
dominant bacteria of the open-ended culture system
ofthe human intestinal tract. It has been estimated that
Bacteroides spp.bare one of the major group's of com¬
mensals that inhabit the human body. They, and other
related bacteria are also found in the upper respiratory
tract, mouth and. urogenital tract of humans and ani¬
mals, This, chapter deals mainly with the Bacteroides
$ensu stricto (Table 1). The oral Gram-negative obli¬
gate- anaerobes Porphyromonas, Prevotella and Fusa-
bmcterium aire considered in Chapter 51. Certain
Bact'eroides species, in particular Bacteroides fragilis
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Table 1 Members of Bacteroides sensu strictoa
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As defined by Shah and Garbia-(1991).
Data from Shaheduzzaman eta/. (1997).
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and B. tbetaiot.aomicrfip,, arq.fheiSpfi^t an^qrq^cs rop^t
frequently isolated frorn clinical,infection,(Jphnspn,
1978), S,uch infections generally .arise ,froj,u> t)he c9,hr.
tamination by the commensal microbiqta of normally
non-colonjsed body sites. In this sense, Bacteroidtf
spp. are opportunistic PfttHqgensi:yjj(n<i\;|,j Jfj -rjgriL?,
Though Louis Pasteur is credited with the
first cultivation of strictly anaerobic bacteria, it was
Veillon and Zuber (1897, 1898) who demonstrated
clearly the involvement of Gram-negative non-spore-
forming strictly anaerobic bacteria in infections such
as: brain and lung abscesses^ peritonitisySbartholinitiB
and otitis media. They named the most abundant
and frequently observed bacterium in appendicitis!and
peritonitis Bacillus (now Batteraides), frdjtilisd nvAYvti
B. fragilis is the, obligate^ anaerqbic-.Gjrahri-negatjvB
bacterium most frequently isolated IfoaT eltnieail
infection and B. thetmdaomicran.-thfijseoortdrmost
frequent isolate (Table 2; Duerdeaa^ :lt?80y, iBrtiloki
1989;: Willis, 1991). Thest infections flidu'UeiitetraH
abdominal,' vaginal, pilonidal,,-.."perianal^;and; /braih
abscesses and soft-tissue iAfectionS).oBiijfoiyfi/fe islalsb
the most common cause ofanaerobic vseptfeaemaa,.-with
a potential. mortality of -up to. 19% ; feedOnd©) bpjttdc\
1995). The risk of B.>frfigilis itifectiojinirafrottisvmgical
operaitions of the loTer intestinal: tracf malffes prdi
pliylactic antibiotic cover, necessary. Before,the intcoy
duetton of aiitibiotics, the mortalitynfrpm. Snfecewn
arising particularly front large-bowel perforations was
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved. doi:10.1006/bkmm.2001.0091
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8. vulgatus 43-45 2-3
B. thetaiotaomicron 15-29 13-17
B. distasonis 9 3-6
B. fragilis 4-13 63-81
B. ovatus 4 0-7
a Compiled from Duerden (1980), Brook (1989), Namavar et al. (1989),
Willis (1991).
30-100%, for example after rupture of an inflamed
appendix. In the 1970s intra-abdominal abscesses were
associated with a mortality of up to 30%, largely
because the role of anaerobes in these infections
was not appreciated and treatment was therefore not
given (Tally and Ho, 1987), in spite of the early
observations ofVeillon and Zuber in the 1890s.
Knowledge and understanding ofB.frojjilisis about
to blossom as a result of the provision of funding by
the Wellcome Trust for the Sanger Centre (UK) to
sequence the complete genome of the B. frajjilis type
strain NCTC 9343 (ATCC 25285) and a partial shot¬
gun sequence of the rifampicin-resistant strain 638 R.
This sequence information is in the public domain and
available for view on the web sites ofWellcome Trust
Beowulf Genomics (http://www.beowulf.org.uk/




The genus Bacteroides was at first a repository for any
Gram-negative strictly anaerobic non-spore forming
bacillus that was neither a Fusobacterium nor a Lepto-
trichia, but it has been refined over the years. Many of
the more than 50 species listed in the ninth edition of
Bcrjjey's Manual of Systematic Bacteriology have been
assigned to new genera (Table 3). The proposal for¬
mally to limit the genus Bacteroides to the species
listed inTable 1 was made by Shah and Collins (1989).
The type species is Bacteroides frajjilis and, therefore,
the 10 species listed in Table 1 are sometimes referred
to as the LB. frajjilis group'. The phylogenetic tree
based on whole genome analyses of 7 species of the
B. frajjilis group was reported to be broadly similar to
that obtained from 16S rRNA sequences, with the
exceptions of B. thetaiotaomicron and B. ovatus. The
sizes of the genomes analysed are included in Table 1
(Shaheduzzaman et al., 1997).







a Designated a member of the Campylobacteraceae but not
yet re-named.
DNA homology studies indicate that there is a good
correlation between DNA homology group and phe-
notypic characteristics of the designated species
(Johnson and Ault, 1978). Although B. frajjilis,
B. ovatus and B. thetaiotaomicron could each be sub¬
divided into more than one homology group, the
phenotypic tests used identified the different hom¬
ology groups as the relevant species. Of a group of 60
strains of DNA homology group I, for which the
source was known, 76.6% were clinical isolates. Of
the 11 group II isolates whose source was known,
approximately halfwere from faeces and the other half
from infections. More recent analysis of the two DNA
homology groups of B. frajjilis indicate that group I
and group II B. frajjilis can also be distinguished on the
basis of ribotyping, analysis of PCR-generated frag¬
ment patterns, insertion sequence content (Podglajen
et al., 1995) and small-subunit rDNA sequencing
(Ruimy et al., 1996). It was noted that B. frajjilis ~D~NA
homology group I lack the gene cfiA (also called ccrA)
which encodes a metallo-/3-lactamase (Ambler class B
enzyme). This enzyme confers resistance to the
majority of /-lactam antibiotics, such as carbapenems,
imipenem and meropenem, and is not susceptible to
inhibitors such as clavulanic acid, sulbactam and
tazobactam. This gene was identified in about 3% of
isolates. Only about one-third of the strains examined
expressed this /3 lactamase, however; the gene is silent
in the remainder of these strains. The data suggest that
DNA homology group II strains relate to the cfiA-
gene positive group. Interestingly, three insertion
sequences (IS4351, 942 and 1186), which provided
promoter sequences for the transcription of cfiA, were
also identified. This will be further considered below.
On the other hand group I strains, which represent the
majority ofclinical isolates, lack the cfiA gene but carry
the cepA gene, which encodes an active-site serine
/3 lactamase, related to the Ambler Class A enzymes.
The B. frajjilis type strain NCTC 9343 (ATCC 25285)
and strain 638R (also known as AIP 638R, TM4000,
IB101 and 638rfm), which has been used extensively
in genetic studies, are members of the DNA homology
group I.
Bacteroides 1923
Position of Bacteroides within the Phylum



















In the wider taxonomic picture, on the basis of
rRNA sequence comparisons, the Bacteroides fall into
the Bacteroides-Flavobacterium phylum (Table 4;
Woese, 1987). Bearing in mind the diverse phenotypes
of these two groups of bacteria, this is an unexpected
taxonomic association, since Flavobacterium, which
includes Cytophaga and Fiexibacter, are aerobic. It may
be that as more is learned of the characteristics ofthese
two bacterial groups, their similarities will become
more apparent. Interestingly, it is thought that this
phylum diverged from other eubacteria early in evo¬
lutionary terms. This is thought to have occurred well
before the divergence of the Gram-positive bacteria
from the phylum, which contains the majority
of Gram-negative bacteria, such as the enteric bac¬
teria Escherichia coli and the pseudomonads (Phylum,
Proteobacteria, Purple bacteria). Indeed, the sequences
of some antibiotic-resistance genes bear remarkable
homology with those of Gram-positive bacteria. This
taxonomic divergence may also explain the difficulties
that have been encountered in carrying out genetic
experiments in Bacteroides, since the methods rely
heavily on E. coli (see below).
For the taxonomic history of the genus Bacteroides
the reader is referred to Shah and Garbia (1991) and
Shah ct al. (1998).
Identification
The key distinguishing feature of the Bacteroides spp.
and related anaerobic Gram-negative bacteria is their
anaerobic nature, but their ability to tolerate oxygen
may be variable (see below). They are non-sporing and






Cell size 0.5-1.3 x 1.6-11pm
Components
Principal respiratory quinones: menaquinones
(with 10 and/or 11 isoprene units)
Dibasic amino acid of peptidoglycan:
meso-diaminopimelic acid
DNA G + C ratio: a40^18 mol%
Lipid content: sphingolipids
Predominant cell fatty acid: 3-hydroxylated and
non-hydroxylated (straight chain saturated,





Fermentation: saccharolytic, major metabolic
end-products acetate and succinate
Metabolic enzymes: enzymes for pentose phosphate
pathway e.g. glucose-6-phosphate dehydrogenase,
6-phosphogluconate dehydrogenase and also
malate dehydrogenase and glutamate dehydrogenase
Compiled from Shah and Garbia (1991).
a Lower figure variously quoted as 39, 40 and 41.
blood agar, they lack the black pigmentation and
fluorescence that may be associated with some of the
oral Gram-negative anaerobes, such as Porphyromonas
or Prevotella spp., and they form circular, entire and
smooth colonies. They are generally sensitive to
metronidazole and resistant to kanamycin, vancomy¬
cin and colistin. Haemin and vitamin Kare stimulatory
for the growth ofmany Bacteroides spp. and they are an
essential requirement for some. The major character¬
istics are detailed in Table 5.
Further details ofthe current techniques used for the
clinical diagnosis of Bacteroides spp. are presented
below. The reader is also directed to the Wadsworth
Anaerobic Bacteriology Manual (Summanen et al.,
1993) and relevant chapters in Cowan and Steel's
Manual for the Identification of Medical Bacteria
(Brown ct al., 1989; Barrow and Felthan, 1993;
Jousimies-Somer et al., 1995). Although it is not yet
part of the routine identification of Bacteroides spp.,
there is scope for the extension to clinical practice of
identification methods based on 16S rRNA sequences
that have been used for the identification of Bacteroides
in human faeces (e.g. Manz ct al., 1996; Bonnett et al.,
1999).
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Structures ^^10ioiBM e 9'^
Fimbriae and extracellular polysaccharide capsules are
two surface structures that have been studied in detail
in Bacteroides. The vast majority of structural investi¬
gations have centred on B. fragilis, which is considered
to be the most frequent clinical isolate. Some strains of
B. fragilis release quantities of outer membrane ves¬
icles that cam* with them the surface polysaccharides
(Fig. 1). The potential role of these structures in viru¬
lence is discussed below.
Polysaccharides
2DlCj> 1 iTpf* i; ■ t'.-'O .) i v ] ■: ,i
Encapsulating structures have been implicated in
resistance to complement-mediated killing, uptake
and killing by phagocytes (Reid and Patrick, 1984),
and in abscess formation in an animal model
(Tzianabos eta/., 1993). These aspects are discussed
in detail below in relation to virulence.
Capsules are discrete clear areas around negatively-
stained B. fragilis, B. ovatus, B. vulgatus and B. thcta-
iotaomicron, but they were not present in live strains
of B. distasonis{Babb and Cummins, 1978). With the
exception ofB. ovatus, which were all capsulate, 10% or
less of the bacteria of other species had capsules.
Capsule size varied between strains and also, notably,
within populations of a given strain. It is now clear that
B. fragilis exhibits not only within-strain phase varia¬
tion in capsule production, but also between- and
within-strain antigenic variation of different types of
capsules, which continues not to be taken into account.
In individual strains of B. fragilis it is possible by elec¬
tron microscopy To identify large (LC) or small cap¬
sules (SC) that are both fibrous in appearance but are
antigenieally different, and bacteria with an encapsu¬
lating electron-dense-layer (EDL) adjacent to the outer
membrane (Fig. 2) (Patrick and Reid, 1983; Patrick
et al., 1986). Bacteria with an EDL.are-non-capsulate
(NC) by light microscopyfbut small and large capsules
are visible with negative staining. Expression of the
different capsular types is inheritable, since popula¬
tions can be enriched by subculture from different
interfaces of Pereoll step density gradients. EDL-
enriched populations also produce polysaccharide
slime (Fig, 3) which shares epitopes with the discrete
LC. Observation by microscopy of the populations
enriched for the three capsular types with monoclonal
antibodies specific for surface polysaccharides shows
that non-capsulate bacteria are antigenically different
from SC bacteria, but share epitopes with LC bacteria.
In addition, immunofluorescent and immunogold
labelling for fluorescence and electron microscopy,
respectively, reveal antigenic variation in populations
Fig. 1 Transmission electron micrographs of outer-membrane
vesicles of B. fragilis: (a) Ultrathin section of-bac'teFifim (nfenj
capsulate by light microscopy) with an EDL adjacent to the
outer membrane. Note the outer membrane vesicle, with
associated electron dense material. (b)!'Ulfrafhih section bf
bacterium to illustrate vesicle being felbd5e:d from1 the buter
membrane, (c) Ne^ativefyritaihed ohfyr membrane vesicles
immunogold-labelled''with! monoclonal antibody QUBF5.
From Lutton et al. (199.1 )pwith/permission. i.
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Fjg; >2 Transmission electron micrograph of ultrathin sections
to. illustrate encapsulating structures of B. fragilis: (a) Bac¬
terium, with large fibrous network, which equates to a LC
visible by light microscopy, (b) Bacterium with small fibrous
network, which equates to a SC visible by light microscopy
(right-hand side) and bacterium with marginal EDL, non-
capsulate by light microscopy (left-hand side and arrow).
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fig. '3 Transmission electron micrograph of negatively stained
bacterium from non-capsulate population of B. fragilis
imrnunogold-labelled' with monoclonal antibody QUBF7 to
illustrate extracellular material. From Lutton etal. (1991), with
permission, n ajfid [aoritj b aftocl aioDalorn A biqil orb to
that appear to be structurally homogeneous (Reid
etal., 1985, 1987; Patrick and Lutton, 1990a; Lutton
etal., 1991). This phenohidnon is observed in recent
clinical isolates Irony a variety of anatomical sites, in
isolates from different geographical locations and in
culture collection type cultures (Patrick etal., 1995b).
If a broth culture; with a mixture of epitopes is plated
on agar and the resulting colonies are labelled with
surface polvsaecharide-specific monoclonal antibody
and a fluorescent, dye and examined by microscopy,
two types of colonies are observed; in one ofthese 90%
or more, and in "the other 10% or less, of the bacteria
express the same epitope. Subculture ofsingle colonics
in which the majority of the bacteria express that par¬
ticular epitope into broth culture, results in enrich¬
ment for this epitope, and failure to enrich for other
epitopes (Patrick et al., 1999). This strongly suggests
that a reversible switching mechanism is in operation.
The genetic mechanism that generates the observed
phase and antigenic variation is not known, but mul¬
tiple mechanisms for the generation of phase and
antigenic variation are well characterised in other
bacteria (Patrick and Larkin, 1995). Examples which
may be relevant to Bacteroides include variation in
Neisseria meningitidis (Jennings et al., 1999) and
Haemophilus influenzae lipopolysaccharide (LPS).
The precise nature of the biochemical differences
that generate the antigenic variation is unknown. It is
possible that polysaccharides arc biochemically similar
in terms of sugar moieties, for example, but for a wide
variety. of antigenic variation to be generated by
alteration of the linkage of the substituent moieties,
their chemical substitution or both. Antigenic varia¬
tion generated by these means is well documented in
the polysaccharides of other pathogenic bacteria such
as H. influenzae, E. ioii aild N. meningitidis^.Patrick
and Larkin, .1995).
Immunochemical analysis of these ahtigenicaljy
variable polysaccharides after polyacrylamide gel elec-
trophoretic (PAGE; separation reveals diffuse bands
of high molecular mass. In the non-capsulate, slime
producing, -populations, associated ladder patterns of
lower molecular mass are also observed. This type of
banding pattern is characteristic of different chain
lengths of heteropolymeric polysaccharides with
repeating subunits, each 'step' in the ladder correspon¬
ding to the addition of another subunit,It may be that
polysaccharides with different chain lengths are more
characteristic of slime as opposed to. discrete capsular
structures. Ladderswith a fine step size and a large step
size have been .observed (Fig. 4). The larger step size
resembles-the pattern observed with the O antigens of
enteric bacteria. The controversy surrounding the
C) antigen ofB. fragilis\$ further discussed below.
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1
Immunoblotsof aqueous phenol extracts from B. fragilis
strain NCTC 9343 after PAGE reacted with QUESF5 (track 1),
QUBF6 (track 2), QUBF7 (track 3) and QUBF8 (track 4). Note
high-molecular-mass material and associated ladder patterns.
From Patrick eta/. (1999), with permission.
Two B. fragilis polysaccharides, extracted from
populations of strain NCTC 9343 which were not
defined for capsule expression by microscopy, have
been chemically characterised and designated A and B
(Pantosti et al., 1991, 1995; Tzianabos et al., 1992).
These two entities can be separated by iso-electro-
focusing from extracts obtained by hot-phenol-water
extraction followed by ethanol precipitation and sepa¬
ration on a Sephacryl S-300 column (Pantosti et al.,
1991), and high-resolution NMR spectroscopy was
used to analyse the two polysaccharides (Baumann
et al., 1992). Polysaccharide A (PSA) is zwitterionic
with a positive and a negative charge. It consists of
tetrasaccharide repeating units of three sugars. Poly¬
saccharide B (PSB) possesses one positive and two
negative charges and has a hexasaccharide repeating
unit. See Fig. 5 for structures of PSA and PSB.
Although it was originally reported that monoclonal
antibodies specific for either polysaccharide had been
produced (Pantosti et al., 1991; Tzianabos et al.,
1992), it was subsequently reported that antibodies
thought to be specific for PSB cross-reacted with PSA
(Comstock et al., 1999). The immunochemistry of
these entities and whether they are co-expressed on the
same bacterial cell is therefore unknown. The evidence
for the involvement of these polysaccharides in abscess
formation is discussed below.
Many strains of B. fragilis are refractory to the intro¬
duction of foreign DNA, which presents difficulties for
genetic studies that involve the use of E. coli- based
vectors. A spontaneous rifampicin-resistant mutant,
638R, seems to lack the restriction enzymes of most
B. fragilisstrains, since it can be conjugated with E. coli
(Privitera et al., 1979). It also lacks a visible capsule
when negatively stained for light microscopy (unpub¬
lished). Mating of this strain with an E. coli strain that
contains the B. fragilis transposon Tn4351 located on
the suicide vector pNJR6 resulted in the production of
transposon mutants that did not react with mono¬
clonal antibody 4D5, which is specific for the PSA ofB.
fragilis NCTC 2429 (Pantosti et al., 1995) and cross-
reacts with 638R but not with NCTC 9343. Sequen¬
cing of the DNA at the junction of the transposon
insertion revealed an open reading frame (ORF) with
approximately 80% similarity to the rmlA genes of
Shigella flexneri and Salmonella enterica. Inthesebac¬
teria this gene encodes a glucose-1-phosphate thymi-
dylate-transferase enzyme known to be involved in
polysaccharide biosynthesis. A 638R rmlA probe
identified a similar gene on the chromosome of
NCTC 9343. Sequencing of the region downstream
resulted in the identification of a 15 379-bp locus
with 16 ORFs, designated wcf Seven ORFs were
identified, which probably encode sugar transferase
enzymes and two O-acetyltransferases. A further two
ORFs were thought to be involved in polysaccharide
transport and polymerisation. Interestingly, a dele¬
tion mutant from which the last 10 of the 16 ORFs
had been removed appeared to lack PSB but not
PSA, in spite of the specificity of the 4D5 mono¬
clonal antibody used to locate the biosynthesis
region. When compared with the wild type, there
was no apparent difference in the ability of the
mutants to induce abscesses in a rat model of intra¬
abdominal infection (Comstock et al., 1999).
Lipopolysaccharide and Common Antigen
The LPS of B. fragilis differs in composition from that
of enteric bacteria in a number of respects (Lindberg
et al., 1990). Enterobacterial lipid A diglucosamine is
bisphosphorylated, whereas in B. fragilis it is mono-
phosphorvlated, since the distal glucosamine residue


























Fig. 5 Structure of PSA and PSB (see Baumann eta/., 1992).
has six fatty acid chains, or acyl groups, per diglucos-
amine backbone, which may have a chain length of 12-
14 carbon atoms, whereas B.fraqilishas 4-5 fatty acids
of chain lengths 15-17 carbon atoms, with branched
3-hydroxylated and non-hydroxylated fatty acids. One
of the predominant fatty acids in enterobacterial lipid
A, 3-hydroxytetradecanoic acid, is thought to be lack¬
ing in B. fragilis. The differences in structure of the
Bacteroides and the enterobacterial lipid A almost cer¬
tainly relate to the different immunomodulatory prop¬
erties of these molecules (Patrick and Larkin, 1995).
The potential role of Bacteroides LPS in systemic
inflammatory response syndrome is discussed later.
Reports are conflicting about the presence or
absence of Bacteroides LPS of L-glycero-D-manno-
heptose and keto-deoxyoctonate (KDO), both of
which are present in enterobacterial LPS. KDO is
almost certainly present in Bacteroides, but in a phos-
phorylated form that renders it undetectable in the
standard thiobarbituric acid assay (Beckmann et al.,
1989; Fujiwara et al., 1990). In addition, rhamnose,
galactose and glucose have been reported in the core
region (Lindberg et al., 1990). Whether the LPS of
Bacteroides spp. possesses an O antigen similar to that
found in the enterobacteria is subject to controversy.
The literature contains emphatic statements that
extended repeating O antigen is absent from Bactcr-
oides (Lindberg et al., 1990; Comstock ct al., 1999). It
is suggested that Bacteroides LPS is more like the
lipooligosaccharide of, for example, N. meningitidis
(Jennings et al., 1999) or 'rough'-type mutants of
enterobacteria. Other publications, however, clearly
illustrate silver-stained LPS PAGE profiles with ladder
patterns characteristic of the smooth LPS of B. fracjilis
(Poxton and Brown, 1986) and B. vulgatus (Dela-
hooke et al., 1995a: Fig. 6). A number of possible
factors may explain the inability of some workers to
isolate the repeating polysaccharide chains of smooth
LPS. The most likely is variation within and between
Bacteroides strains and possible loss of the ability to
synthesise O antigen after repeated subculture in vitro.
A monoclonal antibody, QUBF5, has been described,
which labels a carbohydrate component with a PAGF.
profile similar to that of the apparent O antigen (see
Fig 4: I.utton et al., 1991), but it labels only a pro¬
portion of the bacteria in a population. Enrichment for
two different antigenic types of the high-molecular-








epitope, as determined by immunofluorescence
microscopy (Patrick et a.1.^ 199.9.)kifiWhether this
represents within-strain antigenic), variation of this
component or phase variationjis'hdl known, a& only
one monoclonal antibody specific for this Type of
structure has been described. Further discussiturof the
^ conflicting data and inaccurate literature citation since
the middle of the respect)to \&h(terotd?s
Oci-PS (Weintraub et at., T985";/Poxtgin ,artd %rown,
1986) can be found inPatrick (199*3*)'.-: ^ has been
suggested that some strains of E. coli produce not only
an LPS, but also a. LDS distinct from rough LPS, by a
separate biosynthetic'padi^y.(Heinrichs etal., 1999).
Also, the K3() capsular polysaccharide of E. coli may be
covalently linked"id core lipid A, but this is not essential
either for export of this high-molecular-mass poly¬
saccharide or for formation of a capsular structure at
the ceiy¥£feS% T&I 41 1993). The dis-
nnctionf^betweencan^^iantigerf ahd a capsular or
k' ^"xtfaceflulaY '*^"<^^^?ft^4^%-|h^|refore somewhat
blurred and may finally only be resolved for Bacteroides
when the genetic loci and pathways for biosynthesis
, fi^p.b?epjd^^ inc^f;^i^l&|st|-ains.
The commojKoaBtigefp6lt®s€bibeSSl bv Poxton and
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Fig.6 Si Iverstained PAGE profiles: (a) B. frag/7/sstrain NCTG9344
aqueous phenol extract (track 1), phenol chloroform petroleum
ether extract (track 2); (b) B. vulgatus strain MRPL f985 aqueous
phenol extract (track 1), dhenol chlbroform petroleum ether
extract (track 2), triton-magnesium extract (track<3y.:iPH6tb+
graphscburtesyofl.R.Poxtonan.cfD.M.Delahooke, Department
of Medical Microbiology, University of Edinburgh).-' if >q ;vxrn
fjpenol-water, runs
behind the^ rough LPS (MsS©®iPAGE and is distinct
from mono-specific
antiserum raised against immunoblot-purified ma-
terial'-'detPbts;the^anfigeh in It. frdjjilis strains' froth
culture collections and recent clinical isolates from a
range! of geographical! locationsii-Thiiianti'Sertiniialsd
-labelT strains! oSi&'jwiutub and BythetMotuoinitYonyby
ihtniunoflHofescdnbecmit:rbscopy(!biitiWith; kssJintehi-
iityl-This antiserum ihars< afoo'-bteinhised ifpr'-the rdirect
detection.': by? iitenitujofliupfeiscenben. rtiierbstse^rldf
IBccfiidroidcsiA pti&isampksjfandjrbloodiieulttawibcjttlfes
(Patrick <et i«!A,nP995ib)f i The natu.fe'.'Ofnthisnipihmoh
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Two types-of fikhbriaevhavecbeCn identified-owB.
j-r/apltnitfimeompariscMJiwith; ©then bacterial species, the
fimbriae.-.arq nob we]1;dhacacterihedr.iThis isiprpbSbly
duertor poonknchs'ledge eifl the. precise vgl-oUth/eorKdi-;
tionsfrequirhd for. the ;assembly off the fltnfejriae .'Pruzzd
et ui(l(f1984)1 desoibedtfilanvemiioitis'.firirlpriae dfiiapf
proximatxjlyjfBO rimv .im.!V'fiMaaahetav,oapdl ^subsequently
fimbriaeidf 4j-t5ininni in diameter!ndere;defedtibed-'(<vdq
Doorn - at mill*. 1987 )l ,-Finibria were observed iby lekar
tron: imialosccopy and nanmWhbgold- labelMngt xs'itb'fi.Fhi-
briarspecificjpolydonal jdntiscruniiYiIixarhunoblottitig
aftet'i.palflacrylbmid^: . glcMKcIectrophoresih r irdvtea'laiT va
fiiribrial;jiubunityctf i 40)-42 kJ^. .ciepepding.ion vtshk
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strain. Expression of the fimhrial subunit was reduced
at low iron concentrations and low temperature. In a
variety of strains of B. fmjjilis, grown in broth or on
agar, and in a model of peritoneal infection in vivos,
fimbria! subunits can be detected bv immunoblotting.
Intact fimbriae, however, have consistently been, ob¬
served only by transmission electron microscopy after
negative staining in agar cultures. One of the difficul¬
ties in observing fimbriae bv electron microscopy
relates to the interference by polysaccharide. Long
strands of material are observed under the electron
microscope when B. fragilis from broth cultures and
producing a small capsule are platinum-gold shadowed
or coated. Shorter strands are also observed with the
LG population (Fig. 7). It remains to be determined
whether these strands are purely polysaccharide or
cover underlying, fimbrial appendages. If the latter is
the case, the polysaccharides would mask epitopes on
the fimbriae, and account for erratic immunolabelling.
Another possibility is that fimbrial subunits are
expressed, but not always assembled into intact fim¬
briae (button et al., 1989). N-Terminal amino acid
sequencing of the 40-kDa subunit of B. frncjilis strain
BET did not reveal any similarity with the sequences of
Porphyrpwonas jjinjjivrtlis, Dichelobacter (formerly
Bai&teroiiies)'p.odosus or E. coli tvpc 1, K88 or CFA/1
fimbrial subunits (van Doom ct nl., 1992). The rela¬
tionship between B. frapfilis fimbriae and microbial
attachment to host cells is considered below.
Fig. 7 Transmission electron micrographs of platinum gold-
shadowed B. fragilis: (a) bacteria with aSC by light microscopy;
(b) bacteria with a LC by light microscopy; (c) non-capsulate
by light microscopy. . iolos
Physiology
Iron Uptake Mechanisms
The success of the majority of bacteria that grow jn
human hosts depends on their ability to obtain iron,
which is strictly limited in availability. In the host iron is
bound to transferrin and iactofcrrin, and concentration
offrcxly available iron in body fluids is about 10 18 mol/
I. ( Patrick and Larkin, 1995). B. frctgilishas not only a
requirement for iron, but also an absolute requirement
for haem, which is necessary for cytochrome and catalase
synthesis (Morris, 1991). Although B. frajjiliscan use
free haem, it is unlikely that in vivo there would be suf¬
ficient of this to sustain growth; it is, however, likely
that B.frajjiHs\s-Ab\c to release haem from haemoglobin',
haptoglobin-haemoglobin complexes or haemopexin-
haemoglobin complexes in vivo. In defined medium
depleted of iron bv precipitation with calcium chloride,
B. ifrctjfilis can use haemoglobin or haptoglobin—
haemoglobin as a source of both iron and pro¬
toporphyrin (Otto et al., 1990, 1994). This is related
to the expression of a number of iron-repressible
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outer-membrane proteins (OMP). Four haem-bind-
ing proteins have been isolated by haemin-agarose
affinity chromatography and a further 44-kDa iron-
repressible OMP is required for the haem-binding
protein complex in B. fragilis strain BE1. B. vulgatus,
grown under similar conditions, does not produce the
same range of OMP; in particular, it lacks the 44-kDa
OMP (Otto et al., 1988). This may be a key factor in
the predominance of B. fragilis over B. vulgatus in
clinical infections (Table 2). An iron-repressible OMP
of approximately 40 kDa associated with increased
binding of Congo red has also been described in the
type strain B. fragilis NCTC 9343 (Larkin et al.,
1988). The presence of specific antibody to the 44-
kDa OMP in experimentally infected rats and also in
sera from patients with B. fragilis infection, indicates
that it is produced in vivo (Otto et al., 1991). There
was no detectable response in patients infected with
other Bacteroidesspp., such as B. ovatus, B. distasonisox
B. vulgatus. The gene encoding the 44-kDa protein,
hupA, from B. fragilis strain BE1 has been cloned and
sequenced. The deduced amino acid sequence indi¬
cates that there are haem-binding motifs characteristic
ofhaem lyase enzymes, but little similarity with other
putative bacterial haem receptors (Otto et al., 1996).
There is no evidence that Bacteroidesspp. produce their
own iron-chelating agents such as the siderophores
found in other bacteria, but the possibility cannot be
ruled out. A comparison of the OMP profiles of
B. fragilis growing in vivo and in vitro did not, how¬
ever, reveal the induction of the high-molecular-mass
OMP which is characteristically produced by E. coli
grown under iron limitation (Patrick and Lutton,
1990b) and are associated with siderophore uptake.
Oxygen Sensitivity and Redox Potential
Bacteroides spp. are obligate anaerobes that, for their
isolation and cultivation, require reducing conditions
and, therefore, the absence of dissolved oxygen in
media. To achieve this, media are usually boiled to
drive off dissolved oxygen and a reducing agent, such
as cysteine, is included. A redox potential of less than
—42 rnV at pH 7, as monitored by the redox dye
resazurin, is suitable for the isolation and growth of
Bacteroides spp. (Poxton et al., 1989; Morris, 1991).
Pure cultures of some strains will, however, grow in
oxygen-free defined medium at an initial redox
potential of + 100 ntV (Goldner et al., 1993). Sepa¬
rate from this need for reducing conditions, oxygen
may be directly toxic to Bacteroides spp., but this sen¬
sitivity is variable and some survive exposure to
oxygen for quite long periods. The relative aero-
tolerance of some Bacteroides spp. probably relates to
the production of superoxide dismutase and catalase.
B. fragilis and B. distasonis produce catalase, but only
some strains of B. thetaiotaomicron, B. ovatus and B.
cggerthi do so, and B. vulgatus and B. uniformis are
catalase negative. It has been proposed that the relative
aerotolerance of B. fragilis contributes to its virulence,
and recent clinical isolates have been reported as more
aerotolerant than faecal isolates. The catalase of B.
fragilis, KatB, is induced in late exponential phase
cultures and in cultures exposed to oxidative stress
when moved from anaerobic to aerobic incubation
conditions. The catalase is a haemoprotein, composed
of two identical subunits, each with an approximate
molecular mass of 60 kDa. The catalase of B. theta¬
iotaomicron is similar but has a molecular mass of
approximately 250 kDa. Cloning and sequencing of
the katB gene of B. fragilis 638R has indicated amino
acid sequence similarities with Gram-positive bacterial
and mammalian catalases. This may reflect the taxo-
nomic position of the Bacteroides-Flavobacterium
phylum, but interestingly the B. fragilis catalase shares
71% amino acid similarity and 66% nucleotide identity
with the catalase of H. influenzae (HktE). It has been
suggested that this reflects transfer of the catalase gene
into both B. fragilis and H. influenzae from a common
source in the evolutionary past (Rocha and Smith,
1995). A strain with a mutation in the katB gene sur¬
vived as well as the parent strain when exposed to
oxygen, but it was more sensitive to the toxic effects of
hydrogen peroxide (Rocha et al., 1996). Apart from
catalase, oxidative stress or exposure to hydrogen
peroxide induces a further 28 proteins ranging in
molecular mass from 12 to 79 kDa. Ifprotein synthesis
is inhibited by chloramphenicol, the survival of
B. fragilis under aerobic conditions is limited (Rocha
et al., 1996). A number of genes are, therefore, asso¬
ciated with survival to oxidative stress. Some of these
may also be involved in the ability of B. fragilis to
penetrate HeLa cells (Goldner et al., 1993) and in
observed changes to the fermentation pathways after
growth under oxidising conditions (Goldner et al.,
1997). Another mutant of B. fragilis 63>8K, generated
by transposon mutagenesis, grows poorly in associa¬
tion with murine fibroblast or Chinese hamster ovary
(CHO) cell line when compared with the parent strain
(Tang et al., 1999). This mutant was also less tolerant
ofexposure to oxygen than the parent strain. A 6.6 kbp
fragment complemented the mutant, and sequencing
of this region revealed five open reading frames which
have been designated the Bacteroides aerotolerance
operon (bat A-Fi). The precise function of the proteins
is unknown, but they may form a membrane-asso¬
ciated complex involved in the generation or export of





The release from Bacteroides spp. of extracellular
enzymes with the potential to degrade components of
the host has been long recognised (Rudek and Haque,
1976; von Nicolai et al., 1983) and, indeed, a scheme
for the rapid identification of Bacteroides spp. based on
enzymatic activities has been proposed (Hofstad,
1980). Enzymes so far described include those capable
of degrading components of the host extracellular
matrix, host cells and tissue such as hyaluronidase,
chondroitin sulphatase, fibrinolysin, DNAase, lipases,
proteases and neuraminidase. These may play a role in
virulence, but in many cases their precise contribution
is not proven. It may be that some of these enzymatic
activities are related to the growth of Bacteroidesspy. in
the intestinal environment as part of the normal
microbiota, rather than for virulence.
Proteolytic activity that may be related to either or
both ofvirulence and survival in the intestine has been
reported in B. frajjilis. Arylamidases for the amino
acids leucine, valyl-alanine and glycyl-proline are peri-
plasntic or outer-membrane-associated in exponential
phase of batch cultures. Proteolytic activity increased
in the culture medium in stationary phase and was
either in a soluble form or associated with particulate
matter (Macfarlane ct al., 1992a, b). It is probable that
the particle-associated enzymatic activity relates to the
release of outer membrane vesicles (see below). These
proteases are active against casein and gelatin (collagen
type IV), but not elastin, collagen types I, II, III, VI,
ovalbumin or bovine serum albumin. A protease with
similar hydrolytic activity for valyl-alanine and glycyl-
proline hydrolyses fibrinogen, casein and gelatin
(Chen et al., 1995). The purified enzyme has a mo¬
lecular mass of approximately 100 kDa and the char¬
acteristics of a serine-thiol-like protease. It completely
hydrolysed the a chain of fibrinogen. When the fi¬
brinolytic activity of crude extracts of B. frajjilis, B.
ovatns, B. ejjjjerthii, B. uniformis and B. thetaiotaomi-
cron were compared, B. frajjilis had the greatest activ¬
ity. Since soluble fibrinogen is converted to insoluble
fibrin as part of the normal blood coagulation and
wound healing, this enzyme has the potential to slow
clot formation, and this may play a role in virulence.
Similarly, a clear distinction between glycosidase
activities of Bacteroides spp. that may play a role in
virulence, and those that relate to degradation of
intestinal components, has yet to be made. A range of
glycosidases has been identified in B. frajjilis (Table 6).
For example, an endo-/3-galactosidase releases oligo¬
saccharides from the human blood group O erythro¬
cytes (Scudder etal., 1987), whereas some glycosidases
degrade the carbohydrate moieties of gastric mucin.
The latter may, therefore, be involved in survival
within the intestine (Macfarlane and Gibson, 1991).
Glycosidase, esterase, lipase (Patrick ct al., 1996) and
neuraminidase (Domingues et al., 1997) activities are
associated with purified outer-membrane vesicles of
B. frajjilis. In culture, B. frajjilis produces large
amounts of single membrane-bound outer-membrane
vesicles. These can be observed, by electron micro¬
scopy of ultrathin sections, and are released from the
outer membrane (Fig. 1b). Immunogold labelling
Major bacteria of the adult human faecal microbiota
Bacteria Gram reaction Morphology Total viable count'
(per g of faeces)
Bacteroides _ Rod 109-1014
Eubacterium + Rod 105-1013
Bifidobacterium + Rod 105-1013
Clostridium + Rod 103-1013
Lactobacillus + Rod 104-1013
Peptostreptococcus + Coccus 104-1013
Ruminococcus + Coccus 105-1o13
Streptococcus + Coccus 107-1012
Methanobrevibacter + Cocco-bacillus 107-1011
Desulfovibrio - Rod 105-1011
Fusobacterium - Rod 109
Enterococcus + Coccus 107
Escherichia coli - Rod 107
Prevotella/Porphyromonas - Rod 104
a Compiled from Willis (1991) and Macfarlane and Gibson (1994).
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indicates that these vesicles carry epitopes associated
nil // *j2E3iO"iq A .nirnijrTifi rnirpa ontyoafio. mrrujalGVOwith, the outer membrane (Fiq. 1c). Purified outer--IvdvIs orifi oni/iur;-mi. / ■loiVlrarDE odvIoTDyri "lcjirruz
membrane vesicles cause ejyntqrpcyteSj to agglutinate
[Patock^tjf aL^ i.99j5^'<.If is, therefore, interesting to
speculate tjhat tmsjta&et^,ana also,pos^ibl^ limits,, the
destructive enzvmatic activity to particular host cell
ypJalqffnoD ft -jf.a-jJcnq am-lcfirn-afinaa u iQjSDjjgndlae
types. It ma.)! also partly explain why B.jragiUsdoes not
act as a progressive) rapidly acting, Eistplvpc pamogehj
like other bacteria that release enzymes, such as Clos-
-ummunnMva A orifiUMWOWM .a asvuwi .a ,v.«Yim
ft bintc 3 3w TI
Polysaccharide-degrading enzymes of B. thetaiota-MdyToBni 03 Mriavnoijy tfr-mmm *.T . ■ . ..
Qmicron have been studied in relation to their potential
role in the intestinal environment. B. theiaiotaomicron
wola ofTEifnaToq am acn ■jttvt.snn aim,.aniiibn bntrow
produces two enzymes capable of degrading chon-
drqitin sulphate and.related mucopolysaccharides into■Mu\.>i,'xyy!iS ciTMpua noronmiD YeSra, a p/TiElirruc.
disacchandes. Ihese two enzymes have a similar
fll *JK)"i /j VBlQ VEIO JfifLJ ClCtP. iQ ffVniVmR
molecular mass of 104-108 kDa, but they differ in their
affinitv for heparin. The gene for one of these chon-
ip otforri ad or r/f end ,fnarp)qrrip^ ir,rm?/jjni.droitan lyase enzymes has been cloned in t. colt
(Cjuthrie etat., 1985). Studies of.starch breakdown by
E32£3T3T.32ETjtet>JPETKg-n-OBn3 flB f3lqnjBZ3,10"l
B. thetaiotaomicron indicate that the enzymes involved
•oiruyvj '7 quombotna ncrnur! arB frrarnaobnEnaaca
are not extracellular and that initial binding or the
starch to an OMP complex and. translocation into the
.nnufrt anazisa fo.gamrorn SlBTDynornca odi •jmsiu'Ju
penplasmic space is necgssary. An operon or live gefips
tiia^^ncode CtMjPs *jWio0^YSrl| ru aWr rJJ*v/
jisatipp At least four or the''OMPs, are' involved ;'ip
binding ofst^rp^/^eeyyS 'et #/.'
•j N^urammifajjeSi whic^i clqavpsialic ,acid,from oli¬
gosaccharides on host.,cell glycoproteins and glycdr
Syrcr o-.,«jtiouq v.\uytvs\ ,i)°hidfio rrl o.oooPrf .alipids, may have a more subtle effect on the host and
■jfisncrnvjcr, -muo oMiMsOrVufporii jfn alnru-: . r;.nuo!m.
could play a key role in virulence. More than 20
-oiaimfncraaafo.ycr j/armdp. *j<T nsp y^jtil jsuI-jhov
naturally occurring sialic acids are known; they are
formed i by. various substitutions and additions to
'i:' • ' ' - J '/c 1 lOO" -p. ■ ' ■ • '
neuraminic acid (Schauer, 1985). there is growing
evidence that these sugar residues are involved in the
biological activities of the host cells and molecules
(Rademacher etal., 1988). A prime example ofthe role
of'Mlib^cfd'TSV'fidrmal host function Ts'Tts'rble in the
mov6me!h'f 6'f1'lymphocytes (Irnai et aL, 1991J.
Microbial ngpraminidases may subvert dsP; normal
function of the immune system or other systems of the
host (Patrifblahfdi I.arkin, 1995). The neuraminidase
gene of B. frajjilis 63811, nanH, has been 'Cloned. A
mutant, prodticdd by an insertion in nanH,was able to
revert to natl'H " , whereas another in which part of the
gene had beCri deleted could not. The mutant capable
of reversion, grew as well as the parent, Strain in asso¬
ciation with 01IO cells and in a rat granuloma pouch
model of infection, and reverted to nanH+ r,Glucoseus ooh
limitation favouo/qd reversion to nanH . The-,deletion
mutant also grew as well as the parent strain tvith the
CHO cell line, but grew more slowly in the rat model
of infection (Godoy" ef7t/.,'199^3T' Thesmresultsindi~
cate that neuraminidase may play a role in virulence.
Enterotoxin
Enterotoxigenic B. fragilis were first described as a
cause of acute watery diarfhoWab'diseasfe an mewborri
lambs (Myers, et at, 1984). Subsequently they were
also implicated as a cause ofdiarrhoea in calves (border
etal., 1985) and humans -particularly children (Myers
et til., 1987). The toxin can be detected in culture
supernatjants by its stimulation of secretion in ligated
intestinal loops in animals and alteration of
the morphology of the colonic epithelial cell line
HT29/Q (Weikel et al., 1992). The enterotoxin is a
zihe-dependent metalloprotease of approximately
20kD.a. Purified toxin undergoes spontaneous break¬
down by autodigestion at 37°C. The enterotoxin is
fll 9JO"I fi YfilQ 7f,r(r i p2£DIiliJ(TIfilIX3ri Dftf>.ytiYlfj
active against type IV collagen (gelatin), actin, tropo:
myosin and fibrinogen (Moncrief et al„ 1995). Three
isoforms of the protein have been identified. BFT:1
and BFT-2 have 92% amino acid sequence similarity.
The third isoform, Korea-BFT, was identified in extra¬
intestinal isolates obtained in Korea and wias related
to BFT-2 (Chung et al., 1999). The enterotoxin gene
is contained in a small genetic element, termed
'pathogenicity islet', ofabout 6 kpb, which is bounded
by 12 bp nearly perfect direct repeats. In non-toxigenic
strains, a putative chromosomal integration site has
beenfidentified in a 17 bp G + C-rich region. The
toxin gene encodes a 44kDa pre-pro-toxin. It, is
thought that removal of a signal peptide produces a
22 kDa pro toxin w hich is then cleaved to produce
the 20 kDa protease. A second ORF in the patho¬
genicity islet that also encodes a predicted metallo¬
protease was identified and has a deduced amino acid
sequence of 28.5% identify to the enterotoxin
(Moncrief et al., 1998).
In spite, of the association pfenterotpxin-producing
strains of B:fmgilis with diarrhoea,-its importance as
a cause of diarrhoea as compared with other bacterial
types is a matter for debate. A study in Italy indicates
that the carriage rate of enterotoxigenic B. jranilit in
healthy adults is 15% and in adults with diarrhoea it is
only 9.4%. In children it was identified in T7%'.of
children with diarrhoea, but also in 12% of healthy
children (Pantosti et al., 1997). Polymerase chain
reaction (PGR) assays based on the eritferbfOxin gehe
have been developed and correlate 'reliably''^fh
enterotoxin production in isolates (Kato: et al.. 1996;
Leszczynski et al., 1997). Of 188 B. fragilis not asso¬
ciated with diarrhoea isolated in a Japanese clinical
laboratory 18.6% carried the enterotoxin gene, Inclu¬
ded in these were 64 bacteraemia isolates, of which
approximately 28% carried the enterotoxin gene t Kato
et ui., 1996). The precise role of the cnterotoxin in
II.virulence therefore: remains tfnclear.
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Bacteroides as Part of the
Resident Microbiota
In normal humans Bacteroides spp. may colonise a
number of sites, where generally their interaction with
the host is considered to be either benign or potentially
beneficial. Comprehensive information pertaining to
aspects of the normal microbiota of humans and ani¬
mals can be found in the books by Gibson (1994) and
Mackie et al. (1997).
Although Bacteroides spp., including B. fragilis
(Leszczynski et al., 1997), may be isolated from the
female genital tract and also transiently from skin in the
anal region, the major reservoir for Bacteroides spp. in
the human body is the large intestine (Drasar and
Duerden, 1991). It is estimated that in humans there
are at least 1011 bacteria per gram of faeces, with prob¬
ably as many as 500 different bacterial types, and many
of these remain to be cultured. The application of
nucleic-acid-based analysis of the human microbiota,
such as 16S rRNA-specific oligonucleotide probes, in
combination with the detection of expression of par¬
ticular components, will undoubtedly provide a com¬
prehensive picture of the complexity of the ecology of
the normal microbiota which is currently not possible
with cultural techniques (Raskin et al., 1997).
By far the predominant group that can be isolated
from faeces are Bacteroides spp. of the 'B. fragilis
group', with an estimated average of 101 l/g of faeces.
The prevalence ofdifferent bacterial types is presented
in Table 6. Bacteroides spp. can be isolated from
infants in the first day of life, but they do not begin to
predominate in numbers until the introduction of
solid foods (Conway, 1997). The relative incidence of
different Bacteroides spp. in the faecal microbiota does
not reflect the frequency with which these species
are isolated from clinical infections, such as intra¬
abdominal abscesses (Table 2). B. fragilis is the pre¬
dominant clinical isolate, whereas B. vulgatus may
account for 40% or more of Bacteroides in faeces. This
has led to the assumption that B. fragilis has deter¬
minants ofvirulence lacking in B. vulgatus, which may
be the case, but in their virulence studies few workers
have compared B. vulgatus with B. fragilis. Only a few
studies of the mucosa-associated microbiota of the
human intestine have been carried out, probably be¬
cause of the difficulty in obtaining such samples, in
particular from healthy individuals. Those that have
been done indicate that the mucosa-adherent Bacter¬
oides spp. distribution may differ considerably from
that in faeces, with B. fragilis found in greater numbers
in faeces than B. vulgatus (Namavar et al., 1989;
Poxton et al., 1997).
Given that there are estimated to be more bacterial
cells in the normal microbiota than there are mam¬
malian cells in the human, it is highly likely that the
metabolic activity of these bacteria has a major impact
on the host. It has been suggested that in terms of
metabolic activity and biochemical transformations,
the human large intestine rivals the liver (Macfarlane
and Gibson, 1994). In the gut Bacteroides spp. de¬
grade ingested material, in particular heterologous
polysaccharides in plant material, that the mammalian
system is incapable ofdegrading. This process results in
the production of short-chain fatty acids, which, once
absorbed, are potential substrates for energy metabo¬
lism in the intestinal mucosal epithelium. There is also
evidence that bacteria in the intestine produce vitamins
that can be used by the host (Drasar and Duerden,
1991). Other positive interactions of the host with the
microbiota include, development of the immune sys¬
tem, which does not reach its full repertoire in 'germ-
free' animals, and colonisation resistance to enteric
pathogens provided by the resident microbiota. A
detailed account ofcurrent knowledge of the complex
relationship between the mucosal immune system and
the intestinal microbiota is provided by Gaskins (1997).
Negative aspects of the resident microbiota include
the possibility that bacterial metabolism in the intes¬
tine produces potential carcinogens (Gibson and
Macfarlane, 1994). The role of anaerobic bacteria,
such as Bacteroides, in chronic inflammatory bowel
disease (IBD) of humans is controversial. There are
two major types of IBD: ulcerative colitis, mainly of
the colon, and Crohn's disease, which affects both the
small and large intestine. A range of bacteria,
including B. vulgatus, has been suggested as playing
a role in Crohn's disease. Since the lesions in Crohn's
disease are granulomatous, attention has been
focused on possible mycobacterial involvement, in
particular M. paratuberculosis. A similar situation
arises with ulcerative colitis where a conclusive rela¬
tionship with one type of bacterium has yet to be
made. Evidence for anaerobe involvement includes
the response of the condition to treatment with
metronidazole (Gibson and Macfarlane, 1994). An
allele of the major histocompatability complex
(MHC) class I, HLA-B27, is associated with anky¬
losing spondylitis and reactive arthritis, and there is
evidence of a relationship between patients with
ankylosing spondylitis and IBD. Rats transgenic for
human HLA-B27 spontaneously develop colitis, fol¬
lowed by arthritis and spondylitis. This does not
occur, however, if the rats are raised under germ-free
conditions. B. vulgatus was found to be a critical
component of the microbiota introduced into germ-
free rats for the induction of colitis (Rath et al., 1996,
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1999). This strongly suggests that at least one of the
members of the resident microbiota could play a key
role in IBD.
Although few molecular studies have been carried
out concerning the fine detail of molecular interaction
between the normal microbiota and humans, studies
of B. thetaiotaomicron hint at the potential for intimate
interactions and bacterial adaptation to different eco¬
logical niches along the length of the intestine. In the
developing intestinal epithelium, multipotent stem
cells proliferate in the crypts ofLieberkiihn, and several
crypts 'supply' cells for each villus. The stem cells dif¬
ferentiate into Paneth cells (antimicrobial-peptide-
producing cells) as they migrate to the base of the
crypt, and into absorptive enterocytes, enteroendo-
crine cells and mucus-producing goblet cells as they
move up to the apex of the villus. During this differ¬
entiation, alterations occur in the composition of cell
surface oligosaccharides (glycoconjugates) which can
be related to the stage ofdifferentiation ofdifferent cell
types. In the mouse ileal epithelium differences in the
degree of fucosylation of the glycoconjugates can be
observed with the age of the germ-free mice. At 21
days, Paneth cell glycoconjugates became fucosylated
in some crypts and this gradually spreads by 28 days to
Paneth cells in all crypts. In contrast, when mice are
raised with a conventional microbiota, not only Paneth
cells, but also enterocyte and goblet-cell lineages
became fucosylated. Similar development of fucosyla¬
tion was noted if the germ-free mice were colonised
with the normal microbiota at a later date. For exam¬
ple, 70-day-old germ-free mice developed fucosylation
of some villi 7 days after introduction of the normal
microbiota and full fucosylation 14 days later. Colo¬
nisation of the germ-free mice with a pure culture of
B. thetaiotaomicron also restored full glycosylation,
whereas an isogenic transposon insertion mutant
incapable of using L-fucose as a carbon source did not.
There was no difference between fucosylation of large
intestinal epithelium ofgerm-free and colonised mice,
which were both fucose positive (Bry et al., 1996).
Since the major site ofcolonisation by Bacteroidesis the
large intestine, rather than the small intestine (Drasar
and Duerden, 1991; Wilson, 1997), this appears to
represent specific adaptation to the small-intestinal
environment. The suggestion is that the bacterium
induces fucosylation of the villus glycoconjugates,
then cleaves the fucose with secreted ct-fucosidase,
which B. thetaiotaomicron are known to produce, and
uses the fucose as a source of carbon and energy.
Further studies of B. thetaiotaomicron have identified
FucR, a molecular sensor of L-fucose concentration,
that represses the genes in the fucose utilisation oper-
on. FucR binds fucose and it is thought that this
reduces its interaction with the promoter for the
L-fucose utilisation operon (Fig. 8). This is very dif¬
ferent from the control of the fucose-utilisation gene
cluster in E. coli which is regulated by an activator. It
is not known how B. thetaiotaomicron causes the
epithelial cells to become fucosylated, but it is postu¬
lated that there is a separate 'control of signal pro¬
duction' locus which is also regulated by FucR
(Hooper et al., 1999).
It is possible that in future the normal microbiota
will no longer be seen as simple colonisers but more as
an integral part of the mammalian host, inextricably
linked with the normal development and functioning
of the eukaryotic component. A better understanding
of the normal microbiota should also allow a better


















fueA; L-fucolase aldolase gene
fucK: L-fucolase kinase gene
fueP; L-fucose permease gene
csp; control of signal production locus
Fig. 8 Fucose induction of L-fucose metabolic pathway enzymes in Baeteroides thetaiotaomicron.
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organisms cause opportunistic infection at body sites
that are not normally colonised.
Bacteroides as Pathogens
Pathogenesis by Bacteroides results from opportunistic
infection by the normal microbiota, usually manifested
by abscess formation or soft-tissue infection, which
may lead to septicaemia. The possible involvement of
large-scale leakage of Bacteroides from the intestine, in
conditions such as systemic inflammatory response
syndrome, has recently been examined. Enterotoxi¬
genic B. fragilis associated with diarrhoea have been
described (see above). The possible role of Bacteroides
in the gastrointestinal microbiota in chronic inflam¬
mation of the bowel was also considered above. In this
section, attachment mechanisms, avoidance of the host
defences and immunomodulatory activities are con¬
sidered. Most studies have centred on B.fragilis, since
it is the most common clinical isolate, and the potential
virulence determinants ofB.fragilis are summarised in
Table 7.
Attachment Mechanisms
B. fragilis can attach to host cells and components of
the extracellular matrix. Studies of the attachment of
B. fragilis to host cells have yielded apparently con¬
flicting results. Polysaccharides (Riley and Mee, 1984;
Vel et al., 1986; Patrick et al., 1996) and fimbriae
(Pruzzo et al., 1984) have been reported to be
involved in attachment. It appears that B.fragilis may
produce more than one type of ligand to mediate host
cell attachment, and that expression of these ligands is
subject to within-strain variation. B. fragilis popula¬
tions enriched for the EDL (see above) cause haem-
agglutination and this is reduced by pre-treatment of
the bacteria with sodium periodate, which suggests
that saccharides are involved. Populations enriched for
the LC do not cause haemagglutination, and it is
possible to mix different proportions of these popu¬
lations and correlate the degree of haemagglutination
with the proportion of EDL bacteria present (Patrick
et al., 1988). Since recent clinical isolates vary con¬
siderably in the proportion of bacteria that express the
LC, it is not surprising that there is confusion in the
literature. Furthermore, the EDL population releases
extracellular vesicles (see above and Fig. 1) which by
themselves will cause haemagglutination (Patrick et al.,
1996) and also extracellular polysaccharide (Fig. 3). If
quantities of vesicles or polysaccharides are present,
they may block attachment sites on tissue cell lines and
therefore exclude bacteria, and in assays that rely on
quantification of the attached bacteria, erroneously
negative results may be obtained. In assessing attach¬
ment potential it is therefore essential to have bacterial
populations that are clearly defined for surface struc¬
ture expression and the presence of vesicles or
polysaccharide. Despite the confusion in identifying
the structures involved in attachment, it is clear that
Table 7 Potential virulence determinants of B. fragilis
Characteristic Bacterial component/genea implicated
Attachment to host cells and extracellular matrix Surface polysaccharides
Fimbriae
Aerotolerance Catalase (KatB)




Fibrinogen hydrolysis 100-kDa serine-thiol-like protease
Degradation of extracellular matrix/oligosaccharides Glycosidases, esterase lipase, neuraminidase (nanH)
Enterotoxicity/diarrhoea 20kDa metalloprotease
Endotoxicity/immunomodulation LPS
Avoidance of host defence (Antigenically variable surface polysaccharides?)15
Resistance to phagocytic uptake and killing LC
(Outer membrane vesicles/extracellular polysaccharide?)
Resistance to complement-mediated killing (Electron dense layer/extracellular polysaccharide/
outer membrane vesicles?)
Abscess formation Extracellular polysaccharide
a If identified.
b Brackets indicate speculative involvement.
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B. fragilis can attach to host cells. This may relate to
both the virulence of B. fragilis and to its ability to
colonise the intestine as part of the normal microbiota.
In a comparative study of a number of isolates from
faeces, abscesses and blood culture, in which the
attachment ligand was not characterised, strains from
all three sources caused haemagglutination and
attached to human cheek epithelial cells, the intestinal
cell line Intestine 407 and human polymorphonuclear
leucocytes (PMNL) (Guzman et al., 1997). Sialic-
acid-containing glycoproteins have been implicated as
potential adhesin receptors, since sialic acid and com¬
pounds that contain this sugar inhibit haemaggluti-
nation. Treatment of erythrocytes with sialidase,
however, increases haemagglutination in some strains
(Domingues et al., 1992). This suggests that there is
more than one attachment ligand in B. fragilis and also
more than one cell receptor. There is evidence that,
when grown under less reduced conditions, B. fragilis
can penetrate tissue culture cells (Goldner et al.,
1993). The mechanism of penetration is unknown,
but clearly this may be important for the virulence of
B. fragilis, particularly in bacteraemia where the route
of spread from the initial focus of infection to the
bloodstream is unclear.
Studies of the attachment to components of the
extracellular matrix are subject to the same criticism -
a lack of appreciation of variability within strains, and
the potential attachment of bacterial extracellular
components. There is, however, clear evidence that
Bacteroides can attach to some components of the
human extracellular matrix. Binding by B. fragilis and
B. vulgatus to fibronectin, collagen type I and vitro¬
nectin has been demonstrated. The binding was heat-
and protease-sensitive, suggesting the involvement of
a bacterial protein ligand, but fimbriae were not
observed by electron microscopy (Szoke et al., 1996).
B. fragilis also binds to laminin, a major structural
component of basement membranes (Eiring et al.,
1995).
Avoidance of the Host Defences
Resistance to complement-mediated cell lysis by
B. fragilis in normal human serum can be observed in
bacteria non-capsulate by light microscopy but with
an EDL adjacent to the outer membrane (Fig. 2). The
relationship between encapsulation and complement
resistance is not clear, since a capsulate strain may
be sensitive to complement, whereas non-capsulate
populations of the same strain are resistant (Reid and
Patrick, 1984; Allan and Poxton, 1994). Other Bac¬
teroides spp., including B. thetaiotaomicron, B. caccae,
B. ovatus and B. vulgatus, may also resist killing by
serum (Bjornson, 1987; Allan and Poxton, 1994),
but the proportion of bacteria that resist killing by
serum can vary with the growth conditions (Allan and
Poxton, 1994). Clearly, different Bacteroides spp. can
potentially survive killing by the alternative comple¬
ment pathway. Comprehensive studies of the opsoni-
sation of B. fragilis with isolated components of the
alternative pathway, indicate that C3 deposition
occurred with C3, properdin, factors H, I, B and D.
This indicates that resistance is not due to a lack of
initial activation of the complement cascade, and may
be due to interference with the regulation ofcascade at
another point in the pathway, as is the case with other
bacteria that resist complement-mediated lysis (Patrick
and Larkin, 1995).
Populations of Bacteroides enriched for the large
capsule are not phagocytosed by isolated PMNL in
normal human serum, but those that are non-capsulate
are phagocytosed (Reid and Patrick, 1984). Though
this appears to confirm the well-recognised potential
antiphagocytic properties of the capsules, its relevance
to infection can be questioned in the light of experi¬
ments in vivo. Bacteria enriched for the LC and grown
in vivo in a chamber implanted in the mouse peritoneal
cavity, not only no longer produce the LC, but on
subculture they are enriched for a non-capsulate
population (Patrick et al., 1984). This is observable
both in the presence and absence of apparently active
mouse PMNL which contain phagocytosed bacteria
(Patrick, 1988; Patrick et al., 1995a). The small cap¬
sule-enriched population and non-capsulate bacteria
do not alter capsule expression during growth in vivo
and survive equally well in the implanted chambers.
Interestingly, the influx ofPMNL has no impact on the
total viable count of the bacteria in the mouse perito¬
neal cavity model over periods of 20 days or more.
Similarly, in a mouse peritoneal abscess model induced
by injection of a mixture of B. fragilis and E. coli with
bran, bacteria remain viable for 10 weeks or more,
despite the infiltration ofPMNL (Kocher et al., 1996).
In these abscesses, high levels of CP-10, a murine
chemo-attractant which recruits neutrophils and
monocytes-macrophages, and migration inhibition
factor-related protein (MRP-14) which retains the
recruited cells were detected. These high levels were
measurable in the early acute stages of abscess forma¬
tion and in chronic abscesses after 30-55 days. The
release of factors such as succinic acid by B. fragilis,
which inhibit PMNL chemotaxis (Rotstein et al.,
1989b), has been suggested to play a role in virulence,
but this appears to be contrary to the evidence for high
levels of neutrophils in models of abscess infection.
Pathogenic synergy, whereby B. fragilis protects and
enhances the survival of other facultatively anaerobic
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bacteria, such as E. coli, has been recognised (Rotstein
et ill., 1989a). Interestingly, abscess-derived neu¬
trophils harbour viable bacteria and are less efficient at
killing bacteria than neutrophils derived from perito¬
neal aspirates or peripheral blood in vitro (Finlay-Jones
et cil., 1991). It is highly likely that factors other than
capsules are involved in intraperitoneal survival of B.
fragilis (Patrick et al., 1995a). The potential for
excreted extracellular polysaccharide and extracellular
vesicles to mop up opsonins, activate complement and
interact with phagocytes, to divert host defences from
bacteria, should not be overlooked.
The primary opsonising molecules for attachment
to PMNL have been identified as C3b and iC3b, which
interact with CR3 and CR1. Purified IgM from normal
humans doubles the deposition of opsonising C3 on
B. fragilis, which suggests a potential role for IgM in
alternative complement pathway activation for opso-
nisation of B. fragilis (Foreman and Bjornson, 1994).
Opsonisation of B. thetaiotaomicron with penta-
meric, but not monomeric, IgM and complement
components renders the capsule visible by electron
microscopy after paraformaldehyde and glutar-
aldehyde fixation (Bjornson and Detmers, 1995). This
was interpreted as evidence that the opsonins modified
the capsular structure, and prevented it from being
destroyed during processing for electron microscopy.
The inclusion ofosmium tetroxide and ruthenium red
is necessary to make Bacteroides capsules sufficiently
electron dense for observation by electron microscopy
(Patrick et al., 1986). Fixation with paraformaldehyde
and glutaraldehyde, although necessary to retain suf¬
ficient antigenicity for immunolabelling, does not
resolve the capsule even if it is present (Reid et al.,
1987). A more probable explanation is that the opso¬
nising proteins render the capsule sufficiently electron
dense to be visible with the electron microscope.
Nevertheless, pentameric IgM enhances alternative
complement pathway opsonisation of B. thetaiota-
omicron and its subsequent adherence to PMNL.
When the extracted capsular complex of B. fragilis
NCTC 9343, which contains PSA and PSB, is injected
into the rat peritoneal cavity along with sterile caecal
contents, abscesses are formed in approximately 80%
of rats. The presence of both carboxyl (negative
charge) and amino (positive charge) groups on the
PSA is required for abscess induction in this model
(Tzianabos et al., 1993), and a 5-week regime of
subcutaneous inoculation with the polysaccharide
protects against abscess formation in at least 70% of
the rats. The presence of the positive and negatively
charged groups is essential for this protection. Inter¬
estingly, inoculation with Strep, pneumoniae capsule
type 1 protects against challenge with the B. fragilis PS
and vice versa, and indicates that this phenomenon is
not restricted to B. fragilis (Tzianabos et al., 1994).
Immunity to challenge with bacteria and poly¬
saccharide can be passively transferred by splenic lym¬
phocytes, and T cells appear to be involved in the
process (e.g. Tzianabos et al., 1999). The precise role
of individual T-cell types is unclear, but CD4+8-I-,
CD4+ and CD8+ T lymphocytes may all be involved.
Early reports indicated a role for CD4+8+ in abscess
induction and CD8+ T cells in protection (Crabb
et al., 1990). More recent reports implicate CD4+
T cells in protection against abscess formation
(Tzianabos et al., 1999) and also conversely in an
increase in abscess formation (Sawyer et al., 1995).
A serum IgG response to B. fragilis protein and poly¬
saccharide surface antigens is detectable in a mouse
chamber model of intra-peritoneal infection (Patrick
et al., 1995a) but it does not alter the numbers of
viable bacteria in the chambers. Although the humoral
immune response may not affect abscess formation, it
may be an important limiting factor in bacteraemia
and the systemic inflammatory response syndrome
(see below). Interestingly, IgA specific for Bacteroides
has also been detected in whole-gut lavage fluid
(Poxton et al., 1995). Perhaps a clearer understanding
of how the Bacteroides spy), in the normal microbiota
interact with the immune system will help to resolve





Systemic inflammatory response Syndrome (SIRS) or
'sepsis' is the most common cause of death in patients
who are critically ill in intensive care units. LPS is
known to play a central role. In patients who do not
have obvious septicaemia, bacteria or bacterial com¬
ponents appear to translocate across the ischaemic
intestinal wall, and the normal intestinal microbiota are
thought to be the source of the endotoxin. This sets
in motion a cascade of events involving cytokines,
complement and clotting factors; essentially, non-
clonal immune recognition events occur. The extent
of the immune response is concentration-dependent;
high concentrations of bacterial immunomodu¬
latory molecules result in what has been termed immu¬
nological 'panic'. This may ultimately result in shock,
multiple organ failure and a mortality of up to 90%. It
has generally been considered that the major cause of
Grant-negative SIRS is the LPS of enterobacteria, but
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the possible role of immunopotentiation by compo¬
nents of the B. fragilis cell envelope, such as the LPS,
has not been much considered in the literature. This
is largely because of the low toxicity of B. fragilis LPS
in mouse lethality studies as compared with E. coli
LPS. Bacteroides LPS is reported to be up to 10 000-
fold less active than that of E. coli (Lindberg et al.,
1990). More recent investigations indicate that the
extraction procedure used to prepare Bacteroidcs LPS
is critical in studies of its immunomodulatory activ¬
ity. Although B. fragilis LPS is 5000-fold less toxic in
a mouse lethality model, it was 7-fold more active
than phenol-water extracted E. coli LPS in the Limulus
amoebocyte assay. It was also able to induce tumour
necrosis factor at levels similar to E. coli LPS, but
independently of CD 14 expression. Given the high
numbers of Bacteroides spp. in the intestinal tract,
where enterobacteria may be outnumbered by up to
1000 to 1, and even allowing for the lower toxicity, it
is likely that the quantitative dominance of Bacteroides
LPS plays a role in endotoxic shock and SIRS
(Delahooke et al., 1995a, b). A decrease in the level
of serum IgG specific for enterobacterial LPS corre¬
lates well with endotoxaemia; non-survivors of sepsis
had low levels of enterobacteria-specific IgG. In a
small study of 6 survivors and 6 non-survivors of
sepsis, levels of IgG specific for B. fragilis endotoxin
fluctuated more than in the healthy controls, but it is
difficult to draw conclusions from such small num¬
bers of patients; exposure to Bacteroides LPS had
occurred in these patients (Allan et al., 1995). A study
of 55 patients undergoing cardiac surgery provided
evidence for a decrease in anti-R. fragilis immu¬
noglobulin levels during surgery, which indicates that
the patients were exposed to B. fragilis endotoxin
(Bennett-Guerrero et al., 2000). In the light of
these results, the potential role of Bacteroides in SIRS
warrants further consideration.
Diagnosis
The diagnosis of Bacteroides and related bacteria
depends largely on classical cultural methods, and in
the clinical setting is usually taken no further than the
genus level. For details of clinical diagnostic methods
the reader is referred to the Wadsivorth Anaerobic
Bacteriology Manual [Summanen et al., 1993), Brown
et al. (1989), Wren (1991), and Jousimies-Somer et al.
(1995). Bacteroides spp. can be detected in pus by
direct immunofluorescence microscopy, providing the
target antigen is carefully chosen and not antigenically
variable (Patrick et al., 1995b).
Molecular detection methods for Bacteroides are not
as yet in general use in clinical diagnostic laboratories.
PCR finger printing identification of pure culture
isolates has been examined and resulted in good
identification and differentiation of members of the
fragilis group (Claros et al., 1997). PGR-based assays
for the detection of enterotoxigenic B. fragilis have
proved reliable (e.g. Leszczynski et al., 1997). Fluor¬
escence in situ hybridisation (FISH) of 16S rRNA is
possible with pure cultures of B. fragilis, but such
techniques must be approached with caution when
applied directly to clinical samples, as the penetration
of the probe into the bacterial cell depends on the
nature of encapsulating surface structures (Ramage
et al., 1998). Reliable direct identification of Bac¬
teroides spp. and other obligate anaerobes in clinical
samples is attractive, because in spite of efforts to
ensure the handling and transit of samples under
anaerobic conditions, a high proportion of Bacteroides
infections may be missed because of loss of viability
(Patrick et al., 1995b).
Antimicrobial Agents
Antibiotics are used for the treatment of anaerobic
infections and as prophylaxis for patients undergoing
intestinal surgery. Bacteroides are intrinsically resistant
to aminoglycoside antibiotics, as they are unable to
transport these antibiotics. This is exploited for the
selection of Bacteroides spp. from clinical samples that
contain enterobacteria. Current understanding of the
genetic systems of Bacteroides has come largely from
studies of antibiotic resistance.
Metronidazole
Since the 1970s (e.g. Willis et al., 1976) metronida¬
zole has frequently been used for prophylaxis and for
the treatment of non-clostridial anaerobic infection.
Resistance to metronidazole in anaerobic bacteria is
extremely low, and it has excellent tissue penetrability
(Freeman et al., 1997). The activity of metronidazole
is restricted to anaerobes and organisms during anae¬
robic metabolism, as reduction of the nitro group of
the drug is necessary for its antibacterial action.
Reduction of the drug results in the production of
radicals with the potential to accept electrons from
DNA, resulting in strand breaks and helix destabilisa-
tion. In the presence ofoxygen, DNA accepts electrons
from the reduced drug and converts it back to the
oxidised form, in a futile cycle (Edwards, 1997). False







tet Q; tetracycline resistance X; excision genes
gene TP; transfer and mating
rte A; sensor gene pore formation genes
rte B,C; regulator gene I; integration genes
m; mobilisation and DNA
nicking gene
Fig. 9 Mechanism of tetracycline-inducible transfer of conjugative transposons and mobilisable elements in Bacteroides spp.
a result of this futile cycle if the Bacteroides are not
cultured under strictly anaerobic conditions.
Resistance to metronidazole is rare, particularly
in the USA (Dubreuil, 1996; Snydman et al., 1996).
It is also used for the treatment of peptic ulcer dis¬
ease (Freeman et al., 1997) and this wider use may
lead to the development of resistance in Bacteroides
of the normal microbiota. 5-Nitroimidazole resistance
determinants {nim genes) have been identified on
the chromosome of some strains and small plasmids
(e.g. pIP417, 7.7 kbp; pIP419, lOkpb) of B. fragilis.
The plasmids can be transferred by a conjugation¬
like process in B. fragilis, B. vulgatus, B. thetaiotao-
micron and Prevotella spp. (Breuil et al., 19S9;
Sebald, 1994; Trinh et al., 1996). The plasmids are
not thought to be self-transmissible, but rely on con¬
jugal helper elements, which may be chromosomal
(see below and Fig. 9). Three nim genes that encode
proteins with 85% similarity have been cloned and
sequenced from plasmids and chromosomal sites
(Sebald, 1994). Insertion sequences (IS) elements
have been identified in the 5' upstream region of nim
genes, and these are involved in the regulation of
expression of the antibiotic resistance gene (Smith
et al., 1998: Table 8). IS element involvement in
the regulation of antibiotic resistance determinant
expression in Bacteroides has also been reported for
other antibiotics (see below). The mechanism of
resistance to the activity of metronidazole is not fully
understood.
(3 Lactams
The B. fragilis group are usually resistant to benzyl-
penicillin, other penicillins and many cephalosporins,
with the exception of cephamycins such as cefoxitin.
Carbapenems such as imipenem and meropenem are
active, but some monobactams are inactive, because
they lack affinity for the penicillin-binding proteins
(PBP) of B. fragilis (Greenwood and Edwards, 1997).
Resistance to penicillin in B. fragilis homology
group 1 is associated with the production of active-site
serine-/? lactamases distantly related to Ambler's class
A. Serine-/? lactamases attack the carbonyl (C = O)
group of the /?-lactam ring with the nucleophilic
hydroxyl group of an active site serine, which results in
hydrolysis ofthe C-N bond (Wang et al., 1999). These
/? lactamases are susceptible to the inhibitory' effects of
compounds such as clavulanic acid, sulbactam and
tazobactam. Cephalosporinase genes of this type -
cepA from B. fragilis, cficA from B. vnlgatus and cblA
from B. uniformis have been cloned and sequenced
(Rogers et al., 1993). In terms ofamino acid sequence,
these three /? lactamases are more similar to each other
than to all other /? lactamases so far identified in other
bacteria. From phylogenetic analyses, it appears that
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Table 8 Examples of genetic elements of Bacteroides spp.
Genetic element Size (kbp) Resistance marker Gene Gene product action
Self-transmissible
Plasmids
pBF4 41 aMLS ermF RNA-methyltransferase
(associated transposon Tn4351) (5) btetX
PBI136 80 MLS ermFS
(associated transposon Tn4551) (8.5) caadS
Chromosomal conjugative transposons
Tcr DOT and related elements e.g. Tcr 70-150 Tetracycline tetQ Ribosome protection
ERL, V479, 12256 (also termed Tn5030) MLS ermF
Tcr7853 70-80 Tetracycline tetQ
MLS ermG
XBU4422 65 ? 7
Mobilisable by self-transmissible plasmid
or conjugative transposons
Plasmids
PBFTM10 (also termed pCP1) 15




e.g. p1P417 7.7 5-Nitroimidazole nimA 7
PIP419 10 nimC 7
Cryptic plasmids
e.g. pB8-51 <8 ? ?
pBI143 (also termed pBFTM2006)
Chromosomal integrated elements
Transposons
Tn4555 12 Cephalosporin, cfxA Serine protease
Tn4399 9.6 Penicillin, cefoxitin
NBU 1, 2, 3 10-12 ? 7
Insertion sequences involved in gene activation
IS942 1.6 0 Lactam ccrA Metallo 0 lactamase
IS 1224 >1.7 0 Lactam cepA Serine protease
IS1186 1.3 0 Lactam cfiA Metallo 0 lactamase
IS1168 1.3 5-Nitroimidazole nimA, B 7
IS1169 1.3 5-Nitroimidazole nimD 7
IS1170 1.6 5-Nitroimidazole nimC 7
IS4351 1.2 MLS ermF/FS RNA-methyltransferase
a Macrolide, lincosamide, streptogramin.
b Silent tetracycline-resistance gene.
c Silent streptomycin-resistance gene.
Compiled from Sebald (1994), Salyers and Shoemaker (1996), Smith etal. (1998).
these Bacteroides enzymes evolved at an earlier stage,
which is consistent with the early evolutionary diver¬
gence of the Bacteroides.
Determinants for these f3 lactamases may be chro¬
mosomal, but can be transferred between species
of the B.fragilis'group'. The co-transfer of ampicillin
resistance with a conjugative transposon that carries
a tetracycline resistance marker has been demon¬
strated. Similarly, the cfxA gene, which encodes a
cephalosporinase that degrades cephalosporins, peni¬
cillins and cefoxitin, is located on a mobilisable trans¬
poson, Tn4555 (see below; Sebald, 1994). Ampicillin
resistance has also been located on a large transferable
plasmid, but plasmid-mediated resistance to extended
/3 lactams such as carbapenem and cefoxitin has not
been reported.
B. frajjilis strains that express either high or low
levels of the CepA (3 lactam, which does not degrade
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cefoxitin or imipenem, have been identified. A 40-fold
increase in expression has been linked with the inser¬
tion of IS1224 upstream of the cepA gene. It has
been suggested that the up-regulation arises from the
formation of a promoter partly encoded by the IS
element (Smith et al., 1998).
A minority of B. fragilis strains produce a zinc-
requiring metallo-/3-lactamase of Ambler's class B,
which is associated with resistance to cephamycins and
carbapenems. These enzymes are resistance to the /3-
lactam inhibitors (clavulanic acid, sulbactam and
tazobactam) and sensitive to EDTA, which chelates
zinc. The proposed mechanism for the hydrolysis
of the C-N bond involves an initial interaction of
the nuclophile zinc hydroxide in the active site of the
enzyme. This polarises the carbonyl group of the
/3 lactam, and a second zinc interacts with the nitrogen,
resulting in bond cleavage (Wang et al., 1999). The
chromosomal genes cfiA and ccrA have been identi¬
fied. With the cfiA as a probe, the gene was identified
in 3% of B. fragilis clinical isolates, which relates to the
B. fragilis DNA homology group II (Ruimy et al.,
1996). These strains were lacking in the cepA gene that
encodes the more common /3 lactamase of B. frapilis
found in DNA homology group I. Differences in the
composition of the OMPs and LPS of the two groups
have also been noted (Edwards and Greenwood,
1997). The cfiA gene-positive group also carried one
or more of the three IS elements IS4351, IS1186 or
IS942. These are involved in the regulation of gene
expression and appear to encode promoters for the
antibiotic resistance genes. A promoter region has
been identified in IS1186, and IS4351 encodes three
promoter-like sequences. These insertion sequences
were found in only 1% of the c/iM-negative group
(Podglajen et al., 1994). It has been suggested that
the low incidence of the cfiA gene in B.frajjilis isolates
is indicative of recent acquisition of the gene (Ruimy
et al., 1996). Alteration ofpenicillin-binding proteins
or outer membrane permeability may also play a role in
Bacteroides spp. resistance to penicillin, but this
remains to be fully determined (Greenwood and
Edwards, 1997).
Macrolide, Lincosamide and Streptogramin
Macrolide (e.g. erythromycin), lincosamide (e.g. clin¬
damycin) and streptogramin (e.g. pristinamycin, vir-
giniamycin) (MLS) resistance is transferable within and
between Bacteroides spp. by conjugative plasmid
transfer (Privitera et al., 1979; Sebald, 1994). MLS
resistance can also be located on self-transmissible
conjugative elements which also carry tetracycline
resistance genes. Plasmids that have been studied
includepBF4(41 kb),pBFTMlOorpCPl (15kb)and
pBI136 (80 kb). Plasmids pBF4 and pBI136 are self-
transmissible, whereas pBFTMlO relies on mobilisa¬
tion by conjugal helper elements (see below). MLS
resistance is conferred by the genes ermFor ermFSfht
latter differs by a single base) present on compound
transposons (TN 4351, 4551 and 4400). The ermF
gene encodes a rRNA methylase. Expression of the erm
genes can be up-regulated by the presence of IS ele¬
ments (Table 8). These erm genes are similar in
sequence to the erm genes of Gram-positive bacteria.
The G + C content of these genes is 32%, which is
considerably less than the rest of the B. fragilis (42%).
Tn 4351 and 4400 also carry the tetX gene, which is
silent in B.frajjilis, but confers tetracycline resistance in
aerobically grown E. coli, as resistance is mediated by an
NADP-requiring oxidoreductase enzyme. Tn4551
carries a silent streptomycin-resistance gene, aadS. The
equivalent protein sequence for the aadS is 30% iden¬
tical to the protein produced by the aadK gene of
Bacillus subtilis. The intrinsic resistance of Bacteroides
spp. to aminoglycoside antibiotics, because of lack of
uptake, adds weight to the hypothesis that these genes
have been acquired from a Gram-positive source. The
IS elements that flank these transposons are either
identical (IS4351 in Tn 4351 and 4551) or almost
identical (IS4400 in Tn 4400). IS4351 encodes a
putative transposase and is similar in G + C content to
the B. fragHis genome (Smith et al., 1998). It seems,
therefore, that although the transposon genes may be of
Gram-positive origin, the flanking IS elements are not.
Tetracyclines
Resistance to tetracycline is widespread in clinical and
bowel Bacteroides spp., and mediated by the tetQgene
product which has a 45% amino acid identity with the
tetM and tetO products in Gram-positive bacteria.
TetQ and the related TetM, O, B (P) and S of other
bacteria have a molecular mass of about 72 kDa and
protect the ribosome from the action of tetracyclines.
They have N-terminal sequence similarities with elon¬
gation factors Tu and G. The mechanism of action of
TetQ is not known, but TetM increases the rate of
dissociation of tetracycline from the ribosome when
GTP is present (Leng et al., 1997). The tetCf gene is
carried on a large conjugative element (70 to
> 150 kb) which is capable of self-transfer and may
also carry the MLS resistance erm gene. These ele¬
ments are sometimes referred to as Tet elements, Tcr
elements or conjugative transposons (CT or CTn), but
it has been proposed that CTn should be used as the
convention (Salyers et al., 1999). They are similar to
the conjugative transposons found in Gram-positive
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bacteria. They differ from standard transposons in that
they are larger and are not flanked by insertion
sequences, but imperfect repeats of 24 bp have been
identified at the ends of the element and these may be
involved in the binding of excision proteins. A model
has been proposed for the mechanism of conjugation
in which the CTn is excised from the chromosome and
forms a non-replicating plasmid-like covalently closed
circle. This is transferred in a manner similar to a
plasmid, with the centre of origin located near the
centre of the element. A single-stranded copy enters
the recipient, the second strand is synthesised to form a
double-stranded circular element which integrates
into the recipient chromosome, without duplication of
the target site. This process may result in the mobili¬
sation of other plasmids which are not self-transmis¬
sible and other unlinked chromosomal regions.
Resistance to tetracycline has increased in recent
years as result of the spread of the fct<2,gene (Leng
et al., 1997). TetQ can be transferred by conjugative
transposition not only among Bacteroides such as
B. frajjilis, B. uniformis and B. thetaiotaomicron, but
also between Bacteroides spp. and bacteria from the
bovine rumen, such as Prevotella (Bacteroides) m-
minicola (Shoemaker et al., 1992) and Enterococcus
faecalis (Leng et al., 1997). Given the apparent gen¬
etic mobility of the Bacteroides antibiotic-resistance
genes, there is the potential for the development of
multiple-drug-resistant B. fragilis.
Genetic Systems
The development of genetic systems in B. fragilis has
been hampered by the general lack of genetic com¬
patibility between E. coli and the majority of strains of
B.fragilis (Salyers and Shoemaker, 1996; Salyers et al.,
1999). E. coli promoters do not function in Bac¬
teroides, and E. coli plasmids do not replicate in Bac-
teroidesspp. The restriction endonucleases ofB. frajjilis
preclude the introduction of E. coli DNA by electro-
poration and in many strains also by conjugation. Also,
there are so far no reports of Bacteroides plasmids that
replicate in E. coli (Smith et al., 1998). The lack of
replication of E. coli plasmids in Bacteroides has, how¬
ever, been used to some advantage in the construction
ofsuicide vectors. Bacteroides also appear to lack GATC
sites, which are methylated at the adenine residue by the
Dam methylase in E. coli. This process is important in E.
coli for the repair ofdamaged DNA, regulation ofgene
expression and some gene re-arrangements (Holdman
et al., 1976; Patrick and Larkin, 1995). It has been
suggested that this may explain the instability of Bac¬
teroides DNA in cosmid clones in E. coli hosts
(Shoemaker et al., 2000). The apparent general
genetic incompatibility probably reflects the taxo-
nomic distance between the two genera. Bacteroides
spp. fall into the Bacteroides-Flavobacterium phylum
(Woese, 1987). It is thought that this phylum, which
includes the majority of Gram-negative organisms,
such as the enteric bacteria, E. coli and the pseudo-
monads, diverged from other eubacteria early in evo¬
lutionary terms, well before the divergence of the
Gram-positive bacteria from the Purple bacteria.
In spite of this, the study of the potential spread of
antibiotic-resistance determinants has lead to the
recognition of two key features in Bacteroides. First,
they possess a number of different types ofpotentially
mobile genetic elements. These include the unusual
chromosomal transposons that are mobilisable by other
genetic elements and have not yet been described in
other genera (see Table 8, Fig. 8 and below). Second,
there is a relationship between insertion sequences and
up-regulation of antibiotic gene expression, but
whether this up-regulation occurs with other genes
remains to be determined. Interestingly in D. nodosus,
the. causative agent of ovine footroot, chromosomal
genetic elements (intA, B and C elements) that up-
regulate virulence determinants have been described
(Whittle etal., 1999).
Mobile Genetic Elements
A small number of self-transmissible plasmids that
carry antibiotic resistance genes have been identified
(e.g. pBF4 which carries MLS resistance), but much
of the movement of genetic elements among Bac¬
teroides appears to be driven by large chromosomal
conjugative transposons. The most extensively stud¬
ied of these are the- Tcr elements that carry the
tetracycline resistance gene, tetQ, but other 'cryptic'-
elements have also been identified (e.g. XBU4422 in
B. uniformis). The chromosomal insertion site of
these elements seems to be non-random and restric¬
ted to 3-7 chromosomal sites. These elements carry
the genes necessary for self-transmission by conjuga¬
tion, and the mechanism of transfer is thought to
involve a circular, non-replicating intermediate form
(Salyers and Shoemaker, 1996). Unusually, the fre¬
quency of conjugation increases more than 100-fold
at low concentrations of tetracycline (about 1 gg/
mL). The QRFs of two genes downstream of trr<2.are
similar to the two-component sensor/regulator genes
described in a wide range of other bacteria. These
have been designated rte (regulation ofTC1 elements)
A (sensor kinase) and B (regulator) (Stevens et al.,
1992). A third unlinked gene, rteC, is also involved in
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regulation. These conjugative transposons mediate
the conjugative transfer of other genetic elements
that are not capable of transferring by themselves.
They act as conjugative helpers for plasmids and also
a novel class of mobile genetic elements, chromoso¬
mal mobilisable transposons, which includes the non-
replicating Bacteroides units (NBU). RteB activates
the excision and integration genes of the mobilisable
transposons. The conjugative transposons provide the
mating pore proteins. Interestingly, many of these
mobilisable elements are also mobilised by the IncP
plasmids of E. coli (Salyers and Shoemaker, 1996;
Smith et al., 1998).
It has been estimated that up to 50% of Bacteroides
faecal and clinical isolates carry cryptic plasmids for
which a phenotype has yet to be detected. All the
cryptic plasmids so far studied carry an origin of
transfer site (oriT), regions essential for replication and
a mobilisation gene {mob). Although they are not self-
transmissible, these genes enable them to be mobilised
in trans by the chromosomal conjugative transposons.
Antibiotic-resistance carrying plasmids that encode
5-nitroimidazole resistance and the pBFTMlO plas-
mid which carries MLS resistance are thought to be
mobilised by the Tc1 elements.
The mobilisable transposons are 9-12 kb in size and
carry the genes necessary for their own excision from
the chromosome, nicking of the circular intermediate
and subsequent re-integration, but not conjugation
(Murphy and Malamy, 1995; Smith et al., 1998).
Excision may be induced by RteB encoded on a con¬
jugative transposon and is therefore also up-regulated
by tetracycline concentration. After excision, the
mobilisable transposon forms into a non-replicating
circular element, hence the assignation of the name
'non-replicating Bacteroides unit' (NBU) to some of
these elements. The circular element is nicked by the
Mob protein at the transfer origin and a single strand of
the element is transferred to the recipient through the
mating pore provided by the conjugative transposon.
The elements identified to date include Tn4399
(B.frayjilis), Tn4555 which encodes the cfxA cefoxitin
resistance gene (B. vulyyatus), NBU1 (B. thetaiota-
omicron), NBU1 and 2 (B. uniformis). The NBU1
element has been sequenced. The intNl gene and the
region of the closed ends of the circularised transpo¬
son, attNl, are required for the integration of NBU1
at the target chromosomal site. The intNl gene
encodes the integrase, which has some amino acid
similarity with the A-integrase family. The mobilisation
gene, mobNl, has been located upstream of the origin
of transfer site, oriT. The process of excision requires,
in addition to the integrase region and oriT, two-thirds
of the mobNl gene region (prmNl) which encodes
a protein involved in excision, but which is not a
primase, since the circular transposon does not repli¬
cate nor is it self-transmissible. Three additional QREs
are also necessary for the excision process (Shoemaker
et al., 2000). The excision process therefore appears to
be complex, and this may relate to the subsequent
conjugation mediated by the Tcr elements. Unlike the
Tc' elements, NBU1 integrates at a specific site located
at the 3' end of the leucine-tRNA gene.
Studies of a range of mobilisable plasmids and
transposons suggest that a common feature is the
cassette of genes necessary for DNA processing, and
which with adjacent oriT form a 'mobilisation region'.
Although the number and content of genes in these
mobilisation regions may vary, where they are incor¬
porated into Bacteroides plasmids and transposons, it
enables their co-transfer with self-transmissible plas¬
mids and Tc' elements. Smith and colleagues (1998)
provide a comprehensive review of mobile genetic
elements of Bacteroides.
References
Allan E, Poxton IR (1994) The influence ofgrowth medium
on serum sensitivity of Bacteroides species. J. Med.
Microbiol. 41: 45-50.
Allan E, Poxton IR, Barclay GR (1995) Anti-bacteroides
lipopolysaccharide IgG levels in healthy adults and sepsis
patients. FEMS Immunol. Med. Microbiol. 11: 5-12.
Babb JL, Cummins CS (1978) Encapsulation of Bacteroides
species. Infection 19: 1088-1091.
Barrow GI, Felthan RICA (1993) Cowan and Steel's Manual
for the Identification of Medicial Bacteria 3rd edn.
Cambridge: Cambridge University Press.
Baumann EI, Tzianabos AO, Brisson J, Kasper DL,
Jennings HJ (1992) Structural elucidation oftwo capsular
polysaccharides from one strain of Bacteroides frayyilis
using high-resolution NMR spectroscopy. Biochemistry
31: 4081 —4089.
Beckmann I, Eijk HG van, Meisel-Mikolajczyk E,
Wallenburg HC (1989) Detection of 2-keto-3-deoxyoc-
tonate in endotoxins isolated from six reference strains
of the Bacteroides frayyilis group. Int. J. Biochem. 21:
661-666.
Bennett-Guerrero E, Barclay GR, Youssef ME et al. (2000)
Exposure to Bacteroidesfrayyilis endotoxin during cardiac
surgery. Anesth. Analyj. 90: 819-823.
Bjornson AB, Detmers PA (1995) The pentameric struc¬
ture of IgM is necessary to enhance opsonization of
Bacteroides thetaiotaomieron and Bacteroides frayyilis via
the alternative complement pathway. Microb. Pathoyy. 19:
117-128.
Bjornson AB (1987) Opsonization of bacteroides by the
alternative complement pathway reconstructed from iso¬
lated plasma proteins. /. Exp. Med. 164: 777-798.
1944 ANAEROBIC INFECTIONS
Bonnett SA, Sutren M, Godon JJ etal. (1999) Direct analysis
ofgenes encoding 16S rRNA from complex communities
reveals many novel molecular species within the human
gut. Appl. Environ. Microbiol. 65: 4799M807.
Border M, Firehammer BD, Shoop DS, Myers LL (1985)
Isolation of Bacteroidesfragilis from the feces ofdiarrheic
calves and lambs. /. Clin. Microbiol. 21: 472M73.
Breuil J, Dublanchet A, Truffaut N, Sebald M (1989)
Transferable 5-nitroimidazole resistance in the Bac-
teroidesfragilis group. Plasmid 21: 151-154.
Brook I (1989) Pathogenicity of the Bacteroides fragilis
group. Ann. Clin. Lab. Sci. 19: 360-376.
Brown R, Collee JG, Poxton III, Fraser AG (1989)
Bacteroides, Fusobacterium and related organisms: anae¬
robic cocci: identification of anaerobes. In: Collee JG,
Duguid JP, Fraser AG, Marmion BP (eds) Mackie and
McCartney Practical Medical Microbiology, 13th edn.
Edinburgh: Churchill Livingstone, pp. 553-570.
Bry L, Falk PG, Midtvedt T, Gordon JI (1996) A model of
host-microbial interactions in an open mammalian eco¬
system. Science 273: 1380-1383.
Chen Y, Kinouchi T, Kataoka K, Akimoto S, Ohnishi Y
(1995) Purification and characterization of a fibrinogen-
degrading protease in Bacteroidesfragilis strain YCH46.
Microbiol. Immunol. 39: 967-977.
Chung G, Franco AA, Wu B et al. (1999) Identification
of a third metalloprotease toxin gene in extraintestinal
isolates of Bacteroides fragilis. Infect. Immun. 67: 4945-
4949.
Claros MC, Citron DM, Schonian G, Hunt-Gerardo S,
Goldstein EJC (1997) Characterization of Bacteroides
species using PCR fingerprinting. In: Eley AR,
Bennett KW (eds) Anaerobic Pathogens. Sheffield:
Sheffield Academic Press, pp. 359-369.
Comstock LE, Coyne MJ, Tzianabos AO et al. (1999)
Analysis of a capsular polysaccharide biosynthesis locus of
Bacteroides fragilis. Infect. Immun. 67: 3525-3532.
Conway PL (1997) Development of the intestinal micro-
biota. In: Mackie RI, White BA, Isaacson RE (eds)
Gastrointestinal Microbiology, Vol. 2. London: Chapman
& Hall, pp. 3-38.
Crabb JH, Finberg R, Onderdonk AB, Kasper DL (1990)
T cell regulation ofBacteroidesfragilis- induced intraabdo¬
minal abscesses. Rev. Infect. Dis. 12 Suppl. 2: S178-184.
Delahooke DM, Barclay GR, Poxton IR (1995a) A re¬
appraisal of the biological activity of bacteroides LPS.
J. Med. Microbiol. 42: 102 -112.
Delahooke DM, Barclay GR, Poxton IR (1995b) Tumor
necrosis factor induction by an aqueous phenol-extracted
lipopolysaccharide complex from Bacteroides species.
Infect. Immun. 63: 840-846.
Dontingues RMCP, Cavalcanti SMB, Andrade AFB,
Ferreira MCS (1992) Sialic acid as receptor of Bacteroides
fragilis lectin-like adhesin. Zlb. Bakteriol. 277: 340-344.
Domingues RMCP, Souza WGSS, Moraes SR et al.
(1997) Surface vesicles: a possible function in commen¬
sal relations of Bacteroides fragilis. Zlb. Bakteriol. 285:
509-517.
Doom J van, Mooi J, Verweij-van Vught AMJJ, MacLaren
DMA (1987) Characterization of fimbriae from Bac¬
teroidesfragilis. Microb. Pathog. 3: 87-95.
Doom J van , Oudega B, MacLaren DM (1992) Character¬
ization and detection of the 40-kDa fimbrial subunit of
Bacteroidesfragilis BE1. Microb. Pathog. 13: 75-79.
Drasar BS, Duerden BI (1991) Anaerobes in the normal flora
of man. In: Duerden BI, Drasar BS (eds) Anaerobes in
Human Disease. London: Edward Arnold, pp. 162-179.
Dubreuil L (1996) Antibiotic susceptibility patterns of
the Bacteroides fragilis group. Med. Mai. Infect. 26:
196-207.
Duerden BI (1980) The identification of gram-negative
anaerobic bacilli isolated from clinical infections.
J. Hygiene BA: 301-313.
Edwards DI (1997) Resistance to nitroimidazoles in anae¬
robes. In: Eley AR, Bennett KW (eds) Anaerobic Patho¬
gens. Sheffield: Sheffield Academic Press, pp. 437M-48.
Edwards R, Greenwood D (1997) Distinctive outer mem¬
brane protein and lipopolysaccharide composition of
Bacteroides fragilis strains that produce metallo-beta-
lactamase. Anaerobe 3: 233-236.
Eiring P, Manncke B, Gerbracht K, Werner H (1995)
Bacteroidesfragilis adheres to laminin significantly stron¬
ger than Bacteroides thetaiotaomicron and other species of
the genus. Zlb. Bakteriol. 282: 279-286.
Finlay-Jones JJ, Hart PH, Spencer LK et al. (1991) Bacterial
killing in vitro by abscess-derived neutrophils. ]. Med.
Microbiol. 34: 73-81.
Foreman KE, Bjornson AB (1994) The alternative com¬
plement pathway promotes IgM antibody-dependent
and -independent adherence of Bacteroides to polymor¬
phonuclear leukocytes through CR3 and CR1. J. Leuko¬
cyte Biol. 55: 603-611.
Freeman CD, Klutman NE, Lamp KC (1997) Metro¬
nidazole - a therapeutic review and update. Drugs 54:
679-708.
Fujiwara T, Ogawa T, Sobue S, Hamada S (1990) Chemical,
immunobiological and antigenic characterizations of
lipopolysaccharides from Bacteroides gingivalis strains.
J. Gen. Microbiol. 136: 319-326.
Gaskins HR (1997) Immunological aspects of host/micro-
biota interactions at the intestinal epithelium. In: Mackie
RI, White BA, Isaacson RE (eds) Gastrointestinal Micro¬
biology, London: Chapman & Hall, Vol. 2, pp. 537-587.
Gibson GR, Macfarlane GT (1994) Intestinal bacteria and
disease. In: Gibson SAW (ed.) Human Health: the
Contribution of Microorganisms. Berlin: Springer,
pp. 53-62.
Gibson SAW (ed.) (1994) Human Health: the Contribution
ofMicroorganisms. Berlin: Springer.
Godoy VG, Dallas MM, Russo TA, Malamy MH (1993)
A role for Bacteroides fragilis neuraminidase in bac¬
terial growth in two model systems. Infect. Immun. 61:
4415M426.
Goldner M, Coquis-Rondon M, Carlier J-P (1993) Effect
of growth of Bacteroides fragilis at different redox
levels on potential pathogenicity in a HeLa cell
Bacteroides 1945
system: demonstration by confocal laser scanning micros¬
copy. Zlb. Bakteriol. 278: 529-540.
Goldner M, Mingot N, Emond JP, Dublanchet A (1997)
Influence ofdifferent levels of redox potential on fermen¬
tative products formed by Bacteroides fragilis. Clin.
Infect. Dis. 25 (Suppl)(2): S147-S150.
Greenwood D, Edwards R (1997) Mechanisms of
resistance to beta-lactam antibiotics in Bacteroides
fragilis. In: Eley AR, Bennett KW (eds) Anaerobic
Pathogens. Sheffield: Sheffield Academic Press, pp.
449M56.
Guthrie EP, Shoemaker NB, Salyers AB (1985) Cloning and
expression in Escherichia coli of a gene coding for a
chondroitin lyase from Bacteroides thetaiotaomicron.
J. Bacteriol. 164: 510-515.
Guzman CA, Biavasco F, Pruzzo C (1997) Adhesiveness of
Bacteroides fragilis strains isolated from feces of healthy
donors, abscesses and blood. Curr. Microbiol. 34:
332-334.
Heinrichs DE, Yethon JA, Whitfield C (1999) Molecular
basis for structural diversity in the core regions of the
lipopolysaccharides of Escherichia coli and Salmonella
enterica. Mol. Microbiol. 30: 221-232.
Hofstad T (1980) Evaluation of the API ZYM system for
identification of Bacteroides and Fusobacterium species.
Med. Microbiol. Immunol. 168: 173-177.
Holdman LV, Good I J, Moore WEC (1976) Human fecal
flora: variation in bacterial composition within individuals
and possible effect of emotional stress. Appl. Environ.
Microbiol. 31: 359-375.
Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI
(1999) A molecular sensor that allows a gut
commensal to control its nutrient foundation in a
competitive ecosystem. Proc. Natl Acad. Sci. USA 96:
9833-9838.
Imai Y, Singer MS, Fennie C, Lasky LA, Rosen SD (1991)
Identification of a carbohydrate-based endothelial ligand
for a lymphocyte homing receptor. J. Cell Biol. 113:
1213-1221.
Jennings MP, Srikhanta YN, Moxon ER et al. (1999) The
genetic basis of the phase variation repertoire of lipo-
polysaccharide immunotypes in Neisseria meningitidis.
Microbiology 145: 3013-3021.
Johnson JL (1978) Taxonomy of the Bacteroides 1. Deoxy¬
ribonucleic acid homologies among Bacteroides fragilis
and other saccharolytic Bacteroides species. Int. J. Syst.
Bacteriol. 28: 245-256.
Johnson JL, Ault DA (1978) Taxonomy of Bacteroides II.
Correlation ofphenotypic characteristics with deoxyribo¬
nucleic acid homology groupings for Bacteroides fragilis
and other saccharolytic Bacteroides species. Int. J. Syst.
Bacteriol. 28: 257-268.
Jousimies-Somer HR, Summanen PH, Finegold SM (1995)
Bacteroides, Porphyromonas, Prevotella, Fusobacterium,
and other anaerobic Gram-negative bacteria. In:
Murray PR (ed.) Manual of Clinical Microbiology, 6th
edn. Washington, DC: American Society for Microbiol-
ogy, pp. 603-620.
Kato N, Kato H, Watanabe K, Ueno K( 1996) Association of
enterotoxigenic Bacteroides fragilis with bacteraemia.
Clin. Infect. Dis. 23 (Suppl)(l): S83-S86.
Kocher M, Kenny PA, Farram E et al. (1996) Functional
chemotactic factor CP-10 and MRP-14 are abundant in
murine abscesses. Infect. Immun. 64: 1342-1350.
Larkin MJ, McGuigan J, Patrick S (1988) Iron limitation and
induction of congo red binding in Bacteroides fragilis
NCTC9343. In: Hardie JM, Boriello SP (eds) Anaerobes
Today. Chichester: Wiley, pp. 216-217.
Leng Z, Riley DR, Berger RE, Krieger JN, Roberts MC
(1997) Distribution and mobility of the tetracycline
resistance determinant tetQ. J. Antimicrob. Chemother.
40:551-559.
Leszczynski P, Belkum A van, Pituch H, Verbrugh H,
Meisel-Mikolajczyk F (1997) Vaginal carriage of entero¬
toxigenic Bacteroidesfragilis in pregnant women. /. Clin.
Microbiol. 35: 2899-2903.
Lindberg AA, Weintraub A, Zahringer U, Rietschel ET
(1990) Structure-activity relationships in lipopolysac¬
charides of Bacteroides fragilis. Rev. Infect. Dis. 12
Suppl. 2: S133-S141.
Lutton DA, Patrick S, Doom J van, Emmerson M, Clarke G
(1989) Expression of Bacteroides fragilis fimbrial
antigen in vitro and in vivo. Biochem. Soc. Trans. 17:
758-759.
Lutton DA, Patrick S, Crockard AD et al. (1991)
Flow cytometric analysis of within-strain variation in
polysaccharide expression by Bacteroides fragilis by use
of murine monoclonal antibodies. J. Med. Microbiol. 35:
229-237.
MacLachlan PR, Keenleyside WJ, Dodgson C, Whitfield C
(1993) Formation of the K30 (Group I) capsule of
Escherichia coli Q9:K30 does not require attachment to
lipopolysaccharide lipid A-core. J. Bacteriol. 175:
7515-7522.
Macfarlane GT, Gibson GR (1991) Formation of glycopro¬
tein degrading enzymes by Bacteroides fragilis. FEMS
Microbiol. Lett. 77: 289-293.
Macfarlane GT, Gibson GR (1994) Metabolic activities of
the normal colonic flora. In: Gibson SAW (ed.) Human
Health. The Contribution of Microorganisms. Berlin:
Springer, pp. 17-52.
Macfarlane GT, Gibson SAW, Gibson GR (1992a) Proteo¬
lytic activities of the fragilis Group of Bacteroides spp. In:
Duerden BI, Brazier JS, Seddon SV, Wade WG (eds)
Medical and Environmental Aspects of Anaerobes.
Petersfield: Wrightson Biomedical Publishing, pp. ISO-
MS.
Macfarlane GT, Macfarlane S, Gibson GR( 1992b) Synthesis
and release of proteases by Bacteroides fragilis. Curr.
Microbiol. 24: 55-59.
Mackie RI, White BA, Isaacson RE (eds) (1997) Gastrointest¬
inal Microbiology, Vol. 2 New York: Chapman 8c Hall.
Manz W, Amman R, Ludwig W, Vancanney M,
Schleifer K-H (1996) Application of a suite of 16S rRNA-
specific oligonucleotide probes designed to investigate
bacteria of the phylum cytophaga-flavobacter-bacteroides
1946 ANAEROBIC INFECTIONS
in the natural environment. Microbiology 142:
1097-1106.
Moncrief JS, Obiso R, Barroso LA et al. (1995) The
enterotoxin of Bacteroides fragilis is a metalloprotease.
Infect. Immun. 63: 175-181.
Moncrief JS, Duncan AJ, Wright RL, Barroso LA,
Wilkins TD (1998) Molecular characterization of the
fragilysin pathogenicity islet of enterotoxigenic Bac¬
teroidesfragilis. Infect. Immun. 66: 1735-1739.
Morris JG (1991) Characteristics of anaerobic metabolism.
In: Duerden BI, Drasar BS (eds) Anaerobes in Human
Disease. London: Edward Arnold, pp. 16-37.
Murphy CG, Malamy MM (1995) Requirements for strand-
and site-specific cleavage within the oriT region of the
Tn(4399), a mobilizing transposon from Bacteroides
fragilis. J. Bacteriol. 177: 3158-3165.
Myers LL, Firchammer BD, Shoop DS, Border MM
(1984) Bacteroides fragilis. a possible cause of acute
diarrheal disease in newborn lambs. Infect. Immun. 44:
241-244.
Myers LL, Shoop DS, Stackhouse LL et al. (1987) Isolation
of enterotoxigenic Bacteroidesfragilis from humans with
diarrhea. /. Clin. Microbiol. 25: 2330-2333.
Namavar F, Theunissen EB, Verweij-Van Vught AMJJ et al.
(1989) Epidemiology of the Bacteroidesfragilis group in
the colonic flora of patients with colonic cancer. J. Med.
Microbiol. 29: 171-176.
Nicolai H von, Hammann R, Werner H, Zilliken F (1983)
Isolation and characterization of sialidase from Bac¬
teroidesfragilis. FEMS Microbiol. Lett. 17: 217-220.
Otto BR, Verweij-van Vught AMJJ, van Doom J, MacLaren
DM (1988) Outer membrane proteins of Bacteroides
fragilis and Bacteroides vulgatus in relation to iron uptake
and virulence. Microb. Pathog. 4: 279-287.
Otto BR, Sparrius M, Verweij-van Vught AMJJ,
MacLaren DM (1990) Iron-regulated outer membrane
protein of Bacteroides fragilis involved in heme uptake.
Infect. Immun. 58: 3954-3958.
Otto BR, Verweij WR, Sparrius M, Verweij-van Vught
AMJJ, Nord CE, Maclaren DM (1991) Human
immune-response to an iron-repressible outer-membrane
protein. Infect. Immun. 59: 2999-3003.
Otto BR, Sparrius M, Wors DJ, GraafFKde, MacLaren DM
(1994) Utilization of haem from the haptoglobin-
haemoglobin complex by Bacteroides fragilis. Microb.
Pathog. 17: 137-147.
Otto BR, Kusters JG, Luirink J, Graaf FK de, Oudega B
(1996) Molecular characterization of a heme-binding
protein of Bacteroides fragilis BE1. Infect. Immun. 64:
4345M350.
Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL
(1991) Immunochemical characterization of two surface
polysaccharides of Bacteroidesfragilis. Infect. Immun. 59:
2075-2082.
Pantosti A, Colangeli R, Tzianabos AO, Kasper DL (1995)
Monoclonal antibodies to detect capsular diversity
among Bacteroides fragilis isolates. /. Clin. Microbiol.
33: 2647-2652.
Pantosti A, Menozzi MG, Frate A et al. (1997) Detection of
enterotoxigenic Bacteroidesfragilis and its toxin in stool
samples from adults and children in Italy. Clin. Infect. Dis.
24: 12-16.
Patrick S (1988) Phagocytosis of Bacteroidesfragilis in vitro.
In: Hardie JM, Boriello SP (eds) Anaerobes Today.
Chichester: Wiley, pp. 31 Ml.
Patrick S (1993) The virulence of Bacteroides fragilis. Rev.
Med. Microbiol. 4: 40-49.
Patrick S, Reid JH (1983) Separation of capsulate and non-
capsulate Bacteroides fragilis on a discontinuous density
gradient, j. Med. Microbiol. 16: 239-241.
Patrick S, Lutton DA (1990a) Bacteroides fragilis surface
structure expression in relation to virulence. Med. Malad.
Infect. 20(hors serie): 19-25.
Patrick S, Lutton DA (1990b) Outer membrane proteins of
Bacteroides fragilis grown in vivo. FEMS Microbiol. Lett.
71: 1 -4.
Patrick S, Larkin MJ (1995) Immunological and Molecular
Aspects ofBacterial Virulence. Chichester: Wiley.
Patrick S, Rcid JH, Larkin MJ (1984) The growth and
survival ofcapsulate and non-capsulate Bacteroidesfragilis
in vivo and in vitro. J. Med. Microbiol. 17: 237-246.
Patrick S, Reid JH, Coffey A (1986) Capsulation of in vitro
and in vivo grown Bacteroides species. /. Gen. Microbiol.
132: 1099-1109.
Patrick S, Coffey A, Emmerson AM, Larkin MJ (1988) The
relationship between cell surface structure expression
and haemagglutination in Bacteroides fragilis. FEMS
Microbiol. Lett. 50: 67-71.
Patrick S, Lutton SA, Crockard AD (1995a) Immune
reactions to Bacteroides fragilis populations with three
different types of capsule in a model of infection.
Microbiology 141: 1969-1976.
Patrick S, Stewart LD, Damani N et al. (1995b) Immuno¬
logical detection of Bacteroidesfragilis in clinical samples.
J. Med. Microbiol. 43: 99-109.
Patrick S, McKenna JP, O'Hagan S, Dermott E
(1996) A comparison of the haemagglutinating
and enzymic activities of Bacteroides fragilis whole
cells and outer membrane vesicles. Microb. Pathog. 20:
191-202.
Patrick S, Gilpin D, Stevenson L (1999) Detection of
intrastrain antigenic variation of Bacteroides fragilis sur¬
face polysaccharides by monoclonal antibody labelling.
Infect. Immun. 67: 4346-4351.
Podglajen I, Breuil J, Collatz E (1994) Insertion of a novel
DNA sequence, IS 1186, upstream of the silent carbape-
nemase gene cfiA, promotes expression of carbapenem
resistance in clinical isolates of Bacteroides fragilis. Mol.
Microbiol. 12: 105-114.
Podglajen I, Breuil J, Casin 1, Collatz E (1995) Genotypic
identification of two groups within the species Bacteroides
fragilis by ribotyping and by analysis of PCR-generated
fragment patterns and insertion sequence content.
/. Bacteriol. 177: 5270-5275.
Poxton IR, Myers CJ, Johnstone A, Drudy TA, Ferguson A
(1995) An ELISA to measure mucosal IgA specific for
Bacteroides 1947
Bacteroides surface antigens in whole gut lavage fluid.
Microb. Ecol. Health Dis. 8: 129-136.
Poxton IR, Brown R (1986) Immunochemistry of the
surface carbohydrate antigens of Bacteroides fragilis and
definition of a common antigen. J. Gen. Microbiol. 132:
2475-2481.
Poxton IR, Brown R, Wilkinson JF (1989) pH measure¬
ments and buffers, oxidation-reduction potentials,
suspension fluids and preparation of glassware. In:
Collee JG, Duguid JP, Fraser AG, Marmion BP (eds)
Mackie & McCartney Practical Medical Microbiology,
13th edn., Edinburgh: Churchill Livingstone, Vol. 2,
pp. 90-99.
Poxton IR, Brown R, Sawyerr A, Ferguson A (1997)
Mucosa-associated bacterial flora of the human colon.
J. Med. Microbiol. 46: 85-91.
Privitera G, Dublanchet A, Sebald M (1979) Transfer of
multiple antibiotic resistance between subspecies of
Bacteroides fragilis. J. Infect. Dis. 139: 97-101.
Pruzzo C, Dainelli B, Ricchetti M (1984) Piliated Bacteroides
fragilis strains adhere to epithelial cells and are more
sensitive to phagocytosis by human neutrophils than
nonpiliated strains. Infect. Immun. 34: 189-194.
Rademacher TW, Parekh RB, Dwelt RA (1988) Glycobiol-
ogy. Annu. Rev. Biochem. 57: 785-838.
Rarnage G, Patrick S, Houston S (1998) Combined fluor¬
escent in situ hybridisation and immunolabelling of
Bacteroidesfrctgilis. J. Immunol. Meth. 212: 139-147.
Raskin L, Capman WC, Sharp R, Poulsen LK, Stahl DA
(1997) Molecular ecology of gastrointestinal eco¬
systems. In: Mackie III, White BA, Isaacson RFI (eds)
Gastrointestinal Microbiology. New York: Chapman &
Hall, pp. 243-297.
Rath HC, Herfarth HH, Ikeda JS et al. (1996) Normal
luminal bacteria, especially Bacteroides species, mediate
chronic colitis, gastritis and arthritis in HLA-B27/human
beta2 microglobulin transgenic rats. /. Clin. Invest. 98:
945-953.
Rath HC, Wilson KH, Sortor RB (1999) Differential
induction of colitis and gastritis in HLA-B27 transgenic
rats selectively colonized with Bacteroides vulgatus or
Escherichia coli. Infect. Immun. 67: 2969-2974.
Redondo MC, Arbo MDJ, Grindlinger J, Snydman Dll
(1995) Attributable mortality of bacteraemia associated
with the Bacteroides fragilis group. Clin. Infect. Dis. 20:
1492-1496.
Reeves AR, Wang G, Salyers AA (1997) Characterization of
four outer membrane proteins that play a role in utiliza¬
tion ofstarch by Bacteroides thetaiotaomicron. J. Bacteriol.
179: 643-649.'
Reid JH, Patrick S (1984) Phagocytic and serum killing of
capsulate and non-capsulate Bacteroides fragilis. J. Med.
Microbiol. 17: 247-257.
Reid JH, Patrick S, Dermott E, Trudgett A, Tabaqchali S
(1985) Investigation of antigenic expression of Bac¬
teroides fragilis by immunogold labelling and immuno-
blotting with a monoclonal antibody. FEMS Microbiol.
Lett. 30: 289-293.
Reid JH, Patrick S, Tabaqchali S (1987) Immunochemical
characterization of a polysaccharide antigen of Bacteroides
fragilis with an IgM monoclonal antibody. ]. Gen.
Microbiol. 133: 171-179.
Riley TV, Mee BJ (1984) Haemagglutination of Bacteroides
fragilis. FEMS Microbiol. Lett. 25: 229-232.
Rocha ER, Smith CJ (1995) Biochemical and genetic
analyses of a catalase from the anaerobic bacterium
Bacteroides fragilis. J. Bacteriol. 177: 3111-3119.
Rocha ER, Selby T, Coleman JP, Smith CJ (1996) Oxidative
stress response in an anaerobe, Bacteroidesfragilis: a role
for catalase in protection against hydrogen peroxide.
J. Bacteriol. 178: 6895-6903.
Rogers MB, Parker AC, Smith DJ (1993) Cloning and
characterization of the endogenous cephalosporinase
gene, cepA, from Bacteroides fragilis reveals a new
subgroup of Ambler class A beta-lactamases. Antimicrob.
Agents Chemother. 37: 2391-2400.
Rotstein OD, Kao J, Houston I< (1989a) Reciprocal synergy
between Escherichia coli and Bacteroides fragilis in an
intraabdominal infection model. J. Med. Microbiol. 29:
269-276.
Rotstein OD, Vittorini T, Kao J et al. (1989b) A soluble
Bacteroides by-product impairs phagocytic killing ofEsche¬
richia coli by neutrophils. Infect. Immun. 57: 745-753.
Rudek W, Haquc R (1976) Extracellular enzymes of the
genus Bacteroides. J. Clin. Microbiol. 4: 458M60.
Ruimy R, Podgaljen I, Breuil J, Christen 11, Collatz E
(1996) A recent fixation of cfiA genes in a monophyl-
etic cluster of Bacteroides fragilis is correlated with
the presence of multiple insertion elements. J. Bacteriol.
178: 1914-1918.
Salyers AA, Shoemaker N (1996) Genetics ofhuman colonic
bacteroides. In: Mackie RI, White BA, Isaacson RE (eds)
Gastrointestinal Microbiology. New York: Chapman &
Hall, pp. 299-320.
Salyers AA, Shoemaker N, Cooper A, D'Elia J, Shipman JA
(1999) Genetic methods for Bacteroides species. In:
Smith MCM, Socket RE (eds) Genetic Methodsfor Diverse
Prokaryotes. Methods in Microbiology, Vol. 29. London:
Academic Press, pp. 229-249.
Sawyer RG, Adams RB, May AK, Rosenlof LK, Pruett TL
(1995) CD4 + T cells mediate preexposure-induced
increases in murine intraabdominal abscess formation.
Clin. Immunol. Immunopathol. 77: 82-88.
Schauer R (1985) Sialic acids and their role as biological
masks. Trends Biochem. Sci. 10: 357-360.
Scudder P, Lawson AM, Hounsell EF et al. (1987)
Characterisation of oligosaccharides released from
human-blood-group O erythrocyte glycopeptides by the
endo-beta-galactosidase of Bacteroides fragilis. Eur. J.
Biochem. 168: 585-593.
Sebald M (1994) Genetic basis for antibiotic resistance in
anaerobes. Clin. Infect. Dis. 18 (Suppl)(4): S297-304.
Shah HN, Collins MD (1989) Proposal to restrict the genus
Bacteroides (Castellani and Chalmers) to Bacteroides
fragilis and closely related species. Int. J. Syst. Bacteriol.
39:85-87.
1948 ANAEROBIC INFECTIONS
Shah HN, Gharbia SE (1991) Bacteroides and
Fusobacterium: classification and relationships to other
bacteria. In: Duerden BI, Drasar BS (eds) Anaerobes in
Human Disease. London: Edward Arnold, pp. 62-84.
Shah HN, Gharbia SE, Duerden BI (1998) Bacteroides,
Prevotella, Porpbyromonas. In: Collier L, Balows A, Suss-
man M (eds) Topley and Wilson's Microbiology and
Microbial Infections, 9th edn, London: Edward Arnold,
Vol. 2, pp. 1305-1330.
Shaheduzzaman SM, Akimoto S, Kuwahara T, Kinouchi T,
Ohnishi Y (1997) Genome analysis of Bacteroides by
pulsed-field gel electrophoresis: chromosome sizes and
restriction patterns. DNA Res. 4: 19-25.
Shoemaker NB, Wang G, Salyers AA (1992) Evidence for
natural transfer of a tetracycline resistance gene between
bacteria from the human colon and bacteria from the
bovine rumen. Appl. Environ. Microbiol. 58: 1313-1320.
Shoemaker NB, Wang G, Salyers AA (2000) Multiple
gene products and sequences required for excision of
the mobilizable integrated Bacteroides element NBU1.
/. Bacteriol. 182: 928-936.
Smith CJ, Tribble GD, Bayley DP (1998) Genetic
elements of Bacteroides species: a moving story. Plasmid
40: 19-29.
Snydman DR, McDermott L, Cuchural GJ et al.
(1996) Analysis of trends in antimicrobial resistance
patterns among clinical isolates of Bacteroides fragilis
group species from 1990 to 1994. Clin. Infect. Dis. 23
Suppl. 1: S54-S65.
Stevens AM, Sanders JM, Shoemaker NB, Salyers AA (1992)
Genes involved in production of plasmid-like forms by a
Bacteroides conjugal chromosomal element share amino
acid homology with two-component regulatory systems.
/. Bacteriol. 174: 2935-2942.
Summanen P, Baron EJ, Citron DM et al. (1993) Wadsivorth
Anaerobic Bacteriology Manual, 5th edn. Belmont, CA:
Star Publishing Company.
Szoke I, Pascu C, Nagy E, Ljung A, Wadstrom T (1996)
Binding of extracellular matrix proteins to the surface of
anaerobic bacteria. /. Med. Microbiol. 45: 338-343.
Tally FP, Ho JL (1987) Management of patients with
intraabdominal infection due to colonic perforation.
Cnrr. Clin. Topics Infect. Dis. 8: 266-295.
Tang YP, Dallas MM, Malarny MH (1999) Characterization
of the BatI (Bacteroides aerotolerance) operon in Bacter¬
oidesfragilis: isolation ofa B. fragilis mutant with reduced
aerotolerance and impaired growth in in vivo model
systems. Mol. Microbiol. 32: 139-149.
Trinh S, Haggoud A, Reysset G (1996) Conjugal transfer of
the 5-nitroimidazole resistance plasmid pIP417 from
Bacteroides vulgatus ftV-17: characterization and nucleo¬
tide sequence analysis of the mobilization region.
/. Bacteriol. 178: 6671-6676.
Tzianabos AO, Pantosti A, Baumann H et al. (1992) The
capsular polysaccharide of Bacteroides fragilis comprises
two ionically linked polysaccharides. J. Biol. Chem. 267:
18230-18235.
Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL,
Kasper DL (1993) Structural features of polysaccharides
that induce intra-abdominal abscesses. Science 262:
416^19.
Tzianabos AO, Onderdonk AB, Smith RS, Kasper DL
(1994) Structure-function relationships for polysac-
charide-induced intra-abdominal abscesses. Infect.
Immun. 62: 3590-3593.
Tzianabos AO, Russell PR, Onderdonk AB et al. (1999) IL-
2 mediates protection against abscess formation in an
experimental model ofsepsis. J. Immunol. 163: 893-987.
Veillon A, Zuber A (1897) Sur quelques microbes stricte-
ment anaerobies et leur role dans la pathologie humaine.
C R Soc. Biol. (Paris) 49: 253-255.
Veillon A, Zuber A (1898) Sur quelques microbes stricte-
ment anaerobies et leur role en pathologie. Arch. Med.
Exp. Anat. 10: 517-545.
Vel WAC, Namavar F, Marian A et al. (1986) Haemagglu-
tination by the Bacteroides fragilis group. /. Med. Micro¬
biol. 21: 105-107.
Wang Z, East W, Benkovic SJ (1999) On the mechanism of
the metallo-beta-lactamase from Bacteroides fragilis.
Biochemistry 38: 10013-10023.
Weikcl CS, Grieco FD, Reuben J, Myers LL, Sack RB (1992)
Human colonic epithelial cells, HT29/C1, treated with
crude Bacteroides fragilis enterotoxin dramatically alter
their morphology. Infect. Immun. 60: 321-327.
Weintraub A, Larsson BE, Lindberg AA (1985) Chemical
and immunochemical analyses of Bacteroides fragilis
lipopolysaccharides. Infect. Immun. 49: 197-201.
Whittle G, Bloomfield GA, Katz ME, Cheetham BF (1999)
The site-specific integration of genetic elements may
modulate thermostable protease production, a virulence
factor in Dichelobacter nodosus, a causative agent of ovine
footrot. Microbiology 145: 2845-2855.
Willis AT (1991) Abdominal sepsis. In: Duerden BI,
Drasar BS (eds) Anaerobes in Human Disease. London:
Edward Arnold, pp. 197-223.
Willis AT, Ferguson JR, Jones PH et al. (1976) Metronida¬
zole in prevention and treatment ofbacteroides infections
after appendicectomy. BMJ 1: 318-321.
Wilson KH (1997) Biota of the human gastrointestinal tract.
In: Mackie RI, White BA, Isaacson RE (eds) Gastrointest¬
inal Microbiology. New York: Chapman & Hall, Vol. 2,
pp. 39-58.
Woese CR (1987) Bacterial evolution. Microbiol. Rev. 51:
221-271.
Wren MD (1991) Laboratory diagnosis of anaerobic
infection. In: Duerden BI, Drasar BS (eds) Anaerobes in
Human Disease. London: Edward Arnold, pp. 180-196.
45
Patrick S, Parkhill J, McCoy LJ, Lennard N, Larkin MJ, Collins M,
Sczaniecka M and Blakely G.
2003.
Multiple inverted DNA repeats ofBacteroidesfragilis that control
polysaccharide antigenic variation are similar to the hin region inverted
repeats of Salmonella typhimurium.
Microbiology 149, 915-924.




Received 2 December 2002
Revised 15 January 2003
Accepted 17 January 2003
Multiple inverted DNA repeats of Bacteroides
fragilis that control polysaccharide antigenic
variation are similar to the hin region inverted
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The important opportunistic pathogen Bacteroides fragilis is a strictly anaerobic Gram-negative
bacterium and a member of the normal resident human gastrointestinal microbiota. Our earlier
studies indicated that there is considerable within-strain variation in polysaccharide expression, as
detected by mAb labelling. Analysis of the genome sequence has revealed multiple invertible DNA
regions, designated fragilis invertible (fin) regions, seven of which are upstream of polysaccharide
biosynthesis loci and are approximately 226 bp in size. Using orientation-specific PCR primers and
sequence analysis with populations enriched for one antigenic type, two of these invertible regions
were assigned to heteropolymeric polysaccharides with different sizes of repeating units, as
determined by PAGE pattern. The implication of these findings is that inversion of the fin regions
switches biosynthesis of these polysaccharides off and on. The invertible regions are bound by
inverted repeats of 30 or 32 bp with striking similarity to the Salmonella typhimurium H flagellar
antigen inversion cross-over (hix) recombination sites of the invertible hin region. It has been
demonstrated that a plasmid-encoded Hin invertase homologue (FinB), present in B. fragilis NCTC
9343, binds specifically to the invertible regions and the recombination sites have been designated
as fragilis inversion cross-over (fix) sites.
INTRODUCTION
Bacteroides fragilis is the Gram-negative strictly anaerobic
bacterium most frequently isolated from clinical infection,
including intra-abdominal, vaginal, pilonidal, perianal and
brain abscesses. It is also the most common cause of
anaerobic bacteraemia, with a potential mortality of up to
19% (Redondo et al., 1995). The major source of these
infections is the normal resident colonic microbiota
where Bacteroides spp. outnumber facultatively anaerobic
bacteria such as Escherichia coli by a factor of at least 102-
103 (Drasar & Duerden, 1991).
A number of factors may contribute to the virulence of
B. fragilis; however, extracellular polysaccharides (PSs) are
considered to play a key role (Patrick, 2002). Intra-strain
Abbreviations: EDL, electron-dense layer; HMMPS, high-molecular-
mass polysaccharides; LC, large capsule; MBP, maltose-binding protein;
PS, polysaccharide; SC, small capsule.
phase variation, defined as whether a given characteristic
is present or not (Saunders, 1986), is evident with respect
to encapsulating surface structures (Babb & Cummins,
1978; Patrick & Reid, 1983). A large capsule (LC) and small
capsule (SC) are visible by light microscopy. By electron
microscopy, an encapsulating electron-dense layer (EDL)
is visible adjacent to the outer membrane on bacteria
non-capsulate by light microscopy (Patrick et al., 1986).
Expression of the different capsular types is heritable;
populations can be enriched by subculture from different
interfaces of Percoll step density gradients (Patrick 8c Reid,
1983). In addition, antigenic variation of individual cap¬
sular types can be demonstrated using mAb labelling;
variable proportions of bacterial cells within these popula¬
tions label with individual mAbs (Lutton et al., 1991). The
LC and EDL phases have shared epitopes; however, the SC
is antigenically different (Reid et al., 1985; Lutton et al.,
1991). mAb labelling indicates that there are potentially six
different high-molecular-mass polysaccharides (HMMPS)
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Table 1. Oligonucleotide primers used in the study
Primer A B C
PS1 ccagattattatctgataat attatcagataataatctgg tagaaaagacgcaccccgta
PS2 gtatataatactcttataat attataagagtattatatac ggaacatgatcatccttcgtg
PS3 tccaataattcattgattta taaatcaatgaattattgga cgctcgttcttgacgatgta
PS4 ctctatatatatttgagaat attctcaaatatatatagag gccctggtaagcaggtcttt
PS5 gtttatagatatttgattac gtaatcaaatatctataaac acggatcttacgctcaccac
PS6 tcataaatacctgtggttta taaaccacaggtatttatga gtgcatggggatgaaattct
PS7 agatatctatctagaaatta taatttctagatagatatct aggaaccaaaacacggacttt
associated with both the EDL and LC. One additional
HMMPS is associated with the SC. Antigenic variation has
been observed in clinical isolates from a variety of anatomi¬
cal sites and different geographical locations, and also in
bacteria grown in an in vivo model of peritoneal infection
(Patrick et al., 1995a, b). Immunoblotting of these anti-
genically variable PSs after PAGE reveals patterns char¬
acteristic of heteropolymeric PSs with repeating subunits.
Ladders with two different sizes of steps have been observed
(Lutton et al., 1991), one with a ladder pattern suggesting











































































Fig. 1. Alignment of the 6. fragilis NCTC
9343 invertible regions of DNA upstream of
PS biosynthesis loci 1-7. Note inverted
repeats at the right and left ends (arrows)
and the B. fragilis consensus promoter
sequence (box).
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that it may be similar to the O-antigen of smooth Gram-
negative bacteria identified by some workers (Poxton &
Brown, 1986; Delahooke et al., 1995), but not others
(Lindberg et al., 1990; Comstock et al, 1999).
If an antigenically mixed broth culture is spread onto agar
plates and the resulting colonies examined microscopically
after immunofluorescence labelling, 90% or more of the
bacteria carry a given epitope in some colonies and 10%
or less in others. The proportion of bacteria expressing a
given epitope within a colony is maintained on subculture
of the colony into broth culture (Patrick et al., 1999).
The possible mechanism underlying this complex variation
was entirely unknown until the B. fragilis whole-genome
sequencing project being carried out at the Sanger Wellcome
Institute UK (http://www.sanger.ac.uk/Projects/B_fragilis/)
revealed the presence of multiple regions of DNA with
inverted repeat elements at either end that appear to be
present in alternative orientations, within the bulk DNA
supplied for sequencing. The DNA was extracted from a
defined population, enriched for the EDL/non-capsulate
population, but which contained different PS antigenic
types. A recent paper concluded that variation of PS
expression in B. fragilis was probably controlled by invertible
regions bound by 19 bp inverted repeats upstream of the
seven putative biosynthesis loci (Krinos et al., 2001). We
present evidence that the inverted repeat regions at these
loci are in fact 30 or 32 bp in length and similar to the
Salmonella typhimurium H flagellar antigen inversion cross¬
over (hix) recombination sites of the invertible hin region of
S. typhimurium that controls biphasic flagellar antigenic
variation (Zieg et al., 1977). We also show, using mAbs, that
PS epitope expression associated with defined subpopula-
tions is related to specific S. typhimurium H flagellar antigen
invertase (Hin)-like inversions and that a plasmid-encoded
Hin-like recombinase binds to the invertible regions.
METHODS
Bacterial strains and culture methods. B. fragilis NCTC 9343
(National Collection of Type Cultures, Colindale Avenue, London,
UK), representative of the original strain deposited in the culture
collection in 1955 and originally isolated from an abdominal abscess,
was used. Identity was confirmed by partial sequencing of 16S
rDNA. Bacteria were grown in defined medium (DM) broth or on
DM plates (van Tassell & Wilkins, 1978) in an anaerobic cabinet
[MACS Anaerobic Workstation; Don Whitley (80% N2, 10% C02,
10% H2)]. Percoll density gradient enrichment was used to obtain
populations that either were non-capsulate by light microscopy or
produced an LC detectable by light microscopy, as described pre¬
viously (Patrick 8c Larkin, 1993). Populations enriched for individual
epitopes were obtained by picking individual colonies from DM
agar plates and subculturing in DM broth (Patrick et al., 1999). The
proportion of bacteria labelled within a population was monitored
by double immunofluorescence labelling with mAbs and polyclonal
antisera as detailed previously (Patrick 8c Larkin, 1993). Images
were viewed with a Leitz Ortholux fluorescence microscope, a
Nikon DMX1200 digital camera and Lucia GF software. PAGE and
immunoblotting were carried out as described previously (Lutton
etal, 1991).
DNA sequencing and PCR amplification. Genomic sequence
data were produced by the Bacteroides fragilis Sequencing Group at
the Wellcome Trust Sanger Institute. These data are available from
http://www.sanger.ac.uk/Projects/B_fragilis/. The complete sequence
and annotation of the genome will be described elsewhere.
DNA was extracted from populations enriched for one capsular
phase and antigenic type, as determined by microscopy, using Qiagen
Genomic-tip 100G in accordance with the manufacturer's instruc¬
tions. DNA concentration was measured spectrophotometrically
and diluted accordingly to 1 pg ml-1. Oligonucleotide primer pairs
(Table 1) were synthesized by Life Technologies. The PCR mixture
used was 45 pi ABgene Reddymix containing 1-5 mM MgCl2, 200 pi
each dNTP, 0-025 units Thermoprime Plus DNA Polymerase, 75 mM
Tris/HCl (pH 8-8), 20 mM (NH4)2S04 and 0-01% (v/v) Tween 20.
To the PCR mix described above, 2-5 pi each primer (20 pM) and
2-5 pi template (1 pg ml-1) were added. Primer pairs were either A
and C or B and C (Table 1). PCR amplification was performed for
25 cycles of 94 °C for 1 min 30 s, 50 °C for 1 min 30 s and 72 °C for
1 min 30 s using an MJ Research PTC-200 Peltier Thermal Cycler.
Samples were then cooled to 4 °C and retained at this temperature
until collected. After amplification, 5 pi of the amplified product was
electrophoresed through a 1% (w/v) agarose gel in lx Tris-acetate-
EDTA. PCR product bands were detected by ethidium bromide
staining, visualized by UV light (Transilluminator TFX-35M; Gibco-
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ttaa r ^g-c—a :a
cttt r 3ga a :a
ttataa-ac—a -a
cttt7 -ga—aa :a
tcaat gga a :a
cttt r -ga--aa :a
ttga r tga a :a
ctat i -ga--aa :a
ctaa i tga-acg :a
ttaaaa-ac—a :a
ttaar tga-acg :a
ctat : pga a :a







Fig. 2. Alignment of the B. fragilis NCTC 9343 inverted repeat
regions ([fix1-7) at the left (top strand) and right (inverse
bottom strand) end of the invertible regions upstream of PS
biosynthesis loci 1 -7 with the promoter in the correct orienta¬
tion for PS expression and top-strand left-hand inverted repeats
of the 'Hin' family {hix, pix, cix, gix, M. bovis pilus). Central
dinucleotides are in lower case. Bases that interact with the
Hin invertase in S. typhimurium are in bold. Other conserved
regions are boxed.
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fitted to a Kodak EDAS290 Gel Imaging Hood. Gel images were
analysed using Kodak ID Image Analysis Software Version 3.5 MAC
USB. 16S rDNA primers were included as an internal standard. PCR
products were purified using the MinElute PCR Purification Kit
(Qiagen), according to the manufacturer's instructions. The nucleo¬
tide sequences of purified PCR products were determined using the
ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit
(Applied Biosystems) and halfBD Terminator Sequencing Reagent
(Sigma) using an ABI Prism 3100 Genetic Analyser (Applied
Biosystems), according to the manufacturer's instructions.
Protein purification and gel retardation. DNA fragments corre¬
sponding to coding sequences of the finA and fitiB genes, generated
by PCR using Pfu polymerase, were cloned into pMAL-c2 (NEB) to
produce translational fusions with the maltose-binding protein
(MBP) encoded by malE. E. coli strain DH5a was transformed with
Fig. 3. Immunofluorescence micrographs of mAb QUBF5-enriched population of non-capsulate B. fragilis NCTC 9343
labelled with mAb QUBF5 (a), rabbit anti-B. fragilis polyclonal antiserum (b; same field of view as in a), mAb QUBF6 (c) and
rabbit anti-B. fragilis polyclonal antiserum (d; same field of view as in c). The secondary antibodies are anti-mouse FITC and
anti-rabbit TRITC conjugates.
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plasmids that expressed the invertase-MBP fusions, grown to an
ODMo of 0-4 and induced with 1 mM IPTG for 1 h. Cells were
harvested by centrifugation and resuspended in lysis buffer (20 mM
Tris/HCl, pH 7-4, 200 mM NaCl, 1 mM EDTA, 1 mM PMSF),
before addition of lysozyme (1 mg mf1) and sonication to produce
cell lysates. After centrifugation to remove cell debris, the invertase-
MBP fusion proteins were purified by affinity chromatography on
amylose resin, according to the manufacturer's instructions (NEB).
Gel retardation methods were carried out as detailed by Blakely et al.
(1993). DNA for gel retardation analysis of the entire invertible finl
region was generated by PCR with Pfu polymerase, using primers that
flanked the fixlL and fixlR sequences shown in Fig. 1, followed by
radiolabelling using [y-3:P]ATP and T4 polynucleotide kinase. Binding
reactions (10 pi) containing approximately 0-03 pmol radiolabelled
DNA were performed in 100 mM NaCl, 20 mM Tris/HCl, pH 8,
1 mM EDTA, 10% glycerol and 100 pg poly-dldC ml-1 at 37°C for
10 min before electrophoresis through a pre-run, non-denaturing
4% polyacrylamide gel. Binding gels were dried and then visualized
by autoradiography.
RESULTS AND DISCUSSION
An alignment of the invertible regions upstream of the PS
biosynthesis loci in B. fragilis is presented in Fig. 1. At either
end of these invertible regions are AT-rich sequences
containing imperfect dyad symmetry spanning 30-32 bp
(inverted repeat regions). The recently proposed consensus
B. fragilis promoter regions (Bayley et al., 2000) are
conserved and overlap the repeat region by 2 bp.
The inverted repeat regions, designated fragilis inversion
cross-over (fixL and fixR) sites (Fig. 2) bear striking simi¬
larity to recombination sites found at the ends of some
enteric bacterial invertible DNA sequences, for example, the
995 bp hin region within the chromosome of S. typhimu-
rium, the invertible regions of phage Mu (Gin system), the
E. coli K-12 el4 element (Pin system) and phage PI
(Cin system) (van de Putte & Goosen, 1992; Fig. 2). In
S. typhimurium, the reversible expression of two antigeni-
cally different flagella, HI and H2 (Lederberg & lino, 1956)
is controlled by inversion of the hin region which carries a
promoter and is upstream of the H2 gene, and a repressor
for HI. In Mu and PI phage DNA inversion alters the tail
fibres, thereby changing the phage host range (Plasterk
et al., 1983; Hiestand-Nauer & Iida, 1983). There is also
some similarity with the Moraxella bovis invertible region
which is within the Q/I (formerly f and oc) pilus gene
(Fulks et al., 1990), the inversion of which mediates pilus
phase and antigenic variation. There is no apparent
relationship with the 9 bp repeat of the 314 bp invertible
region that varies expression of type 1 fimbriae in E. coli
which is mediated by the tyrosine family recombinases
FirnBE (Abraham et al., 1985).
To test the hypothesis that orientation of these regions,
with respect to the downstream PS biosynthesis operons,
controls variation of different PSs associated with sub-
populations that are definable using mAbs, a series of
experiments were carried out using 'orientation-specific'
PCR primers. Primer pairs (Table 1) were designed such
that the PCR product would bridge the right end of the
invertible region. A product from primer pair A and C
would be obtained when the proposed B. fragilis consensus
promoter (Bayley et al., 2000) within the invertible region
(Fig. 1) was in the correct orientation with respect to the
PS biosynthesis operon ('on' position); a product from
primer pair B and C would be expected when in the oppo¬
site orientation ('off position). Populations enriched for
reactivity with mAbs QUBF5, 6 and 7 by immunofluore¬
scence microscopy were prepared; a QUBF5-enriched
population is illustrated in Fig. 3. Each of these mAbs
reacts with antigenically variable epitopes associated with
both the LC and non-capsulate/EDL phases. After PAGE
and immunoblotting, these mAbs label HMMPS with
associated ladder patterns characteristic of heteropoly-
meric PS with repeating units (Lutton et al., 1991). QUBF7
reacts with PS C (Coyne et al., 2000) which lacks an
invertible region upstream of the biosynthesis locus. mAb
QUBF5 reacts with an HMMPS with a larger ladder step-
size pattern after PAGE and immunoblotting than QUBF6
and 7 (Lutton et al., 1991) (Fig. 4). Primer pairs 1A/C and
5A/C yielded a product with populations enriched for
mAbs QUBF6 and 5, respectively (Fig. 5). None of the
other A/C primer pairs yielded a similar product for these
populations. As the enriched populations contain low
1 2 3
Fig. 4. Immunoblots of proteinase K extracts from B. fragilis
NCTC 9343 after PAGE reacted with mAbs QUBF5 (lane 1),
QUBF6 (lane 2) and QUBF7 (lane 3).
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On Off On Off On Off On Off On Off On Off On Off
fin fin 1
mAb
QUBF5 98 100 1 3 2 2 2 6
QUBF6 1 2 <1 8 7 100 1 00 100 100
QUBF7 9 10 100 98 99 5 4 17 7
Fig. 5. PCR products, obtained from B. fragilis NCTC 9343 non-capsulate/EDL phase populations enriched for QUBF5,
QUBF6 or QUBF7 antigenic phenotype, using primer pairs for PS biosynthesis loci 1 and 5 designed to detect fragilis
invertible (fin) regions in the 'on' or 'off position with respect to PS expression. Note products in the 'on' position for primer
pairs for locus 1 and QUBF6-enriched, and locus 5 and QUBF5-enriched (arrows). Lanes 1 and 24, standards starting from
the bottom at 100 bp with 100 bp increments. The numbers underneath each lane show the proportion (percentage enriched)
of populations labelled with mAbs QUBF5, QUBF6 and QUBF7 as determined by immunofluorescence microscopy.
proportions of bacteria positive for other epitopes (Fig. 5),
PCR product was sometimes obtained in the 'on' position
from populations enriched for another epitope. For example,
where 7-8% of the population enriched for reactivity to
mAb QUBF7 also reacted with mAb QUBF6, some PCR
product was obtained from primer pairs 1A/C, although
this was considerably less than the product from primers
1B/C (Fig. 5). The antigenic variation of the Bf5 FiMMPS
could explain the conflicting literature concerning the
presence or absence of an 'O-antigen' in B. fragilis (Patrick,
2002).
Sequencing of the PCR products confirmed the sequence
of the right end of the invertible region and showed that
the inner half-sites of the fixR inverted repeats (i.e. the half-
site that 'flips' during recombination within the inverting
DNA) were in opposite orientations in the 'on' and 'off
positions and confirmed that site-specific recombination
had occurred. This pattern of PCR product was observed
for both non-capsulate/EDL and LC phases enriched for
the different mAb epitopes. This suggests that the phase
change associated with LC formation is not controlled by
these loci. A minimum of three separate populations
enriched for each phenotype was examined. Comparison















Fig. 6. Alignment of top-strand right-hand of fix1-7 with 19 bp
invertible regions (PS A-H) proposed by Krinos et al. (2001
supplementary data Table 1, available on-line). Central dinucleo-
tides of fixR are in lower case.
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correspond with PS E and PS D designated by Krinos et al.
(2001) who suggested that the invertible repeat associated
with the control of PS expression was 19 bp in length and of
identical sequence in four of the seven regions (Krinos et al.,
2001 supplementary data Table 1, available on-line). The
position of the 19 bp repeat relative to the suggested 30 bp
repeat is illustrated in Fig. 6. There is a variable gap between
the 19 bp repeat element and the consensus promoter
(Bayley et al., 2000) sequence situated within the invertible
region, whereas the fixL repeat consistently overlaps the
consensus promoter (Fig. 1). The asymmetry in the PS1 fix
sites would result in the generation of different sequences if
the DNA was cut in the 19 bp region rather than the 30 bp
palindromic sequence. Examination of the sequences of the
PCR product of PS 1 revealed a sequence consistent with the
DNA inversion occurring as a result of a double-stranded
DNA cut in the centre of the 30 bp (not illustrated). These
sequence data were obtained with two replicate enriched
populations on two separate occasions.
S. typhimurium H flagellar antigen invertase (Hin)-
mediated DNA inversion occurs within a topologically
defined synapse and proceeds by a concerted pair of
double-stranded staggered cuts, at the central dinucleo-
tides of each recombination site, catalysed by nucleophilic
attacks mediated by the active site serine from each of the
four monomers within the synapse (Heichman et al., 1991).
Binding specificity for Hin resides in 4 amino acid residues,
invariant amongst the enteric invertases, that interact with
base pairs through both the major and minor grooves of
the recombination half-site (Feng et al., 1994). Important
base pair interactions mediated by helix 3, within the
helix-turn—helix structural motif, through the major
groove, include Serl74 with A10 and Argl78 with G9.
Hin recognition is highly sensitive to alterations at either
of these base pairs (Hughes et al., 1992). These bases are
highly conserved within the left half-sites of all proposed
fix recombination sites, but are more variable in the right
half-sites (Fig. 2a). Interactions of Hin with the minor
groove of hixL involve Argl40 with A —6, Glyl39 with T
5, Lys 187 with T —12 and Asnl90 with T —10 and A 10.
All these base pairs are conserved within the putative fix
recombination sites. This suggested that the fix DNA
sequences would interact with recombinases related to the
enteric invertase family. Two strong candidates for invert¬
ases have been located in B. fragilis NCTC 9343. Fragilis
invertase (Fin)A is similar to E. coli transposon Tn2I
resolvase TnpR (30-6% identity in 196 aa) and FinB is
homologous to S. typhimurium Hin (46-6% identity in
191 aa). An alignment of FinA, FinB and Hin amino acid
sequences is presented in Fig. 7. In addition to these, there
are 21 proteins belonging to the 'phage integrase' family,
which includes the recombinases xerCID and fimB/E,
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Fig. 7. Alignment of amino acid sequences
of FinB, S. typhimurium Hin and FinA gener¬
ated by CLUSTAL X. The active site residue
and helix-turn-helix motif, inferred from Hin,
are marked with an asterisk and a bar,
respectively.
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further members of the resolvase family and one protein
with weak similarity to the Moraxella pilin inverting gene
piv. FinB is encoded on a B. fragilis NCTC 9343 36-5 kbp
closed circular plasmid (unpublished).
To investigate the hypothesis that the observed inversions
might be mediated by a member of the enteric resolvase/
invertase family, we partially purified both FinA and FinB as
N-terminal fusions to the MBP. A 263 bp DNA fragment
that corresponded to the invertible finl region was then
used to assess the binding specificity of each invertase to the
recombination sites. Fig. 8 demonstrates that increasing
concentrations of FinB-MBP gave rise initially to a single
protein/DNA complex (complex 1) that was eventually
converted to a slower migrating complex (complex 2). Based
on the documented attributes of the serine family of site-
specific recombinases to either form dimers in solution or
bind cooperatively to DNA as dimers (Spaeny-Dekking
et al., 1995; Blake et al., 1995), one simple interpretation of
the binding pattern (Fig. 8) is that a dimer of FinB-MBP was
bound at either fix1L or fix1R to generate complex 1 and that
at higher protein concentrations both recombination sites
were occupied to give rise to complex 2. The relative





Fig. 8. Autoradiogram of in vitro binding between B. fragilis
FinB-MBP and DNA, corresponding to the invertible fixl region,
analysed by gel retardation. Radiolabeled fixl DNA was incu¬
bated with increasing concentrations of FinB-MBP. Lanes: 1,
no FinB-MBP; 2-6, increasing concentrations of FinB-MBP.
that interactions between these complexes are not coopera¬
tive. Further analysis of the binding specificities and
stoichiometry of FinB present in higher order complexes
such as complex 2, however, is required to distinguish
between dimer binding or formation of synaptic inter¬
mediates. FinB-MBP is also able to bind to a single
recombination site derived from the fix5 locus, while the
MBP fusion to FinA did not show binding to either
invertible fixl or fix5 region (data not shown).
Together these data show that expression of a significant
number of PS biosynthetic operons in B. fragilis is directly
regulated by a DNA site-specific recombination inversion
that appears to involve a newly identified member of the
resolvase/invertase family. Whether the observed level of
reversible variation of PS expression reflects the ability of
B. fragilis to colonize the hostile environment of the human
host as an opportunistic pathogen, as a member of the
normal intestinal microbiota or both, remains to be deter¬
mined. Variation of the surface PSs in B. fragilis undoub¬
tedly occurs during natural infection by B. fragilis. Direct
examination of pus drained from abdominal, perianal,
ischiorectal, pilonidal, vaginal, Bartholin's, diverticular,
colostomy, groin and neoplasm abscesses as well as blood
culture bottles and labelled with six different PS-specific
mAbs, revealed diverse labelling patterns. No single PS or
group of PSs could be related to infection at one particular
site (Patrick et al., 1995b).
The evolutionary origin of the B. fragilis recombination
sites remains open to speculation, although it has been
suggested that the Hin system in Salmonella arose as a
result of integration of a Mu-like phage (van de Putte 8c
Goosen, 1992). The Bacteroidetes diverged early, in evolu¬
tionary terms, from other eubacteria, well before the
divergence of the Gram-positive bacteria from the phylum
Proteobacteria which contains the majority of Gram-
negatives such as the enteric bacteria, E. coli and the
pseudomonads (Woese, 1987). Given the relatively
limited number of other examples of reversible variation
in pathogenic bacteria arising by DNA inversion, it may
be that the high number of invertible sequences in
B. fragilis reflects this early evolutionary divergence. The
presence of the invertase gene, which may be responsible
for controlling variable expression of multiple chromo¬
somal loci, on a plasmid also raises a number of interest¬
ing evolutionary questions. For example, did the plasmid
introduce the invertase gene or did it acquire the gene as a
mechanism to ensure maintenance?
In conclusion, the putative recombination sites involved
in the unprecedented level of DNA inversion observed
in B. fragilis show striking similarity to those of the
S. typhimurium Hin and related systems and appear to
involve a plasmid-borne Hin-like invertase, FinB, which
we have demonstrated binds to the invertible regions. We
therefore propose that the invertible regions in B. fragilis
are designated fin regions and the inverted repeats fixL
or fixR.
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Abstract
Failure to treat and eradicate prosthetic hip infection with systemic antibiotic regimens is usually due to the fact that the infection
is associated with biofilm formation and that bacterial cells growing within a biofilm exhibit increased resistance to antimicrobial
agents. In this in vitro study, we investigated the susceptibility of prosthetic hip Propionibacterium acnes and Staphylococcus spp.
isolates growing within biofilms on polymethylmethacrylate (PMMA) bone cement to a range of antibiotics. All P. acnes isolates in
the biofilm mode of growth demonstrated considerably greater resistance to cefamandole, ciprofloxacin and vancomycin. In
contrast, only four of the eight P. acnes isolates demonstrated an increase in resistance to gentamicin. All ten Staphylococcus spp.
isolates in the biofilm mode of growth exhibited large increases in resistance to gentamicin and cefamandole with eight of the ten
isolates also exhibiting an increase in resistance to vancomycin. However, only three of the ten Staphylococcus spp. isolates exhibited
an increase in resistance to ciprofloxacin. Biofilms were also formed on three different titanium alloys and on PMMA bone cement
using P. acnes, Staphylococcus epidermidis and Staphylococcus aureus strains to determine if the underlying biomaterial surface had
an effect on biofilm formation and the antimicrobial susceptibility of the bacteria growing within biofilms. Although differences in
the rate at which the three strains adhered to the different biomaterials were apparent, no differences in biofilm antibiotic resistance
between the biomaterials were observed. In the light of these results, it is important that the efficacy of other antibiotics against
P. acnes and Staphylococcus spp. prosthetic hip isolates growing within biofilms on orthopaedic biomaterials be determined to
ensure optimal treatment of orthopaedic implant infection.
© 2003 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Although total hip replacement has become common¬
place in recent years, bacterial infection remains a
significant complication following this procedure. In a
recent study, in which we combined mild ultrasonication
to dislodge the bacteria growing within adherent
biofilms on the surface of the removed prosthesis with
the use of strict anaerobic techniques, we cultured
bacteria from 26 of 120 (22%) retrieved prostheses [1].
'Corresponding author. Tel.: + 44-28-902-7208-7; fax: + 44-28-902-
4779-4.
E-mail address: m.tunncy@qub.ac.uk (M.M. Tunney).
1 Current address: Department of Biological Sciences, University of
Calgary, 2500 University Drive, NW, Calgary, Alberta, T2N 1N4,
UK.
Sixteen of the 26 implants (62%) were infected by the
anaerobic bacterium, Propionibacterium acnes, either as
the single infecting organism (12 implants) or in
combination with a Gram-positive coccus (four im¬
plants). The results of our study demonstrated for the
first time that P. acnes, which when previously isolated
had been disregarded as a skin contaminant, is
associated with chronic low-grade infection of
implanted biomaterials as frequently as Staphylococcus
spp.
Attempts to treat prosthetic hip infections using
systemic antibiotics usually fail as the infecting bacteria
grow predominantly within a confluent biofilm on the
surface of the prosthesis, rendering them resistant to
currently employed antibiotics. Although previous
studies have examined the antimicrobial susceptibility
0142-9612/03/$-see front matter © 2003 Elsevier Science Ltd. All rights reserved,
doi: 10.1016/S0142-9612(03)00173-X
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of Staphylococcus epidermidis [2,3] and Staphylococcus
aureus [2,4,5] biofilms formed on orthopaedic biomater¬
ials and determined the antimicrobial susceptibility of
planktonically grown P. acnes strains isolated from
retrieved orthopaedic implants [6], there is a lack of
detail with regard to P. acnes biofilm formation. To
date, no studies have examined either the formation of
P. acnes biofilms on orthopaedic biomaterials or
determined the antimicrobial susceptibility of P. acnes
strains growing within biofilms.
In this study we investigated P. acnes and Staphylo¬
coccus spp. biofilm formation on polymethylmethacry¬
late (PMMA) bone cement and titanium alloys and
determined the susceptibility of these biofilms to a range
of antimicrobial agents.
2. Materials and methods
2.1. Bacterial strains
Fourteen of the 18 clinical prosthetic hip isolates used
in this study (HJ1 to HJ14, Table 2) were isolated as
described previously [1], with a further four P. acnes
strains (L671, LI49, LI958, CK77) which had also been
isolated from prosthetic joints kindly supplied by
Dr. Carl Kamme, University of Lund, Sweden.
2.2. Antimicrobial agents
The following antimicrobial agents were used: Gen-
tamicin sulphate (Sigma Chemical Co. Dorset, UK);
cefamandole naftate as Kefadol® (Dista Products Ltd,
Basingstoke, UK); ciprofloxacin as Ciproxin11 (Bayer
pic, Newbury, UK) and vancomycin as Vancocin®
(Eli Lilly and Company Ltd, Basingstoke, UK).
2.3. Biomaterials
Palacos R® PMMA bone cement (Schering-Plough,
Herts, UK) was prepared in accordance with the
manufacturer's instructions by mixing the powdered
methylmethacrylate with the liquid monomer in a bowl
using a spatula. The cement mixture was immediately
placed between two glass plates covered with non-
adhesive backing paper (Scotch Pak, 3M, France),
which were pressed together to form a sheet of cement
approximately 1 mm thick. Following hardening of the
cement, 1 cm2 sections were cut with a sterile scalpel
blade and stored under dark, sterile conditions at room
temperature. Three different titanium-aluminium-
vanadium (Ti-6A1-4V) alloys with variable surface
roughness were provided in the form of alloy discs
(3.5 cm diameter) by Johnson and Johnson Medical,
Ascot, UK. These were: titanium alloy 1 (TA1), 36 grit
A102 blast; titanium alloy 2 (TA2), 36 grit A1Q2 and wet
ceramic bead blast; titanium alloy 3 (TA3), 24 grit A102
and wet ceramic bead blast. TA2 was the smoothest of
the three surfaces followed by TA1 and TA3 in order of
increasing roughness.
2.4. In vitro development of bacterial biofilms
For comparison of biofilm formation on the four
different biomaterials, one isolate from each of three
major bacterial species which have been previously
shown to cause prosthetic hip infection [1] (P. acnes [HJ
4], S. epidermidis [HJ 5] and S. aureus [HJ 9]) was
selected. An overnight culture of the P. acnes strain
which had been grown on anaerobic horse blood agar
(ABA) at 37°C in an anaerobic chamber was suspended
in pre-reduced cation-supplemented Mueller-Hinton
broth (CSMHB, Unipath Ltd, Basingstoke, UK) at an
inoculum density of approximately 1 x 108cfu/ml. The
inoculum for S. epidermidis and S. aureus was prepared
by adding an aliquot (10 ml) of an overnight culture to
fresh pre-warmed CSMHB (100 ml) and incubating at
37°C in an orbital incubator for 4-6 h until the
exponential growth phase had been reached. This
culture was then adjusted by spectrophotometric mea¬
surement to provide a final inoculum density of
approximately 1 x 108cfu/ml. Bacterial biofilms were
formed by adding 5 and 25 ml of the final inoculum for
each test strain to bottles containing PMMA sections
and titanium alloy discs, respectively. Samples were
subsequently incubated at 37°C for 0.5, 1, 2, 3, 4, 6, 8 or
18 h either aerobically (S. epidermidis, S. aureus) or
anaerobically (P. acnes). Following biofilm formation
the biomaterial samples were removed with sterile
forceps and gently washed by the addition of sterile
phosphate-buffered saline (PBS) three times to remove
any non-adherent bacteria. The biomaterial samples
were then placed in PBS and bacteria retained on the
biomaterial dislodged by mild ultrasonication (5 min) in
a 150W ultrasonic bath operating at a nominal
frequency of 50 Hz followed by rapid vortex mixing
(30 s). Serial ten-fold dilutions were performed and
viable counts estimated following the Miles and Misra
drop plate count method [7]. After overnight incubation,
the number of colony forming units on each biomaterial
sample were counted and expressed relative to the
surface area of the biomaterial sample (cfu/cm2). All
experiments were performed in triplicate with three
samples of each biomaterial at each time point and the
mean values were calculated.
2.5. Bactericidal activity ofantibacterials against biofilm-
grown cells
To test the bactericidal activity of antibiotics against
the biofilm cells grown on different biomaterial sub¬
strates, the PMMA bone cement and titanium alloy
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samples were incubated with the three selected test
isolates (P. acnes [HJ 4], S. epidermidis [HJ 5] and
S. aureus [HJ 9]) used for the formation of biofilms
described above at 37°C for 18 h. The samples were then
removed, washed by the addition of sterile PBS three
times to remove any non-adherent bacteria and trans¬
ferred to a series of doubling dilutions of a given
antibiotic (8-1024 pg/ml) in CSMHB and incubated at
37°C for 24 h. Antibiotic-free controls were included for
each biomaterial. Following incubation, the biomaterial
samples were removed, washed, sonicated and the total
viable count following antibiotic treatment determined
as described previously. Sessile minimum bactericidal
concentrations (MBCs) were determined as the lowest
concentration of antibiotic giving a 99.9% reduction in
viable cells (cfu/cm2) on a biomaterial compared to the
number of cfu/cm2 on the antibiotic-free control.
The bactericidal activity of the selected antibacterial
agents against the remaining 15 prosthetic hip isolates
was determined as described above, following the
formation of biofilms using PMMA bone cement as
the biomaterial substrate.
Planktonic MBCs of all the isolates had been
determined previously following evaluation of the
planktonic MICs using the broth microdilution method
[6,8]. In brief, aliquots from wells in the microdilution
trays were plated out and after overnight incubation the
planktonic MBC was defined as the lowest antibiotic
concentration that produced greater than 99.9% killing
of the initial inoculum.
2.6. Statistical analysis
Statistical analysis was performed using two-way
analysis of variance to determine if biomaterial surface
and time had a significant effect on bacterial adherence.
P<0.05 denotes significance (Statview, Abacus Con¬
cepts Inc., CA, USA).
3. Results
Adherence of the three selected prosthetic hip isolates
to the four different biomaterials are shown in Fig. 1.
Analysis of variance of the results obtained showed that
both biomaterial surface and time exerted a significant
effect on adherence of the isolates to the biomaterials.
Significant differences were observed in the adherence of
P. acnes to each of the biomaterials. P. acnes adherence
to TA1 was greater than to the other three biomaterials
during the initial 3h period. However, at 4 and 6h,
adherence to PMMA was greater than adherence to the
other biomaterials but at 8 and 18 h adherence of
P. acnes was again greatest to TA1. Significant
differences were also observed in the adherence of S.
epidermidis to each of the biomaterials with S. epidermi¬
dis adherence to TA1 significantly greater than adher¬
ence to the other biomaterials after 18 h. In contrast to
the results for P. acnes and S. epidermidis, where
adherence to each of the biomaterials was significantly
different, significant differences in adherence of S.
aureus were only observed between PMMA and the
titanium alloys with no differences in adherence
observed between the titanium alloys.
The sessile MBCs for the three representative
prosthetic hip isolates growing on the four different
biomaterial surfaces are shown in Table 1. The
planktonic MBCs determined previously [6,8] are also
shown for comparative purposes. Differences in the
biomaterial surface on which the bacteria were grown
did not appear to have an effect on antibiotic resistance
with all sessile MBC values for a given antibiotic and
test isolate being similar to within one dilution for all
four biomaterials.
The sessile MBCs of all 18 isolates grown on PMMA
are shown in Table 2. The planktonic MBCs determined
previously [6,8] are also shown for comparative pur¬
poses. Four of the eight P. acnes isolates tested showed
no increase in resistance to gentamicin when in the
biofilm mode of growth. The remaining four isolates
showed either a two- or four-fold increase in resistance.
In contrast, all of the P. acnes isolates in the biofilm
mode of growth exhibited considerably greater resis¬
tance to cefamandole, ciprofloxacin and vancomycin.
All 10 Staphylococcus spp. isolates tested were consider¬
ably more resistant to gentamicin and cefamandole
when growing in a biofilm. Similarly, eight of the ten
isolates also showed an increased resistance to vanco¬
mycin when growing in a biofilm. In contrast, seven of
the ten isolates tested showed no increase in resistance to
ciprofloxacin when growing in a biofilm.
4. Discussion
This study is the first to describe the formation of
P. acnes biofilm on different orthopaedic biomaterials
and to determine the susceptibility of biofilm-grown
P. acnes to a range of antimicrobial agents. The three
titanium alloys compared were of the same chemical
composition, but all possessed a different surface finish
and, therefore, a different surface roughness. The
differences in surface finish of the alloys were based on
different regions of the femoral component of a
prosthetic hip, which are related to aiding tissue
integration and the biocompatibility of the prosthesis.
P. acnes, S. epidermidis and S. aureus strains that had
been isolated from retrieved prosthetic hip implants
formed biofilms on PMMA and on the three titanium
alloys. With the exception of 5". aureus, which adhered in
similar numbers to each of the three titanium alloys,
differences in the biomaterial surface did have an effect










































Fig. 1. Adherence of prosthetic hip isolates to biomaterials: (A) P. acnes; (B) S. epidermidis; and (C) S. aureus.
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Table 1
Sessile minimum bactericidal concentrations of three prosthetic hip isolates grown on four different biomatcrials
Strain and antibiotic MBC" (pg/ml) for MBC (pg/ml) for bacteria adherent to
planktonic bacteria
PMMA TA1 TA2 TA3
P. acnes (HJ 4)
Gentamicin 16 32 16 16 32
Cefamandole <0.5 > 1024 > 1024 > 1024 > 1024
Vancomycin 32 > 1024 > 1024 > 1024 > 1024
Ciprofloxacin 16 512 1024 1024 1024
S. epidermic/is (HJ 5)
Gentamicin 128 > 1024 > 1024 > 1024 > 1024
Cefamandole 1 1024 512 1024 512
Vancomycin 32 32 32 32 32
Ciprofloxacin 32 32 32 32 32
S. aureus (HJ 9)
Gentamicin 32 64 64 64 64
Cefamandole 64 > 1024 > 1024 > 1024 > 1024
Vancomycin 16 > 1024 > 1024 > 1024 > 1024
Ciprofloxacin 8 256 512 512 512
0 Minimum Bactericidal Concentration.
Table 2
Minimum bactericidal concentrations of prosthetic hip isolates grown on polymethylmethacrylate
Strain Gentamicin Cefamandole Vancomycin Ciprofloxacin
PMBC" SMBCb PMBC SMBC PMBC SMBC PMBC SMBC
(pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml) (pg/ml)
P. acnes strains
HJ 1 32 32 1 >1024 32 > 1024 8 512
HJ 2 32 32 <0.5 512 8 512 16 512
HJ 3 32 32 <0.5 > 1024 16 > 1024 16 256
HJ 4 16 32 <0.5 > 1024 32 > 1024 16 512
L671 32 128 4 > 1024 8 > 1024 16 512
L149 16 64 2 > 1024 8 > 1024 4 1024
L1958 32 64 1 256 1 > 1024 8 512
CK77 32 32 1 > 1024 32 >1024 4 512
5. epidermidis
HJ 5 128 > 1024 1 1024 32 32 32 32
HJ 6 I 128 1 64 16 > 1024 16 16
HJ 7 32 > 1024 128 > 1024 32 1024 1 32
HJ 8 128 > 1024 4 > 1024 32 32 0.5 0.
S. aureus (HJ 9) 32 64 64 > 1024 16 > 1024 8 256
S. hominis (HJ 10) 2 16 1 8 16 512 32 32
S. capitis (HJ 11) 64 256 16 64 32 64 16 16
S. haemolylicus (HJ 12) 256 512 64 >1024 1 > 1024 4 4
S. sciuiri (HJ 13) 16 > 1024 1 >1024 32 1024 32 64
Micrococcus sp. (HJ 14) 32 128 8 > 1024 1 > 1024 2 2
"Planktonic minimum bactericidal concentration.
b Sessile minimum bactericidal concentration.
on adherence of the isolates. These results are similar to
the results of previous studies, which also reported
differences in adherence of S. epidermidis and S. aureus
to orthopaedic biomaterials [9,10], Differences in both
the adhesins expressed by the different bacteria and
biomaterial surface characteristics such as surface
energy, hydrophobicity, roughness and chemical com¬
position can affect bacterial adherence to a biomaterial
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and may be responsible for the differences in adherence
described in this study. However, despite the fact that
bacterial adherence to each of the biomaterial surfaces
was significantly different, differences in biomaterial
surface did not have an effect on the antimicrobial
resistance of the three isolates growing within a biofilm,
with few differences in sessile MBC apparent between
different biomaterials. These results which indicate that
once the initial biofilm has formed, the surface
characteristics of the underlying biomaterial does not
influence antibiotic resistance contrast with results
from previous studies which reported that bacterial
biofilm resistance to antibiotics was biomaterial specific
[11-13],
The susceptibility of a number of additional P. acnes
and Staphylococcal spp. prosthetic hip isolates growing
in a biofilm on PMMA to a range of antimicrobial
agents was also determined. The antibiotics studied were
gentamicin, which is currently mixed with bone cement
used for prosthesis fixation at the time of revision
surgery, cefamandole, which is routinely used peropera-
tively during revision surgery and ciprofloxacin and
vancomycin, which were shown to be most effective
against the prosthetic hip isolates growing planktoni-
cally [6]. The high levels of gentamicin resistance
determined previously [6,8] amongst planktonically
grown Staphylococcus spp. strains may be due to the
fact that gentamicin bone cement was used to fix in place
the majority of implants from which the strains were
isolated. Following the initial release of high levels of
gentamicin from the bone cement, the subsequent low-
level release of sub-inhibitory concentrations of genta¬
micin could have caused an increase in resistance to
gentamicin amongst strains. In general, the results of
this study which showed that bacteria growing within
biofilms were highly resistant to the antibiotics tested are
in accordance with results from previous studies
examining the antimicrobial susceptibility of S. aureus
and S. epidermidis biofilms [14,15]. All Staphylococcus
spp. isolates tested exhibited large increases in resistance
to gentamicin when growing in a biofilm. In contrast,
biofilm-grown P. acnes exhibited either no or a minimal
increase in resistance to gentamicin. Gentamicin resis¬
tance of sessile Staphylococcus spp. has also been
previously observed by Chuard et al. [14] who demon¬
strated that sessile 5". aureus isolates were considerably
more resistant to gentamicin than the same isolates
growing planktonically. Both the P. acnes and Staphy¬
lococcus spp. isolates demonstrated greatly increased
resistance to cefamandole and vancomycin when grow¬
ing in a biofilm. Previous studies have reported that
vancomycin is unable to eradicate S. epidermidis
growing within a biofilm [16] and suggested that this
may be because as the drug enters the biofilm it is
trapped in the glycocalyx and, therefore, does not reach
the cell. Ciprofloxacin was the most effective antibiotic
tested against Staphylococcus spp. prosthetic hip iso¬
lates, with seven of the ten isolates tested showing no
increase in resistance to ciprofloxacin when growing in a
biofilm. Earlier studies have reported that ciprofloxacin
can be used effectively to eradicate bacterial biofilms
[17,18]. It may, therefore, be a suitable pre-, per- and
post-operative systemic antibiotic, both for prophylaxis
and in the direct treatment of prosthetic joint infection
caused by Staphylococcus spp. However, eradication of
established P. acnes biofilms with ciprofloxacin is more
problematic with all of the P. acnes isolates showing an
increase in resistance when growing in a biofilm. At
present, there is insufficient information available
regarding the antimicrobial susceptibility of planktonic
and biofilm-grown P. acnes and further studies are
required in this area.
In conclusion, this in vitro study has shown for the
first time that P. acnes is capable of forming bacterial
biofilms on orthopaedic biomaterials and that the
antimicrobial susceptibility of representative prosthetic
hip isolates growing within a biofilm is independent of
the underlying biomaterial substrate. It has also shown
that no single antibiotic is effective against both P. acnes
and Staphylococcus spp. isolates, both of which have
been shown to be causative pathogens in prosthetic hip
infection [1], Although ciprofloxacin was effective
against biofilm-grown Staphylococcus spp. and genta¬
micin effective against biofilm-grown P. acnes, it is
important that the efficacy of other antibiotics, for
example rifampicin which has been shown to have good
antistaphylococcal activity and penetrative properties,
be determined to ensure optimal treatment of orthopae¬
dic implant infection.
Acknowledgements
M.M. Tunney and the work were funded by the
Arthritis Research Campaign of the United Kingdom
(Project Grant Number P0522); G. Ramage was funded
by a Department of Education for Northern Ireland
Research Studentship.
The technical assistance of Stef McGrath, School of
Pharmacy, The Queen's University of Belfast, is grate¬
fully acknowledged.
References
[1] Tunney MM, Patrick S, Gorman SP, Nixon JR. Anderson N,
Davis RI, et al. Improved detection of infection in hip
replacements—a currently underestimated problem. J Bone Jt
Surg 1998;80:568-72.
[2] Chang CC, Merritt K. Microbial adherence on poly(methy!
methacrylate) (PMMA) surfaces. J Biomed Mater Res 1992;
26:197-207.
G. Ramage et al. / Biomaterials 24 (2003) 3221-3227
[3] Henry SL, Galloway KP. Local antibacterial therapy for the
management of orthopaedic infections. Pharmacokinetic consid¬
erations. Clin Pharmacokinet 1995;29:36-45.
[4] van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC,
Busscher HJ. Gentamicin release from polymethylmethacrylate
bone cements and Staphylococcus aureus biofilm formation. Acta
Orthop Scand 2000;71:625-9.
[5] van dc Belt H, Neut D, Schenk W, van Horn JR, van Dcr Mei
HC, Busscher HJ. Staphylococcus aureus biofilm formation on
different gentamicin-loaded polymethylmethacrylate bone ce¬
ments. Biomaterials 2001;22:1607-11.
[6] Tunncy MM, Ramagc G, Patrick S, Nixon JR, Murphy PG,
Gorman SP. Antimicrobial susceptibility of bacteria isolated from
orthopedic implants following revision hip surgery. Antimicrob
Agents Chemother 1998;42:3002-5.
[7] Hedges AJ, Shannon R, Hobbs RP. Comparison of the precision
obtained in counting viable bacteria by the spiral plate maker, the
droplette and the Miles & Misra methods. J Appl Bacteriol 1978;
45:57-65.
[8] Tunney MM, Ramage G, Patrick S, Gorman SP, Nixon JR.
Antimicrobial susceptibility of prosthetic hip isolates growing
within bacterial biofilms. In: Program and Abstracts of the British
Pharmaceutical Conference, Glasgow, UK, 2001. p. 111.
[9] Gracia E, Fernandez A, Conchello P, Lacleriga A, Paniagua L,
Serai F, Amorena B. Adherence of Staphylococcus aureus slime-
producing strain variants to biomaterials used in orthopaedic
surgery. Int Orthop 1997;21:46-51.
[10] Oga M, Sugioka Y, Hobgood CD, Gristina AG, Myrvik QN.
Surgical biomaterials and differential colonization by Staphylo¬
coccus epidermidis. Biomatcrials 1988;9:285-9.
[11] Gristina AG. Jennings RA, Naylor PT, Myrvik QN, Webb LX.
Comparative in vitro antibiotic resistance of surface-colonizing
coagulase-negative staphylococci. Antimicrob Agents Chemother
1989;33:813-6.
[12] Naylor PT, Myrvik QN, Gristina A. Antibiotic resis¬
tance of biomaterial-adherent coagulase-negative and
coagulase-positive staphylococci. Clin Orthop 1990;261:
126-33.
[13] Webb LX, Holman J, de Araujo B, Zaccaro DJ, Gordon ES.
Antibiotic resistance in staphylococci adherent to cortical bone.
J Orthop Trauma 1994;8:28-33.
[14] Chuard C, Vaudaux P, Waldvogcl FA, Lew DP. Susceptibility of
Staphylococcus aureus growing on fibronectin-coated surfaces to
bactericidal antibiotics. Antimicrob Agents Chemother
1993;37:625-32.
[15] Prosser BL, Taylor D, Dix BA, Cleeland R. Method of evaluating
effects of antibiotics on bacterial biofilm. Antimicrob Agents
Chemother 1987;31:1502-6.
[16] Polonio RE, Mermel LA, Paquette GE, Sperry JF. Eradication of
biofilm-forming Staphylococcus epidermidis (RP62A) by a combi¬
nation of sodium salicylate and vancomycin. Antimicrob Agents
Chemother 2001;45:3262-6.
[17] Goto T, Nakame Y, Nishida M, Ohi Y. In vitro bactericidal
activities of beta-lactamases, amikacin, and fluoroquinolones
against Pseudomonas aeruginosa biofilm in artificial urine.
Urology 1999;53:1058-62.
[18] Preston CAK, Khoury AE, Reid G, Bruce AW, Costerton JW.
Pseudomonas aeruginosa biofilms are more susceptible to
ciprofloxacin than tobramycin. Int J Antimicrob Agents 1996;
7:251-6.
47
McLorinan GC, Glenn JV, McMullan MG and Patrick S.
2005.
Propionibacterium acnes wound contamination at the time of spinal surgery.
Clinical Orthopaedics and Related Research 437, 76-73.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
Number 437, pp. 67-73
© 2005 Lippincott Williams & Wilkins
Propionibacterium acnes Wound Contamination at the
Time of Spinal Surgery
Gregory C. McLorinan, MRCS*; Josephine V. Glenn, PhD*; Michael G. McMullan, MRCSf;
and Sheila Patrick, PhD*
Bacteria of the normal skin microbiota such as Propionibac¬
terium acnes and coagulase-negative staphylococci often are
dismissed as contaminants when detected in clinical samples.
Propionibacterium acnes is described as a cause of spinal
infection and more recently has been linked to sciatica. To
date no researchers formally have examined the incidence of
bacterial wound contamination during spinal surgery. Sur¬
gical specimens were removed from 79 patients having spinal
surgery for analysis using agar culture detection, broth en¬
richment, and immunofluorescence microscopy. Bacteria
were identified in 29.1% of skin samples, 21.5% of tissue
samples and 16.5% of washings retrieved from operative
wounds. Propionibacterium acnes was identified more fre¬
quently than Staphylococcus spp in each of the three sample
types. Bacteria were detected using enrichment in 9 (11%)
patients and using fluorescence microscopy in 15 (19%). The
results of immunofluorescence microscopy suggest that Pro¬
pionibacterium acnes detected in wounds originates from pa¬
tient skin. Bacteria from contaminated wounds appeared as
single cells using fluorescence microscopy; however previous
work shows that bacteria from infected hip prosthesis are
observed as large aggregates. Therefore, it is suggested that
immunofluorescence microscopy is a useful tool to help dis¬
criminate between surgical contamination and infection.
Level of Evidence: Diagnostic study, Level I (prospective
study). See the Guidelines for Authors for a complete de¬
scription of levels of evidence.
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Propionibacterium acnes is an anaerobic gram-positive
diphtheroid bacterium that forms part of the resident skin
microbiota. Propionibacterium acnes has two distinct phe-
notypes, known as Types I and II.13 The phenotypes are
distinguished by serologic agglutination tests and cell wall
sugar analysis. Propionibacterium acnes has become in¬
creasingly recognized as an important pathogen not only in
acne,3'11'21 but in medical-device,2 dental,6 ocular,20 and
neurosurgical infections,10 and also has been linked to
synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO)
syndrome14 and even sarcoidosis.8 It has been reported
previously that there is a strong association between P.
acnes and failed prosthetic hip implants.23'24
Despite the increasing recognition of P. acnes as a
pathogen, its presence in clinical samples, especially those
from orthopaedic sources, might result from simple con¬
tamination. For example, sampling of clean orthopaedic
wounds has shown a relatively high proportion of con¬
tamination by P. acnes,7 whereas salvaged intraoperative
blood from patients having primary hip arthroplasty has
revealed contamination by P. acnes and Staphylococcus
25
spp.
Propionibacterium acnes also is associated with spinal
infection. It has been isolated in cases of spinal osteomy¬
elitis and discitis.5'9'16 Stirling and colleagues suggested a
possible link between P. acnes and sciatica.22 Despite the
apparent association between P. acnes and the spine no
study to date quantifies the incidence of intraoperative
wound contamination during spinal surgery.
The primary aim of this study is to ascertain the level of
bacterial contamination of wound samples during spinal
surgery. As well as identifying the principal bacteria in¬
volved in spinal wound contamination, possible associa¬
tion between the site of surgical incision and the incidence
of bacterial contamination is examined. The usefulness of
alternative methods to bacterial detection using agar cul¬
ture, including the use enrichment broth and immunoflu¬
orescence microscopy (IFM) is assessed. Specifically we
hoped to be able to demonstrate that immunofluorescence
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microscopy permits the distinction between contamination
and infection.
The study also describes a technique used to quantify P.
acnes at different sites of the human body and also to
identify the P. acnes phenotypes at those sites. The phe-
notypes of P. acnes identified in surgical wounds are com¬
pared to the phenotypes identified on the surface of
healthy skin to help identify the possible origin of P. acnes
in the surgical wound.
MATERIALS AND METHODS
Surgical material was removed from 79 consecutive patients
having spinal surgery for a range of spinal conditions in Belfast
between August 2002 and August 2004. Surgical material was
examined for the presence of bacteria by means of agar culture,
broth enrichment and immunofluorescence microscopy. A fur¬
ther group of 10 healthy volunteers had skin swabs taken for
quantification of P. acnes at different skin sites for comparison.
The study was approved by the local ethical committee.
Surgical specimens were retrieved from 79 patients: 46
(58.2%) men and 33 (41.8%) women, with indications for sur¬
gery as follows: 50 (63.3%) having discectomy for sciatica, 12
(15.2%) having laminectomy for disc degeneration, 10 (12.7%)
having anterior correction of scoliosis, four (5.0%) having fixa¬
tion of fracture caused by trauma, and three (3.8%) having re¬
section of vertebral tumor. Metallic implants were inserted in all
patients in the scoliosis, fracture, and tumor groups. Seven
(58.3%) patients in the degeneration group had metallic implants
inserted, two (16.6%) had carbon fiber implants inserted and
three (25.0%) had no implant inserted. No implants were used in
the sciatica group. There were 56 (70.9%) lumbar incisions, 13
(16.5%) thoracic or thoracoabdominal, six (7.6%) anterior cer¬
vical and four (5.1%) midline abdominal incisions. Sixty-eight
(86.1%) were primary procedures, 10 (12.9%) were revision
surgeries, and the procedure status of one (1.3%) patient was not
known. Of the 10 patients who had revision surgeries seven
patients had removal of recurrent disc prolapse and three had
already had previous discectomy and currently were having
laminectomy for spinal stenosis. Sixteen (20.3%) patients had
previous spinal cannulation (epidural/intradural injection). Two
(2.5%) had a previous acne history, five (6.3%) were unsure, and
72 (91.1%) had no previous acne history. Four (5.1%) patients
received no prophylactic antibiotic, one (1.3%) received ce-
fadrine, four (5.1%) received erythromycin, 29 (36.7%) received
cephamandole, and 41 (51.9%) received cefuroxime. Patients
were excluded from the study if infection was suspected based
on clinical criteria. All surgery was done in a laminar airflow
theater.
Patients' skin in all cases was prepared with Betadine (Seton
Healthcare, Oldham, England) antiseptic solution. The following
samples were obtained from all patients: a sample of skin (ap¬
proximately 1 mm x 5 mm x 3 mm) was removed from the
wound edge and a piece of tissue (approximately 3 mm x 3 mm
x 3 mm) was removed from within the wound. In addition,
sterile saline (10 mL) was poured into the base of the wound and
was allowed to collect; then 10 mL of this fluid was aspirated for
culture.
The skin sample was pulped by vortex mixing with glass
beads in Vi strength Ringer's solution containing 0.05g/l L-
cysteine (QSR). Wound tissue fragments in 5 mL of QSR in
universal bottles (International Scientific Supplies Limited,
Bradford, UK) were exposed to ultrasonication for 5 minutes at
50 kHz in an ultrasound bath (Decon, 150W Model FS200B,
Decon Laboratories Limited, Hove, UK). Skin, wound, and wash
samples (0.5 mL volumes) were spread plated onto blood agar
(BA; Oxoid Ltd., Basingstoke, UK) and anaerobic blood agar
(ABA; Oxoid Ltd., Hampshire, England) plates in triplicate and
incubated either aerobically or anaerobically for 14 days as pre¬
viously described.24 Agar culture was considered positive if bac¬
teria were cultured on two of three aerobic or two of three
anaerobic agar plates. Wound samples (0.5 mL) also were added
to Robertson's cooked meat broth enrichment culture (Oxoid
Ltd.), incubated for 3 weeks, plated onto BA and ABA, and these
plates were examined after a further week. For the purposes of
analysis, agar culture was considered the reference standard with
which broth enrichment was compared. Stringent aseptic tech¬
nique was adhered to at all times and any open sample process¬
ing was done within the confines of an anaerobic workstation
(MACS MG 1000, Don Whitley Scientific, Shipley, UK) in
which a gas mixture (80% N2, 10% C02 and 10% H2) was
bubbled continuously through glutaraldehyde (2%) to prevent
aerial contamination by bacteria. Pure cultures of bacteria were
identified using commercially available biochemical test galler¬
ies (API, BioMerieux, Basingstoke, UK).
A modification of the immunofluorescence microscopy
(IFM) procedure described by Tunney et al was done on the
wound diluents.23 Three P. acnes antibodies were used. Anti¬
body QUB Palll reacts with a common antigen present on P.
acnes Types 1 and 2. Antibodies QUB Pal and QUB Pa2 react
with P. acnes Types 1 and 2 respectively. QUB PA3 cross-reacts
with some Propionibacterium granulosum, Actinomyces naes-
lundii and A. israelii isolates. These bacteria were not, however,
identified in any specimen using biochemical tests. QUB Pal
and QUB Pa2 do not react with other propionibacterium species
or a range of other related bacteria including the aerobic coryne-
forms.
Wound wash samples (1 mL) were centrifuged at 16,100 g for
15 minutes. The supernatant was removed, leaving a small pellet.
The pellet was re-suspended in 40 p.L of phosphate buffered
saline (PBS; 1.061g Na2HP04, 0.389g NaH2PO4.2H20 and 8.5g
NaCl per liter of H20). Samples (20 qL) then were applied to
multiwell slides, air-dried, and fixed in 100% methanol for 10
minutes at -20°C. The fixed material was incubated for 45 min¬
utes at 37°C with either undiluted hybridoma cell culture super¬
natant (30 p.L) containing P. acnes reactive monoclonal antibody
(QUB Pa3) or an appropriate dilution of rabbit anti-
Staphylococcus spp polyclonal antiserum (30 |xL). The primary
antibody was gently washed off and the slide immersed in a
0.01M PBS for 15 minutes. Goat antimouse or goat antirabbit
flourescein-isothiocyanate conjugate (FITC, Sigma, Poole,
UK), at 1:100 dilution in PBS (30 p,L) containing 0.02%
(volume/volume) Evans Blue (Sigma, Poole, UK) was applied to
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each well. After a further 45-minute incubation period, the slides
were again washed in PBS, mounted in glycerol-PBS containing
an anti-photobleaching agent (Citifluor, Agar Scientific Ltd,
Stansted, UK) and examined using a Leitz Dialux 20 fluores¬
cence microscope (Leitz, Wetzler, Germany).
When P. acnes was identified from more than one site of any
patient, up to three separate colonies from each site were exam¬
ined by IFM using monoclonal antibodies that react with either
Type 1 (QUB Pal) or Type 2 (QUB Pa2) P. acnes. This permit¬
ted the typing of P. acnes isolated from surgical specimens.
Skin swabs were taken from 10 healthy volunteers. Sites rep¬
resenting areas of common orthopaedic incision including skin
over the lateral aspect of the hip, lateral aspect of the chest wall,
neck, lumbar spine, and below the umbilicus were swabbed us¬
ing a sterile paper template (10 cm2). The forehead also was
swabbed for comparison. The swab tip was vortex agitated in
QSR (1.0 mL) and 0.5 mL was used to make a series of 10-fold
dilutions in QSR. Each dilution was spread plated in triplicate
onto TYG agar plates (20g/L tryptone, lOg/L yeast extract,
5 g/L glucose with 1% agar) containing 2 fig per mL furazoli¬
done (Sigma, Poole, UK) to inhibit staphylococcal growth.21
Plates were incubated anaerobically for 4 days at 37°C and
the number of colonies was recorded. Immunoreaction was
done as previously described, with minor modification.19 In
brief, nitrocelluose was blocked with 0.01 M PBS containing
0.05% (volume/volume) Tween-20 (PBS-Tween) and 5%
(weight/volume) nonfat milk powder (Marvel, Premier brands,
Spalding, UK). After washing with PBS-Tween, the nitrocellu¬
lose was incubated in undiluted MAb-containing supernatant
(QUB Pal or QUB Pa2). The nitrocelluose then was washed in
PBS-Tween before incubation with a goat anti-mouse IgG
(whole molecule) alkaline phosphatase conjugate (Sigma, Poole,
UK). Bound MAbs were detected using an alkaline phosphatase
conjugate substrate kit, containing nitroblue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate (Biorad Laboratories
Ltd., Hercules, CA). The number of each subtype of P. acnes
then was counted.
The incidence of bacterial contamination in each type of
wound was compared using Fischer's exact test. A significance
level of 0.05 was used.
RESULTS
Bacteria most frequently were cultured from skin samples
(29.1%) and less frequently from wound tissue (21.5%)
and wound wash (16.5%) (Fig 1). Staphylococcus aureus
was detected in the skin, wound tissue and wound wash of
one patient. All other Staphylococcus spp identified were
coagulase-negative staphylococci (CoNS). We found no
association between wound type (lumbar or nonlumbar)
and either detection of or particular bacteria in the skin
samples or wound wash using agar. We also found no
association between wound type and the presence of P.
acnes. Staphylococcus spp was detected more frequently
in nonlumbar wounds than other sites (p = 0.004).
D Positive culture (all bacteria)
0 Positive culture (P. acnes only)
0 Positive culture (Staphylococcus spp. only)





Fig 1. A histogram shows the bacteria detected in surgical
specimens (skin, wound tissue, and wound washings) re¬
trieved from patients having spinal surgery.
Seventeen (25.0%) of patients having primary surgery
had positive cultures from wound tissue and 13 (19.1%)
had positive cultures from wound washings. No patients
having revision surgery had positive cultures from wound
tissue or wound wash. This also was the case for the pa¬
tient of whom the revision status was not known. There
was no significant difference between revision status and
positive culture from tissue or positive culture from wound
wash.
Nine (11.4%) broth samples from the 79 patients had a
positive culture. Propionibacterium acnes was cultured in
eight (88.9%) of positive broth cultures and Staphylococ¬
cus spp was cultured in the remaining broth (11.1%). No
enrichment broth contained both P. acnes and Staphylo¬
coccus spp. Enrichment broth was 57.7% specific and
96.1% sensitive for the detection of P. acnes and 25.0%
sensitive and 99.0% specific for the detection of Staphy¬
lococcus spp.
The pure cultures isolated from 14 patients who were
culture positive for P. acnes in the skin and other areas of
the wound including 10 lumbar wounds, three anterior
cervical wounds, and one abdominal wound, were typed
using monoclonal antibodies specific for Type 1 and Type
2 P. acnes. The mean number of P. acnes colonies tested
per patient was 11 colonies (range, 2-18 colonies per pa¬
tient). In eight patients, only Type 1 P. acnes was detected
and in four patients, only Type 2 P. acnes was detected.
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Only two of 14 patients had a mixture of Type 1 and Type
2 P. acnes. Mixed P. acnes populations were detected in
one lumbar and one anterior cervical wound.
Fifteen (19.0%) of 79 wound tissue samples examined
using IFM had visible bacteria. P. acnes was the only
bacterium observed in nine (60%) immunofluorescence
positive samples. P. acnes was detected with Staphylococ¬
cus spp using IFM in a further three (20%) samples. Staph¬
ylococcus spp was the only bacterium detected using IFM
in 3 (20%) cases.
Five of 14 (35.7%) wound tissue samples that had posi¬
tive agar cultures for P. acnes also were IFM positive.
Seven of 65 (89.2%) of wound tissue samples that had
negative agar culture were IFM positive. Compared with
agar culture of bacteria, IFM for the detection of P. acnes
in this setting had a sensitivity value of 35.7%, specificity
89.2%, positive predictive value (PPV) 41.6%, negative
predictive value (NPV) 86.6%.
One of 10 (10%) wound samples that were agar-culture
positive for Staphylococcus spp also was IFM positive.
Five of 69 (7.2%) wound tissue samples that were agar-
culture negative were IFM positive. Immunofluorescence
microscopy had a sensitivity value of 10%, specificity
92.8%, PPV 16.6%, and NPV 87.7%.
When bacteria were detected, they typically appeared as
single cells (Fig 2) using fluorescence microscopy whereas
bacteria detected in cases of prosthetic hip loosening ap¬
peared as large aggregates (Fig 3).
In the 10 healthy volunteers the area of skin most heav¬
ily colonized by P. acnes was the neck followed by the
forehead, the lumbar spine, the abdomen, the chest, and
the hip (Table 1). The forehead, neck and lumbar spine
contained approximately 102 to 103 as many bacteria as
the other sites. The lumbar spine had 4 x 102 as many P.
acnes per cm2 as the hip. Colonies were lifted from the
agar onto nitrocellulose and reacted with either Type 1 or
Type 2 monoclonal antibodies. In all sites sampled, P.
acnes was detected most frequently in mixed Type 1 and
Type 2 populations (Fig 4). The neck and the hip were the
sites with the highest number of mixed populations. The
forehead was the site most likely to contain only Type 1 P.
acnes. The chest was the only site to contain an exclu¬
sively Type 2 P. acnes population.
DISCUSSION
The purpose of this study was to determine the incidence
of intraoperative wound contamination during spinal sur¬
gery and to identify the most likely source of contaminat¬
ing organisms. We show that wound contamination during
spinal surgery occurs relatively frequently by bacteria that
form part of the normal skin microbiota. To date, there has
been no formal examination of the incidence of wound
M
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Fig 2A-B. Immunofluorescence micrographs show (A) P. ac¬
nes and (B) Staphylococcus spp detected in a contaminated
spinal wound.
contamination during spinal surgery. Other authors also
have shown the presence of normal skin microbiota in
surgical wounds. Padgett et al18 found that 30% of revision
hip arthroplasty wounds had positive bacterial cultures.
The predominant organisms identified were principally S.
epidermidis and P. acnes, as was the case in the current
study. Dietz et al,7 who sampled clean orthopaedic wounds
(excluding total joint replacements) for the presence of
bacteria, found that as many as 58% of wound samples had
positive cultures and that the predominant bacteria isolated
were also skin microbiota. Wollinsky et al25 had similar
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Fig 3A-B. Immunofluorescence micrographs show (A) P. ac¬
nes and (B) Staphylococcus spp detected in material dis¬
lodged by ultrasound from a failed hip replacement prosthesis
(note large aggregates).
findings when they salvaged intraoperative blood from the
surgical wounds was screened for the presence of bacteria.
The incidence of positive cultures from wound tissue
samples in the current study is slightly lower than that
described in the literature (Table 2). This perhaps is ex¬
plained by the fact that the majority of patients in the
current study received antibiotics before samples were
taken whereas no antibiotics were administered before
samples were taken in the other studies. Stirling et al22
make no reference to antibiotic prophylaxes in their study.
The studies by Padgett et al,18 Wollinsky et al,25 and Dietz
et al7 show that CoNS are identified more frequently from
orthopaedic wounds than P. acnes.7'18,25 In the current
study P. acnes was detected more frequently than CoNS.
Stirling et al22 also detected P. acnes more frequently from
spinal surgical specimens and in the study by Dietz et al.7
P. acnes was identified as frequently as CoNS when only
spinal wounds are considered.7'22 The current study did
not identify previous spinal injection as a risk factor for
positive culture from a wound. This also was the finding of
Stirling et al.22 Broth enrichment culture in our experience
did not improve the detection of bacteria from surgical
specimens. Broth enrichment often is used to improve the
detection of bacteria. Dietz et al7 demonstrated that en¬
richment improved bacterial detection by 15%.7 It is pos¬
sible in the current study that agar culture detection was
more sensitive than broth enrichment because of the strict
adherence to anaerobic conditions during transportation of
samples, or the enrichment broth used might not be an
ideal medium for the bacteria present in samples.
There were high numbers of cutaneous P. acnes par¬
ticularly on the forehead, neck and lumbar spine area the
skin of healthy volunteers. McGinley et al,15 in a study of
the regional variations on cutaneous propionibacteria, also
found also found high levels of P. acnes in the forehead
and other sebum rich areas.15 To date no authors have
examined specifically the phenotypes or numbers of P.
acnes areas used to site orthopaedic incisions.
Bacterial contamination of the surgical wound is
thought to occur because of aerial contamination of the
wound,4 or contamination from the patients own skin. Us¬
ing fluorescence microscopy to identify the phenotypes of
P. acnes found in operative samples we hoped this would
enable the determination of origin of the P. acnes detected.
When fluorescence microscopy was compared with the
colony lift method it was noted that only one of 10 (10%)
lumbar wounds contained Type 1 and Type 2 P. acnes.
This was in contrast with the P. acnes populations detected
in unprepared lumbar skin from healthy volunteers, 7 of 10
(70%) who had a mixture of Type 1 and Type 2 P. acnes.
The source of the P. acnes identified in the patient's
wound is most likely to be the patient's own skin and this
is supported by the fact that that the P. acnes phenotype
identified in the surgical wound was the same as the P.
acnes phenotype identified from the operative skin sample.
Although the sample sizes are relatively small and the
methods used are not directly comparable, it is possible
that antiseptic solution may alter the natural balance of the
P. acnes population in normal skin. Further work into the
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1 48 F 3.6 x 105 3.0 x 105 1.0 x 103 2.3 x 103 1.8 x 104 8.4 x 102
2 31 M 2.3 x 105 8.5 x 105 6.5 x 102 1.2 x 102 1.0 x 105 5.0 x 10°
3 27 F 6.8 x 103 1.1 x 102 7.2 x 10° 6.0 x 101 0 1.0 x 10°
4 21 F 2.0 x 103 2.1 x 102 1.1 x 101 1.5 x 101 4.3 x 102 1.2 x 102
5 12 F 6.9 x 102 6.5 x 102 1.6 x 103 7.6 x 101 1.0 x 102 6.2 x 101
6 34 M 2.7 x 103 2.8 x 105 4.5 x 102 2.7 x 102 1.0 x 102 9.0 x 10°
7 30 M 3.7 x 104 3.1 x 103 4.0 x 10° 3.7 x 103 3.3 x 104 9.0 x 10°
8 27 F 6.8 x 103 9.0 x 102 4.0 x 10° 3.0 x 101 0 1.0 x 10°
9 28 M 4.0 x 104 2.3 x 10s 1.9 x 102 2.0 x 101 2.8 x 10s 5.2 x 101
10 18 F 2.8 x 104 1.2 x 101 1.0 x 10° 9.0 x 10° 3.0 x 10° 1.0 x 10°
Mean 27.6 7.2 x 104 1.7 x 104 3.3 x 102 6.6 x 102 4.4 x 104 1.1 x 102
*95% confidence intervals of colony counts fell within 1 log of stated values.
M = male; F = female; cfu = colony-forming units
possible resistance of the different P. acnes phenotypes to
antiseptics is required.
It is known that antiseptic solutions used in surgery
reduce the total bacterial count of the skin surface; how¬
ever, they do not render the skin or wounds sterile.1,12'17 It
seems that P. acnes, which is less aerotolerant than the
CoNS and usually is found in the depths of the follicle,3
escapes the effects of an antiseptic as do some of the
CoNS. When skin is incised, the bleeding skin edges fa¬
cilitate the transport of bacteria from the follicles into the
J Type I P. acnes only
ES Type II P. acnes only
U Mixed P. acnes population


















Fig 4. The number of P. acnes colonies detected at different
sites in healthy volunteers is shown.
wound. Our results confirm the presumption because P.
acnes was detected more frequently than Staphylococcus
spp in surgical wounds. We also showed that the wound
tissue and wound washings were positive for bacterial cul¬
ture less frequently than skin. The interpretation of culture
results from any spinal surgical wound must be treated
with caution because 29.1% of wound skin was culture
positive for P. acnes or CoNS. Staphylococcus aureus does
not seem to cause substantial bacterial contamination of
surgical wounds; authors of other studies failed to detect it
at all.7,25
In contrast with the detection of biofilm-associated
prosthetic joint infection, in the current wound study, IFM
did not increase the chance of detection of bacteria when
compared with culture.23 In experiments with pure cul¬
tures in which total viable count (TVC) was compared
with the limit of detection by IFM, only one or two bac¬
teria were observed on a microscope slide well to which a
20 p.L drop containing approximately 400 cfu/mL of P.
acnes had been applied. This suggests that the bacteria
observed in association with prosthesis biofilm are non-
culturable whereas those in the wound study are viable and
are present in much lower numbers. The majority of cul¬
ture-positive clinical samples analyzed had fewer cfu/mL,
and this explains why IFM often was negative.
Immunofluorescence microscopy has proven to be a
useful tool in the detection of bacteria from failed hip
prosthesis.23 Most importantly, IFM permits observation
of bacteria. Large aggregates are highly suggestive of bac¬
terial biofilm-related infection; however, single bacterial
cells suggest intraoperative contamination. In the contami¬
nated wounds we studied, bacteria typically were detected
as single cells (Fig 3); however, in cases of prosthetic hip
loosening, large aggregates are found (Fig 4), and this
would suggest biofilm formation.
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TABLE 2. Comparison of Bacteria Isolated from Orthopaedic Wounds
Number of Number of Patients Percentage of Positive Percentage of
Patients with Positive Cultures for Positive Cultures for
Study Site Sampled Cultures (%) P. acnes Staphylococcus spp
Padgett et al18 Hip 138 42 (30.4%) 23.6% 56.3%
Dietz et al7 Various* 40 23 (57.5%) 24.2% 57.6%
Dietz et al7f Spine 12 7 (58.3%) 44.4% 44.4%
Stirling et al22 Spine 50 19(38.0%) 84.2% 10.5%
Current Studyf Spine 79 17(21.5%) 64.7% 23.5%
'Various = extremity, pelvis, spine.
tA subset of 12 spine wounds out of the larger group of 40 wounds is considered.
fWound tissue sample culture results expressed.
Bacterial contamination of spinal surgical wounds oc¬
curs relatively frequently. This almost certainly reflects
the high numbers of resident skin microbiota in the areas
where the surgical incision is made. We suggest that P.
acnes cultured from spinal surgery wounds originates from
the skin and not from other sources. Bacterial culture using
agar and enrichment techniques do not help distinguish
bacterial contamination from infection. Immunofluores¬
cence microscopy is potentially a valuable tool in distin¬
guishing between contamination and infection because it
permits direct observation of bacterial cells.
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Analysis of the draft genome sequence of the opportunistic pathogen Propionibacterium
acnes type strain NCTC 737 ( = ATCC 6919) revealed five genes with sequence identity to the
co-haemolytic Christie-Atkins-Munch-Peterson (CAMP) factor of Streptococcus agalactiae.
The predicted molecular masses for the expressed proteins ranged from 28 to 30 kDa. The
genes were present in each of the three recently identified recA-based phylogenetic groupings
of P. acnes (IA, IB and II), as assessed by PCR amplification. Conserved differences in CAMP
factor gene sequences between these three groups were also consistent with their previous
phylogenetic designations. All type IA, IB and II isolates were positive for the co-haemolytic
reaction on sheep blood agar. Immunoblotting and silver staining of SDS-PAGE gels, however,
revealed differential protein expression of CAMP factors amongst the different groups. Type IB
and II isolates produced an abundance of CAMP factor 1, detectable by specific antibody
labelling and silver staining of SDS-PAGE gels. In contrast, abundant CAMP factor production
was lacking in type IA isolates, although larger amounts of CAMP factor 2 were detectable by
immunoblotting compared with type II isolates. While the potential role of the abundant CAMP
Received 25 November 2004 factor 1 in host colonization or virulence remains to be determined, it should be noted that
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The GenBank/EMBL/DDBJ accession numbers for the CAMP factor
sequences of P. acnes strains NCTC 737 (IA), KPA171202 (IB), NCTC
10390 (II) and SG2 (II) are given in Table 3.
INTRODUCTION
As a member of the resident human microbiota, the Gram-
positive anaerobic coryneform bacterium Propionibacterium
acnes is found predominantly in the sebaceous gland-rich
areas of the skin in adults (Eady & Ingham, 1994). It can,
however, also be isolated from the conjunctiva, the external
ear canal, the mouth, the upper respiratory tract and, in
some individuals, the intestine (Funke et al, 1997). It
accounts for approximately half of the total skin micro-
biota (Tancrede, 1992), with an estimated density of ID2 to
10s-6 cm 2 (Leyden et ah, 1998; McGinley et ah, 1978). In
most people it outnumbers coagulase-negative Staphylo¬
coccus spp. (CoNS) on the skin by 10- to 100-fold (Eady
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& Ingham, 1994). P. acnes is a well-recognized opportunistic
pathogen, especially in relation to medical implants such as
central nervous system shunts (Brook & Frazier, 1991),
silicone implants (Ahn et al., 1996) and prosthetic hip joints,
where it is recovered as frequently as CoNS (Tunney et al.,
1998, 1999b). It is also responsible for ocular and peri¬
ocular infections and endophthalmitis (Aldave et al., 1999;
Clark et al., 1999) and has been implicated in periodontal
and dental infections (Le Goff et al., 1997). Indeed, dental
probing and treatment can lead to the dissemination of P.
acnes in the bloodstream (Debelian et al., 1992), which is
a recognized cause of endocarditis in relation to damaged
or prosthetic heart valves. P. acnes is also considered to
play a crucial role in inflammatory acne (Eady & Ingham,
1994), since antimicrobial therapy directed against P. acnes
results in improvement, while the development of anti¬
biotic resistance in P. acnes is associated with relapse
(Leyden et al., 1998). The common form of acne, known as
acne vulgaris, affects up to 80 % of the population at some
time in their lives, making it the most common skin
infection. There is also a strong association between severe
forms of acne and joint pain, inflammation of the bone
(osteitis) and arthritis. In patients suffering from this
condition, known as SAPHO (synovitis, acne, pustulosis,
hyperostosis and osteitis) syndrome, isolates of P. acnes
have been recovered from bone biopsy samples, as well as
synovial fluid and tissue (Schaeverbeke et al., 1998).
Immunologists have long recognized and exploited the
potent adjuvant activity of P. acnes and utilized it in models
of inflammation, although many continue to refer to it as
'Corynebacterium parvum' (Tasaka et al., 1996).
Studies by Johnson & Cummins (1972) first revealed two
distinct phenotypes of P. acnes, known as types I and
II, based on serological agglutination tests and cell-wall
sugar analysis. Recently, recA-based sequence analysis has
revealed that P. acnes types I and II represent phylogeneti-
cally distinct groups (McDowell et al., 2005). Furthermore, a
small subgroup of phylogenetically distinct type I strains
with atypical mAb labelling characteristics, which we now
designate type IB to distinguish them from other type I
strains, designated type IA, were also described. The
observation that the phenotypic differences between strains
of the various P. acnes types reflect deeper differences in
their phylogeny raises the possibility that they may also
display variation in their expression of putative virulence
factors.
P. acnes produces a co-haemolytic reaction with both
sheep and human erythrocytes (Choudhury, 1978) similar
to the Christie-Atkins-Munch-Petersen (CAMP) reaction
first demonstrated in 1944 (Christie et al., 1944). The
CAMP reaction describes the synergistic haemolysis of
sheep erythrocytes by the CAMP factor from Streptococcus
agalactiae and the p-toxin (sphingomyelinase C) from
Staphylococcus aureus, with the CAMP factor demonstrat¬
ing non-enzymic affinity for ceramide (Bernheimer et al.,
1979). Examination of sphingomyelinase-treated sheep
erythrocytes has revealed the formation of discrete
membrane pores by recombinant Streptococcus agalactiae
CAMP factor (Lang 8c Palmer, 2003). In addition to the
extensive study of the CAMP factor of Streptococcus
agalactiae (Bernheimer et al., 1979; Brown et al., 1974;
Jurgens et al., 1985, 1987; Ruhlmann et al., 1988; Skalka
et al., 1980), a number of other Gram-positive and Gram-
negative bacteria are known to produce a positive CAMP
reaction, including Pasteurella haemolytica (Fraser, 1962),
Aeromonas species (Figura & Guglielmetti, 1987), some
Vibrio species (Kohler, 1988) and group G streptococci
(Soedermanto & Lammler, 1996). Some of these species can
also use phospholipase C (a-toxin) from Clostridium per-
fringens or phospholipase D from Corynebacterium pseudo¬
tuberculosis as a co-factor for haemolysis in addition to the
Staphylococcus aureus p-toxin (Frey et al., 1989). The CAMP
factor genes ofActinobacillus pleuropneumoniae and Strepto¬
coccus uberis have also been identified, cloned and expressed
in Escherichia coli (Frey et al., 1989; Jiang et al., 1996).
The precise role of the CAMP molecule in bacterial virulence
remains unclear. It is likely that the co-haemolytic reaction
represents a laboratory phenotype, or epiphenomenon, that
is convenient for CAMP factor detection, but which may
not be directly related to the role of the molecule in coloni¬
zation and pathogenesis. The CAMP factor from Streptoc¬
occus agalactiae binds to the Fc region of IgG and IgM
molecules, similar to the binding of IgG by Staphylococcus
aureus protein A (Jurgens et al, 1987), and partial amino
acid sequence similarity between the CAMP factor protein
of Streptococcus agalactiae and Staphylococcus aureus pro¬
tein A has been demonstrated (Ruhlmann et al., 1988). We
now present evidence of differences amongst P. acnes types
IA, IB and II in the expression of proteins with sequence
similarity to the CAMP co-haemolysin.
METHODS
Bacterial isolates, media and culture conditions. The follow¬
ing reference strains were from the National Collection of Type
Cultures (NCTC, Colindale, UK), the American Type Culture Collec¬
tion (ATCC, Manassas, VA, USA) and the National Collections
of Industrial, Marine and Food Bacteria (NCIMB, Aberdeen, UK):
P. acnes NCTC 737 (=ATCC, 6919) and NCTC 10390, Propioni-
bacterium granulosum NCTC 10387, Staphylococcus aureus ATCC
25923, Actinomyces israelii NCTC 8047, Actinomyces naeslundii
NCTC 10301, Micrococcus luteus NCIMB 13267 (formerly Fleming
strain 2665) and Bacteroides fragilis NCTC 9343. A total of 112 iso¬
lates of P. acnes were examined. Sixty-seven isolates were recovered
from failed prosthetic hip joints and associated bone, tissue and skin
samples removed from patients attending Musgrave Park Orthopaedic
Hospital, Belfast, as detailed previously (Tunney et al., 1998, 1999b).
In addition, a further group of P. acnes isolates recovered from
tissue samples removed during revision arthroplasty in Sweden
(n=18), as well as acne (n—19) and dental (n = 8) infections, were
kind gifts. Isolates of Propionibacterium acidipropionici, Streptococcus
agalactiae, Staphylococcus epidermidis, Streptococcus lactis, Streptococcus
equi, Streptococcus sanguis, Streptococcus salivarius, E. coli DH5x and
Propionibacterium avidum were obtained from the Department of
Microbiology and Immunobiology culture collection, Queen's
University, Belfast.
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Bacterial culture. All anaerobic strains were grown on anaerobic
blood agar (ABA) (CM0972; Oxoid) or in brain heart infusion
(BHI) (CM225; Oxoid) broth. Cultures were incubated at 37 °C in
an anaerobic cabinet (MACS MG 1000; Don Whitley Scientific), in
an atmosphere of 80 % N2, 10 % C02 and 10 % H2. All Staphylo¬
coccus and Streptococcus strains were also grown at 37 °C on blood
agar (BA). E. coli DH5a was grown aerobically on Luria-Bertani
agar plates at 37 °C. Isolates of P. acnes were routinely identified
using the API 20A multitest identification system (bioMerieux) in
accordance with the manufacturer's instructions.
Co-haemolysis assay. Co-haemolytic activity was monitored by
a modification of the classical co-haemolysis reaction on sheep BA
plates as originally described (Christie et al., 1944). Briefly, the
Staphylococcus aureus strain ATCC 25923 was streaked vertically
onto sheep BA and the test strain was then streaked horizontally
outwards from either side, starting close to, but not touching, the
Staphylococcus aureus streak. Plates were incubated anaerobically at
37 °C for 48 h. A butterfly-shaped zone of lysis at the junction of
the streaks was caused by the co-effect of diffusing Staphylococcus
aureus /i-toxin and co-haemolytic factor.
Production of mAb and rabbit polyclonal antisera. The mAb
QUBPa4 was generated using the protocol described previously
(Harlow & Lane, 1988; Tunney et al., 1999a). Four BALB/c mice
were immunized with killed whole cells (10s c.f.u. mf1) of P. acnes.
The hybridoma cell line producing QUBPa4 was then cloned by
limiting dilution (Harlow 8t Lane, 1988).
Rabbit polyclonal antisera were prepared against the five CAMP
proteins using recombinant products expressed in E. coli. CAMP genes
were amplified from P. acnes NCTC 737 genomic DNA and subcloned
into the plasmid vector pET17b (Stratagene). Ligation products were
first transformed into E. coli XL-1 Blue competent cells (Stratagene)
and the plasmid DNA isolated from XL-1 Blue transformants was
subsequently transformed into E. coli BL21 (DE3) pLysE or pLysS host
cells (Novagen). The recombinant proteins were expressed in E. coli
with a poly-histidine tag at the N terminus and were purified from
IPTG-induced batch cultures, in the presence of 8 M urea, by affinity
chromatography using the one-step QIAexpress Ni-NTA agarose
matrix (Qiagen). Purity of the recombinant proteins was assessed
by SDS-PAGE, followed by Coomassie brilliant blue staining and
N-terminal sequencing using Edman chemistry with a Precise 494
protein sequencer (Perkin-Elmer Applied Biosystems). All recombi¬
nant proteins were assayed for endotoxin contamination using the
Limulus amoebocyte assay (BioWhittaker) and shown to contain less
than 50 endotoxin units mg Polyclonal rabbit antiserum was raised
against all recombinant proteins by injecting New Zealand white
rabbits (R8tR rabbitry) with 200 pg purified recombinant protein in
incomplete Freund's adjuvant (IFA) plus 100 gg muramyl dipeptide
(Sigma). Serum was collected following two subsequent boosts
separated by 3 weeks with 100 pg protein in IFA. As a result of
problems with stability of the CAMP factor 1 and 5 recombinant
proteins, only an N-terminal fragment of the CAMP 1 protein and
N-terminal and C-terminal fragments of the CAMP 5 protein were
used for immunization.
Patient serum. Serum was prepared from venous blood (10 ml)
taken pre-operatively from patients about to undergo either primary
or revision total hip arthroplasty at Musgrave Park Hospital, Belfast,
and from acne patients attending a Dermatology outpatients clinic
in the Royal Victoria Hospital, Belfast. These procedures were
approved by the local ethical committee and all patients gave full
consent.
Immunofluorescence microscopy (IFM). IFM was carried out as
described previously (Patrick et al., 1995) with minor modification.
Briefly, bacterial cultures were grown on ABA or BA and a suspension
of 10s c.f.u. ml 1 was prepared in 0-01 M PBS (0-15 M NaCl,
0-0075 M Na2HP04> 0-0025 M NaH2P04.2H20; pH 7-4). Samples
(10 pi) were then applied to multiwell slides, air-dried and fixed in
100% methanol for 10 min at — 20 °C. Undiluted hybridoma cell
culture supernatant containing mAb QUBPa4 (30 pi) was added to
each well of the slides and incubated for 45 min at 37 °C. After
washing in 0-01 M PBS for 20 min at room temperature, a 1; 100
dilution of a fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse antibody (Sigma) in PBS containing 0-1 % (w/v) Evans Blue
(Merck Sharp & Dome) counterstain (30 pi) was applied to each
well and incubated for 45 min at 37 °C. Control wells in which
primary antibody was replaced with PBS were routinely included to
monitor non-specific binding of the secondary antibody. Slides were
then washed and mounted in glycerol-PBS, containing an anti-
photobleaching agent (Citifluor; Agar Scientific), and examined
using a Leitz Dialux 20 fluorescence microscope.
Preparation of bacterial extracts. To obtain efficient extraction
and reproducible recovery of loosely cell-associated and secreted
CAMP factor 1, standardized whole cell bacterial preparations of
1 x 1010 c.f.u. ml-1 were obtained by suspending a culture grown
for 6 days on ABA directly into PBS, such that a 1:100 dilution had
an ODmw of 0-3. Cells were then disrupted by ultrasound (Soniprep
150; 26 pm amplitude) for 5 min at 4 C. The sonicated suspension
was brought to room temperature and Tween 20 (Bio-Rad) was
added to a final concentration of 2 mM. The sample was then cen-
trifuged and the resulting pellet discarded. Sodium azide was added
to the supernatant (final concentration 0-02% v/v) before storage at
-20 "a
To investigate the presence of secreted CAMP factor 1 protein in
culture supernatant, bacteria were grown in BHI broth for 24 h and
then centrifuged at 2370 g for 30 min (Mistral; MSE) at room
temperature and the supernatant retained. An equal volume of ice-
cold ethanol was then added to the supernatant followed by overnight
incubation at 4 °C. The precipitated material was recovered by
centrifugation at 12 000 g for 30 min (Sorvall) and the pellet was
resuspended in 500 pi distilled water.
SDS-PAGE and immunoblotting. Bacterial extracts, prepared as
detailed above, were analysed using 9% SDS-PAGE gels (Laemmli,
1970) and the resolved proteins were visualized using a silver stain¬
ing kit (Amersham Pharmacia Biotech). To afford standardization
and comparison of different P. acnes isolates for CAMP factor 1
expression, the colour development was carried out for between 110
and 120 s. Gels were washed three times for 5 min each in distilled
water, placed in a drying solution [30% (v/v) ethanol, 5-3% (v/v)
glycerol] for two periods of 30 min and preserved between cello¬
phane sheets. The gels were then photographed using a Kodak
DC290 digital camera fitted on a Kodak EDAS290 gel imaging hood
and images were analysed using Kodak IK image analysis software
version 3.5. Known positive and negative strains were included in
each experiment as internal controls and indicated that the experi¬
mental system was reproducible.
Immunoblotting was carried out as described previously with a minor
modification (Patrick 8; Lutton, 1990). In brief, nitrocellulose was
blocked with 0-01 M PBS containing 0-05% (v/v) Tween 20 (PBST)
and 5 % (w/v) non-fat milk powder (Marvel; Premier brands). After
washing with PBST, the nitrocellulose was incubated in undiluted
mAb supernatant or an appropriate dilution of polyclonal antiserum
in PBS. The nitrocellulose was then washed in PBST before incuba¬
tion with alkaline phosphatase-conjugated goat anti-human IgG (H),
anti-mouse IgG (H + L) or anti-rabbit IgG (H + L) (Sigma). Controls
in which the primary antibody was replaced by PBS were routinely
included to monitor non-specific binding of the secondary antibody.
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Bound antibodies were detected using an alkaline phosphatase con¬
jugate substrate kit containing nitroblue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate (Bio-Rad).
Purification and analysis of CAMP factor 1 protein. The mAb
QUBPa4 was purified using a HiTrap protein G column (Amersham
Biosciences), concentrated by ultrafiltration and immobilized on
CNBr-activated agarose (Sigma). The antibody gel was packed into a
column and equilibrated with PBS. Extracts of ABA-grown P. acnes
(isolate SG2), prepared as detailed above, were diluted in PBS and
recycled through the column overnight. The bound antigen was
released with 100 mM glycine/HCl buffer, pH 2-7, and immediately
neutralized with 1 M Tris before storage at — 20 "C. For trypsin
digestion, the eluted fractions from the affinity chromatography
column, containing approximately 120 pg purified protein, were
pooled and dialysed against distilled water at 4 °C overnight. The
sample was then lyophilized using a Speed-Vac (Savant), the precipi¬
tate dissolved in 20 pi 8 M urea, 0-4 M NH4CO3 and the pH
adjusted to between 7-5 and 8. DTT (0-25 pmol) was added and the
suspension was incubated at 50 °C for 15 min. After cooling to
room temperature, iodoacetic acid (0-5 pmol) was added and the
suspension was incubated at room temperature for a further 15 min.
The final concentration of urea was then reduced to 2 M (final
volume of digest 80 pi) by the addition of 50 pi distilled water.
Trypsin (2-5 mg ml- ; Roche) was added in a 1:25 ratio to the
CAMP factor 1 protein (w/w) and the mixture was incubated at
37 °C for 24 h. Digestion was stopped by freezing the sample at
—20 "C. Purified antigen and its fragments were subjected to SDS-
PAGE and electroblotted onto PVDF membrane (Bio-Rad). The bands
were stained with Coomassie brilliant blue, excised and sequenced
by Edman chemistry at the Babraham Institute (Cambridge, UK).
PCR amplification and sequencing. PCR was used to detect the
five CAMP factor homologue genes in a selection of P. acnes strains.
CAMP factor genes were amplified using primers directed to down¬
stream and upstream flanking sequences of each ORF (based on the
P. acnes NCTC 737 genome sequence), thus facilitating accurate
sequence determination of the 5' and 3' ends of each ORF. Prepara¬
tion of bacterial genomic DNA and PCR amplifications were carried
out essentially as described previously (McDowell et ah, 2005). PCR
samples contained 1 x PCR buffer, 200 pM of each dNTP (Amersham
Pharmacia Biotech), 200 pM of each appropriate CAMP factor
oligonucleotide primer (Table 1), 1-5 mM MgCl,, 1-25 U Platinum
Taq DNA polymerase (Invitrogen Life Technologies) and 2-5 pi
bacterial lysate, in a total volume of 25 pi. Samples were initially
heated at 95 °C for 3 min, followed by 35 cycles of 1 min at 95 °C,
30 s at the appropriate annealing temperature (Table 1) and 1 min
at 72 °C. The PCR was completed with a final extension step at
72 °C for 10 min. A negative water control was included in all
experiments. All PCR products were analysed as described before
(McDowell et al., 2005). Sequencing reactions were performed using
ABI PRISM Ready Reaction Terminator cycle sequencing kits
(Perkin Elmer Applied Biosystems) according to the manufacturer's
instructions. Samples were analysed on an ABI PRISM 3100 DNA
sequencer (Perkin Elmer Applied Biosystems).
Sequence and phylogenetic analyses. A draft sequence of the
P. acnes NCTC 737 genome was commissioned from Genset (Evry,
France) by Corixa Corporation (Seattle, WA, USA). A total of 26
million bases of DNA were sequenced, representing approximately
10 genome equivalents. An annotated database of ORFs was created
using seven Genemark predictive models, as well as B1 AST!'. Psort,
SignalP, Pfamm, InterProScan and other bioinformatic applications.
Comparison with the P. acnes KPA171202 genome sequence
(Bruggemann et al., 2004) was carried out using the Artemis
Comparison Tool (ACT; http://www.sanger.ac.uk/Soffware/ACT/).
Consensus trees showing protein and nucleotide sequence relation¬
ships were generated using the Data Analysis in Molecular Biology
and Evolution software (DAMBE; http://aixl.uottawa.ca/~xxia/
software/software.htm). Multiple sequence alignments were per¬
formed using the CLUSTAL W algorithm (Thompson et al., 1994) and
exported into the DAMBE program. For nucleotide analysis, con¬
sensus trees were constructed using the maximum-parsimony
method and the neighbour-joining method using the )ukes-Cantor-
based algorithm. Sequence input order was randomized and boot¬
strapping resampling statistics were performed using 100 datasets
for each analysis.
RESULTS
Identification of multiple genes with CAMP
factor sequence identity
Analysis of Ihe draft genome sequence of the P. acnes type
IA strain NCTC 737 ( = ATCC 6919) (property of Corixa
Corporation) identified five related genes, sited at different
locations within the genome, with similarity to the Strepto¬
coccus agalactiae co-haemolysin or CAMP factor protein
(GenBank accession no. X72754.1) originally described by
Christie, Atkins and Munch-Petersen in 1944 (Christie ef al.,
1944). The resulting CAMP factor protein sequences had
predicted molecular masses that ranged from approximately
28 to 30 kDa. All five genes have a putative N-terminal
signal peptide cleavage site (Table 2).
Table 1. PCR primers used in this study for amplification of P. acnes CAMP factor genes
Target Primer Sequence (5'-3') Position Annealing temperature (°C) Product size (bp)
CAMP 1 Cl-F GCTTGCAGTTGCGAGCAATTGTTC -44 to -21 60 946
CI -R CCCATGCCGTAAATGATTTCGATG 902 to 879
CAMP 2 C2-F GTCGTAGCCATACACCACACG -172 to -152 60 1015
C2-R GCACCGAGTGTTGATGTCAATTAGC 843 to 819
CAMP 3 C3-F AATCGTGGCGGGGAGGTTAGTA -102 to -81 62 1000
C3-R GACACGTCAATAGGGGAGAAGAAG 898 to 875
CAMP 4 C4-F CAGATCGACCAACGCTTTAGG -139 to -119 58 1039
C4-R CCACCACAGGCACGGATTGA 900 to 881
CAMP 5 C5-F CCACGCCATGAGCTAAGGACAG -246 to -225 62 1178
C5-R TGAACTAGACCGCGGCAAACATT 932 to 910
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Table 2. Characteristics of the predicted P. acnes CAMP factor proteins of NCTC 737, KPA 171202 and NCTC 10390
Strains belong to types IA (NCTC 737), IB (KPA171202) and II (NCTC 10390).
Protein Calculated molecular mass (Da)* Amino
acids
Theoretical pi Putative signal sequence
cleavage site (positions)
NCTC 737 KPA 171202 NCTC 10390 NCTC 737 KPA 171202 NCTC 10390
CAMP 1 30 391 30 376 30160 285 9-77 9-88 9-74 AHA-AP (27-28)
CAMP 2 28 538 28608 28673 267 9-52 9-61 9-52 AHA-VE (27-28)
CAMP 3 29042 29210 29159 271 9-50 9-67 9-59 AVA-AP (25-26)
CAMP 4 28 245 28211 28273 267 9-50 9-50 9-50 AQA-SA (27-28)
CAMP 5 29 855 29 821 29 905 281 9-68 9-68 9-61 AQA-AXt (27-28)
'Including signal sequence.
tV in type I; I in type II.
Construction of a bootstrapping consensus tree (using 100
bootstrapping replications) based on the different P. acnes
CAMP factor protein sequences of NCTC 737, along with
the CAMP factor sequences from Streptococcus agalactiae
(GenBank accession no. NP_736433.1), Streptococcus uberis
(accession no. AAA78910.1) and Streptococcus pyogenes
(accession no. NP_802366.1), revealed that CAMP factor
3 was more distantly related to the other P. acnes CAMP
factor proteins (Fig. 1). The P. acnes CAMP factors 1 and
5 were found to be more closely related to one another, as
were CAMP factors 2 and 4.
Nucleotide sequence analysis of CAMP factor
genes in P. acnes types I and II
The presence of all five CAMP factor genes in other strains
of P. acnes type IA, as well as strains of type IB and type
II, was revealed by PCR with primers designed to down¬
stream and upstream flanking sequences of each CAMP







- S. agalactiae CAMP (NP_736433.1)
■ a uberis CAMP (AAA78910.1)
NCTC 737
(Type IA)
■ a pyogenes CAMP (NP_802366.1)
Fig. 1. Consensus tree illustrating the relationship between
CAMP factor protein sequences from P. acnes NCTC 737
(type IA), Streptococcus agalactiae, Streptococcus uberis and
Streptococcus pyogenes. Multiple sequence alignments were
performed and the resulting phylogenetic tree was rooted with
the Streptococcus pyogenes sequence. Bootstrapping resam¬
pling statistics were applied to the trees (100 datasets) and
bootstrap values are shown at each node of the tree.
P. acnes type IA (NCTC 737, RM1, PV37), type IB (CK17,
LED2, RM9, W1392, W1998) and type II (NCTC 10390,
SG2, RM4 and P24) resulted in PCR products of the
correct size for all five CAMP factor genes, in all the isolates
examined (data not shown). Nucleotide sequence analysis
of all five CAMP factor genes from strains selected to
represent type IA (NCTC 737) and type II (NCTC 10390 and
SG2) was carried out (Table 3). These sequences were then
compared with the CAMP factor gene sequences from the
recently published genome sequence of P. acnes KPA171202
(Bruggemann et al., 2004; accession no. AE017283), which
we identified as a type IB strain based on recA and tly
phylogenetic analysis. Consensus trees of the individual
CAMP factor gene sequences from these strains were con¬
structed using the maximum-parsimony and neighbour-
joining methods. After 100 bootstrapping replications, the
consensus trees derived using the two methods gave identi¬
cal topologies. For CAMP factors 1, 2, 4 and 5, the phylo¬
genetic relationships between the LA, IB and II strains were
identical to that determined previously by recA and tly
gene analysis (illustrated in Fig. 2a for CAMP factor 1). For
CAMP 3, however, the consensus tree differed, as the type
IA sequence was found to have a closer relationship to the
type II sequence, with the type IB sequence being more
distinct (Fig. 2b).
Comparison was also made between strains NCTC 737
(IA) and KPA171202 (IB) for nucleotide and amino acid
Table 3. GenBank accession numbers for CAMP factor
sequences of P. acnes NCTC 737 (IA), KPA171202 (IB),
NCTC 10390 (II) and SG2 (II)
Protein NCTC 737 KPA171202 NCTC 10390 SG2
CAMP 1 AY527218 AAT83089 AY787764 AY787769
CAMP 2 AY726656 AAT82444 AY787765 AY787770
CAMP 3 AY726657 AAT83815 AY787766 AY787771
CAMP 4 AY726658 AAT82980 AY787767 AY787772
CAMP 5 AY726659 AAT82947 AY787768 AY787773
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NCTC 737 CAMP 3
SG2CAMP 3
Fig. 2. Consensus trees illustrating the relationship between P.
acnes types IA, IB and II CAMP factor genes. Multiple align¬
ments of CAMP factor 1 (a) and CAMP factor 3 (b) gene
sequences from strains NCTC 737 (type IA), KPA171202
(type IB) and SG2 (type II) were performed, along with the
published CAMP sequence of Streptococcus pyogenes, which
was used as an outgroup for the phylogenetic analysis. Con¬
sensus trees were constructed using the neighbour-joining
method (with Jukes-Cantor-based algorithm). Bootstrapping
resampling statistics were applied to the trees (100 datasets)
and bootstrap values are shown at each node on the trees.
sequence differences in proteins putatively involved in the
degradation of host molecules, as well as those thought
to be cell-surface-associated. Analysis revealed variable
numbers of nucleotide and amino acid sequence differences
between the two strains (Table 4).
CAMP factor homologues of P. acnes and
IgG-binding domains of protein A
As IgG binding by the Streptococcus agalactiae CAMP factor
(Jurgens et al., 1987), as well as partial amino acid sequence
similarity of the molecule to protein A of Staphylococcus
aureus (Ruhlmann et al., 1988), has been demonstrated,
sequence comparisons were made between the P. acnes
CAMP factors and staphylococcal protein A. CLUSTAL W
analyses identified a protein domain between positions 108
and 157 in CAMP factor 1 with 25 % or more identity to the
IgG-binding domains E, B and C of Staphylococcus aureus
protein A (Table 5). In addition, CAMP factor 3 showed
approximately 25 % identity to domain A between positions
104 and 142. The CAMP factor of Streptococcus agalactiae
was found to have considerably lower percentage identity.
Co-haemolytic (CAMP) reactivity of P. acnes
types I and II
Fifty isolates of P. acnes (types IA, IB and II) recovered from
failed prosthetic hip joints and associated bone and tissue
samples, as well as skin and dental sources and strains
of Staphylococcus epidermidis, A. israelii, A. naeslundii and
Streptococcus agalactiae, were positive for the co-haemolytic
CAMP reaction on sheep BA using a positive /?-toxin-
producing strain of Staphylococcus aureus (ATCC 25923).
All P. granulosum strains were negative for the CAMP
reaction, as were strains of P. avidum, P. acidipropionici,
Table 4. Percentage identity and number of nucleotide/amino acid differences between KPA1 71 202













0687 CAMP factor 1 99-9 1 99-6
1198 CAMP factor 1 99-9 1 99-6
1231 CAMP factor 1 99-9 1 99-6
1340 CAMP factor 2 99-8 2 99-3
2108 CAMP factor 9 98-9 3 98-5
1396 Haemolysin 2 99-7 1 99-6
0685 Sialidase 2 99-9 0 100
1560 Sialidase 39 97-2 18 96-3
1569 Sialidase 56 98-6 19 98-6
1796 Triacyl glycerol lipase 37 96-4 11 96-5
2105 Triacyl glycerol lipase 9 99-1 6 98-2
1745 Phosphoesterase 3 99-9 2 99-8
0109 Myosin cross-reactive antigen 47 97-4 7 98-8
0453 GroEL 10 99-4 0 100
1955 Surface protein 57 96-9 27 95-6
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Table 5. Comparison of predicted CAMP factor amino acid sequences of P. acnes type IA
(NCTC 737) and type II (NCTC 10390) with the IgG-binding domains of Staphylococcus
aureus protein A
Values are percentages of identity. Where type IA and II differ, the values are listed before (NCTC 737)
and after (NCTC 10390) the solidus (/).
CAMP factor Staphylococcus aureus protein A IgG-binding domain
E D A B C
1 25-0 23-2 17-6 28-0 30-0
2 12-0/14-0 14-9/15-7 15-7 10-9/15-7 13-5
3 19-2 19-3 25-6 19-1 17-0
4 15-4 16-7 14-5 13-0 15-7
5 18-4 11-1 14-0 15-8 22-0
Streptococcus agalactiae 12-2 11-8 11-5 13-5 15-4
Streptococcus uberis 14-3 18-0 17-5 14-8 16-7
Streptococcus pyogenes 15-4 14-8 19-6 17-6 17-6
M. luteus, Streptococcus equi, Streptococcus sanguis, Strepto¬
coccus salivarius, Streptococcus lactis, E. coli DH5a and
B. fragilis.
Differences in CAMP factor protein expression
between P. acnes types i and II
Expression of the five CAMP factor proteins by type I and
II isolates was investigated by immunoblotting with rabbit
polyclonal antisera raised against recombinant forms of
each NCTC 737 CAMP factor protein, as well as a mouse
mAb specific for CAMP factor 1. Representative immuno-
blots of NCTC 737 (type IA) and the prosthetic hip joint
isolate SG2 (type II) are presented in Fig. 3. Labelled
bands were observed in the correct region for the predicted
molecular mass of the proteins, minus the signal sequence.
Bands of lower molecular mass than that of the predicted
secreted protein were sometimes observed and are believed
to relate to degradation of a predicted labile N-terminal
region. Isolates of P. acnes type II were found to produce
large amounts of CAMP factor 1 compared with type LA
strains. A corresponding abundant protein band was also
observed on silver-stained SDS-PAGE gels of P. antes type
II, but was absent in type IA isolates (Fig. 4) and NCTC
10390 (type II; data not shown). Larger quantities of CAMP
2, however, were detectable in type IA isolates compared
with type II by immunoblotting, although levels of the
protein were still considerably less than CAMP factor 1
production (Fig. 3). Analysis of strains of P. acnes type IB
by immunoblotting and silver staining of SDS-PAGE gels
revealed a pattern ofCAMP factor expression similar to that
of type II organisms, with the production of large amounts
of CAMP factor 1 and reduced expression of CAMP factor
2 compared with type IA strains (data not shown). Nucleo¬
tide sequences immediately upstream of the CAMP genes
were compared to determine whether sequence differences
in these regions could be influencing expression. Analysis
revealed conservation of putative core Shine-Dalgarno
sequences amongst the different P. acnes types for CAMP
factors 1, 2, 3 and 5, but one base difference in the CAMP
factor 1 Shine-Dalgarno sequence of NCTC 10390 was
observed. The upstream sequences of CAMP factor 4 were
more variable. The CAMP factor 4 gene for all isolates
examined had a GTG start codon, whereas the start codon
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Fig. 3. Immunoblots probed with rabbit anti-CAMP factor
protein polyclonal antiscra and mouse anti-CAMP factor
1 mAb (QUBPa4). (a) P. acnes NCTC 737 (type IA); (b) P.
acnes SG2 (type II). C, Control with no primary antibody;
U, undiluted.
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Fig. 4. Analysis of P. acnes extracts by SDS-PAGE followed
by silver staining (top) or immunoblotting with a mouse anti-
CAMP factor 1 mAb (QUBPa4) (bottom). Lanes: 1-3 and 5,
type II P. acnes isolates JJK1 (lane 1), HMJ3 (2), SG2 (3) and
PC3 (5); 4 and 6, type IA P. acnes isolates SB1 (4) and AT3
























Fig. 5. Comparison of upstream regions of P. acnes CAMP
factor genes. Consensus sequence for P. acnes NCTC 737
(type IA), KPA171202 (type IB) and SG2 (type II). Base
matches representing equivalent DNA sequence of putative
core Shine-Dalgarno sequences are illustrated in bold. *,
Mismatch in NCTC 10390.
Comparison of CAMP factor 1 expression by
P. acnes type I and II isolates
Comparison of CAMP factor 1 expression between types
IA, IB and II was performed by silver staining of bacterial
extracts resolved on SDS-PAGE gels. Confirmation that
the abundant protein band observed was CAMP factor 1 was
obtained by immunoblotting with our mAb specific for
the CAMP factor 1 protein (QUBPa4; Fig. 4). Specificity
of the mAb was confirmed by N-terminal sequencing of
affinity-purified complete and trypsin-digested protein (data
not shown). The staining intensity of the 28 kDa CAMP
factor 1 band in extracts from NCTC 737 and NCTC 10390
was compared, as well as 76 type IA, 5 type IB and 31 type II
isolates recovered from a variety of sources. The type IA
strain NCTC 737 was used as an internal standard on all
gels (arbitrary value of 1 -0). All 31 type II P. acnes isolates,
from failed prosthetic hip joints and associated bone and
tissue samples, as well as one acne isolate, had a band
intensity for CAMP factor 1 that was at least sixfold greater
than that for NCTC 737 (mean =14). The type II strain
NCTC 10390 was an exception and lacked an intense band
in this region of the gel, consistent with its absence after
immunoblotting (not illustrated). The five type IB isolates
recovered from dental sources (n = 2), a failed prosthetic
hip joint (n=l), a prosthetic hip joint-associated tissue
sample (n= 1) and a skin sample from the hip of a patient
undergoing revision arthroplasty (n= 1), also had at least
sixfold greater band intensity for CAMP factor 1 (mean =
18). Type IA isolates recovered from dental sources (n= 6),
failed prosthetic hip joints and associated bone and tissue
samples (n = 52) and patients with acne (n= 18) had a band
intensity in the range of 1-9 (mean = 3).
Immunofluorescence labelling of CAMP factor 1
on whole cells of P. acnes
IFM with mAb QUBPa4 indicated that the CAMP factor 1
protein was both cell-associated and secreted (Fig. 6a).
Mouse mAbs of the same isotype as QUBPa4, specific for
cell-surface components of P. acnes I and II, respectively,
did not label extracellular material by IFM (Fig. 6b, c). A
centrifugation wash in PBS of bacteria harvested from agar
plates was sufficient to remove most of the CAMP factor 1
protein (Fig. 6d, e). In addition, we also found that the
protein could be obtained from broth culture after 50-fold
concentration by ethanol precipitation. P. acnes type II
strain NCTC 10390, which did not react with QUBPa4
by immunoblotting, was also non-reactive by IFM. IFM
revealed no reactivity of QUBPa4 with P. granulosum, P.
acidipropionici, Staphylococcus aureus, Staphylococcus epi-
dermidis and Streptococcus agalactiae (data not shown).
Although A. israelii and A. naeslundii showed no reaction
with QUBPa4 by IFM, reactivity was observed after SDS-
PAGE and immunoblotting (data not shown).
Reactivity with patient antisera
The sera from acne patients (n — 9) and patients under¬
going primary total hip arthroplasty (n=10) and revision
1376 Microbiology 151





















0 K > %
^ a
Fig. 6. Immunofluorescence micrographs of
P. acnes clinical isolates labelled with mouse
isotype lgG2b mAbs. (a)-(c) Type II isolate
labelled with QUBPa4, specific for CAMP 1
(a), type II isolate labelled with QUBPa2,
specific for P. acnes type ll-associated
carbohydrate antigen (b) and P. acnes type
IA clinical isolate labelled with mouse iso¬
type lgG2b mAb QUBPa5, specific for a
protein antigen associated with type IA (c).
(d)-(e) Unwashed and washed P. acnes
type IA clinical isolate labelled with CAMP
factor 1-specific QUBPa4: bacterial suspen¬
sion dried and fixed directly onto slide (d)
and bacterial suspension first centrifuged
and then resuspended in PBS (e). Images
were viewed with fluorescein-detecting filter
(a, b) or with combined fluorescein- and
Evans Blue-detecting filter (c-e). Microscope
magnification, x 1000.
arthroplasty (n=ll) were examined by immunoblotting
at a single dilution of 1:500 for their reactivity against
immunoaffinity-purified CAMP factor 1 protein from a
type II isolate (SG2). In total, sera from three patients with
acne, five patients undergoing primary arthroplasty and four
patients undergoing revision arthroplasty were reactive.
DISCUSSION
A total of five individual genes with sequence identity to
the co-haemolytic CAMP factor, originally described in
Streptococcus agalactiae (Christie et al., 1944), were identi¬
fied in the draft genome sequence of the P. acnes type
IA strain NCTC 737. Recently, these genes have been
independently identified in the genome sequence of the
P. acnes strain KPA171202 (Bruggemann et al., 2004),
which we identified as type IB based on comparison of recA
and tly sequences (McDowell et al., 2005). PCR analysis of
a selection of type IA, IB and type II isolates indicated that
all five genes are present in each of the different P. acnes
types. To our knowledge, multiple CAMP homologues have
not been described in any other organisms. The conserved
nucleotide and amino acid sequence differences observed
with the CAMP factors from all three P. acnes types pro¬
vided additional evidence for the phylogenetically dis¬
tinct nature of the groups and confirmed previous results
obtained with recA and tly genes (McDowell et al., 2005).
In contrast, CAMP factor sequences from two serotypes
of Streptococcus agalactiae (serotype III strain NEM316
and serotype V strain 2603V/R) have been shown to be
identical (Glaser et al., 2002). In addition, varying numbers
of nucleotide and amino acid differences were observed
between the sequences of NCTC 737 (1A) and KPA171202
(IB) for a selection of putative secreted and cell-surface-
associated proteins, providing further evidence for their
http://mic.sgmjournals.org
designation as distinct phylogenetic groups within type I
(McDowell et al., 2005).
Analysis of CAMP factor protein expression by immuno¬
blotting and silver staining of SDS-PAGE gels revealed an
abundance of CAMP factor 1 production by type II and
type IB isolates, but not IA organisms. The type II strain
NCTC 10390, however, was an exception, as abundant
CAMP factor 1 protein was not detected. As the genes for
all five CAMP factors are present in all three P. acnes
groups, observed differences reflected different levels of
expression rather than missing genes. One factor amongst
many that could influence expression levels is the inter¬
action between a Shine-Dalgarno ribosome-binding site
and 16S rRNA. Strong Shine-Dalgarno sequences (e.g.
GGAG, GAGG or AGGA) are associated with genes that
are predicted to be highly expressed (Karlin & Mrazek,
2000). Interestingly, we identified a base difference in the
putative Shine-Dalgarno sequence associated with the CAMP
factor 1 gene of NCTC 10390, a type II strain that lacks
abundant CAMP factor 1 production and is not reactive
with our specific mAb by IFM. Whether or not this reduces
the efficiency of interaction with the 16S ribosomal sub-
unit, and therefore the level of expression of the protein,
remains to be determined. The observation that NCTC
10390 differs from other type II organisms with respect to
CAMP factor 1 production indicates that it is not the most
appropriate representative strain of P. acnes type II.
Immunoblotting also revealed that type IA isolates express
greater quantities of CAMP factor 2 compared with type II
and type IB isolates; however, neither this nor the other
CAMP factors were produced in quantity by IA strains,
as the abundant protein band was not detectable by SDS-
PAGE and silver staining. The putative Shine-Dalgarno
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sequences of CAMP factors 1 and 2 are conserved for all
three phylogenetic groups; therefore, this cannot explain
the differences in expression. No striking differences were
observed with respect to the expression of CAMP factor
proteins 3, 4 and 5, although CAMP factor 4 reacted only
weakly in immunoblotting experiments with type IA and
II isolates. The putative Shine-Dalgarno sequences upstream
of the CAMP factor 4 genes were more varied amongst the
three phylogenetic groupings, but comparison with the
Shine-Dalgarno sequences of the other CAMP genes did
not reveal any clear relationship that could explain the
different expression levels. CAMP factor 4 does, however,
have a GTG start codon, which is reported to be a weaker
translational initiator than ATG (Ringquist et al, 1992).
All of the CAMP factor sequences contain a putative
signal sequence cleavage site (Table 2) and molecular mass
comparison of the proteins by SDS-PAGE and immuno¬
blotting was in keeping with the loss of this signal sequence.
IFM analysis and detection in ethanol-precipitated super¬
natant from broth culture confirmed that the CAMP factor
1 protein was secreted, although it was also detected on the
surface of the P. acnes cells. Studies with Streptococcus
agalactiae similarly detected CAMP factor protein in the
external milieu, as well as on the cell surface (Jurgens et al.,
1987). None of the CAMP factor homologues from P. acnes
or Streptococcus agalactiae contain a C-terminal Leu-Pro-
X-Thr-Gly (LPXTG) motif, although 25 genes encoding
other proteins with an LPXTG motif have been described
in the genome of P. acnes strain KPA171202 (Bruggemann
et al, 2004).
Despite our observations of differential expression of the
five CAMP factor homologues amongst P. acnes types LA,
IB and II, all isolates from both groups were positive for
the co-haemolytic phenotype. The P. acnes co-haemolytic
reaction is therefore likely to be mediated by more than
one CAMP factor protein. We are currently addressing the
relationship between individual CAMP factors and the
co-haemolytic phenotype. In our studies, some sequence
identity between the P. acnes CAMP factor 1 and 3 proteins
and Staphylococcus aureus protein A was demonstrated
within the Fc-binding region, suggesting they may have
immunoglobulin-binding activity. Interestingly, the per¬
centage identities were greater than those of the Strepto¬
coccus agalactiae CAMP factor, which has been shown to
bind IgG (Jurgens et al, 1987). It may be that the multiple
P. acnes CAMP factors have arisen from divergence of a
replicated common ancestral gene and now have divergent
functions.
In addition to the P. acnes isolates studied, A. israelii and
A. naeslundii produced a co-haemolytic reaction whereas
P. granulosum did not. It would be interesting to determine
whether this difference reflects the relative pathogenic
potential of these organisms. The positive reaction between
purified CAMP factor 1 protein and human sera obtained
from patients with acne, as well as those undergoing
primary or revision hip arthroplasty, indicates that the
protein is expressed by P. acnes during human colonization.
Whether its production relates to virulence remains to be
determined, as the serum samples used were from a single
time point and therefore give no indication of rising titre.
In conclusion, we have identified five genes with sequence
identity to the co-haemolytic CAMP factor of Streptococcus
agalactiae in strains of P. acnes types IA, IB and II. Differ¬
ential protein expression of the CAMP factors amongst
the various P. acnes phylogenetic groupings was observed;
in particular, the extracellular and cell-associated CAMP
factor 1 protein was produced in striking abundance by
type IB and type II isolates. The observation of differential
expression of putative virulence determinants amongst the
various P. acnes types will have important consequences.
In particular, it will impact on our interpretation of pre¬
viously published virulence data that have been based on
the study of only one isolate type, such as NCTC 737, which
has often been used as a model organism for studies of
P. acnes virulence (Roszkowski et al, 1980; Webster et al,
1985). More generally, such data, in combination with the
recent demonstration that P. acnes is genetically hetero¬
geneous, will serve to challenge our current understanding
of the virulence and pathogenic potential of clinical isolates
of P. acnes.
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Evaluation of Nonculture Methods for the Detection of
Prosthetic Hip Biofilms
Andrew McDowell, PhD; and Sheila Patrick, PhD
Authors of previous studies have found that culture-based
detection of prosthetic hip infections can be improved by
adherence to strict anaerobic protocols and mild ultrasoni-
cation of retrieved prostheses to remove bacteria growing as
an adherent biofilm. Furthermore, direct analyses of soni¬
cate samples by immunofluorescence microscopy (with ge¬
nus-specific and species-specific monoclonal antibodies or
polyclonal antisera) produces significantly greater and more
rapid detection rates for infection compared with culture
alone. Despite its diagnostic value within a research setting,
the practical advantages and limitations of immunofluores¬
cence microscopy for a busy diagnostic laboratory needs con¬
sideration. In addition, the method must be evaluated against
other nonculture-based techniques that may prove more ap¬
propriate. In this review, we describe how immunofluores¬
cence microscopy presents an attractive and reliable method
for routine detection of prosthetic hip biofilms compared,
primarily, to polymerase chain reaction, although other non-
culture methods of diagnosis based on fluorescent in situ
hybridization and serologic analysis are considered. We de¬
scribe how the immunofluorescence microscopy technique is
robust, relatively simple and, in contrast to broad-range 16S
recombinant-deoxyribonucleic-acid-based polymerase chain
reaction, does not require a separate clean-room facility or
strict adherence to aseptic techniques. More importantly we
highlight how dislodged biofilm, which appears as large ag¬
gregates of bacteria, easily can be identified from skin con¬
taminants that occur as single cells or small aggregates of
only a few cells.
Total hip replacement surgery is a medical success
story and has improved the quality of life considerably for
countless people. The majority of patients who receive a
prosthetic hip implant have dramatic and immediate relief
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of pain and regain satisfactory hip function and quality of
life.5 However, a proportion of patients do develop various
complications that require further surgery and replacement
of the prosthesis (revision arthroplasty).27 The morbidity
and trauma associated with revision arthroplasty is con¬
siderable, and in the United Kingdom, incurs large costs to
the National Health Service. Although aseptic biomechan-
ical loosening is thought to be the most common under¬
lying cause for prosthetic hip replacement, revision arthro¬
plasties caused by prosthetic hip-associated infections also
constitute a substantial burden to the healthcare system
and are a disastrous complication for the surgeon.13 Un¬
fortunately, the rate of infection-related failure for second
implants is thought to be even higher than that seen with
primary revision surgery.7 This may be a consequence of
the longer operating times involved or unrecognized in¬
fection at the time of the revision surgery, which leads to
implantation of the second prosthesis without debridement
and antimicrobial intervention.36 In contrast, the incorrect
suspicion that a prosthetic hip implant may be infected at
the time of revision surgery not only increases the anxiety
and stress to the patient, but also results in additional sur¬
gery, a prolonged hospital stay, and extra expense. As a
consequence, early and accurate diagnosis of prosthetic
hip infections would serve to improve the treatment and
management of patients considerably.
Although different methods have been used to detect
the presence of prosthetic hip infections, no standardized
protocol or set of diagnostic guidelines has been univer¬
sally adopted. Most patients routinely are assessed for the
presence of infection before revision surgery using a poly-
phasic approach that includes clinical history and exami¬
nation of the patient, measurement of leukocyte count,
erythrocyte sedimentation rate and C-reactive protein lev¬
els, radiographic and radionuclide imaging, and culture
analysis of synovial fluid aspirated from the hip joint (as¬
piration arthrography).15'24'36,39 Postoperatively, detection
of infection normally is investigated by routine culture
analysis of the explanted prosthesis and periprosthetic tis¬
sue samples.36 Authors of histopathology studies also have
provided evidence that the presence of inflammatory cells
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in periprosthetic tissue biopsies is a valuable marker for
the presence of infection. Indeed, researchers who have
participated in the Oxford Skeletal Infection Research and
Intervention Service (OSIRIS) in the United Kingdom
have recommended that patients having revision surgery
routinely are evaluated for infection by histologic screen¬
ing.2'26 Although the combined use of all these methods
usually is sufficient to detect the presence of acute infec¬
tion that may occur soon after surgery, their diagnostic
sensitivity for the detection of chronic low-grade infection
may be problematic.
Against this background, we now review nonculture-
based methods for the routine detection and identification
of prosthetic hip infections. We initially describe how
strict anaerobic processing of retrieved prostheses fol¬
lowed by the detection of dislodged prosthetic hip-
associated biofilms can improve the diagnosis of pros¬
thetic hip infections. We then highlight the value of non-
culture-based methods for the detection of such infections
and compare polymerase chain reaction (PCR)-based
methods and fluorescent in situ hybridization (FISH) and
serologic analysis with immunofluorescence microscopy
(IFM). We conclude that IFM currently provides the best
diagnostic platform for the detection of prosthetic hip in¬
fections and describe how the technique allows dislodged
biofilm, which appears as large aggregates of bacteria, to
be differentiated from skin contaminants that occur as
single cells or small aggregates of only a few cells.
Detection of Prosthetic Hip Joint Biofilms
Authors of previous studies have provided evidence that
the incidence of prosthetic hip joint infection is grossly
underestimated by various diagnostic methods routinely
practiced in clinical laboratories.37'38 In these studies, in¬
fection was identified as a major cause of prosthetic joint
failure in 26 of 120 (22%) retrieved prostheses exam¬
ined.37'38 Organisms cultured from the prostheses primar¬
ily were coagulase-negative staphylococci, mainly Staph¬
ylococcus epidermidis and Propionibacterium acnes,
which are associated with chronic low-grade infections.
When the patient's notes from 18 of these 26 individuals
were scrutinized, it was apparent that infection only had
been suspected in six cases (33%). Furthermore, in only
two cases were bacteria cultured by the routine diagnostic
laboratory from preoperative aspirates or periprosthetic
tissue removed at the time of surgery. This considerably
increased culture-based detection of infection was
achieved by immediate placement of the retrieved hip
prosthesis in an anaerobic atmosphere, mild ultrasonica-
tion (5 min, 50 kHz) of the prosthesis in prereduced quar¬
ter-strength Ringer's solution, containing cysteine, to dis¬
lodge bacteria growing on the surface as an adherent bio¬
film, and strict anaerobic processing of the resulting
sonicate samples. In addition, direct sampling of sonicate
samples by IFM, with a monoclonal antibody (MAb) spe¬
cific for P. acnes and a polyclonal antiserum specific for
Staphylococcus spp., revealed the presence of bacteria in
63% of revised prostheses, providing evidence that cul¬
ture-based analyses alone may not be the most sensitive
diagnostic technique. Molecular detection of infection by
broad range 16S recombinant deoxyribonucleic acid
(rDNA)-based PCR, using universal primers, seemed to
confirm this view because positive PCR results were ob¬
tained for 72% of the revised prosthetic hip samples. Al¬
though neutrophilic infiltration in periprosthetic tissues
has been recommended as a useful nonculture method for
the detection of prosthetic hip joint infections, eight of the
culture-positive cases (30%) identified in these studies
were found to be negative for the presence of neutrophils
in prosthetic-hip-associated tissue samples (where avail¬
able).37'38 In contrast, lymphocytes and/or macrophages
were present, which could be explained, in theory, by the
slow release of bacterial components from the prosthetic-
hip-associated biofilm. Histopathologic examination of
tissue taken from culture-negative patients revealed the
presence of high-level neutrophilic infiltration (10 or more
neutrophils per high-power field) in eight samples. A fur¬
ther 36 samples with low levels of neutrophils or none at
all had high numbers of lymphocytes or macrophages (10
or more lymphocytes or macrophages per high-power
field). For a number of these samples, although the tissue
pathology score was high, bacteria were present in small
numbers by IFM. It therefore remains to be established
whether the observed inflammatory response in such
samples was driven by wear debris from the prosthesis,34
bacterial components, or indeed a combination of both. On
the basis of these data it has been recommended that cur¬
rent methods routinely used for the detection of prosthetic
hip infections be reassessed.37'38
Importance of Nonculture Methods for Detection of
Prosthetic Hip Joint Biofilms
Because of shorter processing times, nonculture-based
methods, such as broad-range 16S rDNA-based PCR and
IFM, provide the opportunity for earlier postsurgical de¬
tection and identification of prosthetic hip biofilms com¬
pared with conventional culture-based approaches, espe¬
cially those involving anaerobic growth (Fig 1). More im¬
portantly, such techniques can facilitate the detection of
viable but nonculturable infections in prosthetic hip joints
and periprosthetic tissue and bone samples. This may oc¬
cur because of low numbers of organisms, the use of pro¬
phylactic antibiotic therapy, or the fact that bacteria grow¬
ing within a biofilm community can enter a state of dor¬
mancy or quiescence caused by inappropriate growth
conditions, which contributes to their increased resistance
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Fig 1. A comparison of conventional culture, PCR, and IFM
processing times for the detection and identification of pros¬
thetic hip infections in the routine diagnostic laboratory is
shown. Sonicate samples are prepared by mild ultrasonication
(5 min, 50 kHz) of the retrieved prosthesis in prereduced Va-
strength Ringer's solution containing cysteine.
to antimicrobials."'31 Also, it cannot be discounted that
organisms growing as a biofilm may become so highly
adapted to their environment that the fastidious growth
requirements necessary for their cultivation are not pro¬
vided within the laboratory setting.37 Clearly, the contri¬
bution that nonculture-based methods make to the detec¬
tion of prosthetic hip joint infections should not be under¬
valued. Their capacity to provide faster post-surgical
detection of infection, as well as the identification of pa¬
tients with prosthetic hip infections that traditional ap¬
proaches may have missed, will facilitate earlier and more
aggressive antimicrobial intervention and therefore will
educe the possibility that a new infection will be estab¬
lished. This will substantially contribute to the universal
goal of improving and refining patient treatment and care.
Comparison of Nonculture-Based Methods for the
Detection of Prosthesis Hip Joint Biofilms
Polymerase-Chain-Reaction-Based Protocols
Although nonculture-based methods may prove to be valu¬
able for the detection of prosthetic hip joint biofilms
within a research setting, the practical advantages and
limitations of such approaches for routine detection of
such infections within the context of a busy clinical mi¬
crobiology laboratory must be considered. Because most
modern diagnostic laboratories now have access to thermal
cyclers it is only natural that nonculture detection methods
based on PCR technology are adopted. Such an approach
is even more obvious when one considers that universal or
broad-range 16S rDNA-based PCR, using highly con¬
served oligonucleotide primers, provides an ideal molecu¬
lar platform for the detection of almost all types of bacte¬
rial infection with normally high sensitivity.10'21'43 How¬
ever, despite the initial attractiveness that PCR may offer
for the detection of prosthetic hip joint infections, a num¬
ber of potential caveats associated with the use of the
technique, especially within a routine laboratory, do exist.
Most notably, the exquisite sensitivity that is often asso¬
ciated with PCR detection methods can be a considerable
burden practically and economically for the diagnostic
laboratory, which must ensure that the positive result ob¬
tained for a patient's sample is not caused by coamplifi-
cation of contaminating DNA.4'22 Indeed, based only on
this, many of laboratories have decided not to adopt broad-
range 16S rDNA-based PCR as part of their diagnostic
service. Potential DNA contamination can arise from a
variety of different sources, including nonsterile sites sur¬
rounding the clinical specimen, the specimen vial, surgical
or laboratory personnel, aerosols and reagents used for the
extraction of DNA and PCR setup, and even unrelated
PCR activities in adjacent laboratories.4'22'32'43 In addi¬
tion, contamination from pipettes and other equipment,
such as PCR cabinets and reaction vials, also can occur.
The detection of contamination from nonsterile sites par¬
ticularly is an important consideration when analyzing re¬
trieved prosthetic hip joints because the organisms fre¬
quently responsible for infection, such as Staphylococcus
spp, also are part of the normal skin microbiota. To help
avoid contamination during broad-range 16S rDNA-based
PCR, a wide range of preventative measures need to be
taken. These include the use of molecular grade reagents
that must be screened for artifactual DNA before use, the
wearing of sterile gloves and protective clothing, and ded¬
icated rooms for DNA extraction and PCR setup that con¬
tain safety cabinets fitted with ultraviolet lamps (for DNA
degradation), pipettes, filtered pipette tips, reaction vials,
and other general equipment that must remain on site.4'22
Elimination of potential contaminants from PCR reagents
and equipment can also be achieved by enzymatic and
chemical treatments. Furthermore, when carrying out ex¬
periments it is imperative that appropriate positive and
negative controls (for DNA extraction and PCR setup) are
included in each diagnostic run. The use of internal am¬
plification controls also will serve to highlight any false-
negative results that may arise from PCR inhibitors within
the clinical sample.43 Although the use of control samples
provides some reassurance that contamination of clinical
samples has not occurred, it does not completely eliminate
such a possibility. For example, we recently identified the
presence of artifactual DNA from a (i-proteobacterium in
batches of sterile irrigation fluid routinely used during
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prosthetic hip surgery. Retrospective sequencing studies
now also have identified the presence of this DNA in a
number of sonicate samples analyzed in our earlier
study.37 As a consequence, the 72% detection rate previ¬
ously reported for the presence of bacteria in failed pros¬
thetic hip implants by broad-range 16S rDNA-based PCR
was an overestimate. The detection of a number of false-
positive samples, even when all controls gave expected
results, strikingly highlights the potential complications
that can arise when using a broad-range 16S rDNA-based
PCR approach.
Researchers who conducted previous studies in our
laboratory showed that PCR can be used reliably to detect
Staphylococcus organisms to concentrations of 104
cfu/mL, whereas detection limits for P. acnes reliably do
not go below 105 cfu/mL.37 To date, results of ongoing
studies with various DNA extraction protocols and broad-
range 16S rDNA primer sets have not improved on these
detection limits (data not published). Detection limits for
the PCR-based diagnosis of gram-positive bacteria can be
problematic because of the robust nature of the cell enve¬
lope, which is composed of a 3-dimensional matrix of
polymers, primarily peptidoglycan and techoic and/or li-
poteichoic acids. In addition, P. acnes is a member of the
actinomycetales, which are known to have additional cell
envelope polymers, making them even more robust than
other Gram-positive bacteria. This may therefore explain,
at least in part, why it is especially difficult to optimally
extract P. acnes genomic DNA. Although this relatively
poor detection limit may negate the possibility that low
levels of P. acnes contamination from nonsterile sites or
surgical or laboratory personnel would be detected, it also
does raise the possibility that smaller numbers of the or¬
ganism that may be present in a chronic infection would be
missed. Although the use of a nested or semi-nested PCR
method undoubtedly would improve the detection of P.
acnes, we are uncomfortable with such an approach for
diagnosis because of the greater risk of cross-contami¬
nation (from first-round amplification) during routine
processing.
Despite the fact that broad-range 16S rDNA-based PCR
offers the potential to detect all types of bacterial organ¬
isms it does not directly identify the specific nature of the
infection without further laboratory investigations. This
usually is achieved by DNA sequence analysis of the 16S
rDNA amplicon followed by comparison of the sequence
to those previously deposited in global sequence data¬
bases, such as GenBank at the National Center for Bio¬
technology Information, and the Ribosomal Database
Project.6'14 However, in addition to increasing the labora¬
tory processing time (Fig 1), this approach will not work
when a polymicrobial hip infection is present. In such
circumstances, PCR amplicons for each species present in
the sample may be generated leading to nonsensical DNA
sequences that cannot be interpreted. To overcome this
problem, amplicons would have to be separated, either by
cloning or some form of polyacrylamide gel electropho¬
resis, which would delay identification and further in¬
crease processing times.41'42
Alternate PCR approaches are available to the molecu¬
lar microbiologist to circumvent the problems associated
with the broad-range 16S rDNA-based approach for de¬
tection of prosthetic hip biofilm. These include the use of
genus or species-specific primers, which serve to reduce,
although not eliminate, the potential problems that could
arise from contamination. The use of species-specific
primers would also negate the necessity for subsequent
DNA sequence analysis as the organism could be directly
identified from the positive PCR result. Such specific
primer sets still can be based on the 16S rDNA locus,
although other nonribosomal targets frequently are used
with great success.12'18 These alternate targets are often
less well conserved than 16S rDNA sequences affording
more opportunity to design specific primers that will dif¬
ferentiate closely related organisms. For example, we re¬
cently found that P. acnes serotypes I and II were almost
indistinguishable based on 16S rDNA sequences.20 How¬
ever, analysis based on the recA housekeeping gene re¬
vealed considerably greater serotype-specific polymor¬
phisms that will facilitate the generation of diagnostic
primers specific for each type.20 Another example is the
glyceradehyde-3-phosphate dehydrogenase gene, which is
a useful tool for the differentiation of most Staphylococcus
spp.45 One obvious disadvantage with the use of genus-
specific or species-specific primers would be the possibil¬
ity that certain pathogens may not be detected from an
infected hip prosthesis. To reduce this possibility, multiple
primer sets specific for the organisms most likely to be
detected would have to be used. Realistically, this would
include primers for various Staphylococcus spp., primarily
S. aureus and S. epidermidis, and primers for P. acnes. The
use of genus-specific primers for Staphylococcus spp. also
may be useful and would highlight the presence of other
species in addition to S. aureus and S. epidermidis. These
individual PCR tests could be combined into a multiplex
assay to save time during setup and also reduce the number
of samples to process.12'19 However, optimization of such
assays can prove problematic depending on the number of
primer sets to be used and their compatibility with respect
to annealing temperatures. Also, each primer set must gen¬
erate different product sizes that are easily distinguished
on an agarose gel.
Fluorescent In Situ Hybridization
In addition to PCR, the discriminatory potential of 16S
rRNA sequences also could be used for the detection of
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prosthetic-hip-associated bacteria by FISH. In this tech¬
nique, a single oligonucleotide probe (15-30 nucleotides)
that has been linked covalently to a fluorescent dye at the
5' end is hybridized to ribosomes present within the bac¬
terial cell.1,23,30'40 After stringent washing, the stained
cells are detected by fluorescence microscopy or flow cy¬
tometry. Fluorescent in situ hybridization not only pro¬
vides the opportunity to observe and identify microbial
cells within clinical samples, but, in combination with con-
focal laser scanning microscopy, it can be used to recon¬
struct the spatial arrangement of infecting organisms
within their habitat.40 As with broad-range 16S rDNA-
based PCR, universal probes that will react with all bac¬
teria can be used or, alternatively, more specific probes
can be designed that discriminate between different bac¬
terial species.30 The method has been used to study com¬
plex microbial communities in the oral cavity, the gastro¬
intestinal tract, and infections of the respiratory tract and
pathogenic organisms in blood culture bottles.23 Although
this technique is appealing for the detection of prosthetic
hip biofilms because of its potential for direct observation
of bacteria, and the relative low cost and ease with which
different oligonucleotide probes can be produced, there are
a number of practical problems that remain to be over¬
come. In particular, autofluorescence of the organisms
themselves, or material surrounding the bacteria, can de¬
crease the signal-to-noise ratio and hinder detection of
specific fluorescent signals.23 Also, the complex nature of
the cell envelope in gram-positive bacteria, especially
those exhibiting long or medium chain mycolic acids, and
the large extracellular polysaccharide capsules present on
some gram-negative organisms, can create problems relat¬
ing to insufficient penetration of the oligonucleotide probe
into the bacterial cell.23'30,40 The recent introduction of
peptide nucleic acid probes, which have an uncharged
polyamide backbone, may help to reduce this problem
because they have the capacity to diffuse through hydro¬
phobic cell walls.25'28 However, the expensive nature of
such probes and problems associated with their specificity
currently are hindering their widespread application. Prob¬
lems also can arise because of the accessibility of the
oligonucleotide probe to target sites on the 16S rRNA
molecule. This occurs because of loop and hairpin forma¬
tions in the higher-order structure of the ribosome and
protein-rRNA interactions. The use of unlabelled helper
probes, which bind adjacent to the probe target site and are
thought to open up higher order structures that hinder
binding, can enhance detection.9 Other issues that can
arise when using FISH include the relationship between
ribosome number and fluorescent signal. The content of
rRNA can vary considerably between cells of a given
strain because of their physiologic state, which is depen¬
dent on their phase of growth.30 This particularly is per¬
tinent to slow-growing or dormant biofilm bacteria in
which ribosome numbers likely are to be low. As a con¬
sequence, low-signal intensity or a false-negative result
may occur. Attempts to address this issue have focused on
increasing cellular ribosome content by incubating
samples with a cocktail of substrate and antibiotics that
cause cell activation and rRNA synthesis without cell di¬
vision.16 Although this can lead to an increase in signal
intensity, the caveat with such an approach is the selec¬
tivity of the substrates and antibiotics. Consequently, al¬
though FISH remains an extremely useful research tool, its
application to routine diagnosis in the short term may be
troublesome.
Serologic-Based Analysis
Nonculture-based serological detection of gram-positive
infections on prosthetic hip implants by enzyme-linked
immunosorbent assay (ELISA) also has been described.29
This method measures the serum immunoglobulin G re¬
sponse to a short-chain length form of lipoteichoic acid
that is present in the cell membrane and extracellular ma¬
terial of Staphylococcus spp. The technique also has been
applied to the detection of gram-positive infections asso¬
ciated with intravenous catheters and sciatica.8'33 The sen¬
sitivity (93.3%) and specificity (96.9%) of the ELISA has
provided evidence that it could be useful in the detection
of occult prosthetic hip infections. Furthermore, because
the method is quick and relatively inexpensive, it may be
easily adapted into the diagnostic laboratory. However,
authors of the original ELISA study only examined 15
patients with proven prosthetic hip infections; therefore
evaluation of this technique with a much greater number of
patients would be required to fully assess its diagnostic
value.29 Furthermore, as the technique is not specific for
prosthetic hip infections; patients with other bacterial in¬
fections at the time of analysis or those with a recent
history of infection may not be suitable for testing. A
further problem with this method is the presence of anti¬
bodies to the staphylococcal antigen within the normal
population. As a consequence, basal IgG titer levels need
to be evaluated for the population being studied. The de¬
termination of a suitable titer cut-off point is somewhat
subjective, and the possibility also remains that titers may
overlap between the patient and control groups.
Immunofluorescence Microscopy
An alternative nonculture detection method for prosthetic
hip biofilms based on IFM is being developed (Fig 2).37 In
this approach, adherent biofilms dislodged from the pros¬
thesis by mild ultrasonication are concentrated and directly
fixed to the wells of a glass slide before incubation with a
MAb or polyclonal antisera specific for the organism(s)
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Fig 2. An IFM-based protocol for the detection and identifica¬
tion of prosthetic hip infections is shown. Sonicate samples are
prepared by mild ultrasonication (5 min, 50 kHz) of the re¬
trieved prosthesis in prereduced 14-strength Ringer's solution
containing cysteine.
under investigation. After incubation with a secondary an¬
tibody conjugated to a fluorogenic dye, such as fluorescein
isothiocyanate (FITC) or tetramethylrhodamine isothio-
cyanate (TRITC), bacteria present in the samples can be
detected by fluorescence microscopy (indirect labeling).
With specific regard to the detection of prosthetic hip bio¬
films, we think this approach has a number of key advan¬
tages over a PCR-based method and, consequently, may be
more suitable for routine diagnostic laboratories. In par¬
ticular, the current IFM method has a considerably shorter
processing time compared with PCR, which means the
clinician can be informed of any underlying infection
within an earlier timeframe (Fig l).37 Also, the IFM-based
method provides the opportunity to distinguish bacterial
contamination from a real infection, which is one of the
critical advantages of the technique. In conventional PCR,
the basis of a positive result is the detection of a band of
the correct size on an agarose gel. However, even when all
positive and negative control samples are correct, there
still remains the possibility that the clinical specimen itself
could have been contaminated, which observation of a
DNA band will not highlight. In contrast, with IFM the
bacterial cells can be seen directly (with coryneform or
cocci morphology), which facilitates identification of con¬
taminating organisms from those that have been growing
as an adherent biofilm on the prosthesis. On the basis of
control experiments conducted in our laboratory, as well
as our experience processing large numbers of retrieved
hip prostheses, organisms that we normally would classify
as contaminants are observed infrequently within the well
of the slide and occur either as single cells or a small
aggregates composed of only a few cells.37 In contrast,
dislodged biofilm can be easily identified as large aggre¬
gates of bacterial cells consisting of several layers (Fig 3).
These bacterial aggregates, which vary in depth from 3.5
to 4.0 p,m, are only ever seen after sonication, but never
after a simple diluent wash of the prosthesis.37 Because of
the differences in bacterial morphology for coryneform
and cocci species, the combined use of antibodies specific
for P. acnes and Staphylococcus spp. also enables any
dislodged biofilm containing both types of organisms to be
observed (Fig 4). Although the use of specific MAbs or
polyclonal antisera enables the nature of the infecting or¬
ganism^) to be directly identified, it does create the pos¬
sibility that other organisms unreactive with the antibodies
would not be identified. Although this is a potential limi¬
tation of the technique, the introduction of additional
MAbs or antisera raised to other putative pathogens would
improve this situation. To illustrate this point, we have
improved our detection of prosthetic hip infections by gen¬
erating MAbs specific for the two serotypes of P. acnes
(Types I and II).20
We have found IFM-based detection of prosthetic hip
biofilms to be a very robust technique that does not require
much expertise or training to do. Apart from the initial cost
of a fluorescence microscope, the method is relatively in¬
expensive and does not require the scrupulous adherence
to aseptic technique that is required to eliminate DNA
contamination when using broad-range 16S rDNA-based
PCR. Indeed, the technique can be conducted comfortably
on the laboratory bench once the sonicate sample has been
prepared and fixed to the microscope slide. Furthermore,
our IFM method does not suffer from the various problems
that can arise when using a FISH-based approach, such as
insufficient penetration of the oligonucleotide probe into
the bacterial cell or accessibility of the oligonucleotide
probe to target sites on the 16S rRNA molecule. As a
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Fig 3. A confocal laser-scanning micrograph of bacterial bio-
films removed from retrieved prostheses by ultrasonication is
shown. Biofilms were labeled with either (A) anti-Staphy-
lococcus spp. antiserum (1/400) or (B) undiluted anti-P. acnes
MAb hybridoma culture supernatant (QUBPa3) before incuba¬
tion with a secondary antibody conjugated to a fluorescent dye
(FITC).
consequence, the method represents an attractive noncul-
ture-based method that could be implemented, at least in
the short term, for the detection of prosthetic-hip-
associated infections. The IFM technique also could be
applied to other medical devices used in orthopedics, such
Fig 4. A confocal laser-scanning micrograph of a bacterial
biofilm dislodged from a retrieved prosthesis by ultrasonication
is shown. The biofilm was labeled with an anti-Staphylococcus
spp. antiserum (1/400) and an undiluted anti-P. acnes MAb
hybridoma culture supernatant (QUBPa3) before incubation
with a secondary antibody conjugated to a fluorescent dye
(FITC). Note cocci and coryneform morphology of Staphylo¬
coccus spp. and P. acnes respectively, which allows visual
differentiation of the organisms.
as intramedullary nails and devices used in other areas of
medicine, such as prosthetic heart valves.
DISCUSSION
Although IFM seems to be the most appropriate noncul-
ture method currently available for the reliable detection of
prosthetic hip biofilms, it is important to recognize that
continuing technological advances likely are to develop
improved or alternate nonculture approaches to those used
currently. In particular, real-time PCR offers a notable
improvement on conventional PCR methods because of its
capacity for greatly reduced assay times and postamplifi-
cation analysis.17 This particularly could be advantageous
for the detection of prosthetic hip infections. The method
also offers increased specificity and sensitivity, as well as
the capacity to identify background amplification products
based on quantification and melting curve analysis. Cur¬
rently, the main limitation with this approach is the rela¬
tively expensive nature of the technology, which prevents
it from being a routine feature for many diagnostic labo¬
ratories. Other developments in the molecular field that are
likely to directly impact the detection of prosthetic hip
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infections include the use of DNA microarray or DNA
chip technology.3'44 For example, the use of diagnostic
microarrays containing species-specific 16S rDNA oligo¬
nucleotide sequences (20-25 nucleotides) from a wide
range of pathogens would allow the simultaneous detec¬
tion and identification of organisms in one experiment.
This greatly would reduce the time taken for diagnosis
compared to conventional culture-based methods. Cur¬
rently, the use of DNA-microarray technology is not fi¬
nancially viable for most diagnostic laboratories. Further¬
more, for an 'average' laboratory, setting up an 'in-house'
microarray does require a great level of expertise ranging
from the construction of an arraying robot to the design of
multiple species-specific 16S rDNA oligonucleotides and
computer-based analysis and interpretation of the output
data.35 Despite these current economic and practical limi¬
tations, microarrays likely are to become routine diagnos¬
tic tools within every laboratory in the future as method¬
ologies improve and equipment costs decrease.
In the more immediate future, now that we have estab¬
lished and validated the IFM-based approach for the de¬
tection of prosthetic hip biofilms, we hope to streamline
the technique so that the time from receipt of the retrieved
prosthesis to identification of infection can be consider¬
ably reduced. Currently, we are optimizing our washing
procedures for the glass slides and eliminating the second¬
ary antibody incubation step by directly labeling our MAb
and polyclonal antisera with FITC and TRITC, respec¬
tively. This will reduce our current processing time for the
procedure (Fig 1), and also further simplify the technique.
Ultimately, the goal is to develop a rapid IFM-based
method to enable detection of infection before the end of
surgery, guiding the clinician on the most appropriate
course of treatment such as a delayed two-stage revision
procedure.46
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Although two phenotypes of the opportunistic pathogen Propionibacterium acnes (types I and II) have been
described, epidemiological investigations of their roles in different infections have not been widely reported.
Using immunofluorescence microscopy with monoclonal antibodies (MAbs) QUBPal and QUBPa2, specific for
types I and II, respectively, we investigated the prevalences of the two types among 132 P. acnes isolates.
Analysis of isolates from failed prosthetic hip implants (n — 40) revealed approximately equal numbers of type
I and II organisms. Isolates from failed prosthetic hip-associated bone (n — 6) and tissue (n = 38) samples,
as well as isolates from acne (n = 22), dental infections (n = 8), and skin removed during surgical incision (n
= 18) were predominately of type I. A total of 11 (8%) isolates showed atypical MAb labeling and could not be
conclusively identified. Phylogenetic analysis of P. acnes by nucleotide sequencing revealed the 16S rRNA gene
to be highly conserved between types I and II. In contrast, sequence analysis of recA and a putative hemolysin
gene (tly) revealed significantly greater type-specific polymorphisms that corresponded to phylogenetically
distinct cluster groups. All 11 isolates with atypical MAb labeling were identified as type I by sequencing.
Within the recA and tly phylogenetic trees, nine of these isolates formed a cluster distinct from other type I
organisms, suggesting a further phylogenetic subdivision within type I. Our study therefore demonstrates that
the phenotypic differences between P. acnes types I and II reflect deeper differences in their phylogeny.
Furthermore, nucleotide sequencing provides an accurate method for identifying the type status of P. acnes
isolates.
Propionibacterium acnes is an opportunistic pathogen impli¬
cated in late-stage prosthetic joint infections, acne vulgaris,
endocarditis, endophthalmitis, osteomyelitis, and shunt-associ¬
ated central nervous system infections (2, 5, 7, 33). Currently,
routine diagnostic practices may underestimate the clinical im¬
portance of this anaerobic organism due to inefficient detec¬
tion and isolation procedures, along with the traditionally held
view that, due to its low virulence, its presence in clinical
samples reflects contamination. While the opportunistic patho¬
genic potential of coagulase-negative staphylococci (CoNS),
such as Staphylococcus epidermidis, is well recognized, the im¬
portance of P. acnes may still be overlooked (13), despite the
fact that it produces more kinds of putative virulence determi¬
nants than CoNS (5, 38). This fact is illustrated by recent
studies in which P. acnes was recovered as frequently as CoNS
from the prosthetic hips of patients undergoing revision ar¬
throplasty (33, 34).
As a member of the resident human microbiota, P. acnes is
found predominantly in the sebaceous gland-rich areas of the
skin in adults (5, 25). It has, however, also been isolated from
the conjunctiva, the mouth, and the large intestine (7). It ac¬
counts for approximately half of the total skin microbiota (31),
* Corresponding author. Mailing address: Department of Microbi¬
ology and Immunobiology, School of Medicine, Queen's University,
Grosvenor Road, Belfast, BT12 6BN, United Kingdom. Phone: 44 (0)
2890 632512. Fax: 44 (0) 2890 635024. E-mail: s.patrick@qub.ac.uk.
with an estimated density of 102 to 10s or 10s organisms per
cm2 (18, 25). Studies by Johnson and Cummins (14) first re¬
vealed two distinct phenotypes of P. acnes, known as types I
and II, that could be distinguished based on serological agglu¬
tination tests and cell wall sugar analysis. The GC contents and
DNA homologies of types I and II were found to be similar to
each other but significantly different from those of Propi¬
onibacterium granulosum and Propionibacterium avidum (14).
Other methods for differentiating the two serotypes, based on
bacteriophage (39) and fermentation typing (10, 16), as well as
immunofluorescence with polyclonal antisera (11), have also
been described. To date, serological methods have proved to
be more specific and/or practical than other approaches for the
differentiation of types I and II.
The roles that P. acnes types I and II play in various clinical
infections, and the potential differences in their production of
putative virulence factors, have not been widely examined.
Furthermore, although serological and biochemical analyses of
P. acnes have revealed two distinct phenotypic groups, no phy¬
logenetic study of these biovars has been performed. Improve¬
ments in the methods used to differentiate P. acnes types I and
II, and a better understanding of their phylogeny, will greatly
aid epidemiological and virulence studies of this opportunistic
pathogen and facilitate the investigation of potentially patho¬
genic strains associated with specific clinical conditions.
In this study, we have improved antibody-based identifica¬
tion of P. acnes types I and II by generating type-specific
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monoclonal antibodies (MAbs) that enable differentiation by
immunofluorescence microscopy (IFM). We have also con¬
ducted a phylogenetic comparison of type I and II isolates
recovered from various sources. We now report that the phe-
notypic differences observed by antibody labeling reflect
deeper differences at the gene level, and we propose that types
1 and II represent phylogenetically distinct cluster groups.
MATERIALS AND METHODS
Bacterial strains. The following reference strains were from the National
Collection of Type Cultures (NCTC; Colindale, England) or the American Type
Culture Collection (ATCC; Manassas, Va.): P. acnes (NCTC 737; NCTC 10390),
Propionibacterium granulosum (NCTC 10387), Staphylococcus aureus (NCTC
10788; ATCC 25923), Staphylococcus epidermidis (NCTC 11047), Staphylococcus
haemolyticus (NCTC 11042), Staphylococcus hominis (NCTC 11320), Staphylo¬
coccus intermedius (NCTC 11048), Staphylococcus lugdunensis (NCTC 12217),
Staphylococcus xylosus (NCTC 11043), Streptococcus equi (NCTC 3767), Strep¬
tococcus lactis (NCTC 66430), Streptococcus mitis (NCTC 3767), Streptococcus
mutans (NCTC 10449), Streptococcus pyogenes (NCTC 11200), Streptococcus
salivarius (NCTC 163034), Streptococcus sanguinis (NCTC 3753), Peptostrepto-
coccus magnus (NCTC 11804), and Bacteroides fragilis (NCTC 9343). A total of
132 P. acnes isolates were examined. Sixty-five isolates were recovered from
failed prosthetic hip joints and associated bone and tissue samples, as detailed
previously (33, 34). A total of 18 skin isolates were obtained from spinal oper¬
ation incision sites after homogenization of skin samples as previously described
(33, 34). In addition, a further 19 P. acnes isolates from tissue samples associated
with failed prosthetic hips, as well as isolates recovered from patients with acne
(n = 22) and dental (n = 8) infections, were kind gifts. Isolates of Corynebac-
terium diphtheriae, Corynebacterium hofmannii, Corynebacterium xerosis, and Pro¬
pionibacterium avidum were provided by the culture collection of the Depart¬
ment of Microbiology and Immunobiology, Queen's University, Belfast, United
Kingdom.
Bacterial culture. All anaerobic strains were grown on anaerobic blood agar
(ABA) (CM0972; Oxoid Ltd., Basingstoke, England). Cultures were incubated at
37°C in an anaerobic cabinet (MACS MG 1000; Don Whitley Scientific, Shipley,
England) under an atmosphere of 80% N2, 10% C02, and 10% H2. Aerobic
coryneform strains were grown aerobically at 37°C on blood agar (BA). All
Staphylococcus and Streptococcus strains were also grown at 37°C on BA. Isolates
of P. acnes were identified by using the API 20A multitest identification system
(BioMerieux, Basingstoke, England) in accordance with the manufacturer's in¬
structions.
Fermentation tests. Fermentation reactions of P. acnes were studied on mod¬
ified protease peptone yeast agar plates containing 40 mg of bromocresol purple
indicator (BDH, Poole, England)/liter and 1% (wt/vol) sorbitol, erythritol, or
ribose (Sigma-Aldrich Company Ltd., Poole, England). Organisms were grown
anaerobically, as described above, and a positive fermentation reaction was
noted if the agar plates turned yellow due to acid production. Fermentation
biotypes (biotypes 1 to 5) based on all three substrates were determined for
culture collection reference strains NCTC 737 and NCTC 10390; strains ATI,
DW1, and ED2, used for MAb production; and strains with atypical MAb
labeling (10, 16). For all other isolates, only sorbitol fermentation was routinely
investigated for type I organisms.
Production of MAbs. MAbs were generated by using the protocol described
previously (33). Four BALB/c mice were immunized with killed whole cells (108
CFU/ml) of the P. acnes strain ATI (type I; biotype 3), while a further four
BALB/c mice were immunized with a combination of killed whole cells of P.
acnes strains DW1 and ED2 (type II; biotype 2). Hybridoma cell lines producing
P. acnes-specific MAbs were cloned by limiting dilution (9).
IFM. A modification of the IFM procedure described by Patrick et al. (27) was
performed on pure cultures. Briefly, bacterial cultures were grown for 18 h on
ABA or BA, and a suspension of 10s CFU/ml in 0.01 M phosphate-buffered
saline (PBS, consisting of 0.15 M NaCl, 0.0075 M Na2HP04, and 0.0025 M
NaH2P04 • 2H20 [pH 7.4]) was prepared. Samples (10 pi) were then applied to
multiwell slides, air dried, and fixed in 100% methanol for 10 min at -20°C.
Undiluted human AB serum (30 pi) (Sigma-Aldrich Ltd.) was added as a block¬
ing agent, and the slides were incubated at 37°C for 45 min. The slides were then
washed in 0.01 M PBS containing 0.5% (vol/vol) AB serum for 20 min. The
appropriate undiluted MAb-containing supernatant (30 pi) was added to each
well of the slides and incubated for 45 min at 37°C. After a wash, as before, wells
were incubated with a 1:100 dilution of a fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse antibody (Sigma-Aldrich Ltd.) in a 0.1% Evans blue
(Merck Sharp & Dome, Hoddesdon, England) counterstain (30 pi) for 45 min at
37°C. Slides were then washed and mounted in glycerol-PBS containing an
antiphotobleaching agent (Citifluor; Agar Scientific Ltd., Stansted, England),
and examined by using a Leitz Dialux 20 fluorescence microscope. A selection of
slides was also examined by confocal laser scanning microscopy.
Immunogold labeling for electron microscopy. P. acnes cultures were sus¬
pended in distilled water, and several drops were applied to a glow-discharged
Formvar carbon-coated copper grid (400 mesh). Grids were air dried and im¬
munogold labeled as described previously (23). The samples were then incubated
with PBS containing 1% (wt/vol) bovine serum albumin (Sigma-Aldrich Ltd.) for
10 min, followed by an undiluted MAb-containing supernatant for 90 min at
room temperature. The grids were washed in 20 mM Tris-HCl (pH 8.2) con¬
taining 0.9 M NaCl and 0.1% (wt/vol) bovine serum albumin before incubation
with goat anti-mouse immunoglobulin G (IgG) conjugated with 15-nm-diameter
gold particles (Amersham Biosciences, Little Chalfont, England) for 90 min.
After a wash in distilled water, bacteria were negatively stained with ammonium
molybdate (2% [wt/vol]) and examined with a transmission electron microscope
(Philips CM10).
Preparation of bacterial whole-cell lysates and cell wall extracts. Whole cells
(25 mg [wet weight]/ml) were suspended in distilled water and disrupted by
ultrasound (Soniprep 150; amplitude, 26 pm) for 5 min at 4°C. Intact lyophilized
bacterial cell walls were obtained by using the method of Hancock and Poxton
(8). Sterile distilled water was added to the lyophilized cell walls (10 mg/ml) prior
to ultrasonication as described above.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotting. Sonicates of whole cells and purified cell wall extracts were
analyzed on 9.0% (wt/vol) discontinuous polyacrylamide gels according to the
method of Laemmli (17). Separated components were then transferred to a
nitrocellulose membrane (Protran; pore size, 0.45 pm; Schleicher and Schuell,
Dassel, Germany) by using a Mini TransBlot apparatus (Bio-Rad Laboratories
Ltd., Hemel Hampsted, England) according to the manufacturer's instructions.
Immunoblotting was carried out as previously described with minor modifica¬
tions (26). In brief, the nitrocellulose membrane was blocked with 0.01 M PBS
containing 0.05% (vol/vol) Tween 20 (PBS-Tween) and 0.5% (wt/vol) nonfat
milk powder (Marvel; Premier Brands, Spalding, England). After a wash with
PBS-Tween, the nitrocellulose membrane was incubated in an undiluted MAb-
containing supernatant. The nitrocellulose membrane was then washed in PBS-
Tween before incubation with alkaline phosphatase-conjugated goat anti-mouse
IgG (H + L) (Sigma-Aldrich Ltd.). Bound MAbs were detected by using an
alkaline phosphatase conjugate substrate kit containing nitroblue tetrazolium
and 5-bromo-4-chloro-3-indolylphosphate (Bio-Rad Laboratories Ltd.). Where
required, and before the addition of the MAb-containing supernatant, nitrocel¬
lulose strips containing electroblotted proteins were preincubated for 1 h at 37°C
with different concentrations of proteinase K (Sigma-Aldrich Ltd.) in 20 mM
Tris-HCl buffer (pH 8.0) containing 2 mM CaCl2 or with different concentrations
of sodium-raeta-periodate (Sigma-Aldrich Ltd.) in citrate buffer (pH 7.5).
PCR analysis. Bacterial genomic DNA was prepared by boiling a suspension
(0.5 ml) of freshly cultured cells in sterile PCR-grade water (LAL grade; Cam-
brex Bioscience, Wokingham, England) for 10 min. The suspension was then
cooled before centrifugation at 15,000 X g for 2 min. The resulting supernatant
containing genomic DNA was stored at -20°C prior to analysis. PCR amplifi¬
cations were carried out using a Gene Cycler (PT-225; MJ Research, Inc.,
Waltham, Mass.). Samples contained lx PCR buffer, 200 pM each deoxynucleo-
side triphosphate (Amersham Biosciences), 200 pM each primer (Invitrogen
Life Technologies, Paisley, Scotland), 1.5 mM MgCl2, 1.25 U of Platinum Taq
DNA polymerase (Invitrogen Life Technologies), and 2.5 jxl of bacterial lysate in
a total volume of 25 |xl. The 16S rRNA gene of P. acnes (1,484 bp; positions 3 to
1486 of GenBank sequence AB042288) was amplified by using the published
universal primers UFPL (5'-AGTTTGATCCTGGCTCAG-3') and URPL (5'-
GGTTACCTTGTTACGACTT-3') (20). The P. acnes recA and tly genes were
amplified by using primers directed to downstream and upstream flanking se¬
quences of each open reading frame, thus facilitating accurate sequence deter¬
mination of the 5' and 3' ends of each open reading frame. The recA primers
PAR-1 (-96 to -75) (5'-AGCTCGGTGGGGTTCTCTCATC-3') and PAR-2
(+1105 to +1083) (5'-GCTTCCTCATACCACTGGTCATC-3') generated a
1,201-bp amplicon, while the tly primers PAT-1 (-85 to -65) (5'-CAGGACG
TGATGGCAATGCGA-3') and PAT-2 (+824 to +803) (5'-TCGTTCACAAG
ACCACAGTAGC-3') generated a 909-bp amplicon. Samples were initially
heated at 95°C for 3 min, followed by 35 cycles consisting of 1 min at 95°C, 30 s
at 55°C, and 1.5 min at 72°C. The PCR was completed with a final extension step
at 72°C for 10 min. A negative control (water) was included in all experiments.
All PCR products were analyzed by electrophoresis on 1% (wt/vol) agarose gels
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(Invitrogen Life Technologies) containing IX Tris-acetate-EDTA buffer. Mo¬
lecular size markers (1-Kb Plus DNA ladder; Invitrogen Life Technologies) were
run in parallel on all gels. Resolved DNA products were stained with ethidium
bromide and viewed under UV light.
Nucleotide sequence analysis. PCR products were purified by using a QIA-
quick PCR purification kit (QIAGEN, Crawley, England). Sequencing reactions
were performed using ABI PRISM Ready Reaction Terminator cycle sequencing
kits (Perkin-Elmer Applied Biosystems, Foster City, Calif.) according to the
manufacturer's instructions. Samples were analyzed on an ABI PRISM 3100
DNA sequencer (Perkin-Elmer Applied Biosystems). Raw sequences from both
DNA strands were obtained by using the appropriate forward and reverse prim¬
ers. Internal sequencing primers were also used to facilitate determination of the
larger 16S rRNA gene sequence.
Phylogenetic analysis. The phylogenetic relationships of recA and tly genes
were determined by using the Data Analysis in Molecular Biology and Evolution
(DAMBE) software (http://web.hku.hk/~xxia/software/software.htm). Multiple
sequence alignments were performed by using the CLUSTAL W algorithm (32)
and were exported into the DAMBE program. Phylogenetic trees were con¬
structed by the maximum-parsimony method and the neighbor-joining method
using the Jukes-Cantor-based algorithm. The sequence input order was random¬
ized, and bootstrapping resampling statistics were performed using 100 data sets
for each analysis. Analysis was performed on a selection of isolates chosen to
represent different nucleotide sequences.
Nucleotide sequence accession numbers. Table 1 summarizes the P. acnes type
I and II isolates which were examined for 16S rRNA, recA, and tly gene se¬
quences. Nucleotide sequences were submitted to GenBank, and each was as¬
signed an accession number as shown in Table 1.
RESULTS
MAb reactivity. Two MAbs (QUBPal and QUBPa2) were
selected on the basis of their reactivities with P. acnes refer¬
ence strains whose type status was inferred from sugar fermen¬
tation reactions. Immunoreactivity was consistent upon re¬
peated testing and was independent of whether the bacterial
cells were prepared from plate or broth culture.
QUBPal reacted with the cell surface antigens of the P.
acnes type I reference strain NCTC 737 (biotype 3) (Fig. 1A).
IFM and immunoelectron microscopy revealed that the sur¬
face antigen localized at the apices and septa of a variable
proportion of P. acnes cells (Fig. 1A and 2). Within a popula¬
tion, at least 95% of the bacterial cells were labeled with the
MAb. QUBPa2 reacted with a cell surface antigen of the P.
acnes type II reference strain NCTC 10390 (biotype 2) (Fig.
IB). Complete labeling of the bacterial surface by QUBPa2
was observed upon IFM (Fig. IB). All cells within the popu¬
lation were labeled. QUBPal and QUBPa2 showed no reac¬
tion with NCTC 10390 and NCTC 737, respectively, as de¬
tected by conventional fluorescence microscopy or confocal
laser scanning microscopy, even with a 10-fold increase in
green channel laser power (data not shown).
Both MAbs were nonreactive with other cutaneous Propi-
onibacterium spp., with the coryneform bacteria C. diphtheriae,
C. hofnrannii, and C. xerosis, and with B. fragilis, Peptostrepto-
coccus magnus, and all Staphylococcus and Streptococcus
strains, as detailed in Materials and Methods.
Antigen characterization. The antigens interacting with
QUBPal and QUBPa2 were characterized by SDS-PAGE and
immunoblotting on sonicate samples from whole cells and pu¬
rified cell wall extracts. With QUBPal, two bands of 61 and 68
kDa were observed for whole-cell sonicates of the P. acnes
reference strain NCTC 737 (type I) (Fig. 3A). Identical results
were also obtained with P. acnes type I isolates (data not
shown). When cell wall sonicates of NCTC 737 were analyzed,
only one band of 68 kDa was detected (Fig. 3A). With
QUBPa2, a diffuse band(s) or smear ranging from 30 to 40 kDa
and a discrete band at 21 kDa were observed for whole-cell
sonicates of the P. acnes reference strain NCTC 10390 (type II)
(Fig. 3B). Similar results were obtained with P. acnes type II
isolates (data not shown). Analysis of cell wall sonicates of
NCTC 10390 revealed a similar banding pattern (Fig. 3B). No
reactivity of QUBPal or QUBPa2 with whole-cell preparations
of P. acnes NCTC 10390 or NCTC 737, respectively, was ob¬
served (Fig. 3).
To characterize the antigens further, immunoblots of whole-
cell sonicates from NCTC 737 and NCTC 10390 were treated
with proteinase K or sodium-zneto-periodate prior to incuba¬
tion with the MAbs. With immunoblots of NCTC 737, the type
I antigen reactivity with QUBPal was sensitive to a proteinase
K concentration of 7.8 X 1CP4 mg/ml (Fig. 4A). Proteinase K
treatment of whole cells prior to IFM analysis also revealed a
similar diminution in QUBPal reactivity. Treatment of blots
with sodium-zneto-periodate had no effect on reactivity (data
not shown). With NCTC 10390, type II antigen reactivity with
QUBPa2 was sensitive to a sodium-meta-periodate concentra¬
tion of 5 X 10~2 M (Fig. 4B). Treatment of whole cells with
sodium-mefa-periodate prior to IFM analysis produced a sim¬
ilar reduction in QUBPa2 reactivity. Treatment of blots with
proteinase K had no effect on QUBPa2 reactivity (data not
shown).
IFM analysis of P. acnes isolates. IFM analysis of 132 iso¬
lates of P. acnes with QUBPal and QUBPa2 identified 87
(66%) as type I and 34 (26%) as type II (Table 2). Approxi¬
mately equal numbers of type I and type II isolates were
recovered directly from failed hip prostheses (Table 2). Iso¬
lates from associated bone and tissue samples were predomi¬
nately of type I, as were the majority of isolates recovered from
patients with acne or dental (periodontitis, pericoronitis, and
endodontic) infections and isolates recovered from skin re¬
moved at the time of surgical incision (Table 2). A total of 11
isolates (8%) gave atypical labeling with our MAbs (Tabic 1).
Nine isolates (CK17, JMK9, LED2, MMG9, RM9, TON9,
W1392, W1998, WMK9) displayed no reaction with MAb
QUBPal but were identified as type I by virtue of their capac¬
ity to ferment sorbitol, a characteristic of some type I, but no
type II, organisms. These isolates did, however, react with
QUBPa2, but with significantly reduced fluorescence intensity
and with an uncharacteristic reduction in the proportion of the
bacterial population labeled with the MAb. This group of P.
acnes organisms was recovered from failed prosthetic hip im¬
plants and associated tissue, patients with acne and dental
infections, and skin wounds. Additional analysis with erythritol
and ribose sugars revealed that all organisms within this atyp¬
ical grouping shared the same fermentation biotype (biotype
1). A further two isolates (PV66 and PV93) reacted with both
QUBPal and QUBPa2. Isolate PV66 exhibited a weak reac¬
tion with QUBPal but a strong reaction with QUBPa2. In
contrast, PV93 was strongly positive with QUBPal but also
displayed weak reactivity with QUBPa2. Neither of these iso¬
lates fermented sorbitol.
The remaining 92% of P. acnes isolates (n = 121) reacted
with either QUBPal or QUBPa2, and no cross-reaction be¬
tween the two MAbs was observed. The visual pattern of the
MAb labeling (apex and septum or complete cell surface la¬
beling [Fig. 1]), as well as the proportion of cells labeled, was
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TABLE 1. Comparison of P. acnes isolates by sorbitol fermentation, MAb labeling, and nucleotide sequence analyses
















NCTC 737 + I AB042288 AY642055 I AY527219 I
NCTC 10390 — II AY642044 AY642061 II AY644409 II
Acne
P6 + I AY642071 I ND
P9 + I AY642072 I ND
P24 - II AY642046 AY642058 II AY644406 II
PV37 + I AY642068 I AY644414 I
PV58 + I AY642073 I ND
PV66 - Atypical AY642041 AY642062 I AY644410 I
PV93 - Atypical AY642043 AY642063 I AY644411 I
P135 + I AY642074 I ND
P136 + I AY642075 I ND
Skin incision
JMK9 + Atypical AY642095 I AY644421 I
MMG9 + Atypical AY642094 I AY644420 I
TON9 + Atypical AY642096 I AY644422 I
WMK9 + Atypical AY642093 I AY644419 I
RM9 + Atypical AY642050 AY642070 I AY644416 I
Dental''
W513 + I AY642079 I ND
W633 + I AY642080 I ND
W891 + 1 AY642081 I ND
W1034 + 1 AY642076 I ND
W1392 + Atypical AY642051 AY642059 I AY644407 I
W1973 + I AY642077 I ND
W1998 + Atypical AY642078 I AYY644417 I
Prosthesis"
ATld + I AY642048 AY642082 I ND
ATB1 - II AY642087 II ND
CK17 + Atypical AY642092 I AY644418 I
DWU - II AY642083 II ND
EDI - II AY642069 II AY644415 II
ED2'' - II AY642052 AY642084 II ND
ET1 - II AY642085 II ND
JP1B - II AY642053 AY642065 II AY644413 II
JR2 + I AY642086 I ND
KC1 - II AY642066 II ND
LI 958 + I AY642042 AY642056 I AY644404 I
LED2 + Atypical AY642049 AY642060 I AY644408 I
RB1B - II AY642067 II ND
RM1 + I AY642097 I AY644423 I
RM4 - II AY642047 AY642057 II AY644405 II
SG2 - II AY642045 AY642064 II AY644412 II
SR2 - II AY642088 II ND
TFJ2 - II AY642089 II ND
WD1 - II AY642054 AY642090 II ND
WD2 - II AY642091 11 ND
a Some isolates gave atypical labeling with MAbs QUBPal and QUBPa2.
b Isolates recovered from patients with periodontitis, pericoronitis, and endodontic infections.
c Isolates recovered directly from prosthetic hips or associated bone and tissue samples.
d Isolates used for the generation of MAbs QUBPal and QUBPa2.
e ND, not determined.
also characteristic of the P. acnes type I or II reference strain
(NCTC 737 or NCTC 10390). All isolates conclusively identi¬
fied as type II by use of our MAbs did not ferment sorbitol.
Nucleotide sequence analysis. All nucleotide sequencing was
carried out on pooled PCR products to eliminate potential
inaccuracies that can arise in the sequencing of individually
cloned PCR products. A total of 15 P. acnes isolates, assigned
to type I or type II on the basis of both MAb labeling and
fermentation profiles, were selected for systematic analysis of
16S rRNA (Table 1). By using the universal bacterial 16S
rRNA-based primers UFPL and URPL, a 1,484-bp product
was amplified from all strains. Nucleotide sequence analysis
with UFPL and URPL, as well as internal 16S rRNA-based
primers, produced a complete sequence. Sequence analysis of
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FIG. 1. Micrographs of P. acnes immunolabeled with a mouse MAb and an FITC-conjugated anti-mouse antibody. Bacteria were counter-
stained with Evans blue and viewed with a combined red/green filter (X100 objective). (A) Reference strain NCTC 737 (type I) reacted with MAb
QUBPal; (B) reference strain NCTC 10390 (type II) reacted with MAb QUBPa2.
the 16S rRNA gene from P. acnes NCTC 737 was carried out
as an internal control. The resulting sequence was identical to
the previously published 16S rRNA gene for this strain (Gen-
Bank accession no. AB042288). Multiple sequence alignments
of the 1,484-bp 16S rRNA genes from P. acnes types I and II
(n = 15) revealed >99.5% sequence identity. Only one type-
specific polymorphism, at position 827 (numbering corre¬
sponds to GenBank accession no. AB042288), was observed.
This corresponded to the nucleotide T in type I strains and C
in type II strains.
Phylogenetic analyses of P. acnes types I and II based on the
recA gene and a putative hemolysin gene (tly), both of which we
identified from the draft genome sequence of NCTC 737
(property of Corixa Corporation, Seattle, Wash.), were also
carried out. By use of PAR-1 and PAR-2, 1,201-bp products
were amplified from the recA genes of NCTC 737 and NCTC
10390 as representatives of the two P. acnes types. Sequence
. ■>Wlp;
FIG. 2. Electron micrograph of P. acnes NCTC 737 (type I), im¬
munolabeled with MAb QUBPal and an anti-mouse IgG conjugated
with 15-nm-diameter gold particles, and negatively stained with am¬
monium molybdate. Note labeling at the septa and apices of cells.
analysis of P. acnes NCTC 737 served as an internal control.
The resulting recA sequence for our NCTC 737 internal-con¬
trol strain was identical to the NCTC 737 genome sequence for
recA (GenBank accession no. AY642055). Alignment of the
1,047-bp recA genes from NCTC 737 and NCTC 10390 re¬
vealed 10 type-specific differences (99% sequence identity). To
facilitate phylogenetic analysis, we sequenced the recA gene
from a further 41 P. acnes strains isolated from different clin¬
ical sources and selected to represent types I and II (Table 1).
By use of PAT-1 and PAT-2, 909-bp products were amplified
from the putative hemolysin genes of NCTC 737 and NCTC
10390. The resulting tly sequence for our NCTC 737 internal-
control strain was identical to the NCTC 737 genome sequence
for tly (GenBank accession no. AY527219). Alignment of the










FIG. 3. Immunoblots of P. acnes with MAbs QUBPal and
QUBPa2. (A) Labeling with QUBPal. Lanes: M, molecular weight
markers (in thousands); 1, whole-cell sonicate preparation of NCTC
737; 2, purified cell wall sonicate preparation of NCTC 737; 3, whole-
cell sonicate preparation of NCTC 10390. (B) Labeling with QUBPa2.
Lanes: M, molecular weight markers (in thousands); 1, whole-cell
sonicate preparation of NCTC 10390; 2, purified cell wall sonicate
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FIG. 4. Effects of proteinase K and sodium-mefa-periodate treat¬
ments on P. acnes reactivities with MAbs QUBPal and QUBPa2.
(A) QUBPal reactivity with proteinase K-treated whole-cell sonicate
preparations. Lane M, molecular weight markers (in thousands).
Lanes 1 to 12 contain the following concentrations (in milligrams per
milliliter) of proteinase K: 10"1 (lane 1), 5 x 10"2 (lane 2), 2.5 x 10~2
(lane 3), 1.25 x 10"2 (lane 4), 6.25 X 10"3 (lane 5), 3.12 x 10"3 (lane
6), 1.56 X 10"3 (lane 7), 7.81 X 10"4 (lane 8), 3.90 X 10"4 (lane 9),
1.95 x 10"4 (lane 10), 9.76 X 10"5 (lane 11), and 4.88 x 10"5 (lane
12). (B) QUBPa2 reactivity with sodium-meto-periodate-treated
whole-cell sonicate preparations. Lane M, molecular weight markers
(in thousands). Lanes 1 to 10 contain the following molar concentra¬
tions of sodium-meta-periodate: 10"1 (lane 1), 5 x 10~2 (lane 2), 2.5
x 10"2 (lane 3), 1.25 X 10"2 (lane 4), 6.25 x 10"3 (lane 5), 3.12 X
10"3 (lane 6), 1.56 X 10"3 (lane 7), 7.81 X 10~4 (lane 8), 3.90 X 10'4
(lane 9), and 1.95 X 10~4 (lane 10).
type-specific differences (98% sequence identity). For phylo-
genetic analysis, we sequenced the tly gene from a further 19 P.
acnes strains isolated from different sources and selected to
represent types I and II (Table 1).
Phylogenetic analysis of recA and tly. Phylogenetic trees of P.
acnes based on recA and tly gene sequences were constructed.
The recA and tly gene sequences from Helicobacterpylori (Gen-
Bank accession no. U13756 and AE000615) and Streptococcus
agalactiae (GenBank accession no. AF326345 and NC_004116)
were used as outgroups for our phylogenetic analysis, which
was performed using the maximum-parsimony and neighbor-
joining methods. After 100 bootstrapping replications, the recA
and tly consensus trees derived by using the two methods gave
TABLE 2. Reactivities of P. acnes isolates with MAbs QUBPal
and QUBPa2
Source
No. of isolates with the following





























Dental 6(100) 0 2(100) 8
Total 87 (88.5) 34 (0) 11 (82) 132
a Bone and tissue associated with failed prosthetic hip implant.
the same topology, with type I and II strains forming distinct
cluster groups. Only the consensus trees obtained by using the
neighbor-joining method are shown (Fig. 5). Both the recA and
tly phylogenies of P. acnes were highly distinct from unrelated
species selected as outgroups for the trees (bootstrap values,
100%). Phylogenetic trees of recA and tly based on protein
translation of each nucleotide sequence revealed the same
clustering of types I and II as distinct phylogenetic groups,
even though the protein sequences were less discriminatory
than the nucleotide sequences (data not shown). Phylogenetic
analysis of the recA and tly sequences from all 11 isolates with
atypical MAb labeling revealed the organisms to belong to type
I. On both trees, all nine atypical type I isolates that were
weakly positive with QUBPa2 clustered separately from other
type I strains.
DISCUSSION
Using IFM, we identified two MAbs, designated QUBPal
and QUBPa2, which were specific for cell surface epitopes of
the reference strains NCTC 737 and NCTC 10390, respec¬
tively. The MAbs were highly specific and did not react with
bacteria from a range of related and unrelated genera. Due to
their specificity, these MAbs may prove especially valuable for
direct IFM-based detection of P. acnes types I and II from
clinical specimens, such as large aggregates of P. acnes biofilm
dislodged by ultrasound from infected prosthetic hip implants
(33).
Immunogold labeling and IFM analysis revealed that
QUBPal was specific for an antigen that accumulates at the
septa and apices of type I cells. Immunoblotting experiments
with whole-cell preparations of NCTC 737 revealed labeling of
two bands at 61 and 68 kDa. With a purified cell wall prepa¬
ration, the 61-kDa component was absent or reduced in quan¬
tity, findings that may be related to dissociation from the cell
envelope. Considering that reactivity with QUBPal was abol¬
ished after treatment of the antigen with proteinase K, but not
after sodium-meta-periodate treatment, it appears that the
bands detected were proteinaceous. Although MAbs have
specificity for a single epitope, it is not uncommon for multiple
bands to be labeled on Western blots (9). Multiple bands may
result from molecules that share the same epitope or from an
antigen that undergoes posttranslational modification or pro¬
teolytic cleavage. For example, we have identified another cell
surface protein in P. acnes that has a labile N-terminal region
and produces components of different molecular masses after
SDS-PAGE and immunoblotting with MAbs (unpublished
data). MAb QUBPa2 labeled the cell surfaces of type II
strains. Immunoblotting revealed a diffuse band(s) between 30
and 40 kDa and a single band at 21 kDa. The immunoreactivity
of these bands was abolished after treatment with sodium-
weto-periodate but not proteinase K, providing evidence that
these antigens share a carbohydrate or glycolipid-containing
epitope. The diffuse or smeared band(s) detected at 30 to 40
kDa is, therefore, likely to represent a polymeric antigen with
a varying number of saccharide units. Previous immunodiffu¬
sion experiments with polyclonal antisera against P. acnes have
also concluded that cell wall polysaccharides of the organism
can act as antigenic determinants (3, 4). A key distinction
between P. acnes types I and II is the absence of galactose in
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FIG. 5. Phylogenetic trees of P. acnes based on the complete recA (A) and tly (B) gene sequences. Multiple sequence alignments were
performed on these genes and the published sequences for H. pylori (U13756 and AE000615) and Streptococcus agalactiae (AF326345 and
NC_004116). The resulting phylogenetic trees were rooted with the H. pylori sequences. Bootstrapping resampling statistics were applied to the
trees (100 data sets), and bootstrap values are shown at each node of the tree. The type status for the different strains analyzed is given on the
right. Phylogenetic analysis was performed on a selection of isolates chosen to represent different nucleotide sequences.
the cell envelopes of type II strains (14), as well as differences
in lipoglycan composition (40). Whether these features relate
to the epitope recognized by QUBPa2 still remains to be de¬
termined. Currently, work to purify and further characterize
the type I and II antigens is ongoing in our laboratory.
Using our MAbs, we conducted a preliminary epidemiolog¬
ical study of P. acnes isolates for type status (Table 2). Previ¬
ously, by adopting strict anaerobic protocols and including a
mild ultrasonication step to remove adherent bacteria growing
as a biofilm, we isolated P. acnes as frequently as Staphylococ¬
cus spp. from implants and associated tissue of patients under¬
going revision hip surgery (33, 34). In this study, analysis of P.
acnes isolates recovered directly from prosthetic hip implants
revealed approximately equal numbers of type I and II strains,
while isolates from associated bone and tissue samples were
predominantly of type I. Isolates recovered from patients with
acne and dental infections, and skin isolates from surgical
incision sites, were also found to be predominantly type I.
Further studies with a larger group of isolates from similar
patients will be valuable for confirming this distribution of
types. Because skin and oral isolates appear to belong predom¬
inantly to type I, yet a significant number of type II isolates
were recovered from prosthetic hip implants, it will be impor¬
tant to identify the exact source of these type II organisms.
Analysis of P. acnes isolates from other sites may help address
this issue and provide a better understanding of infection
routes for prosthetic infections. Also, a more extensive study of
type I and II distribution among oral isolates may prove par¬
ticularly valuable, because dental manipulations and dentogin-
gival infections, such as dental caries and periodontal disease,
have been implicated in prosthetic joint infection through he¬
matogenous spread (19, 30). P. acnes in particular has been
reported to constitute up to 9.0% of the dental microbiota, and
studies to recover obligate anaerobes from carious dentin in¬
dicated that approximately 20% of all isolates were P. acnes (1,
12).
Investigation of the phylogenetic relationship between P.
acnes types I and II revealed only one type-specific base dif¬
ference in the 16S rRNA gene sequence, highlighting the close
relationship between the two groups. Although sequence anal¬
ysis of the 16S rRNA gene is widely recognized as a powerful
method for investigating the phylogenetic relationship between
bacteria, it may not be the most appropriate technique for
distinguishing between related members of a genus or species
(36). In contrast, nonribosomal housekeeping genes (e.g., recA,
ATP-synthase, and GroEL) have frequently been found to give
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better insights into the phylogenetic relationship that exists
between closely related organisms (15, 22, 37). In particular,
analysis of the recA gene has been valuable for the separation
of closely related species, and bacterial classifications based on
recA have proved to be consistent with those obtained by using
rRNA genes (6). As a consequence, we investigated the rela¬
tionship between P. acnes types I and II based on recA. Fur¬
thermore, we also examined the phylogenies of both types by
analyzing a putative P. acnes hemolysin gene, known as tly,
which we also identified from the NCTC 737 genome se¬
quence.
Sequence analysis of the recA and tly genes from a selection
of P. acnes strains revealed a significantly greater number of
conserved type-specific base differences than sequence analysis
of the 16S rRNA locus. Phylogenetic analysis of both the recA
and tly sequences revealed that types I and II represent phy-
logenetically distinct groups, further demonstrating the bene¬
fits of protein-encoding DNA for systematic analysis. The
agreement of the tly phylogenetic tree with that of recA also
demonstrated the value of taxon-specific genes in phylogenetic
investigations. Such genes are under selective pressures differ¬
ent from those for universal housekeeping genes and therefore
may be less well conserved, giving rise to better phylogenetic
resolution of closely related organisms. Recently, analysis of 46
P. acnes isolates by random amplification of polymorphic DNA
(RAPD) revealed two distinct genomic profiles (28). Although
the type status of these various isolates was not determined,
RAPD profiles from the type I and II reference strains, NCTC
737 and NCTC 10390, respectively, did match the two RAPD
lineages of these P. acnes isolates, providing further evidence
for the distinct genomic natures of types I and II. Studies of
Burkholderia cenocepacia (genomovar III), which causes infec¬
tions among patients with cystic fibrosis, has also revealed the
presence of two phylogenetically distinct recA lineages (known
as III-A and III-B) (24). Epidemiological investigations have
shown that strains of these two lineages not only differ in their
distribution among infected patients in different geographical
localities (21, 29) but also display differences in the presence of
specific virulence factors (24). Two further phylogenetically
distinct recA lineages (III-C and III-D) of B. cenocepacia have
also been described recently (35). Whether the different recA
lineages of P. acnes differ significantly with respect to virulence
awaits further research.
Although the majority of P. acnes isolates (92%) could be
conclusively identified as type I or II based on MAb immuno-
reactivity, which was confirmed by DNA sequencing of a rep¬
resentative selection of strains, we did identify nine atypical
strains that fermented sorbitol yet did not react with QUBPal
but showed weak reactions with QUBPa2. In addition, we also
detected two isolates that reacted with both MAbs, although
labeling was strong with one MAb and poor with the other.
recA and tly sequencing of these 11 atypical P. acnes isolates
identified them as type 1. In the recA and tly phylogenetic trees,
all nine atypical type I isolates that were weakly positive with
QUBPa2 clustered on a separate branch from other type I
strains. These organisms may belong to a further phylogenetic
subdivision within type I. It will be necessary, however, to
perform molecular typing experiments, such as pulsed-field gel
electrophoresis, to confirm that these isolates do indeed rep¬
resent different strains and not a single atypical strain or clone
isolated from different patients. We have also found that these
atypical type I isolates express high levels of a surface and
secreted antigen that is normally present in large quantities
only among type II organisms (unpublished data), thus further
demonstrating their distinct nature. The atypical reactions of
PV66 and PV93 with QUBPal and QUBPa2 suggest that their
exact relationship to other type I strains may warrant further
investigation. Indeed, although earlier studies indicated that P.
acnes types I and II had similar GC contents and DNA ho¬
mologies (14), a more detailed polyphasic taxonomic study of
these various P. acnes groups may now be appropriate in the
light of our phylogenetic data.
The identification of type-specific nucleotide differences be¬
tween types I and II has also revealed that DNA sequencing
can be used as an accurate method for the identification of P.
acnes types. Currently, we are investigating more practical
DNA-based methods, such as restriction fragment polymor¬
phism analysis and/or the use of type-specific primers, which
could be used as a complement to DNA sequencing and MAb
labeling.
In conclusion, phylogenetic analysis has revealed that P.
acnes types I and II represent distinct lineages. Therefore, the
well-described antigenic and biochemical differences between
types 1 and II reflect deeper differences in their phylogeny.
Improvements in the identification of P. acnes types I and II,
and a better understanding of the organism's phylogeny, will
facilitate the study of P. acnes epidemiology and pathogenesis.
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REPORTS
Spiroplasma was fully operational. First,
crosses involving heterozygous mothers,
where male-killing was complete, were
conducted concurrently with those using
homozygous mothers, and the females in
these crosses were siblings from the same
vials. Second, in each cross and vial where
homozygous males survived, heterozygous
males (with wild-type function) still died.
Finally, F, females derived from these
crosses, when mated to wild-type males,
produced a full, female-biased sex ratio.
In the case of insl-2, where there is no
maternal supply of MSL-2, survival of
homozygous sons was observed for both
homozygous and heterozygous mothers for
the case of the mutation msl-2s'u (Fig. 1).
For the case of msl-2 «227, no male progeny
were observed from infected females (table
S5). This mutation does not rescue males in
our assay, probably because the two muta¬
tions have different effects on msl-2 expres¬
sion. The msl-2s'34 allele prevents formation
of MSL-2 protein, whereas msl-2 s-27 poten¬
tially encodes the RING-finger element of a
truncated MSL-2 protein {14).
Thus, absence or reduced function of any
of the proteins of the DCC can reduce the
efficiency of male killing, and a functional
DCC is required for male killing by S.
poulsonii. The fact that the genes mediating
this process in Drosophila have been well
studied can be exploited to yield further
insights into the mechanism of male killing.
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Extensive DNA Inversions in the
B. fragilis Genome Control
Variable Gene Expression
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The obligately anaerobic bacterium Bacteroides fragilis, an opportunistic
pathogen and inhabitant of the normal human colonic microbiota, exhibits
considerable within-strain phase and antigenic variation of surface compo¬
nents. The complete genome sequence has revealed an unusual breadth (in
number and in effect) of DNA inversion events that potentially control
expression of many different components, including surface and secreted
components, regulatory molecules, and restriction-modification proteins.
Invertible promoters of two different types (12 group 1 and 11 group 2)
were identified. One group has inversion crossover {fix) sites similar to the hix
sites of Salmonella typhimurium. There are also four independent intergenic
shufflons that potentially alter the expression and function of varied genes.
The composition of the 10 different polysaccharide biosynthesis gene clusters
identified (7 with associated invertible promoters) suggests a mechanism of
synthesis similar to the O-antigen capsules of Escherichia coli.
Bacteroides fragilis is the major obligately
anaerobic Gram negative bacterium isolated
from abscesses, soft tissue infections, and
bacteraemias that arise from contamination of
normally uncolonized body sites by bacteria
from the resident gastrointestinal (GI) micro-
biota. Putative virulence attributes of B.
fragilis include attachment mechanisms,
aerotolerance, extracellular enzyme produc¬
tion, and resistance to complement-mediated
killing and phagocytosis [reviewed in (/)].
The lipopolysaccharide of B. fragilis triggers
inflammatory events via the Toll-like receptor
2 (TLR2) and is likely to be involved in
systemic inflammatory response syndrome
caused by GI tract bacteria (2). B. fragilis
itself only accounts for between 4 and 13% of
the normal human fecal microbiota but is pre¬
sent in 63 to 80% of Bacteroides infections. In
contrast, the related B. thetaiotaomicron
accounts for between 15 and 29% of the
fecal microbiota but is associated with only
13 to 17% of infection cases. B. fragilis is
capable of a high amount of within-strain
phase and antigenic variation of surface com¬
ponents. A single strain of B. fragilis may
reversibly produce three different encapsulat¬
ing surface structures: the large capsule and
the small capsule, both visible by light micros¬
copy, and an electron-dense layer (EDL)
visible by electron microscopy (3). In addi¬
tion, reversible within-strain antigenic varia¬
tion of multiple antigenically distinct high
molecular mass polysaccharides and other
components is evident (4). Before the advent
of the genome sequencing program, the po¬
tential mechanisms generating this variation
were unknown. We determined the complete
genome sequence of the nonenterotoxin-
producing DNA homology group I B. fragilis,
strain NCTC 9343.
The genome of B. fragilis NCTC 9343
contains a single circular chromosome of
5,205,140 base pairs (bp) predicted to encode
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4274 genes and a plasmid, pBF9343 (fig. SI
and table SI). During the assembly of
shotgun data, particular regions could not be
resolved because certain segments of the
sequence were present in two alternative
orientations. This indicated that specific
inversions of these sequences occurred at a
high frequency within the clonal growth of
bacteria used for DNA isolation. These
fragilis invertible {fin) regions can be grouped
on the basis of the inverted repeat sequences
that flank them. Twelve regions (table S2A,
group 1) shown to be invertible or with
sequence similarity are flanked by inverted
repeats, designated fragilis inversion cross¬
over (fix) sites, similar to those acted on by
the Salmonella Hin DNA invertase (J). All of
these invertible regions contain a consensus
promoter, suggesting that they control the
expression of downstream genes. Seven fin
regions (average length of 226 bp) were
found upstream of 7 of the 10 polysaccharide
biosynthesis gene clusters (table S3), imme¬
diately suggesting a mechanism for the ob¬




I ) Other gene Y/Zf) Unuartslaiod fisdS cassette
specific promoters can be correlated experi¬
mentally with expression of specific poly¬
saccharides (b), an observation confirmed in
independent experiments (3). The remaining
five related fin regions in group 1 are 161 bp
in length and are associated with a variety
of other putative proteins (table S2A). We
identified two serine site-specific DNA
invertases similar to Hin in the genome, FinA
(BF2779), chromosomally located but not near
an invertible region, and FinB (pBF9343.01),
on the plasmid. The role of FinA (Mpi) in the
inversion of these segments has been demon¬
strated (7), and the plasmid-encoded FinB
binds to fix sites (5). In total, the genome
encodes 30 enzymes potentially capable of
site-specific DNA inversion: 26 tyrosine
recombinases (integrase family), 3 serine
recombinases (resolvase-invertase family),
and 1 Piv-like transposase-invertase (IS 110
family).
A further 11 fin promoter regions (average
length of 370 bp) are different from the hin-
like group 1 regions and more heterogeneous
in nature (table S2A, group 2). The inverted
repeats that flank these regions and contain
the sites of strand exchange (group 2 fix sites)
are different from the Ait-like regions, in¬
dicating that they are acted on by a different
recombinase. These predominantly control
the expression of a family of outer membrane
proteins, and some might also drive the
expression of divergent genes with diverse
functions [Supporting Online Material (SOM)
Text]. The use of DNA inversion by B.
fragilis goes beyond the control of promoter
sequences. Several more complex inversion
events, or intergenic shufflons, that involve
the inversion of complete and partial coding
sequences were observed in the shotgun
sequence. One example, whereby DNA in¬
version brings silent gene segments into an
expression site, is the two-domain specificity
protein of a type-I restriction-modification
system (BF1839) (table S2B, IR-BB). Each
domain in such proteins is responsible for
recognizing half of the two-part DNA bind¬
ing site. Just after the start codon and
between the two domains of BF1839 are
independent inverted repeats that are un¬
related to group 1 or 2 fix sites, both of
which are present in similar positions in the
downstream convergent gene BF1842, which
does not have an appropriate start codon (Fig.
1A). Independent recombination events be¬
tween these inverted repeats would produce
four different specificity proteins recognizing
four different DNA sequences. Between these
genes are two further gene cassettes, each of
which encodes one C-terminal recognition
domain. At the 5' end of these cassettes are
two further, different inverted repeats that
allow either of the cassettes to be exchanged
with the C-terminal domain of the adjacent
gene (BF1838 or BF1842), increasing the
number of potential recognition specificities
to eight. Three potential recombinases en¬
coded nearby (BF1833, 1843, and 1845)
may be involved in this system. A similar,
although less complex, variable restriction-
modification system has been described in
Mycoplasma pulmonis (8). Three further
independent intergenic shufflons, acting on
outer membrane proteins and a signal trans¬
duction system, were observed in the shotgun
sequence (Fig. 1, table S2B, and SOM Text).
Other intergenomic inversions (IR-Q, IR-R,
and IR-S) (table S3) involve the inversion of
complete coding sequences, often reorientat¬
ing them with or against the apparent
direction of transcription of surrounding
genes. These may also affect the transcription
levels of the genes within these regions.
Comparison of the B. fragilis genome with
the recently sequenced B. thetaiotaomicron
strain VPI 5482 (ATCC 29148) (9) reveals
that there are no orthologous variable pro¬
moters or indeed operons driven by them. B.
thetaiotaomicron does encode some variable
systems (9), but they are unique to that
BF1837 XW/MBF1838 AsdSBF1839 BF1B41
*■ M - X///.\2*
► » < t> nr~r
„ <y///zz///A
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Fig. 1. Examples of invertible regions in the B. fragilis genome (78). (A) Restriction modification
intergenic shufflon: restriction-modification (R/M) complex genes, gray boxes; other genes, open
boxes; potential hsdS DNA binding modules, hatched boxes; different inverted repeats at the
inversion ends, light gray triangles. (B) Inversion of large segments of DNA through large inverted
repeats (black triangles) brings alternative outer membrane protein genes (gray boxes)
downstream of an invertibte promoter (gray diamond). (C) Local inversion through inverted
repeats (black triangles) fuses silent alternative outer membrane protein gene cassettes (hatched
boxes) to a fixed promoter and translation start.
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organism and considerably less numerous
than those in B. fragilis. This enhanced
potential for variation and other genomic
differences (SOM Text) may explain in part
why B. fragilis is isolated more frequently
from infection than B. thetaiotaomicron.
Surface polysaccharides are involved in
establishing abscess formation {10). Ten
separate gene clusters potentially involved in
polysaccharide synthesis are evident in the
genome sequence (table S3). The poly¬
saccharide gene clusters A to H have genes
similar to wzx and wzy that are involved in
transfer of linked sugar repeats across the
cytoplasmic membrane and repeat unit po¬
lymerization, respectively, but are lacking in
genes associated with the export of polymer
across the outer membrane. This suggests that
these gene clusters are similar to the Esche¬
richia coli group 4 O-antigen capsules (11)
and is in keeping with the characteristic
heterogeneity of the polysaccharide chain
length after SDS-polyacrylamide gel electro¬
phoresis (PAGE) and the EDL phenotype
(12). A gene with some similarity to E. coli
wzz (BF1708) that determines chain length is
located within polysaccharide gene cluster J.
Variation in the expression of BF1708 may
explain the varying reports of presence (13)
or absence (14) of repeating O-antigen units
after PAGE.
Phase variation controlled by DNA in¬
version events has been reported in several
other bacteria. For example, Salmonella
typhimurium regulates the expression of a
flagellar protein by using a single invertible
promoter (15), and E. coli plasmids use
shufflons to express one of several variant
pilus proteins (16). Different species of
Mycoplasma have been shown to regulate
the expression of a number of surface proteins
by using invertible promoters (17) or to use a
shufflon system to express variable surface
proteins (8). However, in each of these cases,
the use of these mechanisms is restricted to a
single system or class of surface molecules.
As described here, B. fragilis uses DNA
inversion to control a larger number or greater
breadth of systems than in any other organism
described to date, including surface proteins,
polysaccharides, and regulatory systems. This
may be related to its niche as a commensal
and opportunistic pathogen, because the
resulting diversity in surface structures could
increase both immune invasion and the ability
to colonize novel sites.
Note added in proof: The genome se¬
quence of another strain of B. fragilis has
recently been published (19), and the analy¬
sis is in general agreement with that present¬
ed here.
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The intracellular aspartate-specific cysteine pro¬
tease caspase-8 initiates death receptor signaling
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and humans (4, 5). Patients with caspase-8
deficiency (CED) have defective apoptosis and
immunodeficiency due to impaired activation of
T, B, and natural killer (NK) lymphocytes (4).
Human peripheral blood leukocytes (PBLs)
or mouse T cells treated with the pan-caspase
inhibitor benzyloxycarbonylvalyl-alanyl-
aspartic acid (O-methyl)-fluoro-methylketone
(zVAD) have reduced antigen receptor-
induced expression of interleukin-2 (IL-2)
and its receptor subunit CD25 (4, 6, 7). Be¬
cause nuclear factor kB (NF-kB) is re¬
quired for IL-2 and CD25 gene transcription
as well as lymphocyte activation (8, 9), we
examined this transcription factor in cells
exposed to caspase inhibitor. NF-kB family
members—Rel (c-ret), RelA (p65), RelB,
NF-kB 1 (pi05/50), and NF-kB2 (plOO/52)—
regulate gene transcription as dimers (8, 9).
Requirement for Caspase-8 in
NF-kB Activation by
Antigen Receptor
Helen Su,1* Nicolas Bidere,1* Lixin Zheng,1 Alan Cubre,1
Keiko Sakai,1 Janet Dale,2 Leonardo Salmena,3 Razqallah Hakem,3
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Caspase-8, a proapoptotic protease, has an essential role in lymphocyte
activation and protective immunity. We show that caspase-8 deficiency (CED)
in humans and mice specifically abolishes activation of the transcription factor
nuclear factor kB (NF-kB) after stimulation through antigen receptors, Fc
receptors, or Toll-like receptor 4 in T, B, and natural killer cells. Caspase-8 also
causes the a(3 complex of the inhibitor of NF-kB kinase (IKK) to associate with
the upstream Bcl10-MALT1 (mucosa-associated lymphatic tissue) adapter
complex. Recruitment of the IKKa.p complex, its activation, and the nuclear
translocation of NF-kB require enzyme activity of full-length caspase-8. These
findings thus explain the paradoxical association of defective apoptosis and
combined immunodeficiency in human CED.
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Materials and Methods
This sequence strain NCTC 9343 was originally isolated from an abdominal
infection at St Bartholomew's Hospital, London in 1955. The culture from which
DNA was produced for the genomic sequencing was enriched for the EDL phase,
with minimum subculture from an early freeze dried stock culture, but remained
antigenically mixed. Bacteria were grown in defined medium broth (/) in an
anaerobic cabinet (MACS Anaerobic Workstation Don Whitley Scientific, Shipley,
UK; 80% N2, 10% C02 and 10% H2). Percoll density gradient enrichment was used
to obtain populations that were non-capsulate by light microscopy as described
previously (2).
DNA was isolated using a modification of the basic protocol for preparation of
genomic DNA from bacteria detailed in Ausubel et al. (3). In brief, bacterial cells
were lysed in 10 mM TrisHCl ImM EDTA buffer (pH 8.0) containing SDS (0.5%),
lysozyme (4mg/ml) and proteinase K (O.lmg/ml). Polysaccharide was precipitated
using cetyltrimethylammonium bromide (CTAB) and DNA extracted with
chloroform: isoamyl alcohol and phenol:choloroform:isoamyl alcohol mixtures. DNA
was precipitated using isopropanol, spooled out with a glass rod and washed in
ethanol. The initial genome assembly was obtained from 94,563 paired end sequences
(giving 10-fold coverage) derived from four pUC18 genomic shotgun libraries (with
insert sizes ranging from 2.0 to 4.0 kb) using big-dye terminator chemistry on
ABI3700 automated sequencers. This was supplemented with 4,991 end-reads from
an ml3mpl8 library with an insert size of 2.0-4.0 kb; 3,388 paired-end sequences
from a pBACe3.6 library with insert sizes of 10-18 kb (a clone coverage of 4.56-fold)
were used as a scaffold. All identified repeats were bridged by read-pairs or end-
sequenced PCR products. A further 4,594 sequencing reads were generated during
finishing. The sequences were assembled, finished and annotated as described
previously (4), using Artemis (5) to collate data and facilitate annotation. The DNA
and encoded protein sequences of related species were compared using the Artemis
Comparison Tool (ACT) (K. Rutherford, unpublished;
http://www.sanger.ac.uk/Software/ACT/). Orthologous gene sets were calculated by
reciprocal best match FASTA comparisons, with subsequent manual curation.
Pseudogenes had one or more mutations that would ablate expression; each of the
inactivating mutations was subsequently checked against the original sequencing data.
Genomic comparison of Bacteroidesfragilis with Bacteroides
thetaiotaomicron
The recently sequenced B. thetaiotaomicron strain VPI-5482 (ATCC 29148)(6),
has a larger genome of 6.26 Mb containing 4779 predicted genes and an unusually
low ratio of gene number to genome size with 0.763 genes/kb (6). The proportion of
the genome devoted to protein coding (89.3%) is, however, not unusual. This is
explained by a high average gene length (1173 bp), and abundant large proteins of
over 600 aa. At 1087bp the average gene length in B. fragilis is slightly shorter, but it
is still amongst the highest so far reported in bacteria.
Despite their con-generic taxonomic status, B. fragilis and B. thetaiotaomicron
share remarkably few orthologous genes (as measured by reciprocal-best-match
FASTA analysis). Only 2,384 predicted genes are shared, with B. fragilis containing
1890 unique genes (44.3 % of its coding capacity), and B. thetaiotaomicron
containing 2337 (48.9 %). This is considerably greater than the number of genes
unique to Salmonella vs. Escherichia (7), or to Escherichia vs. Yersinia (8) indicating
the breadth of diversity amongst Bacteroides. This is underlined by the average
amino-acid identity between orthologous gene pairs; just 76.6%.
A comparison of B. thetaiotaomicron with B. fragilis was carried out to
determine the nature of the non-orthologous genes. A particularly interesting feature
is the extent of diversity of cell envelope, transmembrane, polysaccharide and outer
membrane proteins compared to B. thetaiotaomicron (Fig. S2); B. fragilis unique
surface proteins include 128 inner membrane proteins, 2 peptidoglycan associated
proteins and 57 predicted outer membrane proteins. In addition, there are 102 unique
surface polysaccharide biosynthesis genes, arranged in 10 gene clusters (seven of
which are controlled by invertible promoters). This variation in surface
polysaccharides and other antigens may be significant in relation to the difference in
the pathogenic potential between B. fragilis and B. thetaiotaomicron. In terms of
transcriptional regulators, the most abundant class is the AraC family of
transcriptional regulators, with 20 being unique compared to B. thetaiotaomicron. An
additional point of interest in the B. thetaiotaomicron genome is the significantly
increased number of sigma factors and anti-sigma factors relative to genome size; of a
total of 45 sigma factors in B. fragilis there are 16 that are not conserved in B.
thetaiotaomicron.
Additional DNA inversions
In addition to the restriction/modification intergenic shufflon, a further three
different systems were identified. The simplest involves BF0335 and BF0336 (IR-P),
which encode two parts of a sensor-regulator system. BF0336 encodes the putative
sensor domain and transmembrane domain, and BF0335 encodes the histidine kinase,
response receiver and DNA binding domains. The first CDS is flanked by inverted
repeats su such that recombination will fuse the two into a single coding sequence.
Other fused sensor-regulator genes, lacking invertible regions are present both in B.
fragilis and B. thetaiotaomicron (6).
A further two more complex systems involve gene pairs similar to ragA (susC -
like) and ragB of P. gingivalis (Fig. 1). In P. gingivalis RagB is a major
immunodominant surface antigen and ragA/B positive strains are associated with
sites of periodontal destruction (9) SusC is an outer membrane protein, which in
association with SusD, binds starch at the bacterial surface in B. thetaiotaomicron
(10). In one system, five ragA/B like gene pairs (BF1716/8, BF1719/20, BF1722/21,
BF1798/7 and BF1803/2; IR-EE), at either end of a ~90 kb region of the
chromosome, have an extensive repeat sequence (over 200bp) that overlaps the start
codon of the ragA homologs (Fig. 1C). One of these (BF1803) is downstream of an
invertible promoter (Table S2A, Group 2; IR-T), and recombination between these
larger repeats could bring any one of the alternative gene pairs downstream of this
promoter by inversion of the intervening sequence. Evidence that this was indeed
occurring was found in the shotgun data. A potential recombinase (BF1795) is located
close to BF1797/9 and is associated with the putative conjugative transposon encoded
within the 90kb central region.
A second independent system involves a further group of four co-located ragA/B
like gene pairs (BF0590, BF0592, BF0594 and BF0596; Table lb, IR-CC), where
three of the susC (ragA-like) homologues lack an appropriate start codon. Within the
5' end of the coding region of these genes is a 60bp inverted repeat, identical to that
found 68 amino-acids downstream of the start codon of the fourth, BF0594 (Fig. 1C).
Recombination between these inverted repeats would fuse the coding sequences of
any of these genes to the promoter and translation initiation signals of BF0594. Again,
evidence was seen that this was occurring in the shotgun. Another potential
recombinase (BF0593) is encoded adjacent to these genes. Examples of similar
multiple intergenic inversions include ompl ofDichelobacter (formerly Bacteroides)
nodosus and the variable surface antigens ofMycoplasma pulmonis (11). There are
also invertible promoter regions upstream of nine other susC homologues (Table S2A)
and several other predicted outer membrane proteins belonging to a related family
(Table S4). This indicates that there is a strong selective pressure in favour of the
variation of these molecules, which suggests that they play an important role in the
survival of B.fragilis.
Several invertible promoters are between divergent coding regions, thus
potentially driving variable transcription of other genes. These include a
sialoconjugate degradation operon (IR-T; BF1804-BF1817); a sigma factor (IR-W;
BF2944), indicating the possibility of cascade regulation; and the cpnl0-cpn60 operon
encoding the major chaperones GroES and GroEL (IR-M). These genes are known to
be essential, and have not been seen to be phase-variable, in other organisms.
Analysis of the promoter region for cpnlO in B. thetaiotaomicron shows that it is
flanked by 29bp inverted repeats whose sequence is similar to that of B.fragilis,
although it has not been identified as being invertible.
An 1 lkb region of the plasmid (pBF9343) containing partition, replication and
mobilisation functions, and the invertasefinB, undergoes inversion (Fig. SIB). There
appears to be no clear functional consequence of this, although it may affect the
transcription offinB, as one of the ends of the inversion is ~ 100 bp upstream of its
start site. As both FinB and the chromosomally-encoded FinA (MpiA) may be
involved in inversion of hin-like invertible promoters, this raises the possibility of a
random variation in the rate of variation at those promoters in plasmid-containing
strains.
Virulence associated genes
Iron is essential for the growth of most bacteria. Within the human host iron is
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sequestered such that the free iron concentration is estimated to be 10" M, well
below the concentration necessary to support bacterial growth. To overcome this iron
famine, pathogenic bacteria have evolved specific adaptive mechanisms for obtaining
iron. One is the production of secreted iron chelating compounds termed siderophores
that sequester iron and are subsequently re-imported through membrane receptors
(12). Internalisation is generally performed by TonB-dependent outer-membrane
receptors, of which B.fragilis contains at least 57, and is energised by the
TonB/ExbBD complex (BF3737, BF3738 and BF3739). An FhuA (Vibrio cholerae
ferrichrome receptor) homologue, together with a two-component sensor-regulator
pair and a complete sigma, anti-sigma and anti-anti-sigma factor system (BF2844,
BF2842 and BF2843) is evident. Whether B.fragilis synthesises siderophores or
utilizes those produced by other bacteria remains to be determined, although a non-
ribosomal peptide synthase (BF2837), an enzyme family known to be involved in the
biosynthesis pathway for other siderophores, is located nearby and may be part of a
siderophore biosynthesis system. In addition, there are two periplasmic binding-
protein dependent iron uptake systems, of the ferric citrate FecCD family (BF1185
and BF2247), each with an associated periplasmic iron-binding protein. The putative
siderophore uptake systems appear to be independent of the already identified iron-
repressible haem uptake protein HupA that forms part of a haem binding outer
membrane protein complex (75). Although growth is severely limited in the absence
of haem (14), B.fragilis does not produce zones of haemolysis on blood agar. There
are, however, 13 CDSs, fewer than in the B. thetaiotaomicron genome, which may
encode a haemolytic function. One of these (BF0270) is similar to the haemolysin A
of Prevotella rnelaninogenica (formerly Bacteroides melaninogenicus). Interestingly,
within the associated CDSs (BF0266-0269) there is a putative haem receptor,
suggesting that this might be a haem acquisition operon.
Extracellular enzymes, potentially capable of degrading components of the
host's extracellular matrix, host cells and tissue, and therefore potentially involved in
B. fragilis virulence, include hyaluronidase, chondroitin sulphatase, fibrinolysin,
DNAase, lipases, proteases and neuraminidases (75). Bacterial sialidases or
neuraminidases that remove the sialic acid residues from host oligosaccharides are
implicated in bacterial virulence as they potentially interfere with normal host cell
function. The neuraminidase NanH (BF1806) has previously been sequenced from B.
fragilis and a second, highly similar, gene is present (BF4051), which could be
equivalent to the second previously reported in B.fragilis strain SBT3182 by Tanaka,
et al. (16) The observed degradation of hyaluronic acid, a component of the host's
extracellular matrix, may be due to BF3796, which is similar to the hyaluronidase
encoded by a Streptococcus pyogenes bacteriophage (17). Three putative tricorn-like
proteases (BF0080, 2517 and 3752) with similarity in the beta-propeller, PDZ and
catalytic domains are evident, but as in the MdsD protein of Prevotella sp, they also
contain a putative signal peptide (18). Which of the potentially secreted putative 23
peptidases and 2 lipases are involved in virulence rather than nutrition remains to be
determined.
Attachment to host tissues is key to the virulence of many pathogenic bacteria,
and can be promoted by a variety of adhesins. The non-capsulate/EDL population of
B.fragilis haemagglutinates erythrocytes (19). One haemagglutinin (BF1428) that has
a homologue in B. thetaiotaomicron is evident; however, no fimbrial genes have been
identified, despite reports of their observation in other strains (20). There is no
evidence for type III, IV, autotransporter or two-partner secretion systems nor
flagellar biosynthesis systems in the B.fragilis genome, hence secreted virulence
determinants are likely to be exported via Hly-type I secretion systems such as
BF0010 and BF0011, BF0608 and BF0610 or BF3811 and BF3812, which are similar
to the haemolysin type I secretion system HlyDB from E. coli (21), or via the type II
general secretion pathway. B. fragilis produces copious quantities of enzyme-
containing outer membrane vesicles (22). This may therefore be an important export
mechanism.
DNA recombination and repair of metronidazole induced DNA damage
The current drug of choice in treating B.fragilis infections, metronidazole, is
activated intracellularly via anaerobic reduction of the nitro group and interacts with
DNA causing strand breaks. RecA-mediated strand exchange is required for repair of
DNA breaks, the importance of which is shown by the sensitivity of a B.
thetaiotaomicron recA mutant to metronidazole and other DNA damaging agents (23).
RecA (BF1180) is 60% identical to E. coli RecA and can complement an E. coli recA
mutant, demonstrating that DNA repair pathways are conserved in B. fragilis(24).
Two major pathways of recombination have been extensively studied in the
model organisms E. coli and Bacillus subtilis; single-strand gap repair mediated by
the RecFOR proteins and double-strand break repair (reviewed in ref. 25) Specific
DExx motif helicases, belonging to Superfamily I, are essential in cells expressing
RecF; these are Rep and UvrD in Gram negative bacteria and PcrA in Gram positive
bacteria (26). B.fragilis contains a total of 24 putative DNA helicases, compared to
11 in E. coli, the functional significance of which is unknown. RecFOR homologues
are present in B.fragilis together with two homologues of the PcrA helicase usually
found in Gram positive bacteria. The presence of single PcrA homologues has been
suggested to be a hallmark of Gram positive bacteria (26). It remains to be determined
whether the two homologues in B.fragilis have separate roles or overlapping
functions analogous to the activities of Rep and UvrD in E. coli.
Double-strand break repair is mediated by RecBCD in E. coli and AddAB in B.
subtilis (25). B.fragilis contains a CDS (BF0679) encoding a homologue of RecD but
does not contain identifiable homologues of RecBC or AddAB. The RexAB ATP-
dependent exonuclease/helicase has been implicated in repair of double-strand breaks
in the Gram positive bacterium Lactobacillus lactis (27). There is a single RexA
(BF2192) homologue in B.fragilis but no identifiable RexB. A potential hypothesis is
that double-strand break repair in B. fragilis is mediated by a novel mechanism where
the joint action of the RexA and RecD helicases unwind the DNA duplex with
concurrent degradation by the exonuclease function of RexA until the equivalent of a
chi site is encountered. This combination of helicases of opposite polarities (RecD has
5'-3' while RexA has 3'-5' activity) would be analogous to the helicase functions
present in the RecBCD complex (28).
The sequence and annotation of the genome are available with further details
from http://www.Sanger.ac.uk/Projects/B_fragilis/.
Supporting Figures:
Figure SI: A) Circular representation of the B.fragilis NCTC9343 chromosome: From the
outer to the inner circle: Circle 1: DNA coordinates (origin in base 1); Circles 2+3: all CDSs
(forward and reverse strands); Circles 4+5: Unique CDSs in B.fragilis as compared with B.
thetaiotaomicron CDSs (forward and reverse strands); Circle 6: Pathogenicity related CDSs
(blue); Circle 7: polysaccharide biosynthesis clusters (green) and invertible regions (black);
Circle 8: SusC homologues (pink); Circle 9: rRNAs (orange) and tRNAs (blue); Circle 10:
G+C content (plotted using a 10Kb window); Circle 11: GC skew ((G-C)/(G+C)) (plotted
using a 10Kb window). Colour coding for circles 2 and 3: dark blue;
pathogenicity/adaptation, black; energy metabolism, red; information transfer, dark green;
surface associated, cyan; degradation of large molecules, magenta; degradation of small
molecules, yellow; central/intermediary metabolism, pale green; unknown, pale blue;
regulators, orange; conserved hypothetical, brown; pseudogenes, pink; phage+IS elements,
grey; miscellaneous. B) Circular representation of the pBF9343 plasmid: From the outer to
the inner circle: Circle 1: DNA coordinates with repeats marked as blue boxes; Circles 2+3:
CDSs (forward and reverse strands); Circle 4: Transfer region marked with black line; Circle
5: Mobilisation region marked with black line; Circle 6: G+C content (plotted using a 1Kb
window); Circle 7: GC skew ((G-C)/(G+C)) (plotted using a 1Kb window); Circle 8: Inverted
region marked with black line.
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Figure S2: Numbers of orthologous genes between B.fragilis and B. thetaiotaomicron (dark
grey), and genes unique to B.fragilis (light grey) within specific functional categories.
Supporting Tables:
Table SI - General features of the B.fragilis genome.
Chromosome Size (bp) 5,205,140
G+C content (%) 43.19
CDSs 4,274
of which pseudogenes 70
Coding density (%) 88.1




Plasmid pBF9343 Size (bp) 36,560
G+C content (%) 32.24
CDSs 48
Coding density (%) 85.0
Average gene length (bp) 652
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PSA 1635470..1635940 E Yes UpaY / UpaZ
BF1367-
BF1377






- UpcY / UpcZ
BF1009-
BF1026
PSD 4346276..4361140 H Yes UpdY / UpdZ
BF3683 -
BF3699
PSE 3016482..3032253 D Yes UpeY / UpeZ
BF2591 -
BF2606
PS F 1807211..1822424 I No UpfY / UpfZ
BF1549-
BF1565
PS G 894922..917651 DD No UpgY/UpgZ
BF0731 -
BF0752




































Putative TonB dependent outer membrane
exported protein
No
BF0381 465995.-469327 Putative exported protein No
BF0501 581461..584628 Putative outer membrane protein No
BF0518 603565..606753 Putative outer membrane protein No
frrG
(BF0536)
629760..633170 Putative outer membrane protein No
BF0571 680148..683426




















Putative SusC homologue surface
membrane protein
Yes
BF0661 797339..800476 Putative outer membrane protein No
BF0681 828289..831702 Putative outer membrane protein No
BF0711 871405..874152
Putative TonB-dependent outer membrane
receptor protein
No
BF0759 924125..927259 Putative outer membrane protein No
BF0807 989559..992741 Putative outer membrane protein No
BF0864 1070528..1073572 conserved hypothetical protein No
BF0866 1075945.. 1079352 Putative outer membrane protein No
BF0868 1081426..1084734
Putative TonB-linked outer membrane
protein
No
BF0871 1087602..1090943 Putative exported protein No
BF0890 1111869..1115135 Putative outer membrane receptor protein No
BF0893 1118124..1121387 Putative outer membrane receptor protein No
BF0971 1213148..1216468 Putative outer membrane protein No
BF0977 1222361..1225738
Putative TonB-dependent outer membrane
receptor protein
No
BF1204 1463991..1467359 Putative outer membrane protein No
BF1310 1570137..1573439 Putative outer membrane protein No
BF1415 1679751..1683143 Putative outer membrane protein No
BF1512 1771475..1774855 Putative outer membrane protein No
BF1618 1886174..1889299 Putative outer membrane receptor protein No
BF1716 1999994..2002084




















Putative TonB-dependent outer membrane
receptor protein
No
BF1816 2119766..2122507 Putative outer membrane protein No
BF1956 2283190..2286564 Putative outer membrane protein No
BF1992 2330851..2334225 Putative outer membrane protein No
BF2044 2387138..2389924




Putative TonB-dependent outer membrane
receptor protein
No
BF2195 2557432..2560734 Putative exported protein No
BF2270 2654934..2658200 Putative exported protein No
BF2697 3136811..3139111




Putative exported TonB-dependent receptor
protein
No
BF2907 3376170..3379502 Putative exported protein No
BF2942 3416623..3419997 Putative exported protein No
BF3024 3515789..3518941 Putative exported protein No
BF3097 3612821..3616255 Putative exported protein No
BF3146 3670784..3673789 Putative exported protein No
BF3199 3754969..3758121 Putative exported protein No
BF3258 3835857..3839033 Putative exported protein No
BF3307 3899923..3903075 Putative exported protein No
ompl17
(BF3412)
4024110..4027376 Putative outer membrane protein No
BF3444 4066003..4069050 Putative membrane protein No
BF3572 4206914..4210357 Putative membrane protein No
BF3576 4214892..4218104 Putative exported protein No
BF3581 4222187..4225660 Putative membrane protein No
BF3642 4297965..4300640 Putative exported protein No
BF3712 4374951..4378244 Putative exported protein No
BF3724 4392109..4395414 Putative exported protein No
BF3746 4419207..4422644 Putative membrane protein No
BF4056 4769105..4772347 Putative outer membrane protein No
BF4062 4781654..4784647
Putative TonB-linked outer membrane
protein
No
BF4132 4860945..4864271 Putative outer membrane protein No
BF4169 4911410..4914403
Putative TonB-linked outer membrane
protein
No
BF4178 4932416..4935583 Putative outer membrane protein No
BF4246 5030783..5033878 Putative outer membrane protein No
BF4248 5030783..5033878 Putative outer membrane protein No
BF4256 5046824..5050081 Putative outer membrane protein No
BF4268 5067453..5070962
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INTRODUCTION
The major Gram-negative non-sporing anaerobic bacteria of medical
interest are classified within the families Bacteroidaceae and Fusobac-
teriaceae. They are a major component of the normal microbiota of
mucosal surfaces of man and the whole range of animals from inverte¬
brates such as termites to primates and are also important pathogens,
usually in infections related to those colonised mucosal sites. Their
contribution to human infection was first recognised in a report of
pulmonary gangrene and appendicitis by Veillon and Zuber from the
Institute Pasteur in 1898 although organisms now classified as Fuso-
bacterium necrophorum had already been shown to cause calf 'diph¬
theria' (by Loeffler in 1884), liver abscesses in cattle and facial
necrosis in rabbits. In 1861, Pasteur himself had introduced the temi
anaerobe for microbes that would grow only in the absence of free
oxygen. Before 1900, the role of non-sporing anaerobes in suppura¬
tive diseases of the middle ear, mastoid and sinuses, pulmonary
gangrene and genital tract infection was established by the group of
researchers at the Facultd de Medicin de Paris. However, with a few
notable exceptions, non-sporing anaerobes were largely ignored in
mainstream medical microbiology for most of the 20th century, until
the 'anaerobic renaissance' of the 1970s when improved laboratory
methods for reliable routine anaerobic microbiology became more
widely available. The findings of the early workers were then redis¬
covered, and the widespread role of these organisms in infections of
the abdomen, perineum and genitalia, mouth and respiratory tract, and
compromised soft tissues at other sites became more generally recog¬
nised (Finegold, 1994).
DESCRIPTION OF THE ORGANISMS
Development of Taxonomy
Veillon and Zuber named their isolates Bacillus fragilis. Bacillus
fusiformis and others, and the current classification dates from 1919
when Castellani and Chalmers proposed the name Bacteroides for all
obligately anaerobic, non-sporing bacilli; this definition was modified
lo exclude Gram-positive organisms by Weiss and Reltger in 1937.
Knorr introduced the name Fusobacterium in 1922 for the spindle-shaped
Gram-negative anaerobes. Despite various subsequent proposals for
new genus names, all of which were subsequently deemed to be invalid,
these two genera were the basis of the classification presented in the
eighth (1974) edition of Bergey's Manual of Determinative Bacteri¬
ology, with the addition of the single-species genus Leptotrichia
(L. huccalis) for fusiform organisms that produce lactic acid rather
than butyric acid as their major metabolic product (Holdeman and
Moore, 1974). The genus Bacteroides contained five groups of
species: 1. B. fragilis, divided into five sub-species; 2. bile-sensitive
non-pigmented species such as B. oralis; 3. B. melaninogenicus
including all strains that produced black- or brown-pigmented
colonies on lysed blood agar and divided into three sub-species;
4. non-saccharolytic non-pigmented species; and 5. other, unrelated
saccharolytic species. This was the starting point for the rapid growth
of clinical and taxonomic studies with Gram-negative anaerobes
(Ducrdcn, 1983).
It should be remembered that although these bacteria are Gram
negative, they are not closely related taxonomically to facultative and
aerobic Gram-negative bacteria generally encountered in infections
such as the Enterobacteriaceae and the pseudomonads. Bacteroides
and the related Porphyromonas and Prevotella spp. belong to the
Bacteroidetes/Chlorobi superphylum. This group diverged early in
evolutionary terms from other eubacteria, and this is thought to have
occurred well before the divergence of the Gram-positive bacteria
from the phylum that contains Gram-negative species such as
Escherichia coli, the Proteobacteria. Similarly, the fusobactcria are
within their own separate phylum and have similarities at the genome
sequence level with low mol% G + C Gram-positive bacteria.
The early taxonomic studies on these bacteria were based upon
conventional cultural and biochemical tests, which were difficult to
perform reliably and to interpret in anaerobic growth conditions. The
use of gas-liquid chromatography (GLC), introduced into this area of
work in the late 1960s, was a significant advance in showing the
possession of distinct metabolic pathways giving reproducible
patterns of fatty acid end products. A recent description of GLC
methodology for anaerobes is detailed in the Wadswoth-KTL anaerobic
bacteriology manual (Jousimies-Somer etal., 2002). However, the
significant advances since 1980 have been based upon a combina¬
tion of chemotaxonomy and genetic analysis in particular, for
example, phylogenetic 16S rRNA gene sequencing. rRNA gene
sequencing is now a standard method for the validation of culture
identity, and suitable methodology is detailed in, for example,
Stubbs et al. (2000). A comprehensive taxonomic listing of old and
new nomenclature can be found in Jousimies-Somer and Summanen
(2002). The reader is directed to the following publications for
detailed information on taxonomic history and recent updates
(Shah and Garbia, 1991; Jousimies-Somer, 1997; Shah, Gharbia
and Duerden, 1998; Jousimies-Somer and Summanen, 2002). The
chemotaxonomic characters of the main genera are summarized in
Table 45.1.
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Table 45.1 Chemotaxonomic characters of the main genera of Gram-negative anaerobes of clinical importance
Character Bacteroides Bilophila Prevotella Porphyromonas Fusobacterium B. ureolyticus
Major products Acetate, succinate Acetate succinate Acetate succinate Butyrate Butyrate Acetate,
propionate
Dehydrogenases G-6-PDH, 6-PDGH, MDH, GDH MDH, GDH GDA
MDH, GDH
DNA G + C (mol%) QIoo 39-40 40-50 48-54 27-32 28
Peptidoglycan meso-DAP DAP DAP, lysine DAP, lanthionine
diamino acid
Fatty acids Straight saturated ante/so- and Straight saturated anteiso- and ijo-methyl branched Straight chain,
wo-methyl branched /jo-methyl branched monounsaturated
Quinones MK-10, MK-11 MK-10, MK-11, MK-13 MK-9 -
Sphingolipids + - - - -
Urease - + - - - +
6-PGDH, 6-phosphogluconate dehydrogenase; DAP, diaminopimelic acid; G-6-PDH, glucose-6-phosphate dehydrogenase; GDH, glutamate dehydrogenase; MDH, malate dehydrogenase.
Bacteroides
The sub-species of B. fragilis were given species status, and several
new species were added to this fragilis group of intestinal Bacter¬
oides. As other species have been removed to new genera, the genus
Bacteroides sensu stricto should now encompass only those species of
the fragilis group. It was also recognised that a single species B. mela-
ninogenicus, which had been described by Oliver and Wherry in 1921,
could not include organisms as diverse as the saccharolytic subsp.
intermedius and subsp. melaninogenicus and the non-saccharolytic
but highly proteolytic subsp. asaccharolyticus. Bacteroides asaccha-
rolyticus was first separated as a distinct species and then assigned to
a new genus, Porphyromonas, together with related isolates from diseases
of the mouth, P. gingivalis and P. endodontalis', further new species of
human and animal origin were added subsequently. The saccharolytic
pigmented species were shown to share many properties with the
group 2 non-pigmented organisms that were mostly of oral or genital tract
origin. These became the 'melaninogenicus-oralis group' and were
then assigned to a new genus as Prevotella spp. The other 'Bacter¬
oides' species that do not belong to these three main genera of human
isolates have mostly been assigned to various new genera although a
few remain with the inappropriate name 4Bacteroides' while awaiting
reclassification. With the exception of 'B.' ureolyticus and Bilophila
wadsworthia, these are of little concern in medical microbiology.
Fusobacterium
The genus Fusobacterium is now defined in biochemical and genetic
terms as encompassing Gram-negative non-sporing anaerobes with DNA
G + C content of 27-33 mol% that produce butyric and propionic
acids as major metabolic products. Many that conform with this
description do not exhibit the classical fusiform appearance. The
more significant members of the genus in human disease are
F. necrophorum and F. nucleatum.
General Properties
All members of the families Bacteroidaceae and Fusobacteriaceae are
obligately anaerobic, Grani-negative bacilli, although many are highly
pleomorphic and microscopic appearances range from cocco-bacillary
to long filamentous forms. Their susceptibility to oxygen varies;
some, such as B. fragilis, can remain viable (sub-cultivable) after
exposure to oxygen for many hours after growth on agar media,
whereas some others cannot withstand exposure for more than a few
minutes. Most of those of concern in medical microbiology are at the
more tolerant end of this spectrum and can be manipulated on the
open bench, although the speed of regrowth and percentage viability
are generally better if bacteria are handled in an anaerobic cabinet
without exposure to air. Anaerobic conditions for growth are provided
by incubation in anaerobic jars, or cabinets or other small-scale
culture systems that exclude air and have a chemical system for
removing traces of oxygen. The most commonly used gas mixture is
H2 10%, CC>2 10%, N2 80% for cabinets, or jars that incorporate a
palladium catalyst to ensure the removal of remaining oxygen by reac¬
tion with the hydrogen. The species assigned to the main genera of are
listed in Table 45.2. The genera Bacteroides, Prevotella and Porphx-
romonas all fall taxonomically within the class Bacteroides, whereas
the genera Fusobacterium and Leptotrichia are within the class Fuso-
bacteria. Details of the taxonomic status and classification of bacteria,
including anaerobes, can be found at the NCBI taxonomy web site http://
www.ncbi.nlm.nih.gov/Taxonomy/taxonomyhome.html/.
Bacteroides
Bacteroides fragilis and other members of the genus Bacteroides
sensu stricto are indistinguishable by microscopy or by colonial
appearance. They are small, moderately pleomorphic, non-motile
Gram-negative bacilli; cocco-bacilli are common but long filaments
Table 45.2 Gram-negative anaerobic bacteria of clinical significance
Bacteroides Prevotella Porphyromonas Fusobacterium
B. fragilis Pr. melaninogenica♦ P. asaccharolytica F. necrophorum
B. distasonis Pr. denticola* P. gingivalis F. nucleatum
B. ovatus Pr. loescheii* P. endodontalis F. varium
B. thetaiotaomicron Pr. intermedia* P. canontiae** F. pseudonecrophoritm
B. vulgatus Pr. nigrescens♦ F. naviforme
B. uniformis Pr. corporis* P. macacae F. mortiferum
B. eggerthii Pr. tannerae* P. levii F. russii
B. caccae Pr. pallens* P. gulae F. ulcerans
B. merdae
B. stercoris Pr. buccae
B. capillosus Pr. oris
B. coagulans Pr. buccalis
B. putredinis Pr. oralis
Pr. dentalis
Pr. enoeca








♦Black- or brown-pigmented Prevotella spp.
♦♦Non-pigmented Porphyromonas spp.
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are rare. They grow well on conventional laboratory media containing
blood to form circular, low convex, smooth, shiny, translucent or
semi-opaque, grey colonies, 1-3 mm in diameter, that are often moist
or frankly mucoid after incubation for 24-28 h. Most strains are non-
haemolytic, but a few are slightly haemolytic and a small proportion
are distincdy P-haemolytic. They are strongly saccharolytic organisms,
producing acid from a range of carbohydrates, and moderately proteo¬
lytic. The main end products of metabolism detected using GLC are acetic
and succinic acids, with smaller amounts of various other acids but
not n-butyric or lactic acids. Growth is generally stimulated by whole
bile but inhibited by sodium deoxycholate and isolates are tolerant of
the bile salt sodium taurocholate. Bacteroides splanchnicus is an
intestinal Bacteroides that differs from the other true Bacteroides spp. in
producing propionic and n-butyric acids and in genetic and chemotaxo-
nomic characters; it probably represents a distinct genus.
Prevotella
The various species of Prevotella cannot be distinguished by cell
morphology. Most are short pleomorphic Gram-negative bacilli, often
with many cocco-bacillary forms. They are divided into pigmented
and non-pigmented groups by the ability of some to assimilate haemo¬
globin from blood in the medium, converting it to protohaemin which
accumulates in the cells, making the colonies dark brown or black
after incubation for several days. Most pigmented strains are haemolytic,
and pigmentation depends upon lysis of the red cells in the medium
and develops most rapidly on lysed blood agar. Pigmentation can vary
from almost black to pale brown. Colonies of the non-pigmented
species are indistinguishable from each other and very similar to those
of the Bacteroides spp. - 1-2 mm in diameter, circular, shiny, convex
and light buff or grey coloured; most are non-haemolytic. Prevotella
spp. are moderately to strongly saccharolytic. All produce acid from
glucose and various other carbohydrates and, like Bacteroides spp.,
their major metabolic products are acetic and succinic acids; n-butyric
acid is not produced. Most species are moderately to strongly proteolytic.
They are inhibited by bile and bile salts.
Porphyromonas
Formerly known as the asaccharolytic B. melaninogenicus strains,
Porphyromonas spp. are similar to pigmented Prevotella spp. in
microscopic and colony morphology. They are small, mainly cocco-
bacillary organisms with few long filaments. Growth is slower than
with Bacteroides spp. and some Prevotella spp.; small colonies may
be visible after incubation for 24 h but many do not appear until 48 h
when they are <1 mm in diameter, smooth, shiny and grey. Dark
brown or black pigmentation develops after 3-7 days on blood agar,
more rapidly on lysed blood agar. After 4-5 days, they are 1-2 mm in
diameter and haemolytic - lysis of the cells being essential for
pigmentation. Most strains have a characteristically strong, putrid
smell, even more noticeable than those of other non-sporing anaer¬
obes. They do not produce acid from glucose or other carbohydrates
but their metabolism, as with all anaerobes, is fermentative. The major
metabolic end product is n-butyric acid. Like Prevotella spp., Porphy¬
romonas spp. are inhibited by bile or bile salts. They are vigorously
proteolytic, and this is considered to be a factor in their virulence.
Fusobacterium
Fusobacteria are anaerobic Gram-negative bacilli of varied size and
morphology. Classical fusobacteria, such as F. nucleatum are fairly
long (4-6 pm), regular bacilli with tapered or pointed ends. Sphero-
plasts and spindle forms are common. Others (e.g. some strains of
F. necrophorum) are pleomorphic with a mixture of long, filamentous
organisms with rounded ends and many short or even cocco-bacillary
forms and numerous sphcroplasts and L-forms. Yet others arc mostly
cocco-bacillary. Colonial appearance is also varied, but most fusobacteria
produce moderate to large colonies, 1-3 mm in diameter, generally
with an irregular or dentate edge. They vary from translucent to
granular and opaque. Their metabolism varies; carbohydrates are
fermented only feebly or not at all but most species are proteolytic and
the more virulent species such as F. necrophorum produce a range of
enzymes that can break down tissue components (see p. 536 Tissue
damage line 50-62). The major metabolic products of fusobacteria,
which help define the. genus, are n-butyric and propionic acids, the
latter produced by deamination of threonine. The G + C content of
fusobacteria is low at 27-33 mol%, and these and Leptotrichia are
phylogenetically distinct from the Bacteroidaceae.
Leptotrichia
The species L. buccalis may be synonymous with the original fusi¬
form organism described by Vincent. It has typical, long fusobacterial
cells, 5-15 pm long, many with pointed ends. Its colonies are lobate or
convoluted, opaque and grey/yellow in colour. Although it is within
the Fusobacteriaceae, it differs from Fusobacterium spp. in that it
produces acid from several sugars and the only major metabolic
product is lactic acid, with a small amount of acetic acid; n-butyric
acid is not produced. Complete 16S rDNA sequencing and DNA-
DNA hybridisation of strains initially assigned to L buccalis reveals
sufficient generic diversity to warrant the designation of five different
species (including L. buccalis) within this group (Eribe etal., 2004).
Bilophila
The single species Bil. wadsworthia is a slow-growing, small Gram-
negative bacillus that is stimulated by bile, requires pyruvate for
growth and is asaccharolytic and urease positive (Baron etal., 1992).
It has no generic homology with Bacteroides spp. and is classified
within the Desulfovibrionaceae in the phylum Proteobacteria (Laue,
Denger and Cook, 1997).
'Bacteroides' ureolyticus
This slender Gram-negative anaerobe typically forms pitting colonies
on agar media (hence its former name B. corrodens). It is asaccharolytic,
strongly proteolytic and urease positive. Its G + C content of 28 mol%
clearly sets it apart from the other genera of Bacteroidaceae. Geno-
typically it is related to the Campylobacteraceae, in the phylum
Proteobacteria (Jousimies-Somer, 1997). It is likely that it will be
renamed once further similar bacteria have been isolated and studied.
Growth Conditions
As well as requiring anaerobic conditions, most Gram-negative anaerobic
bacilli require enriched media for growth; none grows readily on minimal
media or unsupplemented nutrient agar. Most require a source of
haemin for synthesis of the menaquinones that are essential components
of their anaerobic electron transport systems. Some Prevotella and
Porphyromonas spp. also require menadione (vitamin K). Media for
optimal growth comprise a rich nutrient base, e.g. Fastidious Anaerobe
Agar (Lab M), Columbia agar base (Oxoid), Brucella agar or Wilkins
Chalgren agar, with 5-10% blood plus haemin and menadione.
Bacteroides spp. and some of the more vigorous Prevotella spp. produce
reasonable growth after 24 h, but other species grow more slowly and
require undisturbed anaerobic incubation for 48-72 h, or even longer,
for recognisable growth. Details of the growth conditions for anaerobes of
clinical importance can be found in the following references (Moore
and Moore, 1977; Summanen etal., 1993; Jousimies-Somer etal., 2002).
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NORMAL HUMAN MJCROBIOTA
All the Bacteroides and Fusobacteria associated with man are part of
the normal resident microbiota of the gastrointestinal, oral or geni¬
tourinary mucosae where they form a major part of the complex and
interdependent ecosystems. However, the species found at the three
sites are quite distinct and each species appears to have a distinct
ecological niche (Drasar and Duerden, 1991).
Gastrointestinal Tract
This is the normal habitat of all the species of Bacteroides sensu
stricto (B. fragilis group). They are one of the predominant groups of
organisms in the faecal and colonic microbiota, having populations of
approximately 1012 cfu/g wet weight of faeces and outnumbering the
facultative enterobacteria by at least 1000:1. Not all species are equally
common. The main components of the normal faecal microbiota are
B. vulgatus, B. distasonis, B. thetaiotaomicron and B. uniformis.
Within the gut, Bacteroides spp. contribute to the degradation of
ingested material, in particular heterologous polysaccharides in plant
material, that the mammalian system is incapable of degrading. This
process results in the production of short-chain fatty acids, which once
absorbed from the gut are potential substrates for energy metabolism
in the intestinal mucosal epithelium. The potential for intimate
interaction between the normal microbiota and the human host is
illustrated by B. thetaiotaomicron. Within the environment of the
small intestine, B. thetaiotaomicron appears to induce villus cells to
fucosylate their cell surface glycoconjugates. Bacteroides thetaio¬
taomicron also secretes an a-fucosidase which cleaves the fucose
from the villus cell glycoconjugatcs, thus releasing the fucose, which
then becomes a potential carbon and energy source for the bacterium
(Hooper etal., 1999). Studies of the adherent mucosal microbiota
indicate considerable variation amongst individuals. Mucosal biopsies
of the proximal colon and rectum of 12 individuals showed that in
different people one or two species of Bacteroides predominated by
culture (Poxton etal., 1997). For example, B. fragilis was the major
isolate in one individual, the second most common isolate in three
individuals and not detected in six, whereas B. vulgatus was the
most common isolate in four individuals. Although B. fragilis
accounts for fewer than 10% of faecal isolates and was not detected in
some of the biopsy patients, it is the principal pathogen in gut-associated
sepsis (approximately 75% of isolates from abdominal infections).
This indicates that B. fragilis has a greater pathogenic potential than
the other Bacteroides spp. Bil. wadsworthia is also a common but not
dominant member of the faecal microbiota. The gastrointestinal tract
is probably also the normal habitat of P. asaccharolytica and
'B.' ureolyticus, but these are present only in small numbers.
Genitourinary Tract
Gram-negative anaerobes are part of the normal microbiota of the
vagina although present in relatively small numbers (approximately
10 cfu/g of secretions) and outnumbered by Gram-positive species
such as lactobacilli. Most isolates belong to the genus Prevotella,
principally Pr. bivia and Pr. disiens which are uncommon elsewhere
in the body; the pigmented species Pr. melaninogenica is also present,
but in smaller numbers and less frequently (Drasar and Duerden, 1991).
Mouth
The oral microbiota have long been recognised as a source of a wide
range of Gram-negative anaerobic species. The main habitat for these
organisms in the mouth is the gingival crevice where both Prevotella and
Fusobacterium spp. make a major contribution to the complex micro¬
biota. The most commonly reported isolates are Pr. melaninogenica,
Pr. oralis and other non-pigmented Prevotella spp. and fusobacteria,
mainly F. nucleatum. Prevotella intermedia is also isolated from the
nomial gingival microbiota but, like B. fragilis in the colon, represents
a much smaller proportion of the total count of Prevotella spp. than do
other species. Porphyromonas gingivalis is rarely isolated from
healthy gingivae (Drasar and Duerden, 1991).
PATHOGENICITY
A wide range of Bacteroidaceae and Fusobacteriaceae have been isolated
at one time or another from infections of man but a high proportion of
these infections are caused by only a few, more virulent species. Three
main features are common to most of these infections: 1. the source of
infection is the endogenous microbiota of the patient's own gastrointes¬
tinal, oropharyngeal or genitourinary mucosa; 2. alterations of the host
tissue, e.g. trauma and/or hypoxia, provide suitable conditions for the
development of secondary opportunist anaerobic infections; and 3. the
infections are generally polymicrobial, often involving mixtures of
several anaerobic and facultative species acting synergically to cause
damage. The initiation of infection generally depends on host factors,
but even in such opportunist situations, some species show particular
pathogenic potential not evident for the majority of related species from
the same normal habitat. Thus, most species have some pathogenic
capability but the majority of serious anaerobic infections are caused by
the small number of more virulent species (Duerden, 1994).
The types of infection generally associated with Grant-negative
anaerobes are listed in Table 45.3. The species most commonly
isolated and considered to be significant pathogens in these situations
are: B. fragilis in abdominal infections; Pr. intermedia, P. gingivalis,
and F. nucleatum in periodontal disease and other infections related to
the mouth; P. asaccharolytica and B\ ureolyticus in superficial necro-
tising infections; and F. necrophorum in the invasive disease necro-
bacillosis (Lemmiere's disease). Fusobacterium necrophorum
(including subsp. necrophorum, formerly Biovar A, and subsp.fitndu-
liforme, formerly Biovar B) has more of the characteristics of a viru¬
lent primary pathogen than other anaerobic species; typically, it
causes severe purulent tonsillitis with pseudomembrane formation and
lymph node involvement, septicaemia and metastatic abscess forma¬
tion. It may be fatal even for a previously healthy person.
To establish an infection, bacteria must attach to target cells (generally
mucosal or epithelial cells), invade the tissues, establish themselves
by multiplying at the site of infection and avoiding elimination by the
Table 453 Gram-negative anaerobic bacteria isolated from the norma!
microbiota and from infections
Normal microbiota Infections
Faeces Abdominal
B. vulgatus B. fragilis
B. distasonis Bil. wadsworthia
B. thetaiotaomicron B. thetaiotaomicron
B. uniformis
Vagina Gcnito-urinary
Pr. disiens B. fragilis
Pr. bivia Prevotella spp.
Pr. melaninogenica P. asaccharolytica
'B'. ureolyticus
Mouth Head and neck
Pr. melaninogenica P. gingivalis
Pr. intermedia Pr. intermedia
Pr. ovalis F. nucleatum
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host's defence mechanisms and cause damage both to local tissues
and, in systemic infections, to the whole patient. A factor that may
impact on each of these events is within-strain surface variation in the
form of phase and antigenic variation. This type of variation is medi¬
ated by genomic rearrangements and is reversible within a single
strain (Patrick and Larkin, 1995). Multiple variants may arise during
the progression of infection of a single individual or indeed during one
subculture in the laboratory. The more virulent Gram-negative anaer¬
obes exhibit virulence factors that help elicit the different stages of
infection. A review of the major potential virulence factors of Bacter-
oides fragilis can be found in Patrick (2002). Whole-genome
sequencing programmes have added considerably to our knowledge
and understanding of pathogenic bacteria and will continue to do so in
years to come. Gram-negative non-sporing anaerobe whole-genome
sequencing programmes are listed in Table 45.4.
Surface Variation
A single strain of B. fragilis may have the capability to reversibly
produce three different encapsulating surface structures, namely a
large capsule or small capsule, both visible by light microscopy, or an
electron-dense layer (EDL) outwith the outer membrane, visible by
electron microscopy. In addition, polysaccharides associated with the
EDL and large capsulate bacteria (but which do not appear to form the
bulk of the large capsule structure) exhibit within-strain antigenic
variation (Lutton etal., 1991). This is mediated, at least in part, by
invertible promoter regions upstream of the polysaccharide biosyn¬
thesis opcrons. The invertible regions are bound by inverted repeats of
30 or 32 bp in length with striking similarity to the Salmonella typh-
imurium H flagellar antigen inversion cross-over (hix) recombination
sites of the invertible hin region (Patrick etal., 2003). In B. fragilis
NCTC 9343, there are ten different polysaccharide biosynthesis
operons. The genes within these operons indicate that some may be
similar to enterobacterial 'O-antigen' rather than classical capsules.
Analysis of the entire genome has revealed a further 16 regions with
similar sequence characteristics, suggesting that these may also be
active invertible promoters. Most of these are upstream of conserved
putative secreted and outer membrane proteins of unknown function.
Also there is evidence of large scale (5-120kb) DNA inversion events
within the genome (Cerdeno-Tarraga etal., 2005).
Whether this phenomenal variation relates to the increased
frequency of association of B. fragilis with infection when compared
with other gastrointestinal tract Bacteroides or survival in the
gastrointestinal tract remains to be determined.
Adhesion
Bacteroides fragilis can attach to both host cells and components of
the extracellular matrix; however, studies of adhesion have rarely
taken into account the considerable within-strain surface variation
p. 535 Surface Variation line 19-41. Haemagglutination and attachment
to host cells in B. fragilis is demonstrable in EDL-enriched populations
(Patrick etal., 1988). Sodium pcriodate treatment of the bacteria abolishes
haemagglutination, which suggests that saccharides are involved.
Populations of strain NCTC 9343 enriched for either a large or small
capsule do not haemagglutinate (Patrick etal., 1996). As recent clinical
isolates vary considerably in the proportion of bacteria that express the
different capsules, this probably accounts for the variation in adhesion
observed with different strains. Furthermore, the EDL/non-capsulate
bacteria release extracellular vesicles which by themselves will cause
haemagglutination. Despite reports of fimbria! expression by B. frag¬
ilis, fimbrial genes have not been reliably identified, although a gene
with similarity to a putative non-fimbrial adhesin described in
Pr. intermedia is present in B. fragilis NCTC 9343 (Cerdeno-Tarraga
et al., 2005). Studies of the attachment to components of the extracellular
matrix have generally not taken into account the within-strain variability
and the potential attachment of bacterial extracellular components;
however, there is clear evidence that Bacteroides spp. can attach to
some host components. Examples include fibronectin, collagen type 1
and vitronectin.
Periodontal pathogens also exhibit adhesive properties. Fusobacte-
rium nucleatum, P. gingivalis and Pr. intermedia adhere to crevicular
epithelium and cause haemagglutination. It seems likely that, as with
B. fragilis, both proteinaceous haemagglutinins and surface saccha¬
rides are involved. More than ten genes encoding haemagglutinin-
related proteins have been identified in the P. gingivalis genome
sequence (Nelson etal., 2003). Another aspect of adhesion that may
be important in polymicrobial infections is the ability of bacterial
species to coaggregate. These coaggregates may be important in
creating appropriate conditions for the symbiotic metabolism and
pathogenic interaction characteristic of anaerobic infections. This
feature is manifest by oral Prevotella and Porphyromonas spp.
together with streptococci, actinomyces and other oral species.
Fusobacterium necrophorum haemagglutinates erythrocytes from a
range of species, including humans, and some will also aggregate
human platelets. It is suggested that this causes intravascular coagula¬
tion which contributes to the establishment of infection (Hagelskjacr
Kristensen and Prag, 2000).
Invasion
Most anaerobic pathogens are not primarily invasive. Initiation of
infection depends on initial damage due to trauma, hypoxia, neoplasia
or some other alteration to provide the route of entry for the anaer¬
obes. Fusobacterium necrophorum is an exception to this rule, as
although it may be present as part of the normal microbiota, in some
patients it penetrates the mucosa. The reasons for this are unknown
but may relate to underlying bacterial or viral pharyngitis leading to a
reduction in the host defence at the mucosal surface (Hagelskjaer
Kristensen and Prag, 2000).




Fusobacterium nucleatum subsp. vincentii




Strain Genome size (Mb) Reference
NCTC 9343 5.21 Cerdeno-Tarraga et al. (2005)
638R 5.44 In progress, The Wellcome Trust Sanger Institute http://
www.sanger.ac.uk_NCBl Accession No. NC_003228
YCH46 5.27 Kuwahara et al. (2004)
VPI-5482 6.2 Xu etal. (2003)
ATCC 49256 2.12 Kapatral et al. (2003)
ATCC 25586 2.17 Kapatral et al. (2002)
W83 2.34 Nelson etal. (2003)
17 3.33 In progress, The Institute for Genomic Research http://
www.//gr.org_NCBI Accession No. NC_003441
ATCC 43037 Unfinished In progress, The Institute for Genomic Research http://
www.tigr.org_NCBI Accession No. NC_003915
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Establishing Infection
Once the initial damage has allowed the anaerobes to penetrate the
tissues, they must establish a focus of infection by multiplying and
avoiding elimination by the host's defence mechanisms. Most anaer¬
obic infections are polymicrobial, and the metabolic interdependency
of the bacterial mixtures involved (both anaerobic and facultative
species) is important to their establishment in the tissues, the satisfac¬
tion of their nutritional requirements and the expression of their
synergic pathogenicity (e.g. Rotstein, Kao and Houston, 1989); thus,
the virulence of anaerobic species is a reflection of their ability to
exploit a compromised host environment. Tissue damage and
necrosis, a reduction in blood supply leading to hypoxia and the pres¬
ence of a blood clot or foreign body or substance (especially CaCl^
create conditions appropriate for anaerobic growth. The capacity of
facultative species such as E. coli to consume oxygen may help create
reduced conditions favourable to the growth of anaerobes. Bacter¬
oides fragilis has a cluster of genes, the aerotolerance operon, whose
products aid its survival on exposure to oxygen. A similar cluster had
been identified in the P. gingivalis genome. In addition, B. fragilis can
grow in the presence of nanomolar concentrations of oxygen and this
is linked to the presence of a cytochrome bd oxidase (Baughn and
Malamy, 2004).
Gram-negative anaerobes require several growth factors and nutri¬
ents produced by damaged host tissues or by other bacteria acting in
synergy. For example, B. fragilis uses haemoglobin and haema-
globin-haptoglobin complexes as sources of iron and the porphyrin
component. It has an iron-repressible haem-binding outer membrane
protein involved in the uptake of this essential growth factor (Otto
etal., 1996). Porphyromonas gingivalis demetalates protohaem to
protophorphyrin, providing for its iron needs. Novel putative haemo-
lysin genes with sequence similarity have been identified in B. frag¬
ilis, Pr. melaninogenica, Pr. intermedia and P. gingivalis. Hydrolytic
enzymes and proteases produced by P. gingivalis (e.g. gingipains),
P. asaccharolytica, Pr. intermedia and Pr. denticola release nutrients
from growth factors for these species themselves and for other
members of the polymicrobial ecosystems. Some of the proteases of
P. gingivalis are subject to the post-translational addition of oligosac¬
charides within the catalytic domain (Gallagher etal., 2003). Bacter-
oides fragilis produces a serine-thiol-like protease that hydrolyses the
a-chain of fibrinogen (Chen etal., 1995). As soluble fibrinogen is
converted to insoluble fibrin as part of the normal blood-clot forma¬
tion and wound healing, this enzyme has the potential to slow clot
formation. It also produces heparinase and condroitin sulphatase,
which hydrolyse heparin and condroitin sulphate, allowing their use as
nutrients. The activities of these enzymes are likely to encompass tissue
destruction and, where cells and molecules of the immune system are
attacked, evasion of the immune response (see p. 536 Evasion of the host
defence line 16-34 and Tissue damage line 38-61).
Evasion of the Host Defence
The host response to anaerobic infection includes phagocytosis and
opsonisation and killing by serum immunoglobulin and complement.
The virulent species of Gram-negative anaerobe have various means
of avoiding and resisting these defence mechanisms. Bacteroides
fragilis and some black-pigmented, Gram-negative anaerobes produce
various extracellular polysaccharides that may form encapsulating
structures, not all which are visible by light microscopy (see p. 535
Surface Variation line 21-24). In B. fragilis some of these various
components have been implicated in adhesion (Patrick etal., 1988),
protection against phagocytosis, resistance to killing mediated by the
alternative complement pathway (Reid and Patrick, 1984) and the
induction of abscess formation (Tzianabos etal., 1993).
Bacteroides fragilis also inhibits macrophage migration and
impairs the phagocytosis of other species involved in the polymicro¬
bial infections. Succinic and other short-chain fatty acid metabolic
products have also been shown to inhibit chemotaxis, phagocytosis
and intracellular killing by phagocytic cells (Rotstein etal., 1989).
Porphyromonas gingivalis (Laine and von Winkelhoff, 1998) also
produces a capsule that protects against phagocytosis and intracellular
killing and generates metabolic products that compete with chemo-
tactic peptides, heat-labile opsonins and complement components to
block chemotactic receptors on polymorphs. Abscess-derived
neutrophils are reported to harbour viable bacteria and be less efficient
at killing B. fragilis than neutrophils derived from either peritoneal
aspirates or peripheral blood (Finlay-Jones etal., 1991). The potential
for excreted extracellular polysaccharide and extracellular outer
membrane vesicles to mop up opsonin, activate complement and
interact with phagocytes, thus diverting the host defence from the
bacterial cell, should not be overlooked. Proteases that degrade
cytokines, produced by for example P. gingivalis, may also interfere
with the immune response including phagocytic function.
Fusobacterium necrophorum isolated from animal infection secrete
a well-characterised leukotoxin with specific toxicity for cattle and
sheep neutrophils (Narayanan etal., 2002); however, it is not clear
whether isolates from human infections secrete similar molecules with
specificity for human neutrophils.
Several virulent anaerobic species generate products that inhibit or
destroy the humoral components of the host's defences. The black-
pigmented species produce proteolytic enzymes active against immu¬
noglobulins and complement and most anaerobic bacteria produce
soluble metabolites that are leukotoxic, inhibit chemotaxis and
damage mucosal cells.
Neuraminidases, which cleave sialic acid from oligosaccharides on
host cell glycoproteins and glycolipids, produced by B. fragilis could
play a key role in virulence (Godoy etal., 1993). There are more than
20 known naturally occurring sialic acids formed by various substitu¬
tions and additions to neuraminic acid (Schauer, 1985). There is
growing evidence that these sugar residues are involved in the biolog¬
ical activities of the host cells and molecules, in particular in relation
to immune system function.
Tissue Damage
Once infection is established, several virulence factors appear to act in
combination to produce damage that is manifest as tissue necrosis and
abscess formation. Some products of anaerobic metabolism are toxic
to mammalian cells: volatile fatty acids and sulphur compounds (e.g.
H2S and amines). Most pathogenic anaerobes also produce extra¬
cellular enzymes that hydrolyse tissue components and are thought to
play a significant role in pathogenesis (e.g. Rudek and Haque, 1976).
Bacteroides fragilis, P. gingivalis, P. asaccharolytica, Pr. intermedia,
Pr. melaninogenica and Pr. denticola produce hyaluronidase,
condroitin sulphatase, heparinase and a range of enzymes that hydro¬
lyse carbohydrates. All of these enzymes play dual roles, causing
tissue damage and providing nutrients for the infecting microbes.
Fusobacterium necrophorum produces membrane-damaging lipases
that may be related to haemolytic activity (Hagelskjaer Kristensen and
Prag, 2000).
Proteolytic activity is associated with the strongly proteolytic
Porphyromonas spp. and some Prevotella spp. Proteases, such as the
trypsin-like cysteine proteases (gingipains) of P. gingivalis (Curtis
etal. 2001), are thought to be important in the destruction of gingival
tissue and of the collagen bridges in the gingival crevice in peri¬
odontal disease. Proteases may also be important in the contribution
of P. asaccharolytica and 'B.' ureolyticus to tissue damage in ulcera¬
tive and gangrenous lesions such as genital and perineal ulcers, decu¬
bitus and varicose lesions and diabetic gangrene.
Systemic Inflammatory Response Syndrome
Systemic inflammatory response syndrome (SIRS) or 'sepsis' is the
most common cause of death in patients who are critically ill in
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non-coronary intensive care units. Endotoxin, containing lipopolysac-
charide (LPS), is one bacterial component that is known to play a
central role. In patients where there is no obvious bacterial septi¬
caemia, it is thought that the source of the endotoxin is the normal
intestinal microbiota. Bacteroides fragilis LPS is 5000-fold less toxic
in a mouse lethality model than enterobacterial LPS, but given the
high numbers of Bacteroides spp. in the intestinal tract, where entero-
bactcria may be outnumbered by up to 1000-1, even allowing for the
lower toxicity, it is likely that the numerical dominance of Bacter¬
oides LPS means that it plays some role in endotoxic shock and SIRS
(Delahooke, Barclay and Poxton, 1995a, b). LPS triggers inflamma¬
tory events via the Toll-like receptors (TLRs). LPS from E. coli and
Salmonella spp. interacts with TLR4, whereas LPS from P. gingivalis
interacts with TLR2, resulting in a less efficient production of
proinflammatory cytokines (Erridge, Bennett-Guerrero and Poxton,
2002; Netea era/., 2002). It is now known that the mutation in C3H/HeJ
mice that are hyporesponsive to enteric LPS but react with Bacter¬
oides spp. LPS (Delahooke, Barclay and Poxton, 1995b) is in the
TLR4 gene. The differences in the reactivity of the different LPS
molecules appear to relate to their chemical composition, the number,
length and composition of the fatty acid chains (or acyl groups)
altached to the diglucosamine backbone of the LPSs being different.
The lipid A of P. gingivalis is less conical in shape than that of E. coli.
In addition, enterobacterial lipid A diglucosamine is bisphosphor-
ylated whereas in B. fragilis it is monophosphorylated; the distal
glucosamine residue of the lipid A molecule is lacking in a phosphate
group. Also, the core polysaccharide sugar keto-deoxyoctonate (KDO)
is phosphorylated which renders it undetectable in the standard KDO
thiobarbituric acid assay (Beckmann etal., 1989; Fujiwara era/., 1990).
Whether or not the LPS of Bacteroides spp. possesses or is lacking
in an O-antigen similar to that found in the enterobacteria is subject to
controversy. In the literature, there are reports that extended repeating
O-antigen is absent in Bacteroides (Lindberg era/., 1990; Comstock
era/., 1999). The suggestion is that LPS is more like the lipo-oligosac-
charides of, for example, Nesseria meningitidis (Jennings etal., 1999)
or 'rough' type mutants of the cnterobacteria. Other publications,
however, quite clearly illustrate silver-stained LPS polyacrylamide
gel electrophoresis (PAGE) profiles with ladder patterns characteristic
of smooth LPS in B. fragilis (Poxton and Brown, 1986) and B. vulg-
atus (Delahooke, Barclay and Poxton, 1995a). The controversy over
the presence or absence of an 'O-antigen' component in Bacteroides
spp. can be explained by the use of different chemical extraction
procedures by different laboratories and the variation in the expres¬
sion of the polysaccharide biosynthesis operons. The in silico identity
of the genes within the polysaccharide biosynthesis operons, which
are controlled by invertible promoters (see p. 535 Surface Variation line
26-28), suggests that some of these are related to the O-antigens of
other bacteria (Cerdeno-Tarraga el al„ 2005). The LPS of P. gingivalis
appears to play a significant role in the pathogenesis of periodontal
disease, in which (like the LPS of B. fragilis) it reduces the opsonic
activity of serum, stimulates gingival inflammation, increases the
secretion of collagenase from host cells and reduces collagen formation,
and induces localised bone resorption around the tooth root. These
effects are attributable to the release of biologically active agents,
including the cytokines interleukin-1 and tumour necrosis factor from
host cells.
Fusobacterium necrophorum is an exception, as its LPS contains
classical KDO and displays endotoxic activity similar to that of
enterobacterial LPS, particularly during the septicaemic phase of
human necrobacillosis.
Enterotoxin
Enterotoxigenic B. fragilis were first described as a cause of acute
watery diarrhoeal disease in animals and subsequently humans, in
particular children (Myers etal., 1987). The enterotoxin is a zinc-
dependent metalloprotease of approximately 20kDa. The possible
relationship of the enterotoxin to the virulence of B. fragilis in other
types of infection remains to be proven as only between 9 and 26% of
isolates harbour the gene encoding the toxin (Patrick, 2002).
CLINICAL FEATURES OF ANAEROBIC INFECTIONS
Infections with Gram-negative anaerobes are principally endogenous
in source and related to the body sites where these microbes are part of
the normal microbiota. Several features are typical of most anaerobic
infections: they are necrotising or gangrenous conditions in tissues
rendered susceptible by trauma, reduced blood supply and poor
oxygenation, often in the presence of a foreign body or blood clot, and
producing copious amounts of foul-smelling pus; thrombophlebitis of
surrounding blood vessels is common, enhancing the anaerobic condi¬
tions. The characteristic smell of anaerobic infections is caused by the
volatile end products of anaerobic metabolism. Infections are rarely
'pure', i.e. monobacterial. Anaerobic species are usually present in
association with other anaerobic or facultative species in synergic
mixtures (see p. 534 pathogenicity line 17-19), but the anaerobes
appear to be the principal causes of tissue damage and abscess
formation in these mixed infections. From a clinical perspective,
infections may be divided into five broad groups: 1. those derived
from the gastrointestinal tract, 2. genito-urinary infections in men
and women, 3. infections of the head and neck related to the oral
microbiota, 4. infections of other soft tissues, and 5. bacteraemia
(Finegold and George, 1989; Duerden, 1990).
Gut-Associated Infections
Bacteroides spp. represent a large proportion of the normal microbiota
of the lower intestinal tract and are the main cause of serious sepsis
associated with surgery, injury, perforation or other underlying abnor¬
mality of the large intestine. Bacteroides spp. are the main compon¬
ents of the microbiota of post-operative abdominal wound infections,
peritonitis and intra-abdominal abscesses (appendix, diverticular or
paracolic, pelvic, sub-phrenic etc.). Bacteroides fragilis is the most
common species isolated from these infections, representing about
75% of the Bacteroides isolates in contrast with between 4 and 13% of
Bacteroides isolates from the faecal microbiota. Thus, B. fragilis
clearly appears to have particular pathogenic potential and a much
greater capacity to cause infection than the other Bacteroides spp., as
described in the pathogenicity. Amongst the remaining 25% of
isolates, B. thetaiotaomicron is the most common, with smaller
numbers of B. distasonis and B. vulgatus (Patrick, 2002). The species
other than B. fragilis are usually found in mixtures of multiple anaerobic
species, often representing gross faecal soiling of the tissues. Bilophila
wadsworthia is associated with gangrenous appendicitis and other
intra-abdominal sepsis.
Gram-negative anaerobes are predominant components of the
mixed microbiota of peri-anal, pilonidal and perineal abscesses
(Duerden, 1991). Bacteroides fragilis is again the most common
species isolated, but P. asaccharolytica and 'B.' ureolyticus appear
more frequently in these infections than in abdominal infections, as
they do in other superficial soft-tissue infections such as sebaceous
abscesses and decubitus or diabetic ulcers (Duerden, Bennett and
Faulkner, 1982) (see p. 539 Superficial soft-tissue infections).
Liver abscesses form a specific clinical group of intra-abdominal
abscesses. They are generally polymicrobial and anaerobes, particularly
Bacteroides spp. and anaerobic cocci often predominate. The route of
infection is usually via the portal venous system, and the common
underlying causes are colorectal malignancy, ulcerative colitis,
Crohn's disease and other intra-peritoneal abscesses. The most
common species isolated is, again, B. fragilis, and Bacteroides bacter-
aemia is a well-recognised complication. Anaerobes are responsible
for only a minority of biliary tract infections, being restricted mainly
to obstructive empyema of the gall bladder.
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Commonly associated facultative bacteria include E. coli and
Streptococcus spp., in particular Strep, milleri, which forms pinpoint
colonics and with a characteristic smell.
Gcnito-Urinary Infections
Gram-negative anaerobes are significant pathogens in a wide range of
infections of the genito-urinary tract in both men and women (Duerden,
1991). In men, the infections are principally ulcers and abscesses of
the external genitalia and perineum, but in women there are also
infections of the vagina and of the uterus and deep pelvic tissues.
In local abscesses associated with the secretory glands in women,
e.g. Bartholin's and Skein's abscesses, obstruction of the ducts leads
to a build up of secretions and infection with a mixed bacterial micro-
biota, predominantly anaerobic, that is similar to the microbiota of
sebaceous cysts and pilonidal abscesses; P. asaccharolytica is a
common and important isolate. Anaerobes are also frequent isolates
from genital ulcers, a common problem in both men and women. They
are probably not primary causes (genital herpes or trauma are
common primary diagnoses) but whatever the cause of the initial
damage, anaerobes form a major part of the microbiota of established
ulcers and contribute to the progressive tissue damage. The term
genital ulceration covers a range of superficial necrotising conditions,
from erosive balanitis/balanoposthitis in men and superficial labial
ulceration in women, through deep, spreading ulcers, typically with
undermined edges, to the more severe forms of synergic gangrene.
In all groups, regardless of initiating factors, anaerobic bacteria are
the predominant cultivable bacteria once the superficial debris is
removed. Gram-negative anaerobes are not normally present on the
external genitalia but are the most common isolates from infected ulcers.
Although Bcicteroicies spp. may be present in some cases, the most
common apparently significant isolates are the asaccharolytic and
strongly proteolytic P. asaccharolytica and 'B.' ureolyticus which
have a particular association with superficial necrotising and ulcera¬
tive lesions at various body sites. Prevotella spp., principally
Pr. intermedia (which appears to be the most virulent of the Prevotella
spp.), are also common isolates - being less common than P. asaccha¬
rolytica in men but about equally common in women, in whom Prevo¬
tella spp. are part of the normal vaginal microbiota (Masfari,
Kinghorn and Duerden, 1983; Masfari, Duerden and Kinghom, 1986).
Vaginal discharge is a common complaint of women attending
Genito-urinary Medicine clinics and anaerobes are involved in many
cases (Duerden, 1991). The most common condition is bacterial (anaer¬
obic) vaginosis in which a disturbance of the normal vaginal micro¬
biota with the loss of predominant lactobacilli and their replacement
by increased numbers of Gram-negative anaerobes results in a discharge
with an offensive, fishy smell. With the proliferation of Prevotella
spp.. Gurdncrella vaginalis and Mobiluncus spp., the vaginal pH
rises, the lactate concentration falls and the amounts of succinate,
acetate, propionate and butyrate increase, together with volatile
amines that cause the smell. These same metabolites may induce the
excessive secretion from the vaginal mucosa, but the factors that
initiate the condition, other than its clear association with sexual activity
and a relationship with the presence of seminal fluid in the vagina, are
still not clear. The other main causes of vaginal discharge - gonorrhoea,
chlamydia and trichomonas infection - also cause a major disturbance
of the normal microbiota with significant increases in the numbers of
Grum-ncgative anaerobes (Masfari, Duerden and Kinghorn, 1986).
Ascending infections of the uterus and pelvis with vaginal anaerobes
(mainly Prevotella spp.) or with B. fragilis or P. asaccharolytica are
the cause of serious gynaecological sepsis. Some of these infections
arc the classical infective complications of pregnancy, parturition or
aboition such as post-partum or post-abortal uterine infections in
which retained products of conception provide ideal conditions for
anaerobes to proliferate. With the control of streptococcal puerperal
infection, anaerobes have become the most common cause of post-partum
sepsis. The same microbes also contribute to deep pelvic infections
unrelated to pregnancy - endometritis, parametritis, tubo-ovarian and
pelvic abscesses, generally grouped together as pelvic inflammatory
disease - and wound infections and abscesses complicating gynaeco¬
logical surgery. Laboratory confirmation of the cause of'pelvic sepsis
is difficult without surgical exploration; laparoscopy does not provide
adequate samples for bacteriological culture but evidence from cases
that have required open surgery supports the role of anaerobes in these
infections (Kinghorn, Duerden and Hafiz, 1986). In gynaecological
surgery, the underlying pathology has often resulted in colonisation of
the usually sterile deep sites and the incidence of wound infection,
before antibiotic prophylaxis was routine, was about 20% and most
were anaerobic, with both the vaginal Prevotella spp. and B. fragilis
being common isolates.
Fusobacterium nucleatum, along with Mobiluncus curtisii, has
been recovered from the amniotic fluid of women with preterm
delivery (Citron, 2002).
Infections with Oral Anaerobes
The Gram-negative anaerobes that are part of the normal microbiota
of the gingival crevice cause suppurative infections of the gingiva and
immediate surrounding tissues related to dental problems but can also
cause various abscesses and soft-tissue infections throughout the
head, neck and chest (Hardie, 1991).
Gingivitis and periodontal disease are probably the most common
anaerobic infections, if not the most common of all infections world¬
wide, and are the most important cause of tooth loss. Acute ulcerative
gingivitis (also known as Vincent's angina, Plaut-Vincent's infection
or trench mouth) was one of the first anaerobic infections of man to be
recognised. It is associated with poor oral hygiene, malnutrition and
general debility and is now seen as a complication of AIDS. Clini¬
cally, there is pain, haemorrhage, inflammation and destruction of
gum tissue and a foul odour. Spirochaetes and fusiform organisms are
seen readily in stained films of the exudate and they may play a role in
the disease, but the oral Gram-negative anaerobes, principally Prevo¬
tella and Porphyromonas spp., are also present in large numbers and
may be more important in the pathogenesis of the condition. In other
forms of periodontal disease, P. gingivalis and Pr. intermedia have
been implicated as significant pathogens in rapidly progressive
disease. Fusobacterium nucleatum and non-pigmented Prevotella spp.
are also present in large numbers in periodontal disease and may have
a pathogenic role (Tanner and Stillnian, 1993).
The oral anaerobes are also important in dental abscesses, root canal
infections (a particular association of P. endodontalis) and soft-tissue
abscesses, e.g. buccal and pharyngeal abscesses. In the normal healthy
state, these anaerobes do not colonise other sites in the head and neck
and do not cause acute primary infections of the throat, middle ear,
mastoid or sinuses. However, when pre-existing damage or prolonged
infection leads to the development of chronic otitis media, mastoiditis
or sinusitis, these compromised air passages become infected with a
mixture of oral streptococci and anaerobes such as Prevotella spp.
These anaerobes are also the most common cause of brain abscess,
especially those originating from chronic otitis media, mastoiditis or
sinusitis; cholesteatoma is an important predisposing factor. Infection
spreads by direct extension, often with localised osteomyelitis and
thrombosis of the lateral sinus. Dental infection may also give rise to
brain abscess either by direct extension or by haematogenous spread
(Ingham and Sisson, 1991). Similarly, the oral anaerobes can cause
lung abscesses as a result of aspiration of organisms from the mouth
when there is already some abnonnality such as obstruction due to a
malignant tumour or an inhaled foreign body (Civen etal., 1995).
Fusobacterium necrophorum subsp. necrophorum (previously
F. necrophorum Biovar A) differs from almost all other Gram-negative
anaerobes in being a primary pathogen capable of causing disease in
previously healthy people, although there may be synergic involve¬
ment of other viruses or bacteria that cause pharyngitis in the initial
invasion of the mucosa (Hagelskjaer Kristensen and Prag, 2000).
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Epstein-Barr virus infection (infectious mononucleosis) may be a
predisposing factor.
Classically, the infection (necrobacillosis or Lemmiere's syndrome)
begins as a suppurative tonsillitis with pus formation and a pseu-
domembrane, which spreads to involve the local lymph nodes in the
neck and from there to invade the bloodstream causing septicaemia
and disseminating the organisms widely in the tissues to form multiple
soft-tissue abscesses at many sites in the body (liver, lung, kidney
etc.). It may also occur in children with otitis media, adults with tooth
infections and spread from other foci such as sinusitis or mastoiditis in
all ages. Fusobacterium necrophorum may also cause necrobacillosis
arising from sites other than the head and neck in elderly patients with
other predisposing disease. In patients with anaerobic sepsis arising
from the oropharynx, F. necrophorum should immediately be consid¬
ered as a potential cause, as it is the most frequently isolated species.
The classical symptoms of Lemmiere's syndrome are oropharyngeal
pain, neck swelling, pulmonary symptoms, arthralgia and fever. It
should be considered in patients with severe sepsis and pulmonary
symptoms after acute pharyngotonsillar infection. Unilateral suppurative
thrombophlebitis of the internal jugular vein is characteristic and can
be diagnosed by ultrasonography, axial CT scan or magnetic resonance
angiography of the neck. Multiple bilateral necrotic infiltration of the
lungs with pleural effusion, empyema and/or pulmonary abscesses is
reported in up to 85% of cases (Hagelskjacr Kristensen and Prag, 2000).
Lemmiere's syndrome was first described in the pre-antibiotic era.
It became very uncommon during the second half of the 20th century,
possibly due to widespread and indiscriminate use of antibiotics for
upper respiratory tract infections, but increasing numbers of cases have
been reported in the United Kingdom during the past decade (Brazier
etal., 2002) and also recently in the United States (Ramirez etal., 2003).
Bone and Joint Infection
Anaerobic bacteria, often along with facultative species, may be asso¬
ciated with both osteomyelitis and septic arthritis. Bacteroides fragilis
was the predominant anaerobic isolate from osteomyelitis in a 10-year
study. In addition, Prevotella, Porphyromonas, Fusobacterium and
other Bacteroides spp. were isolated. Bacteroides fragilis was associ¬
ated most frequently with infections of the hands and feet where there
was underlying vascular disease or neuropathy, whereas Prevotella,
Porphyromonas and Fusobacterium were more frequently recovered
from skull and bite infections (Brook and Frazier, 1993). Gram-nega¬
tive non-sporing anaerobes arc rarely isolated from prosthetic joint-
associated infection, where Propionibacterium acnes is the most
frequently isolated anaerobe (Tunney etal., 1998). Bacteroides fragilis
and Fusobacterium spp., however, may cause septic arthritis. In
approximately 50% of instances this arises from haematogenous
spread from a distant focus of infection.
Superficial Soft-Tissue Infections
As well as infections related to the normal carriage sites of Gram-
negative anaerobes, another group of soft-tissue infections occurs at
sites not immediately adjacent to the mucosae but in tissue damaged
by trauma or hypoxia, or where secretory glands become blocked.
These infections include sebaceous and pilonidal abscesses, breast
abscesses in non-lactating women and infection secondary to inad¬
equate perfusion and oxygenation of the skin and subcutaneous tissues
- decubitus and varicose ulcers, diabetic gangrene etc. (Adriaans,
Drasar and Duerden, 1991). Although a wide range of anaerobes and
facultative species can be isolated from these lesions, there is a
particular association between progressively destructive infections
and the presence of P. asaccharolytica and/or 'B.' ureolyticus
(Duerden, Bennett and Faulkner, 1982). There is a specific association
of F. ulcerans with tropical ulcers - deep eroding ulcers, usually of
the lower limb, occurring across many tropical regions (Adriaans Hay
and Drasar, 1987; Adriaans etal., 1987). Since the initial description
of this bacterium, further isolates have not been reported. This may
have arisen from a phenotypic similarity to F. varium (a gastrointestinal
species). Many commercial identification kits lack a test for nitrate
reduction, a distinguishing feature of F. ulcerans. Therefore, an
incorrect identification of F. varium is generated by the kit database
(Citron, 2002).
Bacteraemia
Primary bacteraemia with Gram-negative anaerobes is extremely rare.
It is an integral part of necrobacillosis in which F. necrophorum
invades the bloodstream as part of the spread of infection from the
primary site in the throat (see p. 538 Infections with oral anaerobes line
3-5). In most other cases, the bacteraemia is secondary to localised
infections at some site in the body, e.g. intra-abdominal abscess and
pelvic sepsis, may be the first indication of some serious underlying
condition such as a brain abscess (Goldstein, 1996). Bacteraemia with
a Bacteroides spp. may be the first indication of a malignant tumour
of the colon, rectum or cervix. The most common anaerobic species
isolated from blood cultures is B. fragilis. Mortality and morbidity of
Bacteroides bacteraemia depends generally upon the underlying cause.
A matched-pair study in the United States reported a potential mortality
of up to 19% for B. fragilis group bacteraemia (Redondo etal., 1995).
LABORATORY DIAGNOSES
The site and nature of the infection (e.g. an abdominal abscess or a
necrotising or gangrenous ulcer) may give a clear indication that
anaerobes are likely to be involved, and the presence of a foul-
smelling exudate or pus is the strongest clinical indication of an anaer¬
obic infection. The diagnosis is confirmed by careful anaerobic
culture methods and the identification of the isolates obtained.
Because these infections are often associated with sites that have a
complex normal bacterial microbiota (often including the organisms
that may be the putative pathogens), and because anaerobes are, by
their nature, more or less susceptible to exposure to oxygen, care is
needed in specimen collection and transport to try to ensure that the
organisms sought do not die in transit to the laboratory and that any
cultures obtained represent the microbiota at the infected site and not
contamination from the normal mucosal microbiota (Drasar and
Duerden, 1991; Summanen etal., 1993). Information on all aspects of
laboratory diagnosis of anaerobic bacteria and detailed identification
protocols can be found in the Wadsworth-KTL Anaerobic Bacterio¬
logy Manual (Jousimies-Somer etal., 2002).
Specimen
The most reliable specimens are pus or exudates from the depths of an
open lesion or a closed lesion. Specimens such as sputum collected
from sites with a normal mucosal microbiota are not suitable for
anaerobic culture. Swabs used traditionally to sample wounds and
exudates are not ideal for anaerobes that suffer from desiccation and
exposure to oxygen, as well as being entrapped in the interstices of the
swab. Whenever possible, pus should be aspirated into a sterile
container and delivered promptly to the laboratory (Finegold, 1995).
Transport
Direct plating of a sample at the patient's bedside and immediate
anaerobic incubation are likely to give the best results, but this is an
unattainable ideal in most clinical situations. If pus, or a piece of
necrotic tissue obtained by biopsy, is the specimen, it should be
transported to the laboratory without delay in a sterile container.
Sealed containers with an oxygen-free atmosphere, or from which
oxygen can be removed by a simple chemical reaction, are available
for optimal transport of such specimens. Pus is generally regarded as
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its own best transport medium. If there is no alternative to the use of
swabs, these should be placed in semi-solid anaerobic transport
medium to prevent both desiccation and the toxic effects of oxygen.
Laboratory Examination
Direct microscopy of pus samples may be helpful in some cases; most
of the Gram-negative anaerobes are small, pleomorphic organisms
that are difficult to see in direct smears. The most useful immediate
examination is direct GLC to detect the presence of the volatile fatty
acid products of anaerobic metabolism (Jousimies-Somer etal.,
2002). This will not, generally, give any indication of the specific
identity of the anaerobes present, but the demonstration of a mixture
of short-chain fatty acids confirms the presence of anaerobic bacteria.
Isolation of Gram-negative anaerobes is by anaerobic culture on
selective and non-selective media. Anaerobic culture conditions can
be provided in sealed anaerobic chambers equipped with air locks and
functioning as anaerobic incubators as well as workstations, or in
anaerobic jars. The anaerobic atmosphere generally used in cabinets is
N2 80%, H2 10% and C02 10%, as the growth of many anaerobes is
stimulated by C02. The same gas mixture can be used in jars operated
by an evacuation and refill system and equipped with room-tempera-
uirc-active catalysts (e.g. palladium) to remove any remaining
oxygen. Alternatively, jars can be used with sachets that generate H2
and C02 when water is added and depend upon the H2 to remove all
the oxygen from the jar with the help of the catalyst. There are many
variations on the basic anaerobic jar methodology but all must be
carefully controlled to ensure that as much as possible of the 02 is
removed and that air cannot leak back into the system.
Many anaerobes grow more slowly than most common aerobic
pathogens, and anaerobic cultures must be incubated for at least 48 h
without exposure to oxygen and for an overall minimum of 72-96 h;
however, some of the more virulent anaerobes (e.g. Clostridium
perfringens and B.fragilis) produce acceptable growth in 24 h, and
most laboratories would not wish to delay the diagnosis by 24 h. If
the use of duplicate sets of plates where anaerobic jars are in use
(one for examination after 24 h and the other to remain undisturbed
for 72-96 h) is considered too extravagant of resources, a useful
compromise is for the one set of plates to be examined quickly after
24 h and then re-incubated after as little exposure to air as possible for
another undisturbed 48-72 h. This difficulty is overcome by the use of
anaerobic cabinets in which the initial examination can be done
without removing the plates from the anaerobic atmosphere.
Various media have been recommended for the optimal growth of
Gram-negative anaerobes. All comprise a rich nutrient base with
added blood. Bacteroides fragilis grows well on most formulations of
blood agar, but better growth of a wider range of more fastidious
species needs more specially enriched media. Most species grow more
quickly and produce larger colonies on media such as Fastidious
Anaerobe Agar, Brucella agar or BM medium with ingredients such
as proteose peptone, trypticase and yeast extract. Menadione and
haemin enhance the growth of some species, especially of Prevotella\
other demanding strains such as 'B.' ureolyticus require formate and
fumarate for good growth and Bil. wadsworthia has an absolute
requirement for pyruvate. The use of lysed blood assists in the early
recognition of pigment production.
As anaerobic bacteria are generally present in mixed infections,
their isolation is aided by the use of selective media containing anti¬
biotics inactive against anaerobes. Aminoglycosides have been widely
used for many years. The neomycin blood agar developed for the
selective isolation of Clostridia is too inhibitory for many Gram-negative
anaerobes, and kanamycin (75 mg/1) gives better results. An alter¬
native that may be preferred is the use of nalidixic acid (10 mg/1). When
it is desirable to eliminate Gram-positive bacteria, the addition of
vancomycin (2.5 mg/1) provides a medium highly selective for Bacter¬
oides spp. Selective media should never be used without parallel
non-selective cultures and growth on the selective media generally
requires extended incubation.
Identification ofGram-Negative Anaerobes
Detailed identification to species level of all isolates of Gram-negative
anaerobes is beyond the scope of most diagnostic laboratories and
would require excessive commitment of resources. They are signi¬
ficant pathogens, however, and certain species either show greater
virulence than most of their group (e.g. B. fragilis) or are associated
with particular types of infections (e.g. F. necrophorum, P. gingivalis
and P. asaccharolytica). It is important that primary diagnostic labo¬
ratories can at least determine the presence of the main pathogens and
identify other significant isolates at least to genus level, for more
detailed study in a reference or research laboratory when appropriate.
Preliminary allocation of isolates to the main genera can be made
by a relatively simple set of tests based upon colonial and microscopic
morphology, growth in the presence of bile (20% in broth or agar
medium) or sodium taurocholate (disc tolerance test), disc resistance
tests with antibiotics (neomycin 1 mg, kanamycin 1 mg, penicillin 1 or
2 units, rifampicin 15p.g, colistin lOpg and vancomycin 5|lg) catalase
and urease production (Table 45.4), supported by GLC if available.
More detailed identification depends upon sets of biochemical tests
with carbohydrate and other substrates and detection of particular
enzyme activities. Some of these can be performed with commercial
kits (especially the enzymes tests), and these can be useful for the
identification of the more common species isolated from clinical spec¬
imens. However, most of these systems suffer from the attempt by
most manufacturers to produce a single kit for the whole range of
anaerobes - Gram-positive and Gram-negative, cocci and bacilli.
Tables 45.5-45.9 summarize the sets of tests that enable the identifi¬
cation of most clinically significant Gram-negative anaerobes. The
Table 45.5 Preliminary identification of Gram-negative anaerobic bacteria of clinical importance
Bacteroides Bilophila Prevotella Porphyromonas Fusobacterium Leptotrichia 'B.' ureolyticus
Growth in bile (20%) + + _ +/- +/- _
Tolerance of taurocholate + + - - +/- +/- -
Antibiotic disk resistance tests
Neomycin (1 mg) R S S S S S S
Kanamycin (1 mg) R S R R S S S
Penicillin (1-2 units) R R S/R S/R S S s
Rifampicin (15 pg) S S S S RIS S R
Colislin (10 pg) R S S/R R S R s
Vancomycin (5 pg) R R R S R S R
Urease - + - - - - +
GLC Ac, Su Ac, Su Ac, Su rt-Bu n-Bu Pro, Lac Ac, Pro
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Table 45.8 Identification of pigmented human strains of P. spp.







media and methods for performing these tests are varied, and details
may be found in manuals or monographs devoted specifically to
anaerobic microbiology - the Wadsworth Anaerobic Bacteriology
Manual sixth edition (Jouseimies-Somer etal., 2002), the Virginia
Polytechnic Institute Anaerobe Laboratory Manual (Moore and
Moore, 1977) or Anaerobes in Human Disease (Wren, 1991). Baron
and Citron (1997) provide an outline of a cost-effective protocol.
Non-Culture Detection Methods
The ability to identify reliably obligately anaerobic bacteria directly in
clinical samples without the need for culture is particularly attractive.
Despite the best efforts of clinical bacteriologists to ensure the handling and
transit of samples under anaerobic conditions, a high proportion of infec¬
tions may be missed as a result of loss of viability (Patrick etal., 1995).
Techniques have been developed in some research laboratories for
the direct detection of specific pathogenic anaerobes (B. fragilis,
P. asaccharolytica, P. gingivalis, Pr. intermedia and Bil. wadsworthia)
by DNA probes and by polymerase chain reaction (PCR) technology,
but as yet, there are no non-culture detection methods for anaerobes in
general use in clinical diagnostic laboratories. PCR finger printing
identification (e.g. amplified ribosomal DNA restriction analysis) of
pure culture isolates has resulted in good identification and differenti¬
ation of Bacteroides, Prevotella and Porphyromonas spp. of the fragilis
group, as has a multiplex PCR assay based on 16S rRNA, the 16S-23S
rRNA intergenic spacer region and part of the 23S rRNA gene (Liu
etal., 2003). PCR-based assays for the detection of enterotoxigenic
B. fragilis have also proved reliable. Microarrays enabling the simul¬
taneous detection of multiple genes and therefore multiple bacterial
species have been applied to studies of the faecal microbiota. Fluores¬
cence in situ hybridisation of 16S rRNA is possible with pure cultures
of B. fragilis; however, such techniques must be approached with
caution if they are to be applied directly to clinical samples, as the
penetration of the probe into the bacterial cell is dependent on the
nature of encapsulating surface structures.
It is likely, however, that accurate and specific multiplex and
quantitative (real-time) PCR diagnostic tests or microarray-based
technologies will ultimately become part of routine diagnosis once
inherent problems of sensitivity in clinical specimens and potential for
contamination from exogenous DNA are resolved.
Antibiotic Susceptibility of Gram-Negative Anaerobes
Approaches to susceptibility testing of Gram-negative anaerobes have
been debated amongst microbiologists and infectious disease physicians
for many years. A major consideration is whether susceptibility
testing should be, as for most aerobes, concentrated in the primary
laboratories doing individual susceptibility tests on clinical isolates
from their patients or whether strains should be collected for batch
testing in recognised specialist centres while individual clinical treat¬
ment is based upon accumulated data generated by that batch testing.
For aerobes, laboratories test their significant isolates and clinicians
expect prompt susceptibility data on their own patients' organisms.
This has not been the case with anaerobes because of three perceptions: 1.
anaerobic investigations are slower - initial culture may take several
days and susceptibility tests at least 2 days more, so that individual results
are irrelevant to patient management; 2. methods for susceptibility
testing of anaerobes are unreliable, especially when performed on an
individual basis, and batch testing in specialist centre gives more reli¬
able results; and 3. the susceptibility of anaerobes is predictable so that
clinical treatment can be based upon the batch data with confidence.
These premises were the basis for susceptibility testing of anaerobes
having been neglected in primary laboratories and concentrated in
specialist centres that receive clinical isolates from a wide range of
sources. However, there is an increasing view from clinicians and
microbiologists that the same standard of laboratory data is required in
anaerobic infections as in aerobic infections. Testing of individual
isolates is supported by four changed perceptions: 1. antibiotic
susceptibility in anaerobes is variable and patterns differ in different
places and at different times; 2. modern laboratory methodology
should enable the prompt isolation of the more common anaerobic
pathogens; 3. methods for susceptibility testing of anaerobes are
available that can be used in primary laboratories; and 4. the most
important reason, patients managed with access to accurate and
specific laboratory data on their own anaerobic isolates recover more
rapidly with fewer complications.
Both approaches are necessary. Primary laboratories need to
develop adequate susceptibility tests on anaerobes for first-choice
agents while reference laboratories should enhance their activities in
collecting strains from a wide range of sources and batch testing to
provide the best general advice for clinicians in choosing empirical
therapy and devising antibiotic policies.
Methods
The selection of methods for susceptibility testing of anaerobes has
been a major difficulty. The two basic methodologies for rapidly
growing, relatively non-fastidious aerobes - disc susceptibility tests
on solid media and breakpoint determination in liquid or solid media-
are not readily adaptable to anaerobic work, are difficult to stand¬
ardise and do not give reliably reproducible results with anaerobes.
Anaerobes tend to grow more slowly than many common aerobes, and
the balance between antimicrobial effect, bacterial growth and
antibiotic degradation varies much more, affecting disc susceptibility
methods in particular. Many anaerobes need more enriched media
than are used for susceptibility testing of aerobes; they are more diffi¬
cult to standardise, and there are interactions between media compon¬
ents and the antibiotics. The presence of fermentable nutrients
often results in a very significant drop in pH in the test medium which
can have a major impact of the results obtained with pH-sensitive
antibiotics. Similarly, many anaerobes require C02 for growth and all
Table 45.9 Identification of Fusobacterium spp.
F. nucleatum F. necrophorum F. pseudonecrophorum F. russi F. naviforme F. mortiferum F. varium F. gonidiafonnans F. ulcerans
Indole + + + — + — +/— + —
Lipase - + - — — — -/+ - -
Aesculin hydrolysis - -
Propionate from
lactate - + + _____
threonine + + + - -+ + + +
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standard anaerobic gas mixtures contain C02 which again lowers
the pH (Watt and Brown, 1985). Many anaerobes do not grow well
from small inocula, and semi-confluent growth is difficult to
achieve. A further practical difficulty arises because the MICs of
several agents for anaerobes cluster near the recommended break¬
points for the agents, so that minor variations in method and inev¬
itable margins of error in any technique can give variable results in
terms of clinical interpretation and recommendations. Therefore,
disc susceptibility tests for anaerobes have been regarded as unreli¬
able for other than the fast-growing anaerobes. Recommended
methods in the past have been based upon agar dilution with multi¬
point inoculation or broth micro-dilution or macro-dilution
methods. Some of these have not been entirely satisfactory and are
not appropriate for testing individual clinical isolates, hence the
methodology has exerted pressure in favour of batch testing in
reference laboratories. The E test (AB Biodisc, Denmark) provides
reliable susceptibility testing with MIC determination for indi¬
vidual isolates. A plastic strip coated with an antibiotic gradient on
one side and with an MIC interpretation scale on the other is placed
on a seeded plate as in disc susceptibility testing. After incubation,
the edge of the zone of inhibition reaches the scale at a point
equivalent to the MIC. This shares some of the disadvantages of
disc methods, but experience has shown it to be generally reliable for
a wide range of anaerobes (Wexler, 1993; Duerden, 1995; Jouseimies-
Somer etal., 2002).
It is likely that molecular detection methods for antibiotic resistance
genes will be incorporated into molecular identification protocols. A
PCR-restriction fragment length polymorphism analysis identification
method for Bacteroides spp. that incorporates rum gene detection has
proved to be rapid and accurate (Stubbs etal., 2000).
Antibiotic Susceptibility
The susceptibility of Gram-negative anaerobes varies considerably
both between and within the major genera. Metronidazole has been
the mainstay of therapy and prophylaxis for 20 years, and it is
re-assuring that resistance amongst Gram-negative anaerobes has
remained relatively low (Dubreuil, 1996; Snydman etal., 1996), so
that it remains the drug of choice for many of these infections. Its use
has, however, been extended to the treatment of peptic ulcer disease
with the recognition of the involvement of Helicobacter pylori
(Freeman etal., 1997). Whether this wider use of metronidazole is
leading to the development of increased resistance in Bacteroides of
the normal microbiota is not proven, but metronidazole resistance has
become more widely recognised in Bacteroides spp. in the last 5
years. Of the eight metronidazole resistance genes described
(nirnA-G), all but one (nimB) can be found on potentially mobile
genetic elements in Bacteroides spp. Within the United Kingdom,
referral of isolates to the Anaerobe Reference Laboratory has
shown the incidence of metronidazole resistance in Bacteroides
spp. increasing to around 7% since 1995 (Brazier, Stubbs and
Duerden, 1999).
A number of different types of mobile genetic elements, including
self-transmissible large conjugative transposons and plasmids as well
as niobilisable plasmids and transposons, have been identified in the
Gram-negative anaerobes (Sebald, 1994; Smith, Tribble and Bayley,
1998). There is evidence of horizontal transfer of antibiotic resistance
genes via these mobile elements and the potential transfer of these to
facultative species (Vedantam and Hecht, 2003). In the case of the
large conjugative transposons that carry a tetracycline resistance gene,
exposure to tetracycline, even at sub-inhibitory concentrations,
increases the frequency of conjugation (Patrick, 2002). The normal
microbiota may therefore represent a potential reservoir of transmis¬
sible antibiotic resistance genes.
Bacteroides spp. isolates of B.fragilis and other Bacteroides spp.
are resistant to benzylpenicillin and ampicillin/amoxicillin due to
the production of an amp-C type p-lactamase (Wang, Fast and
Benkovic, 1999); in almost all cases this resistance is overcome by
the use of a combination of ampicillin/amoxicillin with the P-lactamase
inhibitors clavulanate or tazobactam. Bacteroides spp. are also
resistant to many other p-lactam agents. Cefoxitin has been widely
used in the United States for anaerobic infections because it has
greater activity against Bacteroides spp. than most p-lactam agents,
but results of susceptibility tests are variable with up to 40% of
isolates giving MIC values around or above the recommended
breakpoint of 32 mg/1. Most isolates in the United Kingdom remain
susceptible to imipenem, but resistance due to the production of a
metallo-p-lactamase, not affected by clavulanate or tazobactam, and
encoded by the cfiA (ccrA) gene does occur and may become a more
significant problem in the future. With the inhibitors of protein
synthesis, many strains are resistant to erythromycin and tetracy¬
cline but most are susceptible to clindamycin. Like the Bacteroides
spp., Bil. wadsworthia produces a p-lactamase and is resistant to
most p-lactam agents.
Porphyromonas and Prevotella
Although the genera are generally more susceptible to antimicro¬
bial agents than the Bacteroides spp., results are still unpredict¬
able. In the past, they were considered to be generally penicillin
sensitive, but one-third or more of clinical isolates, especially of
Prevotella spp., are resistant due to p-lactamase production. Thus,
they are susceptible to amoxicillin/ampicillin and clavulanate
combinations. Most are susceptible to cefoxitin and highly suscep¬
tible to imipenem. They are generally susceptible to erythromycin
-* and clindamycin, but up to half of clinical isolates are resistant
to tetracycline and up to 15% are resistant to ciprofloxacin and
clindamycin.
Fusobacterium
Most Fusobacterium spp. isolates are highly susceptible to a wide
range of agents including penicillin and all the p-lactam agents, but
resistance mediated by P-lactamase production is increasing. Cefti-
zoxime, ciprofloxacin and erythromycin are poorly active and up to
30% of strains may be resistant to clindamycin and tetracycline (Fine-
gold and Jousimies-Somer, 1997).
MANAGEMENT OF ANAEROBIC INFECTIONS
Because of the multi-factorial nature of infection with Gram-negative
anaerobes (p. 537-539 Clinical features of anaerobic infections) - mixed
infections, tissue necrosis, inadequate blood supply/oxygenation, patient
already compromised by underlying disease - the management of these
infections requires a combination of approaches. Antibiotic treatment is
important but is rarely effective if used alone. The choice is generally
between metronidazole, a P-lactam agent such as amoxicillin-clavulanate
or imipenem, and clindamycin. The recognition of the presence of
aerobic or facultative organisms may also need to be addressed either by
adding an agent effective against, e.g. E. coli to the metronidazole, or by
choosing an agent effective against both (e.g. imipenem).
It is axiomatic in medical microbiology that antibiotics alone are
ineffective, as treatment for abscesses and many of the anaerobic
infections have a component of tissue necrosis and abscess formation.
Debridement of necrotic tissue and drainage of pus are essential to the
effective management of these infections. An interesting exception is
disseminated F. necrophorum infection with metastatic abscess
formation; this responds well to treatment with penicillin or other anti¬
biotics alone.
Many of the patients who develop anaerobic infections are seriously
ill, e.g. peritonitis following major abdominal surgery, and may be
developing sepsis syndrome due to the anaerobes or other components
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of the mixed infection. These patients clearly need intensive
supportive therapy for respiratory and circulatory functions.
PREVENTION AND CONTROL
As most infections with Gram-negative anaerobes are endogenous,
cross infection is not a significant problem with these patients,
although isolation may be appropriate because of the severity of the
infection and, on some occasions, because of the intense malodour
created by the anaerobes which can be embarrassing and distressing to
the patient and unpleasant and disturbing for others.
Prevention of these infections depends upon prophylactic measures
that can be taken to avoid creating the conditions that allow anaerobes
to become established. Most of these measures relate to surgical prac¬
tice in abdominal, gynaecological or oral-facial surgery - i.e. in areas
where anaerobes predominate in the normal microbiota. Prevention of
post-operative anaerobic infection in these situations depends upon
good surgical practice, reduction in the bacterial challenge and the use
of appropriate prophylactic antibiotics. Surgical skill goes a long way
towards preventing anaerobic infections by not leaving non-viable
tissue or foreign bodies at the operation site, ensuring adequate
perfusion and oxygenation of the tissues that are left, preventing
leakage from the viscus or the accumulation of fluid and closing off
any potential spaces where infection can develop. Thus, the 'soil' is
not conducive to anaerobic infection. The bacterial challenge can be
reduced in part by physical removal of the normal microbiota. This is
particularly important in the use of laxatives, enemas or even colonic
irrigation to reduce the volume of faeces in the colon before abdom¬
inal surgery. A further important prophylactic measure is the use of
prophylactic antibiotics per-operatively. These have made a major
impact in reducing the incidence of post-operative infection during the
last three decades. Since the advent of specific prophylaxis encom¬
passing anaerobic organisms, the incidence of post-operative infection
in abdominal and gynaecological surgery has fallen dramatically, e.g.
from 35 to 5-10% for major colonic surgery, 20 to <5% for appendi-
ccctomy, 25 to 5% for hysterectomy (Willis and Fiddian, 1983). The
aim of prophylaxis is to have high levels of appropriate antibiotics in
the tissues at the time of the operation to prevent any implanted organ¬
isms becoming established. Prophylaxis in this way is not designed to
destroy the bacteria in their normal habitat, e.g. in the gastrointestinal
lumen. The choice of agent must include effective anti-anaerobe
activity -- usually by including metronidazole or amoxicillin/clavu-
lanate - plus activity against other organisms likely to be present.
Thus, in abdominal surgery, an aminoglycoside (e.g. gentamicin) or a
cephalosporin (e.g. cefuroxime or cefotaxime) may be added to the
metronidazole. In some circumstances, amoxicillin/clavulanate may
fulfil both functions. For effective prophylaxis and to avoid disturbing
the normal microbiota or selecting resistant strains before surgery, the
antimicrobial agents should be given by intravenous injection at the
induction of anaesthesia. For most operations, a single dose at this
stage is sufficient to give good protection. In some regimens, a second
dose after 4 h or at the completion of the operation has been recom¬
mended in more complex and longer operations. In any case, the
whole period of prophylaxis should not exceed 24 h. If infection is
already present at operation and more prolonged use of antibiotics is
clinically necessary, this becomes a therapeutic course for established
infection and not a prophylactic measure (Willis, 1991; Keighley, 1992).
Mobiluncus
The genus Mobiluncus represents a group of slender, curved, rapidly
motile, Gram-variable anaerobic rods found in the vagina and asso¬
ciated with Gardnerella vaginalis and Prevotella spp. in bacterial
(anaerobic) vaginosis (Duerden, 1991). It is a member of the Actino-
mycetaceae and the phylum of high mol% G + C Gram-positive
bacteria, the Actinobacteria, and has a G + C content of 52-56 mol%.
Two morphologically distinct types of Mobiluncus are recognised and
represent two separate species (Tiveljung, Forsum and Monstein,
1996). Mobiluncus curtisii strains have short Gram-positive or Gram-
variable cells and are much more active in biochemical tests - they
hydrolyse arginine and hippurate, reduce nitrate and produce p-galac-
tosidase. Mobiluncus mulieris gives negative reactions in these tests
and has much longer cells that appear Gram negative. However, both
have a cell wall that is essentially of Gram-positive structure, but the
peptidoglycan layer is thin, probably resulting in the variable staining
pattern. Both species grow well anaerobically but will grow in 5% 02
and growth is enhanced by CO2. Although they may be present in
large numbers in vaginosis and were described in vaginal discharge by
Curtis in 1915, their role in disease is not clear. PCR detection indi¬
cates that, whereas M. curtisii is frequently associated with bacterial
vaginosis, M. mulieris may also be detected in apparently healthy
women (Schwebke and Lawing, 2001). Mobiluncus spp. are always
present along with other potential pathogens such as G. vaginalis and
B. fragilis in vaginosis and may have a synergic role (Spiegel, 1987).
Treatment with metronidazole removes the anaerobes from the
synergic mixture, and vaginosis usually responds well to short-course
treatment with agents active against anaerobes, such as metronidazole
to which Mobiluncus spp. are often resistant (Jones etal., 1985). In
addition, as there is a relationship with the deposition of semen in the
vagina, the use of a condom will prevent the development of vaginosis
(Duerden, 1991).
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INTRODUCTION
Bacteroidea ap.. in particular B. fragilis, are frequently isolated from
intra-abdominal infections, female genital tract infections and bacteremia,
(Lindberg et al, 19/9) and it haa been suggested that serum resistance is one
of the major factors contributing to the pathogenicity of this organism, (Casciato,
1979). Different species of Bacteroides vary in their susceptibility to the
bactericidal effect of human serum, after in vitro growth, (J.Reid, unpubl.).
For example, B. fragilis strains ATCC 23745 and NCTC 10564 are serum resistant
and B. ovatus strain ATCC 8483 is serum sensitive.
The presence of a polysaccharide capsule may be an important factor in the
virulence of B. fragilis. Indeed, purified capsular material from B. fragilis
ATCC 23745 was shown to induce the production of abscesses when implanted in the
peritoneum of Wistar rats, (Onderdonk et al., 1977). However, the relationship
of the polysaccharide capsule to serum resistance remains unclear. B. ovatus
strain ATCC 8483 produces a large capsule, but is serum sensitive.
The encapsulation of a number of Bacteroidea cultures was examined by Babb
and Cummins (1978). They noted a variation in the percentage of encapsulated cells
within an individual culture. Thi3 did not vary with the culture a^e, incubation
temperature, ph or the presence of several organic and inorganic nutrients.
Instability in trie production of capsules in B. thetalotamicron (a faecal isolate)
was noted by Burt et al. (1978). This isolate produced two unstable colonial
variants, capsuiate and non-capsulate. The cnange from capsulate to non-capsulate
occurred at a rate of 1*4 x 10 ^/cell /generation, at 37°C. Treatment with
plasmid curing agents did not affect this frequency. It is interesting to speculate
that this phenotypic shift may be similar to the flagellar phase variation found
in Salmonella sp. The inversion of a DNA sequence 995 base pairs long controls
the expression of two different flagellar antigens and occurs at a rate of between
10"5 and 10 ''/cell /generation, (Silverman et al., 1981).
The phenotype of a bacterium can also vary considerably with the growth
conditions. For example the surface antigens of E. coli varied with the limiting
nutrient when this organism was grown in continuous culture. It is therefore
likely that the full range of pathogenic determinants are only expressed when growth
occurs in vivo, (P. Taylor, unpubl.).
An investigationef the characteristics of in vivo grawn organisms is therefore
of prime importance in studies on the pathogenicity of Bacteroides sp.
Preliminary Experiments : Summary of Results
1. ENCAPSULATION
The presence of capsules was demonstrated hy both India Ink and Eosin/
Carbol Puchsin staining techniques (Cruickshank, 196)8). The capsule wa3 larger
when Bacteroides sp. were grown in a defined medium (van Tassel and Wilkins, 1978)
than when grown in the complex medium of Beacon et al. (1978)
Microscopic examination of Kosin/Carbol Fuchsin stained smears showed that
B. fragilis ATCC23745 produced approximately 20% encapsulated cells and B. fragilis
NCTC 10584 produced less than 1%. Lindberg et al (1979) noted that 77% of
E. fragilis strains isolated from clinical infections had more than 90% encapsulated
cells. However, the loss of surface antigens with continued laboratory sub-culture
is relatively common, and possibly occurs as a result of the removal of the
selective pressures of in vivo growth, (Costerton, 1974).
The two types of bacteria could be seperated by application of broth culture
to a Percoll step density gradient (20-60% in 20% steps) and centrifugation in
an MSE Superminor bench centrifuge at 4»000 r.p.m. for 20 minutes. The capsulate
bacteria remained at the 0 to 20% interface and tne non-capsulate banded at the
60 to 80% interface.
Sub-culture of the two ^ands resulted in the reversion of the non-capsuiate
to the initial percentage of encapsulation after 24 hours incubation in broth
culture. The encapsulated fraction only began to revert after 3 to 4 days of
daily sub-eulture. The degree of encapsulation was determined purely by
microscopic methods. No gross difference in the colony morphology was apparent.
Individual colonies contained mixed populations of capsulate and non-capsulate.
2. EXPERIMENTAL INFECTION
Chambers containing live organisms were implanted into the mouse peritoneum
according to the method of Day et al^ (1980).
Preliminary experiments, using' high inocula (10^ to 10^ colony forming units
(c.f.u.)/ml.) were carried out to determine the survival of B. fragilis ATCC 25745
wi.thin the cnambers.
Bacterial suspensions were incubated for 24 hours within the mouse peritoneum.
When the bacteria were suspended in \ strength Ringer's solution the number of
c.f.u./ml. dropped by 2 to 3 logs, however, numbers were maintained at a constant
level if cysteine HC1 (O05%) was added.
Future Aims
1. The use of the electron microscope to clearly define the capsule e.g. reaction
with anticapsular serum followed by polycationic ferritin labelling (Weiss et al..
1979)
2. The determination of growth/survival of different Bacteroides sp. in peritoneally
implanted chambers and the relationship of this to
i. in vitro serum sensitivity
ii. encapsulation.
3. The inclusion of phagocytes in the chambers, and an examination of the effect
of this on the survival of Bacteroides sp.
4. If in vivo growth occurs, a comparison with the characteristics, (e.g. morphology
serum resistance) of in vitro grown organisms.
5. An investigation of mixed inocula. E. coli is frequently present in the initial
stages of anaerobic infections. Therefore it would be of interest to examine the
eiiect of the presence of E. coli either
a. mixed with the Bacteroides in a chamber
or b. in a chamber adjacent to the Bftcteroides, separated by a membrane filter.
6. An investigation of the hosts immune response to the presence of Bacteroides in
the peritoneum.
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